PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Voog, J; D'Alterio, C; Jones, DL				Voog, Justin; D'Alterio, Cecilia; Jones, D. Leanne			Multipotent somatic stem cells contribute to the stem cell niche in the Drosophila testis	NATURE			English	Article							SELF-RENEWAL; SUPPORT CELLS; GERMLINE; SPERMATOGENESIS; PROLIFERATION; OVARY; MORPHOGENESIS; MELANOGASTER; PROTEIN; MARKER	Adult stem cells reside in specialized microenvironments, or niches, that have an important role in regulating stem cell behaviour(1). Therefore, tight control of niche number, size and function is necessary to ensure the proper balance between stem cells and progenitor cells available for tissue homeostasis and wound repair. The stem cell niche in the Drosophila male gonad is located at the tip of the testis where germline and somatic stem cells surround the apical hub, a cluster of approximately 10 - 15 somatic cells that is required for stem cell self- renewal and maintenance(2-4). Here we show that somatic stem cells in the Drosophila testis contribute to both the apical hub and the somatic cyst cell lineage. The Drosophila orthologue of epithelial cadherin ( DE- cadherin) is required for somatic stem cell maintenance and, consequently, the apical hub. Furthermore, our data indicate that the transcriptional repressor escargot regulates the ability of somatic cells to assume and/ or maintain hub cell identity. These data highlight the dynamic relationship between stem cells and the niche and provide insight into genetic programmes that regulate niche size and function to support normal tissue homeostasis and organ regeneration throughout life.	[Voog, Justin; D'Alterio, Cecilia; Jones, D. Leanne] Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Voog, Justin] Univ Calif San Diego, Dept Biomed Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Jones, DL (corresponding author), Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.	ljones@salk.edu			California Institute for Regenerative Medicine to the University of California-San Diego; Ellison Medical Foundation; American Federation for Aging Research; G. Harold and Leila Y. Mathers Charitable Foundation; ACS; NIH; NATIONAL INSTITUTE ON AGING [R01AG028092] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine to the University of California-San Diego(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); American Federation for Aging Research; G. Harold and Leila Y. Mathers Charitable Foundation; ACS(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Bach, D. Godt, S. Hayahsi, N. Perrimon and R. Read for reagents and fly stocks, and Jones laboratory members, G. Adams, M. Buszczak, C. Schulz, S. DiNardo and M. Fuller for discussions and comments on the manuscript. This work was supported by a training grant from the California Institute for Regenerative Medicine to the University of California-San Diego (L. Goldstein). D. L. J. is funded by the Ellison Medical Foundation, the American Federation for Aging Research, the G. Harold and Leila Y. Mathers Charitable Foundation, the ACS and the NIH.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; BOYLE M, 1995, DEVELOPMENT, V121, P1815; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schulz C, 2002, DEVELOPMENT, V129, P4523; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Streit A, 2002, INT J DEV BIOL, V46, P159; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	27	109	109	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1132	U63		10.1038/nature07173	http://dx.doi.org/10.1038/nature07173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18641633	Green Accepted			2022-12-24	WOS:000258719600041
J	Jit, M; Choi, YH; Edmunds, WJ				Jit, Mark; Choi, Yoon Hong; Edmunds, W. John			Economic evaluation of human papillomavirus vaccination in the United Kingdom	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS; CERVICAL-CANCER; PARTICLE VACCINE; GENITAL WARTS; HEALTH; EFFICACY; MANAGEMENT; INFECTION; SURVIVAL; TYPE-18	Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. Design Economic evaluation. Setting UK. Population Schoolgirls aged 12 or older. Main outcome measures Costs, quality adjusted life years (QALYs), and incremental cost effectiveness ratios for a range of vaccination options. Results Vaccinating 12 year old schoolgirls with a quadrivalent vaccine at 80% coverage is likely to be cost effective at a willingness to pay threshold of 30 pound 000 ((sic)37 700; $59 163) per QALY gained, if the average duration of protection from the vaccine is more than 10 years. Implementing a catch-up campaign of girls up to age 18 is likely to be cost effective. Vaccination of boys is unlikely to be cost effective. A bivalent vaccine with the same efficacy against human papillomavirus types 16 and 18 costing 13- pound 21 pound less per dose (depending on the duration of vaccine protection) may be as cost effective as the quadrivalent vaccine although less effective in terms of health benefits. Conclusions Routine vaccination of 12 year old schoolgirls combined with an initial catch-up campaign up to age 18 is likely to be cost effective in the UK. The results are robust to uncertainty in many parameters and processes. A key influential variable is the duration of vaccine protection.	[Jit, Mark; Choi, Yoon Hong; Edmunds, W. John] Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 6BT, England	Health Protection Agency	Jit, M (corresponding author), Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 6BT, England.	mark.jit@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Jit, Mark/0000-0001-6658-8255	Department of Health [DOH 039/0030, DOH 039/031]	Department of Health	This work was funded by grants from the Department of Health Policy Research programme [reference Nos DOH 039/0030 and DOH 039/031]. The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication.	Bielska-Lasota M, 2007, GYNECOL ONCOL, V105, P609, DOI 10.1016/j.ygyno.2007.01.048; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; *BRIT MED ASS, 2007, BRIT NAT FORM 54; BROWN D, 2007, 47 ANN INT C ANT AG; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Carter JJ, 2001, CANCER RES, V61, P1934; Chen SC, 2004, J INVEST DERM SYMP P, V9, P160, DOI 10.1046/j.1087-0024.2003.09112.x; Chesson HW, 2008, EMERG INFECT DIS, V14, P244, DOI 10.3201/eid1402.070499; Choi YH, 2007, 24 INT PAP C CLIN WO; Curtis L, 2007, UNIT COSTS HLTH SOCI; DASBACH E, 2008, BR J OBSTET GYN 0522; de Rijke JM, 2002, EUR J CANCER, V38, P2041, DOI 10.1016/S0959-8049(02)00315-5; *DEP HLTH, 2008, HPV VACC REC NHS IMM; *DEP HLTH, NHS REF COSTS 2005; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; *HLTH PROT AG, 2006, CDR WEEKLY, P16; *INF CTR, 2006, DEP HLTH STAT B; Insinga RP, 2007, MED DECIS MAKING, V27, P414, DOI 10.1177/0272989X07302128; Institute of Medicine, 2004, FIN VACC 21 CENT ASS; Jit M, 2007, BRIT J CANCER, V97, P989, DOI 10.1038/sj.bjc.6603955; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kahn JA, 2007, LANCET, V369, P2135, DOI 10.1016/S0140-6736(07)60947-7; KAMON J, 2004, HEALTH TECHNOL ASSES, V8, P78; KAMON J, 2004, HEALTH TECHNOL ASSES, V8, P1; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; KIM JJ, 2007, 24 INT PAP C CLIN WO; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kohli M, 2007, BRIT J CANCER, V96, P143, DOI 10.1038/sj.bjc.6603501; Kulasingam Shalini L, 2008, Cost Eff Resour Alloc, V6, P4, DOI 10.1186/1478-7547-6-4; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Langley PC, 2004, INT J STD AIDS, V15, P501, DOI 10.1258/0956462041558168; Martin-Hirsch P, 2007, BJOG-INT J OBSTET GY, V114, P408, DOI 10.1111/j.1471-0528.2007.01261.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2004, 21 INT PAP C CLIN WO; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; National Institute for Health and Clinical Excellence, 2004, GUID METH TECHN APPR; *NHS CANC SCREEN P, 2008, NHSCSP PUBL, V20; *OFF NAT STAT, 2008, CANC STAT 2004 REG; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Postma MJ, 2008, SEX TRANSM INFECT, V84, P152, DOI 10.1136/sti.2007.028043; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; von Krogh G, 2001, INT J STD AIDS, V12, P40, DOI 10.1258/0956462011924100; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; Woodhall S, 2008, SEX TRANSM INFECT, V84, P161, DOI 10.1136/sti.2007.029512; WOODHALL S, 2008, BASHH ASTDA 3 JOINT	53	219	222	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a769	10.1136/bmj.a769	http://dx.doi.org/10.1136/bmj.a769			35	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EO	18640957	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-24	WOS:000258561100031
J	Jaffe, HW				Jaffe, Harold W.			Universal access to HIV/AIDS treatment - Promise and problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV-INFECTION; AFRICA; ADULTS		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Jaffe, HW (corresponding author), Univ Oxford, Dept Publ Hlth, Old Road Campus, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; *JOINT UN PROGR HI, 2007 AIDS EP UPD; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; Seyler C, 2007, AIDS, V21, P1157, DOI 10.1097/QAD.0b013e3281c615da; *U OXF GLOB EC PRO, SETT DEV COUNTR AG G; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; WHO, TASK SHIFT GLOB REC; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, WORLD HLTH STAT 2008; 2006, TREAT GUIDE MED LETT, V4, P67	12	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					573	575		10.1001/jama.300.5.573	http://dx.doi.org/10.1001/jama.300.5.573			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677030				2022-12-24	WOS:000258188900019
J	Pletcher, MJ; Bibbins-Domingo, K; Lewis, CE; Wei, GS; Sidney, S; Carr, JJ; Vittinghoff, E; McCulloch, CE; Hulley, SB				Pletcher, Mark J.; Bibbins-Domingo, Kirsten; Lewis, Cora E.; Wei, Gina S.; Sidney, Steve; Carr, J. Jeffrey; Vittinghoff, Eric; McCulloch, Charles E.; Hulley, Stephen B.			Prehypertension during young adulthood and coronary calcium later in life	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; CHILDHOOD BLOOD-PRESSURE; JOINT NATIONAL COMMITTEE; INTIMA-MEDIA THICKNESS; ARTERY CALCIUM; ATHEROSCLEROTIC LESIONS; HEART-DISEASE; US ADULTS; HYPERTENSION; ASSOCIATION	Background: High blood pressure in middle age is a well-established risk factor for cardiovascular disease, but the consequences of low-level elevations during young adulthood are unknown. Objective: To measure the association between prehypertension exposure before age 35 years and coronary calcium later in life. Design: Prospective cohort study. Setting: Four communities in the United States. Participants: Black and white men and women age 18 to 30 years recruited for the CARDIA (Coronary Artery Risk Development in Young Adults) Study in 1985 through 1986 who were without hypertension before age 35 years. Measurements: Blood pressure trajectories for each participant were estimated by using measurements from 7 examinations over the course of 20 years. Cumulative exposure to blood pressure in the prehypertension range (systolic blood pressure of 120 to 139 mm Hg, or diastolic blood pressure of 80 to 89 mm Hg) from age 20 to 35 years was calculated in units of mm Hg-years (similar to pack-years of tobacco exposure) and related to the presence of coronary calcium measured at each participant's last examination (mean age, 44 years [SD, 4]). Results: Among 3560 participants, the 635 (18%) who developed prehypertension before age 35 years were more often black, male, overweight, and of lower socioeconomic status. Exposure to prehypertension before age 35 years, especially systolic prehypertension, showed a graded association with coronary calcium later in life (coronary calcium prevalence of 15%, 24%, and 38% for 0, 1 to 30, and > 30 mm Hg-years of exposure, respectively; P < 0.001). This association remained strong after adjustment for blood pressure elevation after age 35 years and other coronary risk factors and participant characteristics. Limitation: Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome. Conclusion: Prehypertension during young adulthood is common and is associated with coronary atherosclerosis 20 years later. Keeping systolic pressure below 120 mrn Hg before age 35 years may provide important health benefits later in life.	Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Alabama Birmingham, Birmingham, AL USA; NHLBI, NIH, Bethesda, MD 20892 USA; Kaiser Permanente, Oakland, CA USA; Wake Forest Univ, Winston Salem, NC 27109 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kaiser Permanente; Wake Forest University	Pletcher, MJ (corresponding author), 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.du	Carr, John/AAN-7531-2021; Carr, John Jeffrey/A-1938-2012	Carr, John/0000-0002-4398-8237; Carr, John Jeffrey/0000-0002-4398-8237	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048050, N01HC048049, N01HC095095, N01HC048047] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R43CA094612, R01CA094107, R44CA094612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048048, R01HL048050, R01HL048049, R29HL048048] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conen D, 2007, BMJ-BRIT MED J, V335, P432, DOI 10.1136/bmj.39269.672188.AE; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Drukteinis JS, 2007, CIRCULATION, V115, P221, DOI 10.1161/CIRCULATIONAHA.106.668921; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hoq S, 2002, AM J HYPERTENS, V15, P1036, DOI 10.1016/S0895-7061(02)03066-2; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Iribarren C, 1997, ARCH INTERN MED, V157, P873, DOI 10.1001/archinte.157.8.873; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Juonala M, 2005, CIRCULATION, V112, P1486, DOI 10.1161/CIRCULATIONAHA.104.502161; Juonala M, 2006, HYPERTENSION, V48, P424, DOI 10.1161/01.HYP.0000237666.78217.47; Kshirsagar AV, 2006, AM J MED, V119, P133, DOI 10.1016/j.amjmed.2005.08.023; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liszka HA, 2005, ANN FAM MED, V3, P294, DOI 10.1370/afm.312; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Mainous AG, 2004, AM J CARDIOL, V94, P1496, DOI 10.1016/j.amjcard.2004.08.026; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McMahan CA, 2005, ARCH INTERN MED, V165, P883, DOI 10.1001/archinte.165.8.883; Neal B, 2000, LANCET, V356, P1955; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Psaty BM, 2006, AM J HYPERTENS, V19, P1110, DOI 10.1016/j.amjhyper.2006.04.002; Qureshi AI, 2005, STROKE, V36, P1859, DOI 10.1161/01.STR.0000177495.45580.f1; Qureshi AI, 2002, STROKE, V33, P2781, DOI 10.1161/01.STR.0000039402.05613.0F; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Reynolds K, 2007, J AM SOC NEPHROL, V18, P1928, DOI 10.1681/ASN.2006111199; Seshadri S, 2001, ARCH INTERN MED, V161, P2343, DOI 10.1001/archinte.161.19.2343; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WIFFIAMS B, 2004, BMJ-BRIT MED J, V328, P634; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Youssef AA, 2000, AM J HYPERTENS, V13, P770, DOI 10.1016/S0895-7061(00)00233-8; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08	51	120	128	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2008	149	2					91	99		10.7326/0003-4819-149-2-200807150-00005	http://dx.doi.org/10.7326/0003-4819-149-2-200807150-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329GA	18626048	Green Accepted			2022-12-24	WOS:000257853700003
J	Ruiz, JR; Sui, X; Lobelo, F; Morrow, JR; Jackson, AW; Sjostrom, M; Blair, SN				Ruiz, Jonatan R.; Sui, Xuemei; Lobelo, Felipe; Morrow, James R., Jr.; Jackson, Allen W.; Sjostrom, Michael; Blair, Steven N.			Association between muscular strength and mortality in men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; OPTIMAL GRIP SPAN; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; METABOLIC SYNDROME; RESISTANCE EXERCISE; CLINICAL-CARDIOLOGY	Objective To examine prospectively the association between muscular strength and mortality from all causes, cardiovascular disease, and cancer in men. Design Prospective cohort study. Setting Aerobics centre longitudinal study. Participants 8762 men aged 20-80. Main outcome measures All cause mortality up to 31 December 2003; muscular strength, quantified by combining one repetition maximal measures for leg and bench presses and further categorised as age specific thirds of the combined strength variable; and cardiorespiratory fitness assessed by a maximal exercise test on a treadmill. Results During an average follow-up of 18.9 years, 503 deaths occurred (145 cardiovascular disease, 199 cancer). Age adjusted death rates per 10 000 person years across incremental thirds of muscular strength were 38.9, 25.9, and 26.6 for all causes; 12.1, 7.6, and 6.6 for cardiovascular disease; and 6.1, 4.9, and 4.2 for cancer (all P<0.01 for linear trend). After adjusting for age, physical activity, smoking, alcohol intake, body mass index, baseline medical conditions, and family history of cardiovascular disease, hazard ratios across incremental thirds of muscular strength for all cause mortality were 1.0 (referent), 0.72 (95% confidence interval 0.58 to 0.90), and 0.77 (0.62 to 0.96); for death from cardiovascular disease were 1.0 (referent), 0.74 (0.50 to 1.10), and 0.71 (0.47 to 1.07); and for death from cancer were 1.0 (referent), 0.72 (0.51 to 1.00), and 0.68 (0.48 to 0.97). The pattern of the association between muscular strength and death from all causes and cancer persisted after further adjustment for cardiorespiratory fitness; however, the association between muscular strength and death from cardiovascular disease was attenuated after further adjustment for cardiorespiratory fitness. Conclusion Muscular strength is inversely and independently associated with death from ail causes and cancer in men, even after adjusting for cardiorespiratory fitness and other potential confounders.	[Ruiz, Jonatan R.; Sjostrom, Michael] Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Huddinge, Sweden; [Ruiz, Jonatan R.] Univ Granada, Sch Med, Dept Physiol, Granada, Spain; [Sui, Xuemei; Lobelo, Felipe; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Morrow, James R., Jr.; Jackson, Allen W.; Blair, Steven N.] Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	Karolinska Institutet; University of Granada; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of North Texas System; University of North Texas Denton	Ruiz, JR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Huddinge, Sweden.	ruizj@ugr.es	RUIZ, JONATAN R/M-1338-2015; lobelo, felipe/B-9148-2013; Lobelo, R.L Felipe/AAB-2264-2021	RUIZ, JONATAN R/0000-0002-7548-7138; Lobelo, R.L Felipe/0000-0003-4185-7193	NHLBI NIH HHS [HL62508] Funding Source: Medline; NIA NIH HHS [AG06945] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006945, R37AG006945] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; *AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blair SN, 2004, J PHYS ACT HEALTH, V1, P7, DOI DOI 10.1123/JPAH.1.1.7; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Espana-Romero V, 2008, J HAND SURG-AM, V33A, P378, DOI 10.1016/j.jhsa.2007.11.013; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gibbons LW, 2000, AM J CARDIOL, V86, P53, DOI 10.1016/S0002-9149(00)00827-4; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; Jurca R, 2005, MED SCI SPORT EXER, V37, P1849, DOI 10.1249/01.mss.0000175865.17614.74; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; LAUKKANEN P, 1995, AGE AGEING, V24, P468, DOI 10.1093/ageing/24.6.468; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PHILLIPS P, 1986, AGE AGEING, V15, P53, DOI 10.1093/ageing/15.1.53; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 1997, J AM GERIATR SOC, V45, P1439, DOI 10.1111/j.1532-5415.1997.tb03193.x; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rantanen T., 2016, J AGING PHYS ACTIV, V2, P206, DOI 10.1123/japa.2.3.206; Ruiz LR, 2006, J HAND SURG-AM, V31A, P1367, DOI 10.1016/j.jhsa.2006.06.014; Ruiz-Ruiz J, 2002, J HAND SURG-AM, V27A, P897, DOI 10.1053/jhsu.2002.34315; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Sui XM, 2007, AM J HYPERTENS, V20, P608, DOI 10.1016/j.amjhyper.2007.01.009; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Thomis MAI, 1998, MED SCI SPORT EXER, V30, P724, DOI 10.1097/00005768-199805000-00013; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	52	514	525	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2008	337	7661							a439	10.1136/bmj.a439	http://dx.doi.org/10.1136/bmj.a439			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18595904	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000257961900033
J	Shelton, JD				Shelton, James D.			Counselling and testing for HIV prevention	LANCET			English	Editorial Material							SEXUAL RISK BEHAVIOR; INFECTION; REDUCTION; IMPACT; RAKAI		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Bunnell R, 2008, LANCET, V371, P2148, DOI 10.1016/S0140-6736(08)60929-0; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Kipp W, 2001, AIDS EDUC PREV, V13, P279, DOI 10.1521/aeap.13.3.279.19743; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; MULLER O, 1995, AIDS CARE, V7, P567, DOI 10.1080/09540129550126227; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; *WHO UNIAIDS UNICE, 2008, UN ACC SCAL PRIOR HI; Xu FJ, 2002, J ACQ IMMUN DEF SYND, V29, P284, DOI 10.1097/00042560-200203010-00009	14	11	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					273	275		10.1016/S0140-6736(08)61091-0	http://dx.doi.org/10.1016/S0140-6736(08)61091-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657694				2022-12-24	WOS:000258042800010
J	Cai, YY; Chin, HF; Lazarova, D; Menon, S; Fu, CM; Cai, HQ; Sclafani, A; Rodgers, DW; De La Cruz, EM; Ferro-Novick, S; Reinisch, KM				Cai, Yiying; Chin, Harvey F.; Lazarova, Darina; Menon, Shekar; Fu, Chunmei; Cai, Huaqing; Sclafani, Anthony; Rodgers, David W.; De La Cruz, Enrique M.; Ferro-Novick, Susan; Reinisch, Karin M.			The structural basis for activation of the Rab Ypt1p by the TRAPP membrane-tethering complexes	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; CRYSTAL-STRUCTURE; CIS-GOLGI; GTPASE; BET3; SPECIFICITY; MECHANISM; SUBUNITS; VPS9; REFINEMENT	The multimeric membrane-tethering complexes TRAPPI and TRAPPII share seven subunits, of which four (Bet3p, Bet5p, Trs23p, and Trs31p) are minimally needed to activate the Rab GTPase Ypt1p in an event preceding membrane fusion. Here, we present the structure of a heteropentameric TRAPPI assembly complexed with Ypt1p. We propose that TRAPPI facilitates nucleotide exchange primarily by stabilizing the nucleotide-binding pocket of Ypt1p in an open, solvent-accessible form. Bet3p, Bet5p, and Trs23p interact directly with Ypt1p to stabilize this form, while the C terminus of Bet3p invades the pocket to participate in its remodeling. The Trs31p subunit does not interact directly with the GTPase but allosterically regulates the TRAPPI interface with Ypt1p. Our findings imply that TRAPPII activates Ypt1p by an identical mechanism. This view of a multimeric membrane-tethering assembly complexed with a Rab provides a framework for understanding events preceding membrane fusion at the molecular level.	[Cai, Yiying; Lazarova, Darina; Menon, Shekar; Fu, Chunmei; Cai, Huaqing; Sclafani, Anthony; Ferro-Novick, Susan; Reinisch, Karin M.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Chin, Harvey F.; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rodgers, David W.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Cai, Yiying; Lazarova, Darina; Menon, Shekar; Cai, Huaqing; Sclafani, Anthony; Ferro-Novick, Susan] Yale Univ, Howard Hughes Med Inst, Dept Cell Biol, Sch Med, New Haven, CT 06519 USA	Yale University; Yale University; University of Kentucky; Howard Hughes Medical Institute; Yale University	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	susan.ferronovick@yale.edu; karin.reinisch@yale.edu		Cai, Huaqing/0000-0001-8434-6639	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR020171, P20 RR020171] Funding Source: Medline; NIDA NIH HHS [R01 DA002243, DA02243] Funding Source: Medline; NIDCD NIH HHS [F31 DC009143-01, F31 DC009143, 1F31DC009143-01] Funding Source: Medline; NIGMS NIH HHS [GM071688, R01 GM071688, T32-GM07223, R01 GM080616-01, GM080616, R01 GM080616, R01 GM071688-02] Funding Source: Medline; NINDS NIH HHS [R01 NS038041-04, NS38041, R01 NS038041, R56 NS038041] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616, T32GM007223, R01GM071688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC009143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim MS, 2005, TRAFFIC, V6, P1183, DOI 10.1111/j.1600-0854.2005.00352.x; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Kummel D, 2006, J MOL BIOL, V361, P22, DOI 10.1016/j.jmb.2006.06.012; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; RODGERS DW, 2001, INT TABLES CRYSTAL F, P202; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wang W, 2002, MOL BIOL CELL, V13, P3336, DOI 10.1091/mbc.01-12-0577; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	47	132	136	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1202	1213		10.1016/j.cell.2008.04.049	http://dx.doi.org/10.1016/j.cell.2008.04.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585354	Green Accepted, Bronze			2022-12-24	WOS:000257144600017
J	Tinetti, ME				Tinetti, Mary E.			Over-the-counter sales of statins and other drugs for asymptomatic conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHOLESTEROL; LOVASTATIN; STROKE; HEALTH; RISK		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.							Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bang OY, 2007, NEUROLOGY, V68, P1547; Bang OY, 2007, NEUROLOGY, V68, P737, DOI 10.1212/01.wnl.0000252799.64165.d5; Brass EP, 2006, AM J CARDIOL, V97, P851, DOI 10.1016/j.amjcard.2005.10.022; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GAHART MT, 2003, HLTH AFF MILLWOOD S; Gaist D, 2002, NEUROLOGY, V58, P1333, DOI 10.1212/WNL.58.9.1333; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; McClellan M, 2007, NEW ENGL J MED, V356, P1700, DOI 10.1056/NEJMp078057; Melin JM, 2004, AM J CARDIOL, V94, P1243, DOI 10.1016/j.amjcard.2004.08.007; Nag SS, 2005, AM J CARDIOL, V95, P862, DOI 10.1016/j.amjcard.2004.11.051; Psaty BM, 2006, NEW ENGL J MED, V355, P1753, DOI 10.1056/NEJMp068228; Sinzinger H, 2004, BRIT J CLIN PHARMACO, V57, P525, DOI 10.1111/j.1365-2125.2003.02044.x	17	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2728	2732		10.1056/NEJMsb0801202	http://dx.doi.org/10.1056/NEJMsb0801202			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565867				2022-12-24	WOS:000256815100012
J	Canadell, JG; Raupach, MR				Canadell, Josep G.; Raupach, Michael R.			Managing forests for climate change mitigation	SCIENCE			English	Editorial Material							CARBON-CYCLE; GLOBAL FORESTS	Forests currently absorb billions of tons of CO2 globally every year, an economic subsidy worth hundreds of billions of dollars if an equivalent sink had to be created in other ways. Concerns about the permanency of forest carbon stocks, difficulties in quantifying stock changes, and the threat of environmental and socioeconomic impacts of large-scale reforestation programs have limited the uptake of forestry activities in climate policies. With political will and the involvement of tropical regions, forests can contribute to climate change protection through carbon sequestration as well as offering economic, environmental, and sociocultural benefits. A key opportunity in tropical regions is the reduction of carbon emissions from deforestation and degradation.	[Canadell, Josep G.; Raupach, Michael R.] CSIRO Marine & Atmospher Res, Global Carbon Project, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Canadell, JG (corresponding author), CSIRO Marine & Atmospher Res, Global Carbon Project, GPO Box 3023, Canberra, ACT 2601, Australia.	pep.canadell@csiro.au	Canadell, Pep/E-9419-2010	Canadell, Pep/0000-0002-8788-3218				Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Canadell Josep G., 2007, P1; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gruber N, 2004, SCOPE SER, V62, P45; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; House JI, 2002, GLOBAL CHANGE BIOL, V8, P1047, DOI 10.1046/j.1365-2486.2002.00536.x; *INT TROP TIMB ORG, 2006, TECHN SER ITTO, V24; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Li WH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028364; Nabuurs GJ, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P541; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Raupach MR, 2004, SCOPE SER, V62, P131; Sabine CL, 2004, SCOPE SER, V62, P17; Sathaye J, 2006, ENERG J, P127; Sohngen B, 2006, ENERG J, P109; Strengers BJ, 2008, CLIMATIC CHANGE, V88, P343, DOI 10.1007/s10584-007-9334-4; Wang S, 2007, J ENVIRON MANAGE, V85, P524, DOI 10.1016/j.jenvman.2006.09.019	23	775	822	22	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1456	1457		10.1126/science.1155458	http://dx.doi.org/10.1126/science.1155458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556550	Green Submitted			2022-12-24	WOS:000256676400033
J	Lightbody, S				Lightbody, Sarah			A patient's journey - Epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												radgies@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2008	337	7665							a799	10.1136/bmj.a799	http://dx.doi.org/10.1136/bmj.a799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EO	18676442				2022-12-24	WOS:000258561100036
J	Takashima, S; Mkrtchyan, M; Younossi-Hartenstein, A; Merriam, JR; Hartenstein, V				Takashima, Shigeo; Mkrtchyan, Marianna; Younossi-Hartenstein, Amelia; Merriam, John R.; Hartenstein, Volker			The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling	NATURE			English	Article							SMALL-INTESTINE; EXPRESSION; HEDGEHOG; DIFFERENTIATION; EPITHELIUM; PATTERN; MIDGUT; FATES	The intestinal tract maintains proper function by replacing aged cells with freshly produced cells that arise from a population of self-renewing intestinal stem cells ( ISCs). In the mammalian intestine, ISC self renewal, amplification and differentiation take place along the crypt - villus axis, and are controlled by the Wnt and hedgehog ( Hh) signalling pathways(1). However, little is known about the mechanisms that specify ISCs within the developing intestinal epithelium, or about the signalling centres that help maintain them in their self- renewing stem cell state. Here we show that in adult Drosophila melanogaster, ISCs of the posterior intestine ( hindgut) are confined to an anterior narrow segment, which we name the hindgut proliferation zone ( HPZ). Within the HPZ, self renewal of ISCs, as well as subsequent proliferation and differentiation of ISC descendants, are controlled by locally emanating Wingless ( Wg, a Drosophila Wnt homologue) and Hh signals. The anteriorly restricted expression of Wg in the HPZ acts as a niche signal that maintains cells in a slow- cycling, self- renewing mode. As cells divide and move posteriorly away from the Wg source, they enter a phase of rapid proliferation. During this phase, Hh signal is required for exiting the cell cycle and the onset of differentiation. The HPZ, with its characteristic proliferation dynamics and signalling properties, is set up during the embryonic phase and becomes active in the larva, where it generates all adult hindgut cells including ISCs. The mechanism and genetic control of cell renewal in the Drosophila HPZ exhibits a large degree of similarity with what is seen in the mammalian intestine. Our analysis of the Drosophila HPZ provides an insight into the specification and control of stem cells, highlighting the way in which the spatial pattern of signals that promote self renewal, growth and differentiation is set up within a genetically tractable model system.	[Takashima, Shigeo; Mkrtchyan, Marianna; Younossi-Hartenstein, Amelia; Merriam, John R.; Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Hartenstein, V (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	volkerh@mcdb.ucla.edu						Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Murakami R, 1999, CELL MOL BIOL, V45, P661; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; SMITH AV, 1991, DEVELOPMENT, V112, P997; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	20	145	154	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					651	U58		10.1038/nature07156	http://dx.doi.org/10.1038/nature07156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18633350				2022-12-24	WOS:000258026500050
J	Fauci, AS; Johnston, MI; Dieffenbach, CW; Burton, DR; Hammer, SM; Hoxie, JA; Martin, M; Overbaugh, J; Watkins, DI; Mahmoud, A; Greene, WC				Fauci, Anthony S.; Johnston, Margaret I.; Dieffenbach, Carl W.; Burton, Dennis R.; Hammer, Scott M.; Hoxie, James A.; Martin, Malcolm; Overbaugh, Julie; Watkins, David I.; Mahmoud, Adel; Greene, Warner C.			Perspective - HIV vaccine research: The way forward	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY VIRUS SIVMAC239; MEMORY T-CELLS; AIDS VACCINE; CHALLENGE; INFECTION; PREVENTION; IMMUNITY; FAILURE; MONKEYS; TRIAL		[Fauci, Anthony S.; Johnston, Margaret I.; Dieffenbach, Carl W.; Martin, Malcolm; Mahmoud, Adel] NIAID, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Hammer, Scott M.] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY 10032 USA; [Hoxie, James A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Mahmoud, Adel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Greene, Warner C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Columbia University; University of Pennsylvania; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; Princeton University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Fauci, AS (corresponding author), NIAID, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov	Mahmoud, Azza Ahmed/S-1502-2016; Franzeck, Fabian C/B-5055-2011		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000998, Z01AI000190, ZIAAI000190, Z01AI000998] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Robertson M., 2008, 15 C RETR OPP INF BO, P3; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	19	197	206	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					530	532		10.1126/science.1161000	http://dx.doi.org/10.1126/science.1161000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329RS	18653883				2022-12-24	WOS:000257888900037
J	Read, KA; Mahajan, AS; Carpenter, LJ; Evans, MJ; Faria, BVE; Heard, DE; Hopkins, JR; Lee, JD; Moller, SJ; Lewis, AC; Mendes, L; McQuaid, JB; Oetjen, H; Saiz-Lopez, A; Pilling, MJ; Plane, JMC				Read, Katie A.; Mahajan, Anoop S.; Carpenter, Lucy J.; Evans, Mathew J.; Faria, Bruno V. E.; Heard, Dwayne E.; Hopkins, James R.; Lee, James D.; Moller, Sarah J.; Lewis, Alastair C.; Mendes, Luis; McQuaid, James B.; Oetjen, Hilke; Saiz-Lopez, Alfonso; Pilling, Michael J.; Plane, John M. C.			Extensive halogen-mediated ozone destruction over the tropical Atlantic Ocean	NATURE			English	Article							MARINE BOUNDARY-LAYER; TROPOSPHERIC CHEMISTRY; BROMINE CHEMISTRY; MODEL; SIMULATION; BRO; OH	Increasing tropospheric ozone levels over the past 150 years have led to a significant climate perturbation(1); the prediction of future trends in tropospheric ozone will require a full understanding of both its precursor emissions and its destruction processes. A large proportion of tropospheric ozone loss occurs in the tropical marine boundary layer(2,3) and is thought to be driven primarily by high ozone photolysis rates in the presence of high concentrations of water vapour. A further reduction in the tropospheric ozone burden through bromine and iodine emitted from open- ocean marine sources has been postulated by numerical models(4-7), but thus far has not been verified by observations. Here we report eight months of spectroscopic measurements at the Cape Verde Observatory indicative of the ubiquitous daytime presence of bromine monoxide and iodine monoxide in the tropical marine boundary layer. A year- round data set of co- located in situ surface trace gas measurements made in conjunction with low- level aircraft observations shows that the mean daily observed ozone loss is similar to 50 per cent greater than that simulated by a global chemistry model using a classical photochemistry scheme that excludes halogen chemistry. We perform box model calculations that indicate that the observed halogen concentrations induce the extra ozone loss required for the models to match observations. Our results show that halogen chemistry has a significant and extensive influence on photochemical ozone loss in the tropical Atlantic Ocean boundary layer. The omission of halogen sources and their chemistry in atmospheric models may lead to significant errors in calculations of global ozone budgets, tropospheric oxidizing capacity and methane oxidation rates, both historically and in the future.	[Read, Katie A.; Carpenter, Lucy J.; Moller, Sarah J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Mahajan, Anoop S.; Heard, Dwayne E.; Oetjen, Hilke; Pilling, Michael J.; Plane, John M. C.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Evans, Mathew J.; McQuaid, James B.] Univ Leeds, SEE, Leeds LS2 9JT, W Yorkshire, England; [Faria, Bruno V. E.; Mendes, Luis] INMG, Mindelo, Cape Verde; [Hopkins, James R.; Lee, James D.; Lewis, Alastair C.] Univ York, NCAS, York YO10 5DD, N Yorkshire, England; [Saiz-Lopez, Alfonso] CALTECH, Jet Prop Lab, Div Earth & Space Sci, Pasadena, CA 91109 USA	University of York - UK; University of Leeds; University of Leeds; University of York - UK; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Carpenter, LJ (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	ljc4@york.ac.uk; j.m.c.plane@leeds.ac.uk	Heard, Dwayne/M-3624-2017; Lewis, Alastair C/A-6721-2008; Saiz-Lopez, Alfonso/B-3759-2015; Evans, Mathew J/A-3886-2012; McQuaid, James B/C-7450-2011; Oetjen, Hilke/H-3708-2016; Mahajan, Anoop S/D-2714-2012; Plane, John M C/C-7444-2015; Oetjen, Hilke/AAU-5212-2021; Carpenter, Lucy J/E-6742-2013	Heard, Dwayne/0000-0002-0357-6238; Lewis, Alastair C/0000-0002-4075-3651; Saiz-Lopez, Alfonso/0000-0002-0060-1581; Evans, Mathew J/0000-0003-4775-032X; McQuaid, James B/0000-0001-8702-0415; Oetjen, Hilke/0000-0002-3542-1337; Mahajan, Anoop S/0000-0002-2909-5432; Plane, John M C/0000-0003-3648-6893; Oetjen, Hilke/0000-0002-3542-1337; Read, Katie/0000-0002-4044-455X; Lee, James D/0000-0001-5397-2872; Moller, Sarah/0000-0003-4923-9509; HOPKINS, JAMES/0000-0002-0447-2633; Carpenter, Lucy/0000-0002-6257-3950	NERC [NE/D006570/1, NE/E011330/1, NE/E01111X/1, ncas10008, NE/D006562/1] Funding Source: UKRI; Natural Environment Research Council [ncas10008, NE/E01111X/1, NER/J/S/2002/00641, NE/E011330/1, NE/D006562/1, NE/D006570/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allan BJ, 2000, J GEOPHYS RES-ATMOS, V105, P24191, DOI 10.1029/2000JD900314; Bey I, 2001, J GEOPHYS RES-ATMOS, V106, P23073, DOI 10.1029/2001JD000807; Bloss WJ, 2005, FARADAY DISCUSS, V130, P425, DOI 10.1039/b419090d; Davis D, 2004, ATMOS ENVIRON, V38, P5375, DOI 10.1016/j.atmosenv.2004.04.039; Dickerson RR, 1999, J GEOPHYS RES-ATMOS, V104, P21385, DOI 10.1029/1999JD900023; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Galbally IE, 2000, GEOPHYS RES LETT, V27, P3841, DOI 10.1029/1999GL010943; Hopkins J.R., 2002, J ENVIRON MONITOR, V4, P1; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; *IPCC, CLIM CHANG 2007 PHYS; JUNGE CE, 1962, TELLUS, V14, P363, DOI 10.3402/tellusa.v14i4.9563; Lawrence MG, 2001, ATMOS CHEM PHYS, V1, P37, DOI 10.5194/acp-1-37-2001; Lelieveld J, 2004, SCIENCE, V304, P1483, DOI 10.1126/science.1096777; Leser H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015811; Parrish DD, 1998, J GEOPHYS RES-ATMOS, V103, P13357, DOI 10.1029/98JD00376; Plane JMC, 2006, ANAL TECHNIQUES ATMO; Platt U., 1994, AIR MONITORING SPECT, P27; Sander R, 1999, GEOPHYS RES LETT, V26, P2857, DOI 10.1029/1999GL900478; Simmonds PG, 2004, ATMOS ENVIRON, V38, P4769, DOI 10.1016/j.atmosenv.2004.04.036; TOUMI R, 1994, GEOPHYS RES LETT, V21, P117, DOI 10.1029/93GL03536; Vogt R, 1999, J ATMOS CHEM, V32, P375, DOI 10.1023/A:1006179901037; Vogt R, 1996, NATURE, V383, P327, DOI 10.1038/383327a0; von Glasow R, 2004, ATMOS CHEM PHYS, V4, P2481, DOI 10.5194/acp-4-2481-2004; von Glasow R, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000942; Wild O, 2000, J ATMOS CHEM, V37, P245, DOI 10.1023/A:1006415919030; Yang X, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006244	26	312	317	6	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1232	1235		10.1038/nature07035	http://dx.doi.org/10.1038/nature07035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580948				2022-12-24	WOS:000257075800041
J	Setty, SRG; Tenza, D; Sviderskaya, EV; Bennett, DC; Raposo, G; Marks, MS				Setty, Subba Rao Gangi; Tenza, Daniele; Sviderskaya, Elena V.; Bennett, Dorothy C.; Raposo, Graca; Marks, Michael S.			Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes	NATURE			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; PROTEIN; LOCALIZATION; DISEASE; TRAFFICKING; BLOC-1; GENE; PREMELANOSOMES; MELANOGENESIS	Copper is a cofactor for many cellular enzymes and transporters(1). It can be loaded onto secreted and endomembrane cuproproteins by translocation from the cytosol into membrane- bound organelles by ATP7A or ATP7B transporters, the genes for which are mutated in the copper imbalance syndromes Menkes disease and Wilson disease, respectively(2). Endomembrane cuproproteins are thought to incorporate copper stably on transit through the trans-Golgi network, in which ATP7A accumulates(3) by dynamic cycling through early endocytic compartments(4). Here we show that the pigment- cell- specific cuproenzyme tyrosinase acquires copper only transiently and inefficiently within the trans- Golgi network of mouse melanocytes. To catalyse melanin synthesis, tyrosinase is subsequently reloaded with copper within specialized organelles called melanosomes. Copper is supplied to melanosomes by ATP7A, a cohort of which localizes to melanosomes in a biogenesis of lysosome- related organelles complex-1 ( BLOC-1)- dependent manner. These results indicate that cell- type- specific localization of a metal transporter is required to sustain metallation of an endomembrane cuproenzyme, providing a mechanism for exquisite spatial control of metalloenzyme activity. Moreover, because BLOC- 1 subunits are mutated in subtypes of the genetic disease Hermansky - Pudlak syndrome, these results also show that defects in copper transporter localization contribute to hypopigmentation, and hence perhaps other systemic defects, in Hermansky Pudlak syndrome.	[Setty, Subba Rao Gangi; Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Tenza, Daniele; Raposo, Graca] Ctr Rech, Inst Curie, F-75248 Paris, France; [Tenza, Daniele; Raposo, Graca] CNRS, UMR 144, F-75248 Paris, France; [Sviderskaya, Elena V.; Bennett, Dorothy C.] Univ London St Georges Hosp, Ctr Mol & Metab Signalling, Div Basic Med Sci, London SW17 0RE, England	University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; St Georges University London	Marks, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Marks, Michael S/Q-7223-2019; Bennett, Dorothy C/C-2418-2008; Sviderskaya, Elena V/D-2419-2009	Marks, Michael S/0000-0001-7435-7262; Bennett, Dorothy C/0000-0002-3639-7527; Gangi Setty, Subba Rao/0000-0003-4035-2900; Raposo, graca/0000-0001-9590-1298	National Institute of Health [R01 EY015625, R21 GM078474]; CNRS; Institut Curie and Fondation pour la Recherche Medicale; Wellcome Trust program [064583]; American Heart Association [0625437U]; NATIONAL EYE INSTITUTE [R01EY015625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078474] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie and Fondation pour la Recherche Medicale; Wellcome Trust program(Wellcome Trust); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Gitlin, M. Petris, B. Eipper, S. Lutsenko and A. Peden for reagents; A. Dancis, L. King and C. Burd for comments; and D. Harper for technical assistance. This work was supported by National Institute of Health grants R01 EY015625 and R21 GM078474 ( to M. S. M.), CNRS, Institut Curie and Fondation pour la Recherche Medicale ( to G. R.), Wellcome Trust program grant 064583 ( to E. V. S. and D. C. B.), and postdoctoral fellowship 0625437U from the American Heart Association ( to S. R. G. S.).	BENNETT DC, 1989, DEVELOPMENT, V105, P379; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Boissy RE, 1998, LAB INVEST, V78, P1037; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; Krajacic P, 2006, INVEST OPHTH VIS SCI, V47, P3129, DOI 10.1167/iovs.05-1601; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; MARTINEZ JH, 1985, BIOCHEM INT, V11, P729; MAUL GG, 1971, J CELL BIOL, V48, P41, DOI 10.1083/jcb.48.1.41; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; NOVIKOFF AB, 1968, J HISTOCHEM CYTOCHEM, V16, P299, DOI 10.1177/16.5.299; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; SATO M, 1991, J BIOL CHEM, V266, P5128; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358	33	168	171	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1142	U75		10.1038/nature07163	http://dx.doi.org/10.1038/nature07163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18650808	Green Accepted			2022-12-24	WOS:000258719600043
J	Narkar, VA; Downes, M; Yu, RT; Embler, E; Wang, YX; Banayo, E; Mihaylova, MM; Nelson, MC; Zou, YH; Juguilon, H; Kang, H; Shaw, RJ; Evans, RM				Narkar, Vihang A.; Downes, Michael; Yu, Ruth T.; Embler, Emi; Wang, Yong-Xu; Banayo, Ester; Mihaylova, Maria M.; Nelson, Michael C.; Zou, Yuhua; Juguilon, Henry; Kang, Heonjoong; Shaw, Reuben J.; Evans, Ronald M.			AMPK and PPAR delta Agonists are exercise mimetics	CELL			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; RECEPTOR-DELTA; ENDURANCE EXERCISE; GLUCOSE-TRANSPORT; FOOD-INTAKE; MITOCHONDRIAL-FUNCTION; DIRECT PHOSPHORYLATION; SIGNALING PATHWAYS	The benefits of endurance exercise on general health make it desirable to identify orally active agents that would mimic or potentiate the effects of exercise to treat metabolic diseases. Although certain natural compounds, such as reseveratrol, have endurance-enhancing activities, their exact metabolic targets remain elusive. We therefore tested the effect of pathwayspecific drugs on endurance capacities of mice in a treadmill running test. We found that PPAR beta/ delta agonist and exercise training synergistically increase oxidative myofibers and running endurance in adult mice. Because training activates AMPK and PGC1 alpha, we then tested whether the orally active AMPK agonist AICAR might be sufficient to overcome the exercise requirement. Unexpectedly, even in sedentary mice, 4 weeks of AICAR treatment alone induced metabolic genes and enhanced running endurance by 44%. These results demonstrate that AMPK-PPAR delta pathway can be targeted by orally active drugs to enhance training adaptation or even to increase endurance without exercise.	[Narkar, Vihang A.; Downes, Michael; Yu, Ruth T.; Embler, Emi; Nelson, Michael C.; Zou, Yuhua; Juguilon, Henry; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Banayo, Ester; Evans, Ronald M.] Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Wang, Yong-Xu] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Kang, Heonjoong] Seoul Natl Univ, Sch Earth & Environm Sci, Marine Biotechnol Lab, Seoul 151747, South Korea	Salk Institute; Salk Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU)	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019; Nelson, Michael Shawn/GXF-4934-2022; Mihaylova, Maria M./ACZ-4949-2022	Evans, Ronald/0000-0002-9986-5965; Mihaylova, Maria M./0000-0002-2725-767X; Yu, Ruth/0000-0002-9527-9627	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053803-03]; Howard Hughes Medical Institute, Hilblom Foundation [HD027183]; National Institutes of Health [DK057978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute, Hilblom Foundation(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Cho, G. D. Barish, and C. H. Zhang for valuable suggestions and discussion of the manuscript and S. Ganley and E. Ong for administrative assistance. R. M. E is an investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. V.A.N. is supported by a Ruth L. Kirschstein National Research Service Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR053803-03). This work was supported by the Howard Hughes Medical Institute, Hilblom Foundation, and National Institutes of Health (HD027183 and DK057978).	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Durante PE, 2002, AM J PHYSIOL-ENDOC M, V283, pE178, DOI 10.1152/ajpendo.00404.2001; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lucia A, 2001, SPORTS MED, V31, P325, DOI 10.2165/00007256-200131050-00004; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mahoney Douglas J, 2005, Phys Med Rehabil Clin N Am, V16, P859; Man MQ, 2008, J INVEST DERMATOL, V128, P370, DOI 10.1038/sj.jid.5701026; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Minnaard R, 2005, MUSCLE NERVE, V31, P339, DOI 10.1002/mus.20268; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Schmitt B, 2003, PHYSIOL GENOMICS, V15, P148, DOI 10.1152/physiolgenomics.00089.2003; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Short KR, 2005, J APPL PHYSIOL, V99, P95, DOI 10.1152/japplphysiol.00129.2005; Siu PM, 2004, J APPL PHYSIOL, V97, P277, DOI 10.1152/japplphysiol.00534.2004; Sprecher DL, 2007, ARTERIOSCL THROM VAS, V27, P359, DOI 10.1161/01.ATV.0000252790.70572.0c; Terada S, 2006, AM J PHYSIOL-ENDOC M, V290, pE607, DOI 10.1152/ajpendo.00430.2005; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yoshioka M, 2003, FASEB J, V17, P1812, DOI 10.1096/fj.02-1200com; Zapala MA, 2002, GENOME BIOL, V3	51	905	949	5	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					405	415		10.1016/j.cell.2008.06.051	http://dx.doi.org/10.1016/j.cell.2008.06.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18674809	Green Accepted, Bronze			2022-12-24	WOS:000258665500014
J	Helliker, BR; Richter, SL				Helliker, Brent R.; Richter, Suzanna L.			Subtropical to boreal convergence of tree-leaf temperatures	NATURE			English	Article							OXYGEN-ISOTOPE RATIOS; RELATIVE-HUMIDITY; CELLULOSE; CARBON; WATER; HYDROGEN; FOREST; PLANTS; MODEL; RINGS	The oxygen isotope ratio (delta(18)O) of cellulose is thought to provide a record of ambient temperature and relative humidity during periods of carbon assimilation(1,2). Here we introduce a method to resolve tree-canopy leaf temperature with the use of delta(18)O of cellulose in 39 tree species. We show a remarkably constant leaf temperature of 21.4 +/- 2.2 degrees C across 50 degrees of latitude, from subtropical to boreal biomes. This means that when carbon assimilation is maximal, the physiological and morphological properties of tree branches serve to raise leaf temperature above air temperature to a much greater extent in more northern latitudes. A main assumption underlying the use of delta(18)O to reconstruct climate history is that the temperature and relative humidity of an actively photosynthesizing leaf are the same as those of the surrounding air(3,4). Our data are contrary to that assumption and show that plant physiological ecology must be considered when reconstructing climate through isotope analysis. Furthermore, our results may explain why climate has only a modest effect on leaf economic traits(5) in general.	[Helliker, Brent R.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Richter, Suzanna L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Helliker, BR (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	helliker@sas.upenn.edu						Andersson S, 1998, J PHYS B-AT MOL OPT, V31, P625, DOI 10.1088/0953-4075/31/3/025; Barbour MM, 2000, PLANT CELL ENVIRON, V23, P473, DOI 10.1046/j.1365-3040.2000.00575.x; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brendel O, 2000, PHYTOCHEM ANALYSIS, V11, P7, DOI 10.1002/(SICI)1099-1565(200001/02)11:1&lt;7::AID-PCA488&gt;3.0.CO;2-U; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; Buhay WM, 1996, GEOCHIM COSMOCHIM AC, V60, P2209, DOI 10.1016/0016-7037(96)00073-7; Cernusak LA, 2005, TREE PHYSIOL, V25, P129, DOI 10.1093/treephys/25.2.129; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; EPSTEIN S, 1977, SCIENCE, V198, P1209, DOI 10.1126/science.198.4323.1209; Evans MN, 2004, GEOCHIM COSMOCHIM AC, V68, P3295, DOI 10.1016/j.gca.2004.01.006; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; Gessler A, 2007, NEW PHYTOL, V174, P600, DOI 10.1111/j.1469-8137.2007.02007.x; GRAY J, 1976, NATURE, V262, P481, DOI 10.1038/262481a0; Helliker BR, 2000, P NATL ACAD SCI USA, V97, P7894, DOI 10.1073/pnas.97.14.7894; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Leuzinger S, 2007, AGR FOREST METEOROL, V146, P29, DOI 10.1016/j.agrformet.2007.05.007; Long S. P., 1988, PLANTS TEMPERATURE; Michaletz ST, 2006, NEW PHYTOL, V170, P87, DOI 10.1111/j.1469-8137.2006.01661.x; Miller DL, 2006, P NATL ACAD SCI USA, V103, P14294, DOI 10.1073/pnas.0606549103; MILLER PC, 1972, ECOLOGY, V53, P22, DOI 10.2307/1935708; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; RICHTER SL, IN PRESS GEOCHIM COS; Robertson I, 2001, EARTH PLANET SC LETT, V191, P21, DOI 10.1016/S0012-821X(01)00399-5; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Saurer M, 2000, J GEOPHYS RES-ATMOS, V105, P12461, DOI 10.1029/2000JD900160; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; SMITH WK, 1978, SCIENCE, V201, P614, DOI 10.1126/science.201.4356.614; SMITH WK, 1988, AM J BOT, V75, P496, DOI 10.2307/2444214; Sternberg LDSL., 1989, STABLE ISOTOPES ECOL, P124; Sternberg LDL, 2007, GEOCHIM COSMOCHIM AC, V71, P2463, DOI 10.1016/j.gca.2007.03.004; Wang XF, 1995, PLANT CELL ENVIRON, V18, P1377, DOI 10.1111/j.1365-3040.1995.tb00198.x; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright WE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006806	35	191	196	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					511	U6		10.1038/nature07031	http://dx.doi.org/10.1038/nature07031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18548005				2022-12-24	WOS:000257860300050
J	Havlir, DV; Getahun, H; Sanne, I; Nunn, P				Havlir, Diane V.; Getahun, Haileyesus; Sanne, Ian; Nunn, Paul			Opportunities and challenges for HIV care in overlapping HIV and TB epidemics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISONIAZID PREVENTIVE THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDRUG-RESISTANT TUBERCULOSIS; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE RECONSTITUTION; SOUTH-AFRICA; RISK-FACTORS; NOSOCOMIAL TRANSMISSION	Tuberculosis (TB) and the emerging multidrug-resistant TB epidemic represent major challenges to human immunodeficiency virus (HIV) care and treatment programs in resource-limited settings. Tuberculosis is a major cause of mortality among patients with HIV and poses a risk throughout the course of HIV disease, even after successful initiation of antiretroviral therapy (ART). Progress in the implementation of activities directed at reducing TB burden in the HIV population lags far behind global targets. HIV programs designed for longitudinal care are ideally suited to implement TB control measures and have no option but to address TB vigorously to save patient lives, to safeguard the massive investment in HIV treatment, and to curb the global TB burden. We propose a framework of strategic actions for HIV care programs to optimally integrate TB into their services. The core activities of this framework include intensified TB case finding, treatment of TB, isoniazid preventive treatment, infection control, administration of ART, TB recording and reporting, and joint efforts of HIV and TB programs at the national and local levels.	[Havlir, Diane V.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Getahun, Haileyesus; Nunn, Paul] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Sanne, Ian] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa	University of California System; University of California San Francisco; World Health Organization; University of Witwatersrand	Havlir, DV (corresponding author), San Francisco Gen Hosp, 995 Potrero Ave,Bldg 80,W84, San Francisco, CA 94110 USA.	dhavlir@php.ucsf.edu	Sanne, Ian/ABH-2231-2020; Getahun, Haileyesus/ABC-5181-2020					Achmat Z, 2006, INT J TUBERC LUNG D, V10, P1312; ANDREWS J, 2008, 15 C RETR OPP INF FE; [Anonymous], 2008, 4 WHO; [Anonymous], GLOB TUB CONTR SURV; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blanc FX, 2007, J INFECT DIS, V196, pS46, DOI 10.1086/518658; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Breen RAM, 2006, J INFECT DIS, V193, P1437, DOI 10.1086/503437; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; CAIN K, 2007, 38 WORLD LUNG HLTH C; CHAUHAN LS, 2008, 13 TB HIV COR GROUP; Chintu C, 2003, LANCET, V362, P1516, DOI 10.1016/S0140-6736(03)14779-4; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; DEMISSIE M, 2007, 38 WORLD LUNG HLTH C; *DEP PUBL HLTH FED, REP 2007 TB HIV COLL; Dubrovina I, 2008, INT J TUBERC LUNG D, V12, P756; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; FISCHL MA, 1992, ANN INTERN MED, V117, P184, DOI 10.7326/0003-4819-117-3-184; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; FRAMPTON MW, 1992, ANN INTERN MED, V117, P312, DOI 10.7326/0003-4819-117-4-312; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; GILKS CF, 1990, AIDS, V4, P981, DOI 10.1097/00002030-199010000-00006; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Godfrey-Faussett, 1998, POLICY STATEMENT PRE; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Gray A, 2006, AIDS, V20, P302, DOI 10.1097/01.aids.0000202652.49020.94; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Gunneberg C, 2008, INT J TUBERC LUNG D, V12, pS2; Harries AD, 2005, INT J TUBERC LUNG D, V9, P128; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P526; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; HUTTON MD, 1990, J INFECT DIS, V161, P286, DOI 10.1093/infdis/161.2.286; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; KIMMERLING M, 2007, 38 WORLD LUNG HLTH C; Kirk O, 2000, AM J RESP CRIT CARE, V162, P865, DOI 10.1164/ajrccm.162.3.9908018; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; MEINTJES G, 2008, 15 C RETR OPP INF FE; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moreno S, 2006, AIDS REV, V8, P115; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Ramon-Pardo P, 2008, INT J TUBERC LUNG D, V12, pS51; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; SEPKOWITZ KA, 1995, CLIN MICROBIOL REV, V8, P180, DOI 10.1128/CMR.8.2.180; Serra FC, 2007, BRAZ J INFECT DIS, V11, P462, DOI 10.1590/S1413-86702007000500004; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Srikantiah P, 2007, AIDS, V21, P1972, DOI 10.1097/QAD.0b013e32823ecf6e; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2007, IMPR DIAGN TREATM SM; *WHO, 2006, GUID CONTR PROPH HIV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2006, ANT THER HIV INF AD; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238	98	97	101	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					423	430		10.1001/jama.300.4.423	http://dx.doi.org/10.1001/jama.300.4.423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647985				2022-12-24	WOS:000257831200020
J	Shaffer, AL; Emre, NCT; Lamy, L; Ngo, VN; Wright, G; Xiao, WM; Powell, J; Dave, S; Yu, X; Zhao, H; Zeng, YX; Chen, BZ; Epstein, J; Staudt, LM				Shaffer, Arthur L.; Emre, N. C. Tolga; Lamy, Laurence; Ngo, Vu N.; Wright, George; Xiao, Wenming; Powell, John; Dave, Sandeep; Yu, Xin; Zhao, Hong; Zeng, Yuxin; Chen, Bangzheng; Epstein, Joshua; Staudt, Louis M.			IRF4 addiction in multiple myeloma	NATURE			English	Article							PLASMA-CELL DIFFERENTIATION; LYMPHOMA-CELLS; MYC; EXPRESSION; CANCER; ACTIVATION; PROFILES; SURVIVAL	The transcription factor IRF4 ( interferon regulatory factor 4) is required during an immune response for lymphocyte activation and the generation of immunoglobulin- secreting plasma cells(1-3). Multiple myeloma, a malignancy of plasma cells, has a complex molecular aetiology with several subgroups defined by gene expression profiling and recurrent chromosomal translocations(4,5). Moreover, the malignant clone can sustain multiple oncogenic lesions, accumulating genetic damage as the disease progresses(6,7). Current therapies for myeloma can extend survival but are not curative(8,9). Hence, new therapeutic strategies are needed that target molecular pathways shared by all subtypes of myeloma. Here we show, using a loss- of- function, RNA- interference- based genetic screen, that IRF4 inhibition is toxic to myeloma cell lines, regardless of transforming oncogenic mechanism. Gene expression profiling and genome- wide chromatin immunoprecipitation analysis uncovered an extensive network of IRF4 target genes and identified MYC as a direct target of IRF4 in activated B cells and myeloma. Unexpectedly, IRF4 was itself a direct target of MYC transactivation, generating an autoregulatory circuit in myeloma cells. Although IRF4 is not genetically altered in most myelomas, they are nonetheless addicted to an aberrant IRF4 regulatory network that fuses the gene expression programmes of normal plasma cells and activated B cells.	[Shaffer, Arthur L.; Emre, N. C. Tolga; Lamy, Laurence; Ngo, Vu N.; Dave, Sandeep; Yu, Xin; Zhao, Hong; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, Rockville, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Zeng, Yuxin; Chen, Bangzheng; Epstein, Joshua] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72212 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Arkansas System; University of Arkansas Medical Sciences	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Emre, Tolga/A-1787-2016; Wright, George W/M-1660-2017	Emre, Tolga/0000-0001-8021-5228; Ngo, Vu/0000-0002-9501-6990	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NCI NIH HHS [R01 CA113992-02, CA113992, R01 CA113992, CA97513, R33 CA097513-03] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011010, R33CA097513, R01CA113992, ZIABC011007] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barlogie B, 2004, BLOOD, V103, P20, DOI 10.1182/blood-2003-04-1045; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; DIB A, IN PRESS J NATL CANC; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	29	482	501	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					226	231		10.1038/nature07064	http://dx.doi.org/10.1038/nature07064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18568025	Green Accepted			2022-12-24	WOS:000257466900046
J	Agrawal, A; Chhatre, A; Hardin, R				Agrawal, Arun; Chhatre, Ashwini; Hardin, Rebecca			Changing governance of the world's forests	SCIENCE			English	Editorial Material							PROTECTED AREAS; COMMONS; PARKS	Major features of contemporary forest governance include decentralization of forest management, logging concessions in publicly owned commercially valuable forests, and timber certification, primarily in temperate forests. Although a majority of forests continue to be owned formally by governments, the effectiveness of forest governance is increasingly independent of formal ownership. Growing and competing demands for food, biofuels, timber, and environmental services will pose severe challenges to effective forest governance in the future, especially in conjunction with the direct and indirect impacts of climate change. A greater role for community and market actors in forest governance and deeper attention to the factors that lead to effective governance, beyond ownership patterns, is necessary to address future forest governance challenges.	[Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Chhatre, Ashwini] Univ Illinois, Dept Geog, Urbana, IL 61801 USA; [Hardin, Rebecca] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Hardin, Rebecca] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Agrawal, A (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	arunagra@umich.edu	Chhatre, Ashwini/E-5573-2013; Agrawal, Arun/A-4257-2009	Agrawal, Arun/0000-0001-6796-2958; Chhatre, Ashwini/0000-0002-5374-7867				Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; Andersson K, 2007, J POLICY ANAL MANAG, V26, P99, DOI 10.1002/pam.20229; Cashore B., 2006, CONFRONTING SUSTAINA; Cronkleton P., 2008, ENV GOVERNANCE EMERG; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; *FOOD AGR ORG, 2005, GLOB FOR RES ASS 200; *FOOD AGR ORG, 2001, GLOB FOR RES ASS 200; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; HARDIN R, 2002, 6 WP WORLD RES I I G; Hayes TM, 2006, WORLD DEV, V34, P2064, DOI 10.1016/j.worlddev.2006.03.002; Karsenty A., 2007, OVERVIEW IND FOREST; Keller M, 2007, FRONT ECOL ENVIRON, V5, P213, DOI 10.1890/1540-9295(2007)5[213:TPISLT]2.0.CO;2; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Meidinger E., 1997, HUMAN ECOLOGY REV, V4, P52; Molnar A, 2004, WHO CONSERVES WORLDS; Ostrom, 1990, GOVERNING COMMONS; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ribot JC, 2006, WORLD DEV, V34, P1864, DOI 10.1016/j.worlddev.2005.11.020; *RIGHTS RES IN, 2007, TRANS FOR TEN GOV DR; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; White AM A, 2002, WHO OWNS WORLDS FORE; Zimmerer KS, 2004, AMBIO, V33, P520, DOI 10.1639/0044-7447(2004)033[0520:GAMTIT]2.0.CO;2	22	450	463	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1460	1462		10.1126/science.1155369	http://dx.doi.org/10.1126/science.1155369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556552	Green Submitted			2022-12-24	WOS:000256676400035
J	Swem, LR; Swem, DL; Wingreen, NS; Bassler, BL				Swem, Lee R.; Swem, Danielle L.; Wingreen, Ned S.; Bassler, Bonnie L.			Deducing receptor signaling parameters from in vivo analysis: LuxN/AI-1 quorum sensing in Vibrio harveyi	CELL			English	Article							LOCUS CONTROLLING EXPRESSION; TO-CELL COMMUNICATION; LUXR-LUXI FAMILY; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; TRANSCRIPTIONAL REGULATORS; STRUCTURAL IDENTIFICATION; NUCLEOTIDE-SEQUENCE; HISTIDINE KINASE; GENETIC-ANALYSIS	Quorum sensing, a process of bacterial cell-cell communication, relies on production, detection, and response to autoinducer signaling molecules. LuxN, a nine-transmembrane domain protein from Vibrio harveyi, is the founding example of membrane-bound receptors for acyl-homoserine lactone (AHL) autoinducers. We used mutagenesis and suppressor analyses to identify the AHL-binding domain of LuxN and discovered LuxN mutants that confer both decreased and increased AHL sensitivity. Our analysis of dose-response curves of multiple LuxN mutants pins these inverse phenotypes on quantifiable opposing shifts in the free-energy bias of LuxN for occupying its kinase and phosphatase states. To understand receptor activation and to characterize the pathway signaling parameters, we exploited a strong LuxN antagonist, one of fifteen small-molecule antagonists we identified. We find that quorum-sensing-mediated communication can be manipulated positively and negatively to control bacterial behavior and, more broadly, that signaling parameters can be deduced from in vivo data.	[Swem, Lee R.; Swem, Danielle L.; Wingreen, Ned S.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Swem, Danielle L.; Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@princeton.edu		Bassler, Bonnie/0000-0002-0043-746X	Howard Hughes Medical Institute, National Institutes of Health (NIH) [5R01GM065859]; National Science Foundation [MCB-0343821]; NIH [5R01 AI 054442, GM787552]; National Cancer Institute's Initiative for Chemical Genetics, NIH, [N01-CO-12400]; Broad Institute of Harvard; MIT; Department of Health and Human Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065859] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Institutes of Health (NIH)(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute's Initiative for Chemical Genetics, NIH,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Broad Institute of Harvard; MIT; Department of Health and Human Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (NIH) grant 5R01GM065859, NIH grant 5R01 AI 054442, National Science Foundation grant MCB-0343821 to B. L. B., and NIH postdoctoral fellowship GM787552 to L. R. S. The antagonist screen has been funded in whole or in part with Federal funds from the National Cancer Institute's Initiative for Chemical Genetics, NIH, under contract number N01-CO-12400 and has been performed with the assistance of the Chemical Biology Platform of the Broad Institute of Harvard and MIT. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Service, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; CAO JG, 1989, J BIOL CHEM, V264, P21670; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Endres RG, 2007, PLOS COMPUT BIOL, V3, P1385, DOI 10.1371/journal.pcbi.0030150; ENGEBRECHT J, 1987, NUCLEIC ACIDS RES, V15, P10455, DOI 10.1093/nar/15.24.10455; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Jung K, 2007, J BACTERIOL, V189, P2945, DOI 10.1128/JB.01723-06; KEHRY MR, 1982, CELL, V29, P761, DOI 10.1016/0092-8674(82)90438-X; KEHRY MR, 1982, J BIOL CHEM, V257, P378; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; MADDOCK JR, 1993, SCIENCE, V259, P1717; MARTIN M, 1989, J BACTERIOL, V171, P2406, DOI 10.1128/jb.171.5.2406-2414.1989; McFall-Ngai MJ, 2000, CURR OPIN MICROBIOL, V3, P603, DOI 10.1016/S1369-5274(00)00147-8; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Park H, 1998, P NATL ACAD SCI USA, V95, P6728, DOI 10.1073/pnas.95.12.6728; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHOWALTER RE, 1990, J BACTERIOL, V172, P2946, DOI 10.1128/jb.172.6.2946-2954.1990; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Timmen M, 2006, J BIOL CHEM, V281, P24398, DOI 10.1074/jbc.M604108200; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	48	70	75	2	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 8	2008	134	3					461	473		10.1016/j.cell.2008.06.023	http://dx.doi.org/10.1016/j.cell.2008.06.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692469	Green Accepted, Bronze			2022-12-24	WOS:000258665500019
J	Peters, SE				Peters, Shanan E.			Environmental determinants of extinction selectivity in the fossil record	NATURE			English	Article							MARINE; DIVERSITY; DYNAMICS; HISTORY	The causes of mass extinctions and the nature of biological selectivity during extinction events remain central questions in palaeobiology. Although many different environmental perturbations have been invoked as extinction mechanisms(1-3), it has long been recognized that fluctuations in sea level coincide with many episodes of biotic turnover(4-6). Recent work supports the hypothesis that changes in the areas of epicontinental seas have influenced the macroevolution of marine animals(7,8), but the extent to which differential environmental turnover has contributed to extinction selectivity remains unknown. Here I use a new compilation of the temporal durations of sedimentary rock packages to show that carbonate and terrigenous clastic marine shelf environments have different spatio- temporal dynamics and that these dynamics predict patterns of genus- level extinction, extinction selectivity and diversity among Sepkoski's Palaeozoic and modern evolutionary faunae(9). These results do not preclude a role for biological interactions or unusual physical events as drivers of macroevolution, but they do suggest that the turnover of marine shelf habitats and correlated environmental changes have been consistent determinants of extinction, extinction selectivity and the shifting composition of the marine biota during the Phanerozoic eon.	[Peters, Shanan E.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Peters, SE (corresponding author), Univ Wisconsin, Dept Geol & Geophys, 1215 W Dayton St, Madison, WI 53706 USA.	peters@geology.wisc.edu	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317				ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Alroy J, 2004, EVOL ECOL RES, V6, P1; Bambach R.K., 1985, P191; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; CHILDS OE, 1985, AAPG BULL, V69, P173; Erwin D. H., 2006, EXTINCTION LIFE EART; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; Fraiser ML, 2007, PALEOBIOLOGY, V33, P397, DOI 10.1666/05072.1; HALLAM A, 1989, PHILOS T ROY SOC B, V325, P437, DOI 10.1098/rstb.1989.0098; Hallam A., 1997, MASS EXTINCTIONS THE; JOHNSON J G, 1974, Geology (Boulder), V2, P479, DOI 10.1130/0091-7613(1974)2<479:EOPF>2.0.CO;2; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; McKinney FK, 2006, GEOLOGY, V34, P881, DOI 10.1130/G22707.1; NEWELL NORMAN D., 1952, JOUR PALEONTOL, V26, P371; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2006, PALEOBIOLOGY, V32, P387, DOI 10.1666/05081.1; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; RAUP DM, 1992, PALEOBIOLOGY, V18, P80, DOI 10.1017/S0094837300012227; Sepkoski J., 2002, B AM PALEONTOL, V363; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Stanley S.M., 1977, DEV PALAEONTOLOGY ST, V5, P209, DOI DOI 10.1016/S0920-5446(08)70327-3; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Vermeij G.J, 1987, EVOLUTION ESCALATION; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; Wright V. P., 1996, SEDIMENTARY ENV PROC, P325	30	102	106	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					626	U38		10.1038/nature07032	http://dx.doi.org/10.1038/nature07032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18552839	Green Published			2022-12-24	WOS:000258026500044
J	Powers, ET; Balch, WE				Powers, Evan T.; Balch, William E.			Costly mistakes: Translational infidelity and protein homeostasis	CELL			English	Editorial Material							MODELS	Protein misfolding is increasingly being recognized as a key process in organismal health and disease. Drummond and Wilke (2008) show that misfolding caused by mistakes during the translation of RNA into proteins (mistranslation) also results in a strong selection pressure to optimize translational fidelity, especially for proteins that are highly expressed.	[Powers, Evan T.] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Powers, ET (corresponding author), Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	epowers@scripps.edu; webalch@scripps.edu		Powers, Evan/0000-0001-8185-8487	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033301] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; DILL KA, 1995, PROTEIN SCI, V4, P561; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105	9	20	21	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					204	206		10.1016/j.cell.2008.07.005	http://dx.doi.org/10.1016/j.cell.2008.07.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662533	Bronze			2022-12-24	WOS:000257891700007
J	Zhou, B; Ma, Q; Rajagopal, S; Wu, SM; Domian, I; Rivera-Feliciano, J; Jiang, DW; von Gise, A; Ikeda, S; Chien, KR; Pu, WT				Zhou, Bin; Ma, Qing; Rajagopal, Satish; Wu, Sean M.; Domian, Ibrahim; Rivera-Feliciano, Jose; Jiang, Dawei; von Gise, Alexander; Ikeda, Sadakatsu; Chien, Kenneth R.; Pu, William T.			Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR PROGENITORS; PERICARDIAL MESODERM; REPORTER STRAIN; EXPRESSION; ORIGIN; MOUSE; NEOVASCULARIZATION; DIFFERENTIATION; POPULATION	The heart is formed from cardiogenic progenitors expressing the transcription factors Nkx2-5 and Isl1 ( refs 1 and 2). These multipotent progenitors give rise to cardiomyocyte, smooth muscle and endothelial cells, the major lineages of the mature heart(3,4). Here we identify a novel cardiogenic precursor marked by expression of the transcription factor Wt1 and located within the epicardium - an epithelial sheet overlying the heart. During normal murine heart development, a subset of these Wt1(+) precursors differentiated into fully functional cardiomyocytes. Wt1(+) proepicardial cells arose from progenitors that express Nkx2-5 and Isl1, suggesting that they share a developmental origin with multipotent Nkx2-5(+) and Isl1(+) progenitors. These results identify Wt1(+) epicardial cells as previously unrecognized cardiomyocyte progenitors, and lay the foundation for future efforts to harness the cardiogenic potential of these progenitors for cardiac regeneration and repair.	[Zhou, Bin; Ma, Qing; Rajagopal, Satish; Jiang, Dawei; von Gise, Alexander; Ikeda, Sadakatsu; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Ma, Qing; Rajagopal, Satish; Jiang, Dawei; von Gise, Alexander; Ikeda, Sadakatsu; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin; Ma, Qing; Rajagopal, Satish; Rivera-Feliciano, Jose; von Gise, Alexander; Ikeda, Sadakatsu; Pu, William T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wu, Sean M.; Domian, Ibrahim; Chien, Kenneth R.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA; [Wu, Sean M.; Domian, Ibrahim; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [von Gise, Alexander] Charite Univ Med Berlin, Clin Neonatol, D-10117 Berlin, Germany	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Pu, WT (corresponding author), Childrens Hosp, Harvard Stem Cell Inst, 300 Longwood Ave, Boston, MA 02115 USA.	wpu@enders.tch.harvard.edu	Pu, William/AAJ-8301-2020; von Gise, Alexander/C-3997-2016	Pu, William/0000-0002-4551-8079; von Gise, Alexander/0000-0001-7886-3031; Wu, Sean/0000-0002-0000-3821; Zhou, Bin/0000-0001-5278-5522	NHLBI NIH HHS [P50 HL074734, T32 HL007572, P50 HL074734-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074734] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gutstein DE, 2003, J CELL SCI, V116, P875, DOI 10.1242/jcs.00258; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Manner J, 1999, ANAT RECORD, V255, P212; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhou B, 2006, J THROMB HAEMOST, V4, P993, DOI 10.1111/j.1538-7836.2006.01906.x	36	721	759	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					109	U5		10.1038/nature07060	http://dx.doi.org/10.1038/nature07060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18568026	Green Accepted			2022-12-24	WOS:000257308300047
J	Patterson, GH; Hirschberg, K; Polishchuk, RS; Gerlich, D; Phair, RD; Lippincott-Schwartz, J				Patterson, George H.; Hirschberg, Koret; Polishchuk, Roman S.; Gerlich, Daniel; Phair, Robert D.; Lippincott-Schwartz, Jennifer			Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system	CELL			English	Article							CISTERNAL MATURATION; FLUORESCENT PROTEIN; PLASMA-MEMBRANE; COMPLEX; CELLS; STACK; CHOLESTEROL; CONTINUITIES; MECHANISM; DYNAMICS	The prevailing view of intra-Golgi transport is cisternal progression, which has a key prediction-that newly arrived cargo exhibits a lag or transit time before exiting the Golgi. Instead, we find that cargo molecules exit at an exponential rate proportional to their total Golgi abundance with no lag. Incoming cargo molecules rapidly mix with those already in the system and exit from partitioned domains with no cargo privileged for export based on its time of entry into the system. Given these results, we constructed a new model of intra-Golgi transport that involves rapid partitioning of enzymes and transmembrane cargo between two lipid phases combined with relatively rapid exchange among cisternae. Simulation and experimental testing of this rapid partitioning model reproduced all the key characteristics of the Golgi apparatus, including polarized lipid and protein gradients, exponential cargo export kinetics, and cargo waves.	[Patterson, George H.; Lippincott-Schwartz, Jennifer] NIH, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Phair, Robert D.] Integrat Bioinformat, Los Altos, CA 94024 USA; [Hirschberg, Koret] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Polishchuk, Roman S.] Consorzio Mario Negri Sud Santa Maria Imbaro, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Gerlich, Daniel] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	National Institutes of Health (NIH) - USA; Tel Aviv University; Sackler Faculty of Medicine; Consorzio Mario Negri Sud; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lippincott-Schwartz, J (corresponding author), NIH, Cell Biol & Metab Program, Bldg 18T,Room 101,18 Lib Dr, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov	Patterson, George/ABI-4751-2020; Gerlich, Daniel Wolfram W/A-6991-2016; Hirschberg, Koret/AAF-4566-2019	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Polishchuk, Roman/0000-0002-7698-1955	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM066611, R01GM079305, R43GM066611] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 EB999999, Z01 HD001609-14] Funding Source: Medline; NIGMS NIH HHS [R01GM079305, R43GM066611, R01 GM079305, R43 GM066611, R44 GM066611, R44GM066611, R01 GM079305-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; BERGMANN JE, 1983, J CELL BIOL, V97, P1777, DOI 10.1083/jcb.97.6.1777; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DUNPHY WG, 1983, J CELL BIOL, V97, P270, DOI 10.1083/jcb.97.1.270; FRIES E, 1984, EMBO J, V3, P147, DOI 10.1002/j.1460-2075.1984.tb01775.x; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Griffiths G, 2000, TRAFFIC, V1, P738, DOI 10.1034/j.1600-0854.2000.010906.x; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Kepes F, 2005, INT REV CYTOL, V242, P55; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; MELKONIAN M, 1991, J ELECTRON MICR TECH, V17, P165, DOI 10.1002/jemt.1060170205; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; ROTH J, 1986, J BIOL CHEM, V261, P14307; SLOT JW, 1983, J HISTOCHEM CYTOCHEM, V31, P1049, DOI 10.1177/31.8.6863900; Sun AQ, 2001, AM J PHYSIOL-GASTR L, V280, pG1305, DOI 10.1152/ajpgi.2001.280.6.G1305; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; Volchuk A, 2000, CELL, V102, P335, DOI 10.1016/S0092-8674(00)00039-8; White J, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-19	37	207	208	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					1055	1067		10.1016/j.cell.2008.04.044	http://dx.doi.org/10.1016/j.cell.2008.04.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555781	Green Accepted, Bronze			2022-12-24	WOS:000256693400020
J	Ogawa, Y; Sun, BK; Lee, JT				Ogawa, Yuya; Sun, Bryan K.; Lee, Jeannie T.			Intersection of the RNA interference and X-inactivation pathways	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; CHROMOSOME INACTIVATION; XIST RNA; CHOICE; TSIX; GENE; DIFFERENTIATION; TRANSCRIPTION; DICER; XITE	In mammals, dosage compensation is achieved by X- chromosome inactivation ( XCI) in the female. The noncoding Xist gene initiates silencing of the X chromosome, whereas its antisense partner Tsix blocks silencing. The complementarity of Xist and Tsix RNAs has long suggested a role for RNA interference ( RNAi). Here, we report that murine Xist and Tsix form duplexes in vivo. During XCI, the duplexes are processed to small RNAs ( sRNAs), most likely on the active X ( Xa) in a Dicer- dependent manner. Deleting Dicer compromises sRNA production and derepresses Xist. Furthermore, without Dicer, Xist RNA cannot accumulate and histone 3 lysine 27 trimethylation is blocked on the inactive X ( Xi). The defects are partially rescued by truncating Tsix. Thus, XCI and RNAi intersect, down- regulating Xist on Xa and spreading silencing on Xi.	[Ogawa, Yuya; Sun, Bryan K.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ogawa, Yuya; Sun, Bryan K.; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Ogawa, Yuya; Sun, Bryan K.; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu		Sun, Bryan/0000-0002-0740-0125	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM058839-10, R01 GM058839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avner P, 1998, GENET RES, V72, P217, DOI 10.1017/S0016672398003516; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Shibata S, 2004, CURR BIOL, V14, P1747, DOI 10.1016/j.cub.2004.09.053; Shibata S, 2003, HUM MOL GENET, V12, P125, DOI 10.1093/hmg/ddg010; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	21	218	246	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1336	1341		10.1126/science.1157676	http://dx.doi.org/10.1126/science.1157676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535243	Green Accepted			2022-12-24	WOS:000256441100044
J	Gerber, SH; Rah, JC; Min, SW; Liu, XR; de Wit, H; Dulubova, I; Meyer, AC; Rizo, J; Arancillo, M; Hammer, RE; Verhage, M; Rosenmund, C; Sudhof, TC				Gerber, Stefan H.; Rah, Jong-Cheol; Min, Sang-Won; Liu, Xinran; de Wit, Heidi; Dulubova, Irina; Meyer, Alexander C.; Rizo, Josep; Arancillo, Marife; Hammer, Robert E.; Verhage, Matthijs; Rosenmund, Christian; Sudhof, Thomas C.			Conformational switch of syntaxin-1 controls synaptic vesicle fusion	SCIENCE			English	Article							CALCIUM-CHANNELS; SNARE COMPLEX; N-TYPE; 1A; EXOCYTOSIS; MUNC18	During synaptic vesicle fusion, the soluble N- ethylmaleimide- sensitive factor- attachment protein receptor ( SNARE) protein syntaxin- 1 exhibits two conformations that both bind to Munc18- 1: a "closed" conformation outside the SNARE complex and an "open" conformation in the SNARE complex. Although SNARE complexes containing open syntaxin- 1 and Munc18- 1 are essential for exocytosis, the function of closed syntaxin- 1 is unknown. We generated knockin/knockout mice that expressed only open syntaxin- 1B. Syntaxin- 1B(Open) mice were viable but succumbed to generalized seizures at 2 to 3 months of age. Binding of Munc18- 1 to syntaxin- 1 was impaired in syntaxin- 1B(Open) synapses, and the size of the readily releasable vesicle pool was decreased; however, the rate of synaptic vesicle fusion was dramatically enhanced. Thus, the closed conformation of syntaxin- 1 gates the initiation of the synaptic vesicle fusion reaction, which is then mediated by SNARE- complex/ Munc18- 1 assemblies.	[Rah, Jong-Cheol; Arancillo, Marife; Rosenmund, Christian] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rah, Jong-Cheol; Arancillo, Marife; Rosenmund, Christian] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Gerber, Stefan H.; Min, Sang-Won; Liu, Xinran; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Rah, Jong-Cheol; Meyer, Alexander C.; Rosenmund, Christian] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Liu, Xinran; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, NL-1081 BT Amsterdam, Netherlands; [Rizo, Josep; Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vrije Universiteit Amsterdam; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosenmund, C (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	rosenmun@bcm.tmc.edu; tcs1@stanford.edu	Rosenmund, Christian/AAC-3596-2020; Meyer, Alexander/F-2479-2010	Rosenmund, Christian/0000-0002-3905-2444; verhage, matthijs/0000-0002-6085-7503; Hammer, Robert E./0000-0001-5487-7551; Rah, Jong-Cheol/0000-0003-3780-0522	Deutsche Forschungsgemeinschaft [GE1042/1-1, GE1042/3-1, GE1042/3-2, Ro1296/5-3]; NIH [NS051262, NS37200]; Netherlands Organization for Scientific Research [GpD970-10-036, GpD900-01-001, GpD916-36-043]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051262, R01NS037200] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Hamlin, I. Kornblum, A. Roth, I. Herfort, and E. Borowicz for technical assistance. This work was supported by grants from Deutsche Forschungsgemeinschaft (GE1042/1-1, GE1042/3-1, and GE1042/3-2 to S.H.G. and Ro1296/5-3 to C.R.), NIH (NS051262 to C.R. and NS37200 to J.R.), and Netherlands Organization for Scientific Research (GpD970-10-036 and 900-01-001 to M.V. and 916-36-043 to H.d.W.).	BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bruno N, 2005, TRENDS COGN SCI, V9, P1, DOI 10.1016/j.tics.2004.11.001; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118	21	205	213	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1507	1510		10.1126/science.1163174	http://dx.doi.org/10.1126/science.1163174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18703708	Green Accepted			2022-12-24	WOS:000259121800046
J	Cheng, HC; Skehan, BM; Campellone, KG; Leong, JM; Rosen, MK				Cheng, Hui-Chun; Skehan, Brian M.; Campellone, Kenneth G.; Leong, John M.; Rosen, Michael K.			Structural mechanism of WASP activation by the enterohaemorrhagic E-coli effector EspF(U)	NATURE			English	Article							N-WASP; ARP2/3 COMPLEX; WASP/SCAR PROTEINS; NMR; TIR; BINDING; TCCP; AUTOINHIBITION; SPECTROSCOPY; INTEGRATION	During infection, enterohaemorrhagic Escherichia coli ( EHEC) takes over the actin cytoskeleton of eukaryotic cells by injecting the EspFU protein into the host cytoplasm(1,2). EspFU controls actin by activating members of the Wiskott - Aldrich syndrome protein ( WASP) family(1-5). Here we show that EspFU binds to the autoinhibitory GTPase binding domain ( GBD) in WASP proteins and displaces it from the activity- bearing VCA domain ( for verprolin homology, central hydrophobic and acidic regions). This interaction potently activates WASP and neural ( N)- WASP in vitro and induces localized actin assembly in cells. In the solution structure of the GBD - EspFU complex, EspFU forms an amphipathic helix that binds the GBD, mimicking interactions of the VCA domain in autoinhibited WASP. Thus, EspFU activates WASP by competing directly for the VCA binding site on the GBD. This mechanism is distinct from that used by the eukaryotic activators Cdc42 and SH2 domains, which globally destabilize the GBD fold to release the VCA(6-8). Such diversity of mechanism in WASP proteins is distinct from other multimodular systems, and may result from the intrinsically unstructured nature of the isolated GBD and VCA elements. The structural incompatibility of the GBD complexes with EspFU and Cdc42/SH2, plus high- affinity EspFU binding, enable EHEC to hijack the eukaryotic cytoskeletal machinery effectively.	[Cheng, Hui-Chun; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Cheng, Hui-Chun; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Skehan, Brian M.; Campellone, Kenneth G.; Leong, John M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu			National Institute of Health [NIH-R01-GM56322, NIH-R01-AI46454]; Welch Foundation [I-1544]; Chilton Foundation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Chilton Foundation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Otomo for discussion and assistance on biochemical assays and NMR spectroscopy; P. Li, I. Martins, C. A. Amezcua, K. H. Gardner and Q. Wu for assistance with NMR spectroscopy and structure calculations; G. K. Amarasinghe andD. W. Leung for sharing reagents; D. Trobaugh, J. Rennie and D. Robbins for technical assistance; S. B. Padrick for help with Mathematica and X. Yao and S. B. Padrick for assistance in writing and for critical reading of the manuscript. This work was supported by grants from the National Institute of Health ( NIH- R01- GM56322 to M. K. R.; NIH- R01- AI46454 to J. M. L.), Welch Foundation ( I - 1544 to M. K. R.) and a Chilton Foundation Fellowship to H.- C. C.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Buck M, 2001, BIOCHEMISTRY-US, V40, P14115, DOI 10.1021/bi0157215; Campellone KG, 2006, CELL MICROBIOL, V8, P1488, DOI 10.1111/j.1462-5822.2006.00728.x; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Campellone KG, 2002, MOL MICROBIOL, V43, P1227, DOI 10.1046/j.1365-2958.2002.02817.x; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2002, PYMOL USERS MANUAL; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Garmendia J, 2006, CELL MICROBIOL, V8, P1444, DOI 10.1111/j.1462-5822.2006.00723.x; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leung DW, 2006, METHOD ENZYMOL, V406, P281, DOI 10.1016/S0076-6879(06)06021-6; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	43	78	81	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					1009	U54		10.1038/nature07160	http://dx.doi.org/10.1038/nature07160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18650809	Green Accepted			2022-12-24	WOS:000258591000042
J	Chatterjee, P				Chatterjee, Patralekha			Health costs of recycling	BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com							0	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 16	2008	337	7666							a296	10.1136/bmj.a296	http://dx.doi.org/10.1136/bmj.a296			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18617494				2022-12-24	WOS:000258669200021
J	Hansen, G; Hercus, TR; McClure, BJ; Stomski, FC; Dottore, M; Powell, J; Ramshaw, H; Woodcock, JM; Xu, YB; Guthridge, M; McKinstry, WJ; Lopez, AF; Parker, MW				Hansen, Guido; Hercus, Timothy R.; McClure, Barbara J.; Stomski, Frank C.; Dottore, Mara; Powell, Jason; Ramshaw, Hayley; Woodcock, Joanna M.; Xu, Yibin; Guthridge, Mark; McKinstry, William J.; Lopez, Angel F.; Parker, Michael W.			The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation	CELL			English	Article							COLONY-STIMULATING FACTOR; COMMON BETA-CHAIN; HIGH-AFFINITY BINDING; IL-5 RECEPTORS; ALPHA-CHAIN; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAINS; HUMAN INTERLEUKIN-3; CRYSTAL-STRUCTURE; GROWTH-FACTOR	Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that controls the production and function of blood cells, is deregulated in clinical conditions such as rheumatoid arthritis and leukemia, yet offers therapeutic value for other diseases. Its receptors are heterodimers consisting of a ligand-specific a subunit and a beta c subunit that is shared with the interleukin (IL)-3 and IL-5 receptors. How signaling is initiated remains an enigma. We report here the crystal structure of the human GM-CSF/GM-CSF receptor ternary complex and its assembly into an unexpected dodecamer or higher-order complex. Importantly, mutagenesis of the GM-CSF receptor at the dodecamer interface and functional studies reveal that dodecamer formation is required for receptor activation and signaling. This unusual form of receptor assembly likely applies also to IL-3 and IL-5 receptors, providing a structural basis for understanding their mechanism of activation and for the development of therapeutics.	[Hercus, Timothy R.; McClure, Barbara J.; Stomski, Frank C.; Dottore, Mara; Powell, Jason; Ramshaw, Hayley; Woodcock, Joanna M.; Guthridge, Mark; Lopez, Angel F.] Hanson Inst, Inst Med & Vet Sci, Div Human Immunol, Adelaide, SA 5000, Australia; [Hansen, Guido; Xu, Yibin; McKinstry, William J.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; St. Vincent's Institute of Medical Research; University of Melbourne	Lopez, AF (corresponding author), Hanson Inst, Inst Med & Vet Sci, Div Human Immunol, Adelaide, SA 5000, Australia.	angel.lopez@imvs.sa.gov.au; mparker@svi.edu.au	Parker, Michael W/F-9069-2013; Hansen, Guido/B-8859-2013; guthridge, mark a/I-1889-2014; McKinstry, William J/D-2612-2013; Ramshaw, Hayley/F-3828-2013; Lopez, Angel F/E-2260-2011	Parker, Michael W/0000-0002-3101-1138; Hansen, Guido/0000-0003-3737-5749; guthridge, mark a/0000-0002-0536-3471; McKinstry, William J/0000-0001-9668-9364; McClure, Barbara/0000-0002-5201-4127; Lopez, Angel F/0000-0001-7430-0135; Powell, jason/0000-0001-8493-9178; Woodcock, Joanna/0000-0001-5127-9687; Ramshaw, Hayley/0000-0001-9909-282X	Commonwealth of Australia; U.S. National Institutes of Health; National Center for Research Resources; U.S. Department of Energy; National Health and Medical Research Council of Australia (NHMRC); National Institutes of Health [RO1-AI50744-02]; Australian Cancer Research Foundation; Australian Research Council Federation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050744] Funding Source: NIH RePORTER	Commonwealth of Australia(Australian Government); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy(United States Department of Energy (DOE)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Cancer Research Foundation; Australian Research Council Federation(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jamie Rossjohn for his contributions during the early stages of this work, Richard D'Andrea for the pEQEco plasmid, Chris Bagley for helpful discussions, and Rebecca Krake and Anna Sapa for technical assistance. We thank Harry Tong and other staff at BioCARS for their help during our visit to the Advanced Photon Source (APS). Access to BioCARS was provided by the Australian Synchrotron Research Program funded by the Commonwealth of Australia. BioCARS is supported by the U.S. National Institutes of Health, National Center for Research Resources. APS is supported by the U.S. Department of Energy. This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC), the National Institutes of Health (RO1-AI50744-02), and the Australian Cancer Research Foundation. H. R. is a Peter Nelson Leukaemia Research Fund Senior Research Fellow. M. W. P. is an Australian Research Council Federation Fellow and an NHMRC Honorary Fellow.	Bagley CJ, 1997, BLOOD, V89, P1471, DOI 10.1182/blood.V89.5.1471.1471_1471_1482; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; BARRY SC, 1994, J BIOL CHEM, V269, P8488; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRIZZI MF, 1994, J BIOL CHEM, V269, P31680; Carr PD, 2006, ACTA CRYSTALLOGR F, V62, P509, DOI 10.1107/S1744309106016812; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dirksen U, 1998, BLOOD, V92, P1097; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Haman A, 1999, J BIOL CHEM, V274, P34155, DOI 10.1074/jbc.274.48.34155; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HERCUS TR, 1994, P NATL ACAD SCI USA, V91, P5838, DOI 10.1073/pnas.91.13.5838; HERCUS TR, 1994, BLOOD, V83, P3500; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jenkins BJ, 1999, J BIOL CHEM, V274, P8669, DOI 10.1074/jbc.274.13.8669; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; Lia F, 1996, J BIOL CHEM, V271, P28287, DOI 10.1074/jbc.271.45.28287; Lilly MB, 2001, BLOOD, V97, P1662, DOI 10.1182/blood.V97.6.1662; LOCK P, 1994, P NATL ACAD SCI USA, V91, P252, DOI 10.1073/pnas.91.1.252; LOPEZ AF, 1992, EMBO J, V11, P909, DOI 10.1002/j.1460-2075.1992.tb05129.x; McClure BJ, 2003, BLOOD, V101, P1308, DOI 10.1182/blood-2002-06-1903; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Rajotte D, 1997, J EXP MED, V185, P1939, DOI 10.1084/jem.185.11.1939; Ramshaw HS, 2002, EXP HEMATOL, V30, P1124, DOI 10.1016/S0301-472X(02)00903-7; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rossjohn J, 2000, BLOOD, V95, P2491; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Soldi R, 1997, BLOOD, V89, P863, DOI 10.1182/blood.V89.3.863; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Stomski FC, 1996, MOL CELL BIOL, V16, P3035; Sun XL, 2002, VACCINE, V20, P1466, DOI 10.1016/S0264-410X(01)00476-5; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; WilsonRawls J, 1996, CANCER RES, V56, P3426; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1997, BLOOD, V90, P3005, DOI 10.1182/blood.V90.8.3005; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999	53	223	235	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 8	2008	134	3					496	507		10.1016/j.cell.2008.05.053	http://dx.doi.org/10.1016/j.cell.2008.05.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692472	Bronze			2022-12-24	WOS:000258665500022
J	Keenan, RA; De Riva, A; Corleis, B; Hepburn, L; Licence, S; Winkler, TH; Martensson, IL				Keenan, Rebecca A.; De Riva, Alessandra; Corleis, Bjorn; Hepburn, Lucy; Licence, Steve; Winkler, Thomas H.; Martensson, Inga-Lill			Censoring of autoreactive B cell development by the pre-B cell receptor	SCIENCE			English	Article							SURROGATE LIGHT-CHAIN; ANTIBODY DIVERSITY; SELECTION; GENE; REPERTOIRE; MICE; DNA	Antibody diversity occurs randomly as B cells recombine their immunoglobulin ( Ig) heavy- and light- chain genes during development. This process inevitably generates reactivity against self structures, and several mechanisms prevent the development of autoreactive B cells. We report here a role for the pre- B cell receptor, composed of Ig heavy and surrogate light chains, in the negative selection of cells expressing Ig heavy chains with the potential to generate autoantibodies. Surrogate light- chain- deficient (SLC-/-) mice harbored elevated levels of antinuclear antibodies (ANAs) in their serum and showed evidence of escape of pre- B cells expressing prototypic autoantibody heavy chains from negative selection, leading to mature autoantibody secreting CD21(-)CD23(-) B cells in the periphery. Thus, the pre- B cell receptor appears to censor the development of certain autoantibody- secreting cells and may represent an important factor in multifactorial autoimmune diseases.	[Keenan, Rebecca A.; De Riva, Alessandra; Corleis, Bjorn; Hepburn, Lucy; Licence, Steve; Martensson, Inga-Lill] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Corleis, Bjorn] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Winkler, Thomas H.] Nikolaus Fiebiger Ctr, Hematopoiesis Unit, D-91054 Erlangen, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Freiburg; University of Erlangen Nuremberg	Martensson, IL (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England.	lill.martensson@bbsrc.ac.uk		Martensson, Inga-Lill/0000-0003-3415-0560	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARBAS SM, 1995, P NATL ACAD SCI USA, V92, P2529, DOI 10.1073/pnas.92.7.2529; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Giles I, 2006, J IMMUNOL, V177, P1729, DOI 10.4049/jimmunol.177.3.1729; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Harfst E, 2005, IMMUNOL LETT, V101, P173, DOI 10.1016/j.imlet.2005.05.013; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; KEENAN R, 2006, THESIS CAMBRIDGE U, P23513; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Minegishi Y, 2001, IMMUNITY, V14, P631, DOI 10.1016/S1074-7613(01)00131-5; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vettermann C, 2006, SEMIN IMMUNOL, V18, P44, DOI 10.1016/j.smim.2006.01.001; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	27	100	101	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					696	699		10.1126/science.1157533	http://dx.doi.org/10.1126/science.1157533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18566249				2022-12-24	WOS:000258077700045
J	Lencer, WI				Lencer, Wayne I.			Patching a leaky intestine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Lencer, WI (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.			Lencer, Wayne/0000-0001-7346-2730	NIDDK NIH HHS [P30 DK034854, R01 DK084424, R37 DK048106, P30 DK040561] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R37DK048106, R01DK084424, P30DK040561] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; JOHANSEN FE, 2006, PHYSL GASTROINTESTIN, V2, P1067; MA TY, 2006, PHYSL GASTROINTESTIN, V2, P1559; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2008	359	5					526	528		10.1056/NEJMcibr0803745	http://dx.doi.org/10.1056/NEJMcibr0803745			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331VC	18669433	Green Accepted			2022-12-24	WOS:000258039700014
J	Luik, RM; Wang, B; Prakriya, M; Wu, MM; Lewis, RS				Luik, Riina M.; Wang, Bin; Prakriya, Murali; Wu, Minnie M.; Lewis, Richard S.			Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation	NATURE			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; STORE DEPLETION; PROTEIN; ORAI1; MECHANISM; DOMAIN; SENSOR	Ca(2+)-release-activated Ca(2+) (CRAC) channels generate sustained Ca(2+) signals that are essential for a range of cell functions, including antigen-stimulated T lymphocyte activation and proliferation(1,2). Recent studies(3) have revealed that the depletion of Ca(2+) from the endoplasmic reticulum (ER) triggers the oligomerization of stromal interaction molecule 1 (STIM1), the ER Ca(2+) sensor, and its redistribution to ER-plasma membrane (ER-PM) junctions(4-8) where the CRAC channel subunit ORAI1 accumulates in the plasma membrane and CRAC channels open(9-12). However, how the loss of ER Ca(2+) sets into motion these coordinated molecular rearrangements remains unclear. Here we define the relationships among [Ca(2+)](ER), STIM1 redistribution and CRAC channel activation and identify STIM1 oligomerization as the critical [Ca(2+)](ER)-dependent event that drives store-operated Ca(2+) entry. In human Jurkat leukaemic T cells expressing an ER-targeted Ca(2+) indicator, CRAC channel activation and STIM1 redistribution follow the same function of [Ca(2+)](ER), reaching half-maximum at similar to 200 mu M with a Hill coefficient of similar to 4. Because STIM1 binds only a single Ca(2+) ion(5), the high apparent cooperativity suggests that STIM1 must first oligomerize to enable its accumulation at ER-PM junctions. To assess directly the causal role of STIM1 oligomerization in store-operated Ca(2+) entry, we replaced the luminal Ca(2+)-sensing domain of STIM1 with the 12-kDa FK506- and rapamycin-binding protein (FKBP12, also known as FKBP1A) or the FKBP-rapamycin binding (FRB) domain of the mammalian target of rapamycin (mTOR, also known as FRAP1). A rapamycin analogue oligomerizes the fusion proteins and causes them to accumulate at ER-PM junctions and activate CRAC channels without depleting Ca(2+) from the ER. Thus, STIM1 oligomerization is the critical transduction event through which Ca(2+) store depletion controls store-operated Ca(2+) entry, acting as a switch that triggers the self-organization and activation of STIM1-ORAI1 clusters at ER-PM junctions.	[Luik, Riina M.; Wang, Bin; Prakriya, Murali; Wu, Minnie M.; Lewis, Richard S.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Lewis, RS (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	rslewis@stanford.edu		Lewis, Richard/0000-0002-6010-7403; Prakriya, Murali/0000-0003-0781-4480	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290] Funding Source: Medline; NIGMS NIH HHS [R01 GM045374, R01 GM045374-18] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	31	407	417	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					538	U11		10.1038/nature07065	http://dx.doi.org/10.1038/nature07065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18596693	Green Accepted			2022-12-24	WOS:000257860300056
J	Tabin, CJ; McMahon, AP				Tabin, Clifford J.; McMahon, Andrew P.			Grasping limb patterning	SCIENCE			English	Editorial Material							SONIC-HEDGEHOG; EMBRYONIC LETHALITY; FEEDBACK LOOP; MAMMARY-GLAND; CYCLIN D1; GROWTH; DEFECTS		[Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [McMahon, Andrew P.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@receptor.med.harvard.edu			NINDS NIH HHS [R37 NS033642] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roy S, 2002, J CELL SCI, V115, P4393, DOI 10.1242/jcs.00158; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; TABIN CJ, 1992, DEVELOPMENT, V116, P289; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	19	27	28	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					350	352		10.1126/science.1162474	http://dx.doi.org/10.1126/science.1162474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635784				2022-12-24	WOS:000257713900029
J	Yamada, T; Dautry, A; Walport, M				Yamada, Tadataka; Dautry, Alice; Walport, Mark			Ready for avian flu?	NATURE			English	Editorial Material							VACCINE		[Yamada, Tadataka] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; [Dautry, Alice] Inst Pasteur, F-75724 Paris, France; [Walport, Mark] Wellcome Trust Res Labs, London NW1 2BE, England	Bill & Melinda Gates Foundation; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Yamada, T (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, 1551 Eastlake Ave E, Seattle, WA 98102 USA.			Walport, Mark/0000-0001-7220-5273				Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948	3	9	9	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					162	162		10.1038/454162a	http://dx.doi.org/10.1038/454162a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615064	Bronze			2022-12-24	WOS:000257466900021
J	Goldston, D				Goldston, David			Getting it across	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					16	16		10.1038/454016a	http://dx.doi.org/10.1038/454016a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596778	Bronze			2022-12-24	WOS:000257308300012
J	Coovadia, HM; Schaller, JG				Coovadia, H. M.; Schaller, Jane G.			HIV/AIDS in children: a disaster in the making	LANCET			English	Editorial Material							HIV TRANSMISSION; SURVIVAL; COUNTRIES		[Schaller, Jane G.] British Columbia Childrens Hosp, Dept Pediat, Int Pediat Assoc, Vancouver, BC V6H 3V4, Canada; [Coovadia, H. M.] Nelson Mandela Sch Med, ZA-4013 Congella, South Africa	BC Childrens Hospital; University of British Columbia; University of Kwazulu Natal	Schaller, JG (corresponding author), British Columbia Childrens Hosp, Dept Pediat, Int Pediat Assoc, Vancouver, BC V6H 3V4, Canada.	jschaller@cw.bc.ca						Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Coovadia H, 2008, CURR OPIN INFECT DIS, V21, P11, DOI 10.1097/QCO.0b013e3282f40689; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; *UNAIDS WHO, 2007, AIDS EP UPD; UNICEF, 2007, STAT WORLDS CHILDR 2; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wilfert CM, 2007, J INFECT DIS, V195, P165, DOI 10.1086/510255	12	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					271	273		10.1016/S0140-6736(08)61090-9	http://dx.doi.org/10.1016/S0140-6736(08)61090-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657693				2022-12-24	WOS:000258042800009
J	Wolfe, RR; Miller, SL				Wolfe, Robert R.; Miller, Sharon L.			The recommended dietary allowance of protein - A misunderstood concept	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESSURE; HEALTH; MUSCLE		[Wolfe, Robert R.] Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Ctr Translat Res Aging & Longev, Little Rock, AR 72205 USA; [Miller, Sharon L.] SLM Consulting, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences	Wolfe, RR (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Ctr Translat Res Aging & Longev, 4301 W Markham St,Slot 806, Little Rock, AR 72205 USA.	rwolfe2@uams.edu						Campbell WW, 2001, J GERONTOL A-BIOL, V56, pM373, DOI 10.1093/gerona/56.6.M373; Dawson-Hughes B, 2003, P NUTR SOC, V62, P505, DOI 10.1079/PNS2003267; Institute of Medicine, 2005, DIET REF INT EN CARB; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stratton RJ, 2005, AGEING RES REV, V4, P422, DOI 10.1016/j.arr.2005.03.005; U.S. Department of Agriculture, NAT SCH LUNCH PROGR; U.S. Department of Health and Human Services, 2005, 2005 DIET GUID AM; Wilson MMG, 2002, AM J CLIN NUTR, V75, P944, DOI 10.1093/ajcn/75.5.944; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Wright Jacqueline D, 2003, Adv Data, P1	11	63	66	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2891	2893		10.1001/jama.299.24.2891	http://dx.doi.org/10.1001/jama.299.24.2891			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577734				2022-12-24	WOS:000257021800027
J	Miles, L; Kapos, V				Miles, Lera; Kapos, Valerie			Reducing greenhouse gas emissions from deforestation and forest degradation: Global land-use implications	SCIENCE			English	Editorial Material							TROPICAL FORESTS; PROTECTED AREAS; CONSERVATION	Recent climate talks in Bali have made progress toward action on deforestation and forest degradation in developing countries, within the anticipated post-Kyoto emissions reduction agreements. As a result of such action, many forests will be better protected, but some land-use change will be displaced to other locations. The demonstration phase launched at Bali offers an opportunity to examine potential outcomes for biodiversity and ecosystem services. Research will be needed into selection of priority areas for reducing emissions from deforestation and forest degradation to deliver multiple benefits, on-the-ground methods to best ensure these benefits, and minimization of displaced land-use change into nontarget countries and ecosystems, including through revised conservation investments.	[Miles, Lera; Kapos, Valerie] WCMC, UNEP, Cambridge CB3 0DL, England; [Kapos, Valerie] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England	University of Cambridge	Miles, L (corresponding author), WCMC, UNEP, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	lera.miles@unep-wcmc.org; val.kapos@unep-wcmc.org	Kapos, Valerie/G-3136-2010; Miles, Lera/C-7334-2009	Kapos, Valerie/0000-0002-5739-8262; Miles, Lera/0000-0003-0377-5904				Aukland L, 2003, CLIM POLICY, V3, P123; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dutschke M., 2007, REDUCING EMISSIONS D; Ebeling J, 2008, PHILOS T R SOC B, V363, P1917, DOI 10.1098/rstb.2007.0029; *FAO, FAOSTAT PROD FORESTA; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Laurance WF, 2007, BIOTROPICA, V39, P20, DOI 10.1111/j.1744-7429.2006.00229.x; Mollicone D, 2007, CLIMATIC CHANGE, V83, P477, DOI 10.1007/s10584-006-9231-2; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Niles JO, 2002, PHILOS T ROY SOC A, V360, P1621, DOI 10.1098/rsta.2002.1023; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Santilli M, 2005, CLIMATIC CHANGE, V71, P267, DOI 10.1007/s10584-005-8074-6; Wagner F., 2003, IPCC GOOD PRACTICE G; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; *WORLD BANK, 2002, BIOD CONS FOR EC WOR	17	305	324	7	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1454	1455		10.1126/science.1155358	http://dx.doi.org/10.1126/science.1155358			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556549				2022-12-24	WOS:000256676400032
J	Silverman, JG; Decker, MR; Saggurti, N; Balaiah, D; Raj, A				Silverman, Jay G.; Decker, Michele R.; Saggurti, Niranjan; Balaiah, Donta; Raj, Anita			Intimate partner violence and HIV infection among married Indian women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENDER-BASED VIOLENCE; SEXUALLY-TRANSMITTED INFECTION; RURAL EASTERN CAPE; DOMESTIC VIOLENCE; RISK BEHAVIOR; PHYSICAL VIOLENCE; HIV/AIDS EPIDEMIC; DATING VIOLENCE; SOUTH-AFRICA; MEN	Context Despite reductions in prevalence of human immunodeficiency virus (HIV) infection among the general population of India, women account for a rising percentage of all HIV cases with husbands' risk behavior described as the major source of women's infection. Intimate partner violence (IPV) has been described as being associated with heterosexual transmission of HIV to women in India and elsewhere. Objective To assess the relationship between experiencing IPV and the occurrence of HIV infection in a nationally representative sample of married Indian women tested for HIV. Design, Setting, and Participants The Indian National Family Health Survey 3 was conducted across all Indian states in 2005 through 2006. The nationally representative sample included 124 385 married women; analyses conducted in 2007 and 2008 were limited to 28 139 married women who provided IPV data and HIV test results via systematic selection into respective subsamples. Main Outcome Measures Prevalence estimates of lifetime IPV and HIV infection were calculated and demographic differences assessed. Intimate partner violence was conceptualized as physical violence with or without sexual violence and then was further categorized as physical violence only vs physical and sexual violence. Regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for HIV infection among Indian women based on experiences of IPV after adjusting for demographics and women's HIV risk behaviors. Results One-third of married Indian women (35.49%) reported experiencing physical IPV with or without sexual violence from their husbands; 7.68% reported both physical and sexual IPV, and 27.80% reported experiencing physical IPV in the absence of sexual violence. Approximately 1 in 450 women (0.22%) tested positive for HIV. In adjusted models, married Indian women experiencing both physical and sexual violence from husbands demonstrated elevated HIV infection prevalence vs those not experiencing IPV (0.73% vs 0.19%; adjusted OR, 3.92; 95% CI, 1.41-10.94; P = .01). Physical IPV alone was not associated with risk of HIV infection. Women's personal sexual risk behaviors were not associated with HIV infection. Conclusions Among married Indian women, physical violence combined with sexual violence from husbands was associated with an increased prevalence of HIV infection. Prevention of IPV may augment efforts to reduce the spread of HIV/AIDS.	[Silverman, Jay G.; Decker, Michele R.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Balaiah, Donta] Indian Council Med Res, Inst Res Reprod, Bombay 400012, Maharashtra, India; [Raj, Anita] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Boston University	Silverman, JG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 667 Huntington Ave, Boston, MA 02115 USA.	jsilverm@hsph.harvard.edu		Saggurti, Niranjan/0000-0002-5267-8425; Decker, Michele/0000-0002-7085-7080	NICHD NIH HHS [R03HD055120] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD055120] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], HIV AIDS IND; Bates LM, 2004, INT FAM PLAN PERSPEC, V30, P190, DOI 10.1363/3019004; Bhuiya A, 2003, J HEALTH POPUL NUTR, V21, P48; Chandrasekaran Varalakshmi, 2007, Indian J Med Sci, V61, P253; Chatterjee N, 2006, J HEALTH POPUL NUTR, V24, P81; Decker MR, 2008, INT J GYNECOL OBSTET, V100, P18, DOI 10.1016/j.ijgo.2007.06.045; Decker MR, 2005, PEDIATRICS, V116, pE272, DOI 10.1542/peds.2005-0194; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dunkle KL, 2007, SEX TRANSM INFECT, V83, P173, DOI 10.1136/sti.2007.024950; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gilbert L, 2007, J URBAN HEALTH, V84, P667, DOI 10.1007/s11524-007-9214-2; Go VF, 2003, AIDS BEHAV, V7, P263, DOI 10.1023/A:1025443719490; Godbole S, 2005, INDIAN J MED RES, V121, P356; *INT I POP SCI MAC, IND NAT FAM HLTH SUR; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; *JOINT UN PROGR HI, 2007 AIDS EP UPD; *JOINT UN PROGR HI, IND COUNTR PROF; *JOINT UN PROGR HI, NEP COUNTR PROF; Joint United Nations Programme on HIV/AIDS, REP GLOB AIDS EP; Koenig MA, 2006, AM J PUBLIC HEALTH, V96, P132, DOI 10.2105/AJPH.2004.050872; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.2307/3180801; Krishnan Suneeta, 2005, Health Care Women Int, V26, P87, DOI 10.1080/07399330490493368; Kumar S, 2005, BRIT J PSYCHIAT, V187, P62, DOI 10.1192/bjp.187.1.62; Martin SL, 2004, LANCET, V363, P1410, DOI 10.1016/S0140-6736(04)16133-3; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; Mehta SH, 2006, JAIDS-J ACQ IMM DEF, V41, P75, DOI 10.1097/01.qai.0000174653.17911.4a; Mercer A, 2007, SEX TRANSM DIS, V34, P265, DOI 10.1097/01.olq.0000240384.61924.65; Naved RT, 2006, SOC SCI MED, V62, P2917, DOI 10.1016/j.socscimed.2005.12.001; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Patel V, 2006, SEX TRANSM INFECT, V82, P243, DOI 10.1136/sti.2005.016451; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Purwar M B, 1999, J Obstet Gynaecol Res, V25, P165; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Raj A, 2007, AIDS CARE, V19, P970, DOI 10.1080/09540120701335246; Raj A, 2006, AM J PUBLIC HEALTH, V96, P1873, DOI 10.2105/AJPH.2005.081554; Schensul SL, 2006, J URBAN HEALTH, V83, P614, DOI 10.1007/s11524-006-9076-z; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; Sivaram S, 2005, HEALTH PROMOT INT, V20, P327, DOI 10.1093/heapro/dai012; Slaughter L, 1997, AM J OBSTET GYNECOL, V176, P609, DOI 10.1016/S0002-9378(97)70556-8; StataCorp, 2005, STAT STAT SOFTW REL; Stephenson Rob, 2007, Indian J Med Sci, V61, P251; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; WHO, PUTT WOM 1 ETH SAF R; *WHO JOINT UN PROG, GUID MEAS NAT HIV PR; Wingood GM, 2003, J URBAN HEALTH, V80, P67; Wingood GM, 2000, AM J PREV MED, V19, P270, DOI 10.1016/S0749-3797(00)00228-2; World Health Organization (WHO), VIOL WOM HIV AIDS CR; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	55	191	194	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2008	300	6					703	710		10.1001/jama.300.6.703	http://dx.doi.org/10.1001/jama.300.6.703			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	336OM	18698068	Bronze			2022-12-24	WOS:000258374500022
J	King-Casas, B; Sharp, C; Lomax-Bream, L; Lohrenz, T; Fonagy, P; Montague, PR				King-Casas, Brooks; Sharp, Carla; Lomax-Bream, Laura; Lohrenz, Terry; Fonagy, Peter; Montague, P. Read			The rupture and repair of cooperation in borderline personality disorder	SCIENCE			English	Article							TIT-FOR-TAT; DECISION-MAKING; PRISONERS-DILEMMA; NEURAL BASIS; SOCIAL COOPERATION; INSULA ACTIVATION; EVOLUTION; RISK; TRUST; MECHANISMS	To sustain or repair cooperation during a social exchange, adaptive creatures must understand social gestures and the consequences when shared expectations about fair exchange are violated by accident or intent. We recruited 55 individuals afflicted with borderline personality disorder (BPD) to play a multiround economic exchange game with healthy partners. Behaviorally, individuals with BPD showed a profound incapacity to maintain cooperation, and were impaired in their ability to repair broken cooperation on the basis of a quantitative measure of coaxing. Neurally, activity in the anterior insula, a region known to respond to norm violations across affective, interoceptive, economic, and social dimensions, strongly differentiated healthy participants from individuals with BPD. Healthy subjects showed a strong linear relation between anterior insula response and both magnitude of monetary offer received from their partner (input) and the amount of money repaid to their partner (output). In stark contrast, activity in the anterior insula of BPD participants was related only to the magnitude of repayment sent back to their partner (output), not to the magnitude of offers received (input). These neural and behavioral data suggest that norms used in perception of social gestures are pathologically perturbed or missing altogether among individuals with BPD. This game-theoretic approach to psychopathology may open doors to new ways of characterizing and studying a range of mental illnesses.	[King-Casas, Brooks; Lohrenz, Terry; Montague, P. Read] Baylor Coll Med, Computat Psychiat Unit, Houston, TX 77030 USA; [King-Casas, Brooks; Lohrenz, Terry; Montague, P. Read] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [King-Casas, Brooks; Sharp, Carla; Lomax-Bream, Laura; Fonagy, Peter; Montague, P. Read] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Fonagy, Peter] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Fonagy, Peter] Anna Freud Ctr, London NW3 5SD, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; The Anna Freud Centre	Montague, PR (corresponding author), Baylor Coll Med, Computat Psychiat Unit, 1 Baylor Plaza, Houston, TX 77030 USA.	rmontague@hnl.bcm.edu		Fonagy, Peter/0000-0003-0229-0091; Sharp, Carla/0000-0001-8349-4701	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH078485, R01MH052797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA011723, DA11723] Funding Source: Medline; NIMH NIH HHS [MH078485, MH52797, F32 MH078485, R01 MH052797] Funding Source: Medline; NINDS NIH HHS [R01 NS045790, NS045790] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BENDOR J, 1991, J CONFLICT RESOLUT, V35, P691, DOI 10.1177/0022002791035004007; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chiu PH, 2008, NEURON, V57, P463, DOI 10.1016/j.neuron.2007.12.020; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fonagy P, 2006, J CLIN PSYCHOL, V62, P411, DOI 10.1002/jclp.20241; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; FUDENBERG D, 1990, AM ECON REV, V80, P274; Gintis H., 2000, GAME THEORY EVOLVING; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Putnam KM, 2005, DEV PSYCHOPATHOL, V17, P899, DOI 10.1017/S0954579405050431; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rogers J, 2006, PSYCHOL MED, V36, P1789, DOI 10.1017/S0033291706008853; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Sieswerda S, 2005, J BEHAV THER EXP PSY, V36, P209, DOI 10.1016/j.jbtep.2005.05.004; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Todorov A, 2006, BRAIN RES, V1079, P76, DOI 10.1016/j.brainres.2005.12.114; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; WU JZ, 1995, J CONFLICT RESOLUT, V39, P183, DOI 10.1177/0022002795039001008	54	400	408	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					806	810		10.1126/science.1156902	http://dx.doi.org/10.1126/science.1156902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	334ZQ	18687957	Green Accepted, Green Submitted			2022-12-24	WOS:000258261000037
J	Hong, ST; Bang, S; Hyun, S; Kang, JK; Jeong, K; Paik, D; Chung, JK; Kim, J				Hong, Sung-Tae; Bang, Sunhoe; Hyun, Seogang; Kang, Jongkyun; Jeong, Kyunghwa; Paik, Donggi; Chung, Jongkyeong; Kim, Jaeseob			cAMP signalling in mushroom bodies modulates temperature preference behaviour in Drosophila	NATURE			English	Article							TOXIN LIGHT-CHAIN; SHORT-TERM-MEMORY; OLFACTORY MEMORY; EXPRESSION; NEURONS; GENETICS; SYSTEMS; GENES	Homoiotherms, for example mammals, regulate their body temperature with physiological responses such as a change of metabolic rate and sweating. In contrast, the body temperature of poikilotherms, for example Drosophila, is the result of heat exchange with the surrounding environment as a result of the large ratio of surface area to volume of their bodies(1,2). Accordingly, these animals must instinctively move to places with an environmental temperature as close as possible to their genetically determined desired temperature. The temperature that Drosophila instinctively prefers has a function equivalent to the 'set point' temperature in mammals. Although various temperature-gated TRP channels have been discovered(3,4), molecular and cellular components in Drosophila brain responsible for determining the desired temperature remain unknown. We identified these components by performing a large-scale genetic screen of temperature preference behaviour (TPB) in Drosophila(5,6). In parallel, we mapped areas of the Drosophila brain controlling TPB by targeted inactivation of neurons with tetanus toxin(7) and a potassium channel (Kir2.1)(8) driven with various brain-specific GAL4s. Here we show that mushroom bodies (MBs) and the cyclic AMP-cAMP-dependent protein kinase A (cAMP-PKA) pathway are essential for controlling TPB. Furthermore, targeted expression of cAMP-PKA pathway components in only the MB was sufficient to rescue abnormal TPB of the corresponding mutants. Preferred temperatures were affected by the level of cAMP and PKA activity in the MBs in various PKA pathway mutants.	[Hong, Sung-Tae; Bang, Sunhoe; Hyun, Seogang; Kang, Jongkyun; Jeong, Kyunghwa; Paik, Donggi; Chung, Jongkyeong; Kim, Jaeseob] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kjaeseob@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021	Kang, Jongkyun/0000-0003-0259-110X; Hong, Sung-Tae/0000-0001-5981-4859; Paik, Donggi/0000-0003-1031-0371				Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bear M.F., 2007, NEUROSCIENCE, Vthird; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; EISEL U, 1993, EMBO J, V12, P3365, DOI 10.1002/j.1460-2075.1993.tb06010.x; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rister J, 2006, J NEUROBIOL, V66, P1271, DOI 10.1002/neu.20284; Rodan AR, 2002, J NEUROSCI, V22, P9490; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Skoulakis EMC, 2006, CELL MOL LIFE SCI, V63, P975, DOI 10.1007/s00018-006-6023-9; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	27	56	59	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					771	U97		10.1038/nature07090	http://dx.doi.org/10.1038/nature07090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18594510				2022-12-24	WOS:000258228000046
J	Matsuzawa, A; Tseng, PH; Vallabhapurapu, S; Luo, JL; Zhang, WZ; Wang, HP; Vignali, DAA; Gallagher, E; Karin, M				Matsuzawa, Atsushi; Tseng, Ping-Hui; Vallabhapurapu, Sivakumar; Luo, Jun-Li; Zhang, Weizhou; Wang, Haopeng; Vignali, Dario A. A.; Gallagher, Ewen; Karin, Michael			Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; IKK ACTIVATION; APOPTOSIS; KINASE; TRAF2; UBIQUITINATION; TRANSDUCTION; DOMAIN; DEGRADATION; SPECIFICITY	Cytokine signaling is thought to require assembly of multicomponent signaling complexes at cytoplasmic segments of membrane- embedded receptors, in which receptor- proximal protein kinases are activated. Indeed, CD40, a tumor necrosis factor receptor ( TNFR) family member, forms a complex containing adaptor molecules TRAF2 and TRAF3, ubiquitin- conjugating enzyme Ubc13, cellular inhibitor of apoptosis proteins 1 and 2 ( c-IAP1/2), I kappa B kinase regulatory subunit IKK gamma ( also called NEMO), and mitogen- activated protein kinase ( MAPK) kinase kinase MEKK1 upon ligation. TRAF2, Ubc13, and IKK gamma were required for complex assembly and activation of MEKK1 and MAPK cascades. However, these kinases were not activated unless the multicomponent signaling complex translocated from CD40 to the cytosol upon c-IAP1/2-induced degradation of TRAF3. This two- stage signaling mechanism may apply to other innate immune receptors, accounting for spatial and temporal separation of MAPK and IKK signaling.	[Matsuzawa, Atsushi; Tseng, Ping-Hui; Vallabhapurapu, Sivakumar; Luo, Jun-Li; Zhang, Weizhou; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Matsuzawa, Atsushi; Tseng, Ping-Hui; Vallabhapurapu, Sivakumar; Luo, Jun-Li; Zhang, Weizhou; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Wang, Haopeng; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gallagher, Ewen] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Fac Med, London W2 1PG, England	University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; Imperial College London	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Wang, Haopeng/F-3263-2012; Matsuzawa, Atsushi/GLU-1387-2022	Wang, Haopeng/0000-0002-4995-0838; Luo, Jun-Li/0000-0002-7625-4766; Matsuzawa, Atsushi/0000-0001-8303-3905	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI052199, R56AI052199, R21AI052199] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIAID NIH HHS [R01 AI043477, AI043477, R01 AI043477-12, AI52199] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang HK, 2000, J BIOL CHEM, V275, P26661; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia Z. P., 2005, SCI STKE, V2005, ppe7; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	30	181	191	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					663	668		10.1126/science.1157340	http://dx.doi.org/10.1126/science.1157340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18635759	Green Accepted			2022-12-24	WOS:000258077700036
J	Vonk, FJ; Admiraal, JF; Jackson, K; Reshef, R; de Bakker, MAG; Vanderschoot, K; van den Berge, I; van Atten, M; Burgerhout, E; Beck, A; Mirtschin, PJ; Kochva, E; Witte, F; Fry, BG; Woods, AE; Richardson, MK				Vonk, Freek J.; Admiraal, Jeroen F.; Jackson, Kate; Reshef, Ram; de Bakker, Merijn A. G.; Vanderschoot, Kim; van den Berge, Iris; van Atten, Marit; Burgerhout, Erik; Beck, Andrew; Mirtschin, Peter J.; Kochva, Elazar; Witte, Frans; Fry, Bryan G.; Woods, Anthony E.; Richardson, Michael K.			Evolutionary origin and development of snake fangs	NATURE			English	Article							EMBRYONIC-DEVELOPMENT; PYTHON-SEBAE; VENOM; APPARATUS; DENTITION; GLAND	Many advanced snakes use fangs - specialized teeth associated with a venom gland(1,2) - to introduce venom into prey or attacker. Various front- and rear- fanged groups are recognized, according to whether their fangs are positioned anterior ( for example cobras and vipers) or posterior ( for example grass snakes) in the upper jaw(3-5). A fundamental controversy in snake evolution is whether or not front and rear fangs share the same evolutionary and developmental origin(3-9). Resolving this controversy could identify a major evolutionary transition underlying the massive radiation of advanced snakes, and the associated developmental events. Here we examine this issue by visualizing the tooth- forming epithelium in the upper jaw of 96 snake embryos, covering eight species. We use the sonic hedgehog gene as a marker(10-13), and three- dimensionally reconstruct the development in 41 of the embryos. We show that front fangs develop from the posterior end of the upper jaw, and are strikingly similar in morphogenesis to rear fangs. This is consistent with their being homologous. In front- fanged snakes, the anterior part of the upper jaw lacks sonic hedgehog expression, and ontogenetic allometry displaces the fang from its posterior developmental origin to its adult front position - consistent with an ancestral posterior position of the front fang. In rear- fanged snakes, the fangs develop from an independent posterior dental lamina and retain their posterior position. In light of our findings, we put forward a new model for the evolution of snake fangs: a posterior subregion of the tooth- forming epithelium became developmentally uncoupled from the remaining dentition, which allowed the posterior teeth to evolve independently and in close association with the venom gland, becoming highly modified in different lineages. This developmental event could have facilitated the massive radiation of advanced snakes in the Cenozoic era, resulting in the spectacular diversity of snakes seen today(6,14,15).	[Vonk, Freek J.; Admiraal, Jeroen F.; de Bakker, Merijn A. G.; Vanderschoot, Kim; van den Berge, Iris; van Atten, Marit; Burgerhout, Erik; Witte, Frans; Richardson, Michael K.] Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; [Jackson, Kate] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA; [Reshef, Ram] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Beck, Andrew; Mirtschin, Peter J.; Woods, Anthony E.] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Mirtschin, Peter J.] Venom Supplies Pty Ltd, Tanunda, SA 5352, Australia; [Kochva, Elazar] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Fry, Bryan G.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Parkville, Vic 3010, Australia	Leiden University; Leiden University - Excl LUMC; Whitman College; Technion Israel Institute of Technology; University of South Australia; Tel Aviv University; University of Melbourne	Richardson, MK (corresponding author), Leiden Univ, Inst Biol, Kaiserstr 63,POB 9516, NL-2300 RA Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Richardson, Michael K/E-8269-2011; Burgerhout, Erik/AAI-4527-2020; Woods, Anthony/D-2644-2009	Richardson, Michael K/0000-0003-1222-8101; de Bakker, Merijn/0000-0002-2061-7986				ANTHONY J., 1955, ANN SCI NAT ZOOL, V17, P7; Bogert Charles Mitchill, 1943, BULL AMER MUS NAT HIST, V81, P285; Boulenger G. A., 1896, Proceedings of the Zoological Society of London, P614; Buchtova M, 2007, ZOOLOGY, V110, P231, DOI 10.1016/j.zool.2007.01.006; Cobourne MT, 2005, CURR TOP DEV BIOL, V65, P255; COPE ED, 1900, US NATL MUS REP, P153; Fraser GJ, 2006, EVOL DEV, V8, P446, DOI 10.1111/j.1525-142X.2006.00118.x; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; FRAZZETTA TH, 1966, J MORPHOL, V118, P217, DOI 10.1002/jmor.1051180206; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Gygax P, 1971, Acta Trop, V28, P226; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Jackson K, 2007, TOXICON, V49, P975, DOI 10.1016/j.toxicon.2007.01.007; Jackson Kate, 1995, Amphibia-Reptilia, V16, P273, DOI 10.1163/156853895X00073; Kardong K.V., 1983, Memorias do Instituto Butantan (Sao Paulo), V46, P105; KARDONG KV, 1980, AM ZOOL, V20, P269; KARDONG KV, 1979, EVOLUTION, V33, P433, DOI 10.1111/j.1558-5646.1979.tb04696.x; Kochva E., 1978, P43; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; KOCHVA E, 1963, ACTA ANAT, V52, P49; Kuch U, 2006, NATURWISSENSCHAFTEN, V93, P84, DOI 10.1007/s00114-005-0065-y; MARTIN H, 1899, CR ASSOC ANAT, V1, P56; OVADIA M, 1984, COPEIA, P516; RESHEF R, 1994, J EXP ZOOL, V270, P538, DOI 10.1002/jez.1402700607; RESHEF R, 1994, THESIS U TEL AVIV; SHAYER-WOLLBERG M, 1967, Herpetologica, V23, P249; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Yamanaka A, 2007, EUR J ORAL SCI, V115, P433, DOI 10.1111/j.1600-0722.2007.00499.x; Young Bruce A., 1996, Amphibia-Reptilia, V17, P261, DOI 10.1163/156853896X00432	30	121	122	3	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					630	633		10.1038/nature07178	http://dx.doi.org/10.1038/nature07178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668106				2022-12-24	WOS:000258026500045
J	Iheanacho, I				Iheanacho, Ike			Not a silly story	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com						2008, BRIT MED J, V337, pA618	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a919	10.1136/bmj.a919	http://dx.doi.org/10.1136/bmj.a919			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18650231				2022-12-24	WOS:000258273000048
J	Budovskaya, YV; Wu, K; Southworth, LK; Min, J; Tedesco, P; Johnson, TE; Kim, SK				Budovskaya, Yelena V.; Wu, Kendall; Southworth, Lucinda K.; Jiang, Min; Tedesco, Patricia; Johnson, Thomas E.; Kim, Stuart K.			An elt-3/elt-5/elt-6 GATA transcription circuit guides aging in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE STRESS; GENE-EXPRESSION; CALORIC RESTRICTION; MUTATIONS; LONGEVITY; LONG; DAF-16; DNA	To define the C. elegans aging process at the molecular level, we used DNA microarray experiments to identify a set of 1294 age-regulated genes and found that the GATA transcription factors ELT-3, ELT-5, and ELT-6 are responsible for age regulation of a large fraction of these genes. Expression of elt-5 and elt-6 increases during normal aging, and both of these GATA factors repress expression of elt-3, which shows a corresponding decrease in expression in old worms. elt-3 regulates a large number of downstream genes that change expression in old age, including ugt- 9, col-144, and sod-3. elt-5( RNAi) and elt-6( RNAi) worms have extended longevity, indicating that elt-3, elt-5, and elt-6 play an important functional role in the aging process. These results identify a transcriptional circuit that guides the rapid aging process in C. elegans and indicate that this circuit is driven by drift of developmental pathways rather than accumulation of damage.	[Budovskaya, Yelena V.; Wu, Kendall; Jiang, Min; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Southworth, Lucinda K.; Kim, Stuart K.] Stanford Univ, Med Ctr, Stanford Med Informat, Stanford, CA 94305 USA; [Wu, Kendall] Affymetrix Inc, Santa Clara, CA 95051 USA; [Tedesco, Patricia; Johnson, Thomas E.] Univ Colorado, Inst Behav Genet, Dept Integrat Physiol, Boulder, CO 80309 USA	Stanford University; Stanford University; Affymetrix; University of Colorado System; University of Colorado Boulder	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu	Budovskaya, Yelena/D-2254-2011	Budovskaya, Yelena/0000-0002-1047-693X; /0000-0001-7147-8237	NATIONAL INSTITUTE ON AGING [R01AG025941, R01AG016219] Funding Source: NIH RePORTER; NIA NIH HHS [R01AG025941, R01AG16219, R01 AG016219, R01 AG025941] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2004, IMAGEJ COMPUTER PROG; Anson RM, 2004, AGING CELL, V3, P29, DOI 10.1111/j.1474-9728.2003.00077.x; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Ayub K, 2004, AGING CELL, V3, P145, DOI 10.1111/j.1474-9728.2004.00100.x; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x; FRIEDMAN DB, 1988, GENETICS, V118, P75; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gilleard JS, 2001, MOL CELL BIOL, V21, P2533, DOI 10.1128/MCB.21.7.2533-2544.2001; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; Ishii N, 2002, FREE RADICAL BIO MED, V33, P1021, DOI 10.1016/S0891-5849(02)00857-2; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0; Koh K, 2001, DEVELOPMENT, V128, P2867; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LAWLESS JF, 1982, MODELS METHODS LIFET; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; LIU Y, 2005, GENOME WIDE DISCOVER; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Martin I, 2006, MECH AGEING DEV, V127, P411, DOI 10.1016/j.mad.2006.01.008; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Melov S, 2000, ANN NY ACAD SCI, V908, P219; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Praitis V, 2001, GENETICS, V157, P1217; Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rodriguez-Aguilera JC, 2005, AGEING RES REV, V4, P41, DOI 10.1016/j.arr.2004.09.001; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 1998, GENETICS, V148, P703; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WONG A, 1995, GENETICS, V139, P1247	68	188	217	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					291	303		10.1016/j.cell.2008.05.044	http://dx.doi.org/10.1016/j.cell.2008.05.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662544	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000257891700018
J	Logsdon, RG				Logsdon, Rebecca G.			Dementia: psychosocial interventions for family caregivers	LANCET			English	Editorial Material							ALZHEIMER-DISEASE; HEALTH; PREVALENCE; PLACEMENT; COST		Univ Washington, Sch Nursing, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle	Logsdon, RG (corresponding author), Univ Washington, Sch Nursing, Seattle, WA 98115 USA.	logsdon@u.washington.edu			NIA NIH HHS [P50 AG005136-25, P50 AG005136] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gallagher-Thompson D, 2007, PSYCHOL AGING, V22, P37, DOI 10.1037/0882-7974.22.1.37; Gaugler JE, 2008, J AM GERIATR SOC, V56, P421, DOI 10.1111/j.1532-5415.2007.01593.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.1996.03540210033030; Nichols LO, 2008, J AM GERIATR SOC, V56, P413, DOI 10.1111/j.1532-5415.2007.01569.x; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Zhu CW, 2006, J AM GERIATR SOC, V54, P1596, DOI 10.1111/j.1532-5415.2006.00871.x	10	18	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					182	183		10.1016/S0140-6736(08)61048-X	http://dx.doi.org/10.1016/S0140-6736(08)61048-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	327YH	18640438				2022-12-24	WOS:000257763900006
J	Woodward, D; Labonte, R				Woodward, David; Labonte, Ronald			Reducing poverty sustainably, in a carbon-constrained future	LANCET			English	Editorial Material									[Woodward, David] Rijswijk ZH, NL-2282 BW Rijswijk, Netherlands; [Labonte, Ronald] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada	University of Ottawa	Woodward, D (corresponding author), Rijswijk ZH, NL-2282 BW Rijswijk, Netherlands.	david.woodward@neweconomics.org	Labonte, Ronald/G-4229-2011					Edward P, 2006, THIRD WORLD Q, V27, P377, DOI 10.1080/01436590500432739; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Ravallion M., 2001, GROWTH INEQUALITY PO; Spence M., 2008, GROWTH REP STRAT SUS; WOODWARD D, IN PRESS POOR IS POO; Woodward David, 2006, GROWTH ISNT WORKING; *WORLD BANK, 2008, NEW REP EC GROWTH OF; *WWF, 2006, LIV PLAN REP	8	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					186	188		10.1016/S0140-6736(08)61051-X	http://dx.doi.org/10.1016/S0140-6736(08)61051-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640441				2022-12-24	WOS:000257763900009
J	Hodgson-Zingman, DM; Karst, ML; Zingman, LV; Heublein, DM; Darbar, D; Herron, KJ; Ballew, JD; de Andrade, M; Burnett, JC; Olson, TM				Hodgson-Zingman, Denice M.; Karst, Margaret L.; Zingman, Leonid V.; Heublein, Denise M.; Darbar, Dawood; Herron, Kathleen J.; Ballew, Jeffrey D.; de Andrade, Mariza; Burnett, John C., Jr.; Olson, Timothy M.			Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-FUNCTION MUTATION; SHATTUCK-LECTURE; HEART-FAILURE; RISK; RECEPTORS		[Karst, Margaret L.; Darbar, Dawood; Herron, Kathleen J.; Ballew, Jeffrey D.; Olson, Timothy M.] Mayo Clin, Coll Med, Dept Internal Med, Cardiovasc Genet Lab, Rochester, MN 55905 USA; [Hodgson-Zingman, Denice M.; Zingman, Leonid V.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Olson, Timothy M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Heublein, Denise M.; Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Physiol, Cardiorenal Res Lab, Rochester, MN 55905 USA; [Heublein, Denise M.; Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Internal Med, Cardiorenal Res Lab, Rochester, MN 55905 USA; [de Andrade, Mariza] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; University of Iowa; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Olson, TM (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Cardiovasc Genet Lab, 200 1st St SW, Rochester, MN 55905 USA.	olson.timothy@mayo.edu	Darbar, Dawood/C-9079-2015; Zingman, Leonid V/GXG-0136-2022	Darbar, Dawood/0000-0002-4103-5977; Zingman, Leonid V/0000-0002-7566-4616; de Andrade, Mariza/0000-0003-2329-2686; Hodgson-Zingman, Denice/0000-0002-6875-1367; Olson, Timothy/0000-0003-2716-9423	NHLBI NIH HHS [R01 HL075495-01A2, P01 HL76611, R01 HL075495, R01 HL36634, K23 HL075266-04, R01 HL075495-02, P01 HL076611, R01 HL036634, K23 HL075266] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036634, K23HL075266, R01HL075495, P01HL076611] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CROZIER I, 1993, PACE, V16, P738, DOI 10.1111/j.1540-8159.1993.tb01653.x; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; Fatkin D, 2007, CIRCULATION, V116, P782, DOI 10.1161/CIRCULATIONAHA.106.688889; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; LEGRAND B, 1992, PFLUG ARCH EUR J PHY, V421, P486, DOI 10.1007/BF00370260; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lonardo G, 2004, CARDIOVASC RES, V63, P528, DOI 10.1016/j.cardiores.2004.03.004; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; SORBERA LA, 1990, SCIENCE, V247, P969, DOI 10.1126/science.2154853; Stambler BS, 2005, J CARDIOVASC ELECTR, V16, P1341, DOI 10.1111/j.1540-8167.2005.00259.x	23	239	248	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					158	165		10.1056/NEJMoa0706300	http://dx.doi.org/10.1056/NEJMoa0706300			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614783	Green Accepted			2022-12-24	WOS:000257459000007
J	Lynch, HT; Ferrara, K; Barlogie, B; Coleman, EA; Lynch, JF; Weisenburger, D; Sanger, W; Watson, P; Nipper, H; Witt, V; Thome, S				Lynch, Henry T.; Ferrara, Kelly; Barlogie, Bart; Coleman, Elizabeth A.; Lynch, Jane F.; Weisenburger, Dennis; Sanger, Warren; Watson, Patrice; Nipper, Henry; Witt, Vinetta; Thome, Stephan			Familial myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; CANCER; RISK	We describe a family with five cases of multiple myeloma, three cases of monoclonal gammopathy of undetermined significance (MGUS), and five cases of prostate cancer in two generations. The putative progenitor had progeny with two female partners. The progeny had prostate cancer, multiple myeloma, and MGUS.	[Lynch, Henry T.; Ferrara, Kelly; Lynch, Jane F.; Watson, Patrice; Thome, Stephan] Creighton Univ, Sch Med, Omaha, NE 68178 USA; [Weisenburger, Dennis; Sanger, Warren] Nebraska Med Ctr, Omaha, NE USA; [Nipper, Henry] Creighton Univ, Med Ctr, Omaha, NE USA; [Barlogie, Bart; Coleman, Elizabeth A.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Witt, Vinetta] Newberry Coll, Newberry, SC 29108 USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center; Creighton University; University of Arkansas System; University of Arkansas Medical Sciences	Lynch, HT (corresponding author), Creighton Univ, Sch Med, Omaha, NE 68178 USA.				NCI NIH HHS [U01 CA086389-09, 1U01 CA 86389, U01 CA086389] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA086389] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander DD, 2007, INT J CANCER, P40, DOI 10.1002/ijc.22718; Bradwell AR, 2001, CLIN CHEM, V47, P673; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Brown LM, 1999, CANCER, V85, P2385; Dilworth D, 2000, BLOOD, V95, P1869, DOI 10.1182/blood.V95.5.1869.005k09_1869_1871; ERIKSSON M, 1992, CANCER CAUSE CONTROL, V3, P63, DOI 10.1007/BF00051914; Gerkes EH, 2007, HERED CANCER CLIN PR, V5, P72, DOI 10.1186/1897-4287-5-2-72; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Keren DF, 2002, CLIN LAB MED, P1448; Kyle RA, 2006, BRIT J HAEMATOL, V134, P573, DOI 10.1111/j.1365-2141.2006.06235.x; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Landgren O, 2007, MAYO CLIN PROC, V82, P1468, DOI 10.4065/82.12.1468; Lynch HT, 2005, J CLIN ONCOL, V23, P685, DOI 10.1200/JCO.2005.10.126; Lynch HT, 2002, CANCER-AM CANCER SOC, V94, P84, DOI 10.1002/cncr.10159; Lynch HT, 2001, CANCER, V91, P625, DOI 10.1002/1097-0142(20010215)91:4<625::AID-CNCR1044>3.0.CO;2-4; Lynch HT, 2001, JNCI-J NATL CANCER I, V93, P1479, DOI 10.1093/jnci/93.19.1479; Malpas JS, 1998, MULTIPLE MYELOMA BIO; Morgan GJ, 2002, BIOMED PHARMACOTHER, V56, P223, DOI 10.1016/S0753-3322(02)00194-4; Ogmundsdottir HM, 2005, HAEMATOLOGICA, V90, P66; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Zighelboim I, 2007, GYNECOL ONCOL, V105, P390, DOI 10.1016/j.ygyno.2006.12.022	21	60	61	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					152	157		10.1056/NEJMoa0708704	http://dx.doi.org/10.1056/NEJMoa0708704			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614782	Green Accepted			2022-12-24	WOS:000257459000006
J	Salzberg, S				Salzberg, Steven			The contents of the syringe	NATURE			English	Editorial Material									Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Salzberg, S (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, 3125 Biomol Sci Bldg, College Pk, MD 20742 USA.		Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083873-05, R01 GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845, R01 LM006845-08, R01 LM006845-09] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239	1	36	37	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					160	161		10.1038/454160a	http://dx.doi.org/10.1038/454160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615063	Green Accepted			2022-12-24	WOS:000257466900020
J	Gordon, JG				Gordon, John Guertin			A critique of the financial requirements to fight HIV/AIDS	LANCET			English	Article							HIV PREVENTION; AFRICA	Funds available for HIV/AIDS programmes in low-income and middle-income countries rose from US$300 million in 1996 to $10 billion in 2007. However, a combination of worldwide economic uncertainty a global food crisis, and publications that indicate discontent with progress in fighting the HIV/AIDS pandemic will not only threaten to restrict increases in the overall availability of both donor and national funds, but will also increase the competition for resources during the move towards universal access to treatment and prevention services. Thus, UNAIDS will be under increasing pressure in its presentation and justification of resources needed for HIV/AIDS programming. Here I discuss UNAIDS' 2007 estimates of resource requirements for fighting HIV/AIDS in terms of their usefulness to both donor and recipient governments for budget planning and for setting priorities for HIV/AIDS programmes. I identify weaknesses in the UNAIDS estimates in terms of financial transparency and priority setting, and recommend changes to improve budgeting and priority setting.	[Gordon, John Guertin] Univ Guelph, Dept Food Agr & Resource Econ, Ontario Agr Coll, Guelph, ON N1G 2W1, Canada	University of Guelph	Gordon, JG (corresponding author), Univ Guelph, Dept Food Agr & Resource Econ, Ontario Agr Coll, JD MacLachlan Bldg, Guelph, ON N1G 2W1, Canada.	jgordon@gri.ca						*AVERTING HIV AIDS, 2008, FUND FIGHT AIDS; Chin James, 2007, AIDS PANDEMIC COLLIS; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; EPSTEIN H, 2007, INVISIBLE CURE AFRIC; JACK A, 2007, FINANCIAL TIMES 0928, P11; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; *ORG EC COOP DEV, 2008, OECD EC OUTLOOK  JUN; Over M., 2008, PREVENTION FAILURE B; OVER M, 2004, MACROECONOMICS HIV A; Pisani E, 2008, WISDOM WHORES BUREAU; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; *UNAIDS, 2007, FIN RES REQ AIDS; United Nations (UN), 2008, WORLD EC SIT PROSP 2; WHO, 2006, ANT DRUGS TREAT PREG; 2008, LANCET, V371, P1389; 2007, LANCET, V370, P1190	17	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					333	336		10.1016/S0140-6736(08)61117-4	http://dx.doi.org/10.1016/S0140-6736(08)61117-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657712				2022-12-24	WOS:000258042800034
J	Laughlin, JD; Ha, TS; Jones, DNM; Smith, DP				Laughlin, John D.; Ha, Tal Soo; Jones, David N. M.; Smith, Dean P.			Activation of pheromone-sensitive neurons is mediated by conformational activation of pheromone-binding protein	CELL			English	Article							DROSOPHILA-MELANOGASTER; GYPSY-MOTH; LYMANTRIA-DISPAR; BOMBYX-MORI; ANTHERAEA-POLYPHEMUS; ODORANT RECEPTORS; OLFACTORY NEURONS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; NMR STRUCTURE	Detection of volatile odorants by olfactory neurons is thought to result from direct activation of seven-transmembrane odorant receptors by odor molecules. Here, we show that detection of the Drosophila pheromone, 11-cis vaccenyl acetate (cVA), is instead mediated by pheromone-induced conformational shifts in the extracellular pheromone-binding protein, LUSH. We show that LUSH undergoes a pheromone-specific conformational change that triggers the firing of pheromone-sensitive neurons. Amino acid substitutions in LUSH that are predicted to reduce or enhance the conformational shift alter sensitivity to cVA as predicted in vivo. One substitution, LUSHD118A, produces a dominant-active LUSH protein that stimulates T1 neurons through the neuronal receptor components Or67d and SNMP in the complete absence of pheromone. Structural analysis of LUSHD118A reveals that it closely resembles cVA-bound LUSH. Therefore, the pheromone-binding protein is an inactive, extracellular ligand converted by pheromone molecules into an activator of pheromone-sensitive neurons and reveals a distinct paradigm for detection of odorants.	[Ha, Tal Soo; Smith, Dean P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Ha, Tal Soo; Smith, Dean P.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Jones, David N. M.] Univ Colorado Denver, Program Biomol Struct, Aurora, CO 80045 USA; [Jones, David N. M.] Hlth Sci Ctr, Aurora, CO 80045 USA; [Laughlin, John D.; Jones, David N. M.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, DP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu	Jones, David N/C-5764-2013	Smith, Dean/0000-0002-4271-0436	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA046934] Funding Source: Medline; NIAAA NIH HHS [R01 AA013618] Funding Source: Medline; NIDCD NIH HHS [R01 DC008834, R01 DC002539, R01DC02539] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008834, R01DC002539] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Bucci BK, 2006, BIOCHEMISTRY-US, V45, P1693, DOI 10.1021/bi0516576; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickens JC, 1997, J CHEM ECOL, V23, P2197, DOI 10.1023/B:JOEC.0000006439.21448.53; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Grant GG, 1996, NATURWISSENSCHAFTEN, V83, P328, DOI 10.1007/BF01152217; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NEURON, V42, P359, DOI 10.1016/S0896-6273(04)00256-9; HANSEN K, 1984, PHYSIOL ENTOMOL, V9, P9, DOI 10.1111/j.1365-3032.1984.tb00676.x; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JIN X, 2008, P NATL ACAD IN PRESS; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaissling K.-E., 1998, STRUCTURE INFORM SEN, P98; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kim MS, 1998, GENETICS, V150, P711; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Smith DP, 2007, PFLUG ARCH EUR J PHY, V454, P749, DOI 10.1007/s00424-006-0190-2; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7	64	334	356	8	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1255	1265		10.1016/j.cell.2008.04.046	http://dx.doi.org/10.1016/j.cell.2008.04.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585358	Green Accepted, Bronze			2022-12-24	WOS:000257144600021
J	Phillips, K				Phillips, Katrina			Does blood discriminate?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Phillips, K (corresponding author), The Lancet, London NW1 7BY, England.			Brown, Katrina/0000-0002-0637-1545				[Anonymous], 2008, BBC NEWS        0307; *AUSTR RED CROSS B, 2006, FREQ ASK QUEST; Hickson F, 2003, MAKING IT COUNT COLL; *HLTH PROT AG, 2007, TEST TIM HIV OTH SEX; *NZ BLOOD, 2007, FREQ ASK QUEST; Scott JD, 2007, JAMA-J AM MED ASSOC, V297, P724, DOI 10.1001/jama.297.7.724; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; *WHO, 2008, BLOOD SAF	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 14	2008	371	9629					1983	1984		10.1016/S0140-6736(08)60850-8	http://dx.doi.org/10.1016/S0140-6736(08)60850-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555902				2022-12-24	WOS:000256709500010
J	Boualem, A; Fergany, M; Fernandez, R; Troadec, C; Martin, A; Morin, H; Sari, MA; Collin, F; Flowers, JM; Pitrat, M; Purugganan, MD; Dogimont, C; Bendahmane, A				Boualem, Adnane; Fergany, Mohamed; Fernandez, Ronan; Troadec, Christelle; Martin, Antoine; Morin, Halima; Sari, Marie-Agnes; Collin, Fabrice; Flowers, Jonathan M.; Pitrat, Michel; Purugganan, Michael D.; Dogimont, Catherine; Bendahmane, Abdelhafid			A conserved mutation in an ethylene biosynthesis enzyme leads to andromonoecy in melons	SCIENCE			English	Article							CUCUMBER CUCUMIS-SATIVUS; SEX DETERMINATION; MODEL; INHERITANCE; EXPRESSION; SYNTHASE; FLOWERS; CLONING	Andromonoecy is a widespread sexual system in angiosperms characterized by plants carrying both male and bisexual flowers. In melon, this sexual form is controlled by the identity of the alleles at the andromonoecious (a) locus. Cloning of the a gene reveals that andromonoecy results from a mutation in the active site of 1-aminocyclopropane-1-carboxylic acid synthase. Expression of the active enzyme inhibits the development of the male organs and is not required for carpel development. A causal single-nucleotide polymorphism associated with andromonoecy was identified, which suggests that the a allele has been under recent positive selection and may be linked to the evolution of this sexual system.	[Boualem, Adnane; Fergany, Mohamed; Fernandez, Ronan; Troadec, Christelle; Martin, Antoine; Bendahmane, Abdelhafid] CNRS, INRA, UMR1165, Unite Rech Genom Vegetale, F-91057 Evry, France; [Morin, Halima] Inst Jean Pierre Bourgin, INRA, Biol Cellulaire Lab, UR501, F-78026 Versailles, France; [Sari, Marie-Agnes; Collin, Fabrice] Univ Paris 05, Chim & Biochim Pharmacol & Toxicol Lab, CNRS, UMR 8601, F-75270 Paris 06, France; [Flowers, Jonathan M.; Purugganan, Michael D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Pitrat, Michel; Dogimont, Catherine] INRA, Unite Genet & Ameliorat Fruits & Legumes, UR 1052, BP 94, F-84143 Montfavet, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; New York University; INRAE	Bendahmane, A (corresponding author), CNRS, INRA, UMR1165, Unite Rech Genom Vegetale, 2 Rue Gaston Cremieux, F-91057 Evry, France.	bendahm@evry.inra.fr	Collin, Fabrice/A-7800-2012; Boualem, Adnane/ABC-5019-2021	Collin, Fabrice/0000-0003-4310-112X; Boualem, Adnane/0000-0003-4428-6496; Martin, Antoine/0000-0002-6956-2904; Catherine, DOGIMONT/0000-0001-7399-768X; Bendahmane, Abdelhafid/0000-0003-3246-868X; TROADEC, Christelle/0000-0003-1927-7352				Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; DURAND B, 1991, PLANT SCI, V80, P49, DOI 10.1016/0168-9452(91)90272-A; Huai Q, 2001, J BIOL CHEM, V276, P38210; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1987, GENETICS, V116, P153; Kater MM, 2001, PLANT CELL, V13, P481, DOI 10.1105/tpc.13.3.481; KENIGSBUCH D, 1990, GENOME, V33, P317, DOI 10.1139/g90-049; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Miller JS, 2003, AM J BOT, V90, P707, DOI 10.3732/ajb.90.5.707; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Perin C, 2002, THEOR APPL GENET, V104, P1017, DOI 10.1007/s00122-002-0864-x; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Ralph SG, 2007, PLANT PHYSIOL, V143, P410, DOI 10.1104/pp.106.089425; Vallejo-Marin M, 2007, EVOLUTION, V61, P404, DOI 10.1111/j.1558-5646.2007.00031.x; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yin TJ, 1995, AM J BOT, V82, P1537, DOI 10.2307/2446182	21	225	247	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					836	838		10.1126/science.1159023	http://dx.doi.org/10.1126/science.1159023			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687965				2022-12-24	WOS:000258261000046
J	Miyake, N; Chilton, J; Psatha, M; Cheng, L; Andrews, C; Chan, WM; Law, K; Crosier, M; Lindsay, S; Cheung, M; Allen, J; Gutowski, NJ; Ellard, S; Young, E; Iannaccone, A; Appukuttan, B; Stout, JT; Christiansen, S; Ciccarelli, ML; Baldi, A; Campioni, M; Zenteno, JC; Davenport, D; Mariani, LE; Sahin, M; Guthrie, S; Engle, EC				Miyake, Noriko; Chilton, John; Psatha, Maria; Cheng, Long; Andrews, Caroline; Chan, Wai-Man; Law, Krystal; Crosier, Moira; Lindsay, Susan; Cheung, Michelle; Allen, James; Gutowski, Nick J.; Ellard, Sian; Young, Elizabeth; Iannaccone, Alessandro; Appukuttan, Binoy; Stout, J. Timothy; Christiansen, Stephen; Ciccarelli, Maria Laura; Baldi, Alfonso; Campioni, Mara; Zenteno, Juan C.; Davenport, Dominic; Mariani, Laura E.; Sahin, Mustafa; Guthrie, Sarah; Engle, Elizabeth C.			Human CHN1 mutations hyperactivate alpha 2-chimaerin and cause Duane's retraction syndrome	SCIENCE			English	Article							GROWTH-CONE COLLAPSE; GTPASE-ACTIVATING PROTEIN; CHROMOSOME 2Q31; AXON GUIDANCE; LOCUS; EPHA4; GENE; ALPHA-1-CHIMAERIN; MORPHOLOGY; HINDBRAIN	Duane's retraction syndrome (DRS) is a complex congenital eye movement disorder caused by aberrant innervation of the extraocular muscles by axons of brainstem motor neurons. Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes alpha 2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein previously implicated in the pathfinding of corticospinal axons in mice. We found that these are gain-of-function mutations that increase alpha 2-chimaerin RacGAP activity in vitro. Several of the mutations appeared to enhance alpha 2-chimaerin translocation to the cell membrane or enhance its ability to self-associate. Expression of mutant alpha 2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles. We conclude that alpha 2-chimaerin has a critical developmental function in ocular motor axon pathfinding.	[Miyake, Noriko; Cheng, Long; Andrews, Caroline; Chan, Wai-Man; Law, Krystal; Engle, Elizabeth C.] Childrens Hosp, Dept Med Genet, Boston, MA 02115 USA; [Miyake, Noriko; Cheng, Long; Andrews, Caroline; Sahin, Mustafa; Engle, Elizabeth C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chilton, John; Allen, James] Peninsula Med Sch, Inst Biomed & Clin Sci, Plymouth PL6 8BU, Devon, England; [Psatha, Maria; Cheung, Michelle; Davenport, Dominic; Guthrie, Sarah] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Andrews, Caroline; Mariani, Laura E.; Sahin, Mustafa; Engle, Elizabeth C.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Crosier, Moira; Lindsay, Susan; Engle, Elizabeth C.] Univ Newcastle, Int Ctr Life, MRC Wellcome Trust Human Dev Biol Resource Newcas, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Gutowski, Nick J.; Engle, Elizabeth C.] Royal Devon & Exeter Hosp, Dept Neurol, Exeter EX2 5DW, Devon, England; [Gutowski, Nick J.; Ellard, Sian; Young, Elizabeth] Peninsula Med Sch, Exeter EX2 5DW, Devon, England; [Ellard, Sian] Royal Devon & Exeter Hosp, Dept Mol Genet, Exeter EX2 5DW, Devon, England; [Iannaccone, Alessandro] Univ Tennessee, Ctr Hlth Sci, Hamilton Eye Inst, Memphis, TN 38163 USA; [Appukuttan, Binoy; Stout, J. Timothy] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Christiansen, Stephen] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; [Ciccarelli, Maria Laura] Fatebenefratelli Hosp, Div Ophthalmol, I-00100 Rome, Italy; [Baldi, Alfonso; Campioni, Mara] Univ Naples 2, Dept Biochem F Cedrangolo, Sect Pathol Anat, I-80138 Naples, Italy; [Zenteno, Juan C.] Inst Ophthalmol Conde Valenciana, Dept Genet, Mexico City 06700, DF, Mexico; [Engle, Elizabeth C.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Mariani, Laura E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Plymouth; University of London; King's College London; Harvard University; Boston Children's Hospital; Newcastle University - UK; University of Exeter; University of Exeter; University of Exeter; University of Tennessee System; University of Tennessee Health Science Center; Oregon Health & Science University; University of Minnesota System; University of Minnesota Twin Cities; Universita della Campania Vanvitelli; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Engle, EC (corresponding author), Childrens Hosp, Dept Med Genet, 300 Longwood Ave, Boston, MA 02115 USA.	elizabeth.engle@childrens.harvard.edu	Lindsay, Susan/B-3828-2013; SAHIN, MUSTAFA/I-8653-2019; Baldi, Alfonso/ABG-2397-2021; Tuluc, Petronel/C-2527-2011; Guthrie, Sarah C/C-5727-2009	Lindsay, Susan/0000-0003-2980-4582; SAHIN, MUSTAFA/0000-0001-7044-2953; Christiansen, Stephen/0000-0001-5489-5354; Iannaccone, Alessandro/0000-0001-5737-8424; Baldi, Alfonso/0000-0002-8693-3842; Ellard, Sian/0000-0002-7620-5526	NATIONAL EYE INSTITUTE [R01EY015298] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G9900989, G9900837] Funding Source: Medline; NEI NIH HHS [R01 EY015298-02, R01 EY015298-03, R01 EY015298-04, R01 EY015298-01, R01 EY015298, R01 EY015298-05] Funding Source: Medline; MRC [G9900837, G9900989] Funding Source: UKRI	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Appukuttan B, 1999, AM J HUM GENET, V65, P1639, DOI 10.1086/302656; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chilton JK, 2004, J COMP NEUROL, V472, P308, DOI 10.1002/cne.20071; Chung M, 2000, OPHTHALMOLOGY, V107, P500, DOI 10.1016/S0161-6420(99)00090-1; Cooke JE, 2002, TRENDS NEUROSCI, V25, P260, DOI 10.1016/S0166-2236(02)02134-3; Dalva MB, 2007, NEURON, V55, P681, DOI 10.1016/j.neuron.2007.08.015; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P194, DOI 10.1167/iovs.06-0632; DONG JM, 1995, EUR J BIOCHEM, V227, P636, DOI 10.1111/j.1432-1033.1995.tb20183.x; Engle EC, 2007, ARCH NEUROL-CHICAGO, V64, P633, DOI 10.1001/archneur.64.5.633; Engle EC, 2007, INVEST OPHTH VIS SCI, V48, P189, DOI 10.1167/iovs.06-0631; Evans JC, 2000, HUM GENET, V106, P636, DOI 10.1007/s004390050036; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; HALL C, 1993, MOL CELL BIOL, V13, P4986, DOI 10.1128/MCB.13.8.4986; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	26	110	113	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					839	843		10.1126/science.1156121	http://dx.doi.org/10.1126/science.1156121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18653847	Green Accepted			2022-12-24	WOS:000258261000047
J	Bonetta, L				Bonetta, Laura			Detailed analysis	NATURE			English	Editorial Material							CELLS											Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105	4	9	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					795	798		10.1038/454795a	http://dx.doi.org/10.1038/454795a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685708	Bronze			2022-12-24	WOS:000258228000052
J	Abrahamsen, B; Zhao, J; Asante, CO; Cendan, CM; Marsh, S; Martinez-Barbera, JP; Nassar, MA; Dickenson, AH; Wood, JN				Abrahamsen, Bjarke; Zhao, Jing; Asante, Curtis O.; Cendan, Cruz Miguel; Marsh, Steve; Martinez-Barbera, Juan Pedro; Nassar, Mohammed A.; Dickenson, Anthony H.; Wood, John N.			The cell and molecular basis of mechanical, cold, and inflammatory pain	SCIENCE			English	Article							RESISTANT SODIUM-CHANNEL; NEUROPATHIC PAIN; NOCICEPTORS; EXPRESSION; HEAT; GENE; HYPERSENSITIVITY; NA(V)1.8; DEFICITS; TRPV2	Peripheral pain pathways are activated by a range of stimuli. We used diphtheria toxin to kill all mouse postmitotic sensory neurons expressing the sodium channel Na(v)1.8. Mice showed normal motor activity and low- threshold mechanical and acute noxious heat responses but did not respond to noxious mechanical pressure or cold. They also showed a loss of enhanced pain responses and spontaneous pain behavior upon treatment with inflammatory insults. In contrast, nerve injury led to heightened pain sensitivity to thermal and mechanical stimuli indistinguishable from that seen with normal littermates. Pain behavior correlates well with central input from sensory neurons measured electrophysiologically in vivo. These data demonstrate that Na(v)1.8- expressing neurons are essential for mechanical, cold, and inflammatory pain but not for neuropathic pain or heat sensing.	[Abrahamsen, Bjarke; Zhao, Jing; Cendan, Cruz Miguel; Nassar, Mohammed A.; Wood, John N.] UCL, Mol Nocicept Grp, London WC1E 6BT, England; [Asante, Curtis O.; Marsh, Steve; Dickenson, Anthony H.] UCL, Dept Pharmacol, London WC1E 6BT, England; [Martinez-Barbera, Juan Pedro] UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London; University of London; University College London	Wood, JN (corresponding author), UCL, Mol Nocicept Grp, Gower St, London WC1E 6BT, England.	j.wood@ucl.ac.uk	Martinez-Barbera, Juan Pedro/AAE-9284-2020; babakinejad, babak/G-2674-2012; Martínez, Cruz Miguel Cendán/ABH-1404-2020; Abrahamsen, Bjarke/ABD-5874-2020	Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Martínez, Cruz Miguel Cendán/0000-0001-5431-4513; Zhao, Jing/0000-0003-2587-1198; Abrahamsen, Bjarke/0000-0002-6128-8269	BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G9717869] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: Medline; Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Zhao J, 2006, MOL CELL NEUROSCI, V31, P539, DOI 10.1016/j.mcn.2005.11.008; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	23	341	354	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					702	705		10.1126/science.1156916	http://dx.doi.org/10.1126/science.1156916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669863				2022-12-24	WOS:000258077700047
J	Sprecher, SG; Desplan, C				Sprecher, Simon G.; Desplan, Claude			Switch of rhodopsin expression in terminally differentiated Drosophila sensory neurons	NATURE			English	Article							FINGER TRANSCRIPTION FACTOR; VISUAL-SYSTEM; SINGLE CONES; CLOCK NEURONS; PHOTORECEPTORS; RETINA; ADULT; LIGHT; MELANOGASTER; SENSELESS	Specificity of sensory neurons requires restricted expression of one sensory receptor gene and the exclusion of all others within a given cell. In the Drosophila retina, functional identity of photoreceptors depends on light-sensitive Rhodopsins (Rhs). The much simpler larval eye (Bolwig organ) is composed of about 12 photoreceptors, eight of which are green-sensitive (Rh6) and four bluesensitive (Rh5)(1). The larval eye becomes the adult extraretinal 'eyelet' composed of four green-sensitive (Rh6) photoreceptors(2,3). Here we show that, during metamorphosis, all Rh6 photoreceptors die, whereas the Rh5 photoreceptors switch fate by turning off Rh5 and then turning on Rh6 expression. This switch occurs without apparent changes in the programme of transcription factors that specify larval photoreceptor subtypes. We also show that the transcription factor Senseless (Sens) mediates the very different cellular behaviours of Rh5 and Rh6 photoreceptors. Sens is restricted to Rh5 photoreceptors and must be excluded from Rh6 photoreceptors to allow them to die at metamorphosis. Finally, we show that Ecdysone receptor (EcR) functions autonomously both for the death of larval Rh6 photoreceptors and for the sensory switch of Rh5 photoreceptors to express Rh6. This fate switch of functioning, terminally differentiated neurons provides a novel, unexpected example of hard-wired sensory plasticity.	[Sprecher, Simon G.; Desplan, Claude] NYU, Ctr Dev Genet, Dept Biol, Silver Ctr 1090, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Ctr Dev Genet, Dept Biol, Silver Ctr 1090, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu	Sprecher, Simon/B-5188-2012; Sprecher, Simon/K-4249-2015	Sprecher, Simon/0000-0001-9060-3750; Desplan, Claude/0000-0002-6914-1413	NCRR NIH HHS [C06 RR015518, C06 RR-15518-01] Funding Source: Medline; NEI NIH HHS [R01 EY013010-01, R01 EY013010, EY013010] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Busto M, 1999, J NEUROSCI, V19, P3337; Chandrasekaran V, 2003, DEVELOPMENT, V130, P4719, DOI 10.1242/dev.00677; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Cheng CL, 2006, J COMP NEUROL, V495, P213, DOI 10.1002/cne.20879; Cheng CL, 2004, NATURE, V428, P279, DOI 10.1038/428279a; Daniel A, 1999, DEVELOPMENT, V126, P2945; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kimura H, 2005, DNA REPAIR, V4, P939, DOI 10.1016/j.dnarep.2005.04.012; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; LOI PK, 1993, J EXP BIOL, V181, P175; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Malpel S, 2002, DEVELOPMENT, V129, P1443; Mazzoni EO, 2004, DEV NEUROSCI-BASEL, V26, P388, DOI 10.1159/000082281; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Mealey-Ferrara ML, 2003, J NEUROGENET, V17, P171, DOI 10.1080/01677060390256422; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Sprecher SG, 2007, GENE DEV, V21, P2182, DOI 10.1101/gad.1565407; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Veleri S, 2007, J BIOL RHYTHM, V22, P29, DOI 10.1177/0748730406295754; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Xiao M, 2000, J COMP NEUROL, V425, P545; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	30	83	85	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					533	537		10.1038/nature07062	http://dx.doi.org/10.1038/nature07062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18594514	Green Accepted, Green Submitted			2022-12-24	WOS:000257860300055
J	Millstone, E; Lang, T				Millstone, Erik; Lang, Tim			Risking regulatory capture at the UK's Food Standards Agency?	LANCET			English	Editorial Material									[Millstone, Erik] Univ Sussex, Brighton BN1 9QE, E Sussex, England; [Lang, Tim] City Univ London, Ctr Food Policy, London EC1V 0HB, England	University of Sussex; City University London	Millstone, E (corresponding author), Univ Sussex, Brighton BN1 9QE, E Sussex, England.	e.p.millstone@sussex.ac.uk						AVERY N, 1993, CRACKING CODEX REPOR; *BBC NEWS, 2008, EU BACKS RIV FOOD LA; Bernstein MH., 1955, REGULATING BUSINESS, DOI 10.1515/9781400878789; *CONS RES DEPT, 2007, PUBL HLTH OUR PRIOR; *FOOD STAND AG, DET BOARD MEMB THEIR; *FOOD STAND AG, 2007, 50 FOOD STAND AG; JAMES P, 1997, FOOD STANDARDS AGENC; Lang T, 2005, PUBLIC HEALTH NUTR, V8, P11, DOI [10.1079/PHN2005654, 10.1079/PHN2004654]; LOBSTEIN T, 2008, GUARDIAN        0107; MacMillan T, 2003, GEOFORUM, V34, P187, DOI 10.1016/S0016-7185(02)00091-X; MassonMatthee MD, 2007, CODEX ALIMENTARIUS COMMISSION AND ITS STANDARDS, P1, DOI 10.1007/978-90-6704-515-5; Millstone E, 2000, NAT MED, V6, P1307, DOI 10.1038/82102; Millstone E., 2008, RISK ASSESSMENT POLI; *MIN AGR FISH FOOD, 1998, FOOD STAND AG FORC C; MULLER RA, 1989, EOS, V70, P276; NESTLE M, 2002, FOODS POLITICS; REVILL J, 2007, OBSERVER        0916; WATTERSON A, 1993, LANCET, V342, P131, DOI 10.1016/0140-6736(93)91341-I; Wilson B., 2008, SWINDLED POISON SWEE	19	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					94	95		10.1016/S0140-6736(08)61012-0	http://dx.doi.org/10.1016/S0140-6736(08)61012-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324XJ	18620933				2022-12-24	WOS:000257552400007
J	Steinbrook, R				Steinbrook, Robert			The (slowly) vanishing prescription pad	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Fischer MA, 2007, DRUG SAFETY, V30, P461, DOI 10.2165/00002018-200730060-00001; Grossman JM, 2007, HEALTH AFFAIR, V26, pW393, DOI 10.1377/hlthaff.26.3.w393; Institute of Medicine, 2007, PREV MED ERR; *SURESCRIPTS, 2007, NAT PROGR REP E PRES	4	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2008	359	2					115	117		10.1056/NEJMp0802864	http://dx.doi.org/10.1056/NEJMp0802864			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PJ	18614780				2022-12-24	WOS:000257459000002
J	Cahn, P; McClure, C				Cahn, Pedro; McClure, Craig			Strengthening accountability in the global response to HIV	LANCET			English	Editorial Material							HEALTH		[Cahn, Pedro; McClure, Craig] Int AIDS Soc, CH-1216 Geneva, Switzerland		Cahn, P (corresponding author), Int AIDS Soc, CH-1216 Geneva, Switzerland.	karen.bennett@iasociety.org						[Anonymous], UN ACC SCAL PRIOR HI; Collins S, 2007, BRIT MED J, V335, P646, DOI 10.1136/bmj.39349.591296.59; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Garrett L, 2007, FOREIGN AFF, V86, P14	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					265	265		10.1016/S0140-6736(08)61085-5	http://dx.doi.org/10.1016/S0140-6736(08)61085-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657688				2022-12-24	WOS:000258042800004
J	Ahlberg, PE; Clack, JA; Luksevics, E; Blom, H; Zupins, I				Ahlberg, Per E.; Clack, Jennifer A.; Luksevics, Ervins; Blom, Henning; Zupins, Ivars			Ventastega curonica and the origin of tetrapod morphology	NATURE			English	Article							CRASSIGYRINUS-SCOTICUS LYDEKKER; ACANTHOSTEGA-GUNNARI JARVIK; EARLIEST KNOWN TETRAPOD; DEVONIAN TETRAPOD; EVOLUTION; FISH; SKELETON; INTERRELATIONSHIPS; BRAINCASE; ANATOMY	The gap in our understanding of the evolutionary transition from fish to tetrapod is beginning to close thanks to the discovery of new intermediate forms such as Tiktaalik roseae. Here we narrow it further by presenting the skull, exceptionally preserved braincase, shoulder girdle and partial pelvis of Ventastega curonica from the Late Devonian of Latvia, a transitional intermediate form between the 'elpistostegids' Panderichthys and Tiktaalik and the Devonian tetrapods ( limbed vertebrates) Acanthostega and Ichthyostega. Ventastega is the most primitive Devonian tetrapod represented by extensive remains, and casts light on a part of the phylogeny otherwise only represented by fragmentary taxa: it illuminates the origin of principal tetrapod structures and the extent of morphological diversity among the transitional forms.	[Ahlberg, Per E.; Blom, Henning] Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, S-75236 Uppsala, Sweden; [Clack, Jennifer A.] Univ Cambridge, Museum Zool, Cambridge CB2 3EJ, England; [Luksevics, Ervins] Univ Latvia, Dept Geol, LV-1586 Riga, Latvia; [Zupins, Ivars] Nat Hist Museum Latvia, LV-1712 Riga, Latvia	Uppsala University; University of Cambridge; University of Latvia	Ahlberg, PE (corresponding author), Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Ahlberg, Per/E-8086-2013; Luksevics, Ervins/ABH-9291-2020	Ahlberg, Per/0000-0001-9054-2900				Ahlberg PE, 2005, J VERTEBR PALEONTOL, V25, P720, DOI 10.1671/0272-4634(2005)025[0720:NLOTEK]2.0.CO;2; Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Ahlberg PE, 1998, ZOOL J LINN SOC-LOND, V122, P99; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; [Anonymous], 2004, ACTA U LATVIENSIS; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; CLACK JA, 1987, PHILOS T ROY SOC B, V318, P1, DOI 10.1098/rstb.1987.0082; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; Clack JA, 2003, T ROY SOC EDIN-EARTH, V93, P163; Clack JA, 1998, T ROY SOC EDIN-EARTH, V88, P127, DOI 10.1017/S0263593300006908; CLACK JA, 1988, PALAEONTOLOGY, V31, P85; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; Clement G, 2004, NATURE, V427, P412, DOI 10.1038/427412a; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; JARVIK E, 1990, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; LEBEDEV OA, 1993, PALAEONTOLOGY, V36, P721; LONG JA, 1997, RECORDS W AUSTR MU S, V57, P1; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; PANCHEN AL, 1990, T ROY SOC EDIN-EARTH, V81, P31, DOI 10.1017/S0263593300005113; Rohlf F. J., 2004, TPSDIG VERSION 1 40; ROHLF FJ, 2004, TPSRELW VERSION 1 39; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; SAVESODERBERGH G, 1932, MEDDR GRONLAND, V94, P1; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Vorobeva E.I., 1977, Trudy Paleontologicheskogo Instituta, V163, P1; Vorobyeva E., 1991, P68; Vorobyeva Emilia I., 1995, Geobios Memoire Special (Villeurbanne), V19, P285; Young G. C., 2006, ALCHERINGA, V1, P409; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a	46	67	69	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1199	1204		10.1038/nature06991	http://dx.doi.org/10.1038/nature06991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580942	Green Published			2022-12-24	WOS:000257075800034
J	Pharoah, PDP; Antoniou, AC; Easton, DF; Ponder, BAJ				Pharoah, Paul D. P.; Antoniou, Antonis C.; Easton, Douglas F.; Ponder, Bruce A. J.			Polygenes, risk prediction, and targeted prevention of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; MUTATIONS; VARIANT; BRCA1; WOMEN; TWINS	Background: New developments in the search for susceptibility alleles in complex disorders provide support for the possibility of a polygenic approach to the prevention and treatment of common diseases. Methods: We examined the implications, both for individualized disease prevention and for public health policy, of findings concerning the risk of breast cancer that are based on common genetic variation. Results: Our analysis suggests that the risk profile generated by the known, common, moderate-risk alleles does not provide sufficient discrimination to warrant individualized prevention. However, useful risk stratification may be possible in the context of programs for disease prevention in the general population. Conclusions: The clinical use of single, common, low-penetrance genes is limited, but a few susceptibility alleles may distinguish women who are at high risk for breast cancer from those who are at low risk, particularly in the context of population screening.	[Pharoah, Paul D. P.; Ponder, Bruce A. J.] Univ Cambridge, Dept Oncol, Cambridge, England; [Antoniou, Antonis C.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Ponder, Bruce A. J.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England	University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Pharoah, PDP (corresponding author), Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.	paul.pharoah@srl.cam.ac.uk	Pharoah, Paul/V-6658-2019	Pharoah, Paul/0000-0001-8494-732X	Cancer Research UK [10118] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; ANTONIOU AC, 2005, PLOS MED, V2, pE124; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P688, DOI 10.1038/ng0507-688b; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton H. S., 1999, Ryegrass endophyte: an essential New Zealand symbiosis. Proceedings of a New Zealand Grassland Association symposium held in Napier, New Zealand, 8 October, 1999., P1; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Friend SH, 1996, NAT GENET, V13, P16, DOI 10.1038/ng0596-16; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; *OFF NAT STAT, 2004, SER MB1 OFF NAT STAT, V35; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Pharoah PDP, 1998, BREAST, V7, P255, DOI 10.1016/S0960-9776(98)90091-1; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Swift M, 1997, LANCET, V350, P740, DOI 10.1016/S0140-6736(05)63548-9; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2	31	415	428	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2008	358	26					2796	2803		10.1056/NEJMsa0708739	http://dx.doi.org/10.1056/NEJMsa0708739			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317UO	18579814				2022-12-24	WOS:000257045900006
J	Sohn, RA; Willis, C; Humphris, S; Shank, TM; Singh, H; Edmonds, HN; Kunz, C; Hedman, U; Helmke, E; Jakuba, M; Liljebladh, B; Linder, J; Murphy, C; Nakamura, KI; Sato, T; Schlindwein, V; Stranne, C; Tausenfreund, M; Upchurch, L; Winsor, P; Jakobsson, M; Soule, A				Sohn, Robert A.; Willis, Claire; Humphris, Susan; Shank, Timothy M.; Singh, Hanumant; Edmonds, Henrietta N.; Kunz, Clayton; Hedman, Ulf; Helmke, Elisabeth; Jakuba, Michael; Liljebladh, Bengt; Linder, Julia; Murphy, Christopher; Nakamura, Ko-ichi; Sato, Taichi; Schlindwein, Vera; Stranne, Christian; Tausenfreund, Maria; Upchurch, Lucia; Winsor, Peter; Jakobsson, Martin; Soule, Adam			Explosive volcanism on the ultraslow-spreading Gakkel ridge, Arctic Ocean	NATURE			English	Article							MID-ATLANTIC RIDGE	Roughly 60% of the Earth's outer surface is composed of oceanic crust formed by volcanic processes at mid- ocean ridges. Although only a small fraction of this vast volcanic terrain has been visually surveyed or sampled, the available evidence suggests that explosive eruptions are rare on mid- ocean ridges, particularly at depths below the critical point for seawater ( 3,000 m)(1). A pyroclastic deposit has never been observed on the sea floor below 3,000 m, presumably because the volatile content of mid- ocean- ridge basalts is generally too low to produce the gas fractions required for fragmenting a magma at such high hydrostatic pressure. We employed new deep submergence technologies during an International Polar Year expedition to the Gakkel ridge in the Arctic Basin at 856 E, to acquire photographic and video images of 'zero- age' volcanic terrain on this remote, ice- covered ridge. Here we present images revealing that the axial valley at 4,000 m water depth is blanketed with unconsolidated pyroclastic deposits, including bubble wall fragments (limu o Pele)(2), covering a large ( > 10 km(2)) area. At least 13.5 wt% CO2 is necessary to fragment magma at these depths(3), which is about tenfold the highest values previously measured in a mid- ocean- ridge basalt(4). These observations raise important questions about the accumulation and discharge of magmatic volatiles at ultraslow spreading rates on the Gakkel ridge(5) and demonstrate that large- scale pyroclastic activity is possible along even the deepest portions of the global mid- ocean ridge volcanic system.	[Sohn, Robert A.; Willis, Claire; Humphris, Susan; Shank, Timothy M.; Singh, Hanumant; Kunz, Clayton; Murphy, Christopher; Winsor, Peter; Soule, Adam] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Edmonds, Henrietta N.; Upchurch, Lucia] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX 78373 USA; [Hedman, Ulf] Swedish Polar Secretariat, S-10405 Stockholm, Sweden; [Helmke, Elisabeth; Linder, Julia; Schlindwein, Vera; Tausenfreund, Maria] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Jakuba, Michael] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Liljebladh, Bengt; Stranne, Christian] Univ Gothenburg, S-40530 Gothenburg, Sweden; [Nakamura, Ko-ichi] AIST, Higashi, Tokyo, Japan; [Sato, Taichi] Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; [Jakobsson, Martin] Stockholm Univ, Dept Geol & Geochem, S-10691 Stockholm, Sweden	Woods Hole Oceanographic Institution; University of Texas System; University of Texas Austin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Johns Hopkins University; University of Gothenburg; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Stockholm University	Sohn, RA (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	rsohn@whoi.edu	stranne, christian/A-3932-2010; stranne, christian/L-4382-2013; Jakobsson, Martin/F-6214-2010; Sato, Taichi/N-2235-2018	stranne, christian/0000-0003-1004-5213; Sato, Taichi/0000-0002-2158-3730; Soule, Adam/0000-0002-4691-6300; Sohn, Robert/0000-0002-9050-8603; Pontbriand, Claire/0000-0001-8886-154X; Upchurch, Lucia/0000-0003-1351-6332; Schlindwein, Vera/0000-0001-5570-2753; Jakobsson, Martin/0000-0002-9033-3559				BOTTINGA Y, 1990, J GEOPHYS RES-SOLID, V95, P5125, DOI 10.1029/JB095iB04p05125; Clague D.A., 2003, EXPLOSIVE SUBAQUEOUS, V140, P111; Clague DA, 2002, GEOPH MONOG SERIES, V128, P65; Clague DA, 2000, B VOLCANOL, V61, P437, DOI 10.1007/PL00008910; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Edwards MH, 2001, NATURE, V409, P808, DOI 10.1038/35057258; EISSEN JP, 2003, EXPLOSIVE SUBAQUEOUS, P143; Fouquet Y, 1998, TERRA NOVA, V10, P280; GRAHAM DW, 2006, OFIOLITI, V31, P234; Head JW, 2003, J VOLCANOL GEOTH RES, V121, P155, DOI 10.1016/S0377-0273(02)00425-0; Hekinian R, 2000, J VOLCANOL GEOTH RES, V98, P49, DOI 10.1016/S0377-0273(99)00190-0; HON K, 1988, HAWAII GEOL SOC AM A, V20, pA112; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; MUELLER C, 2000, EOS, V81, P265; Schlindwein V, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023767; SELLA GF, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2000JB0000033; SHANK TM, 2007, EOS, V88; SPARKS RSJ, 1978, J VOLCANOL GEOTH RES, V3, P1, DOI 10.1016/0377-0273(78)90002-1; Tolstoy M, 2001, GEOLOGY, V29, P1139, DOI 10.1130/0091-7613(2001)029<1139:SCOVAA>2.0.CO;2; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; White JD., 2003, EXPLOSIVE SUBAQUEOUS, V140, P1, DOI DOI 10.1029/140GM01	23	93	98	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1236	1238		10.1038/nature07075	http://dx.doi.org/10.1038/nature07075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580949	Green Submitted			2022-12-24	WOS:000257075800042
J	Wen, CP; Cheng, TYD; Tsai, MK; Chang, YC; Chan, HT; Tsai, SP; Chiang, PH; Hsu, CC; Sung, PK; Hsu, YH; Wen, SF				Wen, Chi Pang; Cheng, Ting Yuan David; Tsai, Min Kuang; Chang, Yen Chen; Chan, Hui Ting; Tsai, Shan Pou; Chiang, Po Huang; Hsu, Chih Cheng; Sung, Pei Kun; Hsu, Yi Hua; Wen, Sung Feng			All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan	LANCET			English	Article							CARDIOVASCULAR MORTALITY; SERUM CREATININE; NATIONAL-HEALTH; US POPULATION; PREVALENCE; RISK; ALBUMINURIA; AWARENESS; INDIVIDUALS; ASSOCIATION	Background Both end-stage renal disease and chronic kidney disease are increasing worldwide; however, the full effect of chronic kidney disease is unknown because mortality risks for all five stages are unavailable. We assessed prevalence and mortality risks for all stages of chronic kidney disease and quantified its attributable mortality in Taiwan. Methods The cohort consisted of 462 293 individuals aged older than 20 years who participated in a standard medical screening programme since 1994. As of Dec 31, 2006, we identified 14436 deaths. Chronic kidney disease was determined by glomerular filtration rate and urinary protein. We estimated national prevalence in Taiwan from the cohort by adjusting age and educational levels. Hazard ratios (HRs) were calculated with Cox proportionate hazards model. We calculated mortality attributable to chronic kidney disease for national population and for low socioeconomic status. Findings The national prevalence of chronic kidney disease was 11.93% (95% Cl 11.66-12.28), but only 3.54% (3.37-3.68) of participants in the cohort were aware of their disorder. Prevalence was substantially higher in the group with low socioeconomic status than in the high status group (19.87% [19.84-19.91] vs 7.33% [7.31-7.35]). 56 977 (12%) of cohort participants had chronic kidney disease; those with disease had 83% higher mortality for all cause (HR 1 . 83 [1 . 73-1.93]) and 100% higher for cardiovascular diseases (2 . 00 [1.78-2. 25]), in a cohort that was observed for 13 years with median follow-up of 7.5 years (IQR 4. 0-10. 1). 10.3% (95% CI 9 .57-11.03) of deaths in the entire population were attributable to chronic kidney disease, but 17.5% (16.27-18.67) of deaths in the low socioeconomic status population. 2350 (39%) deaths occurred before 65 years of age in those with chronic kidney disease. Regular users of Chinese herbal medicines had a 20% (odds ratio 1.20 [1.16-1.24]) increased risk of developing chronic kidney disease. Interpretation The high prevalence of chronic kidney disease and its associated all-cause mortality, especially in people with low socioeconomic status, make reduction of this disorder a public-health priority. Promotion of its recognition through the general public knowing their glomerular filtration rate and testing their urine is crucial to reduce premature deaths from all causes and to attenuate this global epidemic.	[Wen, Chi Pang; Tsai, Min Kuang; Chang, Yen Chen; Chan, Hui Ting; Chiang, Po Huang; Hsu, Chih Cheng] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Zhunan 350, Taiwan; [Cheng, Ting Yuan David] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tsai, Shan Pou] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Sung, Pei Kun; Hsu, Yi Hua] MJ Hlth Management Inst, Taipei, Taiwan; [Wen, Sung Feng] Univ Wisconsin, Sch Med & Publ Hlth, Nephrol Sect, Dept Med, Madison, WI USA	National Health Research Institutes - Taiwan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Wisconsin System; University of Wisconsin Madison	Wen, CP (corresponding author), Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, 35 Keyan Rd, Zhunan 350, Taiwan.	cwengood@nhri.org.tw	Wen, Chi-Pang/E-3851-2010; Chiang, Po-Huang/E-3996-2010; Hsu, Chih-Cheng/E-3849-2010					Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P300; Cheng TY, 2005, TOB CONTROL, V14, pI23, DOI 10.1136/tc.2003.005546; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cosyns JP, 2003, DRUG SAFETY, V26, P33, DOI 10.2165/00002018-200326010-00004; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; HOSMER D, 2008, APPL SURVIVAL ANAL R, P392; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nickolas TL, 2004, AM J KIDNEY DIS, V44, P185, DOI 10.1053/j.ajkd.2004.04.023; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; *ROCH, 2008, MID M SPEC INF; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shoham DA, 2007, AM J KIDNEY DIS, V49, P217, DOI 10.1053/j.ajkd.2006.11.031; Stevens LA, 2007, AM J KIDNEY DIS, V50, P21, DOI 10.1053/j.ajkd.2007.04.004; *US REN DAT SYST, 2007, ANN DAT REP ATL CHRO; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wen CP, 2005, TOB CONTROL, V14, pI76, DOI 10.1136/tc.2004.007955; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; Wojcikowski K, 2004, NEPHROLOGY, V9, P313, DOI 10.1111/j.1440-1797.2004.00310.x; Wu DM, 2001, INT J OBESITY, V25, P1189, DOI 10.1038/sj.ijo.0801679	35	691	714	2	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2173	2182		10.1016/S0140-6736(08)60952-6	http://dx.doi.org/10.1016/S0140-6736(08)60952-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326CP	18586172				2022-12-24	WOS:000257635800024
J	Ushioda, R; Hoseki, J; Araki, K; Jansen, G; Thomas, DY; Nagata, K				Ushioda, Ryo; Hoseki, Jun; Araki, Kazutaka; Jansen, Gregor; Thomas, David Y.; Nagata, Kazuhiro			ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; THIOREDOXIN; EDEM; CALNEXIN; GLYCOPROTEINS; ISOMERASE; DOMAINS; STRESS; DNAJ	Membrane and secretory proteins cotranslationally enter and are folded in the endoplasmic reticulum ( ER). Misfolded or unassembled proteins are discarded by a process known as ER- associated degradation ( ERAD), which involves their retrotranslocation into the cytosol. ERAD substrates frequently contain disulfide bonds that must be cleaved before their retrotranslocation. Here, we found that an ER- resident protein ERdj5 had a reductase activity, cleaved the disulfide bonds of misfolded proteins, and accelerated ERAD through its physical and functional associations with EDEM ( ER degradation- enhancing alpha-mannosidase-like protein) and an ER- resident chaperone BiP. Thus, ERdj5 is a member of a supramolecular ERAD complex that recognizes and unfolds misfolded proteins for their efficient retrotranslocation.	[Ushioda, Ryo; Hoseki, Jun; Araki, Kazutaka; Nagata, Kazuhiro] Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Kyoto 6068397, Japan; [Hoseki, Jun; Nagata, Kazuhiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Jansen, Gregor; Thomas, David Y.] McGill Univ, Dept Biochem, Fac Med, Montreal, PQ H3G 1Y6, Canada	Kyoto University; Japan Science & Technology Agency (JST); McGill University	Nagata, K (corresponding author), Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Kyoto 6068397, Japan.	nagata@frontier.kyoto-u.ac.jp	Araki, Kazutaka/L-6296-2018; Hoseki, Jun/AAE-6704-2020; Thomas, David/M-7661-2017	Araki, Kazutaka/0000-0003-2901-2454; Thomas, David/0000-0002-8854-762X; Ushioda, Ryo/0000-0003-2775-8746; Jansen, Gregor/0000-0002-0289-0022	Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365	18	290	295	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					569	572		10.1126/science.1159293	http://dx.doi.org/10.1126/science.1159293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653895				2022-12-24	WOS:000257888900050
J	Intlekofer, AM; Banerjee, A; Takemoto, N; Gordon, SM; DeJong, CS; Shin, HN; Hunter, CA; Wherry, EJ; Lindsten, T; Reiner, SL				Intlekofer, Andrew M.; Banerjee, Arnob; Takemoto, Naofumi; Gordon, Scott M.; DeJong, Caitlin S.; Shin, Haina; Hunter, Christopher A.; Wherry, E. John; Lindsten, Tullia; Reiner, Steven L.			Anomalous type 17 response to viral infection by CD8(+) T cells lacking T-bet and eomesodermin	SCIENCE			English	Article							TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; EFFECTOR; DIFFERENTIATION; DISTINCT; IL-21; INFLAMMATION; DIRECTS; CD4	When intracellular pathogens invade mammalian hosts, naive CD8(+) T cells differentiate into cytotoxic killers, which lyse infected target cells and secrete cytokines that activate intracellular microbicides. We show that CD8(+) T cells deficient in the transcription factors T-bet and eomesodermin (Eomes) fail to differentiate into functional killers required for defense against lymphocytic choriomeningitis virus. Instead, virus-specific CD8(+) T cells lacking both T-bet and Eomes differentiate into an interleukin-17-secreting lineage, reminiscent of the helper T cell fate that has been implicated in autoimmunity and extracellular microbial defense. Upon viral infection, mice with T cells lacking both T-bet and Eomes develop a CD8(+) T cell-dependent, progressive inflammatory and wasting syndrome characterized by multi-organ infiltration of neutrophils. T-bet and Eomes, thus, ensure that CD8(+) T cells adopt an appropriate course of intracellular rather than extracellular destruction.	[Intlekofer, Andrew M.; Banerjee, Arnob; Takemoto, Naofumi; Gordon, Scott M.; DeJong, Caitlin S.; Lindsten, Tullia; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Intlekofer, Andrew M.; Banerjee, Arnob; Takemoto, Naofumi; Gordon, Scott M.; DeJong, Caitlin S.; Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Lindsten, Tullia] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Shin, Haina; Wherry, E. John] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Bldg 2-3,Room 414,421 Curie Blvd, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu	Hunter, Christopher/H-1970-2011; Wherry, John/ABI-1280-2020	Shin, Haina/0000-0002-1014-1451; Intlekofer, Andrew/0000-0001-9046-6549; Gordon, Scott/0000-0003-1028-1953	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076458, R01AI042334, R01AI061699, R01AI071309, T32AI007532, R01AI076458, R01AI042370] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042370, AI007532, R01 AI061699-05, R01 AI071309, R01 AI076458-02, AI071309, R01 AI076458, AI042370, R01 AI061699, R01 AI071309-01, AI042334, R01 AI042370-12, AI076458, AI061699] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	24	301	306	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					408	411		10.1126/science.1159806	http://dx.doi.org/10.1126/science.1159806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635804	Green Accepted			2022-12-24	WOS:000257713900051
J	Monk, BC; Goffeau, A				Monk, Brian C.; Goffeau, Andre			Outwitting multidrug resistance to antifungals	SCIENCE			English	Editorial Material							PLEIOTROPIC DRUG-RESISTANCE; GENOME-WIDE EXPRESSION; CANDIDA-ALBICANS; AZOLE RESISTANCE; SACCHAROMYCES-CEREVISIAE; MULTIPLE RESISTANCE; TRANSPORTER GENES; ABC TRANSPORTERS; IN-VIVO; TRANSCRIPTION		[Monk, Brian C.; Goffeau, Andre] Univ Otago, Dept Oral Sci, Fac Dent, Dunedin, New Zealand; [Monk, Brian C.; Goffeau, Andre] Catholic Univ Louvain, Inst Sci La Vie, B-1348 Louvain, Belgium	University of Otago; Universite Catholique Louvain	Goffeau, A (corresponding author), Univ Otago, Dept Oral Sci, Fac Dent, POB 647, Dunedin, New Zealand.	andre.goffeau@uclouvain.be		Monk, Brian/0000-0003-2264-3480	NIDCR NIH HHS [DE016885] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016885] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; BALZI E, 1994, J BIOL CHEM, V269, P2206; Banerjee D, 2008, EUKARYOT CELL, V7, P68, DOI 10.1128/EC.00256-07; Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425; Boyanton BL, 2008, ARCH PATHOL LAB MED, V132, P667, DOI 10.1043/1543-2165(2008)132[667:DPIOPC]2.0.CO;2; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Cernicka J, 2007, INT J ANTIMICROB AG, V29, P170, DOI 10.1016/j.ijantimicag.2006.08.037; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Gbelska Y, 2006, FEMS YEAST RES, V6, P345, DOI 10.1111/j.1567-1364.2006.00058.x; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kolaczkowska A, 2008, FEBS LETT, V582, P977, DOI 10.1016/j.febslet.2008.02.045; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Larsen B, 2006, YEAST, V23, P795, DOI 10.1002/yea.1394; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Liu MP, 2006, EUKARYOT CELL, V5, P638, DOI 10.1128/EC.5.4.638-649.2006; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Mamnun YM, 2002, MOL MICROBIOL, V46, P1429, DOI 10.1046/j.1365-2958.2002.03262.x; Monk BC, 2005, ANTIMICROB AGENTS CH, V49, P57, DOI 10.1128/AAC.49.1.57-70.2005; Nascimento AM, 2003, ANTIMICROB AGENTS CH, V47, P1719, DOI 10.1128/AAC.47.5.1719-1726.2003; Nourani A, 1997, MOL GEN GENET, V256, P397, DOI 10.1007/s004380050583; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Sanglard Dominique, 2002, P349; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382	34	105	112	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					367	369		10.1126/science.1159746	http://dx.doi.org/10.1126/science.1159746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635793				2022-12-24	WOS:000257713900038
J	Stengel, KF; Holdermann, I; Cain, P; Robinson, C; Wild, K; Sinning, I				Stengel, Katharina F.; Holdermann, Iris; Cain, Peter; Robinson, Colin; Wild, Klemens; Sinning, Irmgard			Structural basis for specific substrate recognition by the chloroplast signal recognition particle protein cpSRP43	SCIENCE			English	Article							LIGHT-HARVESTING PROTEINS; CRYSTAL-STRUCTURE; ANKYRIN REPEAT; BINDING; SRP; PATHWAY; RNA; COMPLEXES; PHD	Secretory and membrane proteins carry amino- terminal signal sequences that, in cotranslational targeting, are recognized by the signal recognition particle protein SRP54 without sequence specificity. The most abundant membrane proteins on Earth are the light- harvesting chlorophyll a/ b binding proteins ( LHCPs). They are synthesized in the cytoplasm, imported into the chloroplast, and posttranslationally targeted to the thylakoid membrane by cpSRP, a heterodimer formed by cpSRP54 and cpSRP43. We present the 1.5 angstrom crystal structure of cpSRP43 characterized by a unique arrangement of chromodomains and ankyrin repeats. The overall shape and charge distribution of cpSRP43 resembles the SRP RNA, which is absent in chloroplasts. The complex with the internal signal sequence of LHCPs reveals that cpSRP43 specifically recognizes a DPLG peptide motif. We describe how cpSPR43 adapts the universally conserved SRP system to posttranslational targeting and insertion of the LHCP family of membrane proteins.	[Stengel, Katharina F.; Holdermann, Iris; Wild, Klemens; Sinning, Irmgard] Heidelberg Univ, Zentrum Biochem, INF328, D-69120 Heidelberg, Germany; [Cain, Peter; Robinson, Colin] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Ruprecht Karls University Heidelberg; University of Warwick	Sinning, I (corresponding author), Heidelberg Univ, Zentrum Biochem, INF328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010; Cain, Peter/H-1515-2011					Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Blankenfeldt W, 1999, PROTEIN SCI, V8, P2406; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; FULSON DR, 1988, PLANT PHYSIOL, V88, P1146, DOI 10.1104/pp.88.4.1146; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; High S, 1997, J BIOL CHEM, V272, P11622; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Lang M, 2001, J BIOL CHEM, V276, P7985, DOI 10.1074/jbc.M006417200; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Matias PM, 1999, STRUCTURE, V7, P119, DOI 10.1016/S0969-2126(99)80019-7; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; Rosenblad MA, 2004, PLANT CELL PHYSIOL, V45, P1633, DOI 10.1093/pcp/pch185; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2007, BIOL CHEM, V388, P907, DOI 10.1515/BC.2007.111; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853	34	71	74	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					253	256		10.1126/science.1158640	http://dx.doi.org/10.1126/science.1158640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621669				2022-12-24	WOS:000257512900041
J	Friedman, M				Friedman, Matt			The evolutionary origin of flatfish asymmetry	NATURE			English	Article							PLEURONECTIFORMES; ACANTHOMORPHS; PHYLOGENY; BEHAVIOR; RECORD	All adult flatfishes ( Pleuronectiformes), including the gastronomically familiar plaice, sole, turbot and halibut, have highly asymmetrical skulls, with both eyes placed on one side of the head. This arrangement, one of the most extraordinary anatomical specializations among vertebrates, arises through migration of one eye during late larval development. Although the transformation of symmetrical larvae into asymmetrical juveniles is well documented(1-7), the evolutionary origins of flatfish asymmetry are uncertain(1,2) because there are no transitional forms linking flatfishes with their symmetrical relatives(8,9). The supposed inviability of such intermediates gave pleuronectiforms a prominent role in evolutionary debates(10-16), leading to attacks on natural selection(11) and arguments for saltatory change(14,15). Here I show that Amphistium and the new genus Heteronectes, both extinct spiny- finned fishes from the Eocene epoch of Europe, are the most primitive pleuronectiforms known. The orbital region of the skull in both taxa is strongly asymmetrical, as in living flatfishes, but these genera retain many primitive characters unknown in extant forms. Most remarkably, orbital migration was incomplete in Amphistium and Heteronectes, with eyes remaining on opposite sides of the head in post- metamorphic individuals. This condition is intermediate between that in living pleuronectiforms and the arrangement found in other fishes. Amphistium and Heteronectes indicate that the evolution of the profound cranial asymmetry of extant flatfishes was gradual in nature.	[Friedman, Matt] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Friedman, Matt] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Friedman, M (corresponding author), Univ Chicago, Comm Evolutionary Biol, 1025 E 57th St, Chicago, IL 60637 USA.	mattf@uchicago.edu	Friedman, Matt/F-6991-2012					AHLSTROM EH, 1984, ONTOGENY SYSTEMATICS, P640; BLOT J, 1969, MEM MUS CIV STOR NAT, V1, P1; Chanet B, 1997, ANN SCI NAT ZOOL, V18, P105; Chanet B., 1999, STUDI RICERCHE GIACI, VVIII, P220; CHANET B, 1994, N JB GEOL PALAONT MH, P391; CHAPLEAU F, 1993, B MAR SCI, V52, P516; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Gaudant J., 1979, Bulletin d'Information des Geologues du Bassin de Paris, V16, P11; Goldschmidt R, 1933, SCIENCE, V78, P539, DOI 10.1126/science.78.2033.539; Goldschmidt R., 1940, MAT BASIS EVOLUTION; GOSLINE WA, 1961, COPEIA, P265; Hoshino K, 2006, ICHTHYOL RES, V53, P435, DOI 10.1007/s10228-006-0366-y; Hubbs Carl L., 1944, PAPERS MICHIGAN ACAD SCI ARTS AND LETT, V30, P229; JOHNSON GD, 1993, B MAR SCI, V52, P554; Kyle HM, 1923, PHILOS T R SOC LON B, V211, P75, DOI 10.1098/rstb.1923.0002; Lamarck JBPAM, 1809, PHILOS ZOOLOGIQUE; LIEW HC, 1988, AUST J MAR FRESH RES, V39, P51; Mivart St. George, 1871, GENESIS SPECIES; Norman JR, 1934, SYSTEMATIC MONOGRAPH, VI; Okada N, 2001, CELL TISSUE RES, V304, P59, DOI 10.1007/s004410100353; Palmer AR, 1996, P NATL ACAD SCI USA, V93, P14279, DOI 10.1073/pnas.93.25.14279; Patterson C., 1993, P621; PATTERSON C, 1993, B MAR SCI, V52, P29; Schreiber AM, 2006, J EXP BIOL, V209, P610, DOI 10.1242/jeb.02056; Stiassny MLJ, 2004, ASSEMBLING THE TREE OF LIFE, P410; STICKNEY RR, 1973, COPEIA, P154, DOI 10.2307/1442378; Trevisani E, 2005, PALAEOGEOGR PALAEOCL, V223, P260, DOI 10.1016/j.palaeo.2005.04.008; Von WAHLERT GERD, 1965, SYST ZOOL, V14, P288; Wagemans F, 2001, J FISH BIOL, V59, P1350, DOI 10.1006/jfbi.2001.1747; Wallace A. R., 1889, DARWINISM	30	95	100	2	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					209	212		10.1038/nature07108	http://dx.doi.org/10.1038/nature07108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615083				2022-12-24	WOS:000257466900042
J	Suzuki, H; Thiele, TR; Faumont, S; Ezcurra, M; Lockery, SR; Schafer, WR				Suzuki, Hiroshi; Thiele, Tod R.; Faumont, Serge; Ezcurra, Marina; Lockery, Shawn R.; Schafer, William R.			Functional asymmetry in Caenorhabditis elegans taste neurons and its computational role in chemotaxis	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTOR-CELLS; C-ELEGANS; BEHAVIOR; RESPONSES; PROTEINS; CIRCUIT; VESICLE	Chemotaxis in Caenorhabditis elegans, like chemotaxis in bacteria(1), involves a random walk biased by the time derivative of attractant concentration(2,3), but how the derivative is computed is unknown. Laser ablations have shown that the strongest deficits in chemotaxis to salts are obtained when the ASE chemosensory neurons ( ASEL and ASER) are ablated, indicating that this pair has a dominant role(4). Although these neurons are left - right homologues anatomically, they exhibit marked asymmetries in gene expression and ion preference(5-7). Here, using optical recordings of calcium concentration in ASE neurons in intact animals, we demonstrate an additional asymmetry: ASEL is an ON- cell, stimulated by increases in NaCl concentration, whereas ASER is an OFF-cell, stimulated by decreases in NaCl concentration. Both responses are reliable yet transient, indicating that ASE neurons report changes in concentration rather than absolute levels. Recordings from synaptic and sensory transduction mutants show that the ON - OFF asymmetry is the result of intrinsic differences between ASE neurons. Unilateral activation experiments indicate that the asymmetry extends to the level of behavioural output: ASEL lengthens bouts of forward locomotion ( runs) whereas ASER promotes direction changes ( turns). Notably, the input and output asymmetries of ASE neurons are precisely those of a simple yet novel neuronal motif for computing the time derivative of chemosensory information, which is the fundamental computation of C. elegans chemotaxis(3,8). Evidence for ON and OFF cells in other chemosensory networks(9-12) suggests that this motif may be common in animals that navigate by taste and smell.	[Thiele, Tod R.; Faumont, Serge; Lockery, Shawn R.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Suzuki, Hiroshi; Schafer, William R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ezcurra, Marina; Schafer, William R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Oregon; University of California System; University of California San Diego; MRC Laboratory Molecular Biology	Lockery, SR (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	shawn@uoregon.edu		Thiele, Tod/0000-0003-2628-8359; Schafer, William/0000-0002-6676-8034	Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01 DA016445, DA016445] Funding Source: Medline; NIMH NIH HHS [R21 MH112105, R01 MH051383, R29 MH051383, R01 MH051383-14, MH051383] Funding Source: Medline; MRC [MC_U105185857] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051383, R21MH112105, R01MH051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Daniels SA, 2000, GENETICS, V156, P123; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DUSENBERY DB, 1980, J COMP PHYSL, V136, P127; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hinterwirth A, 2004, EUR J NEUROSCI, V19, P3389, DOI 10.1111/j.0953-816X.2004.03386.x; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; MAIR RG, 1982, J PHYSIOL-LONDON, V326, P341, DOI 10.1113/jphysiol.1982.sp014197; MICHEL WC, 1991, J NEUROPHYSIOL, V65, P446, DOI 10.1152/jn.1991.65.3.446; Miller AC, 2005, J NEUROSCI, V25, P3369, DOI 10.1523/JNEUROSCI.5133-04.2005; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nonet ML, 1998, J NEUROSCI, V18, P70; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; TAKAGI SF, 1959, NATURE, V184, P60, DOI 10.1038/184060a0; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; WINER BJ, 1991, STAT PRINCIPLES EXPT, P354; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	32	157	169	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					114	U6		10.1038/nature06927	http://dx.doi.org/10.1038/nature06927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596810	Green Accepted			2022-12-24	WOS:000257308300048
J	Groh, WJ; Groh, MR; Saha, C; Kincaid, JC; Simmons, Z; Ciafaloni, E; Pourmand, R; Otten, RF; Bhakta, D; Nair, GV; Marashdeh, MM; Zipes, DP; Pascuzzi, RM				Groh, William J.; Groh, Miriam R.; Saha, Chandan; Kincaid, John C.; Simmons, Zachary; Ciafaloni, Emma; Pourmand, Rahman; Otten, Richard F.; Bhakta, Deepak; Nair, Girish V.; Marashdeh, Mohammad M.; Zipes, Douglas P.; Pascuzzi, Robert M.			Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR-TACHYCARDIA; CARDIAC EVENTS; HEART; DISEASE; ARRHYTHMIAS; EXPANSION; MORTALITY; REPEAT; COHORT	Background Sudden death can occur as a consequence of cardiac- conduction abnormalities in the neuromuscular disease myotonic dystrophy type 1. The determinants of the risk of sudden death remain imprecise. Methods We assessed whether the electrocardiogram (ECG) was useful in predicting sudden death in 406 adult patients with genetically confirmed myotonic dystrophy type 1. A patient was characterized as having a severe abnormality if the ECG had at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or third-degree atrioventricular block. Results Patients with severe abnormalities according to the entry ECG were older than patients without severe abnormalities, had more severe skeletal-muscle impairment, and were more likely to have heart failure, left ventricular systolic dysfunction, or atrial tachyarrhythmia. Such patients were more likely to receive a pacemaker or an implantable cardioverter-defibrillator during the follow-up period. During a mean follow-up period of 5.7 years, 81 patients died; there were 27 sudden deaths, 32 deaths from progressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from other causes. Among the 17 patients who died suddenly in whom postcollapse rhythm was evaluated, a ventricular tachyarrhythmia was observed in 9. A severe ECG abnormality (relative risk, 3.30; 95% confidence interval [CI], 1.24 to 8.78) and a clinical diagnosis of atrial tachyarrhythmia (relative risk, 5.18; 95% CI, 2.28 to 11.77) were independent risk factors for sudden death. Conclusions Patients with adult myotonic dystrophy type 1 are at high risk for arrhythmias and sudden death. A severe abnormality on the ECG and a diagnosis of an atrial tachyarrhythmia predict sudden death.	[Groh, William J.; Groh, Miriam R.; Otten, Richard F.; Bhakta, Deepak; Nair, Girish V.; Marashdeh, Mohammad M.; Zipes, Douglas P.] Indiana Univ, Krannert Inst Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Saha, Chandan] Indiana Univ, Div Biostat, Indianapolis, IN 46202 USA; [Kincaid, John C.; Pascuzzi, Robert M.] Indiana Univ, Dept Neurol, Indianapolis, IN 46202 USA; [Simmons, Zachary] Penn State Univ, Dept Neurol, Hershey, PA USA; [Ciafaloni, Emma] Univ Rochester, Dept Neurol, Rochester, NY USA; [Pourmand, Rahman] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Groh, WJ (corresponding author), Indiana Univ, Krannert Inst Cardiol, Dept Med, 1800 N Capitol,Rm E406, Indianapolis, IN 46202 USA.	wgroh@iupui.edu		Zipes, Douglas/0000-0001-7141-6829	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00750-27S1] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1989, NEW ENGL J MED, V321, P406; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Babuty D, 1999, HEART, V82, P634, DOI 10.1136/hrt.82.5.634; Bassez G, 2004, NEUROLOGY, V63, P1939, DOI 10.1212/01.WNL.0000144343.91136.CF; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bhakta D, 2004, AM HEART J, V147, P224, DOI 10.1016/j.ahj.2003.08.008; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Clarke NRA, 2001, HEART, V86, P411, DOI 10.1136/heart.86.4.411; Colleran JA, 1997, AM J CARDIOL, V80, P1494, DOI 10.1016/S0002-9149(97)00742-X; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; FISCH C, 1951, AM HEART J, V41, P525, DOI 10.1016/0002-8703(51)90020-8; FLOREK RC, 1990, WESTERN J MED, V153, P24; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; GRIGG LE, 1985, J AM COLL CARDIOL, V6, P254, DOI 10.1016/S0735-1097(85)80286-2; Hadian D, 2002, J CARDIOVASC ELECTR, V13, P72, DOI 10.1046/j.1540-8167.2002.00072.x; HAWLEY RJ, 1991, NEUROLOGY, V41, P259, DOI 10.1212/WNL.41.2_Part_1.259; *INT MYOT DYSTR CO, 2005, NEUROLOGY, V54, P1218; Lazarus A, 1999, CIRCULATION, V99, P1041, DOI 10.1161/01.CIR.99.8.1041; Lazarus A, 2002, J AM COLL CARDIOL, V40, P1645, DOI 10.1016/S0735-1097(02)02339-2; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Merino JL, 1998, CIRCULATION, V98, P541, DOI 10.1161/01.CIR.98.6.541; NGUYEN HH, 1988, J AM COLL CARDIOL, V11, P662, DOI 10.1016/0735-1097(88)91547-1; Pelargonio G, 2002, HEART, V88, P665, DOI 10.1136/heart.88.6.665; Phillips MF, 1997, CARDIOVASC RES, V33, P13, DOI 10.1016/S0008-6363(96)00163-0; Pratt CM, 1996, CIRCULATION, V93, P519, DOI 10.1161/01.CIR.93.3.519; Rogers MT, 2002, NEUROMUSCULAR DISORD, V12, P358, DOI 10.1016/S0960-8966(02)00004-4	31	313	321	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2688	2697		10.1056/NEJMoa062800	http://dx.doi.org/10.1056/NEJMoa062800			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565861	Bronze			2022-12-24	WOS:000256815100005
J	Buckley, BM				Buckley, Brendan M.			Clinical trials of orphan medicines	LANCET			English	Article							RANDOMIZED-TRIALS; CYSTIC-FIBROSIS; RARE DISEASES; N-OF-1 TRIALS		Natl Univ Ireland Univ Coll Cork, European Ctr Clin Trials Rare Dis, Cork, Ireland	University College Cork	Buckley, BM (corresponding author), Natl Univ Ireland Univ Coll Cork, European Ctr Clin Trials Rare Dis, Lancaster Hall,7 Little Hanover St, Cork, Ireland.	b.buckley@ucc.ie						Backman CL, 1999, AM J PHYS MED REHAB, V78, P170, DOI 10.1097/00002060-199903000-00022; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bollert FGE, 1999, EUR RESPIR J, V13, P107; Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3; Committee for Medicinal Products for Human Use, 2006, GUID CLIN TRIALS SMA; Cook DJ, 1996, PSYCHOPHARMACOL BULL, V32, P363; FREEDMAN LS, 1994, STAT MED, V13, P1371, DOI 10.1002/sim.4780131312; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; GUNN TR, 1979, J PEDIATR-US, V94, P106, DOI 10.1016/S0022-3476(79)80370-4; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd; Lagakos SW, 2003, NEW ENGL J MED, V348, P2455, DOI 10.1056/NEJMe030024; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; LUBITZ JA, 1973, JAMA-J AM MED ASSOC, V223, P1109, DOI 10.1001/jama.223.10.1109; SCHEIN PS, 1972, CANCER, V30, P1616, DOI 10.1002/1097-0142(197212)30:6<1616::AID-CNCR2820300630>3.0.CO;2-O; Stallard N, 2003, STAT MED, V22, P689, DOI 10.1002/sim.1362; Sung L, 2006, J PEDIAT HEMATOL ONC, V28, P263, DOI 10.1097/01.mph.0000212904.68899.1d; Suri R, 2004, PEDIATR PULM, V37, P305, DOI 10.1002/ppul.10442; Walshe J M, 1979, Prog Clin Biol Res, V34, P271; Whitehead J, 1997, DESIGN ANAL SEQUENTI; 1998, NOTE GUIDANCE STAT P	20	58	59	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2008	371	9629					2051	2055		10.1016/S0140-6736(08)60876-4	http://dx.doi.org/10.1016/S0140-6736(08)60876-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555919				2022-12-24	WOS:000256709500035
J	Li, S; Wei, HC; Zheng, QS				Li, Sumei; Wei, Haichun; Zheng, Qingsi			Elimination of iodine-deficiency disorders in Tibet	LANCET			English	Editorial Material									[Li, Sumei; Zheng, Qingsi] Chinese Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China; [Wei, Haichun] Chinese Ctr Dis Control & Prevent, Natl Ctr Rural Water Supply Tech Guidance, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for Rural Water Supply Technical Guidance, Chinese Center for Disease Control & Prevention	Li, S (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China.	lisumeinttst@163.com						Chen ZP., 2000, J PREV MED INF, V16, P93; HETZEL BS, 2005, CHANCE COMMITMENT; LI SM, 2008, ZHONGGUO DI FANG BIN, V23, P43; XU J, 2007, ZHONGHUA LIU XING BI, V29, P253	4	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 14	2008	371	9629					1980	1981		10.1016/S0140-6736(08)60848-X	http://dx.doi.org/10.1016/S0140-6736(08)60848-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555900				2022-12-24	WOS:000256709500008
J	Tewksbury, JJ; Huey, RB; Deutsch, CA				Tewksbury, Joshua J.; Huey, Raymond B.; Deutsch, Curtis A.			Ecology - Putting the heat on tropical animals	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; THERMAL TOLERANCE; MOUNTAIN PASSES; SENSITIVITY; ADAPTATION; CAPACITY		[Tewksbury, Joshua J.; Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Deutsch, Curtis A.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Tewksbury, JJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	tewksjj@u.washington.edu	Huey, Raymond/F-1597-2010; Deutsch, Curtis A/D-1703-2011	Huey, Raymond/0000-0002-4962-8670				Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Brett J. R., 1970, MARINE ECOLOGY, P515; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Crozier L, 2006, AM NAT, V167, P853, DOI 10.1086/504848; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; IPCC, 2007, CLIM CHANG 2007 PHYS; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; PARSONS PA, 1989, AMBIO, V18, P322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; RUIBAL R, 1961, EVOLUTION, V15, P98, DOI 10.2307/2405846; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; VANBERKUM FH, 1988, AM NAT, V132, P327, DOI 10.1086/284856; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	24	629	643	3	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1296	1297		10.1126/science.1159328	http://dx.doi.org/10.1126/science.1159328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535231				2022-12-24	WOS:000256441100028
J	Wagner, KD				Wagner, Karen Dineen			Baby food	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kwagner@utmb.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					371	372		10.1001/jama.300.4.371	http://dx.doi.org/10.1001/jama.300.4.371			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647970				2022-12-24	WOS:000257831200001
J	Rutherford, GW				Rutherford, George W.			Condoms in concentrated and generalised HIV epidemics	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; BEHAVIOR; DECLINE		Univ Calif San Francisco, Cochrane HIV AIDS Grp & Global Hlth Sci, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Rutherford, GW (corresponding author), Univ Calif San Francisco, Cochrane HIV AIDS Grp & Global Hlth Sci, San Francisco, CA 94105 USA.	grutherford@psg.ucsf.edu						[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; HATCHER RA, 2007, CONTRACEPTIVE TECHNO; Hayes R, 2006, SCIENCE, V311, P620, DOI 10.1126/science.1124072; HEARST N, EVIDENCE DEMANDS ACT; Low-Beer Daniel, 2003, Afr J AIDS Res, V2, P9, DOI 10.2989/16085906.2003.9626555; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					275	276		10.1016/S0140-6736(08)61092-2	http://dx.doi.org/10.1016/S0140-6736(08)61092-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657695				2022-12-24	WOS:000258042800011
J	Dejosez, M; Krumenacker, JS; Zitur, LJ; Passeri, M; Chu, LF; Zhou, SY; Thomson, JA; Zwaka, TP				Dejosez, Marion; Krumenacker, Joshua S.; Zitur, Laura Jo; Passeri, Marco; Chu, Li-Fang; Zhou Songyang; Thomson, James A.; Zwaka, Thomas P.			Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells	CELL			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; GERM-CELLS; DEVELOPMENTAL REGULATORS; POU-DOMAIN; EXPRESSION; PROTEIN; PROLIFERATION; FIBROBLASTS; NANOG	Pluripotency is a unique biological state that allows cells to differentiate into any tissue type. Here we describe a candidate pluripotency factor, Ronin, that possesses a THAP domain, which is associated with sequence-specific DNA binding and epigenetic silencing of gene expression. Ronin is expressed primarily during the earliest stages of murine embryonic development, and its deficiency in mice produces periimplantational lethality and defects in the inner cell mass. Conditional knockout of Ronin prevents the growth of ES cells while forced expression of Ronin allows ES cells to proliferate without differentiation under conditions that normally do not promote self-renewal. Ectopic expression also partly compensates for the effects of Oct4 knockdown. We demonstrate that Ronin binds directly to HCF-1, a key transcriptional regulator. Our findings identify Ronin as an essential factor underlying embryogenesis and ES cell pluripotency. Its association with HCF-1 suggests an epigenetic mechanism of gene repression in pluripotent cells.	[Dejosez, Marion; Krumenacker, Joshua S.; Zitur, Laura Jo; Passeri, Marco; Chu, Li-Fang; Zwaka, Thomas P.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Dejosez, Marion; Zitur, Laura Jo; Zwaka, Thomas P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dejosez, Marion; Zitur, Laura Jo; Zwaka, Thomas P.] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA; [Zhou Songyang] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Thomson, James A.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison	Zwaka, TP (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	tpzwaka@bcm.edu	Chu, Li-Fang/ABC-2853-2020	Chu, Li-Fang/0000-0002-4738-4481; ZITUR, LAURA/0000-0002-1238-2726	NHLBI NIH HHS [T32 HL092332, T32 HL092332-06] Funding Source: Medline; NIBIB NIH HHS [R01 EB005173-01, P20 EB007076, R01 EB005173] Funding Source: Medline; NIDDK NIH HHS [5T32DK060445] Funding Source: Medline; NIGMS NIH HHS [P01 GM081627-010004, R01 GM077442, P01 GM081627, P01 GM81627] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB007076, R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627, R01GM077442] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Bessler JB, 2007, GENETICS, V175, P2029, DOI 10.1534/genetics.107.070987; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Bouvet P, 2000, METH MOL B, V148, P603; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Frengen E, 2000, GENOMICS, V70, P273, DOI 10.1006/geno.2000.6389; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Macfarlan T, 2006, MOL ENDOCRINOL, V20, P335, DOI 10.1210/me.2005-0248; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PEDERSEN RA, 1986, EXPT APPROACHES MAMM, P3; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	141	147	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1162	1174		10.1016/j.cell.2008.05.047	http://dx.doi.org/10.1016/j.cell.2008.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585351	Green Accepted, Bronze			2022-12-24	WOS:000257144600014
J	Ideker, T				Ideker, Trey			Forging new ties between E-coli genes	CELL			English	Editorial Material							NETWORKS; PROTEIN	A recent study in Nature (Isalan et al., 2008) has examined the effects of systematically adding new transcriptional interactions in the bacterium Escherichia coli. Surprisingly, the majority of the engineered connections have no effect on growth, and in some cases the new connections enhance fitness. These findings reveal insights into the robustness and evolvability of gene networks.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu		Ideker, Trey/0000-0002-1708-8454	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES014811-05, R01 ES014811-04, ES14811, R01 ES014811, R01 ES014811-05S1, R01 ES014811-01A1, R01 ES014811-02, R01 ES014811-02S1, R01 ES014811-03] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; DITTO MD, 1994, J BACTERIOL, V176, P3738, DOI 10.1128/JB.176.12.3738-3748.1994; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200	9	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1135	1137		10.1016/j.cell.2008.06.003	http://dx.doi.org/10.1016/j.cell.2008.06.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585345	Green Accepted, Bronze			2022-12-24	WOS:000257144600008
J	Tseng, CK; Cheng, SC				Tseng, Chi-Kang; Cheng, Soo-Chen			Both catalytic steps of nuclear pre-mRNA splicing are reversible	SCIENCE			English	Article							SPLICEOSOME ACTIVATION; INTRON; HELICASE; YEAST; MUTATIONS; INVITRO; PRP22	Nuclear pre- messenger RNA ( pre- mRNA) splicing is an essential processing step for the production of mature mRNAs from most eukaryotic genes. Splicing is catalyzed by a large ribonucleoprotein complex, the spliceosome, which is composed of five small nuclear RNAs and more than 100 protein factors. Despite the complexity of the spliceosome, the chemistry of the splicing reaction is simple, consisting of two consecutive transesterification reactions. The presence of introns in spliceosomal RNAs of certain fungi has suggested that splicing may be reversible; however, this has never been demonstrated experimentally. By using affinity- purified spliceosomes, we have shown that both catalytic steps of splicing can be efficiently reversed under appropriate conditions. These results provide considerable insight into the catalytic	[Tseng, Chi-Kang; Cheng, Soo-Chen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Tseng, Chi-Kang; Cheng, Soo-Chen] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Cheng, SC (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	mbscc@ccvax.sinica.edu.tw	Cheng, Soo-Chen/AAZ-7956-2021	Cheng, Soo-Chen/0000-0002-7570-9415; Tseng, Chi-Kang/0000-0003-0288-1406				AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; JARRELL KA, 1988, J BIOL CHEM, V263, P3432; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; MORL M, 1990, CELL, V60, P629, DOI 10.1016/0092-8674(90)90666-3; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; Will CL, 2006, COLD SPRING HARB MON, V43, P369	14	78	79	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1782	1784		10.1126/science.1158993	http://dx.doi.org/10.1126/science.1158993			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583613				2022-12-24	WOS:000257121200040
J	Ayme, S; Kole, A; Groft, S				Ayme, Segolene; Kole, Anna; Groft, Stephen			Empowerment of patients: lessons from the rare diseases community	LANCET			English	Article							FACIO-CUTANEOUS SYNDROME; PATIENTS ASSOCIATIONS; EXPERT PATIENT; MUTATIONS; INTERNET; FRANCE		[Ayme, Segolene; Kole, Anna] INSERM, F-75014 Paris, France; [Groft, Stephen] NIH, Office Rare Dis, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA	Ayme, S (corresponding author), INSERM, SC11,102 Rue Didot, F-75014 Paris, France.	ayme@orpha.net	Ayme, Segolene/ABE-2545-2020					Angelmar R, 2007, PATIENT EMPOWERMENT; Broom A, 2005, QUAL HEALTH RES, V15, P325, DOI 10.1177/1049732304272916; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; *EUR COMM, STRONG EUR BAS PHARM; European Commission, 2005, INV COMM MEMB STAT I; Fox NJ, 2005, SOC SCI MED, V60, P1299, DOI 10.1016/j.socscimed.2004.07.005; *FRENCH MIN HLTH S, 2004, FRENCH NAT PLAN RAR; GEORGES J, 2006, PHARM POLICY LAW, V8, P133; Knight AW, 2006, MED J AUSTRALIA, V185, P82, DOI 10.5694/j.1326-5377.2006.tb00477.x; Lasker Judith N, 2005, J Med Internet Res, V7, pe10, DOI 10.2196/jmir.7.1.e10; MARC, 2006, WALL ST J NEW Y 0711, pD2; Marcus Amy Dockser, 2006, Wall St J (East Ed), pD2; Marshall E, 2004, SCIENCE, V305, P1226; Neuhauser Duncan, 2003, Qual Manag Health Care, V12, P171; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Rabeharisoa V, 2000, M S-MED SCI, V16, P945, DOI 10.4267/10608/1762; Rabeharisoa V, 2006, SOC SCI MED, V62, P564, DOI 10.1016/j.socscimed.2005.06.036; Rabeharisoa V, 2003, SOC SCI MED, V57, P2127, DOI 10.1016/S0277-9536(03)00084-4; Rabeharisoa V, 2002, INT SOC SCI J, V54, P57, DOI 10.1111/1468-2451.00359; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Tomes N, 2007, LANCET, V369, P698, DOI 10.1016/S0140-6736(07)60318-3; Wallerstein N, 2006, WHAT IS EVIDENCE EFF; Wilson PM, 2001, HEALTH SOC CARE COMM, V9, P134, DOI 10.1046/j.1365-2524.2001.00289.x; World Bank, WHAT IS EMP	24	150	151	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 14	2008	371	9629					2048	2051		10.1016/S0140-6736(08)60875-2	http://dx.doi.org/10.1016/S0140-6736(08)60875-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555918				2022-12-24	WOS:000256709500034
J	Weber, W; Vander Stoep, A; McCarty, RL; Weiss, NS; Biederman, J; McClellan, J				Weber, Wendy; Vander Stoep, Ann; McCarty, Rachelle L.; Weiss, Noel S.; Biederman, Joseph; McClellan, Jon			Hypericum perforatum (St John's Wort) for attention-deficit/hyperactivity disorder in children and adolescents - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEFICIT-HYPERACTIVITY DISORDER; DAILY ATOMOXETINE TREATMENT; DOUBLE-BLIND; OPEN-LABEL; ALTERNATIVE THERAPIES; CHILDHOOD ATTENTION; METHYLPHENIDATE; COMPLEMENTARY; DEPRESSION; SYMPTOMS	Context Stimulant medication can effectively treat 60% to 70% of youth with attention-deficit/ hyperactivity disorder ( ADHD). Yet many parents seek alternative therapies, and Hypericum perforatum ( St John's wort) is 1 of the top 3 botanicals used. Objective To determine the efficacy and safety of H perforatum for the treatment of ADHD in children. Design, Setting, and Participants Randomized, double- blind, placebo-controlled trial conducted between March 2005 and August 2006 at Bastyr University, Kenmore, Washington, among a volunteer sample of 54 children aged 6 to 17 years who met Diagnostic and Statistical Manual of Mental Disorders ( Fourth Edition) criteria for ADHD by structured interview. Intervention After a placebo run- in phase of 1 week, participants were randomly assigned to receive 300 mg of H perforatum standardized to 0.3% hypericin ( n= 27) or a matched placebo ( n= 27) 3 times daily for 8 weeks. Other medications for ADHD were not allowed during the trial. Main Outcome Measures Performance on the ADHD Rating Scale - IV ( range, 0- 54) and Clinical Global Impression Improvement Scale ( range, 0- 7), and adverse events. Results One patient in the placebo group withdrew because of an adverse event. No significant difference was found in the change in ADHD Rating Scale - IV scores from baseline to week 8 between the treatment and placebo groups: inattentiveness improved 2.6 points ( 95% confidence interval [ CI], - 4.6 to - 0.6 points) with H perforatum vs 3.2 points ( 95% CI, - 5.7 to - 0.8 points) with placebo ( P=. 68) and hyperactivity improved 1.8 points ( 95% CI, - 3.7 to 0.1 points) with H perforatum vs 2.0 points ( 95% CI, - 4.1 to 0.1 points) with placebo ( P=. 89). There was also no significant difference between the 2 groups in the percentage of participants who met criteria for improvement ( score <= 2) on the Clinical Global Impression Improvement Scale ( H perforatum, 44.4%; 95% CI, 25.5%- 64.7% vs placebo, 51.9%; 95% CI, 31.9%- 71.3%; P=. 59). No difference between groups was found in the number of participants who experienced adverse effects during the study period ( H perforatum, 40.7%; 95% CI, 22.4%- 61.2% vs placebo, 44.4%; 95% CI, 25.5%- 64.7%; P=. 78). Conclusion In this study, use of H perforatum for treatment of ADHD over the course of 8 weeks did not improve symptoms. Trial Registration clinicaltrials. gov Identifier: NCT00100295.	[Weber, Wendy; McCarty, Rachelle L.] Bastyr Univ, Sch Naturopath Med, Kenmore, WA USA; [Vander Stoep, Ann] Univ Washington, Dept Psychiat & Behav Sci, Childrens Hosp & Reg Med Ctr, Seattle, WA 98195 USA; [Vander Stoep, Ann; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [McClellan, Jon] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Biederman, Joseph] Massachusetts Gen Hosp, Dept Pediat Psychopharmacol, Boston, MA 02114 USA; [Biederman, Joseph] Harvard Univ, Dept Psychiat, Boston, MA 02115 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University	Weber, W (corresponding author), 14500 Juanita Dr NE, Kenmore, WA USA.	wendyw@bastyr.edu			NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT000929, T32AT000815] Funding Source: NIH RePORTER; NCCIH NIH HHS [K23AT000929, T32AT00815, T32 AT000815-05, K23 AT000929-05, K23 AT000929, T32 AT000815] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baumgaertel A, 1999, PEDIATR CLIN N AM, V46, P977, DOI 10.1016/S0031-3955(05)70167-X; Biederman J, 2004, INT J NEUROPSYCHOPH, V7, P77, DOI 10.1017/S1461145703003973; Bussing R, 2002, PSYCHIAT SERV, V53, P1096, DOI 10.1176/appi.ps.53.9.1096; Cala S, 2003, PHARMACOTHERAPY, V23, P222, DOI 10.1592/phco.23.2.222.32092; Chan E, 2002, J DEV BEHAV PEDIATR, V23, pS37, DOI 10.1097/00004703-200202001-00007; Chan E, 2003, J DEV BEHAV PEDIATR, V24, P4, DOI 10.1097/00004703-200302000-00003; Conners C.K., 1997, CONNERSRATING SCALES; Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; DUPAUL GJ, 1998, ADHD RATING SCALE, V4; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Findling RL, 2003, J AM ACAD CHILD PSY, V42, P908, DOI 10.1097/01.CHI.0000046900.27264.2A; Froehlich TE, 2007, ARCH PEDIAT ADOL MED, V161, P857, DOI 10.1001/archpedi.161.9.857; Greenhill LL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.3.e39; Homer CJ, 2000, PEDIATRICS, V105, P1158; Hubner WD, 2001, PHYTOTHER RES, V15, P367, DOI 10.1002/ptr.829; Kalachnik J., 1986, DRUG THERAPY BEHAV D, P153; Kasper S, 2007, EUR ARCH PSY CLIN N, V258, P59, DOI 10.1007/s00406-007-0779-2; Kelsey DK, 2004, PEDIATRICS, V114, pE1, DOI 10.1542/peds.114.1.e1; Kratochvil CJ, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00008; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Markowitz JS, 2003, JAMA-J AM MED ASSOC, V290, P1500, DOI 10.1001/jama.290.11.1500; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Michelson D, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e83; Muller WE, 1997, PHARMACOPSYCHIATRY, V30, P102, DOI 10.1055/s-2007-979528; National Institute of Mental Health, 1985, PSYCHOPHARMACOL BULL, V21, P839; Orth HCJ, 1999, J PHARM PHARMACOL, V51, P193, DOI 10.1211/0022357991772132; Orvaschel H, 1987, SCHEDULE AFFECTIVE D; Prasad S, 2007, CURR MED RES OPIN, V23, P379, DOI 10.1185/030079906X167309; Robison LM, 2004, INT CLIN PSYCHOPHARM, V19, P17, DOI 10.1097/00004850-200401000-00003; Schachter HA, 2001, CAN MED ASSOC J, V165, P1475; Shelton RC, 2001, JAMA-J AM MED ASSOC, V285, P1978, DOI 10.1001/jama.285.15.1978; Spencer T, 2002, J CLIN PSYCHIAT, V63, P1140, DOI 10.4088/JCP.v63n1209; *STATACORP, 2007, STAT SE COMP PROGR V; Stubberfield TG, 1999, J PAEDIATR CHILD H, V35, P450, DOI 10.1046/j.1440-1754.1999.355401.x; Szegedi A, 2005, BMJ-BRIT MED J, V330, P759; Szegedi A, 2005, BMJ-BRIT MED J, V330, P503, DOI 10.1136/bmj.38356.655266.82; U.S. Census Bureau; American Community Survey (ACS), AM FACT FIND; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Visser SN, 2007, PEDIATRICS, V119, pS99, DOI 10.1542/peds.2006-2089O	41	44	45	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2008	299	22					2633	2641		10.1001/jama.299.22.2633	http://dx.doi.org/10.1001/jama.299.22.2633			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311FN	18544723	Green Accepted			2022-12-24	WOS:000256586200020
J	Bertozzi, SM; Laga, M; Bautista-Arredondo, S; Coutinho, A				Bertozzi, Stefano M.; Laga, Marie; Bautista-Arredondo, Sergio; Coutinho, Alex			HIV prevention 5 - Making HIV prevention programmes work	LANCET			English	Article							INFECTION; TRANSMISSION; PROSTITUTES	Even after 25 years of experience, HIV prevention programming remains largely deficient. We identify four areas that managers of national HIV prevention programmes should reassess and hence refocus their efforts-improvement of targeting, selection, and delivery of prevention interventions, and optimisation of funding. Although each area is not wholly independent from one another, and because each country and epidemic context will require a different balance of time and funding allocation in each area, we present the current state of each dimension in the global HIV prevention arena and propose practical ways to remedy present deficiencies. insufficient data for intervention effectiveness and country-specific epidemiology has meant that programme managers have operated, and continue to operate, in a fog of uncertainty. Although priority must be given to the improvement of prevention methods and the capacity for the generation and use of evidence to improve programme planning and implementation, uncertainty will remain. In the meantime, however, we argue that prevention programming can be made much more effective by use of information that is readily available.	[Bertozzi, Stefano M.; Bautista-Arredondo, Sergio] Inst Nacl Salud Publ, Cuernavaca 62508, Morelos, Mexico; [Bertozzi, Stefano M.] Ctr Econ Res & Testing CIDC, Mexico City, DF, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Laga, Marie] Inst Trop Med, B-2000 Antwerp, Belgium; [Coutinho, Alex] Infect Dis Inst, Kampala, Uganda	Instituto Nacional de Salud Publica; University of California System; University of California Berkeley; Institute of Tropical Medicine (ITM)	Bertozzi, SM (corresponding author), Inst Nacl Salud Publ, Av Univ 655,Sta Maria Ahuacatitlan, Cuernavaca 62508, Morelos, Mexico.	sbertozzi@correo.insp.mx	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011; Bertozzi, Stefano M/0000-0002-1723-7085				[Anonymous], 1992, AIDS WORLD; *AUSTR GOV AUSAID, 2004, M CHALL AUSTR INT HI; BAUTISTAARRENDO.S, PREDICTING EFFICIENC; BIDEN JR, 2008, BIDEN LUGAR LEGISLAT; BOLLINGER L, POTENTIAL IMPACT HIV; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; *CENSIDA, 2008, INF UNGASS MEX 2008; *COMM AUSTR, AUSTR OV AID PROGR 2; Committee for the Evaluation of the President's Emergency Plan for AIDS Relief, 2007, PEPFAR IMPL PROGR PR; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; DANDONA L, IN PRESS AIDS; Euromonitor, 2019, WINE CHINA COUNTRY R; *FUT GROUP CONST, RES NEEDS HIV AIDS M; *GLOB FUND FIGHT A, 2005, 11 BOARD M GEN 28 30; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; *GREEK CTR DIS CON, 2008, UNGASS COUNTR PROGR; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GUPTA GR, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; *I MED COMM EV PEP, 2007, PEPFAR IMPL PROGR PR; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kates J., 2006, INT ASSISTANCE HIV A; KUMARANAYAKE L, IN PRESS AIDS; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Marseille E, 2004, HEALTH SERV RES, V39, P1996; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; MARTINEZBRISENO D, TECHNICAL EFFICENCY; Merson MH, 2000, AIDS, V14, pS68; MERSON MH, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60884-3; *NAT AIDS PREV ALL, 2007, UNGASS COUNTR PROGR; NGUYENVANHOUTTE D, 2005, AIDS STRAT ACT PLAN; *PEPFAR, 2008, POW PARTN 4 ANN REP; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; SIRAPRAPASIRI T, 1991, AIDS, V5, P579, DOI 10.1097/00002030-199105000-00017; *SO AFR DEV COMM, 2003, DECL HIV AIDS; STOVER J, COVERAGE SELECTED SE; *TURK MIN HLTH, 2008, UNGASS IND COUNTR RE; *UNAIDS, 2008, UNAIDS REP IN PRESS; *UNAIDS, 3 1S; UNAIDS, 2005, INT HIV PREV UNAIDS; *UNAIDS, 2007, PRACT GUID INT HIV P; *UNAIDS WHO, 2007, AIDS EP UPD; *USAID UNAIDS WHO, 2004, COV SEL SERV HIV AID; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WILLERFORD DM, 1993, J INFECT DIS, V167, P1414, DOI 10.1093/infdis/167.6.1414; *WORLD BANK, 2005, REV NAT HIV AIDS STR; World Health Organization, 2001, MACR HLTH INV HLTH E	49	79	79	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					831	844		10.1016/S0140-6736(08)60889-2	http://dx.doi.org/10.1016/S0140-6736(08)60889-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18687457				2022-12-24	WOS:000259124900026
J	Berman, M; Lavizzo-Mourey, R				Berman, Mark; Lavizzo-Mourey, Risa			Obesity prevention in the information age - Caloric information at the point of purchase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FAST-FOOD; HEALTH; RESTAURANTS; CONSUMPTION; HOSPITALS; ADULTS; IMPACT		[Berman, Mark; Lavizzo-Mourey, Risa] Robert Wood Johnson Fdn, Princeton, NJ 08543 USA	Robert Wood Johnson Foundation (RWJF)	Berman, M (corresponding author), Robert Wood Johnson Fdn, POB 2316, Princeton, NJ 08543 USA.	maberman@rwjf.org						Backstrand J, 1997, FAT CHANCE; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499; *KEYST CTR, 2006, KEYST FOR AW HOM FOO; Kreuter MW, 1997, AM J PREV MED, V13, P277, DOI 10.1016/S0749-3797(18)30175-2; Lesser LI, 2006, J AM BOARD FAM MED, V19, P526, DOI 10.3122/jabfm.19.5.526; Lin B.-H., 1999, NUTR CONTRIBUTION FO; Miles S, 2003, NUTR RES REV, V16, P3, DOI 10.1079/NRR200249; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228; Schmidt M, 2005, ARCH PEDIAT ADOL MED, V159, P626, DOI 10.1001/archpedi.159.7.626; Simon P, 2008, MENU LABELING POTENT; Sproul AD, 2003, MIL MED, V168, P556, DOI 10.1093/milmed/168.7.556; VARIYAM J, 2005, NUTR LABELING FOOD A	14	52	54	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					433	435		10.1001/jama.300.4.433	http://dx.doi.org/10.1001/jama.300.4.433			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647987				2022-12-24	WOS:000257831200022
J	Campillos, M; Kuhn, M; Gavin, AC; Jensen, LJ; Bork, P				Campillos, Monica; Kuhn, Michael; Gavin, Anne-Claude; Jensen, Lars Juhl; Bork, Peer			Drug target identification using side-effect similarity	SCIENCE			English	Article							SMALL-MOLECULE; IN-VITRO; DISCOVERY; PHARMACOLOGY; ANTAGONISTS	Targets for drugs have so far been predicted on the basis of molecular or cellular features, for example, by exploiting similarity in chemical structure or in activity across cell lines. We used phenotypic side- effect similarities to infer whether two drugs share a target. Applied to 746 marketed drugs, a network of 1018 side effect- driven drug- drug relations became apparent, 261 of which are formed by chemically dissimilar drugs from different therapeutic indications. We experimentally tested 20 of these unexpected drug- drug relations and validated 13 implied drug- target relations by in vitro binding assays, of which 11 reveal inhibition constants equal to less than 10 micromolar. Nine of these were tested and confirmed in cell assays, documenting the feasibility of using phenotypic information to infer molecular interactions and hinting at new uses of marketed drugs.	[Campillos, Monica; Kuhn, Michael; Gavin, Anne-Claude; Jensen, Lars Juhl; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Jensen, Lars Juhl] Univ Copenhagen, Panum Inst, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); University of Copenhagen; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Kuhn, Michael/D-4978-2009; Campillos, Monica/M-9849-2014; Jensen, Lars Juhl/C-6492-2008	Bork, Peer/0000-0002-2627-833X; Kuhn, Michael/0000-0002-2841-872X; Campillos, Monica/0000-0002-8591-1713; Jensen, Lars Juhl/0000-0001-7885-715X; Gavin, Anne-Claude/0000-0003-4917-2340				Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Blagg J, 2006, ANNU REP MED CHEM, V41, P353, DOI 10.1016/S0065-7743(06)41024-1; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; CHOUINARD G, 2007, Patent No. 20070082928; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Fliri AF, 2007, CHEMMEDCHEM, V2, P1774, DOI 10.1002/cmdc.200700153; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Guba W, 2007, J MED CHEM, V50, P6295, DOI 10.1021/jm701144e; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; Kuhn M, 2008, FEBS LETT, V582, P1283, DOI 10.1016/j.febslet.2008.02.024; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lin CJ, 2003, PHARMACOTHERAPY, V23, P711, DOI 10.1592/phco.23.6.711.32177; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Martin RE, 2007, J MED CHEM, V50, P6291, DOI 10.1021/jm701143p; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Schuffenhauer A, 2003, J CHEM INF COMP SCI, V43, P391, DOI 10.1021/ci025569t; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	27	910	941	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					263	266		10.1126/science.1158140	http://dx.doi.org/10.1126/science.1158140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621671				2022-12-24	WOS:000257512900044
J	Aral, SO; Adimora, AA; Fenton, KA				Aral, Sevgi O.; Adimora, Adaoro A.; Fenton, Kevin A.			Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans	LANCET			English	Editorial Material							UNITED-STATES; CONCURRENT PARTNERSHIPS; RACIAL DISPARITIES; TRANSMISSION; INEQUALITIES; MORTALITY; NETWORKS		[Aral, Sevgi O.; Fenton, Kevin A.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Adimora, Adaoro A.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Fenton, KA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, 1600 Clifton Rd NE,Mailstop E07, Atlanta, GA 30333 USA.	kfenton@cdc.gov						Adimora AA, 2006, JAIDS-J ACQ IMM DEF, V41, P616, DOI 10.1097/01.qai.0000191382.62070.a5; Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Adimora AA, 2004, ANN EPIDEMIOL, V14, P155, DOI 10.1016/S1047-2797(03)00129-7; Adimora AA, 2003, JAIDS-J ACQ IMM DEF, V34, P423, DOI 10.1097/00126334-200312010-00010; Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Aral SO, 2002, SEX TRANSM INFECT, V78, P2, DOI 10.1136/sti.78.1.2; *CDC, HIV PREV STRAT PLAN; *CDCP, 2005, SEX TRANSM DIS SURV; Center for Disease Control and Prevention, 2005, HIV AIDS SURV REP 20, V16; CHANDRA A, 2003, GEOGRAPHY RACIAL HLT; Geronimus AT, 1996, NEW ENGL J MED, V335, P1552, DOI 10.1056/NEJM199611213352102; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Massey D., 1993, AM APARTHEID SEGREGA; MASSEY DS, 2005, POVERTY INEQUALITY, P117; MAUER M, COMP INT RATES INCAR; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; MOSHER WD, 2005, ADV DATA, V365, P1; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; *PACHA, ACH HIV AIDS GEN REC; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; Roux AVD, 2007, ANN EPIDEMIOL, V17, P569, DOI 10.1016/j.annepidem.2007.03.001; *US BUR CENS, 2000, CENS 2000 SUMM FIL 1, V2003; Zierler S, 1997, ANNU REV PUBL HEALTH, V18, P401, DOI 10.1146/annurev.publhealth.18.1.401	29	163	165	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					337	340		10.1016/S0140-6736(08)61118-6	http://dx.doi.org/10.1016/S0140-6736(08)61118-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657713				2022-12-24	WOS:000258042800035
J	van der Togt, R; van Lieshout, EJ; Hensbroek, R; Beinat, E; Binnekade, JM; Bakker, PJM				van der Togt, Remko; van Lieshout, Erik Jan; Hensbroek, Reinout; Beinat, E.; Binnekade, J. M.; Bakker, P. J. M.			Electromagnetic interference from radio frequency identification inducing potentially hazardous incidents in critical care medical equipment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-EVALUATION; PHONE INTERFERENCE; PATIENT SAFETY; OPERATING-ROOM; TECHNOLOGY; SYSTEM	Context Health care applications of autoidentification technologies, such as radio frequency identification ( RFID), have been proposed to improve patient safety and also the tracking and tracing of medical equipment. However, electromagnetic interference ( EMI) by RFID on medical devices has never been reported. Objective To assess and classify incidents of EMI by RFID on critical care equipment. Design and Setting Without a patient being connected, EMI by 2 RFID systems ( active 125 kHz and passive 868 MHz) was assessed under controlled conditions during May 2006, in the proximity of 41 medical devices ( in 17 categories, 22 different manufacturers) at the Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands. Assessment took place according to an international test protocol. Incidents of EMI were classified according to a critical care adverse events scale as hazardous, significant, or light. Results In 123 EMI tests ( 3 per medical device), RFID induced 34 EMI incidents: 22 were classified as hazardous, 2 as significant, and 10 as light. The passive 868- MHz RFID signal induced a higher number of incidents ( 26 incidents in 41 EMI tests; 63%) compared with the active 125- kHz RFID signal ( 8 incidents in 41 EMI tests; 20%); difference 44% ( 95% confidence interval, 27%- 53%; P <. 001). The passive 868- MHz RFID signal induced EMI in 26 medical devices, including 8 that were also affected by the active 125- kHz RFID signal ( 26 in 41 devices; 63%). The median distance between the RFID reader and the medical device in all EMI incidents was 30 cm ( range, 0.1- 600 cm). Conclusions In a controlled nonclinical setting, RFID induced potentially hazardous incidents in medical devices. Implementation of RFID in the critical care environment should require on- site EMI tests and updates of international standards.	[van Lieshout, Erik Jan; Binnekade, J. M.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1100 AZ Amsterdam, Netherlands; [van der Togt, Remko; Beinat, E.] Vrije Univ Amsterdam, Inst Environm Studies, Spatial Informat Lab, Amsterdam, Netherlands; [van Lieshout, Erik Jan; Binnekade, J. M.] Univ Amsterdam, Acad Med Ctr, Mobile Intens Care Unit, NL-1100 AZ Amsterdam, Netherlands; [Binnekade, J. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 AZ Amsterdam, Netherlands; [Bakker, P. J. M.] Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Innovat, NL-1100 AZ Amsterdam, Netherlands; [Hensbroek, Reinout] TNO Netherlands Org Appl Sci Res, Leiden, Netherlands; [Beinat, E.] Salzburg Univ, Fac Sci, A-5020 Salzburg, Austria	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Organization Applied Science Research; Salzburg University	van Lieshout, EJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Intens Care, Meibergdreef 9, NL-1100 AZ Amsterdam, Netherlands.	e.j.vanlieshout@amc.nl						Ashar BS, 2007, JAMA-J AM MED ASSOC, V298, P2305, DOI 10.1001/jama.298.19.2305; Chang A, 2005, INT J QUAL HEALTH C, V17, P95, DOI 10.1093/intqhc/mzi021; DAS R, 2006, IDT6752; Delvaux M, 2005, ENDOSCOPY, V37, P801, DOI 10.1055/s-2005-870241; Dempsey P, 2005, POWER ENGINEER, V19, P22, DOI 10.1049/pe:20050103; Dzik S, 2007, TRANSFUSION, V47, p125S, DOI 10.1111/j.1537-2995.2007.01367.x; Egan MT, 2007, SURG INNOV, V14, P41, DOI 10.1177/1553350606298971; *EUR TEL STAND I, 2008, ETSI WORLD CLASS STA; Gladman AS, 2007, CRIT CARE, V11, DOI 10.1186/cc6112; HARROP P, RFID HEALTHCARE PHAR; *I EL EL ENG, 1997, C6318 IEEE; *IDTECHEX, RFID HEALTHC RFID KN; *IDTECHEX, 2006, RFID FREQ BANDS DEF; Irnich W, 1996, PACE, V19, P1431, DOI 10.1111/j.1540-8159.1996.tb03155.x; Irnich W, 2002, PACE, V25, P1235, DOI 10.1046/j.1460-9592.2002.01235.x; Kabachinski Jeff, 2005, Biomed Instrum Technol, V39, P131; Kivlahan Coleen, 2002, Jt Comm J Qual Improv, V28, P583; Lawrentschuk N, 2004, MED J AUSTRALIA, V181, P145, DOI 10.5694/j.1326-5377.2004.tb06205.x; Macario A, 2006, ARCH SURG-CHICAGO, V141, P659, DOI 10.1001/archsurg.141.7.659; Marjamaa RA, 2006, ANESTH ANALG, V102, P1183, DOI 10.1213/01.ane.0000196527.96964.72; Nagy P, 2006, SURG INNOV, V13, P61, DOI 10.1177/155335060601300110; Reicher Joshua, 2007, J Clin Monit Comput, V21, P155, DOI 10.1007/s10877-007-9069-9; Rogers A, 2007, SURG ENDOSC, V21, P1235, DOI 10.1007/s00464-007-9308-7; Saito Y, 2007, STUD HEALTH TECHNOL, V129, P1478; Santucci PA, 1998, NEW ENGL J MED, V339, P1371, DOI 10.1056/NEJM199811053391905; Tan K S, 2000, Biomed Instrum Technol, V34, P115; TOMEK A, 2007, IMPLANTABLE RFID GLU; Tri JL, 2001, MAYO CLIN PROC, V76, P11, DOI 10.4065/76.1.11; *US FDA, 2002, DRAFT GUID IND FDA S; Van Lieshout EJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6115; Wallin MKEB, 2005, ANESTH ANALG, V101, P1393, DOI 10.1213/01.ANE.0000180216.83554.00; Wicks Angela M, 2006, Hosp Top, V84, P3, DOI 10.3200/HTPS.84.3.3-9; Young D, 2006, AM J HEALTH-SYST PH, V63, P500, DOI 10.2146/news050060	33	146	151	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2884	2890		10.1001/jama.299.24.2884	http://dx.doi.org/10.1001/jama.299.24.2884			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577733	Bronze			2022-12-24	WOS:000257021800026
J	Cohen, D				Cohen, Deborah			AIDS conference: more junket medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2008	337	7665							a1191	10.1136/bmj.a1191	http://dx.doi.org/10.1136/bmj.a1191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	339EO	18684756				2022-12-24	WOS:000258561100038
J	Oberdoerffer, S; Moita, LF; Neems, D; Freitas, RP; Hacohen, N; Rao, A				Oberdoerffer, Shalini; Moita, Luis Ferreira; Neems, Daniel; Freitas, Rui P.; Hacohen, Nir; Rao, Anjana			Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL	SCIENCE			English	Article							PRE-MESSENGER-RNA; CELLS; ACTIVATION; BINDING; SYSTEM; EXPORT	The transition from naive to activated T cells is marked by alternative splicing of pre- mRNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA interference screen, we identified heterogeneous ribonucleoprotein L- like ( hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up- regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during hematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.	[Oberdoerffer, Shalini; Neems, Daniel; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Moita, Luis Ferreira; Freitas, Rui P.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA; [Hacohen, Nir] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA.	arao@idi.harvard.edu	Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013	Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X	NCI NIH HHS [R01 CA042471, CA42471, R01 CA042471-23] Funding Source: Medline; NHLBI NIH HHS [T32 HL066987] Funding Source: Medline; NIAID NIH HHS [AI44432, R01 AI040127-19, U19 AI070352, R01 AI044432-09, R21 AI071060-01, R01 AI044432, R21 AI071060, R21 AI071060-02, AI40127, R01 AI040127-18, R01 AI080875, R01 AI080875-01, R01 AI040127, R01 AI044432-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080875, R01AI044432, R01AI040127, R21AI071060, U19AI070352] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Salmond RJ, 2008, INT IMMUNOL, V20, P819, DOI 10.1093/intimm/dxn040; Shur I, 2004, GENE, V334, P113, DOI 10.1016/j.gene.2004.03.012; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105	19	143	148	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					686	691		10.1126/science.1157610	http://dx.doi.org/10.1126/science.1157610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669861	Green Accepted			2022-12-24	WOS:000258077700043
J	Hyde, JS; Lindberg, SM; Linn, MC; Ellis, AB; Williams, CC				Hyde, Janet S.; Lindberg, Sara M.; Linn, Marcia C.; Ellis, Amy B.; Williams, Caroline C.			Diversity - Gender similarities characterize math performance	SCIENCE			English	Editorial Material							SEX-DIFFERENCES; ACHIEVEMENT; MATHEMATICS; WOMEN		[Hyde, Janet S.; Lindberg, Sara M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Linn, Marcia C.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ellis, Amy B.; Williams, Caroline C.] Univ Wisconsin, Dept Curriculum & Instruct, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Hyde, JS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	jshyde@wisc.edu	Ellis, Amy/HHS-6792-2022	Lindberg, Sara/0000-0002-0040-8386				Au W., 2007, ED RES, V36, P258, DOI [DOI 10.3102/0013189X07306523, 10.3102/0013189x07306523]; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Frome PM, 1998, J PERS SOC PSYCHOL, V74, P435, DOI 10.1037/0022-3514.74.2.435; Furnham A, 2002, J GENET PSYCHOL, V163, P24, DOI 10.1080/00221320209597966; Halpern CT, 2007, PREV SCI, V8, P1, DOI 10.1007/s11121-006-0046-1; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; HEDGES LV, 1993, REV EDUC RES, V63, P94, DOI 10.3102/00346543063001094; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Li Q, 1999, EDUC RES, V41, P63, DOI 10.1080/0013188990410106; MEECE JL, 1982, PSYCHOL BULL, V91, P324, DOI 10.1037/0033-2909.91.2.324; National Academy of Sciences National Academy of Engineering Institute of Medicine of the National Academies, 2006, BIAS BARR FULF POT W; *NSF, 2006, SCI ENG IND 2006; Roth K, 2006, EDUC LEADERSHIP, V64, P16; SHIELDS SA, 1975, AM PSYCHOL, V30, P739, DOI 10.1037/h0076948; Webb NL, 2007, APPL MEAS EDUC, V20, P7, DOI 10.1207/s15324818ame2001_2	16	507	515	1	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					494	495		10.1126/science.1160364	http://dx.doi.org/10.1126/science.1160364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	329RS	18653867				2022-12-24	WOS:000257888900024
J	Warner, J; Nomani, E				Warner, James; Nomani, Erum			Giving consent in dementia research	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE; PARTICIPATION		[Warner, James; Nomani, Erum] St Charles Hosp, London W10 6DZ, England	Imperial College London	Warner, J (corresponding author), St Charles Hosp, London W10 6DZ, England.	j.warner@imperial.ac.uk						Brodaty H, 1999, ALZ DIS ASSOC DIS, V13, P71, DOI 10.1097/00002093-199904000-00003; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; JEFFERSON AL, 2008, J AM GERIATR SO 0512; Karlawish J, 2008, AM J GERIAT PSYCHIAT, V16, P568, DOI 10.1097/JGP.0b013e318172b406; Karlawish J, 2008, AM J GERIAT PSYCHIAT, V16, P240, DOI 10.1097/JGP.0b013e318162992d; LANDHUIS E, 2008, AD RES PARTICIPATI 1; Lowin A, 2001, INT J GERIATR PSYCH, V16, P1143, DOI 10.1002/gps.499; Medical Research Council, 2007, MRC ETH GUID MED RES; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Warner J, 2008, J MED ETHICS, V34, P167, DOI 10.1136/jme.2006.019786	10	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					183	185		10.1016/S0140-6736(08)61049-1	http://dx.doi.org/10.1016/S0140-6736(08)61049-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	327YH	18640439				2022-12-24	WOS:000257763900007
J	Bass, AH; Gilland, EH; Baker, R				Bass, Andrew H.; Gilland, Edwin H.; Baker, Robert			Evolutionary origins for social vocalization in a vertebrate hindbrain-spinal compartment	SCIENCE			English	Article							TELEOST FISH; VOCAL CONTROL; MUSCLES; NEURONS; MOTOR; NUCLEUS; NERVE; MORPHOGENESIS; NEUROANATOMY; PATHWAYS	The macroevolutionary events leading to neural innovations for social communication, such as vocalization, are essentially unexplored. Many fish vocalize during female courtship and territorial defense, as do amphibians, birds, and mammals. Here, we map the neural circuitry for vocalization in larval fish and show that the vocal network develops in a segment-like region across the most caudal hindbrain and rostral spinal cord. Taxonomic analysis demonstrates a highly conserved pattern between fish and all major lineages of vocal tetrapods. We propose that the vocal basis for acoustic communication among vertebrates evolved from an ancestrally shared developmental compartment already present in the early fishes.	[Bass, Andrew H.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Gilland, Edwin H.] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; [Baker, Robert] NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA; [Bass, Andrew H.; Gilland, Edwin H.; Baker, Robert] Marine Biol Lab, Woods Hole, MA 02543 USA; [Bass, Andrew H.] Univ Calif Bodega, Marine Lab, Bodega Bay, CA 94923 USA	Cornell University; Howard University; New York University; Marine Biological Laboratory - Woods Hole	Bass, AH (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	ahb3@cornell.edu		Baker, Robert/0000-0001-7920-1769; Gilland, Edwin/0000-0002-9426-1919	NIDCD NIH HHS [R01 DC000092, R01 DC000092-33] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000092] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; BASS AH, 1990, J NEUROBIOL, V21, P1155, DOI 10.1002/neu.480210802; BASS AH, 1994, J NEUROSCI, V14, P4025; Bass AH, 1997, BRAIN BEHAV EVOLUT, V50, P3, DOI 10.1159/000113351; Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y; Darwin C., 1981, DESCENT MAN SELECTIO; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Huang RJ, 1999, ANAT EMBRYOL, V200, P137, DOI 10.1007/s004290050268; Jurgens U, 2007, BRAIN RES, V1148, P90, DOI 10.1016/j.brainres.2007.02.020; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KENNEDY MC, 1981, BRAIN RES, V218, P337, DOI 10.1016/0006-8993(81)91311-1; KITAMURA S, 1987, EXP NEUROL, V97, P592, DOI 10.1016/0014-4886(87)90116-6; Knapp R, 1999, J NEUROBIOL, V38, P475, DOI 10.1002/(SICI)1097-4695(199903)38:4<475::AID-NEU4>3.0.CO;2-7; Kubke MF, 2005, J NEUROPHYSIOL, V94, P2379, DOI 10.1152/jn.00257.2005; MOORE BA, 1991, J MORPHOL, V210, P227, DOI 10.1002/jmor.1052100303; MORITA Y, 1987, J COMP NEUROL, V264, P231, DOI 10.1002/cne.902640208; Nelson JS, 1984, FISHES WORLD; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; RUBSAMEN R, 1986, J COMP PHYSIOL A, V159, P689, DOI 10.1007/BF00612041; Straka H, 2006, J COMP NEUROL, V494, P228, DOI 10.1002/cne.20801; TRACY HC, 1959, J COMP NEUROL, V111, P27, DOI 10.1002/cne.901110103; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Zornik E, 2007, J COMP NEUROL, V501, P303, DOI 10.1002/cne.21145	29	126	127	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					417	421		10.1126/science.1157632	http://dx.doi.org/10.1126/science.1157632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635807	Green Accepted			2022-12-24	WOS:000257713900054
J	Wachter, RM; Flanders, SA; Fee, C; Pronovost, PJ				Wachter, Robert M.; Flanders, Scott A.; Fee, Christopher; Pronovost, Peter J.			Public reporting of antibiotic timing in patients with pneumonia: Lessons from a flawed performance measure	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; MEDICARE PATIENTS; CORE MEASURES; OUTCOMES; TIME; MANAGEMENT; MORTALITY; QUALITY	The administration of antibiotics within 4 hours to patients with community-acquired pneumonia has been criticized as a quality standard because it pressures clinicians to rapidly administer antibiotics despite diagnostic uncertainty at the time of patients' initial presentations. The measure was recently revised (to 6 hours) in response to this criticism. On the basis of the experience with the 4-hour rule, the authors make 5 recommendations for the development of future publicly reported quality measures. First, results from samples with known diagnoses should be extrapolated cautiously, if at all, to patients without a diagnosis. Second, for some measures, "bands" of performance may make more sense than "all-or-nothing" expectations. Third, representative end users of quality measures should participate in measure development. Fourth, quality measurement and reporting programs should build in mechanisms to reassess measures over time. Finally, biases, both financial and intellectual, that may influence quality measure development should be minimized. These steps will increase the probability that future quality measures will improve care without creating negative unintended consequences.	[Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, Room M-994,505 Parnassus Ave, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu						[Anonymous], Specifications Manual for Joint Commission National Quality Measures (v2018A); [Anonymous], 2007, MED HOSP VAL BAS PUR; Barlow G, 2007, THORAX, V62, P67, DOI 10.1136/thx.2005.056689; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Caplan LR, 1999, NEW ENGL J MED, V341, P1240; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Fee C, 2006, ANN EMERG MED, V47, P505, DOI 10.1016/j.annemergmed.2005.11.046; Fee C, 2007, ANN EMERG MED, V50, P205, DOI 10.1016/j.annemergmed.2007.03.036; Fee C, 2007, ANN EMERG MED, V49, P553, DOI 10.1016/j.annemergmed.2006.11.008; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Hayward RA, 2007, NEW ENGL J MED, V356, P951, DOI 10.1056/NEJMe068285; Houck PM, 2006, CHEST, V130, P1, DOI 10.1378/chest.130.1.1; Houck Peter M, 2005, Curr Opin Infect Dis, V18, P151, DOI 10.1097/01.qco.0000160905.94684.91; Houck PM, 2004, CHEST, V126, P320, DOI 10.1378/chest.126.1.320; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Metersky ML, 2006, CHEST, V130, P16, DOI 10.1378/chest.130.1.16; Mitka M, 2007, JAMA-J AM MED ASSOC, V297, P1758, DOI 10.1001/jama.297.16.1758; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Novack V, 2006, EUR J INTERN MED, V17, P43, DOI 10.1016/j.ejim.2005.07.008; Pines JM, 2007, ANN EMERG MED, V49, P561, DOI 10.1016/j.annemergmed.2006.12.007; Pines JM, 2006, ACAD EMERG MED, V13, P787, DOI 10.1197/j.aem.2006.02.015; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rothman RE, 2006, ACAD EMERG MED, V13, P983, DOI 10.1197/j.aem.2006.07.019; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silber SH, 2003, CHEST, V124, P1798, DOI 10.1378/chest.124.5.1798; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Vernon DD, 1999, PEDIATRICS, V103, P20, DOI 10.1542/peds.103.1.20; Wachter RM, 2006, JAMA-J AM MED ASSOC, V295, P2780, DOI 10.1001/jama.295.23.2780; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84; Yu KT, 2008, ANN EMERG MED, V51, P651, DOI 10.1016/j.annemergmed.2007.10.022	38	135	136	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					29	+		10.7326/0003-4819-149-1-200807010-00007	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18591635				2022-12-24	WOS:000257428200004
J	Anderson, DC; Gill, JS; Cinalli, RM; Nance, J				Anderson, Dorian C.; Gill, Jason S.; Cinalli, Ryan M.; Nance, Jeremy			Polarization of the C-elegans embryo by RhoGAP-mediated exclusion of PAR-6 from cell contacts	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN LOCALIZATION; MOUSE EMBRYO; POLARITY; CDC-42; GASTRULATION; CONTRACTILITY; ESTABLISHMENT; MECHANISMS; GTPASES	Early embryos of some metazoans polarize radially to facilitate critical patterning events such as gastrulation and asymmetric cell division; however, little is known about how radial polarity is established. Early embryos of Caenorhabditis elegans polarize radially when cell contacts restrict the polarity protein PAR- 6 to contact- free cell surfaces, where PAR- 6 regulates gastrulation movements. We have identified a Rho guanosine triphosphatase activating protein ( RhoGAP), PAC- 1, which mediates C. elegans radial polarity and gastrulation by excluding PAR- 6 from contacted cell surfaces. We show that PAC- 1 is recruited to cell contacts, and we suggest that PAC- 1 controls radial polarity by restricting active CDC- 42 to contact- free surfaces, where CDC- 42 binds and recruits PAR- 6. Thus, PAC- 1 provides a dynamic molecular link between cell contacts and PAR proteins that polarizes embryos radially.	[Anderson, Dorian C.; Gill, Jason S.; Cinalli, Ryan M.; Nance, Jeremy] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA	New York University	Nance, J (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	nance@saturn.med.nyu.edu		Nance, Jeremy/0000-0003-4212-7731	NICHD NIH HHS [T32HD07520] Funding Source: Medline; NIGMS NIH HHS [R01 GM078341-02, R01GM078341, R01 GM078341] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078341] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aceto D, 2006, DEV BIOL, V299, P386, DOI 10.1016/j.ydbio.2006.08.002; CHEN WN, 1994, J BIOL CHEM, V269, P820; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Nance J, 2002, DEVELOPMENT, V129, P387; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001	24	82	92	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1771	1774		10.1126/science.1156063	http://dx.doi.org/10.1126/science.1156063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583611	Green Accepted			2022-12-24	WOS:000257121200037
J	Wolcott, RD; Ehrlich, GD				Wolcott, Randall D.; Ehrlich, Garth D.			Biofilms and chronic infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wolcott, Randall D.] Med Biofilm Res Inst, Lubbock, TX 79410 USA; [Ehrlich, Garth D.] Drexel Coll Med, Ctr Genom Sci, Allegheny Singer Res Inst, Allegheny Gen Hosp, Pittsburgh, PA USA; [Ehrlich, Garth D.] Drexel Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; [Ehrlich, Garth D.] Drexel Coll Med, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA	Allegheny General Hospital; Drexel University; Drexel University; Drexel University	Wolcott, RD (corresponding author), Med Biofilm Res Inst, 2002 Oxford Ave, Lubbock, TX 79410 USA.	randy@randallwolcott.com		Ehrlich, Garth/0000-0003-1140-6594	NIDCD NIH HHS [R01 DC004173] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Blumenfeld TJ, 2006, J ARTHROPLASTY, V21, P689, DOI 10.1016/j.arth.2005.10.010; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; GEESEY GG, 1977, CAN J MICROBIOL, V23, P1733, DOI 10.1139/m77-249; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003	11	175	186	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2008	299	22					2682	2684		10.1001/jama.299.22.2682	http://dx.doi.org/10.1001/jama.299.22.2682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311FN	18544729				2022-12-24	WOS:000256586200026
J	McMichael, AJ; Neira, M; Heymann, DL				McMichael, Anthony J.; Neira, Maria; Heymann, David L.			World Health Assembly 2008: climate change and health	LANCET			English	Editorial Material									[McMichael, Anthony J.] Australian Natl Univ, Canberra, ACT 0200, Australia; [Neira, Maria; Heymann, David L.] WHO, CH-1211 Geneva, Switzerland	Australian National University; World Health Organization	McMichael, AJ (corresponding author), Australian Natl Univ, GPO Box 4, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au						Confalonieri U, 2007, CLIMATE CHANGE 2007; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2008, SOCIAL ECOLOGY OF INFECTIOUS DISEASES, P378, DOI 10.1016/B978-012370466-5.50019-4; *UN, 1992, UN FRAM CONV CLIM CH; *WHO, 2008, IMP CLIM CHANG HUM H; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	6	16	19	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 7	2008	371	9628					1895	1896		10.1016/S0140-6736(08)60811-9	http://dx.doi.org/10.1016/S0140-6736(08)60811-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310OI	18539208				2022-12-24	WOS:000256538500008
J	Kim, JB; Zaehres, H; Wu, GM; Gentile, L; Ko, K; Sebastiano, V; Arauzo-Bravo, MJ; Ruau, D; Han, DW; Zenke, M; Scholer, HR				Kim, Jeong Beom; Zaehres, Holm; Wu, Guangming; Gentile, Luca; Ko, Kinarm; Sebastiano, Vittorio; Arauzo-Bravo, Marcos J.; Ruau, David; Han, Dong Wook; Zenke, Martin; Schoeler, Hans R.			Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors	NATURE			English	Article							FIBROBLASTS; EXPRESSION; MOUSE; GENERATION; GENES; SOX2; P53	Reprogramming of somatic cells is a valuable tool to understand the mechanisms of regaining pluripotency and further opens up the possibility of generating patient- specific pluripotent stem cells. Reprogramming of mouse and human somatic cells into pluripotent stem cells, designated as induced pluripotent stem ( iPS) cells, has been possible with the expression of the transcription factor quartet Oct4 ( also known as Pou5f1), Sox2, c- Myc and Klf4 ( refs 1 - 11). Considering that ectopic expression of c- Myc causes tumorigenicity in offspring(2) and that retroviruses themselves can cause insertional mutagenesis, the generation of iPS cells with a minimal number of factors may hasten the clinical application of this approach. Here we show that adult mouse neural stem cells express higher endogenous levels of Sox2 and c- Myc than embryonic stem cells, and that exogenous Oct4 together with either Klf4 or c- Myc is sufficient to generate iPS cells from neural stem cells. These two- factor iPS cells are similar to embryonic stem cells at the molecular level, contribute to development of the germ line, and form chimaeras. We propose that, in inducing pluripotency, the number of reprogramming factors can be reduced when using somatic cells that endogenously express appropriate levels of complementing factors.	[Kim, Jeong Beom; Zaehres, Holm; Wu, Guangming; Gentile, Luca; Ko, Kinarm; Sebastiano, Vittorio; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Ruau, David; Zenke, Martin] Univ Aachen, Sch Med, Rhein Westfal TH Aachen, Inst Biomed Engn,Dept Cell Biol, D-52074 Aachen, Germany	Max Planck Society; RWTH Aachen University	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	schoeler@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Gentile, Luca/E-4908-2019; Gentile, Luca/L-4473-2014; Marcos, Arauzo-Bravo/A-1706-2011; Han, Dong Wook/D-6041-2011	, HS/0000-0003-2643-5136; Gentile, Luca/0000-0002-7393-7502; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Wu, Guangming/0000-0003-1923-7609; Kim, Jeong Beom/0000-0001-6230-8826				AOI T, 2008, SCIENCE         0214, DOI DOI 10.1126/SCIENCE.1154884; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Miura T, 2001, CYTOTECHNOLOGY, V36, P137, DOI 10.1023/A:1014016315003; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	26	718	874	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					646	U54		10.1038/nature07061	http://dx.doi.org/10.1038/nature07061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18594515				2022-12-24	WOS:000258026500049
J	Macklin, R				Macklin, Ruth			The art of medicine - Standard of care: an evolution in ethical thinking	LANCET			English	Editorial Material									Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Macklin, R (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	macklin@aecom.yu.edu						Lie RK, 2006, LANCET, V368, P522, DOI 10.1016/S0140-6736(06)69160-5; *UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; WHO/UNAIDS, 2004, AIDS, V18, pW1	3	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					284	285		10.1016/S0140-6736(08)61098-3	http://dx.doi.org/10.1016/S0140-6736(08)61098-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18663793				2022-12-24	WOS:000258042800015
J	de Vernal, A; Hillaire-Marcel, C				de Vernal, Anne; Hillaire-Marcel, Claude			Natural variability of Greenland climate, vegetation, and ice volume during the past million years	SCIENCE			English	Article							NORTHERN-HEMISPHERE; SEA; SHEET; MARGIN; MIDDLE; RECORD	The response of the Greenland ice sheet to global warming is a source of concern notably because of its potential contribution to changes in the sea level. We demonstrated the natural vulnerability of the ice sheet by using pollen records from marine sediment off southwest Greenland that indicate important changes of the vegetation in Greenland over the past million years. The vegetation that developed over southern Greenland during the last interglacial period is consistent with model experiments, suggesting a reduced volume of the Greenland ice sheet. Abundant spruce pollen indicates that boreal coniferous forest developed some 400,000 years ago during the "warm" interval of marine isotope stage 11, providing a time frame for the development and decline of boreal ecosystems over a nearly ice- free Greenland.	[de Vernal, Anne; Hillaire-Marcel, Claude] Univ Quebec, Geotop, Geochem & Geodynam Res Ctr, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	de Vernal, A (corresponding author), Univ Quebec, Geotop, Geochem & Geodynam Res Ctr, Case Postale 8888,Succursale Centreville, Montreal, PQ H3C 3P8, Canada.	devernal.anne@uqam.ca	Hillaire-Marcel, Claude/C-9153-2013; de Vernal, Anne/D-5602-2013; Hillaire-Marcel, Claude/H-1441-2012	Hillaire-Marcel, Claude/0000-0002-3733-4632; de Vernal, Anne/0000-0001-5656-724X; 				Aksu A.E., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V105, P689, DOI 10.2973/odp.proc.sr.105.139.1989; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bennike O, 2002, PALAEOGEOGR PALAEOCL, V186, P1, DOI 10.1016/S0031-0182(02)00439-X; Berger A, 2002, SCIENCE, V297, P1287, DOI 10.1126/science.1076120; Bourgeois JC, 2001, J GEOPHYS RES-ATMOS, V106, P5255, DOI 10.1029/2000JD900708; de Vernal A, 2005, QUATERNARY SCI REV, V24, P897, DOI 10.1016/j.quascirev.2004.06.014; DEVERNAL A, 1989, P OCEAN DRILLING PRO, V0105; DEVERNAL A, 1992, NEOGENE QUATERNARY D, P329; Dowdeswell JA, 2006, SCIENCE, V311, P963, DOI 10.1126/science.1124190; Funder S, 1998, QUATERNARY SCI REV, V17, P77, DOI 10.1016/S0277-3791(97)00082-6; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; HEUSSER L, 1977, QUATERNARY RES, V7, P45, DOI 10.1016/0033-5894(77)90013-8; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; Hillaire-Marcel C., 1989, Geographie Physique et Quaternaire, V43, P263; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Koerner RM, 1988, ANN GLACIOL, V10, P85; LARSEN HC, 1994, SCIENCE, V264, P952, DOI 10.1126/science.264.5161.952; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; Meesters AGCA, 1997, BOUND-LAY METEOROL, V85, P475, DOI 10.1023/A:1000514214823; *NAT OC DAT CTR, 2001, WORLD OC DAT 2001 SC; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; ROCHON A, 1994, CAN J EARTH SCI, V31, P115, DOI 10.1139/e94-010; Rousseau DD, 2006, REV PALAEOBOT PALYNO, V141, P277, DOI 10.1016/j.revpalbo.2006.05.001; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	29	149	149	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1622	1625		10.1126/science.1153929	http://dx.doi.org/10.1126/science.1153929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566284				2022-12-24	WOS:000256886700044
J	Schummers, J; Yu, HB; Sur, M				Schummers, James; Yu, Hongbo; Sur, Mriganka			Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex	SCIENCE			English	Article							DEPENDENT GLUTAMATE RELEASE; IN-VIVO; FUNCTIONAL ARCHITECTURE; SYNAPTIC-TRANSMISSION; NEURONAL-ACTIVITY; CALCIUM WAVES; ORIENTATION; BRAIN; NETWORKS; RESOLUTION	Astrocytes have long been thought to act as a support network for neurons, with little role in information representation or processing. We used two- photon imaging of calcium signals in the ferret visual cortex in vivo to discover that astrocytes, like neurons, respond to visual stimuli, with distinct spatial receptive fields and sharp tuning to visual stimulus features including orientation and spatial frequency. The stimulus- feature preferences of astrocytes were exquisitely mapped across the cortical surface, in close register with neuronal maps. The spatially restricted stimulus-specific component of the intrinsic hemodynamic mapping signal was highly sensitive to astrocyte activation, indicating that astrocytes have a key role in coupling neuronal organization to mapping signals critical for noninvasive brain imaging. Furthermore, blocking astrocyte glutamate transporters influenced the magnitude and duration of adjacent visually driven neuronal responses.	[Schummers, James; Yu, Hongbo; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Sur, M (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu		Schummers, James/0000-0002-1030-824X				Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Anderson CM, 2000, GLIA, V32, P1; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Baker GE, 1998, EUR J NEUROSCI, V10, P2657, DOI 10.1046/j.1460-9568.1998.t01-1-00276.x; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; JAN DD, 2005, J NEUROSCI, V25, P2917, DOI DOI 10.1523/JNEUR0SCI.5042-04.2005; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; Porter JT, 1996, J NEUROSCI, V16, P5073; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Schummers J, 2005, PROG BRAIN RES, V149, P65, DOI 10.1016/S0079-6123(05)49006-8; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	55	431	446	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1638	1643		10.1126/science.1156120	http://dx.doi.org/10.1126/science.1156120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566287				2022-12-24	WOS:000256886700049
J	Altschuler, SJ; Angenent, SB; Wang, YQ; Wu, LF				Altschuler, Steven J.; Angenent, Sigurd B.; Wang, Yanqin; Wu, Lani F.			On the spontaneous emergence of cell polarity	NATURE			English	Article							EXCHANGE FACTOR CDC24P; POSITIVE FEEDBACK; SYMMETRY-BREAKING; PLASMA-MEMBRANE; POLARIZATION; GTPASE; CDC42P; PROTEINS; SYSTEM; MODEL	Diverse cell polarity networks require positive feedback for locally amplifying distributions of signalling molecules at the plasma membrane(1). Additional mechanisms, such as directed transport(2) or coupled inhibitors(3,4), have been proposed to be required for reinforcing a unique axis of polarity. Here we analyse a simple model of positive feedback, with strong analogy to the 'stepping stone' model of population genetics(5), in which a single species of diffusible, membrane-bound signalling molecules can self-recruit from a cytoplasmic pool. We identify an intrinsic stochastic mechanism through which positive feedback alone is sufficient to account for the spontaneous establishment of a single site of polarity. We find that the polarization frequency has an inverse dependence on the number of signalling molecules: the frequency of polarization decreases as the number of molecules becomes large. Experimental observation of polarizing Cdc42 in budding yeast is consistent with this prediction. Our work suggests that positive feedback can work alone or with additional mechanisms to create robust cell polarity.	[Altschuler, Steven J.; Wang, Yanqin; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA; [Altschuler, Steven J.; Wang, Yanqin; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Angenent, Sigurd B.] Univ Wisconsin, Dept Math, Madison, WI 53706 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison	Altschuler, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu			NIGMS NIH HHS [R01 GM071794-05, R01 GM071794] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Elf J., 2004, Systems Biology, V1, P230, DOI 10.1049/sb:20045021; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; KIMURA M, 1964, GENETICS, V49, P561; Kozlov MM, 2007, BIOPHYS J, V93, P3811, DOI 10.1529/biophysj.107.110411; Krishnan J, 2007, BIOPHYS J, V92, P816, DOI 10.1529/biophysj.106.087353; Levin SA., 1979, PATTERN FORMATION DY, P210; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Qian H, 2002, P NATL ACAD SCI USA, V99, P10376, DOI 10.1073/pnas.152007599; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shimada Y, 2004, EMBO J, V23, P1051, DOI 10.1038/sj.emboj.7600124; Sohrmann M, 2003, TRENDS CELL BIOL, V13, P526, DOI 10.1016/j.tcb.2003.08.006; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811	30	175	175	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					886	U41		10.1038/nature07119	http://dx.doi.org/10.1038/nature07119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18704086	Green Accepted			2022-12-24	WOS:000258398600036
J	Vestergaard, M; Pedersen, MG; Ostergaard, JR; Pedersen, CB; Olsen, J; Christensen, J				Vestergaard, Mogens; Pedersen, Marianne Giortz; Ostergaard, John R.; Pedersen, Carsten Bocker; Olsen, Jorn; Christensen, Jakob			Death in children with febrile seizures: a population-based cohort study	LANCET			English	Article							EPILEPSY; CONVULSIONS; MORTALITY; RISK; PROGNOSIS	Background No studies have had sufficient size to estimate mortality in children with febrile seizures. We studied mortality after febrile seizures in a large population-based cohort of children in Denmark with up to 28 years of follow-up. Methods We identified 1675 643 children born in Denmark between Jan 1, 1977, and Dec 31, 2004, by linking information from nationwide registers for civil service, health, and cause of death. Children were followed up from 3 months of age, until death, emigration, or Aug 31, 2005. We estimated overall and cause-specific mortality after first febrile seizures with survival analyses. Furthermore, we undertook a case-control study nested within the cohort and retrieved information from medical records about febrile seizure and neurological abnormalities for children who died (N=8172) and individually-matched controls (N=40 860). Findings We identified 8172 children who died, including 232 deaths in 55 215 children with a history of febrile seizures. The mortality rate ratio was 80% higher during the first year (adjusted mortality rate ratio 1.80 [95% CI 1.31-2.40]) and 90% higher during the second year (1.89 [1.27-2.70]) after the first febrile seizure; thereafter it was close to that noted for the general population. 132 of 100 000 children (95% CI 102-163) died within 2 years of a febrile seizure compared with 67 (57-76) deaths per 100 000 children without a history of this disorder. In the nested case-control study, children with simple (<= 15 min and no recurrence within 24 h) febrile seizure had a mortality rate similar to that of the background population (adjusted mortality rate ratio 1.09 [95% CI 0.72-1.64]), whereas mortality was increased for those with complex (> 15 min or recurrence within 24 h) febrile seizures (1.99 [1.24-3.21]). This finding was partly explained by pre-existing neurological abnormalities and subsequent epilepsy. Interpretation Long-term mortality is not increased in children with febrile seizures, but there seems to be a small excess mortality during the 2 years after complex febrile seizures. Parents should be reassured that death after febrile seizures is very rare, even in high-risk children. Funding The Danish Research Agency, Lennart Gram Memorial Trust (Denmark), P A Messerschmidt and Wife's Foundation (Denmark), Managing Director Kurt Bonnelycke and Mrs Grethe Bonnelyckes Foundation (Denmark).	[Vestergaard, Mogens] Aarhus Univ, Dept Gen Practice, Inst Publ Hlth, DK-8000 Aarhus C, Denmark; [Pedersen, Marianne Giortz; Pedersen, Carsten Bocker] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Ostergaard, John R.] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Pharmacol, DK-8000 Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles	Vestergaard, M (corresponding author), Aarhus Univ, Dept Gen Practice, Inst Publ Hlth, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.	mogens.vestergaard@alm.au.dk	Pedersen, Carsten Bøcker/B-8441-2013; Vestergaard, Mogens/M-9333-2014; Olsen, Jørn/F-8801-2015	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Vestergaard, Mogens/0000-0001-8830-2174; Olsen, Jørn/0000-0001-7462-5140; Christensen, Jakob/0000-0002-9385-6435				Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BALSLEV T, 1991, ACTA PAEDIATR SCAND, V80, P466, DOI 10.1111/j.1651-2227.1991.tb11883.x; BAUMER JH, 1981, DEV MED CHILD NEUROL, V23, P462; BERG AT, 1992, NEW ENGL J MED, V327, P1122, DOI 10.1056/NEJM199210153271603; Breslow N E, 1987, IARC Sci Publ, P1; BRESLOW NE, 1996, STAT APPL, V8, P23; Camfield CS, 2002, LANCET, V359, P1891, DOI 10.1016/S0140-6736(02)08779-2; Camfield Peter, 2005, Semin Pediatr Neurol, V12, P10, DOI 10.1016/j.spen.2004.11.005; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Donner EJ, 2001, NEUROLOGY, V57, P430, DOI 10.1212/WNL.57.3.430; EKHOLM E, 1950, ACTA PAEDIATR, V39, P481, DOI 10.1111/j.1651-2227.1950.tb08545.x; FORSGREN L, 1990, ACTA PAEDIATR SCAND, V79, P550, DOI 10.1111/j.1651-2227.1990.tb11510.x; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; Hills, 1993, STAT MODELS EPIDEMIO; Juel K, 1999, DAN MED BULL, V46, P354; Kinney HC, 2007, PEDIATR DEVEL PATHOL, V10, P208, DOI 10.2350/06-08-0144.1; Knudsen LB, 1998, DAN MED BULL, V45, P320; NELSON KB, 1978, PEDIATRICS, V61, P720; *NIH, 1981, EPILEPSIA, V22, P377; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Pedersen CB, 2006, DAN MED BULL, V53, P441; PIERCE DA, 1993, RADIAT RES, V134, P134, DOI 10.2307/3578452; Rosthoj S, 2004, COMPUT METH PROG BIO, V74, P69, DOI 10.1016/S0169-2607(03)00069-5; Rothman K., 1998, MODERN EPIDEMIOLOGY; SENANAYAKE N, 1995, SEIZURE, V4, P273, DOI 10.1016/S1059-1311(95)80004-2; Shinnar S, 2001, EPILEPSIA, V42, P47, DOI 10.1046/j.1528-1157.2001.10000.x; Shinnar S, 1999, PEDIAT NEUROLOGY PRI, P676; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; SUNDERLAND R, 1981, LANCET, V2, P176; van Stuijvenberg M, 1999, ACTA PAEDIATR, V88, P618, DOI 10.1080/08035259950169260; VERITY CM, 1991, BMJ-BRIT MED J, V303, P1373, DOI 10.1136/bmj.303.6814.1373; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Vestergaard M, 2002, ARCH DIS CHILD, V86, P125, DOI 10.1136/adc.86.2.125; Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086	36	45	47	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					457	463		10.1016/S0140-6736(08)61198-8	http://dx.doi.org/10.1016/S0140-6736(08)61198-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335OD	18692714				2022-12-24	WOS:000258299000029
J	Des Marais, DL; Rausher, MD				Des Marais, David L.; Rausher, Mark D.			Escape from adaptive conflict after duplication in an anthocyanin pathway gene	NATURE			English	Article							DIHYDROFLAVONOL 4-REDUCTASE; POSITIVE SELECTION; SUBSTRATE-SPECIFICITY; ZEA-MAYS; EVOLUTION; PRESERVATION; CONSEQUENCES; PROBABILITY; METABOLISM; FLAVONOIDS	Gene duplications have been recognized as an important source of evolutionary innovation and adaptation since at least Haldane(1), and their varying fates may partly explain the vast disparity in observed genome sizes(2). The expected fates of most gene duplications involve primarily non-adaptive substitutions leading to either non-functionalization of one duplicate copy or subfunctionalization(3), neither of which yields novel function. A significant evolutionary problem is thus elucidating the mechanisms of adaptive evolutionary change leading to evolutionary novelty. Currently, the most widely recognized adaptive process involving gene duplication is neo-functionalization (NEO-F), in which one copy undergoes directional selection to perform a novel function after duplication(4). An alternative, but understudied, adaptive fate that has been proposed is escape from adaptive conflict (EAC), in which a single-copy gene is selected to perform a novel function while maintaining its ancestral function(5,6). This gene is constrained from improving either novel or ancestral function because of detrimental pleiotropic effects on the other function. After duplication, one copy is free to improve novel function, whereas the other is selected to improve ancestral function. Here we first present two criteria that can be used to distinguish NEO-F from EAC. Using both tests for positive selection and assays of enzyme function, we then demonstrate that adaptive evolutionary change in a duplicated gene of the anthocyanin biosynthetic pathway in morning glories (Ipomoea) is best interpreted as EAC. Finally, we argue that this phenomenon likely occurs more often than has been previously believed and may thus represent an important mechanism in generating evolutionary novelty.	[Des Marais, David L.; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Des Marais, David L.; Rausher, Mark D.] Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA	Duke University; Duke University	Des Marais, DL (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	dld3@duke.edu; mrausher@duke.edu						Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Force A, 1999, GENETICS, V151, P1531; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Halbwirth H, 2003, PLANT SCI, V164, P489, DOI 10.1016/S0168-9452(02)00433-8; Haldane JBS, 1933, AM NAT, V67, P5, DOI 10.1086/280465; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Iwashina T, 2000, J PLANT RES, V113, P287, DOI 10.1007/PL00013940; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Li W. H, 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; NICHOLSON RL, 1987, P NATL ACAD SCI USA, V84, P5520, DOI 10.1073/pnas.84.16.5520; Ohno S., 1970, EVOLUTION GENE DUPLI; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHWARZSOMMER Z, 1987, EMBO J, V6, P287, DOI 10.1002/j.1460-2075.1987.tb04752.x; STAFFORD HA, 1982, PLANT PHYSIOL, V70, P695, DOI 10.1104/pp.70.3.695; STAFFORD HA, 1965, PLANT PHYSIOL, V40, P130, DOI 10.1104/pp.40.1.130; Stefanovic S, 2002, AM J BOT, V89, P1510, DOI 10.3732/ajb.89.9.1510; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852	30	262	265	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					762	U85		10.1038/nature07092	http://dx.doi.org/10.1038/nature07092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18594508				2022-12-24	WOS:000258228000044
J	Hall, HI; Song, RG; Rhodes, P; Prejean, J; An, Q; Lee, LM; Karon, J; Brookmeyer, R; Kaplan, EH; McKenna, MT; Janssen, RS				Hall, H. Irene; Song, Ruiguang; Rhodes, Philip; Prejean, Joseph; An, Qian; Lee, Lisa M.; Karon, John; Brookmeyer, Ron; Kaplan, Edward H.; McKenna, Matthew T.; Janssen, Robert S.		HIV Incidence Surveillance Grp	Estimation of HIV incidence in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE PROGRESSION; SURVEILLANCE DATA; AIDS EPIDEMIC; RISK; PREVENTION; INFECTION; HIV/AIDS; INFORMATION; BEHAVIORS; TRENDS	Context Incidence of human immunodeficiency virus ( HIV) in the United States has not been directly measured. New assays that differentiate recent vs long- standing HIV infections allow improved estimation of HIV incidence. Objective To estimate HIV incidence in the United States. Design, Setting, and Patients Remnant diagnostic serum specimens from patients 13 years or older and newly diagnosed with HIV during 2006 in 22 states were tested with the BED HIV- 1 capture enzyme immunoassay to classify infections as recent or long- standing. Information on HIV cases was reported to the Centers for Disease Control and Prevention through June 2007. Incidence of HIV in the 22 states during 2006 was estimated using a statistical approach with adjustment for testing frequency and extrapolated to the United States. Results were corroborated with back-calculation of HIV incidence for 1977- 2006 based on HIV diagnoses from 40 states and AIDS incidence from 50 states and the District of Columbia. Main Outcome Measure Estimated HIV incidence. Results An estimated 39 400 persons were diagnosed with HIV in 2006 in the 22 states. Of 6864 diagnostic specimens tested using the BED assay, 2133 ( 31%) were classified as recent infections. Based on extrapolations from these data, the estimated number of new infections for the United States in 2006 was 56 300 ( 95% confidence interval [ CI], 48 200- 64 500); the estimated incidence rate was 22.8 per 100 000 population ( 95% CI, 19.5- 26.1). Forty- five percent of infections were among black individuals and 53% among men who have sex with men. The back- calculation ( n= 1.230 million HIV/ AIDS cases reported by the end of 2006) yielded an estimate of 55 400 ( 95% CI, 50 000- 60 800) new infections per year for 2003- 2006 and indicated that HIV incidence increased in the mid- 1990s, then slightly declined after 1999 and has been stable thereafter. Conclusions This study provides the first direct estimates of HIV incidence in the United States using laboratory technologies previously implemented only in clinic-based settings. New HIV infections in the United States remain concentrated among men who have sex with men and among black individuals.	[Hall, H. Irene; Song, Ruiguang; Rhodes, Philip; Prejean, Joseph; Lee, Lisa M.; McKenna, Matthew T.; Janssen, Robert S.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [An, Qian] Ginn Grp Inc, Peachtree City, GA USA; [Karon, John] Emergint Corp, Louisville, KY USA; [Brookmeyer, Ron] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kaplan, Edward H.] Yale Univ, Sch Management, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [Kaplan, Edward H.] Yale Univ, Sch Med, New Haven, CT USA; [Kaplan, Edward H.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Yale University; Yale University	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, MS E-47,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	ixh1@cdc.gov		Kaplan, Edward/0000-0002-8722-7667; Lee, Lisa M/0000-0002-3397-3269	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038209] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD038209-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aalen OO, 1997, STAT MED, V16, P2191, DOI 10.1002/(SICI)1097-0258(19971015)16:19&lt;2191::AID-SIM645&gt;3.0.CO;2-5; Anderson JE, 2000, AM J PUBLIC HEALTH, V90, P1089, DOI 10.2105/AJPH.90.7.1089; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 1999, GUID DEF PUBL HLTH R; Bellocco R, 2000, STAT MED, V19, P297, DOI 10.1002/(SICI)1097-0258(20000215)19:3&lt;297::AID-SIM340&gt;3.0.CO;2-6; BIGGAR RJ, 1993, CLIN INFECT DIS, V17, pS219, DOI 10.1093/clinids/17.Supplement_1.S219; Bishop YM., 2007, DISCRETE MULTIVARIAT; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P595; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2007, US BED HIV 1 CAPT EI; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P540; Centers for Disease Control and Prevention, 2007, HIV AIDS SURVEILLANC, P17; Centers for Disease Control and Prevention, 2006, HIV COUNS TEST CDC S; Centers for Disease Control and Prevention, 1999, COMP HIV PREV INT EV; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Cui JS, 2000, STAT MED, V19, P1165, DOI 10.1002/(SICI)1097-0258(20000515)19:9&lt;1165::AID-SIM419&gt;3.0.CO;2-7; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Hall HI, 2007, AM J PUBLIC HEALTH, V97, P1060, DOI 10.2105/AJPH.2006.087551; Hall HI, 2005, PUBLIC HEALTH REP, V120, P89, DOI 10.1177/003335490512000115; *I MED, 2000, NO TIM LOS GETT MOR; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarlais DCD, 2005, AIDS, V19, pS20, DOI 10.1097/01.aids.0000192066.86410.8c; *JOINT UN PROGR HI, 2007, AIDS EP UPD 07; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Lee LM, 2007, PUBLIC HEALTH REP, V122, P72, DOI 10.1177/00333549071220S111; *MAN INC, 1995, APL PLUS 3 COMP PROG; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MARSCHNER IC, 1994, STAT MED, V13, P1959, DOI 10.1002/sim.4780131908; *NAT CTR HLTH STAT, 2006, BRIDG RAC VINT 2006; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; ROSENBERG PS, 1994, STAT MED, V13, P1975, DOI 10.1002/sim.4780131909; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sanchez T., 2006, MMWR MORB MORTAL WKL, V55, P752; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Santibanez SS, 2006, J URBAN HEALTH, V83, P86, DOI 10.1007/s11524-005-9009-2; *SAS I INC, 2002, SAS WIND COMP PROGR; Song RG, 2005, STAT MED, V24, P453, DOI 10.1002/sim.1935; *UNAIDS, 2005, M UNAIDS REF GROUP E; *US BUR CENS, 2006, POP EST ENT DAT SET; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd	46	1020	1049	0	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					520	529		10.1001/jama.300.5.520	http://dx.doi.org/10.1001/jama.300.5.520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333YG	18677024	Green Accepted			2022-12-24	WOS:000258188900013
J	Kravchenko, VV; Kaufmann, GF; Mathison, JC; Scott, DA; Katz, AZ; Grauer, DC; Lehmann, M; Meijler, MM; Janda, KD; Ulevitch, RJ				Kravchenko, Vladimir V.; Kaufmann, Gunnar F.; Mathison, John C.; Scott, David A.; Katz, Alexander Z.; Grauer, David C.; Lehmann, Mandy; Meijler, Michael M.; Janda, Kim D.; Ulevitch, Richard J.			Modulation of gene expression via disruption of NF-kappa B signaling by a bacterial small molecule	SCIENCE			English	Article							DEFICIENT MICE; MACROPHAGE APOPTOSIS; TEMPORAL CONTROL; ACTIVATION; RECOGNITION; INHIBITION; LETHALITY; MECHANISM; VIRULENCE; PATHWAYS	The control of innate immune responses through activation of the nuclear transcription factor NF-kappa B is essential for the elimination of invading microbial pathogens. We showed that the bacterial N-( 3- oxo- dodecanoyl) homoserine lactone ( C12) selectively impairs the regulation of NF-kappa B functions in activated mammalian cells. The consequence is specific repression of stimulus- mediated induction of NF-kappa B- responsive genes encoding inflammatory cytokines and other immune regulators. These findings uncover a strategy by which C12- producing opportunistic pathogens, such as Pseudomonas aeruginosa, attenuate the innate immune system to establish and maintain local persistent infection in humans, for example, in cystic fibrosis patients.	[Kravchenko, Vladimir V.; Kaufmann, Gunnar F.; Mathison, John C.; Scott, David A.; Katz, Alexander Z.; Grauer, David C.; Lehmann, Mandy; Meijler, Michael M.; Janda, Kim D.; Ulevitch, Richard J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Meijler, Michael M.; Janda, Kim D.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Meijler, Michael M.; Janda, Kim D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ulevitch, RJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ulevitch@scripps.edu	Grauer, David/F-2777-2011; Ulevitch, Richard J/Q-3393-2017	Meijler, Michael/0000-0001-7095-1467				Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	28	168	180	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					259	263		10.1126/science.1156499	http://dx.doi.org/10.1126/science.1156499			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18566250				2022-12-24	WOS:000257512900043
J	Lopez-Garcia, E; van Dam, RM; Li, TY; Rodriguez-Artalejo, F; Hu, FB				Lopez-Garcia, Esther; van Dam, Rob M.; Li, Tricia Y.; Rodriguez-Artalejo, Fernando; Hu, Frank B.			The relationship of coffee consumption with mortality	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; RISK; DEATH; MEN; CAFFEINE; DRINKING; HEALTH	Background: Coffee consumption has been linked to various beneficial and detrimental health effects, but data on its relation with mortality are sparse. Objective: To assess the association between coffee consumption and mortality from cardiovascular disease (CVD), cancer, and all causes during 18 years of follow-up in men and 24 years of follow-up in women. Design: Sex-specific Cox proportional hazard models were used to investigate the association between coffee consumption and incidence of all-cause and disease-specific mortality in a prospective cohort study. Setting: Health Professionals Follow-up Study and Nurses' Health Study. Participants: 41 736 men and 86 214 women with no history of CVD or cancer at baseline. Measurements: Coffee consumption was assessed first in 1986 for men and in 1980 for women and then every 2 to 4 years through 2004. Investigators documented 6888 deaths (2049 due to CVD and 2491 due to cancer) among men and 11 095 deaths (2368 due to CVD and 5011 due to cancer) among women. Results: After adjustment for age, smoking, and other CVD and cancer risk factors, the relative risks for all-cause mortality in men across categories of coffee consumption (<1 cup per month, 1 cup per month to 4 cups per week, 5 to 7 cups per week, 2 to 3 cups per day, 4 to 5 cups per day, and >= 6 cups per day) were 1.0, 1.07 (95% CI, 0.99 to 1.16), 1.02 (CI, 0.95 to 1.11), 0.97 (CI, 0.89 to 1.05), 0.93 (CI, 0.81 to 1.07), and 0.80 (CI, 0.62 to 1.04), respectively (P for trend = 0.008). For women, the relative risks were 1.0, 0.98 (CI, 0.91 to 1.05), 0.93 (CI, 0.87 to 0.98), 0.82 (CI, 0.77 to 0.87), 0.74 (CI, 0.68 to 0.81), and 0.83 (CI, 0.73 to 0.95), respectively (P for trend < 0.001). This inverse association was mainly due to a moderately reduced risk for CVD mortality and was independent of caffeine intake. By contrast, coffee consumption was not statistically significantly associated with risk for cancer death after adjustment for potential confounders. Decaffeinated coffee consumption was associated with a small reduction in all-cause and CVD mortality. Limitation: Coffee consumption was estimated from self-report; thus, some measurement error is inevitable. Conclusion: Regular coffee consumption was not associated with an increased mortality rate in either men or women. The possibility of a modest benefit of coffee consumption on all-cause and CVD mortality needs to be further investigated.	Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, E-28049 Madrid, Spain; Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; CIBERESP CIBER Epidemiol & Publ Health, Barcelona, Spain	Autonomous University of Madrid; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Lopez-Garcia, E (corresponding author), Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, Avenida Arzobispo Morcillo 4, E-28049 Madrid, Spain.	esther.lopez@uam.es	Hu, Frank/C-1919-2013; Lopez-Garcia, Esther/A-8894-2019; van Dam, Rob M/F-9674-2010	van Dam, Rob M/0000-0002-7354-8734	NATIONAL CANCER INSTITUTE [P01CA087969, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712, R01HL034594] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnlov J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI 10.1001/jama.291.10.1199-a; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; DAWBER TR, 1974, NEW ENGL J MED, V291, P871, DOI 10.1056/NEJM197410242911703; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; Greenberg JA, 2007, AM J CLIN NUTR, V85, P392, DOI 10.1093/ajcn/85.2.392; Happonen P, 2004, J NUTR, V134, P2381, DOI 10.1093/jn/134.9.2381; Hart C, 1997, J EPIDEMIOL COMMUN H, V51, P461, DOI 10.1136/jech.51.4.461; Hartley TR, 2004, AM J CARDIOL, V93, P1022, DOI 10.1016/j.amjcard.2003.12.057; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Huber WW, 2002, ARCH TOXICOL, V75, P685, DOI 10.1007/s00204-001-0295-5; Iwai Nobuo, 2002, J Epidemiol, V12, P191; JACOBSEN BK, 1986, J NATL CANCER I, V76, P823; Jazbec A, 2003, J HEALTH POPUL NUTR, V21, P332; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Kurozawa Y, 2005, BRIT J CANCER, V93, P607, DOI 10.1038/sj.bjc.6602737; La Vecchia C, 2005, J HEPATOL, V42, P444, DOI 10.1016/j.jhep.2005.01.004; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; LEGRADY D, 1987, AM J EPIDEMIOL, V126, P803, DOI 10.1093/oxfordjournals.aje.a114717; LINDSTED KD, 1992, J CLIN EPIDEMIOL, V45, P733, DOI 10.1016/0895-4356(92)90051-N; Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; MURRAY SS, 1981, AM J EPIDEMIOL, V113, P661, DOI 10.1093/oxfordjournals.aje.a113145; Paganini-Hill A, 2007, PREV MED, V44, P305, DOI 10.1016/j.ypmed.2006.12.011; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; ROSENGREN A, 1991, J INTERN MED, V230, P67, DOI 10.1111/j.1365-2796.1991.tb00407.x; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Scharf G, 2001, ADV EXP MED BIOL, V500, P535; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stensvold I, 1996, BRIT MED J, V312, P544, DOI 10.1136/bmj.312.7030.544; Tavani A, 2004, CANCER CAUSE CONTROL, V15, P743, DOI 10.1023/B:CACO.0000043415.28319.c1; Tavani A, 2003, ORAL ONCOL, V39, P695, DOI 10.1016/S1368-8375(03)00081-2; Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001; TVERDAL A, 1990, BRIT MED J, V300, P566, DOI 10.1136/bmj.300.6724.566; van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; VANDENBROUCKE JP, 1986, AM J EPIDEMIOL, V123, P359, DOI 10.1093/oxfordjournals.aje.a114245; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481; Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f	49	132	138	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2008	148	12					904	+		10.7326/0003-4819-148-12-200806170-00003	http://dx.doi.org/10.7326/0003-4819-148-12-200806170-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323DU	18559841	Green Accepted			2022-12-24	WOS:000257425000002
J	Wang, XM; Harris, RE; Bayston, LJ; Ashe, HL				Wang, Xiaomeng; Harris, Robin E.; Bayston, Laura J.; Ashe, Hilary L.			Type IV collagens regulate BMP signalling in Drosophila	NATURE			English	Article							BONE MORPHOGENETIC PROTEINS; GERMLINE STEM-CELLS; BASEMENT-MEMBRANE; DPP; GRADIENT; EMBRYO; SOG; DIFFERENTIATION; STIMULATION; BINDING	Dorsal-ventral patterning in vertebrate and invertebrate embryos is mediated by a conserved system of secreted proteins that establishes a bone morphogenetic protein (BMP) gradient. Although the Drosophila embryonic Decapentaplegic ( Dpp) gradient has served as a model to understand how morphogen gradients are established, no role for the extracellular matrix has been previously described. Here we show that type IV collagen extracellular matrix proteins bind Dpp and regulate its signalling in both the Drosophila embryo and ovary. We provide evidence that the interaction between Dpp and type IV collagen augments Dpp signalling in the embryo by promoting gradient formation, yet it restricts the signalling range in the ovary through sequestration of the Dpp ligand. Together, these results identify a critical function of type IV collagens in modulating Dpp in the extracellular space during Drosophila development. On the basis of our findings that human type IV collagen binds BMP4, we predict that this role of type IV collagens will be conserved.	[Wang, Xiaomeng; Harris, Robin E.; Bayston, Laura J.; Ashe, Hilary L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Ashe, HL (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	hilary.ashe@manchester.ac.uk	Wang, Xiaomeng/F-9504-2015; Harris, Robin/ABA-6788-2020	Harris, Robin/0000-0001-6945-6741; Wang, Xiaomeng/0000-0002-1036-2764	BBSRC project grant; Biotechnology and Biological Sciences Research Council [BBS/B/11672] Funding Source: researchfish	BBSRC project grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. O'Connor for plasmids, flies and advice on Dpp-HA staining; W. Chia, R. Ray and the Bloomington stock centre for fly stocks; E. Bier, P. ten Dijke, H. Bellen, L. Fessler and D. McKearin for antibodies; T. Jowitt for help with SPR; S. Lunj, M. Ronshaugen and W. Song for help; M. Ashe and W. Miles for reading the manuscript; and M. Levine whose laboratory this work was initiated in. This work was funded by a BBSRC project grant to H. L. A. and a BBSRC studentship to R. E. H.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Ashe HL, 2005, CURR BIOL, V15, pR375, DOI 10.1016/j.cub.2005.05.003; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Harradine KA, 2006, ANN MED, V38, P403, DOI 10.1080/07853890600919911; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; KNIBIEHLER B, 1990, CELL DIFFER DEV, V30, P147, DOI 10.1016/0922-3371(90)90082-8; Larrain J, 2000, DEVELOPMENT, V127, P821; LEE HS, 1988, MOL CELL BIOL, V8, P4727, DOI 10.1128/MCB.8.11.4727; LUNSTRUM GP, 1988, J BIOL CHEM, V263, P18318; Maduzia LL, 1997, BIOCHEM BIOPH RES CO, V238, P595, DOI 10.1006/bbrc.1997.7353; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Medioni C, 2005, DEVELOPMENT, V132, P3069, DOI 10.1242/dev.01886; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yasothornsrikul S, 1997, GENE, V198, P17, DOI 10.1016/S0378-1119(97)00274-6; Yu K, 2000, DEVELOPMENT, V127, P2143	37	241	243	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					72	U49		10.1038/nature07214	http://dx.doi.org/10.1038/nature07214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18701888				2022-12-24	WOS:000258890200038
J	Barfield, RC; Kane, JR				Barfield, Raymond C.; Kane, Javier R.			Balancing disclosure of diagnosis and assent for research in children with HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barfield, Raymond C.; Kane, Javier R.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Kane, Javier R.] St Jude Childrens Res Hosp, Palliat & End Life Care Program, Memphis, TN 38105 USA; [Barfield, Raymond C.; Kane, Javier R.] St Jude Childrens Res Hosp, Eth Committee, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kane, JR (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	javier.kane@stjude.org		Barfield, Raymond/0000-0003-1006-1985	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, P30 CA021765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1998, J Child Fam Nurs, V1, P57; Barfield RC, 2005, CURR OPIN PEDIATR, V17, P20, DOI 10.1097/01.mop.0000145718.77939.b1; Field Marilyn J, 2004, ETHICAL CONDUCT CLIN; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Kline MW, 2001, PEDIATRICS, V107, P188, DOI 10.1542/peds.107.1.188; KOHRMAN A, 1994, PEDIATRICS, V93, P532; Lesch A, 2007, AIDS CARE, V19, P811, DOI 10.1080/09540120601129301; Nelson RM, 2001, PEDIATRICS, V107, P205; *US DEP HHS, I REV BOARD GUIDB, pCH6; *US DEP HHS, SUBP D ADD PROT CHIL; van Dulmen AM, 1998, PEDIATRICS, V102, P563, DOI 10.1542/peds.102.3.563; Waugh S, 2003, AIDS CARE, V15, P169, DOI 10.1080/0954012031000068317; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilfert C, 1999, PEDIATRICS, V103, P164; 2000, PEDIATRICS, V105, P1358	15	3	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					576	578		10.1001/jama.300.5.576	http://dx.doi.org/10.1001/jama.300.5.576			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677031				2022-12-24	WOS:000258188900020
J	Running, SW				Running, Steven W.			Climate change - Ecosystem disturbance, carbon, and climate	SCIENCE			English	Editorial Material							NATURAL DISTURBANCES; FEEDBACK; BEETLE		Univ Montana, Coll Forestry, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA	University of Montana System; University of Montana	Running, SW (corresponding author), Univ Montana, Coll Forestry, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA.	swr@ntsg.umt.edu						Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; IPCC, 2007, CLIM CHANG 2007 PHYS; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Mildrexler DJ, 2007, ECOL APPL, V17, P235, DOI 10.1890/1051-0761(2007)017[0235:ANSMFC]2.0.CO;2; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Stockli R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000562; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Tansey K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031567	15	204	217	13	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					652	653		10.1126/science.1159607	http://dx.doi.org/10.1126/science.1159607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669853				2022-12-24	WOS:000258077700032
J	Likhtik, E; Popa, D; Apergis-Schoute, J; Fidacaro, GA; Pare, D				Likhtik, Ekaterina; Popa, Daniela; Apergis-Schoute, John; Fidacaro, George A., Jr.; Pare, Denis			Amygdala intercalated neurons are required for expression of fear extinction	NATURE			English	Article							MEDIAL PREFRONTAL CORTEX; DOPAMINE D1 RECEPTOR; POTENTIATED STARTLE; NMDA RECEPTORS; FACILITATION; MECHANISMS; MU	Congruent findings from studies of fear learning in animals and humans indicate that research on the circuits mediating fear constitutes our best hope of understanding human anxiety disorders(1-4). In mammals, repeated presentations of a conditioned stimulus that was previously paired to a noxious stimulus leads to the gradual disappearance of conditioned fear responses. Although much evidence suggests that this extinction process depends on plastic events in the amygdala(1-7), the underlying mechanisms remain unclear. Intercalated ( ITC) amygdala neurons constitute probable mediators of extinction because they receive information about the conditioned stimulus from the basolateral amygdala ( BLA)(8,9), and contribute inhibitory projections to the central nucleus ( CEA)(10,11), the main output station of the amygdala for conditioned fear responses(12). Thus, after extinction training, ITC cells could reduce the impact of conditioned- stimulus- related BLA inputs to the CEA by means of feed- forward inhibition. Here we test the hypothesis that ITC neurons mediate extinction by lesioning them with a toxin that selectively targets cells expressing mu- opioid receptors (mu ORs). Electron microscopic observations revealed that the incidence of mu OR- immunoreactive synapses is much higher in ITC cell clusters than in the BLA or CEA and that mORs typically have a post- synaptic location in ITC cells. In keeping with this, bilateral infusions of the mu OR agonist dermorphin conjugated to the toxin saporin in the vicinity of ITC neurons caused a 34% reduction in the number of ITC cells but no significant cell loss in surrounding nuclei. Moreover, ITC lesions caused a marked deficit in the expression of extinction that correlated negatively with the number of surviving ITC neurons but not CEA cells. Because ITC cells exhibit an unusual pattern of receptor expression, these findings open new avenues for the treatment of anxiety disorders.	[Likhtik, Ekaterina; Popa, Daniela; Apergis-Schoute, John; Fidacaro, George A., Jr.; Pare, Denis] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	pare@andromeda.rutgers.edu		Popa, Daniela/0000-0002-8389-1122	NIMH NIH HHS [F31 MH076415, R01MH-073610, F31 MH76415, R01 MH073610-04, R01 MH073610, F31 MH076415-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH076415, R01MH073610] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Davis M., 2000, AMYGDALA, P213; FALLS WA, 1992, J NEUROSCI, V12, P854; Fuxe K, 2003, NEUROSCIENCE, V119, P733, DOI 10.1016/S0306-4522(03)00148-9; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Hobin JA, 2003, J NEUROSCI, V23, P8410; Jacobsen KX, 2006, NEUROSCIENCE, V141, P2007, DOI 10.1016/j.neuroscience.2006.05.054; Lee H, 1998, J NEUROSCI, V18, P8444; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poulin JF, 2006, J COMP NEUROL, V496, P859, DOI 10.1002/cne.20956; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wiley RG, 2003, ADV DRUG DELIVER REV, V55, P1043, DOI 10.1016/S0169-409X(03)00102-9	30	339	343	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					642	U48		10.1038/nature07167	http://dx.doi.org/10.1038/nature07167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18615014	Green Accepted			2022-12-24	WOS:000258026500048
J	Dreses-Werringloer, U; Lambert, JC; Vingtdeux, V; Zhao, HT; Vais, H; Siebert, A; Jain, A; Koppel, J; Rovelet-Lecrux, A; Hannequin, D; Pasquier, F; Galimberti, D; Scarpini, E; Mann, D; Lendon, C; Campion, D; Amouyel, P; Davies, P; Foskett, JK; Campagne, F; Marambaud, P				Dreses-Werringloer, Ute; Lambert, Jean-Charles; Vingtdeux, Valerie; Zhao, Haitian; Vais, Horia; Siebert, Adam; Jain, Ankit; Koppel, Jeremy; Rovelet-Lecrux, Anne; Hannequin, Didier; Pasquier, Florence; Galimberti, Daniela; Scarpini, Elio; Mann, David; Lendon, Corinne; Campion, Dominique; Amouyel, Philippe; Davies, Peter; Foskett, J. Kevin; Campagne, Fabien; Marambaud, Philippe			A polymorphism in CALHM1 influences Ca2+ homeostasis, A beta levels, and Alzheimer's disease risk	CELL			English	Article							CHROMOSOME 10Q; ASSOCIATION; CHANNELS; LOCUS; IDENTIFICATION; BINDING; LINKAGE; SCAN; GENE	Alzheimer's disease (AD) is a genetically heterogeneous disorder characterized by early hippocampal atrophy and cerebral amyloid-beta (A beta) peptide deposition. Using TissueInfo to screen for genes preferentially expressed in the hippocampus and located in AD linkage regions, we identified a gene on 10q24.33 that we call CALHM1. We show that CALHM1 encodes a multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentrations and Ab levels. CALHM1 homomultimerizes, shares strong sequence similarities with the selectivity filter of the NMDA receptor, and generates a large Ca2+ conductance across the plasma membrane. Importantly, we determined that the CALHM1 P86L polymorphism (rs2986017) is significantly associated with AD in independent case-control studies of 3404 participants (allele-specific OR = 1.44, p = 2 x 10(-10)). We further found that the P86L polymorphism increases A beta levels by interfering with CALHM1-mediated Ca2+ permeability. We propose that CALHM1 encodes an essential component of a previously uncharacterized cerebral Ca2+ channel that controls Ab levels and susceptibility to late-onset AD.	[Campagne, Fabien] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Campagne, Fabien] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulazix Alsau, New York, NY 10021 USA; [Dreses-Werringloer, Ute; Vingtdeux, Valerie; Zhao, Haitian; Koppel, Jeremy; Davies, Peter; Marambaud, Philippe] N Shore LIJ, Litwin Zucker Res Ctr Study Alzheimers Dis, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille 2, Inst Pasteur, INSERM, U744, F-59019 Lille, France; [Vais, Horia; Siebert, Adam; Jain, Ankit; Foskett, J. Kevin] Univ Penn, Dept Phys, Sch Med, Philadelphia, PA 19104 USA; [Rovelet-Lecrux, Anne; Hannequin, Didier; Campion, Dominique] Fac Med, INSERM, U614, F-76000 Rouen, France; [Pasquier, Florence] Univ Hosp, Dept Neurol, F-59037 Lille, France; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, IRCCS Osped Maggiore Policlin, I-20122 Milan, Italy; [Mann, David] Univ Manchester, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England; [Lendon, Corinne] Queensland Inst Med Res, Mol Psychiat Grp, Brisbane, Qld 4006, Australia; [Davies, Peter; Marambaud, Philippe] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Cornell University; Cornell University; Northwell Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Manchester; QIMR Berghofer Medical Research Institute; Yeshiva University; Albert Einstein College of Medicine	Campagne, F (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	fac2003@med.cornell.edu; pmaramba@aecom.yu.edu	LICEND, CEMND/F-1296-2015; Campagne, Fabien/F-5158-2010; lambert, jean-charles/F-8787-2013; Pasquier, Florence/F-1527-2017; Lambert, jean-charles/A-9553-2014; Galimberti, Daniela/N-7209-2019; Rovelet-Lecrux, Anne/AAL-4305-2020; Foskett, Kevin/R-2549-2019; Vingtdeux, Valerie/C-2463-2012; Scarpini, Elio/K-6547-2016	lambert, jean-charles/0000-0003-0829-7817; Pasquier, Florence/0000-0001-9880-9788; Lambert, jean-charles/0000-0003-0829-7817; Galimberti, Daniela/0000-0002-9284-5953; Vingtdeux, Valerie/0000-0003-4550-503X; Amouyel, Philippe/0000-0001-9088-234X; Foskett, J. Kevin/0000-0002-8854-0268; Scarpini, Elio/0000-0002-6395-2119; Jain, Ankit/0000-0003-4032-1442; Campagne, Fabien/0000-0001-6237-3564; Marambaud, Philippe/0000-0002-8983-1497	NIMH NIH HHS [R01 MH059937, R01 MH059937-09] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertram L, 2006, AM J HUM GENET, V79, P180, DOI 10.1086/505032; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRESLOW NE, 1978, AM J EPIDEMIOL, V108, P299, DOI 10.1093/oxfordjournals.aje.a112623; Campagne F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-481; Conrad C, 2002, P NATL ACAD SCI USA, V99, P7751, DOI 10.1073/pnas.112194599; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; KHACHATURIAN ZS, 1989, ANN NY ACAD SCI, V568, P1, DOI 10.1111/j.1749-6632.1989.tb12485.x; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Minster RL, 2006, NEUROSCI LETT, V408, P170, DOI 10.1016/j.neulet.2006.08.081; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Pastor Pau, 2004, Curr Psychiatry Rep, V6, P125, DOI 10.1007/s11920-004-0052-6; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; Skrabanek L, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e102; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005	35	259	272	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1149	1161		10.1016/j.cell.2008.05.048	http://dx.doi.org/10.1016/j.cell.2008.05.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585350	Green Accepted, Bronze			2022-12-24	WOS:000257144600013
J	Nechiporuk, A; Raible, DW				Nechiporuk, Alex; Raible, David W.			FGF-dependent mechanosensory organ patterning in zebrafish	SCIENCE			English	Article							LATERAL-LINE; FLUORESCENT PROTEIN; TISSUE MIGRATION; REGENERATION; NEUROMASTS; EXPRESSION; COMPLEX; DOMAIN; GENES; PEA3	During development, organ primordia reorganize to form repeated functional units. In zebrafish ( Danio rerio), mechanosensory organs called neuromasts are deposited at regular intervals by the migrating posterior lateral line ( pLL) primordium. The pLL primordium is organized into polarized rosettes representing proto- neuromasts, each with a central atoh1a- positive focus of mechanosensory precursors. We show that rosettes form cyclically from a progenitor pool at the leading zone of the primordium as neuromasts are deposited from the trailing region. fgf3/10 signals localized to the leading zone are required for rosette formation, atoh1a expression, and primordium migration. We propose that the fibroblast growth factor ( FGF) source controls primordium organization, which, in turn, regulates the periodicity of neuromast deposition. This previously unrecognized mechanism may be applicable to understanding segmentation and morphogenesis in other organ systems.	[Nechiporuk, Alex; Raible, David W.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nechiporuk, A (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Cell & Dev Biol, Portland, OR 97239 USA.	nechipor@ohsu.edu; draible@u.washington.edu		Raible, David/0000-0002-5342-5841	NICHD NIH HHS [R00 HD055303, K99 HD055303] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Grandel H, 2000, DEVELOPMENT, V127, P4169; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Kiefer P, 1996, GENE, V168, P211, DOI 10.1016/0378-1119(95)00736-9; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020	21	148	148	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1774	1777		10.1126/science.1156547	http://dx.doi.org/10.1126/science.1156547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583612				2022-12-24	WOS:000257121200038
J	Haffner, ME; Torrent-Farnell, J; Maher, PD				Haffner, Marlene E.; Torrent-Farnell, Josep; Maher, Paul D.			Does orphan drug legislation really answer the needs of patients?	LANCET			English	Article							PHARMACOGENOMICS; DEFICIENCY; WORLD		[Haffner, Marlene E.] Amgen Corp, Washington, DC 20004 USA; [Torrent-Farnell, Josep; Maher, Paul D.] US FDA, Off Orphan Prod Dev, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Haffner, ME (corresponding author), Amgen Corp, 555 13th St NW,Suite 600 W, Washington, DC 20004 USA.	marlene.haffner@amgen.com						ANAND G, 2005, WALL STREET J   1116; Anand Geeta, 2005, Wall St J (East Ed), pA10; [Anonymous], REP INF DIS REM OBST; Arnon SS, 2007, PEDIATRICS, V119, P785, DOI 10.1542/peds.2006-0646; Broder S, 2002, EMBO REP, V3, P806, DOI 10.1093/embo-reports/kvf187; Cheung Richard Y, 2004, Health Law J, V12, P183; *DEP HHS, 2001, ORPH DRUG ACT IMPL I; *FDA, MEFL HCL DES TREATM; *FDA, RIF DES TREATM PUL T; *FDA, QUIN SULF DES TREATM; *FDA, HAL DES TREATM AD WH; *FDA, CUM LIST DES APPR OR; *FDA, 2004, CHALL POO CRIT PATH; *FDA, RIF COMB IS PYRAZ DE; *FDA, RIF DES ANT TREATM U; Futerman AH, 2004, TRENDS PHARMACOL SCI, V25, P147, DOI 10.1016/j.tips.2004.01.004; HERSHFIELD M, 1989, SCIENCE, V246, P1375; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; *HOFFM LA ROCH, PEG PEG ALPH 2A PACK; *INT MYEL FDN, 2006, INT MYEL FDN APPL FD; Joppi R, 2006, BRIT J CLIN PHARMACO, V61, P355, DOI 10.1111/j.1365-2125.2006.02579.x; Loughnot D, 2005, AM J LAW MED, V31, P365, DOI 10.1177/009885880503100210; LOVE J, BRIEF NOTE ABUSE ORP; Maeder T, 2003, SCI AM, V288, P80, DOI 10.1038/scientificamerican0503-80; Maher PD, 2006, BIODRUGS, V20, P71, DOI 10.2165/00063030-200620020-00001; Milne CP, 2002, NAT BIOTECHNOL, V20, P780, DOI 10.1038/nbt0802-780; Office of Orphan Products Development, LIST ORPH DES APPR; Rados Carol, 2003, FDA Consum, V37, P10; Scott CR, 2006, AM J MED GENET C, V142C, P121, DOI 10.1002/ajmg.c.30092; SIMON HJ, 1981, ANN INTERN MED, V95, P231, DOI 10.7326/0003-4819-95-2-231; SMITH A, ORPHAN BLOCKBUSTER B; *TUFTS CTR STUD DR, 2001, PEGS COST NEW PRESCR	32	55	58	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 14	2008	371	9629					2041	2044		10.1016/S0140-6736(08)60873-9	http://dx.doi.org/10.1016/S0140-6736(08)60873-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555916				2022-12-24	WOS:000256709500032
J	Chen, WS; Antic, D; Matis, M; Logan, CY; Povelones, M; Anderson, GA; Nusse, R; Axelrod, JD				Chen, Wei-Shen; Antic, Dragana; Matis, Maja; Logan, Catriona Y.; Povelones, Michael; Anderson, Graham A.; Nusse, Roel; Axelrod, Jeffrey D.			Asymmetric homotypic interactions of the atypical cadherin Flamingo mediate intercellular polarity signaling	CELL			English	Article							PLANAR-CELL-POLARITY; 7-PASS TRANSMEMBRANE CADHERIN; CYSTEINE-RICH DOMAIN; TISSUE POLARITY; DROSOPHILA; MORPHOGENESIS; MECHANISM; ADHESION; NIGHT; PROTOCADHERIN	Acquisition of planar cell polarity (PCP) in epithelia involves intercellular communication, during which cells align their polarity with that of their neighbors. The transmembrane proteins Frizzled (Fz) and Van Gogh (Vang) are essential components of the intercellular communication mechanism, as loss of either strongly perturbs the polarity of neighboring cells. How Fz and Vang communicate polarity information between neighboring cells is poorly understood. The atypical cadherin, Flamingo (Fmi), is implicated in this process, yet whether Fmi acts permissively as a scaffold or instructively as a signal is unclear. Here, we provide evidence that Fmi functions instructively to mediate Fz-Vang intercellular signal relay, recruiting Fz and Vang to opposite sides of cell boundaries. We propose that two functional forms of Fmi, one of which is induced by and physically interacts with Fz, bind each other to create cadherin homodimers that signal bidirectionally and asymmetrically, instructing unequal responses in adjacent cell membranes to establish molecular asymmetry.	[Chen, Wei-Shen; Antic, Dragana; Matis, Maja; Anderson, Graham A.; Axelrod, Jeffrey D.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Logan, Catriona Y.; Povelones, Michael; Nusse, Roel] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Logan, Catriona Y.; Povelones, Michael; Nusse, Roel] Beckman Ctr, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	jaxelrod@stanford.edu	Matis, Maja/P-1437-2019; Matis, Maja/J-3562-2017	Matis, Maja/0000-0003-3972-1983; Matis, Maja/0000-0003-3972-1983	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM059823-07, R01 GM059823-08, R01 GM059823, R01 GM059823-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2001, GENE DEV, V15, P1182; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Chae J, 1999, DEVELOPMENT, V126, P5421; Chen CM, 2004, P NATL ACAD SCI USA, V101, P15961, DOI 10.1073/pnas.0407103101; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Povelones M, 2005, EMBO J, V24, P3493, DOI 10.1038/sj.emboj.7600817; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Strutt D, 2007, DEV BIOL, V302, P181, DOI 10.1016/j.ydbio.2006.09.026; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wasserscheid I, 2007, DEV DYNAM, V236, P1064, DOI 10.1002/dvdy.21089; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	35	180	184	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					1093	1105		10.1016/j.cell.2008.04.048	http://dx.doi.org/10.1016/j.cell.2008.04.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555784	Green Accepted, Bronze			2022-12-24	WOS:000256693400023
J	Shafir, S; Reich, T; Tsur, E; Erev, I; Lotem, A				Shafir, Sharoni; Reich, Taly; Tsur, Erez; Erev, Ido; Lotem, Arnon			Perceptual accuracy and conflicting effects of certainty on risk-taking behaviour	NATURE			English	Article							APIS-MELLIFERA; DECISION; CHOICE	The 'certainty effect'(1,2) is a notable violation of expected utility theory by decision makers(3-6). It shows that people's tendency to select the safer of two prospects increases when this prospect provides a good outcome with certainty ( for example, people prefer a monetary gain of 3 with certainty over 4 with a probability of 0.8, but do not prefer 3 with a probability of 0.25 over 4 with a probability of 0.2). Subsequent work on experience- based decision making in rats(7) extended the certainty effect to other animals, suggesting its generality across different species and different decision- making mechanisms. However, an attempt to replicate this study with human subjects showed a surprising 'reversed certainty effect'(8,9), namely, the tendency to prefer the safer option decreases when this prospect is associated with certainty ( and people now prefer 4 with a probability of 0.8 over 3 with certainty). Here we show that these conflicting results can be explained by perceptual noise and that the certainty effect can be restored experimentally by reducing perceptual accuracy. Using complementary experiments in humans and honeybees ( Apis mellifera), we show that by manipulating perceptual accuracy in experience-based tasks, both the certainty and the reversed certainty effects can be exhibited by humans and other animals: the certainty effect emerges when it is difficult to discriminate between the different rewards, whereas the reversed certainty effect emerges when discrimination is easy. Our results fit a simple process- based model of matching behaviour(10,11), capable of explaining the certainty effect in humans and other animals that make repeated decisions based on experience. This mechanism should probably be distinguished from those involved in the original certainty effect that was exhibited by human subjects in single description- based problems(1,2).	[Lotem, Arnon] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Shafir, Sharoni; Tsur, Erez] Hebrew Univ Jerusalem, B Triwaks Bee Res Ctr, Dept Entomol, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; [Reich, Taly; Erev, Ido] Technion Israel Inst Technol, Max Wertheimer Minerva Ctr Cognit Studies, Fac Ind Engn & Management, IL-32000 Haifa, Israel	Tel Aviv University; Hebrew University of Jerusalem; Technion Israel Institute of Technology	Lotem, A (corresponding author), Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel.	erev@techunix.technion.ac.il; lotem@post.tau.ac.il	Shafir, Sharoni/D-9821-2011	Shafir, Sharoni/0000-0002-9068-1078; Reich, Taly/0000-0002-2978-4406; Erev, Ido/0000-0001-9889-4070				Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Barron G, 2003, J BEHAV DECIS MAKING, V16, P215, DOI 10.1002/bdm.443; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; Erev I, 2005, PSYCHOL REV, V112, P912, DOI 10.1037/0033-295X.112.4.912; ESTES WK, 1950, PSYCHOL REV, V57, P94, DOI 10.1037/h0058559; GIBBON J, 1988, PSYCHOL REV, V95, P102, DOI 10.1037/0033-295X.95.1.102; Gottlieb DA, 2007, PSYCHOL SCI, V18, P240, DOI 10.1111/j.1467-9280.2007.01883.x; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; MACDONALD DH, 1991, ECON J, V101, P1065; March JG, 1996, PSYCHOL REV, V103, P309, DOI 10.1037/0033-295X.103.2.309; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; Neumann J., 1944, THEORY GAMES EC BEHA; Osborne MJ, 1998, AM ECON REV, V88, P834; Real LA, 1996, AM ZOOL, V36, P518; Savage L.J., 1954, FDN STAT; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Shafir S, 2005, ANIM BEHAV, V69, P859, DOI 10.1016/j.anbehav.2004.07.011; Stevens S. S., 1975, PSYCHOPHYSICS; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; TVERSKY A, 1995, ECONOMETRICA, V63, P1255, DOI 10.2307/2171769	22	59	59	4	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2008	453	7197					917	U51		10.1038/nature06841	http://dx.doi.org/10.1038/nature06841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18548069				2022-12-24	WOS:000256632000043
J	Steel, N; Bachmann, M; Maisey, S; Shekelle, P; Breeze, E; Marmot, M; Melzer, D				Steel, Nicholas; Bachmann, Max; Maisey, Susan; Shekelle, Paul; Breeze, Elizabeth; Marmot, Michael; Melzer, David			Self reported receipt of care consistent with 32 quality indicators: national population survey of adults aged 50 or more in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE; OF-CARE; MEDICAL-CARE; MANAGEMENT; UK; PAY	Objective To assess the receipt of effective healthcare interventions in England by adults aged 50 or more with serious health conditions. Design National structured survey questionnaire with face to face interviews covering medical panel endorsed quality of care indicators for both publicly and privately provided care. Setting Private households across England. Participants 8688 participants in the English longitudinal study of ageing, of whorn 4417 reported diagnoses of one or more of 13 conditions. Main outcome measures Percentage of indicated interventions received by eligible participants for 32 clinical indicators and seven questions on patient centred care, and aggregate scores. Results Participants were eligible for 19082 items of indicated care. Receipt of indicated care varied substantially by condition. The percentage of indicated care received by eligible participants was highest for ischaemic heart disease (83%, 95% confidence interval 80% to 86%), followed by hearing problems (79%, 77% to 81%), pain management (78%, 73% to 83%), diabetes (74%, 72% to 76%), smoking cessation (74%, 71% to 76%), hypertension (72%, 69% to 76%), stroke (65%, 54% to 76%), depression (64%, 57% to 70%), patient centred care (58%, 57% to 60%), poor vision (58%, 54% to 63%), osteoporosis (53%, 49% to 57%), urinary incontinence (51%, 47% to 54%), fails management (44%, 37% to 51%), osteoarthritis (29%, 26% to 32%), and overall (62%, 62% to 63%). Substantially more indicated care was received for general medical (74%, 73% to 76%) than for geriatric conditions (57%, 55% to 58%), and for conditions included in the general practice pay for performance contract (75%, 73% to 76%) than excluded from it (58%, 56% to 59%). Conclusions Shortfalls in receipt of basic recommended care by adults aged 50 or more with common health conditions in England were most noticeable in areas associated with disability and frailty, but few areas were exempt. Efforts to improve care have substantial scope to achieve better health outcomes and particularly need to include chronic conditions that affect quality of life of older people.	[Steel, Nicholas; Bachmann, Max; Maisey, Susan] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Shekelle, Paul] RAND Corp, Santa Monica, CA USA; [Breeze, Elizabeth; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London, England; [Melzer, David] Peninsula Med Sch, Exeter, Devon, England	University of East Anglia; RAND Corporation; University of London; University College London; University of Exeter	Steel, N (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	n.steel@uea.ac.uk	Steel, Nicholas/K-1592-2014; Breeze, Elizabeth/AAK-4927-2021; Marmot, M G/Y-3920-2019	Steel, Nicholas/0000-0003-1528-140X; Marmot, M G/0000-0002-2431-6419; Bachmann, Max Oscar/0000-0003-1770-3506; Melzer, David/0000-0002-0170-3838	UK National Coordinating Centre for Research Capacity Development, and the Commonwealth Fund; US National Institute on Aging; UK Department of Health; Department for Work and Pensions; Office for National Statistics; Department for Environment Food and Rural Affairs; Department for Transport; Department for Education and Skills; Department of Culture Media and Sport; HM Treasury; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G19/35, G0100222] Funding Source: researchfish	UK National Coordinating Centre for Research Capacity Development, and the Commonwealth Fund; US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Department of Health; Department for Work and Pensions; Office for National Statistics; Department for Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Department for Transport; Department for Education and Skills; Department of Culture Media and Sport; HM Treasury; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NS was supported by the UK National Coordinating Centre for Research Capacity Development, and the Commonwealth Fund (a New York City based private independent foundation). The English longitudinal study of ageing was funded by the US National Institute on Aging, the UK Department of Health, Department for Work and Pensions, Office for National Statistics, Department for Environment Food and Rural Affairs, Department for Transport, Department for Education and Skills, Department of Culture Media and Sport, and HM Treasury. The funders had no influence over the analysis or presentation of results.	*AG HEALTHC RES QU, 2008, CONS ASS HEALTHC PRO; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Banks J., 2006, RETIREMENT HLTH RELA; BETHELL C, 2001, PORTRAIT CHRONICALLY; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Chang JT, 2007, J GEN INTERN MED, V19, pS109; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; *CTR MED MED SERV, 2005, MED CURR BEN SURV; Department of Health, 2001, NAT SERV FRAM OLD PE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Ganz DA, 2007, MED CARE, V45, P8, DOI 10.1097/01.mlr.0000241115.31531.15; Gemmell I, 2006, QUAL SAF HEALTH CARE, V15, P339, DOI 10.1136/qshc.2005.017061; *GEN PRACT COMM BM, 2003, INV GEN PRACT NEW GE; Grol R, 2001, MED CARE, V39, pII46; Hart JT, 2000, BRIT MED J, V320, P18; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; *I MED COMM HLTH C, 2001, CROSS QUAL CHASM NEW; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; LEATHERMAN S, 2005, QUEST QUALITY NHS CH; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Majeed A, 2005, PUBLIC HEALTH, V119, P105, DOI 10.1016/j.puhe.2004.06.006; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Millett C, 2006, J MED SCREEN, V13, P152, DOI 10.1258/096914106778440608; Reeves D, 2007, MED CARE, V45, P489, DOI 10.1097/MLR.0b013e31803bb479; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Steel N, 2004, QUAL SAF HEALTH CARE, V13, P260, DOI 10.1136/qshc.2004.010280; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Taylor R, 2007, HLTH WEALTH LIFESTYL; Tinetti ME, 2006, GERONTOLOGIST, V46, P717, DOI 10.1093/geront/46.6.717; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; WILKIN D, 2002, NATL TRACKER SURVEY	37	73	73	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2008	337	7667							a957	10.1136/bmj.a957	http://dx.doi.org/10.1136/bmj.a957			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346FD	18703659	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000259053100026
J	Palopoli, MF; Rockman, MV; TinMaung, A; Ramsay, C; Curwen, S; Aduna, A; Laurita, J; Kruglyak, L				Palopoli, Michael F.; Rockman, Matthew V.; TinMaung, Aye; Ramsay, Camden; Curwen, Stephen; Aduna, Andrea; Laurita, Jason; Kruglyak, Leonid			Molecular basis of the copulatory plug polymorphism in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; NATURAL-POPULATIONS; TEMPORAL DYNAMICS; MATING-BEHAVIOR; EVOLUTION; MUCINS; RNAI; PREDICTION; PHYLOGENY	Heritable variation is the raw material for evolutionary change, and understanding its genetic basis is one of the central problems in modern biology. We investigated the genetic basis of a classic phenotypic dimorphism in the nematode Caenorhabditis elegans. Males from many natural isolates deposit a copulatory plug after mating, whereas males from other natural isolates - including the standard wild- type strain ( N2 Bristol) that is used in most research laboratories - do not deposit plugs(1). The copulatory plug is a gelatinous mass that covers the hermaphrodite vulva, and its deposition decreases the mating success of subsequent males(2). We show that the plugging polymorphism results from the insertion of a retrotransposon into an exon of a novel mucin- like gene, plg-1, whose product is a major structural component of the copulatory plug. The gene is expressed in a subset of secretory cells of the male somatic gonad, and its loss has no evident effects beyond the loss of male mate- guarding. Although C. elegans descends from an obligate- outcrossing, male - female ancestor(3,4), it occurs primarily as self- fertilizing hermaphrodites(5-7). The reduced selection on male - male competition associated with the origin of hermaphroditism may have permitted the global spread of a loss-of-function mutation with restricted pleiotropy.	[Palopoli, Michael F.; TinMaung, Aye; Ramsay, Camden; Curwen, Stephen; Aduna, Andrea; Laurita, Jason] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Rockman, Matthew V.; Kruglyak, Leonid] Princeton Univ, Carl Icahn Lab, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rockman, Matthew V.; Kruglyak, Leonid] Princeton Univ, Carl Icahn Lab, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Bowdoin College; Princeton University; Princeton University	Palopoli, MF (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	mpalopol@bowdoin.edu			NIH [P20 RR-016463, R01 HG004321, P50 GM071508]; INBRE Program of the National Center for Research Resources; NSF [0110994]; Howard Hughes Medical Institute under the Undergraduate Science Education Program; James S. McDonnell Foundation Centennial Fellowship; Jane Coffin Childs Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute under the Undergraduate Science Education Program(Howard Hughes Medical Institute); James S. McDonnell Foundation Centennial Fellowship; Jane Coffin Childs Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center, M. Ailion, E. Dolgin, A. Barrie` re, M.- A. Fe ' lix and P. McGrath for strains and reagents. Work at Bowdoin College was supported by college funds, by the NIH (grant P20 RR- 016463 from the INBRE Program of the National Center for Research Resources), the NSF (grant 0110994), and by an award to Bowdoin College by the Howard Hughes Medical Institute under the Undergraduate Science Education Program. Work at Princeton University was supported by grants from the NIH (R01 HG004321 to L. K. and P50 GM071508 to the Lewis- Sigler Institute), a James S. McDonnell Foundation Centennial Fellowship ( L. K.), and a Jane Coffin Childs Fellowship ( M. V. R.). Wethank S. Civillico for assistance in the laboratory, F. Hagen for experimental advice, and E. Anderson, H. Coller, L. Gordon and H. Seidel for comments on the manuscript.	BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BARR MM, 2006, WORMBOOK; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2005, WORMBOOK, DOI 10.1895/wormbook.1.43.1; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRITTEN RJ, 1995, P NATL ACAD SCI USA, V92, P599, DOI 10.1073/pnas.92.2.599; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Chasnov JR, 2002, GENETICS, V160, P983; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Cutter AD, 2005, MOL BIOL EVOL, V22, P178, DOI 10.1093/molbev/msh267; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Fisher R.A., 1930, GENETICAL THEORY NAT; Ganko EW, 2001, GENOME RES, V11, P2066, DOI 10.1101/gr.196201; Hodgkin J, 1997, GENETICS, V146, P149; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; Lints R., 2005, WORMATLAS; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Peden EM, 2005, CURR BIOL, V15, P394, DOI 10.1016/j.cub.2004.12.073; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stewart AD, 2002, GENETICS, V160, P975; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7	32	98	99	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					1019	U66		10.1038/nature07171	http://dx.doi.org/10.1038/nature07171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18633349	Green Accepted			2022-12-24	WOS:000258591000044
J	Abreu, MT				Abreu, Maria T.			Harnessing the power of bacteria to protect the gut	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOUSE; INTESTINE; CELLS; TOLL							Abreu, Maria T./0000-0002-7294-0574				ABRAMS GD, 1963, LAB INVEST, V12, P355; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Riehl T, 2000, GASTROENTEROLOGY, V118, P1106, DOI 10.1016/S0016-5085(00)70363-5	6	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2008	359	7					756	759		10.1056/NEJMcibr0804223	http://dx.doi.org/10.1056/NEJMcibr0804223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336XE	18703481				2022-12-24	WOS:000258397900016
J	El-Sadr, WM; Hoos, D				El-Sadr, Wafaa M.; Hoos, David			The President's Emergency Plan for AIDS Relief - Is the emergency over?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[El-Sadr, Wafaa M.] Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA; [El-Sadr, Wafaa M.; Hoos, David] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [El-Sadr, Wafaa M.] Harlem Hosp Med Ctr, Div Infect Dis, New York, NY USA; [Hoos, David] ICAP, Multicountry Columbia Antiretroviral Program, New York, NY USA	Columbia University; Columbia University; Columbia University	El-Sadr, WM (corresponding author), Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA.							El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Rosner David., 1995, HIVES SICKNESS PUBLI; *UNAIDS, 2003, PROGR REP GLOB RESP; *WHO, 2004, COR HLTH IND MOZ	4	30	30	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					553	555		10.1056/NEJMp0803762	http://dx.doi.org/10.1056/NEJMp0803762			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334IY	18669420	Green Published			2022-12-24	WOS:000258216700001
J	Boulle, A; Van Cutsem, G; Cohen, K; Hilderbrand, K; Mathee, S; Abrahams, M; Goemaere, E; Coetzee, D; Maartens, G				Boulle, Andrew; Van Cutsem, Gilles; Cohen, Karen; Hilderbrand, Katherine; Mathee, Shaheed; Abrahams, Musaed; Goemaere, Eric; Coetzee, David; Maartens, Gary			Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	38th World Conference on Lung Health of the International-Union-Against-Tuberculosis-and-Lung-Disease	NOV 08-12, 2007	Cape Town, SOUTH AFRICA	Int Union Against Tuberculosis & Lung Dis			HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; TUBERCULOSIS; REGIMENS; COHORT; HEPATOTOXICITY; KHAYELITSHA; ADHERENCE; TOXICITY	Context Rifampicin- based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well described. Objective To assess the effectiveness and tolerability of concomitant efavirenz- or nevirapine-based combination antiretroviral therapy and rifampicin- based antitubercular therapy. Design, Setting, and Participants Cohort analysis of prospectively collected routine clinical data in a community - based South African antiretroviral treatment program. Antiretroviral treatment- naive adults enrolled between May 2001 and June 2006 were included in the analysis, and were followed up until the end of 2006. Interventions Patients starting antiretroviral therapy with or without concurrent antitubercular therapy received either efavirenz or nevirapine at standard doses. Patients developing tuberculosis while taking antiretroviral therapy that included nevirapine were either changed to efavirenz or continued taking nevirapine. Main Outcome Measures Viral load of 400 copies/ mL or more after 6, 12, and 18 months of antiretroviral therapy; time to the first viral load of 400 copies/ mL or more; time to confirmed virological failure ( 2 consecutive values >= 5000 copies/ mL); time to death; and time to treatment- limiting toxicity were assessed. Results The analysis included 2035 individuals who started antiretroviral therapy with efavirenz ( 1074 with concurrent tuberculosis) and 1935 with nevirapine ( 209 with concurrent tuberculosis). There were no differences in time to death or substitution of either antiretroviral drug for toxicity with and without concurrent tuberculosis. Patients starting nevirapine with concurrent tuberculosis were at a higher risk of elevated viral load most notably at 6 months ( 16.3%; 95% confidence interval [ CI], 10.6%- 23.5%) than those without tuberculosis ( 8.3%; 95% CI, 6.7%- 10.0%; adjusted odds ratio [ OR], 2.1; 95% CI, 1.2- 3.4; and in the combined estimate, adjusted OR, 1.7; 95% CI, 1.2- 2.6). In the time-to-event analysis of confirmed virological failure ( 2 consecutive values of >= 5000 copies/ mL), patients starting nevirapine with concurrent tuberculosis developed virological failure sooner ( adjusted hazard ratio [ HR] 2.2; 95% CI, 1.3- 3.7). There were no differences between patients starting efavirenz with and without concurrent tuberculosis ( adjusted OR, 1.1; 95% CI, 0.8- 1.5 [ combined estimate] and adjusted HR, 1.1; 95% CI, 0.6- 2.0, respectively). There was no difference in time to virological rebound in patients free of tuberculosis and those developing tuberculosis during follow- up while taking nevirapine ( adjusted HR, 1.0; 95% CI, 0.5- 2.0) or efavirenz ( adjusted HR, 0.8; 95% CI, 0.4- 1.7). Conclusion In this cohort study, virological outcomes were inferior when nevirapine-based antiretroviral therapy was commenced while taking antitubercular treatment ( vs without concurrent tuberculosis) but comparable when starting efavirenz- based antiretroviral therapy ( vs without concurrent tuberculosis) or when tuberculosis developed while taking established nevirapine- or efavirenz- based therapies.	[Boulle, Andrew; Hilderbrand, Katherine; Coetzee, David] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Cohen, Karen; Maartens, Gary] Univ Cape Town, Div Clin Pharmacol, Dept Med, ZA-7925 Cape Town, South Africa; [Van Cutsem, Gilles; Hilderbrand, Katherine; Goemaere, Eric] Prov Govt Western Cape, Med Sans Frontieres, Cape Town, South Africa; [Mathee, Shaheed; Abrahams, Musaed] Prov Govt Western Cape, Site B Community Hlth Ctr, Dept Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town	Boulle, A (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	andrew.boulle@uct.ac.za	Boulle, Andrew/C-1413-2008; Cohen, Karen/D-4036-2017; Van Cutsem, Gilles/ABB-1171-2021; Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Boulle, Andrew/0000-0002-7713-8062; Van Cutsem, Gilles/0000-0002-8972-4480; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Cohen, Karen/0000-0002-1892-4207				BOULLE A, 2004, 15 INT AIDS C JUL 11; Boulle A, 2007, ANTIVIR THER, V12, P753; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; *CDCP, 2004, UPD GUID US RIF TREA; *CDCP, 2007, MAN DRUG INT TREATM; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Cohen K, 2008, J ANTIMICROB CHEMOTH, V61, P389, DOI 10.1093/jac/dkm484; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cozzi-Lepri A, 2002, J INFECT DIS, V185, P1062, DOI 10.1086/339821; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Keiser Philip, 2002, HIV Clin Trials, V3, P296; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lopez-Cortes LF, 2002, CLIN PHARMACOKINET, V41, P681, DOI 10.2165/00003088-200241090-00004; Manosuthi W, 2008, HIV MED, V9, P294, DOI 10.1111/j.1468-1293.2008.00563.x; Manosuthi W, 2006, AIDS, V20, P131, DOI 10.1097/01.aids.0000196181.18916.9b; Manosuthi W, 2005, AIDS, V19, P1481, DOI 10.1097/01.aids.0000183630.27665.30; Manosuthi W, 2007, CLIN INFECT DIS, V44, P141, DOI 10.1086/510078; MARTIN DJ, 1995, J ACQ IMMUN DEF SYND, V8, P386; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; *NAT DEP HLTH, 2004, S AFR NAT ANT TREATM; Oliva J, 2003, AIDS, V17, P637, DOI 10.1097/00002030-200303070-00024; Patel A, 2004, JAIDS-J ACQ IMM DEF, V37, P1166, DOI 10.1097/01.qai.0000135956.96166.f0; Pedral-Sampaio Diana B., 2004, Braz J Infect Dis, V8, P211, DOI 10.1590/S1413-86702004000300004; *PROV ADM W CAP, 2006, 2005 HIV ANT PROV AR; *PROV GOV W CAP, 2004, ANT TREATM PROT; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Ramachandran G, 2006, JAIDS-J ACQ IMM DEF, V42, P36; Ribera E, 2001, J ACQ IMMUN DEF SYND, V28, P450, DOI 10.1097/00042560-200112150-00007; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; van Oosterhout JJ, 2007, ANTIVIR THER, V12, P515; World Health Organization, 2006, ANT THER HIV INF AD	36	155	162	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					530	539		10.1001/jama.300.5.530	http://dx.doi.org/10.1001/jama.300.5.530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	333YG	18677025	Bronze			2022-12-24	WOS:000258188900014
J	von Bernuth, H; Picard, C; Jin, ZB; Pankla, R; Xiao, H; Ku, CL; Chrabieh, M; Ben Mustapha, I; Ghandil, P; Camcioglu, Y; Vasconcelos, J; Sirvent, N; Guedes, M; Vitor, AB; Herrero-Mata, MJ; Arostegui, JI; Rodrigo, C; Alsina, L; Ruiz-Ortiz, E; Juan, M; Fortuny, C; Yague, J; Anton, J; Pascal, M; Chang, HH; Janniere, L; Rose, Y; Garty, BZ; Chapel, H; Issekutz, A; Marodi, L; Rodriguez-Gallego, C; Banchereau, J; Abel, L; Li, XX; Chaussabel, D; Puel, A; Casanova, JL				von Bernuth, Horst; Picard, Capucine; Jin, Zhongbo; Pankla, Rungnapa; Xiao, Hui; Ku, Cheng-Lung; Chrabieh, Maya; Ben Mustapha, Imen; Ghandil, Pegah; Camcioglu, Yildiz; Vasconcelos, Julia; Sirvent, Nicolas; Guedes, Margarida; Vitor, Artur Bonito; Herrero-Mata, Maria Jose; Arostegui, Juan Ignacio; Rodrigo, Carlos; Alsina, Laia; Ruiz-Ortiz, Estibaliz; Juan, Manel; Fortuny, Claudia; Yague, Jordi; Anton, Jordi; Pascal, Mariona; Chang, Huey-Hsuan; Janniere, Lucile; Rose, Yoann; Garty, Ben-Zion; Chapel, Helen; Issekutz, Andrew; Marodi, Laszlo; Rodriguez-Gallego, Carlos; Banchereau, Jacques; Abel, Laurent; Li, Xiaoxia; Chaussabel, Damien; Puel, Anne; Casanova, Jean-Laurent			Pyogenic bacterial infections in humans with MyD88 deficiency	SCIENCE			English	Article							MYELOID DIFFERENTIATION FACTOR-88; AERUGINOSA LUNG INFECTION; HERPES-SIMPLEX-VIRUS; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; HOST RESPONSE; MYD88-DEFICIENT MICE; PROTECTIVE IMMUNITY; HUMORAL IMMUNITY; CUTTING EDGE	MyD88 is a key downstream adapter for most Toll- like receptors ( TLRs) and interleukin- 1 receptors ( IL- 1Rs). MyD88 deficiency in mice leads to susceptibility to a broad range of pathogens in experimental settings of infection. We describe a distinct situation in a natural setting of human infection. Nine children with autosomal recessive MyD88 deficiency suffered from life- threatening, often recurrent pyogenic bacterial infections, including invasive pneumococcal disease. However, these patients were otherwise healthy, with normal resistance to other microbes. Their clinical status improved with age, but not due to any cellular leakiness in MyD88 deficiency. The MyD88- dependent TLRs and IL- 1Rs are therefore essential for protective immunity to a small number of pyogenic bacteria, but redundant for host defense to most natural infections.	[von Bernuth, Horst; Picard, Capucine; Ku, Cheng-Lung; Chrabieh, Maya; Ben Mustapha, Imen; Ghandil, Pegah; Janniere, Lucile; Rose, Yoann; Abel, Laurent; Puel, Anne; Casanova, Jean-Laurent] INSERM, U550, Paris, France; [von Bernuth, Horst; Picard, Capucine; Ku, Cheng-Lung; Chrabieh, Maya; Ben Mustapha, Imen; Ghandil, Pegah; Janniere, Lucile; Rose, Yoann; Abel, Laurent; Puel, Anne; Casanova, Jean-Laurent] Univ Paris 05, F-75270 Paris 06, France; [Picard, Capucine] Hop Necker Enfants Malad, Study Ctr Primary Immunodeficiencies, Assistance Publ Hop Paris, Paris, France; [Jin, Zhongbo; Pankla, Rungnapa; Banchereau, Jacques; Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Jin, Zhongbo] Baylor Univ, Waco, TX 76798 USA; [Pankla, Rungnapa] Khon Kaen Univ, Khon Kaen, Thailand; [Xiao, Hui; Li, Xiaoxia] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Ben Mustapha, Imen] Pasteur Inst Tunis, Tunis, Tunisia; [Camcioglu, Yildiz] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey; [Vasconcelos, Julia; Guedes, Margarida] Gen Hosp Santo Antonio, Oporto, Portugal; [Sirvent, Nicolas] Univ Hosp Archet 2, Nice, France; [Vitor, Artur Bonito] Hosp Sao Joao, Oporto, Portugal; [Herrero-Mata, Maria Jose; Ruiz-Ortiz, Estibaliz] Inst Invest Germans Trias & Pujol, LIRAD Banco Sangre & Tejidos, Barcelona, Spain; [Arostegui, Juan Ignacio; Juan, Manel; Yague, Jordi; Pascal, Mariona] IDIBAPS, Dept Immunol, Hosp Clin, Barcelona, Spain; [Rodrigo, Carlos] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, Barcelona, Spain; [Alsina, Laia; Fortuny, Claudia; Anton, Jordi] Univ Barcelona, Sant Joan Deu Hosp, Barcelona, Spain; [Chang, Huey-Hsuan] Inst Pasteur, Paris, France; [Chang, Huey-Hsuan] INSERM, U818, Paris, France; [Garty, Ben-Zion] Schneider Childrens Med Ctr, Petah Tiqwa, Israel; [Chapel, Helen] Univ Oxford, Oxford, England; [Chapel, Helen] Oxford Radcliffe Hosp, Oxford, England; [Issekutz, Andrew] Dalhousie Univ, Halifax, NS, Canada; [Marodi, Laszlo] Univ Debrecen, H-4012 Debrecen, Hungary; [Rodriguez-Gallego, Carlos] Gran Canaria Dr Negrin Hosp, Las Palmas Gran Canaria, Spain; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Baylor Scott & White Health; Baylor University; Khon Kaen University; Cleveland Clinic Foundation; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Istanbul University; Istanbul University - Cerrahpasa; CHU Nice; Sao Joao Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; University of Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; University of Oxford; Dalhousie University; University of Debrecen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), INSERM, U550, Paris, France.	jean-laurent.casanova@inserm.fr	Chaussabel, Damien/AAX-1909-2020; KU, Cheng-Lung/AAT-1033-2020; Picard, Capucine/H-3914-2017; chrabieh, maya/H-7370-2017; Ghandil, Pegah/K-4186-2018; Rodrigo, Carlos/F-7602-2017; Juan, Manel/Q-2931-2019; Sranujit, Rungnapa Pankla/AAB-9327-2020; von Bernuth, Horst/AAQ-9797-2021; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; KU, Cheng-Lung/L-6073-2015; Casanova, Jean-Laurent/I-3418-2017; Anton, Jordi/A-9848-2017; Marodi, Laszlo/AAU-9915-2020; Alsina, Laia/AID-4372-2022; Pascal, Mariona/HCG-9380-2022; Puel, Anne/H-7305-2017; Abel, Laurent/H-8888-2017; Alsina, Laia/GQI-3516-2022	KU, Cheng-Lung/0000-0002-0643-2256; Picard, Capucine/0000-0001-8788-5056; chrabieh, maya/0000-0003-0772-4805; Ghandil, Pegah/0000-0001-7828-6465; Rodrigo, Carlos/0000-0003-1140-2585; von Bernuth, Horst/0000-0002-5812-7675; KU, Cheng-Lung/0000-0002-0643-2256; Anton, Jordi/0000-0002-8792-4219; Puel, Anne/0000-0003-2603-0323; Abel, Laurent/0000-0001-7016-6493; Juan, Manel/0000-0002-3064-1648; Xiao, Hui/0000-0001-5304-243X; Chaussabel, Damien/0000-0002-6131-7242; Arostegui, Juan Ignacio/0000-0003-4757-504X; Alsina, Laia/0000-0002-3559-0018; Casanova, Jean-Laurent/0000-0002-7782-4169; RUIZ-ORTIZ, ESTIBALIZ/0000-0002-3003-934X; Rodriguez-Gallego, Carlos/0000-0002-4344-8644	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19 AI057234-02, U19 AI057234] Funding Source: Medline; PHS HHS [U19 AIO57234-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; HIRSCH MS, 1970, J IMMUNOL, V104, P1160; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Power MR, 2006, CLIN EXP IMMUNOL, V146, P323, DOI 10.1111/j.1365-2249.2006.03210.x; Power MR, 2004, J BIOL CHEM, V279, P49315, DOI 10.1074/jbc.M402111200; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Smahi A, 2000, NATURE, V405, P466; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	29	574	582	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					691	696		10.1126/science.1158298	http://dx.doi.org/10.1126/science.1158298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669862	Green Accepted			2022-12-24	WOS:000258077700044
J	Firkins, L				Firkins, Lester			Setting research priorities: a layman's experience	BRITISH MEDICAL JOURNAL			English	Editorial Material												lesterfirkins@mac.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a212	10.1136/bmj.a212	http://dx.doi.org/10.1136/bmj.a212			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SA	18614461				2022-12-24	WOS:000257961900039
J	Scherf, A; Riviere, L; Lopez-Rubio, JJ				Scherf, Artur; Riviere, Loic; Lopez-Rubio, Jose Juan			SnapShot: var gene expression in the malaria parasite	CELL			English	Editorial Material							MUTUALLY EXCLUSIVE EXPRESSION; PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; VIRULENCE GENES		[Scherf, Artur; Riviere, Loic; Lopez-Rubio, Jose Juan] CNRS, Inst Pasteur, URA 2581, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Scherf, A (corresponding author), CNRS, Inst Pasteur, URA 2581, Paris, France.		Scherf, Artur/A-9674-2014; lopez-rubio, jose juan/A-4509-2014	Scherf, Artur/0000-0003-2411-3328; lopez-rubio, jose juan/0000-0002-0555-1122				Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407	9	12	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					190	U12	190.e1	10.1016/j.cell.2008.06.042	http://dx.doi.org/10.1016/j.cell.2008.06.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614021	Bronze			2022-12-24	WOS:000257513100026
J	Cully, M; Downward, J				Cully, Megan; Downward, Julian			SnapShot: Ras signaling	CELL			English	Editorial Material							SMALL GTPASES; MTOR		[Cully, Megan; Downward, Julian] Canc Res UK London Res Inst, London WC2A 3PX, England	Cancer Research UK	Cully, M (corresponding author), Canc Res UK London Res Inst, London WC2A 3PX, England.		Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729; Cully, Megan/0000-0003-4726-134X				BUDAY L, 2008, BIOCH BIOPHYS ACTA, DOI DOI 10.1016/J.BBCAN.2008.05.001; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869	10	59	60	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1292	U190	1292.e1	10.1016/j.cell.2008.06.020	http://dx.doi.org/10.1016/j.cell.2008.06.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585361	Bronze			2022-12-24	WOS:000257144600026
J	Remuzzi, G; Garattini, S				Remuzzi, Giuseppe; Garattini, Silvio			Rare diseases: what's next?	LANCET			English	Editorial Material							DRUG		[Remuzzi, Giuseppe; Garattini, Silvio] Mario Negri Inst Pharmacol Res, Lab Negri Bergamo, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Lab Negri Bergamo, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	Garattini, Silvio/AAA-6390-2020; Remuzzi, Giuseppe/V-9766-2017	Garattini, Silvio/0000-0003-0647-9297; Remuzzi, Giuseppe/0000-0002-6194-3446				Ayme S, 2008, LANCET, V371, P2048, DOI 10.1016/S0140-6736(08)60875-2; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Cyranoski D, 2007, NAT MED, V13, P1005, DOI 10.1038/nm0907-1005; *EUR COMM, 2007, PUBL CONS REG EUR AC; Fischer A, 2008, LANCET, V371, P2044, DOI 10.1016/S0140-6736(08)60874-0; *FRENCH NAT PLAN R, 2004, ENS EQ ACC DIAGN TRE; Haffner ME, 2008, LANCET, V371, P2041, DOI 10.1016/S0140-6736(08)60873-9; Joppi R, 2006, BRIT J CLIN PHARMACO, V61, P355, DOI 10.1111/j.1365-2125.2006.02579.x; *OSS NAZ IMP FARM, 2006, US FARM IT; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Taruscio Domenica, 2003, Community Genet, V6, P123, DOI 10.1159/000073009	11	30	30	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 14	2008	371	9629					1978	1979		10.1016/S0140-6736(08)60847-8	http://dx.doi.org/10.1016/S0140-6736(08)60847-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555899				2022-12-24	WOS:000256709500007
J	Cuzick, J				Cuzick, Jack			Primary endpoints for randomised trials of cancer therapy	LANCET			English	Editorial Material							EXTENDED ADJUVANT THERAPY; BREAST-CANCER; ANASTROZOLE; TAMOXIFEN		[Cuzick, Jack] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England	Cancer Research UK; University of London; Queen Mary University London	Cuzick, J (corresponding author), Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	jack.cuzick@cancer.org.uk						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jakesz R, 2007, JNCI-J NATL CANCER I, V99, P1845, DOI 10.1093/jnci/djm246; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; US Food & Drug Administration, 2007, CLIN TRIAL ENDP APPR; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	12	26	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2156	2158		10.1016/S0140-6736(08)60933-2	http://dx.doi.org/10.1016/S0140-6736(08)60933-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586160				2022-12-24	WOS:000257635800009
J	Richards, T				Richards, Tessa			Orphan diseases: which ones do we adopt?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a1225	10.1136/bmj.a1225	http://dx.doi.org/10.1136/bmj.a1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18694885				2022-12-24	WOS:000258669200022
J	Service, RF				Service, Robert F.			Problem solved* (*sort of)	SCIENCE			English	News Item																			0	47	47	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					784	786		10.1126/science.321.5890.784	http://dx.doi.org/10.1126/science.321.5890.784			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687949				2022-12-24	WOS:000258261000029
J	Stowell, G				Stowell, Gillian			"Would you like to see the wound?"	BRITISH MEDICAL JOURNAL			English	Editorial Material												gillstowell@doctors.org.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a1064	10.1136/bmj.a1064	http://dx.doi.org/10.1136/bmj.a1064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18667472				2022-12-24	WOS:000258561000036
J	Shah, SJ; Gheorghiade, M				Shah, Sanjiv J.; Gheorghiade, Mihai			Heart failure with preserved ejection fraction - Treat now by treating comorbidities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTOLIC FUNCTION; OUTCOMES; REGISTRY; TRIAL; MANAGEMENT; UPDATE		[Shah, Sanjiv J.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med, 201 E Huron St,Galter 10-240, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Shah, Sanjiv J./AFQ-9480-2022					Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Hogg K, 2006, HEART FAIL REV, V11, P141, DOI 10.1007/s10741-006-9488-6; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; JUDGE KW, 1991, J AM COLL CARDIOL, V18, P377, DOI 10.1016/0735-1097(91)90589-2; O'Connor CM, 2000, AM J CARDIOL, V86, P863, DOI 10.1016/S0002-9149(00)01107-3; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	15	125	129	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					431	433		10.1001/jama.300.4.431	http://dx.doi.org/10.1001/jama.300.4.431			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647986				2022-12-24	WOS:000257831200021
J	Kaveri, SV; Lacroix-Desmazes, S; Bayry, J				Kaveri, Srini V.; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh			The antiinflammatory IgG	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FC		Univ Paris 06, Inst Natl Sante & Rech Med, Paris, France; Univ Paris 05, Ctr Rech Cordeliers, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kaveri, SV (corresponding author), Univ Paris 06, Inst Natl Sante & Rech Med, Paris, France.		Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447				Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360	6	65	66	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					307	309		10.1056/NEJMcibr0803649	http://dx.doi.org/10.1056/NEJMcibr0803649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326KD	18635437				2022-12-24	WOS:000257656600013
J	An, JJ; Gharami, K; Liao, GY; Woo, NH; Lau, AG; Vanevski, F; Torre, ER; Jones, KR; Feng, Y; Lu, B; Xu, B				An, Juan Ji; Gharami, Kusumika; Liao, Guey-Ying; Woo, Newton H.; Lau, Anthony G.; Vanevski, Filip; Torre, Enrique R.; Jones, Kevin R.; Feng, Yue; Lu, Bai; Xu, Baoji			Distinct role of long 3 ' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons	CELL			English	Article							DENDRITIC PROTEIN-SYNTHESIS; NEUROTROPHIC FACTOR; TERM POTENTIATION; KNOCKOUT MICE; REGULATORY MECHANISMS; RECEPTOR; TRANSLATION; TRKB; TRANSMISSION; ELEMENT	The brain produces two brain-derived neurotrophic factor (BDNF) transcripts, with either short or long 30 untranslated regions (30 UTRs). The physiological significance of the two forms of mRNAs encoding the same protein is unknown. Here, we show that the short and long 30 UTR BDNF mRNAs are involved in different cellular functions. The short 30 UTR mRNAs are restricted to somata, whereas the long 30 UTR mRNAs are also localized in dendrites. In a mouse mutant where the long 30 UTR is truncated, dendritic targeting of BDNF mRNAs is impaired. There is little BDNF in hippocampal dendrites despite normal levels of total BDNF protein. This mutant exhibits deficits in pruning and enlargement of dendritic spines, as well as selective impairment in long-term potentiation in dendrites, but not somata, of hippocampal neurons. These results provide insights into local and dendritic actions of BDNF and reveal a mechanism for differential regulation of subcellular functions of proteins.	[An, Juan Ji; Gharami, Kusumika; Liao, Guey-Ying; Vanevski, Filip; Xu, Baoji] Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20057 USA; [Woo, Newton H.; Lu, Bai] NICHHD, Sect Neural Dev & Plast, Bethesda, MD 20892 USA; [Lau, Anthony G.; Feng, Yue] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Torre, Enrique R.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University; Emory University; University of Colorado System; University of Colorado Boulder	Xu, B (corresponding author), Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20057 USA.	bx3@georgetown.edu	Lu, Bai/A-4018-2012	JONES, KEVIN/0000-0002-3802-7562; Feng, Yue/0000-0002-7905-2182; Lu, Bai/0000-0001-5418-9759	NINDS NIH HHS [R01 NS050596-03, R01 NS050596-01A1S1, R01 NS050596-02, R56 NS050596, NS050596, R01 NS050596-01A1, R01 NS050596] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS050596, R01NS050596] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gorski JA, 2003, J NEUROSCI, V23, P6856; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kobayashi H, 2005, EUR J NEUROSCI, V22, P2977, DOI 10.1111/j.1460-9568.2005.04508.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lochner JE, 2006, J NEUROBIOL, V66, P564, DOI 10.1002/neu.20250; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paradies MA, 1997, J NEUROBIOL, V33, P473, DOI 10.1002/(SICI)1097-4695(199710)33:4<473::AID-NEU10>3.0.CO;2-D; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	49	466	479	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					175	187		10.1016/j.cell.2008.05.045	http://dx.doi.org/10.1016/j.cell.2008.05.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614020	Bronze, Green Accepted			2022-12-24	WOS:000257513100023
J	Hackbarth, G; Reischauer, R; Mutti, A				Hackbarth, Glenn; Reischauer, Robert; Mutti, Anne			Collective accountability for medical care - Toward bundled medicare payments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hackbarth, Glenn; Reischauer, Robert; Mutti, Anne] Med PAC, Washington, DC USA; [Reischauer, Robert] Urban Inst, Washington, DC 20037 USA	Urban Institute	Hackbarth, G (corresponding author), Med PAC, Washington, DC USA.							Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; *PENNS HLTH CAR CO, 2006, PENNS GUID COR ART B; Stason W., 1998, MED PARTICIPATING HE	5	126	126	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					3	5		10.1056/NEJMp0803749	http://dx.doi.org/10.1056/NEJMp0803749			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320PB	18596270				2022-12-24	WOS:000257246000002
J	Renggli, V; De Ryck, I; Jacob, S; Yeneneh, H; Sirgu, S; Sebuyira, LM; Pfitzer, A; Downing, J; Portillo, C; Murray, J; Gove, S; Colebunders, R				Renggli, V.; De Ryck, I.; Jacob, S.; Yeneneh, H.; Sirgu, S.; Sebuyira, L. Mpanga; Pfitzer, A.; Downing, J.; Portillo, C.; Murray, J.; Gove, S.; Colebunders, R.			HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training	LANCET			English	Editorial Material									[Renggli, V.; De Ryck, I.; Colebunders, R.] Inst Trop Med, B-2000 Antwerp, Belgium; [Jacob, S.] Univ Washington, Int Training & Educ Ctr HIV, Seattle, WA 98195 USA; [Yeneneh, H.; Murray, J.] Emory Univ, Sch Nursing, Carter Ctr, Ethiopia Publ Hlth Training Initiat, Atlanta, GA 30322 USA; [Sirgu, S.] WHO, Country Off, Addis Ababa, Ethiopia; [Sebuyira, L. Mpanga] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Pfitzer, A.] Johns Hopkins Univ, Jhpiego Corp, Baltimore, MD USA; [Downing, J.] African Palliat Care Assoc, Kampala, Uganda; [Portillo, C.] Univ Calif San Francisco, Sch Nursing, Dept Community Hlth Syst, San Francisco, CA 94143 USA; [Gove, S.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Colebunders, R.] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Washington; University of Washington Seattle; Emory University; World Health Organization; Makerere University; Jhpiego; Johns Hopkins University; University of California System; University of California San Francisco; World Health Organization; University of Antwerp	Colebunders, R (corresponding author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.	bcoleb@itg.be	Pfitzer, Anne/H-3177-2019; Pfitzer, Anne/GPF-5485-2022	Downing, Julia/0000-0002-3450-785X; Jacob, Shevin/0000-0003-2425-9394				DOWNING J, 2006, THESIS MANCHESTER ME; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Idigbe E O, 2006, SAHARA J, V3, P488; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304; NTAMBWE M, 2006, BMJ-BRIT MED J, V333, P98; Quach L, 2005, AIDS PATIENT CARE ST, V19, P335, DOI 10.1089/apc.2005.19.335; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; *WHO, EFF TEACH GUID ED HE; *WHO, IMAI IMCI CHRON HIV; *WHO, GLOB AIDS TREATM EM; World Health Organization, UN ACC 2010; World Health Organization, WORLD HLTH REP 2006; World Health Organization (WHO), WHO REC CLIN MENT SU	13	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					341	343		10.1016/S0140-6736(08)61119-8	http://dx.doi.org/10.1016/S0140-6736(08)61119-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331WH	18657714				2022-12-24	WOS:000258042800036
J	Enquist, JA; Stoltz, BM				Enquist, John A., Jr.; Stoltz, Brian M.			The total synthesis of (-)-cyanthiwigin F by means of double catalytic enantioselective alkylation	NATURE			English	Article							SPONGE MYRMEKIODERMA-STYX; QUATERNARY STEREOCENTERS; ORGANIC-SYNTHESIS; ALLYLATION; AC	Double catalytic enantioselective transformations are powerful synthetic methods that can facilitate the construction of stereochemically complex molecules in a single operation(1,2). In addition to generating two or more stereocentres in a single reaction, multiple asymmetric reactions also impart increased enantiomeric excess to the final product in comparison with the analogous single transformation(3-6). Furthermore, multiple asymmetric operations have the potential to independently construct several stereocentres at remote points within the same molecular scaffold, rather than relying on pre- existing chiral centres that are proximal to the reactive site(1). Despite the inherent benefits of multiple catalytic enantioselective reactions, their application to natural product total synthesis remains largely underutilized(2). Here we report the use of a double stereoablative(7) enantioselective alkylation reaction in a concise synthesis of the marine diterpenoid ( -)-cyanthiwigin F ( ref. 8). By employing a technique for independent, selective formation of two stereocentres in a single stereoconvergent operation, we demonstrate that a complicated mixture of racemic and meso diastereomers may be smoothly converted to a synthetically useful intermediate with exceptional enantiomeric excess. The stereochemical information generated by means of this catalytic transformation facilitates the easy and rapid completion of the total synthesis of this marine natural product.	[Enquist, John A., Jr.; Stoltz, Brian M.] CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Stoltz, BM (corresponding author), CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Div Chem & Chem Engn, 1200 E Calif Blvd,MC164-30, Pasadena, CA 91125 USA.	stoltz@caltech.edu			NIGMS NIH HHS [R01 GM080269, R01GM080269-01, R01 GM080269-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080269] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba S., 1994, B SOC CHIM FR, V131, P525; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Behenna DC, 2004, J AM CHEM SOC, V126, P15044, DOI 10.1021/ja044812x; Cozzi PG, 2007, EUR J ORG CHEM, V2007, P5969, DOI 10.1002/ejoc.200700318; EBERT H, 1885, LIEBIGS ANN CHEM, V229, P45; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, P965; Greene T.W., 1999, PROTECTIVE GROUPS OR, V3; Helmchen G, 2000, ACCOUNTS CHEM RES, V33, P336, DOI 10.1021/ar9900865; Hoffmann RW, 2006, SYNTHESIS-STUTTGART, P3531, DOI 10.1055/s-2006-950311; Kagan HB, 2001, TETRAHEDRON, V57, P2449, DOI 10.1016/S0040-4020(01)00065-5; Kolodiazhnyi OI, 2003, TETRAHEDRON, V59, P5953, DOI 10.1016/S0040-4020(03)00911-6; Langenbeck W, 1936, Z PHYS CHEM A-CHEM T, V177, P401; MASAMUNE S, 1985, ANGEW CHEM INT EDIT, V24, P1, DOI 10.1002/anie.198500013; McFadden RM, 2006, J AM CHEM SOC, V128, P7738, DOI 10.1021/ja061853f; Mohr JT, 2005, ANGEW CHEM INT EDIT, V44, P6924, DOI 10.1002/anie.200502018; Mohr JT, 2007, ORG BIOMOL CHEM, V5, P3571, DOI 10.1039/b711159m; Peng JN, 2003, ORG LETT, V5, P4575, DOI 10.1021/ol035592f; Peng JN, 2002, TETRAHEDRON, V58, P7809, DOI 10.1016/S0040-4020(02)00937-7; Pfeiffer MWB, 2005, J AM CHEM SOC, V127, P5334, DOI 10.1021/ja0509836; POSS CS, 1994, ACCOUNTS CHEM RES, V27, P9, DOI 10.1021/ar00037a002; RAUTENSTRAUCH V, 1994, B SOC CHIM FR, V131, P515; Reddy TJ, 2006, ORG LETT, V8, P5585, DOI 10.1021/ol062304h; Robinson R, 1917, J CHEM SOC, V111, P762, DOI 10.1039/ct9171100762; Saito T, 1998, J ANTIBIOT, V51, P983, DOI 10.7164/antibiotics.51.983; SENNETT SH, 1992, J NAT PROD, V55, P1421, DOI 10.1021/np50088a006; Stewart IC, 2007, ORG LETT, V9, P1589, DOI 10.1021/ol0705144; Taishi T, 1998, TETRAHEDRON LETT, V39, P4347, DOI 10.1016/S0040-4039(98)00769-2; Trost BM, 2006, SYNTHESIS-STUTTGART, P369, DOI 10.1055/s-2006-926302; VIGNERON JP, 1973, TETRAHEDRON, V29, P1055, DOI 10.1016/0040-4020(73)80060-2; Yoshikai K, 2005, J ORG CHEM, V70, P681, DOI 10.1021/jo048275a	30	204	226	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1228	1231		10.1038/nature07046	http://dx.doi.org/10.1038/nature07046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	318FA	18580947	Green Accepted			2022-12-24	WOS:000257075800040
J	Richardson, AJ; Poloczanska, ES				Richardson, Anthony J.; Poloczanska, Elvira S.			Ocean science - Under-resourced, under threat	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; MARINE; IMPACT; BIODIVERSITY; PHENOLOGY; COMMUNITY; ECOLOGY		[Richardson, Anthony J.] CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, Cleveland, Qld 4163, Australia; [Richardson, Anthony J.] Univ Queensland, Dept Math, St Lucia, Qld 4072, Australia; [Poloczanska, Elvira S.] CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Richardson, AJ (corresponding author), CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, POB 120, Cleveland, Qld 4163, Australia.	anthony.richardson@csiro.au; elvira.poloczanska@csiro.au	Poloczanska, Elvira/F-4366-2014; poloczanska, elvira/P-5356-2014; Richardson, Anthony J/B-3649-2010	Richardson, Anthony J/0000-0002-9289-7366; poloczanska, elvira/0000-0001-8470-0925				BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Chambers LE, 2004, 100 BUR MET RES CTR; Duarte CM, 2007, TRENDS ECOL EVOL, V22, P331, DOI 10.1016/j.tree.2007.04.001; DUARTE CM, 1992, NATURE, V356, P190, DOI 10.1038/356190a0; Edwards K, 2004, PLANT BIOTECHNOL J, V2, P1, DOI 10.1111/j.1467-7652.2004.00058.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Field DB, 2006, SCIENCE, V311, P63, DOI 10.1126/science.1116220; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hendriks IE, 2006, SCIENCE, V312, P1715, DOI 10.1126/science.1128548; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Levin P, 2004, CONSERV BIOL, V18, P1160, DOI 10.1111/j.1523-1739.2004.00452.x; Mackas DL, 1998, CAN J FISH AQUAT SCI, V55, P1878, DOI 10.1139/cjfas-55-8-1878; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Raven J, 2005, OCEAN ACIDIFICATION; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sabates A, 2006, GLOBAL CHANGE BIOL, V12, P2209, DOI 10.1111/j.1365-2486.2006.01246.x; STEELE JH, 1991, J THEOR BIOL, V153, P425, DOI 10.1016/S0022-5193(05)80579-X; Stergiou KI, 2005, MAR ECOL PROG SER, V304, P292; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x	24	163	166	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1294	1295		10.1126/science.1156129	http://dx.doi.org/10.1126/science.1156129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535230				2022-12-24	WOS:000256441100027
J	Stumvoll, M; Goldstein, BJ; van Haeften, TW				Stumvoll, Michael; Goldstein, Barry J.; van Haeften, Timon W.			Type 2 diabetes: pathogenesis and treatment	LANCET			English	Editorial Material							GENOME-WIDE ASSOCIATION; BASAL INSULIN; RISK LOCI; FTO GENE; THERAPY; OBESITY; REPLICATION; CHILDHOOD; VARIANTS		[van Haeften, Timon W.] Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands; [Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Goldstein, Barry J.] Thomas Jefferson Univ, Div Endocrinol Diabet & Metabol Dis, Dept Med, Philadelphia, PA 19107 USA	Utrecht University; Utrecht University Medical Center; Leipzig University; Jefferson University	van Haeften, TW (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands.	T.W.vanHaeften@umcutrecht.nl	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240				Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *EUR MED AG, EMEA REC NEW WARN CO; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	18	83	87	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2153	2156		10.1016/S0140-6736(08)60932-0	http://dx.doi.org/10.1016/S0140-6736(08)60932-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586159				2022-12-24	WOS:000257635800008
J	Wijeysundera, DN; Beattie, WS; Austin, PC; Hux, JE; Laupacis, A				Wijeysundera, Duminda N.; Beattie, W. Scott; Austin, Peter C.; Hux, Janet E.; Laupacis, Andreas			Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: a population-based cohort study	LANCET			English	Article							PROPENSITY-SCORE METHODS; ADMINISTRATIVE DATA; RANDOMIZED-TRIALS; ANALGESIA; OUTCOMES; MORTALITY; COMORBIDITIES; COMPLICATIONS; METAANALYSIS; MORBIDITY	Background Although epidural anaesthesia and analgesia have numerous benefits, their effects on postoperative survival are unclear. We therefore undertook a population-based cohort study to determine whether perioperative epidural anaesthesia or analgesia is associated with improved 30-day survival. Methods We used population-based linked administrative 6latabases to do a retrospective cohort study of 259037 patients, aged 40 years or older, who underwent selected elective intermediate-to-high risk non-cardiac surgical procedures between April 1, 1994, and March 31, 2004, in Ontario, Canada. Propensity-score methods were used to construct a matched-pairs cohort that reduced important baseline differences between patients who received epidural anaesthesia or analgesia as opposed to those that did not. We then determined the association of epidural anaesthesia with 30-day mortality within these matched-pairs. Findings Of the 259037 patients, 56556 (22%) received epidural anaesthesia. Within the matched-pairs cohort (n=88 188), epidural anaesthesia was associated with a small reduction in 30-day mortality (1 . 7% vs 2. 0%; relative risk 0 . 89, 95% Cl 0 . 81-0. 98, p=0. 02). Interpretation Epidural anaesthesia and analgesia were associated with a small improvement in 30-day survival, but this effect should be interpreted cautiously. The estimate had borderline significance, despite a large sample size. Its absolute magnitude was also small, corresponding to a number needed to treat of 477. Our study, therefore, does not provide compelling evidence that epidural anaesthesia improves postoperative survival. Nonetheless, our results support the safety of perioperative epidural anaesthesia when used for indications other than improving survival (eg, improving postoperative pain relief, preventing postoperative pulmonary complications). Funding Institute for Clinical Evaluative Sciences.	[Wijeysundera, Duminda N.; Beattie, W. Scott] Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada; [Wijeysundera, Duminda N.; Austin, Peter C.; Hux, Janet E.; Laupacis, Andreas] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Wijeysundera, Duminda N.; Austin, Peter C.; Hux, Janet E.; Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Austin, Peter C.; Hux, Janet E.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; [Hux, Janet E.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Laupacis, Andreas] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Laupacis, Andreas] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wijeysundera, DN (corresponding author), Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada.	duminda.wijeysundera@uhn.on.ca	Beattie, William Scott/A-4352-2008; Wijeysundera, Duminda/L-3350-2018	Wijeysundera, Duminda/0000-0002-5897-8605; Austin, Peter/0000-0003-3337-233X	Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Clinician-Scientist Award; Canadian Institutes of Health Research	Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Clinician-Scientist Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported in part by the Institute for Clinical Evaluative Sciences, which is itself supported in part by a grant from the Ontario Ministry of Health and Long-Term Care. DNW is supported by a Clinician-Scientist Award, and PCA by a New Investigator Award from the Canadian Institutes of Health Research. WSB is the Fraser Elliot Chair of Cardiovascular Anaesthesiology at the University Health Network.	Agresti A, 2004, STAT MED, V23, P65, DOI 10.1002/sim.1589; [Anonymous], 2005, TECHN SUPPL HLTH CAR; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Ballantyne JC, 1998, ANESTH ANALG, V86, P598, DOI 10.1097/00000539-199803000-00032; Basinski ASH, 1999, CARDIOVASCULAR HLTH, P31; Beattie WS, 2001, ANESTH ANALG, V93, P853, DOI 10.1097/00000539-200110000-00010; Beattie WS, 2003, ANESTH ANALG, V97, P919, DOI 10.1213/01.ANE.0000074660.05733.10; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Block BM, 2003, JAMA-J AM MED ASSOC, V290, P2455, DOI 10.1001/jama.290.18.2455; BONDY SJ, 1999, CARDIOVASCULAR HLTH, P22; Bourne RB, 2005, ACCESS HLTH SERVICE, P114; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; Gentleman JF, 1996, CAN J SURG, V39, P361; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Juurlink D, 2006, CANADIAN I HLTH INFO; Koch CG, 2003, J THORAC CARDIOV SUR, V126, P2032, DOI 10.1016/S0022-5223(03)00950-4; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; Liu SS, 2007, ANESTH ANALG, V105, P789, DOI 10.1213/01.ane.0000278089.16848.1e; Moen V, 2004, ANESTHESIOLOGY, V101, P950, DOI 10.1097/00000542-200410000-00021; Ochroch EA, 2007, ANESTH ANALG, V105, P1787, DOI 10.1213/01.ane.0000290339.76513.e3; Oldman M, 2004, ANESTH ANALG, V98, P1486, DOI 10.1213/01.ANE.0000113549.98873.B1; Park WY, 2001, ANN SURG, V234, P560; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R Development Core Team, 2007, R LANG ENV STAT COMP; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Romano PS, 2002, AM J MED QUAL, V17, P145, DOI 10.1177/106286060201700404; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; TU K, 2007, OPEN MED, V1, pE3; Williams J. I., 1996, PATTERNS HLTH CARE O, P339; Wu CL, 2004, REGION ANESTH PAIN M, V29, P525, DOI 10.1016/j.rapm.2004.07.002; Yeager MP, 2004, REGION ANESTH PAIN M, V29, P515, DOI 10.1016/j.rapm.2004.08.024; YEAGER MP, 1987, ANESTHESIOLOGY, V66, P729, DOI 10.1097/00000542-198706000-00004; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	41	161	166	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 16	2008	372	9638					562	569		10.1016/S0140-6736(08)61121-6	http://dx.doi.org/10.1016/S0140-6736(08)61121-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339MS	18692893				2022-12-24	WOS:000258582300030
J	Metrangolo, P; Resnati, G				Metrangolo, P.; Resnati, G.			Chemistry - Halogen versus hydrogen	SCIENCE			English	Editorial Material							BONDS; CONFORMATION		[Metrangolo, P.; Resnati, G.] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20131 Milan, Italy	Polytechnic University of Milan	Metrangolo, P (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20131 Milan, Italy.	pierangelo.metrangolo@polimi.it; giuseppe.resnati@polimi.it	Metrangolo, Pierangelo/D-4106-2011; Resnati, Giuseppe/C-8650-2011	Resnati, Giuseppe/0000-0002-0797-9296; METRANGOLO, PIERANGELO/0000-0002-7945-099X				Aakeroy CB, 2007, J AM CHEM SOC, V129, P13772, DOI 10.1021/ja073201c; Aakeroy CB, 2007, CHEM COMMUN, P4236, DOI 10.1039/b707458a; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Corradi E, 2000, ANGEW CHEM INT EDIT, V39, P1782, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1782::AID-ANIE1782>3.0.CO;2-5; HASSEL O, 1970, SCIENCE, V170, P497, DOI 10.1126/science.170.3957.497; Hays FA, 2003, BIOCHEMISTRY-US, V42, P9586, DOI 10.1021/bi0346603; Legon AC, 2008, STRUCT BOND, V126, P17, DOI 10.1007/430_2007_063; Lim CW, 2007, P NATL ACAD SCI USA, V104, P6986, DOI 10.1073/pnas.0611123104; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Saha BK, 2005, CRYSTENGCOMM, V7, P355, DOI 10.1039/b501693b; Sun AW, 2006, SCIENCE, V312, P1030, DOI 10.1126/science.1124621; Voth AR, 2007, P NATL ACAD SCI USA, V104, P6188, DOI 10.1073/pnas.0610531104; VOTH AR, THESIS OREGON STATE	13	390	393	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					918	919		10.1126/science.1162215	http://dx.doi.org/10.1126/science.1162215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18703728				2022-12-24	WOS:000258436700022
J	Gardner, JM; DeVoss, JJ; Friedman, RS; Wong, DJ; Tan, YX; Zhou, XY; Johannes, KP; Su, MA; Chang, HY; Krummel, MF; Anderson, MS				Gardner, James M.; DeVoss, Jason J.; Friedman, Rachel S.; Wong, David J.; Tan, Ying X.; Zhou, Xuyu; Johannes, Kellsey P.; Su, Maureen A.; Chang, Howard Y.; Krummel, Matthew F.; Anderson, Mark S.			Deletional tolerance mediated by extrathymic Aire-expressing cells	SCIENCE			English	Article							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; T-CELLS; SELF; ANTIGEN; IDENTIFICATION; PROTEIN; MICE	The prevention of autoimmunity requires the elimination of self-reactive T cells during their development and maturation. The expression of diverse self-antigens by stromal cells in the thymus is essential to this process and depends, in part, on the activity of the autoimmune regulator (Aire) gene. Here we report the identification of extrathymic Aire-expressing cells (eTACs) resident within the secondary lymphoid organs. These stromally derived eTACs express a diverse array of distinct self-antigens and are capable of interacting with and deleting naive autoreactive T cells. Using two-photon microscopy, we observed stable antigen-specific interactions between eTACs and autoreactive T cells. We propose that such a secondary network of self- antigen-expressing stromal cells may help reinforce immune tolerance by preventing the maturation of autoreactive T cells that escape thymic negative selection.	[Gardner, James M.; DeVoss, Jason J.; Tan, Ying X.; Zhou, Xuyu; Johannes, Kellsey P.; Su, Maureen A.; Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94122 USA; [Friedman, Rachel S.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Wong, David J.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Canc Biol Program, Stanford, CA 94305 USA; [Su, Maureen A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94122 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco	Anderson, MS (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94122 USA.	manderson@diabetes.ucsf.edu	Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; Su, Maureen/0000-0002-3680-9982; Gardner, James/0000-0003-3470-9520	NIAID NIH HHS [P01 AI035297-170009, P01 AI035297-150009, K08 AI076429-05, P01 AI035297-159001, P01 AI035297-169001, P01 AI035297, P01 AI035297-179001, K08 AI076429, P01 AI035297-160009] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720, P30 DK063720-05] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076429, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Halonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P197, DOI 10.1177/002215540104900207; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lin MS, 2000, J CLIN INVEST, V105, P207, DOI 10.1172/JCI8075; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NAGATA M, 1994, J IMMUNOL, V152, P2042; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	22	351	362	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					843	847		10.1126/science.1159407	http://dx.doi.org/10.1126/science.1159407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687966	Green Accepted			2022-12-24	WOS:000258261000048
J	Ananworanich, J; Puthanakit, T; Saphonn, V; Cooper, DA; Ruxrungtham, K				Ananworanich, Jintanat; Puthanakit, Thanyawee; Saphonn, Vonthanak; Cooper, David A.; Ruxrungtham, Kiat			Lessons from a multicentre paediatric HIV trial	LANCET			English	Editorial Material									[Ananworanich, Jintanat; Puthanakit, Thanyawee; Cooper, David A.; Ruxrungtham, Kiat] HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand; [Saphonn, Vonthanak] Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Cooper, David A.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand	University of New South Wales Sydney; Kirby Institute; Chulalongkorn University	Ananworanich, J (corresponding author), HIV Netherlands Australia Thailand Res Collaborat, Bangkok 10330, Thailand.	jintanat.a@hivnat.org	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Puthanakit, Thanywee/0000-0003-1873-1867	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075408] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075408] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		UNAIDS, 2006, REP GLOB AIDS EP; VOLARI A, 2007, 4 IAS C HIV PATH TRE; World Health Organisation, 2006, ANT THER HIV INF INF	3	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					356	357		10.1016/S0140-6736(08)61139-3	http://dx.doi.org/10.1016/S0140-6736(08)61139-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675673	Green Accepted			2022-12-24	WOS:000258196000009
J	Wang, W; Fang, HQ; Groom, L; Cheng, AW; Zhang, WR; Liu, J; Wang, XH; Li, KT; Han, PD; Zheng, M; Yin, JH; Wang, WD; Mattson, MP; Kao, JPY; Lakatta, EG; Sheu, SS; Ouyang, KF; Chen, J; Dirksen, RT; Cheng, HP				Wang, Wang; Fang, Huaqiang; Groom, Linda; Cheng, Aiwu; Zhang, Wanrui; Liu, Jie; Wang, Xianhua; Li, Kaitao; Han, Peidong; Zheng, Ming; Yin, Jinhu; Wang, Weidong; Mattson, Mark P.; Kao, Joseph P. Y.; Lakatta, Edward G.; Sheu, Shey-Shing; Ouyang, Kunfu; Chen, Ju; Dirksen, Robert T.; Cheng, Heping			Superoxide flashes in single mitochondria	CELL			English	Article							PERMEABILITY TRANSITION PORE; OXIDATIVE STRESS; CYCLOPHILIN-D; CA2+ SPARKS; CALCIUM; RELEASE; CELLS; ROS; OSCILLATIONS; MODULATION	In quiescent cells, mitochondria are the primary source of reactive oxygen species (ROS), which are generated by leakiness of the electron transport chain (ETC). High levels of ROS can trigger cell death, whereas lower levels drive diverse and important cellular functions. We show here by employing a newly developed mitochondrial matrix-targeted superoxide indicator, that individual mitochondria undergo spontaneous bursts of superoxide generation, termed "superoxide flashes.'' Superoxide flashes occur randomly in space and time, exhibit all-or-none properties, and provide a vital source of superoxide production across many different cell types. Individual flashes are triggered by transient openings of the mitochondrial permeability transition pore stimulating superoxide production by the ETC. Furthermore, we observe a flurry of superoxide flash activity during reoxygenation of cardiomyocytes after hypoxia, which is inhibited by the cardioprotective compound adenosine. We propose that superoxide flashes could serve as a valuable biomarker for a wide variety of oxidative stress-related diseases.	[Wang, Wang; Lakatta, Edward G.] NIA, NIH, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Cheng, Aiwu; Mattson, Mark P.] NIA, NIH, Neurosci Lab, Baltimore, MD 21224 USA; [Yin, Jinhu; Wang, Weidong] NIA, NIH, Genet Lab, Baltimore, MD 21224 USA; [Fang, Huaqiang; Zhang, Wanrui; Liu, Jie; Wang, Xianhua; Li, Kaitao; Han, Peidong; Zheng, Ming; Cheng, Heping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Fang, Huaqiang; Zhang, Wanrui; Liu, Jie; Wang, Xianhua; Li, Kaitao; Han, Peidong; Zheng, Ming; Cheng, Heping] Peking Univ, Natl Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Groom, Linda; Sheu, Shey-Shing; Dirksen, Robert T.] Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Kao, Joseph P. Y.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ouyang, Kunfu; Chen, Ju] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; Peking University; University of Rochester; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Wang, W (corresponding author), NIA, NIH, Cardiovasc Sci Lab, Baltimore, MD 21224 USA.	wangwang@umich.edu; chengp@pku.edu.cn	cheng, heping/A-7299-2011; wang, wang/GWQ-7272-2022; Lakatta, Edward G/AAL-1447-2020; Mattson, Mark P/F-6038-2012; Chen, Ju/E-5579-2011; Wang, Weidong/AAV-2446-2021; Heping, Cheng/AAE-2680-2019; ouyang, kunfu/B-3073-2011; Sheu, Shey-Shing/Y-4009-2019	Heping, Cheng/0000-0002-9604-6702; ouyang, kunfu/0000-0003-0292-375X; Sheu, Shey-Shing/0000-0003-3838-3601; Lakatta, Edward/0000-0002-4772-0035; Wang, Weidong/0000-0002-0658-7928; Kao, Joseph/0000-0002-8875-2180; Wang, Wang/0000-0001-9093-412X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333, R01HL093671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000235, Z01AG000661, ZIAAG000317, ZIAAG000313] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL033333, HL-33333, R01 HL033333-12, R01 HL093671] Funding Source: Medline; NIAMS NIH HHS [AR44657, R01 AR044657, R01 AR044657-11, R29 AR044657] Funding Source: Medline; NIGMS NIH HHS [R01 GM056481, R01 GM056481-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; DYPBUKT JM, 1994, J BIOL CHEM, V269, P30553; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Isaeva EV, 2005, J PHYSIOL-LONDON, V565, P855, DOI 10.1113/jphysiol.2005.086280; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Montero M, 2004, BRIT J PHARMACOL, V141, P263, DOI 10.1038/sj.bjp.0705609; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakamura K, 2001, J BIOL CHEM, V276, P34402, DOI 10.1074/jbc.M103766200; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Otani H, 2004, ANTIOXID REDOX SIGN, V6, P449, DOI 10.1089/152308604322899521; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Ramesh V, 1998, ANN NY ACAD SCI, V853, P341, DOI 10.1111/j.1749-6632.1998.tb08295.x; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Takahashi A, 2001, BIOTECHNIQUES, V30, P804, DOI 10.2144/01304rv01; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774; Wallace D C, 2001, Novartis Found Symp, V235, P247; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	57	568	586	3	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					279	290		10.1016/j.cell.2008.06.017	http://dx.doi.org/10.1016/j.cell.2008.06.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662543	Green Accepted, Bronze			2022-12-24	WOS:000257891700017
J	Cerletti, M; Jurga, S; Witczak, CA; Hirshman, MF; Shadrach, JL; Goodyear, LJ; Wagers, AJ				Cerletti, Massimiliano; Jurga, Sara; Witczak, Carol A.; Hirshman, Michael F.; Shadrach, Jennifer L.; Goodyear, Laurie J.; Wagers, Amy J.			Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles	CELL			English	Article							MYOGENIC PROGENITOR CELLS; SATELLITE CELLS; HEMATOPOIETIC STEM; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; MOUSE MUSCLE; QUIESCENT; MICE; REGENERATION; ACTIVATION	Satellite cells reside beneath the basal lamina of skeletal muscle fibers and include cells that act as precursors for muscle growth and repair. Although they share a common anatomical localization and typically are considered a homogeneous population, satellite cells actually exhibit substantial heterogeneity. We used cell-surface marker expression to purify from the satellite cell pool a distinct population of skeletal muscle precursors (SMPs) that function as muscle stem cells. When engrafted into muscle of dystrophin-deficient mdx mice, purified SMPs contributed to up to 94% of myofibers, restoring dystrophin expression and significantly improving muscle histology and contractile function. Transplanted SMPs also entered the satellite cell compartment, renewing the endogenous stem cell pool and participating in subsequent rounds of injury repair. Together, these studies indicate the presence in adult skeletal muscle of prospectively isolatable muscle-forming stem cells and directly demonstrate the efficacy of myogenic stem cell transplant for treating muscle degenerative disease.	[Cerletti, Massimiliano; Jurga, Sara; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02115 USA; [Witczak, Carol A.; Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Metab Sect, Boston, MA 02115 USA; [Cerletti, Massimiliano; Jurga, Sara; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cerletti, Massimiliano; Jurga, Sara; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard University	Wagers, AJ (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, 1 Joslin Pl, Boston, MA 02115 USA.	amy.wagers@joslin.harvard.edu	Jurga, Stefan/E-8862-2017	Jurga, Stefan/0000-0002-1665-6077	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068626] Funding Source: NIH RePORTER; NIAMS NIH HHS [F32 AR051663, F32AR051663] Funding Source: Medline; NIDDK NIH HHS [R01DK068626, R01 DK068626] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachrach E, 2006, MUSCLE NERVE, V34, P44, DOI 10.1002/mus.20560; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COMELISON DD, 2001, DEV BIOL, V239, P79, DOI DOI 10.1006/DBI0.2001.0416; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heslop L, 2000, J CELL SCI, V113, P2299; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Luz MAM, 2002, BRAZ J MED BIOL RES, V35, P691, DOI 10.1590/S0100-879X2002000600009; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rouger K, 2004, CELL TISSUE RES, V317, P319, DOI 10.1007/s00441-004-0911-9; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wernig G, 2005, P NATL ACAD SCI USA, V102, P11852, DOI 10.1073/pnas.0502507102; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; WRIGHT WE, 1985, EXP CELL RES, V157, P343, DOI 10.1016/0014-4827(85)90119-3; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	48	333	349	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					37	47		10.1016/j.cell.2008.05.049	http://dx.doi.org/10.1016/j.cell.2008.05.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614009	Bronze, Green Accepted			2022-12-24	WOS:000257513100012
J	Ringe, D; Petsko, GA				Ringe, Dagmar; Petsko, Gregory A.			How enzymes work	SCIENCE			English	Editorial Material							CATALYSIS; INTERMEDIATE; PROTEIN		[Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University	Ringe, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	petsko@brandeis.edu	Petsko, Gregory/AAO-7962-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032415] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM032415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER T, 1983, CIBA F SYMP, V93, P4; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Koshland DE, 2004, NATURE, V432, P447, DOI 10.1038/432447a; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Lerner R A, 1996, Harvey Lect, V92, P1; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; STEITZ TA, 1983, CIBA F SYMP, V93, P25; Sumner JB, 1926, J BIOL CHEM, V69, P435; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106	20	161	161	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1428	1429		10.1126/science.1159747	http://dx.doi.org/10.1126/science.1159747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556536				2022-12-24	WOS:000256676400020
J	Klein, ML; Shinoda, W				Klein, Michael L.; Shinoda, Wataru			Large-scale molecular dynamics simulations of self-assembling systems	SCIENCE			English	Editorial Material							CHEMISTRY; COMPUTER; POWER; MODEL		[Klein, Michael L.] Univ Penn, Dept Chem, Ctr Mol Modeling, Philadelphia, PA 19104 USA; [Shinoda, Wataru] Natl Inst Adv Ind Sci & Technol, Res Inst Computat Sci, Tsukuba, Ibaraki 3058568, Japan	University of Pennsylvania; National Institute of Advanced Industrial Science & Technology (AIST)	Klein, ML (corresponding author), Univ Penn, Dept Chem, Ctr Mol Modeling, Philadelphia, PA 19104 USA.	klein@lrsm.upenn.edu; w.shinoda@aist.go.jp	Shinoda, Wataru/M-9948-2018	Shinoda, Wataru/0000-0002-3388-9227	NIGMS NIH HHS [GM 40712] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040712] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; ARKHIPOV A, 2008, BIOPHYS J, DOI DOI 10.1529/BIOPHYSJ.107.121160; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Borrell B, 2008, NATURE, V451, P240, DOI 10.1038/451240a; Carter EA, 2008, SCIENCE, V321, P800, DOI 10.1126/science.1158009; Cooper VR, 2008, J AM CHEM SOC, V130, P1304, DOI 10.1021/ja0761941; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Head-Gordon M, 2008, PHYS TODAY, V61, P58, DOI 10.1063/1.2911179; Kitao A, 2006, P NATL ACAD SCI USA, V103, P4894, DOI 10.1073/pnas.0510285103; MARKOFF J, 2008, NY TIMES        0609; Mirijanian DT, 2008, P NATL ACAD SCI USA, V105, P1204, DOI 10.1073/pnas.0707500105; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Neri M, 2008, BIOPHYS J, V94, P71, DOI 10.1529/biophysj.107.116301; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Sanbonmatsu KY, 2007, J STRUCT BIOL, V157, P470, DOI 10.1016/j.jsb.2006.10.023; Shelley JC, 2001, J PHYS CHEM B, V105, P4464, DOI 10.1021/jp010238p; Shih AY, 2007, J STRUCT BIOL, V157, P579, DOI 10.1016/j.jsb.2006.08.006; Shinoda W, 2007, MOL SIMULAT, V33, P27, DOI 10.1080/08927020601054050; SMIT B, 1990, NATURE, V348, P624, DOI 10.1038/348624a0; Studt F, 2008, SCIENCE, V320, P1320, DOI 10.1126/science.1156660; Treptow W, 2008, J PHYS CHEM B, V112, P3277, DOI 10.1021/jp709675e; van Meel JA, 2008, MOL SIMULAT, V34, P259, DOI 10.1080/08927020701744295; Vanden-Eijnden E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2833040; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	25	333	343	5	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					798	800		10.1126/science.1157834	http://dx.doi.org/10.1126/science.1157834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687954				2022-12-24	WOS:000258261000034
J	Jones, PA; Archer, TK; Baylin, SB; Beck, S; Berger, S; Bernstein, BE; Carpten, JD; Clark, SJ; Costello, JF; Doerge, RW; Esteller, M; Feinberg, AP; Gingeras, TR; Greally, JM; Henikoff, S; Herman, JG; Jackson-Grusby, L; Jenuwein, T; Jirtle, RL; Kim, YJ; Laird, PW; Lim, B; Martienssen, R; Polyak, K; Stunnenberg, H; Tlsty, TD; Tycko, B; Ushijima, T; Zhu, JD; Pirrotta, V; Allis, CD; Elgin, SC; Rine, J; Wu, C				Jones, Peter A.; Archer, Trevor K.; Baylin, Stephen B.; Beck, Stephan; Berger, Shelley; Bernstein, Bradley E.; Carpten, John D.; Clark, Susan J.; Costello, Joseph F.; Doerge, Rebecca W.; Esteller, Manel; Feinberg, Andrew P.; Gingeras, Thomas R.; Greally, John M.; Henikoff, Steven; Herman, James G.; Jackson-Grusby, Laurie; Jenuwein, Thomas; Jirtle, Randy L.; Kim, Young-Joon; Laird, Peter W.; Lim, Bing; Martienssen, Robert; Polyak, Kornelia; Stunnenberg, Henk; Tlsty, Thea Dorothy; Tycko, Benjamin; Ushijima, Toshikazu; Zhu, Jingde; Pirrotta, Vincenzo; Allis, C. David; Elgin, Sarah C.; Rine, Jasper; Wu, Carl		Amer Assoc Canc Res Human Epigenom; European Union Network Excellence	Moving AHEAD with an international human epigenome project	NATURE			English	Editorial Material							DNA METHYLATION; HUMAN GENOME; ARABIDOPSIS-THALIANA; CELLS; TRANSCRIPTION; PLURIPOTENT		[Jones, Peter A.; Laird, Peter W.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Archer, Trevor K.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ, Baltimore, MD 21231 USA; [Beck, Stephan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Berger, Shelley] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Carpten, John D.] TGen, Phoenix, AZ 85004 USA; [Clark, Susan J.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Doerge, Rebecca W.] Purdue Univ, W Lafayette, IN 47907 USA; [Esteller, Manel] Spanish Natl Canc Ctr, Madrid, Spain; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Oncol & Mol Biol, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD 21205 USA; [Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA; [Greally, John M.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jackson-Grusby, Laurie] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Jirtle, Randy L.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Kim, Young-Joon] Yonsei Univ, Seoul 120719, South Korea; [Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Martienssen, Robert] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Polyak, Kornelia] Dana Farber Canc Inst, Boston, MA 02115 USA; [Stunnenberg, Henk] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Tlsty, Thea Dorothy] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Tycko, Benjamin] Columbia Univ, New York, NY 10032 USA; [Ushijima, Toshikazu] Natl Canc Ctr, Tokyo 1040045, Japan; [Zhu, Jingde] Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Pirrotta, Vincenzo] Rutgers State Univ, Piscataway, NJ 08854 USA; [Allis, C. David] Rockefeller Univ, New York, NY 10021 USA; [Elgin, Sarah C.] Washington Univ, St Louis, MO 63130 USA; [Rine, Jasper] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Wu, Carl] NCI, Bethesda, MD 20892 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Wellcome Trust Sanger Institute; The Wistar Institute; Harvard University; Massachusetts General Hospital; Translational Genomics Research Institute; Garvan Institute of Medical Research; University of California System; University of California San Francisco; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centro Nacional de Investigaciones Oncologicas (CNIO); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Affymetrix; Yeshiva University; Albert Einstein College of Medicine; Fred Hutchinson Cancer Center; Harvard University; Harvard Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Duke University; Yonsei University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cold Spring Harbor Laboratory; Harvard University; Dana-Farber Cancer Institute; Radboud University Nijmegen; University of California System; University of California San Francisco; Columbia University; National Cancer Center - Japan; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rockefeller University; Washington University (WUSTL); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jones, PA (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	jones_p@ccnt.hsc.usc.edu	Clark, Susan J/B-2272-2008; Archer, Trevor K/E-5191-2019; Greally, John/AAF-9540-2019; Stunnenberg, Hendrik G./D-6875-2012; Ushijima, Toshikazu/AAP-5742-2021; Esteller, Manel/L-5956-2014; Feinberg, Andrew/AAY-7666-2020; Clark, Susan J/U-7365-2019; Laird, Peter W/G-8683-2012; Clark, Stewart/A-3462-2012	Clark, Susan J/0000-0001-5925-5030; Greally, John/0000-0001-6069-7960; Stunnenberg, Hendrik G./0000-0002-0066-1576; Ushijima, Toshikazu/0000-0003-3405-7817; Esteller, Manel/0000-0003-4490-6093; Clark, Susan J/0000-0001-5925-5030; Laird, Peter W/0000-0001-9117-3641; Archer, Trevor K/0000-0001-7651-3644; Feinberg, Andrew/0000-0002-8364-1991; Gingeras, Thomas/0000-0001-9106-3573; Elgin, Sarah C. R./0000-0002-5176-2510; Henikoff, Steven/0000-0002-7621-8685; Clark, Stewart/0000-0003-4792-7738; Berger, Shelley/0000-0001-5398-4400	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050760] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA135454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES071006-09] Funding Source: Medline; NCI NIH HHS [R37 CA054358-18, R01 CA135454] Funding Source: Medline; NICHD NIH HHS [R01 HD050760] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; FEINBERG AP, WORKSH DEF EP ADDR V; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	16	123	132	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					711	715		10.1038/454711a	http://dx.doi.org/10.1038/454711a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685699	Green Accepted, Green Submitted			2022-12-24	WOS:000258228000034
J	Kashiyama, Y; Miyashita, H; Ohkubo, S; Ogawa, NO; Chikaraishi, Y; Takano, Y; Suga, H; Toyofuku, T; Nomaki, H; Kitazato, H; Nagata, T; Ohkouchi, N				Kashiyama, Y.; Miyashita, H.; Ohkubo, S.; Ogawa, N. O.; Chikaraishi, Y.; Takano, Y.; Suga, H.; Toyofuku, T.; Nomaki, H.; Kitazato, H.; Nagata, T.; Ohkouchi, N.			Evidence of global chlorophyll d	SCIENCE			English	Article							D-PRODUCING CYANOBACTERIUM		[Kashiyama, Y.; Ogawa, N. O.; Chikaraishi, Y.; Takano, Y.; Suga, H.; Toyofuku, T.; Nomaki, H.; Kitazato, H.; Ohkouchi, N.] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Miyashita, H.; Ohkubo, S.] Kyoto Univ, Dept Interdisciplinary Environm, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Nagata, T.] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University; Kyoto University	Kashiyama, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	chiro@jamstec.go.jp	Chikaraishi, Yoshito/O-5250-2019; Ohkouchi, Naohiko/B-2071-2008; Ohkubo, Satoshi/N-6795-2014; Kashiyama, Yuichiro/AAW-1036-2020; Ogawa, Nanako O/AAJ-6456-2020; Takashi, Toyofuku/E-4441-2011	Chikaraishi, Yoshito/0000-0002-7506-1524; Ohkubo, Satoshi/0000-0002-2485-2561; Kashiyama, Yuichiro/0000-0001-7337-2209; Takashi, Toyofuku/0000-0001-8095-6077; OGAWA, Nanako O/0000-0002-3823-6444; Ohkouchi, Naohiko/0000-0002-6355-7469				Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyachi S, 1997, Z NATURFORSCH C, V52, P636; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Mizoguchi T, 2006, PHOTOCH PHOTOBIO SCI, V5, P291, DOI 10.1039/b514088a; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105	7	55	57	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					658	658		10.1126/science.1158761	http://dx.doi.org/10.1126/science.1158761			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669855				2022-12-24	WOS:000258077700034
J	Farrelly, C				Farrelly, Colin			Has the time come to take on time itself?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE-SPAN; MICE		Univ Waterloo, Dept Polit Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Farrelly, C (corresponding author), Univ Waterloo, Dept Polit Sci, Waterloo, ON N2L 3G1, Canada.	farrelly@uwaterloo.ca						Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Couzin J, 2005, SCIENCE, V309, P83, DOI 10.1126/science.309.5731.83; *FED INT FOR AG RE, 2004, OLD AM 2004 KEY IND; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Hadley EC, 2005, CELL, V120, P557, DOI 10.1016/j.cell.2005.01.030; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Kitani K, 2007, GERIATR GERONTOL INT, V7, P97, DOI 10.1111/j.1447-0594.2007.00377.x; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Miller RA, 2005, SCIENCE, V308, P1875, DOI 10.1126/science.1114393; NCI, 2011, SEER CANC STAT REV 1; Olshansky SJ, 2006, SCIENTIST, V20, P28; PEARSON H, 2006, NATURE          1102; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; *US DEP HHS, PREV CONTR CANC NAT; *US DEP HHS, 2004, HLTH US 2004, P234	17	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a414	10.1136/bmj.a414	http://dx.doi.org/10.1136/bmj.a414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	330SB	18614507	Green Published			2022-12-24	WOS:000257962000037
J	Bozec, A; Bakiri, L; Hoebertz, A; Eferl, R; Schilling, AF; Komnenovic, V; Scheuch, H; Priemel, M; Stewart, CL; Amling, M; Wagner, EF				Bozec, Aline; Bakiri, Latifa; Hoebertz, Astrid; Eferl, Robert; Schilling, Arndt F.; Komnenovic, Vukoslav; Scheuch, Harald; Priemel, Matthias; Stewart, Colin L.; Amling, Michael; Wagner, Erwin F.			Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia	NATURE			English	Article							LEUKEMIA INHIBITORY FACTOR; PAGETS-DISEASE; STEM-CELLS; C-FOS; MICE; EXPRESSION; GENE; GROWTH; BCL-2; DIFFERENTIATION	Osteoclasts are multinucleated haematopoietic cells that resorb bone. Increased osteoclast activity causes osteoporosis, a disorder resulting in a low bone mass and a high risk of fractures(1). Increased osteoclast size and numbers are also a hallmark of other disorders, such as Paget's disease and multiple myeloma(2). The protein c- Fos, a component of the AP- 1 transcription factor complex, is essential for osteoclast differentiation(3). Here we show that the Fos- related protein Fra- 2 controls osteoclast survival and size. The bones of Fra- 2- deficient newborn mice have giant osteoclasts, and signalling through leukaemia inhibitory factor ( LIF) and its receptor is impaired. Similarly, newborn animals lacking LIF have giant osteoclasts, and we show that LIF is a direct transcriptional target of Fra- 2 and c- Jun. Moreover, bones deficient in Fra- 2 and LIF are hypoxic and express increased levels of hypoxia- induced factor 1 alpha ( HIF1 alpha) and Bcl- 2. Overexpression of Bcl- 2 is sufficient to induce giant osteoclasts in vivo, whereas Fra- 2 and LIF affect HIF1a through transcriptional modulation of the HIF prolyl hydroxylase PHD2. This pathway is operative in the placenta, because specific inactivation of Fra- 2 in the embryo alone does not cause hypoxia or the giant osteoclast phenotype. Thus placenta- induced hypoxia during embryogenesis leads to the formation of giant osteoclasts in young pups. These findings offer potential targets for the treatment of syndromes associated with increased osteoclastogenesis.	[Bozec, Aline; Bakiri, Latifa; Hoebertz, Astrid; Eferl, Robert; Komnenovic, Vukoslav; Scheuch, Harald; Wagner, Erwin F.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schilling, Arndt F.; Priemel, Matthias; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Ctr Biomech & Skeletal Biol, D-20246 Hamburg, Germany; [Stewart, Colin L.] Inst Med Biol, Dev & Regenerat Biol Lab, Singapore 138648, Singapore	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Hamburg; University Medical Center Hamburg-Eppendorf; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Wagner, EF (corresponding author), CNIO, C Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	wagner@imp.ac.at	Bakiri, Latifa/N-5780-2014; Bakiri, Latifa/AAP-1674-2020	Eferl, Robert/0000-0002-6074-7144; bakiri, latifa/0000-0002-6300-2420; Wagner, Erwin F/0000-0001-7872-0196				Adamopoulos IE, 2006, BIOCHEM BIOPH RES CO, V350, P478, DOI 10.1016/j.bbrc.2006.09.076; Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Brandwood CP, 2003, J PATHOL, V201, P504, DOI 10.1002/path.1463; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; Eferl R, 2007, GENESIS, V45, P447, DOI 10.1002/dvg.20311; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Ehrlich LA, 2005, IMMUNOL REV, V208, P252, DOI 10.1111/j.0105-2896.2005.00323.x; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HSU LW, 1994, BIOCHEM J, V302, P103, DOI 10.1042/bj3020103; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawasaki K, 1997, ENDOCRINOLOGY, V138, P4959, DOI 10.1210/en.138.11.4959; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007; WARE CB, 1995, DEVELOPMENT, V121, P1283	34	145	154	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					221	U61		10.1038/nature07019	http://dx.doi.org/10.1038/nature07019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18548006				2022-12-24	WOS:000257466900045
J	Santos, FC; Santos, MD; Pacheco, JM				Santos, Francisco C.; Santos, Marta D.; Pacheco, Jorge M.			Social diversity promotes the emergence of cooperation in public goods games	NATURE			English	Article							EVOLUTIONARY DYNAMICS; INDIRECT RECIPROCITY; NETWORKS; PUNISHMENT; DILEMMAS; GRAPHS	Humans often cooperate in public goods games(1-3) and situations ranging from family issues to global warming(4,5). However, evolutionary game theory predicts(4,6) that the temptation to forgo the public good mostly wins over collective cooperative action, and this is often also seen in economic experiments(7). Here we show how social diversity provides an escape from this apparent paradox. Up to now, individuals have been treated as equivalent in all respects(4,8), in sharp contrast with real- life situations, where diversity is ubiquitous. We introduce social diversity by means of heterogeneous graphs and show that cooperation is promoted by the diversity associated with the number and size of the public goods game in which each individual participates and with the individual contribution to each such game. When social ties follow a scale- free distribution(9), cooperation is enhanced whenever all individuals are expected to contribute a fixed amount irrespective of the plethora of public goods games in which they engage. Our results may help to explain the emergence of cooperation in the absence of mechanisms based on individual reputation and punishment(10-12). Combining social diversity with reputation and punishment will provide instrumental clues on the self- organization of social communities and their economical implications.	[Santos, Marta D.; Pacheco, Jorge M.] Univ Lisbon, CFTC, ATP Grp, P-1649003 Lisbon, Portugal; [Santos, Francisco C.] Univ Libre Brussels, Comp & Decis Engn Dept, IRIDIA, B-1050 Brussels, Belgium; [Santos, Marta D.; Pacheco, Jorge M.] Univ Lisbon, Dept Fis, P-1649003 Lisbon, Portugal	Universidade de Lisboa; Universite Libre de Bruxelles; Universidade de Lisboa	Pacheco, JM (corresponding author), Univ Lisbon, CFTC, ATP Grp, Complexo Interdisciplinar,Av Prof Gama Pinto 2, P-1649003 Lisbon, Portugal.	pacheco@cii.fc.ul.pt	Pacheco, Jorge M/B-6116-2008; Santos, Francisco C./D-2394-2010; Santos, Marta/C-9573-2011; Santos, Francisco C./W-7781-2019; Santos, Marta/N-4772-2015; Pacheco, Jorge M./O-8184-2019	Pacheco, Jorge M/0000-0002-2579-8499; Santos, Francisco C./0000-0002-9103-2862; Santos, Marta/0000-0003-1824-0080; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M./0000-0002-2579-8499				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Binmore K.G., 1994, GAME THEORY SOCIAL C, V1; BOHEM C, 1999, HIERARCHY FOREST EVO; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Dorogotsev SN, 2003, EVOLUTION NETWORKS B; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; HARDIN G, 1968, SCIENCE, V162, P1248; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909	30	936	952	22	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					213	U49		10.1038/nature06940	http://dx.doi.org/10.1038/nature06940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615084				2022-12-24	WOS:000257466900043
J	Nabi, H; Kivimaki, M; De Vogli, R; Marmot, MG; Singh-Manoux, A				Nabi, Hermann; Kivimaki, Mika; De Vogli, Roberto; Marmot, Michael G.; Singh-Manoux, Archana			Positive and negative affect and risk of coronary heart disease: Whitehall II prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL FACTORS; GLOBAL BURDEN; DEPRESSION; ANXIETY; ADULTS; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; PREDICTORS	Objective To examine the associations between positive and negative affect and subsequent coronary heart disease events independently of established risk factors. Design Prospective cohort study with follow-up over 12 years. Setting 20 civil service departments originally located in London. Participants 10308 civil servants aged 35-55 years at entry into Whitehall II study in 1985. Main outcome measures Fatal coronary heart disease, clinically verified incident non-fatal myocardial infarction, and definite angina (n=619, mean follow-up 12.5 years). Results In Cox regression analysis adjusted for age, sex, ethnicity, and socioeconomic position, positive affect (hazard ratio=1.01, 95% confidence interval 0.82 to 1.24) and the balance between positive and negative affect, referred to as the affect balance score (hazard ratio = 0.89, 0.73 to 1.09), were not associated with coronary heart disease. Further adjustment for behaviour related risk factors (smoking, alcohol consumption, daily fruit and vegetable intake, exercise, body mass index), biological risk factors (hypertension, blood cholesterol, diabetes), and psychological stress at work did not change these results. However, participants in the highest third of negative affect had an increased incidence of coronary events (hazard ratio = 1.32, 1.09 to 1.60), and this association remained unchanged after adjustment for multiple confounders. Conclusions Positive affect and affect balance did not seem to be predictive of future coronary heart disease in men and women who were free of diagnosed coronary heart disease at recruitment to the study. A weak positive association between negative affect and coronary heart disease was found and needs to be confirmed in further studies.	[Nabi, Hermann; Kivimaki, Mika; De Vogli, Roberto; Marmot, Michael G.; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Nabi, Hermann; Singh-Manoux, Archana] INSERM, U687, IFR69, F-94807 Villejuif, France; [Singh-Manoux, Archana] Hop St Perrine, Ctr Gerontol, F-75781 Paris, France	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP	Nabi, H (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	H.Nabi@public-health.ucl.ac.uk	Marmot, M G/Y-3920-2019; Kivimaki, Mika/B-3607-2012; Singh-Manoux, Archana/F-6804-2013	Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Singh-Manoux, Archana/0000-0002-1244-5037; Nabi, Hermann/0000-0002-7832-0413	AHRQ HHS [HS06516] Funding Source: Medline; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G8802774, G0100222] Funding Source: Medline; Department of Health Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Blazer DG, 2004, J AM GERIATR SOC, V52, P2052, DOI 10.1111/j.1532-5415.2004.52564.x; Bradburn N.M., 1969, STRUCTURE PSYCHOL WE, DOI DOI 10.1037/T10756-000; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854, DOI 10.1093/oxfordjournals.aje.a116381; French-Belgian Collaborative Group, 1982, ADV CARDIOL, V29, P25; Grippo AJ, 2002, NEUROSCI BIOBEHAV R, V26, P941, DOI 10.1016/S0149-7634(03)00003-4; GUTZWILLER F, 1994, ANN MED, V26, P61, DOI 10.3109/07853899409147329; HAINES AP, 1987, BRIT MED J, V295, P297, DOI 10.1136/bmj.295.6593.297; Hamer DH, 1996, NAT GENET, V14, P125, DOI 10.1038/ng1096-125; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Huppert F, 2004, SCI WELL BEING INTEG; Karasek R, 1990, HLTH WORK STRESS PRO; Kawachi I, 1996, CIRCULATION, V94, P2090, DOI 10.1161/01.CIR.94.9.2090; KOSKENVUO M, 1988, PSYCHOSOM MED, V50, P330, DOI 10.1097/00006842-198807000-00002; Kubzansky LD, 2000, J PSYCHOSOM RES, V48, P323, DOI 10.1016/S0022-3999(99)00091-4; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Paterniti S, 2001, ARTERIOSCL THROM VAS, V21, P136, DOI 10.1161/01.ATV.21.1.136; Polk DE, 2005, PSYCHONEUROENDOCRINO, V30, P261, DOI 10.1016/j.psyneuen.2004.08.004; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Rose G, 1982, CARDIOVASCULAR SURVE; Stewart JC, 2007, ARCH GEN PSYCHIAT, V64, P225, DOI 10.1001/archpsyc.64.2.225; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	34	50	50	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2008	337	7660							a118	10.1136/bmj.a118	http://dx.doi.org/10.1136/bmj.a118			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326DF	18595926	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000257637500031
J	De Cock, KM; De Lay, P				De Cock, Kevin M.; De Lay, Paul			HIV/AIDS estimates and the quest for universal access	LANCET			English	Editorial Material									[De Cock, Kevin M.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [De Lay, Paul] UNAIDS, Dept Evidence Monitoring & Policy, Geneva, Switzerland	World Health Organization; UNAIDS	De Cock, KM (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	DecockK@who.int						[Anonymous], UN ACC SCAL UP PRIOR; *G8 GLEN SUMM, 2005, CHAIRS SUMM GLEN SUM; LAWRENCE J, 2008, INDEPENDENT     0608; *UN GEN ASS, 2008, IMPL DECL COMM HIV A	4	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 21	2008	371	9630					2068	2070		10.1016/S0140-6736(08)60732-1	http://dx.doi.org/10.1016/S0140-6736(08)60732-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	316ER	18571714				2022-12-24	WOS:000256932200010
J	Mitnick, CD; Shin, SS; Seung, KJ; Rich, ML; Atwood, SS; Furin, JJ; Fitzmaurice, GM; Viru, FAA; Appleton, SC; Bayona, JN; Bonilla, CA; Chalco, K; Choi, S; Franke, MF; Fraser, HSF; Guerra, D; Hurtado, RM; Jazayeri, D; Joseph, K; Llaro, K; Mestanza, L; Mukherjee, JS; Munoz, M; Palacios, E; Sanchez, E; Sloutsky, A; Becerra, MC				Mitnick, Carole D.; Shin, Sonya S.; Seung, Kwonjune J.; Rich, Michael L.; Atwood, Sidney S.; Furin, Jennifer J.; Fitzmaurice, Garrett M.; Alcantara Viru, Felix A.; Appleton, Sasha C.; Bayona, Jaime N.; Bonilla, Cesar A.; Chalco, Katiuska; Choi, Sharon; Franke, Molly F.; Fraser, Hamish S. F.; Guerra, Dalia; Hurtado, Rocio M.; Jazayeri, Darius; Joseph, Keith; Llaro, Karim; Mestanza, Lorena; Mukherjee, Joia S.; Munoz, Maribel; Palacios, Eda; Sanchez, Epifanio; Sloutsky, Alexander; Becerra, Mercedes C.			Comprehensive treatment of extensively drug-resistant tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY-BASED TREATMENT; MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; MDR-TB; TREATMENT OUTCOMES; INTERFERON-GAMMA; SOUTH-AFRICA; THERAPY; PERU	Background: Extensively drug-resistant tuberculosis has been reported in 45 countries, including countries with limited resources and a high burden of tuberculosis. We describe the management of extensively drug-resistant tuberculosis and treatment outcomes among patients who were referred for individualized outpatient therapy in Peru. Methods: A total of 810 patients were referred for free individualized therapy, including drug treatment, resective surgery, adverse-event management, and nutritional and psychosocial support. We tested isolates from 651 patients for extensively drug-resistant tuberculosis and developed regimens that included five or more drugs to which the infecting isolate was not resistant. Results: Of the 651 patients tested, 48 (7.4%) had extensively drug-resistant tuberculosis; the remaining 603 patients had multidrug-resistant tuberculosis. The patients with extensively drug-resistant tuberculosis had undergone more treatment than the other patients (mean [+/-SD] number of regimens, 4.2+/-1.9 vs. 3.2+/-1.6; P<0.001) and had isolates that were resistant to more drugs (number of drugs, 8.4+/-1.1 vs. 5.3+/-1.5; P<0.001). None of the patients with extensively drug-resistant tuberculosis were coinfected with the human immunodeficiency virus (HIV). Patients with extensively drug-resistant tuberculosis received daily, supervised therapy with an average of 5.3+/-1.3 drugs, including cycloserine, an injectable drug, and a fluoroquinolone. Twenty-nine of these patients (60.4%) completed treatment or were cured, as compared with 400 patients (66.3%) with multidrug-resistant tuberculosis (P=0.36). Conclusions: Extensively drug-resistant tuberculosis can be cured in HIV-negative patients through outpatient treatment, even in those who have received multiple prior courses of therapy for tuberculosis.	[Mitnick, Carole D.; Fraser, Hamish S. F.; Becerra, Mercedes C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shin, Sonya S.; Atwood, Sidney S.; Furin, Jennifer J.; Fitzmaurice, Garrett M.; Hurtado, Rocio M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Seung, Kwonjune J.; Rich, Michael L.; Choi, Sharon; Jazayeri, Darius; Joseph, Keith; Mukherjee, Joia S.] Partners Hlth, Boston, MA USA; [Appleton, Sasha C.; Franke, Molly F.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sloutsky, Alexander] Massachusetts State Lab Inst, Boston, MA USA; [Alcantara Viru, Felix A.; Bayona, Jaime N.; Chalco, Katiuska; Guerra, Dalia; Llaro, Karim; Mestanza, Lorena; Munoz, Maribel; Palacios, Eda] Socios Salud, Lima, Peru; [Bonilla, Cesar A.] Peruvian Minist Hlth, Lima, Peru; [Sanchez, Epifanio] Hosp Nacl Sergio E Bernales, Lima, Peru	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Mitnick, CD (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022; Mitnick, Carole/GRO-1991-2022; Franke, Molly/AAK-7559-2020; Fraser, Hamish HS/E-3773-2013; Fraser, Hamish/AGP-6129-2022	BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939; Mitnick, Carole/0000-0002-3455-658X; Franke, Molly/0000-0002-4890-5728; Fraser, Hamish/0000-0003-4383-2854; Atwood, Sidney/0000-0001-8865-6300	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI065836] Funding Source: NIH RePORTER; NHLBI NIH HHS [K01 HL080939-02, K01 HL080939-01, K01 HL080939-03, 5 K01 HL080939, K01 HL080939-04, K01 HL080939] Funding Source: Medline; NIAID NIH HHS [K01 AI065836, K01 AI065836-03, K01 AI065836-01A1, K01 AI065836-02] Funding Source: Medline; PHS HHS [5 K01 A1065836] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Chalco K, 2006, INT NURS REV, V53, P253, DOI 10.1111/j.1466-7657.2006.00490.x; Chauhan L S, 2007, J Indian Med Assoc, V105, P196; CHAUHAN LS, 2007, J INDIAN MED ASSOC, V105, P194; CHAUHAN LS, 2007, J INDIAN MED ASSOC, V105, P196; Condos R, 1997, LANCET, V349, P1513, DOI 10.1016/S0140-6736(96)12273-X; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; de Bruyn G, 2003, COCHRANE DB SYST REV, V1; Donald PR, 2001, SCAND J INFECT DIS, V33, P466, DOI 10.1080/00365540152029954; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Farnia P, 2008, J CLIN MICROBIOL, V46, P796, DOI 10.1128/JCM.01435-07; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Hamilton CD, 2007, CLIN INFECT DIS, V45, P338, DOI 10.1086/519292; Iseman MD, 2007, CLIN INFECT DIS, V45, P1415, DOI 10.1086/522988; Janulionis E, 2004, ANTIMICROB AGENTS CH, V48, P3133, DOI 10.1128/AAC.48.8.3133-3135.2004; Jouveshomme S, 1998, AM J RESP CRIT CARE, V157, P1609, DOI 10.1164/ajrccm.157.5.9709047; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Lan NTN, 2001, INT J TUBERC LUNG D, V5, P575; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lee CN, 1996, J CHEMOTHERAPY, V8, P137, DOI 10.1179/joc.1996.8.2.137; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Masjedi MR, 2006, CLIN INFECT DIS, V43, P841, DOI 10.1086/507542; Matrat S, 2006, ANTIMICROB AGENTS CH, V50, P4170, DOI 10.1128/AAC.00944-06; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Ministerio de Salud, 2001, ACT DOCTR NORM PROC; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Mitchison DA, 2004, SEMIN RESP CRIT CARE, V25, P307, DOI 10.1055/s-2004-829503; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; NITTA AT, 1993, CLIN INFECT DIS, V16, P219, DOI 10.1093/clind/16.2.219; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Park SK, 2007, INT J INFECT DIS, V11, P434, DOI 10.1016/j.ijid.2006.12.004; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Partners In Health Harvard Medical School Bill & Melinda Gates Foundation, 2002, DOTS PLUS HDB GUID C; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Rich ML, 2006, INT J TUBERC LUNG D, V10, P290; RICH ML, 2003, PIH GUIDE MED MANAGE; Sato K, 2000, INT J ANTIMICROB AG, V16, P25, DOI 10.1016/S0924-8579(00)00163-1; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961; Spigelman M, 2006, LANCET, V367, P945, DOI 10.1016/S0140-6736(06)68388-8; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; Vega F, 2004, INT J TUBERC LUNG D, V8, P749; Wang JY, 2007, J ANTIMICROB CHEMOTH, V59, P860, DOI 10.1093/jac/dkm061; WHO, 2001, REP M GROUND LARV BL; *WHO IUATLD GLOB P, 2008, WHOHTMTB2008394; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; 2006, MMWR MORB MORTAL WKL, V55, P301; 2006, MMWR MORB MORTAL WKL, V55, P1176	60	274	284	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					563	574		10.1056/NEJMoa0800106	http://dx.doi.org/10.1056/NEJMoa0800106			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687637	Green Accepted, Green Submitted			2022-12-24	WOS:000258216700004
J	Burris, S; Cameron, E				Burris, Scott; Cameron, Edwin			The case against criminalization of HIV transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION PROGRAMS; SEXUAL TRANSMISSION		[Burris, Scott] Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; [Burris, Scott] Johns Hopkins Univ, Ctr Law & Publ Hlth, Philadelphia, PA USA; [Burris, Scott] Georgetown Univ, Ctr Law & Publ Hlth, Philadelphia, PA USA; [Cameron, Edwin] Supreme Court Appeal S Africa, Bloemfontein, South Africa	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Georgetown University	Burris, S (corresponding author), Temple Univ, Beasley Sch Law, 1719 N Broad St, Philadelphia, PA 19122 USA.	scott.burris@temple.edu		Burris, Scott/0000-0002-6013-5842				*AWARE HIV AIDS, 2004, REG WORKSH AD MOD LA; Burris S., 2007, ARIZONA STATE LAW J, V2007, P1; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Dodds C, 2006, INT J STD AIDS, V17, P315, DOI 10.1258/095646206776790114; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; HOLTGRAVE DR, 1995, PUBLIC HEALTH REP, V110, P134; KOVACH G, 2008, NY TIMES        0516; Lazzarini Z, 2002, J LAW MED ETHICS, V30, P239, DOI 10.1111/j.1748-720X.2002.tb00390.x; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Weait M, 2007, INTIMACY RESPONSIBIL, DOI [10.4324/9780203937938, DOI 10.4324/9780203937938]; WOLF LE, 2004, WHITTIER LAW REV, V25, P821; Worth H., 2005, SEX RES SOC POLICY, V2, P22, DOI [10.1525/srsp.2005.2.2.15, DOI 10.1525/SRSP.2005.2.2.15]	13	74	74	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					578	581		10.1001/jama.300.5.578	http://dx.doi.org/10.1001/jama.300.5.578			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677032				2022-12-24	WOS:000258188900021
J	Manning, KD				Manning, Kimberly D.			A person of status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kdmanni@emory.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					483	484		10.1001/jama.300.5.483	http://dx.doi.org/10.1001/jama.300.5.483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677015				2022-12-24	WOS:000258188900001
J	Verheyden, JM; Sun, X				Verheyden, Jamie M.; Sun, Xin			An Fgf/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth	NATURE			English	Article							CONDITIONAL KNOCKOUT MICE; APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; FGF; GREMLIN; ANTAGONISM; EXPRESSION; SIZE; INACTIVATION; GENERATION	During organ formation and regeneration a proper balance between promoting and restricting growth is critical to achieve stereotypical size. Limb bud outgrowth is driven by signals in a positive feedback loop involving fibroblast growth factor ( Fgf) genes, sonic hedgehog ( Shh) and Gremlin1 ( Grem1)(1). Precise termination of these signals is essential to restrict limb bud size(2-4). The current model predicts a sequence of signal termination consistent with that in chick limb buds(4). Our finding that the sequence in mouse limb buds is different led us to explore alternative mechanisms. Here we show, by analysing compound mouse mutants defective in genes comprising the positive loop, genetic evidence that FGF signalling can repress Grem1 expression, revealing a novel Fgf/Grem1 inhibitory loop. This repression occurs both in mouse and chick limb buds, and is dependent on high FGF activity. These data support a mechanism where the positive Fgf/ Shh loop drives outgrowth and an increase in FGF signalling, which triggers the Fgf/ Grem1 inhibitory loop. The inhibitory loop then operates to terminate outgrowth signals in the order observed in either mouse or chick limb buds. Our study unveils the concept of a self- promoting and self- terminating circuit that may be used to attain proper tissue size in a broad spectrum of developmental and regenerative settings.	[Verheyden, Jamie M.; Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sun, X (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	xsun@wisc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD045522-01A1, R01 HD045522-05, R01 HD045522-02, R01 HD045522, R01 HD045522-04, R01 HD045522-05S1, R01 HD045522-03] Funding Source: Medline; NIGMS NIH HHS [T32 GM007133, 5T32GM07133, T32 GM007133-25, T32 GM007133-26, T32 GM007133-27, T32 GM007133-24] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Day SJ, 2000, DEVELOPMENT, V127, P2977; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Garcia-Bellido AC, 1998, INT J DEV BIOL, V42, P353; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172; Merino R, 1999, DEVELOPMENT, V126, P5515; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Niswander L, 2002, INT J DEV BIOL, V46, P877; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Pizette S, 1999, DEVELOPMENT, V126, P883; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	32	133	137	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					638	U45		10.1038/nature07085	http://dx.doi.org/10.1038/nature07085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18594511	Green Accepted			2022-12-24	WOS:000258026500047
J	Saito, T; Owen, DM; Jiang, FG; Marcotrigiano, J; Gale, M				Saito, Takeshi; Owen, David M.; Jiang, Fuguo; Marcotrigiano, Joseph; Gale, Michael, Jr.			Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA	NATURE			English	Article							ANTIVIRAL RESPONSES; GENE-EXPRESSION; REPLICATION; TRANSLATION; ACTIVATION; INFECTION; RIBOSOME; HELICASE; ELEMENTS; PROTEIN	Innate immune defences are essential for the control of virus infection and are triggered through host recognition of viral macromolecular motifs known as pathogen-associated molecular patterns (PAMPs)(1). Hepatitis C virus (HCV) is an RNA virus that replicates in the liver, and infects 200 million people worldwide(2). Infection is regulated by hepatic immune defences triggered by the cellular RIG-I helicase. RIG-I binds PAMP RNA and signals interferon regulatory factor 3 activation to induce the expression of interferon-alpha/beta and antiviral/interferon-stimulated genes (ISGs) that limit infection(3-10). Here we identify the polyuridine motif of the HCV genome 3 ' non-translated region and its replication intermediate as the PAMP substrate of RIG-I, and show that this and similar homopolyuridine or homopolyriboadenine motifs present in the genomes of RNA viruses are the chief feature of RIG-I recognition and immune triggering in human and murine cells(8). 5 ' terminal triphosphate on the PAMP RNA was necessary but not sufficient for RIG-I binding, which was primarily dependent on homopolymeric ribonucleotide composition, linear structure and length. The HCV PAMP RNA stimulated RIG-I-dependent signalling to induce a hepatic innate immune response in vivo, and triggered interferon and ISG expression to suppress HCV infection in vitro. These results provide a conceptual advance by defining specific homopolymeric RNA motifs within the genome of HCV and other RNA viruses as the PAMP substrate of RIG-I, and demonstrate immunogenic features of the PAMP-RIG-I interaction that could be used as an immune adjuvant for vaccine and immunotherapy approaches.	[Saito, Takeshi; Owen, David M.; Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Owen, David M.] Univ Texas Dallas, SW Med Ctr, Dept Microbiol, Dallas, TX 75235 USA; [Jiang, Fuguo; Marcotrigiano, Joseph] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Rutgers State University New Brunswick	Gale, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	mgale@u.washington.edu	Saito, Takeshi/N-2788-2014; Marcotrigiano, Joseph/K-6697-2016; JIANG, FUGUO/G-6581-2012	Saito, Takeshi/0000-0002-6165-664X; Marcotrigiano, Joseph/0000-0003-0346-3353; JIANG, FUGUO/0000-0003-4469-1803; Gale, Michael/0000-0002-6332-7436; Owen, David/0000-0002-5724-0342	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060389, R56AI060389, U19AI040035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024563] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060389-01, R01 AI060389-05, R01 AI060389-07, R01 AI060389-06, R01 AI060389-02, R01AI060389, U19 AI040035-100004, U19 AI040035-110004, U19 AI040035-140004, R01 AI060389-08, U19 AI040035-130004, U19 AI040035, R56 AI060389, N01AI40035, R01 AI060389-04, R01 AI060389-03, U19 AI040035-120004, R01 AI060389, U19AI40035, R01 AI060389-09] Funding Source: Medline; NIDA NIH HHS [R01DA021353, R01 DA024563, R01 DA024563-02, R01 DA024563-03, R01 DA024563-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Beard MR, 1999, HEPATOLOGY, V30, P316, DOI 10.1002/hep.510300137; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda M, 1996, VIROLOGY, V222, P31, DOI 10.1006/viro.1996.0395; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ito T, 1999, VIROLOGY, V254, P288, DOI 10.1006/viro.1998.9541; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2007, J INTERF CYTOK RES, V27, P697; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith MW, 2006, GASTROENTEROLOGY, V130, P179, DOI 10.1053/j.gastro.2005.08.015; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tse K, 2007, ANN RHEUM DIS, V66, P77, DOI 10.1136/ard.2007.078998; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You S, 2008, J VIROL, V82, P184, DOI 10.1128/JVI.01796-07; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	551	585	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					523	527		10.1038/nature07106	http://dx.doi.org/10.1038/nature07106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18548002	Green Accepted			2022-12-24	WOS:000257860300053
J	Holt, LJ; Krutchinsky, AN; Morgan, DO				Holt, Liam J.; Krutchinsky, Andrew N.; Morgan, David O.			Positive feedback sharpens the anaphase switch	NATURE			English	Article							MITOTIC EXIT; PHOSPHATASE CDC14; BUDDING YEAST; DNA-DAMAGE; PHOSPHORYLATION; SEPARASE; MITOSIS; APC; DESTRUCTION; DYNAMICS	At the onset of anaphase, sister- chromatid cohesion is dissolved abruptly and irreversibly, ensuring that all chromosome pairs disjoin almost simultaneously. The regulatory mechanisms that generate this switch- like behaviour are unclear. Anaphase is initiated when a ubiquitin ligase, the anaphase- promoting complex ( APC), triggers the destruction of securin, thereby allowing separase, a protease, to disrupt sister- chromatid cohesion(1-4). Here we demonstrate that the cyclin- dependent kinase 1 ( Cdk1)- dependent phosphorylation of securin near its destruction- box motif inhibits securin ubiquitination by the APC. The phosphatase Cdc14 reverses securin phosphorylation, thereby increasing the rate of securin ubiquitination. Because separase is known to activate Cdc14 ( refs 5 and 6), our results support the existence of a positive feedback loop that increases the abruptness of anaphase. Consistent with this model, we show that mutations that disrupt securin phosphoregulation decrease the synchrony of chromosome segregation. Our results also suggest that coupling securin degradation with changes in Cdk1 and Cdc14 activities helps coordinate the initiation of sister- chromatid separation with changes in spindle dynamics.	[Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94158 USA; [Krutchinsky, Andrew N.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.morgan@ucsf.edu		Holt, Liam/0000-0002-4002-0861; Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [R01 GM069901, R01 GM069901-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal R, 2003, J BIOL CHEM, V278, P45027, DOI 10.1074/jbc.M306783200; Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Blethrow JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000358; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VIG BK, 1983, CANCER GENET CYTOGEN, V8, P249, DOI 10.1016/0165-4608(83)90142-5; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; WAN J, 1992, J BIOL CHEM, V267, P11274; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523	30	148	150	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					353	357		10.1038/nature07050	http://dx.doi.org/10.1038/nature07050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18552837	Green Accepted			2022-12-24	WOS:000257665300043
J	Morrow, EM; Yoo, SY; Flavell, SW; Kim, TK; Lin, YX; Hill, RS; Mukaddes, NM; Balkhy, S; Gascon, G; Hashmi, A; Al-Saad, S; Ware, J; Joseph, RM; Greenblatt, R; Gleason, D; Ertelt, JA; Apse, KA; Bodell, A; Partlow, JN; Barry, B; Yao, H; Markianos, K; Ferland, RJ; Greenberg, ME; Walsh, CA				Morrow, Eric M.; Yoo, Seung-Yun; Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Hill, Robert Sean; Mukaddes, Nahit M.; Balkhy, Soher; Gascon, Generoso; Hashmi, Asif; Al-Saad, Samira; Ware, Janice; Joseph, Robert M.; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Yao, Hui; Markianos, Kyriacos; Ferland, Russell J.; Greenberg, Michael E.; Walsh, Christopher A.			Identifying autism loci and genes by tracing recent shared ancestry	SCIENCE			English	Article							TRANSCRIPTION FACTORS; MUTATIONS; DISORDERS; LINKAGE; PROTEIN; MEMBER; ASSOCIATION; SUPERFAMILY; INHERITANCE; PLASTICITY	To find inherited causes of autism- spectrum disorders, we studied families in which parents share ancestors, enhancing the role of inherited factors. We mapped several loci, some containing large, inherited, homozygous deletions that are likely mutations. The largest deletions implicated genes, including PCDH10 ( protocadherin 10) and DIA1 ( deleted in autism1, or c3orf58), whose level of expression changes in response to neuronal activity, a marker of genes involved in synaptic changes that underlie learning. A subset of genes, including NHE9 (Na+/H+ exchanger 9), showed additional potential mutations in patients with unrelated parents. Our findings highlight the utility of "homozygosity mapping" in heterogeneous disorders like autism but also suggest that defective regulation of gene expression after neural activity may be a mechanism common to seemingly diverse autism mutations.	[Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Yao, Hui; Markianos, Kyriacos; Walsh, Christopher A.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Yao, Hui; Markianos, Kyriacos; Walsh, Christopher A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Greenblatt, Rachel; Gleason, Danielle; Ertelt, Julia A.; Apse, Kira A.; Bodell, Adria; Partlow, Jennifer N.; Barry, Brenda; Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; [Morrow, Eric M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Walsh, Christopher A.] MIT, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Hill, Robert Sean; Walsh, Christopher A.] Harvard Univ, Cambridge, MA 02142 USA; [Morrow, Eric M.; Yoo, Seung-Yun; Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Hill, Robert Sean; Ware, Janice; Joseph, Robert M.; Apse, Kira A.; Greenberg, Michael E.; Walsh, Christopher A.] Autism Consortium, Boston, MA 02115 USA; [Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Greenberg, Michael E.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Flavell, Steven W.; Kim, Tae-Kyung; Lin, Yingxi; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mukaddes, Nahit M.] Istanbul Univ, Istanbul Fac Med, Dept Child Psychiat, Istanbul, Turkey; [Balkhy, Soher; Gascon, Generoso] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci & Pediat, Jeddah, Saudi Arabia; [Gascon, Generoso] Brown Univ, Sch Med, Providence, RI 02912 USA; [Hashmi, Asif] Combined Mil Hosp, Dept Neurol, Lahore, Pakistan; [Al-Saad, Samira] Kuwait Ctr Autism, Kuwait, Kuwait; [Ware, Janice] Childrens Hosp, Dev Med Ctr, Boston, MA 02115 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Ferland, Russell J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Istanbul University; King Faisal Specialist Hospital & Research Center; Brown University; Harvard University; Boston Children's Hospital; Boston University; Rensselaer Polytechnic Institute	Walsh, CA (corresponding author), Childrens Hosp, Div Genet, 300 Longwood Ave, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Warfield, Simon/B-3352-2009; Morrow, Eric/J-2767-2013; Ferland, Russell/E-3500-2010; Kim, Tae-Kyung/AAX-4230-2020; Ferland, Russell/Q-6793-2019; Yao, Huiqin/AAX-3787-2020	Warfield, Simon/0000-0002-7659-3880; Morrow, Eric/0000-0003-3430-3520; Kim, Tae-Kyung/0000-0001-5161-9864; Ferland, Russell/0000-0002-8044-2479; Yao, Huiqin/0000-0003-4742-8971; /0000-0002-7002-1275; Markianos, Kyriacos/0000-0003-0214-6014; Walsh, Christopher/0000-0002-0156-2238; Joseph, Robert/0000-0001-6879-0254; Flavell, Steven/0000-0001-9464-1877	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, K23MH080954, R01MH083565, K01MH071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [N01-HG-65403] Funding Source: Medline; NICHD NIH HHS [5P30HD018655-26] Funding Source: Medline; NIMH NIH HHS [K01 MH071801-04, R01 MH083565, MH64547, K01 MH071801-05, K23 MH080954, K01 MH071801, 1K23MH080954-01, K23 MH080954-01, 1R01 MH083565, 1K01MH71801] Funding Source: Medline; NINDS NIH HHS [R01 NS048276, R01 NS048276-05, R01 NS048276-02, R01 NS048276-04, 5R01NS048276-05, R01 NS048276-03, R01 NS048276-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Hamamy HA, 2007, SAUDI MED J, V28, P1015; Hoodfar E, 1996, J MED GENET, V33, P212, DOI 10.1136/jmg.33.3.212; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LI C, 2001, GENOME BIOL, V2, P8; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Palferman S, 2001, AM J HUM GENET, V69, P570; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P187; Rudan I, 2006, NAT GENET, V38, P1224, DOI 10.1038/ng1106-1224; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; SMITH CAB, 1953, J R STAT SOC B, V15, P153; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takano Y, 2004, J BIOL CHEM, V279, P18926, DOI 10.1074/jbc.M309148200; Takatalo MS, 2006, PROTEOMICS, V6, P3502, DOI 10.1002/pmic.200500516; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; YOSHIHARA Y, 1994, NEURON, V13, P415, DOI 10.1016/0896-6273(94)90357-3	43	537	560	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					218	223		10.1126/science.1157657	http://dx.doi.org/10.1126/science.1157657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621663	Green Accepted			2022-12-24	WOS:000257512900031
J	Sobngwi, E; Choukem, SP; Agbalika, F; Blondeau, B; Fetita, LS; Lebbe, C; Thiam, D; Cattan, P; Larghero, J; Foufelle, F; Ferre, P; Vexiau, P; Calvo, F; Gautier, JF				Sobngwi, Eugene; Choukem, Simeon Pierre; Agbalika, Felix; Blondeau, Bertrand; Fetita, Lila-Sabrina; Lebbe, Celeste; Thiam, Doudou; Cattan, Pierre; Larghero, Jerome; Foufelle, Fabienne; Ferre, Pascal; Vexiau, Patrick; Calvo, Fabien; Gautier, Jean-Francois			Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-Saharan Africans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; VIRUS-INFECTION; GENITAL HERPES; ONSET; KETOACIDOSIS; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; ANTIBODIES	Context An atypical form of type 2 diabetes mellitus (DM-2) is revealed by ketosis (ketosis-prone type 2 diabetes mellitus), frequently occurring in individuals who are black and of African origin, and characterized by an acute onset requiring transient insulin therapy. Its sudden onset suggests precipitating factors. Objective To investigate the putative role of human herpesvirus 8 (HHV-8) in the pathogenesis of ketosis-prone DM-2. Design, Setting, and Participants A cross-sectional study in which antibodies were searched against latent and lytic HHV-8 antigens using immunofluorescence. The presence of HHV-8 in genomic DNA was investigated in 22 of the participants at clinical onset of diabetes. We also tested whether HHV-8 was able to infect human pancreatic beta cells in culture in vitro. The study was conducted at Saint-Louis University Hospital, Paris, France, from January 2004 to July 2005. All participants were black and of African origin: 187 were consecutive diabetic patients of whom 81 had ketosis-prone DM-2 and 106 had nonketotic DM-2, and 90 individuals were nondiabetic control participants who were matched for age and sex. Main Outcome Measures Seroprevalence of HHV-8 and percentage of patients with HHV-8 viremia at onset in ketosis-prone DM-2. Results HHV-8 antibodies were found in 71 patients (87.7%) with ketosis-prone DM-2 vs 16 patients (15.1%) with nonketotic DM-2 (odds ratio, 39.9; 95% confidence interval, 17.1-93.4; P < .001) and 36 of the control participants (40.0%) (odds ratio, 10.7; 95% confidence interval, 4.9-23.4; P < .001). HHV-8 in genomic DNA was present in 6 of 13 patients with ketosis-prone DM-2 tested at acute onset and in 0 of 9 patients with nonketotic DM-2. HHV-8 proteins were present in human islet cells that were cultured for 4 days in the presence of HHV-8. Conclusions In this preliminary cross-sectional study, the presence of HHV-8 antibodies was associated with ketosis-prone DM-2 in patients of sub-Saharan African origin. Longitudinal studies are required to understand the clinical significance of these findings.	[Sobngwi, Eugene; Choukem, Simeon Pierre; Agbalika, Felix; Vexiau, Patrick; Gautier, Jean-Francois] Hop St Louis, Dept Endocrinol & Diabet, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Agbalika, Felix] Hop St Louis, Dept Virol, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Lebbe, Celeste] Hop St Louis, Dept Dermatol, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Cattan, Pierre; Larghero, Jerome] Hop St Louis, Cell Therapy Unit, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Cattan, Pierre] Hop St Louis, Dept Gen Surg, Assistance Publ Hop Paris, F-75475 Paris 10, France; [Calvo, Fabien; Gautier, Jean-Francois] Hop St Louis, INSERM, Assistance Publ Hop Paris, CIC9504, F-75475 Paris 10, France; [Agbalika, Felix; Lebbe, Celeste; Cattan, Pierre; Larghero, Jerome; Vexiau, Patrick; Calvo, Fabien; Gautier, Jean-Francois] Univ Paris 07, Paris, France; [Blondeau, Bertrand; Foufelle, Fabienne; Ferre, Pascal; Gautier, Jean-Francois] Univ Paris 06, INSERM, Ctr Rech Cordeliers, UMRS 872, F-75252 Paris 05, France; [Sobngwi, Eugene] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thiam, Doudou] Univ Cheikh Anta Diop Dakar, Inst Hematol, Dakar, Senegal	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Newcastle University - UK; University Cheikh Anta Diop Dakar	Gautier, JF (corresponding author), Hop St Louis, Dept Endocrinol & Diabet, Assistance Publ Hop Paris, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	jean-francois.gautier@sls.aphp.fr	Ferré, Pascal/K-1250-2013	Ferré, Pascal/0000-0003-0115-7045; FOUFELLE, Fabienne/0000-0002-0752-622X; calvo, fabien/0000-0002-0298-7633; Blondeau, Bertrand/0000-0002-1106-1509				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; BANERJI MA, 1990, MEDICINE, V69, P176, DOI 10.1097/00005792-199005000-00005; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Chiou CC, 2006, J AM ACAD DERMATOL, V54, pS14, DOI 10.1016/j.jaad.2005.03.057; Crispo A, 2001, INT J MOL MED, V7, P535; DeOcampo A, 1999, CLIN PEDIATR, V38, P661, DOI 10.1177/000992289903801105; Goudsmit J, 2000, P NATL ACAD SCI USA, V97, P4838, DOI 10.1073/pnas.97.9.4838; Imagawa A, 2005, DIABETOLOGIA, V48, P290, DOI 10.1007/s00125-004-1624-z; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; Jarviluoma A, 2006, BBA-REV CANCER, V1766, P140, DOI 10.1016/j.bbcan.2006.05.001; Kitabchi AE, 2003, J CLIN ENDOCR METAB, V88, P5087, DOI 10.1210/jc.2003-031656; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; LEBBE C, 1995, LANCET, V345, P1180, DOI 10.1016/S0140-6736(95)91011-5; Lecube A, 2006, DIABETES CARE, V29, P1140, DOI 10.2337/dc05-1995; Lisco A, 2006, J CLIN MICROBIOL, V44, P3863, DOI 10.1128/JCM.00791-06; LOPES EPA, 1994, LANCET, V343, P244, DOI 10.1016/S0140-6736(94)91035-9; Maldonado MR, 2004, ETHNIC DIS, V14, P243; Mauvais-Jarvis F, 2003, DIABETOLOGIA, V46, P728, DOI 10.1007/s00125-003-1093-9; Mauvais-Jarvis F, 2004, HUM MOL GENET, V13, P3151, DOI 10.1093/hmg/ddh341; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; Min J, 1999, AIDS RES HUM RETROV, V15, P51, DOI 10.1089/088922299311709; Narita R, 2004, J HEPATOL, V41, P132, DOI 10.1016/j.jhep.2004.03.020; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Pellet C, 2002, J INFECT DIS, V186, P110, DOI 10.1086/341088; Platt G, 2002, ONCOGENE, V21, P1823, DOI 10.1038/sj.onc.1205360; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Schulz TF, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.suppl_4.15; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; Sobngwi E, 2005, J CLIN ENDOCR METAB, V90, P4446, DOI 10.1210/jc.2004-2545; Sobngwi E, 2002, DIABETIC MED, V19, P832, DOI 10.1046/j.1464-5491.2002.00802.x; Sobngwi E, 2002, DIABETES METAB, V28, P5; Sobngwi E, 2002, DIABETOLOGIA, V45, P283, DOI 10.1007/s00125-001-0739-8; Sun YH, 2005, DIABETES CARE, V28, P435, DOI 10.2337/diacare.28.2.435; TESFAYE S, 1991, DIABETES RES CLIN PR, V13, P83, DOI 10.1016/0168-8227(91)90037-E; Umpaichitra V, 2001, J CLIN ENDOCR METAB, V86, P1605, DOI 10.1210/jc.86.4.1605; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; UMPIERREZ GE, 1995, DIABETES, V44, P790, DOI 10.2337/diabetes.44.7.790; Umpierrez GE, 1999, DIABETES CARE, V22, P1517, DOI 10.2337/diacare.22.9.1517; Weissmann A, 2000, J EUR ACAD DERMATOL, V14, P91, DOI 10.1046/j.1468-3083.2000.00022.x; WINTER WE, 1987, NEW ENGL J MED, V316, P285, DOI 10.1056/NEJM198702053160601	41	67	68	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2770	2776		10.1001/jama.299.23.2770	http://dx.doi.org/10.1001/jama.299.23.2770			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560004	Bronze			2022-12-24	WOS:000256805200025
J	Jones, AM; Chory, J; Dangl, JL; Estelle, M; Jacobsen, SE; Meyerowitz, EM; Nordborg, M; Weigel, D				Jones, Alan M.; Chory, Joanne; Dangl, Jeffery L.; Estelle, Mark; Jacobsen, Steven E.; Meyerowitz, Elliot M.; Nordborg, Magnus; Weigel, Detlef			The impact of Arabidopsis on human health: Diversifying our portfolio	CELL			English	Article							BLUE-LIGHT PHOTORECEPTOR; UBIQUITIN LIGASE; COP9 SIGNALOSOME; PROTEIN; PLANT; THALIANA; DISEASE; GENE; RNA; METHYLATION	Studies of the model plant Arabidopsis thaliana may seem to have little impact on advances in medical research, yet a survey of the scientific literature shows that this is a misconception. Many discoveries with direct relevance to human health and disease have been elaborated using Arabidopsis, and several processes important to human biology are more easily studied in this versatile model plant.	[Jones, Alan M.; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Estelle, Mark] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Meyerowitz, Elliot M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Nordborg, Magnus] Univ So Calif, Los Angeles, CA 90089 USA; [Weigel, Detlef] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Indiana University System; Indiana University Bloomington; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology; University of Southern California; Max Planck Society	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Weigel, Detlef/C-1418-2008; Estelle, Mark/ABD-6742-2021; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Meyerowitz, Elliot M/A-7118-2009	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM052413-16, R01 GM052413] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; CHANG C, 1992, PLANT CELL, V4, P1263, DOI 10.1105/tpc.4.10.1263; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; CHORY J, 1989, CELL, V58, P991, DOI 10.1016/0092-8674(89)90950-1; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; CORRELA JD, 2007, P NATL ACAD SCI USA, V107, P6764; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kepinski S, 2007, BIOESSAYS, V29, P953, DOI 10.1002/bies.20657; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim HJ, 2007, CELL DEATH DIFFER, V14, P103, DOI 10.1038/sj.cdd.4401935; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Parry G, 2006, CURR OPIN CELL BIOL, V18, P152, DOI 10.1016/j.ceb.2006.02.001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Schwartz Peter J., 2005, V266, P186; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Wang WH, 2004, CURR OPIN NEPHROL HY, V13, P549, DOI 10.1097/00041552-200409000-00011; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	40	77	79	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					939	943		10.1016/j.cell.2008.05.040	http://dx.doi.org/10.1016/j.cell.2008.05.040			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555767	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000256693400006
J	Qi, HH; Ongusaha, PP; Myllyharju, J; Cheng, DM; Pakkanen, O; Shi, YJ; Lee, SW; Peng, JM; Shi, Y				Qi, Hank H.; Ongusaha, Pat P.; Myllyharju, Johanna; Cheng, Dongmei; Pakkanen, Outi; Shi, Yujiang; Lee, Sam W.; Peng, Junmin; Shi, Yang			Prolyl 4-hydroxylation regulates Argonaute 2 stability	NATURE			English	Article							MICRORNA-DEPENDENT LOCALIZATION; P-BODIES; PROTEIN; EXPRESSION; COLLAGEN; HYDROXYLASES; PROCOLLAGEN; DOMAIN; RISC; FORM	Human Argonaute ( Ago) proteins are essential components of the RNA- induced silencing complexes ( RISCs). Argonaute 2 ( Ago2) has a P-element- induced wimpy testis ( PIWI) domain, which folds like RNase H and is responsible for target RNA cleavage in RNA interference(1). Proteins such as Dicer, TRBP, MOV10, RHA, RCK/p54 and KIAA1093 associate with Ago proteins and participate in small RNA processing, RISC loading and localization of Ago proteins in the cytoplasmic messenger RNA processing bodies(1,2). However, mechanisms that regulate RNA interference remain obscure. Here we report physical interactions between Ago2 and the alpha-(P4H-alpha(I)) and beta-(P4H-beta) subunits of the type I collagen prolyl- 4- hydroxylase (C-P4H( I)). Mass spectrometric analysis identified hydroxylation of the endogenous Ago2 at proline 700. In vitro, both Ago2 and Ago4 seem to be more efficiently hydroxylated than Ago1 and Ago3 by recombinant human C-P4H( I). Importantly, human cells depleted of P4H-alpha(I) or P4H-beta by short hairpin RNA and P4H-alpha(I) null mouse embryonic fibroblast cells showed reduced stability of Ago2 and impaired short interfering RNA programmed RISC activity. Furthermore, mutation of proline 700 to alanine also resulted in destabilization of Ago2, thus linking Ago2 P700 and hydroxylation at this residue to its stability regulation. These findings identify hydroxylation as a post- translational modification important for Ago2 stability and effective RNA interference.	[Qi, Hank H.; Ongusaha, Pat P.; Shi, Yujiang; Lee, Sam W.; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ongusaha, Pat P.; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Myllyharju, Johanna; Pakkanen, Outi] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; [Myllyharju, Johanna; Pakkanen, Outi] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Cheng, Dongmei; Peng, Junmin] Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Sch Med, Atlanta, GA 30322 USA; [Shi, Yujiang] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA; [Shi, Yujiang] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, BCMP, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Oulu; University of Oulu; Emory University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, New Res Bldg 854,77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Hu, Ruogu/B-2203-2008; Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Qi, Hank/0000-0002-3401-4940	Canadian Institute of Health Research; Health Science Council of the Academy of Finland [202469]; S. Juselius foundation; National Institutes of Health [AG025688, GM53874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Health Science Council of the Academy of Finland(Academy of Finland); S. Juselius foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. C. Mello, A. Grishok and P. A. Sharp for reading this manuscript and discussion. We thank E. Lehtimaki and R. Juntunen for in vitro hydroxylation assays, J. Lykke-Andersen and N. Kedersha for polyclonal anti-Dcp1a antibody and anti-Tia1 antibody, and the personnel of the Biocenter Oulu Transgenic Animal Core Facility and the University of Oulu Laboratory Animal Centre for technical assistance. We also thank the Kazusa DNA Research Institute (Japan) for providing the KIAA clones with numbers 1567, 1093, 1582 and 1460 and N. R. Wall for pOZ-FH-Ago1 plasmid. H. H. Q. was supported by a Canadian Institute of Health Research postdoctoral fellowship. This work was supported by grants from the Health Science Council of the Academy of Finland (202469) and the S. Juselius foundation to J. M. and National Institutes of Health grants to J. P. (AG025688) and Y.S. (GM53874).	BERG RA, 1982, METHOD ENZYMOL, V82, P372; Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Rocnik EF, 1998, J CLIN INVEST, V101, P1889, DOI 10.1172/JCI1025; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467	26	167	173	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					421	U78		10.1038/nature07186	http://dx.doi.org/10.1038/nature07186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18690212	Green Accepted			2022-12-24	WOS:000259265200051
J	Canfield, DE; Poulton, SW; Knoll, AH; Narbonne, GM; Ross, G; Goldberg, T; Strauss, H				Canfield, Donald E.; Poulton, Simon W.; Knoll, Andrew H.; Narbonne, Guy M.; Ross, Gerry; Goldberg, Tatiana; Strauss, Harald			Ferruginous conditions dominated later neoproterozoic deep-water chemistry	SCIENCE			English	Article							GRAND-CANYON; CHUAR GROUP; OXYGENATION; EVOLUTION; IRON; SULFATE; SULFUR; ANOXIA; RECORD; CYCLE	Earth's surface chemical environment has evolved from an early anoxic condition to the oxic state we have today. Transitional between an earlier Proterozoic world with widespread deep- water anoxia and a Phanerozoic world with large oxygen- utilizing animals, the Neoproterozoic Era [ 1000 to 542 million years ago ( Ma)] plays a key role in this history. The details of Neoproterozoic Earth surface oxygenation, however, remain unclear. We report that through much of the later Neoproterozoic (< 742 +/- 6 Ma), anoxia remained widespread beneath the mixed layer of the oceans; deeper water masses were sometimes sulfidic but were mainly Fe2+- enriched. These ferruginous conditions marked a return to ocean chemistry not seen for more than one billion years of Earth history.	[Canfield, Donald E.] Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark; [Canfield, Donald E.] Univ So Denmark, Inst Biol, DK-5230 Odense, Denmark; [Poulton, Simon W.; Goldberg, Tatiana] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Knoll, Andrew H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Narbonne, Guy M.] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada; [Ross, Gerry] Kupaa Farm, Kula, HI 96790 USA; [Strauss, Harald] Univ Munster, Inst Geol Palaontol, D-48149 Munster, Germany	University of Southern Denmark; University of Southern Denmark; Newcastle University - UK; Harvard University; Queens University - Canada; University of Munster	Canfield, DE (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, Campusvej 55, DK-5230 Odense, Denmark.	dec@biology.sdu.dk	Canfield, Don/C-1735-2012; Narbonne, Guy M/I-7518-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X; Goldberg, Tatiana/0000-0001-6919-9976	Natural Environment Research Council [NE/C518465/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Dehler CM, 2001, SEDIMENT GEOL, V141, P465, DOI 10.1016/S0037-0738(01)00087-2; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Goldberg T, 2007, PALAEOGEOGR PALAEOCL, V254, P175, DOI 10.1016/j.palaeo.2007.03.015; GREEN JW, 1989, GEOL MAG, V126, P567, DOI 10.1017/S0016756800022858; Hoffman PF, 2005, S AFR J GEOL, V108, P557, DOI 10.2113/108.4.557; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOLLAND HD, 1982, CHEM EVOLUTION ATMOS; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Karlstrom KE, 2000, GEOLOGY, V28, P619, DOI 10.1130/0091-7613(2000)028<0619:CGOTGC>2.3.CO;2; Kimura H, 2001, GEOLOGY, V29, P995, DOI 10.1130/0091-7613(2001)029<0995:OAATPC>2.0.CO;2; KIRSCHVINK JL, 1991, AAPG BULL, V75, P610; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Lehmann B, 2007, GEOLOGY, V35, P403, DOI 10.1130/G23543A.1; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; OEHLER DZ, 1979, SCIENCE, V205, P388, DOI 10.1126/science.205.4404.388; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Schroder S, 2007, J GEOL SOC LONDON, V164, P175, DOI 10.1144/0016-76492005-022; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2	32	532	581	5	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2008	321	5891					949	952		10.1126/science.1154499	http://dx.doi.org/10.1126/science.1154499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18635761	Bronze			2022-12-24	WOS:000258436700035
J	Grant, RM; Hamer, D; Hope, T; Johnston, R; Lange, J; Lederman, MM; Lieberman, J; Miller, CJ; Moore, JP; Mosier, DE; Richman, DD; Schooley, RT; Springer, MS; Veazey, RS; Wainberg, MA				Grant, Robert M.; Hamer, Dean; Hope, Thomas; Johnston, Rowena; Lange, Joep; Lederman, Michael M.; Lieberman, Judy; Miller, Christopher J.; Moore, John P.; Mosier, Donald E.; Richman, Douglas D.; Schooley, Robert T.; Springer, Marty S.; Veazey, Ronald S.; Wainberg, Mark A.			Perspective - Whither or wither microbicides?	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; VAGINAL MICROBICIDE; DRUG-RESISTANCE; NONOXYNOL-9; HIV; STRATEGIES		[Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94518 USA; [Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94518 USA; [Hamer, Dean] NCI, NIH, Bethesda, MD 20817 USA; [Hope, Thomas] Northwestern Univ, Chicago, IL 60611 USA; [Johnston, Rowena] Fdn AIDS Res amfAR, New York, NY 10005 USA; [Lange, Joep] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lederman, Michael M.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA; [Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Mosier, Donald E.] Scripps Res Inst, La Jolla, CA 92037 USA; [Richman, Douglas D.] San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Richman, Douglas D.; Schooley, Robert T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Springer, Marty S.] Merck & Co Inc, Rahway, NJ 07090 USA; [Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; University of Amsterdam; Academic Medical Center Amsterdam; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis; Cornell University; Scripps Research Institute; University of California System; University of California San Diego; Merck & Company; Tulane University; McGill University	Grant, RM (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94518 USA.		Lieberman, Judy/A-2717-2015; Johnston, Rowena/R-4173-2019	Grant, Robert/0000-0002-0851-7085; Johnston, Rowena/0000-0002-5027-737X	NIAID NIH HHS [U19 AI076981, U19 AI076981-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076981] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Coplan PM, 2004, SCIENCE, V304, P1911, DOI 10.1126/science.1100441; De Clercq E, 2004, CHEM BIODIVERS, V1, P44, DOI 10.1002/cbdv.200490012; Duran AS, 2007, AIDS, V21, P199, DOI 10.1097/QAD.0b013e328011770b; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; FLEXNER C, 1991, ANTIMICROB AGENTS CH, V35, P2544, DOI 10.1128/AAC.35.12.2544; HEERA J, 2008, 15 C RETR OPP INF 3; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Malcolm Karl, 2004, Biotechnol Genet Eng Rev, V21, P81; Martinez J, 2006, ANTIVIR RES, V71, P343, DOI 10.1016/j.antiviral.2006.05.013; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; MEYLAN PRA, 1994, ANTIMICROB AGENTS CH, V38, P2910, DOI 10.1128/AAC.38.12.2910; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; SAAG M, 2007, 4 INT AIDS SOC C HIV; Shattock RJ, 2002, NAT MED, V8, P425, DOI 10.1038/nm0502-425; Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; Ward H, 1996, SEX TRANSM DIS, V23, P413, DOI 10.1097/00007435-199609000-00012	19	108	116	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					532	534		10.1126/science.1160355	http://dx.doi.org/10.1126/science.1160355			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653884	Green Accepted			2022-12-24	WOS:000257888900038
J	Lee, K; Zhang, Y; Lee, SE				Lee, Kihoon; Zhang, Yu; Lee, Sang Eun			Saccharomyces cerevisiae ATM orthologue suppresses break-induced chromosome translocations	NATURE			English	Article							DOUBLE-STRAND BREAK; DNA-DAMAGE CHECKPOINT; TELOMERE LENGTH; MRE11 COMPLEX; GENOMIC INSTABILITY; BUDDING YEAST; S-PHASE; CHROMATIN; RECOMBINATION; REPAIR	Chromosome translocations are frequently associated with many types of blood-related cancers and childhood sarcomas. Detection of chromosome translocations assists in diagnosis, treatment and prognosis of these diseases(1); however, despite their importance to such diseases, the molecular mechanisms leading to chromosome translocations are not well understood. The available evidence indicates a role for non-homologous end joining (NHEJ) of DNA double-strand breaks (DSBs) in their origin(1-3). Here we develop a yeast-based system that induces a reciprocal chromosome translocation by formation and ligation of breaks on two different chromosomes. We show that interchromosomal end joining is efficiently suppressed by the Tel1- and Mre11-Rad50-Xrs2-dependent pathway; this is distinct from the role of Tel1 in telomeric integrity and from Mec1- and Tel1- dependent checkpoint controls. Suppression of DSB-induced chromosome translocations depends on the kinase activity of Tel1 and Dun1, and the damage-induced phosphorylation of Sae2 and histone H2AX proteins. Tel1- and Sae2-dependent tethering and promotion of 59 to 39 degradation of broken chromosome ends discourage error-prone NHEJ and interchromosomal NHEJ, preserving chromosome integrity on DNA damage. Our results indicate that, like human ATM, Tel1 serves as a key regulator for chromosome integrity in the pathway that reduces the risk for DSB-induced chromosome translocations, and are probably pertinent to the oncogenic chromosome translocations in ATM-deficient cells.	[Lee, Kihoon; Zhang, Yu; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Lee, Kihoon; Zhang, Yu; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lee, SE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA.	lees4@uthscsa.edu		Zhang, Yu/0000-0002-6525-2458				ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Bassing CH, 2004, CELL CYCLE, V3, P149; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chakhparonian M, 2005, CURR GENET, V48, P310, DOI 10.1007/s00294-005-0020-7; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Mallory JC, 2003, DNA REPAIR, V2, P1041, DOI 10.1016/S1568-7864(03)00115-0; Moreau S, 1999, MOL CELL BIOL, V19, P556; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	30	58	58	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					543	U12		10.1038/nature07054	http://dx.doi.org/10.1038/nature07054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650924				2022-12-24	WOS:000257860300057
J	Campellone, KG; Webb, NJ; Znameroski, EA; Welch, MD				Campellone, Kenneth G.; Webb, Neil J.; Znameroski, Elizabeth A.; Welch, Matthew D.			WHAMM is an Arp2/3 complex activator that binds microtubules and functions in ER to Golgi transport	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; N-WASP; ACTIN CYTOSKELETON; LIVING CELLS; RUFFLE FORMATION; CORTACTIN; PROTEINS; WAVE2; DYNAMICS; MOTILITY	The Arp2/3 complex is an actin nucleator that plays a critical role in many cellular processes. Its activities are regulated by nucleation- promoting factors (NPFs) that function primarily during plasma membrane dynamics. Here we identify a mammalian NPF called WHAMM (WASP homolog associated with actin, membranes, and microtubules) that localizes to the cis- Golgi apparatus and tubulo- vesicular membrane transport intermediates. The modular organization of WHAMM includes an N- erminal domain that mediates Golgi membrane association, a coiled- coil region that binds microtubules, and a WCA segment that stimulates Arp2/3-mediated actin polymerization. Overexpression and depletion studies indicate that WHAMM is important for maintaining Golgi structure and facilitating anterograde membrane transport. The ability of WHAMM to interact with microtubules plays a role in membrane tubulation, while its capacity to induce actin assembly promotes tubule elongation. Thus, WHAMM is an important regulator of membrane dynamics functioning at the interface of the microtubule and actin cytoskeletons.	[Campellone, Kenneth G.; Webb, Neil J.; Znameroski, Elizabeth A.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Campellone, KG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	campellone@berkeley.edu; welch@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059609-09, R01-GM59609, R01 GM059609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hehnly H, 2007, FEBS LETT, V581, P2112, DOI 10.1016/j.febslet.2007.01.094; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774	42	191	199	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					148	161		10.1016/j.cell.2008.05.032	http://dx.doi.org/10.1016/j.cell.2008.05.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614018	Bronze, Green Accepted			2022-12-24	WOS:000257513100021
J	Petesch, SJ; Lis, JT				Petesch, Steven J.; Lis, John T.			Rapid, transcription-independent loss of nucleosomes over a large chromatin domain at Hsp70 loci	CELL			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK GENES; IN-VIVO; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CHROMOSOMAL DOMAINS; DYNAMIC REGULATION; SODIUM-SALICYLATE; DNA INTERACTIONS; HUMAN GENOME	To efficiently transcribe genes, RNA Polymerase II (Pol II) must overcome barriers imposed by nucleosomes and higher- order chromatin structure. Many genes, including Drosophila melanogaster Hsp70, undergo changes in chromatin structure upon activation. To characterize these changes, we mapped the nucleosome landscape of Hsp70 after an instantaneous heat shock at high spatial and temporal resolution. Surprisingly, we find an initial disruption of nucleosomes across the entire gene within 30 s after activation, faster than the rate of Pol II transcription, followed by a second further disruption within 2 min. This initial change occurs independently of Pol II transcription. Furthermore, the rapid loss of nucleosomes extends beyond Hsp70 and halts at the scs and scs' insulating elements. An RNAi screen of 28 transcription and chromatin- related factors reveals that depletion of heat shock factor, GAGA Factor, or Poly(ADP)-Ribose Polymerase or its activity abolishes the loss of nucleosomes upon Hsp70 activation.	[Petesch, Steven J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu			NIGMS NIH HHS [T32-GM70723, R01 GM025232-31, R01 GM025232, R37 GM025232, GM25232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; CROWLEY TE, 1984, CELL, V39, P149, DOI 10.1016/0092-8674(84)90200-9; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; GIARDINA C, 1995, J BIOL CHEM, V270, P10369, DOI 10.1074/jbc.270.18.10369; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kuhn EJ, 2004, MOL CELL BIOL, V24, P1470, DOI 10.1128/MCB.24.4.1470-1480.2004; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEWIS M, 1975, P NATL ACAD SCI USA, V72, P3604, DOI 10.1073/pnas.72.9.3604; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCKNIGHT SL, 1979, CELL, V17, P551; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; VAZQUEZ J, 1994, EMBO J, V13, P5984, DOI 10.1002/j.1460-2075.1994.tb06944.x; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Winegarden NA, 1996, J BIOL CHEM, V271, P26971, DOI 10.1074/jbc.271.43.26971; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	67	245	252	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					74	84		10.1016/j.cell.2008.05.029	http://dx.doi.org/10.1016/j.cell.2008.05.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614012	Green Accepted, Bronze			2022-12-24	WOS:000257513100015
J	Hall-Spencer, JM; Rodolfo-Metalpa, R; Martin, S; Ransome, E; Fine, M; Turner, SM; Rowley, SJ; Tedesco, D; Buia, MC				Hall-Spencer, Jason M.; Rodolfo-Metalpa, Riccardo; Martin, Sophie; Ransome, Emma; Fine, Maoz; Turner, Suzanne M.; Rowley, Sonia J.; Tedesco, Dario; Buia, Maria-Cristina			Volcanic carbon dioxide vents show ecosystem effects of ocean acidification	NATURE			English	Article							CLIMATE-CHANGE; CO2; SEA; EMISSION; IMPACT	The atmospheric partial pressure of carbon dioxide (p(CO2)) will almost certainly be double that of pre- industrial levels by 2100 and will be considerably higher than at any time during the past few million years(1). The oceans are a principal sink for anthropogenic CO2 where it is estimated to have caused a 30% increase in the concentration of H+ in ocean surface waters since the early 1900s and may lead to a drop in seawater pH of up to 0.5 units by 2100 ( refs 2, 3). Our understanding of how increased ocean acidity may affect marine ecosystems is at present very limited as almost all studies have been in vitro, short- term, rapid perturbation experiments on isolated elements of the ecosystem(4,5). Here we show the effects of acidification on benthic ecosystems at shallow coastal sites where volcanic CO2 vents lower the pH of the water column. Along gradients of normal pH ( 8.1 - 8.2) to lowered pH ( mean 7.8 - 7.9, minimum 7.4 - 7.5), typical rocky shore communities with abundant calcareous organisms shifted to communities lacking scleractinian corals with significant reductions in sea urchin and coralline algal abundance. To our knowledge, this is the first ecosystem- scale validation of predictions that these important groups of organisms are susceptible to elevated amounts of p(CO2). Sea- grass production was highest in an area at mean pH 7.6 ( 1,827 mu atm p(CO2)) where coralline algal biomass was significantly reduced and gastropod shells were dissolving due to periods of carbonate sub- saturation. The species populating the vent sites comprise a suite of organisms that are resilient to naturally high concentrations of p(CO2) and indicate that ocean acidification may benefit highly invasive non- native algal species. Our results provide the first in situ insights into how shallow water marine communities might change when susceptible organisms are removed owing to ocean acidification.	[Hall-Spencer, Jason M.; Rodolfo-Metalpa, Riccardo; Ransome, Emma; Rowley, Sonia J.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Inst Marine, Plymouth PL4 8AA, Devon, England; [Martin, Sophie] Univ Paris 06, CNRS, F-06234 Villefranche Sur Mer, France; [Fine, Maoz] Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; [Fine, Maoz] Interuniv Inst Marine Sci, IL-88103 Elat, Israel; [Turner, Suzanne M.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Tedesco, Dario] Univ Naples 2, Dept Environm Sci, I-81100 Caserta, Italy; [Tedesco, Dario] CNR, Ist Geol Ambientale & Geoingn, I-00138 Rome, Italy; [Buia, Maria-Cristina] Stn Zool Anton Dohrn, Lab Ecol Benthos, I-80077 Naples, Italy	University of Plymouth; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Bar Ilan University; University of East Anglia; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geologia Ambientale e Geoingegneria (IGAG-CNR); Stazione Zoologica Anton Dohrn di Napoli	Hall-Spencer, JM (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Inst Marine, Plymouth PL4 8AA, Devon, England.	jhall-spencer@plymouth.ac.uk	Hall-Spencer, Jason/AFN-7866-2022; Buia, Maria-Cristina/L-9948-2017; Fine, Maoz/S-5582-2019; Hall-Spencer, Jason/F-9179-2013; Buia, Maria Cristina/K-8771-2016	Hall-Spencer, Jason/0000-0002-6915-2518; Fine, Maoz/0000-0003-4911-4562; Buia, Maria Cristina/0000-0002-2370-898X; Ransome, Emma/0000-0002-5720-1570; MARTIN, Sophie/0000-0002-1256-3674				Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Dando PR, 1999, PROG OCEANOGR, V44, P333, DOI 10.1016/S0079-6611(99)00032-4; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; GAMBI MC, 2003, MARINO COSTIERO TERR; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; KERRICK DM, 1995, CHEM GEOL, V121, P285, DOI 10.1016/0009-2541(94)00148-2; Kleypas JA, 2006, WORKSH HELD 18 20 AP; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; The Royal Society, 2005, 1205 ROYAL SOC; WILLIAMS SN, 1992, GEOCHIM COSMOCHIM AC, V56, P1765, DOI 10.1016/0016-7037(92)90243-C	22	1080	1102	18	642	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					96	99		10.1038/nature07051	http://dx.doi.org/10.1038/nature07051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18536730	Green Submitted			2022-12-24	WOS:000257308300044
J	Gohn, GS; Koeberl, C; Miller, KG; Reimold, WU; Browning, JV; Cockell, CS; Horton, JW; Kenkmann, T; Kulpecz, AA; Powars, DS; Sanford, WE; Voytek, MA				Gohn, G. S.; Koeberl, C.; Miller, K. G.; Reimold, W. U.; Browning, J. V.; Cockell, C. S.; Horton, J. W., Jr.; Kenkmann, T.; Kulpecz, A. A.; Powars, D. S.; Sanford, W. E.; Voytek, M. A.			Deep drilling into the Chesapeake Bay impact structure	SCIENCE			English	Article							GLOBAL SEA-LEVEL; SUBSEAFLOOR SEDIMENTS; BOLIDE IMPACT; YAXCOPOIL-1; CHICXULUB; ORIGIN; LIFE	Samples from a 1.76- kilometer- deep corehole drilled near the center of the late Eocene Chesapeake Bay impact structure ( Virginia, USA) reveal its geologic, hydrologic, and biologic history. We conducted stratigraphic and petrologic analyses of the cores to elucidate the timing and results of impact- melt creation and distribution, transient- cavity collapse, and ocean- water resurge. Comparison of post- impact sedimentary sequences inside and outside the structure indicates that compaction of the crater fill influenced long- term sedimentation patterns in the mid- Atlantic region. Salty connate water of the target remains in the crater fill today, where it poses a potential threat to the regional groundwater resource. Observed depth variations in microbial abundance indicate a complex history of impact- related thermal sterilization and habitat modification, and subsequent post- impact repopulation.	[Gohn, G. S.; Horton, J. W., Jr.; Powars, D. S.; Sanford, W. E.; Voytek, M. A.] US Geol Survey, Reston, VA 20192 USA; [Koeberl, C.] Univ Vienna, Dept Lithospher Res, Ctr Earth Sci, A-1090 Vienna, Austria; [Miller, K. G.; Browning, J. V.; Kulpecz, A. A.] Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; [Reimold, W. U.; Kenkmann, T.] Humboldt Univ, Museum Nat Hist Mineral, D-10115 Berlin, Germany; [Cockell, C. S.] Open Univ, Ctr Earth Planetary Space & Astron Res, Milton Keynes MK7 6AA, Bucks, England	United States Department of the Interior; United States Geological Survey; University of Vienna; Rutgers State University New Brunswick; Humboldt University of Berlin; Open University - UK	Gohn, GS (corresponding author), US Geol Survey, Reston, VA 20192 USA.	ggohn@usgs.gov	Reimold, Wolf Uwe/AAI-6226-2021	Hauser, Natalia/0000-0002-6975-6186	STFC [ST/F003102/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F003102/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BROWNING JV, 2006, GEOL SOC AM BULL, V118, P657; Collins GS, 2005, GEOLOGY, V33, P925, DOI 10.1130/G21854.1; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Deutsch A, 2006, METEORIT PLANET SCI, V41, P689, DOI 10.1111/j.1945-5100.2006.tb00985.x; Gohn G.S., 2006, EOS T AM GEOPHYS UN, V87, P349, DOI DOI 10.1029/2006EO350001; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; GRONSTAL AL, 2007, GEOL SOC AM ABSTR, V39, P316; Hayden T, 2008, GEOLOGY, V36, P327, DOI 10.1130/G24408A.1; Horton J. W., 2007, GEOLOGICAL SOC AM AB, V39, P451; HORTON JR. J. W., 2005, 1688 US GEOL SURV; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; Koeberl C, 1996, SCIENCE, V271, P1263, DOI 10.1126/science.271.5253.1263; MALINCRONICO ML, 2008, C LARG MET IMP PLAN; Manheim F.T., 1968, SOUTHEAST GEOL, V9, P215; MCFARLAND ER, 2005, 16885 US GEOL SURV; Miller KG, 1996, SCIENCE, V271, P1092, DOI 10.1126/science.271.5252.1092; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; POAG CW, 1999, CHESAPEAKE INVADER; POAG CW, 2004, CHESAPEAKE BAY CRATE; POWARS D. S., 1999, 1612 US GEOL SURV; POWARS D. S., 2000, 1622 US GEOL SURV; RADFORD L, 1980, DOEET283731 US DOE; Robertson P. B., 1977, IMPACT EXPLOSION CRA, P687; Sanford W, 2003, J GEOCHEM EXPLOR, V78-9, P243, DOI 10.1016/S0375-6742(03)00108-0; Sanford W.E., 2004, EOS T AM GEOPHYS UN, V85, P369, DOI DOI 10.1029/2004EO390001; Sanford WE, 2005, GEOFLUIDS, V5, P185, DOI 10.1111/j.1468-8123.2005.00110.x; Stoffler D, 2004, METEORIT PLANET SCI, V39, P1035, DOI 10.1111/j.1945-5100.2004.tb01128.x; Wittmann A, 2007, GEOL SOC AM BULL, V119, P1151, DOI 10.1130/B26116.1	30	91	91	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1740	1745		10.1126/science.1158708	http://dx.doi.org/10.1126/science.1158708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583604				2022-12-24	WOS:000257121200029
J	Satyanand, T				Satyanand, Tara			Aftermath of the Bhopal accident	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Satyanand, T (corresponding author), The Lancet, London NW1 7BY, England.							MOORIS C, 2008, BBC NEWS        0529; 2008, TIMES INDIA     0529	2	3	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 7	2008	371	9628					1900	1900		10.1016/S0140-6736(08)60814-4	http://dx.doi.org/10.1016/S0140-6736(08)60814-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310OI	18539211				2022-12-24	WOS:000256538500011
J	Osika, W; Montgomery, SM				Osika, Walter; Montgomery, Scott M.			Physical control and coordination in childhood and adult obesity: longitudinal birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE-DEVELOPMENT; DEMENTIA; RISK; IQ; ENVIRONMENT; IMPAIRMENT; MECHANISMS; PREGNANCY; SMOKING; INSULIN	Objective To identify whether measures of childhood physical control and coordination as markers of neurological function are associated with obesity in adults. Design Longitudinal birth cohort study. Setting National child development study in Great Britain. Participants 11042 people born during one week in 1958. Main outcome measure Obesity at age 33 years deflned as body mass index >= 30. Results Among 7990 cohort members at age 7 years, teachers reported that poor hand control, poor coordination, and clumsiness "certainly applied" more often among those who would be obese adults, producing adjusted odds ratios of 1.57 (95% confidence interval 1.13 to 2.20; P=0.008) for poor hand control, 2.30 (1.52 to 3.46; P<0.001) for poor coordination, and 3.91 (2.61 to 5.87; P<0.001) for clumsiness. Among 6875 participants who had doctor administered assessments with continuous scores at age 11 years, poorer function was associated with later obesity, indicated by adjusted odds ratios (change in risk per unit increase in score) of 0.88 (0.81 to 0.96; P=0.003) for copying designs, 0.84 (0.78 to 0.91; P<0.001) for marking squares, and 1.14 (1.06 to 1.24; P<0.001) for picking up matches (a higher score indicates poor function in this test). Further adjustment for contemporaneous body mass index at age 7 or 11 years did not eliminate statistical significance for any of the associations. Conclusion Some aspects of poorer neurological function associated with adult obesity may have their origins in childhood.	[Osika, Walter] Orebro Univ Hosp, Dept Cardiol, SE-70185 Orebro, Sweden; [Montgomery, Scott M.] Orebro Univ Hosp, Clin Res Ctr, SE-70185 Orebro, Sweden; [Montgomery, Scott M.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Primary Care & Social Med, London, England; [Montgomery, Scott M.] Karolinska Univ Hosp, Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden	Orebro University; Orebro University; Imperial College London; Karolinska Institutet; Karolinska University Hospital	Osika, W (corresponding author), Orebro Univ Hosp, Dept Cardiol, SE-70185 Orebro, Sweden.	osika@hotmail.com	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494; Osika, Walter/0000-0002-1583-7319	ESRC [ES/G002452/1] Funding Source: UKRI; Economic and Social Research Council [ES/G002452/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Breslau N, 2005, INT J EPIDEMIOL, V34, P1047, DOI 10.1093/ije/dyi163; Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Douglas James W.B, 1964, HOME SCH; FERRI E, 1993, LIFE 33 5 FOLLOW UP; Graf C, 2004, INT J OBESITY, V28, P22, DOI 10.1038/sj.ijo.0802428; Gustafson D, 2006, LANCET NEUROL, V5, P713, DOI 10.1016/S1474-4422(06)70526-9; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Knecht S, 2008, PROG NEUROBIOL, V84, P85, DOI 10.1016/j.pneurobio.2007.09.003; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; Olsson GM, 2008, DIABETES CARE, V31, P514, DOI 10.2337/dc07-1399; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Stott GH, 1987, SOCIAL ADJUSTMENT CH; Strachan MWJ, 2008, BRIT MED J, V336, P6, DOI 10.1136/bmj.39386.664016.BE; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Toschke AM, 2003, AM J EPIDEMIOL, V158, P1068, DOI 10.1093/aje/kwg258; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yki-Jarvinen H, 2000, INT J OBESITY, V24, pS25, DOI 10.1038/sj.ijo.0801272	24	49	49	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2008	337	7667							a699	10.1136/bmj.a699	http://dx.doi.org/10.1136/bmj.a699			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346FD	18698093	Green Published, hybrid			2022-12-24	WOS:000259053100028
J	Mermin, J; Musinguzi, J; Opio, A; Kirungi, W; Ekwaru, JP; Hladik, W; Kaharuza, F; Downing, R; Bunnell, R				Mermin, Jonathan; Musinguzi, Joshua; Opio, Alex; Kirungi, Wilford; Ekwaru, John Paul; Hladik, Wolfgang; Kaharuza, Frank; Downing, Robert; Bunnell, Rebecca			Risk factors for recent HIV infection in Uganda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	15th Conference on Retroviruses and Opportunistic Infections	FEB 03-06, 2008	Boston, MA				SEXUALLY-TRANSMITTED-DISEASES; POPULATION-BASED COHORT; BED-ENZYME IMMUNOASSAY; INJECTION-DRUG USERS; PREVALENCE; RAKAI; WOMEN; TRENDS; SEROPREVALENCE; SURVEILLANCE	Context Studies of factors associated with acquiring human immunodeficiency virus ( HIV) are often based on prevalence data that might not reflect recent infections. Objective To determine demographic, biological, and behavioral factors for recent HIV infection in Uganda. Design and Setting Nationally representative household survey of cross- sectional design conducted in Uganda from August 2004 through January 2005; data were analyzed until November 2007. Participants There were 11 454 women and 9905 men aged 15 to 59 years who were eligible. Questionnaires were completed for 10 826 women ( 95%) and 8830 men ( 89%); of those interviewed, blood specimens were collected for 10 227 women ( 94%) and 8298 men ( 94%). Main Outcome Measure Specimens seropositive for HIV were tested with the BED IgG capture- based enzyme immunosorbent assay to identify recent seroconversions ( median, 155 days) using normalized optical density of 0.8 and adjustments. Results Of the 1023 HIV infections with BED results, 172 ( 17%) tested as recent. In multivariate analysis, risk factors associated with recent HIV infection included female sex ( adjusted odds ratio [ aOR], 2.4; 95% confidence interval [ CI], 1.1- 5.2); current marital status ( widowed vs never married, aOR, 6.1; 95% CI, 2.8- 13.3; divorced vs never married, aOR, 3.0; 95% CI, 1.5- 6.1); geographic region ( north central Uganda vs central Uganda/ Kampala, aOR, 2.6; 95% CI, 1.7- 4.1); number of sex partners in past year ( >= 2 compared with none; aOR, 2.9; 95% CI, 1.6- 5.5); herpes simplex virus type 2 infection ( aOR, 3.9; 95% CI, 2.6- 5.8); report of a sexually transmitted disease in the past year ( aOR, 1.7; 95% CI, 1.2- 2.4); and being an uncircumcised man ( aOR, 2.5; 95% CI, 1.1- 5.3). Among married participants, recent HIV infection was associated with never using condoms with partners outside of marriage ( aOR, 3.2; 95% CI, 1.7- 6.1) compared with individuals having no outside partners. The risk of incident HIV infection for married individuals who used condoms with at least 1 outside partner was similar to that of those who did not have any partners outside of marriage ( aOR, 1.0; 95% CI, 0.3- 2.7). Conclusion A survey of individuals in Uganda who were tested with an HIV assay used to establish recent infection identified risk factors, which offers opportunities for prevention initiatives.	[Mermin, Jonathan] CDC Kenya, Kenya Med Res Inst, Coordinating Off Global Hlth, Nairobi, Kenya; [Mermin, Jonathan; Ekwaru, John Paul; Hladik, Wolfgang; Kaharuza, Frank; Downing, Robert; Bunnell, Rebecca] Ctr Dis Control & Prevent CDC Uganda, Global AIDS Program, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Entebbe, Uganda; [Musinguzi, Joshua; Opio, Alex; Kirungi, Wilford] CDC Kenya, Uganda Minist Hlth, Nairobi, Kenya	Kenya Medical Research Institute	Mermin, J (corresponding author), CDC Kenya, Kenya Med Res Inst, Coordinating Off Global Hlth, Mbagathi Rd Off Mbagathi Way, Nairobi, Kenya.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; BATTER V, 1994, AIDS, V8, P811, DOI 10.1097/00002030-199406000-00014; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Changalucha J, 2002, AIDS, V16, P661, DOI 10.1097/00002030-200203080-00019; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gregson S, 1998, AIDS, V12, P2049, DOI 10.1097/00002030-199815000-00017; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; *INT HIV AIDS ALL, POS PREV PREV STRAT; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jiang Y, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000304696.62508.8a; *JOINT UN PROGR HI, 2007 AIDS EP UPD; *JOINT UN PROGR HI, 3 5 IN TREAT 3 MILL; Karim SSA, 2007, SAMJ S AFR MED J, V97, P190; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; *OFF US GLOB AIDS, INT REC US BED CAPT; Pappas G, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-16; Parekh BS, 2005, INDIAN J MED RES, V121, P510; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roehr B, 2005, BRIT MED J, V330, P496, DOI 10.1136/bmj.330.7490.496-a; Saidel T, 1996, AM J EPIDEMIOL, V144, P214, DOI 10.1093/oxfordjournals.aje.a008916; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Stoneburner R, 1998, AIDS, V12, P226; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; *UNAIDS WHO WORK G, GUID MEAS NAT HIV PR; Wawer MJ, 1997, AIDS, V11, P1023, DOI 10.1097/00002030-199708000-00011; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; Wolday D, 2007, J INTERN MED, V261, P132, DOI 10.1111/j.1365-2796.2006.01740.x	50	102	104	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					540	549		10.1001/jama.300.5.540	http://dx.doi.org/10.1001/jama.300.5.540			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	333YG	18677026				2022-12-24	WOS:000258188900015
J	Palmieri, C; Coombes, RC; Kim, SB; Cleator, S				Palmieri, Carlo; Coombes, R. Charles; Kim, Sung-Bae; Cleator, Suzy			Ethnicity and breast cancer research	LANCET			English	Editorial Material							RECEPTOR POLYMORPHISMS		[Palmieri, Carlo; Coombes, R. Charles; Cleator, Suzy] Univ London Imperial Coll Sci Technol & Med, Canc Res UK Labs, Dept Canc Med, London W12 0NN, England; [Kim, Sung-Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Div Oncol,Dept Med, Seoul, South Korea	Cancer Research UK; Imperial College London; University of Ulsan; Asan Medical Center	Palmieri, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Canc Res UK Labs, Dept Canc Med, London W12 0NN, England.	c.palmieri@imperial.ac.uk		Coombes, Raoul Charles/0000-0002-4811-1100				BUCHANA D, 2008, NAT CONS BREAST CTR; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Lehrnbecher T, 1999, BLOOD, V94, P4220, DOI 10.1182/blood.V94.12.4220.424k08_4220_4232; McBride R, 2007, CANCER-AM CANCER SOC, V110, P1201, DOI 10.1002/cncr.22884; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; NEMOTO T, 1977, J NATL CANCER I, V58, P193, DOI 10.1093/jnci/58.2.193; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2008	372	9634					188	189		10.1016/S0140-6736(08)61052-1	http://dx.doi.org/10.1016/S0140-6736(08)61052-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640442				2022-12-24	WOS:000257763900010
J	Zeebe, RE; Zachos, JC; Caldeira, K; Tyrrell, T				Zeebe, Richard E.; Zachos, James C.; Caldeira, Ken; Tyrrell, Toby			Oceans - Carbon emissions and acidification	SCIENCE			English	Editorial Material							MARINE PLANKTON; CORAL-REEFS; CALCIFICATION; CO2		[Zeebe, Richard E.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Zachos, James C.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA; [Caldeira, Ken] Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; [Tyrrell, Toby] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	University of Hawaii System; University of California System; University of California Santa Cruz; Carnegie Institution for Science; NERC National Oceanography Centre; University of Southampton	Zeebe, RE (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	zeebe@soest.hawaii.edu	Zachos, James C/A-7674-2008; Caldeira, Ken/E-7914-2011	Zachos, James C/0000-0001-8439-1886; Caldeira, Ken/0000-0002-4591-643X	Division Of Ocean Sciences [0751959] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Montenegro A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030905; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Raven J, 2005, OCEAN ACIDIFICATION; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; US EPA, 1976, QUAL CRIT WAT; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	15	185	196	16	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					51	52		10.1126/science.1159124	http://dx.doi.org/10.1126/science.1159124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599765				2022-12-24	WOS:000257320800029
J	Melbourne, BA; Hastings, A				Melbourne, Brett A.; Hastings, Alan			Extinction risk depends strongly on factors contributing to stochasticity	NATURE			English	Article							DEMOGRAPHIC STOCHASTICITY; SMALL POPULATIONS; MATING SYSTEM; SURVIVAL; DYNAMICS; TIME	Extinction risk in natural populations depends on stochastic factors that affect individuals, and is estimated by incorporating such factors into stochastic models(1-9). Stochasticity can be divided into four categories, which include the probabilistic nature of birth and death at the level of individuals ( demographic stochasticity(2)), variation in population- level birth and death rates among times or locations ( environmental stochasticity(1,3)), the sex of individuals(6,8) and variation in vital rates among individuals within a population ( demographic heterogeneity(7,9)). Mechanistic stochastic models that include all of these factors have not previously been developed to examine their combined effects on extinction risk. Here we derive a family of stochastic Ricker models using different combinations of all these stochastic factors, and show that extinction risk depends strongly on the combination of factors that contribute to stochasticity. Furthermore, we show that only with the full stochastic model can the relative importance of environmental and demographic variability, and therefore extinction risk, be correctly determined. Using the full model, we find that demographic sources of stochasticity are the prominent cause of variability in a laboratory population of Tribolium castaneum ( red flour beetle), whereas using only the standard simpler models would lead to the erroneous conclusion that environmental variability dominates. Our results demonstrate that current estimates of extinction risk for natural populations could be greatly underestimated because variability has been mistakenly attributed to the environment rather than the demographic factors described here that entail much higher extinction risk for the same variability level.	[Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Melbourne, BA (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	brett.melbourne@colorado.edu	Hastings, Alan/O-6864-2019; Lin, Pei-Chun/F-7857-2012	Hastings, Alan/0000-0002-0717-8026; Lin, Pei-Chun/0000-0002-4400-923X; MELBOURNE, BRETT/0000-0002-8843-4131				ATHREYA KB, 1971, ANN MATH STAT, V42, P1499, DOI 10.1214/aoms/1177693150; Bartlett MS., 1960, STOCHASTIC POPULATIO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Costantino R. F., 1991, POPULATION DYNAMICS; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; Engen S, 2003, ECOLOGY, V84, P2378, DOI 10.1890/02-0123; FELLER W., 1939, ACTA BIOTHEORETICA, V5, P11, DOI 10.1007/BF01602932; Fox GA, 2006, J ANIM ECOL, V75, P921, DOI 10.1111/j.1365-2656.2006.01110.x; GABRIEL W, 1992, THEOR POPUL BIOL, V41, P44, DOI 10.1016/0040-5809(92)90049-Y; Goodman D., 1987, P11, DOI 10.1017/CBO9780511623400.003; Grimm V, 2004, OIKOS, V105, P501, DOI 10.1111/j.0030-1299.2004.12606.x; Kendall BE, 2003, CONSERV BIOL, V17, P1170, DOI 10.1046/j.1523-1739.2003.02411.x; KENDALL DG, 1949, J R STAT SOC B, V11, P230; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lande R., 2003, OXFORD SERIES ECOLOG; Legendre S, 1999, AM NAT, V153, P449, DOI 10.1086/303195; LEIGH EG, 1981, J THEOR BIOL, V90, P213; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Ludwig D, 1996, AM NAT, V147, P506, DOI 10.1086/285863; May R. M., 1973, STABILITY COMPLEXITY; MAY RM, 1973, AM NAT, V107, P621, DOI 10.1086/282863; Morris W. F., 2002, QUANTITATIVE CONSERV; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROUGHGARDEN J, 1975, AM NAT, V109, P713, DOI 10.1086/283039; Saether BE, 2004, J ANIM ECOL, V73, P925, DOI 10.1111/j.0021-8790.2004.00869.x; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Soule M., 1987, VIABLE POPULATIONS C; TULJAPURKAR S, 1989, THEOR POPUL BIOL, V35, P227, DOI 10.1016/0040-5809(89)90001-4	30	366	369	6	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					100	103		10.1038/nature06922	http://dx.doi.org/10.1038/nature06922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18596809				2022-12-24	WOS:000257308300045
J	Julu, POO; Engerstrom, IW; Hansen, S; Apartopoulos, F; Engerstrom, B; Pini, G; Delamont, RS; Smeets, EEJ				Julu, Peter O. O.; Engerstrom, Ingegerd Witt; Hansen, Stig; Apartopoulos, Flora; Engerstrom, Bengt; Pini, Giorgio; Delamont, Robert S.; Smeets, Eric E. J.			Cardiorespiratory challenges in Rett's syndrome	LANCET			English	Editorial Material							DISORDER		[Julu, Peter O. O.] Barts & London Queen Marys Sch Med & Dent, Wingate Inst Neurogastroenterol, London E1 2AJ, England; [Julu, Peter O. O.; Engerstrom, Ingegerd Witt; Engerstrom, Bengt] Ostersund Hosp, Rett Ctr, Froson, Sweden; [Hansen, Stig; Apartopoulos, Flora] S Glasgow Univ Hosp, Inst Neurol Sci, Glasgow, Lanark, Scotland; [Pini, Giorgio] Area Vasta Toscana, Child Neuropsychiat, Nord Occidentale, Italy; [Pini, Giorgio] Area Vasta Toscana, Ctr Rett Versilia, Nord Occidentale, Italy; [Delamont, Robert S.] Kings Coll Hosp NHS Fdn Trust & Kings Coll, Reg Neurosci Ctr, London, England; [Smeets, Eric E. J.] Univ Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands	University of London; Queen Mary University London; University of Glasgow; University of London; King's College London; Maastricht University; Maastricht University Medical Centre (MUMC)	Julu, POO (corresponding author), Barts & London Queen Marys Sch Med & Dent, Wingate Inst Neurogastroenterol, London E1 2AJ, England.	p.julu@imperial.ac.uk		Julu, Peter/0000-0001-7903-1990				Armstrong DD, 2002, MENT RETARD DEV D R, V8, P72, DOI 10.1002/mrdd.10027; Glaze DG, 2002, MENT RETARD DEV D R, V8, P66, DOI 10.1002/mrdd.10024; Julu POO, 2001, ARCH DIS CHILD, V85, P29, DOI 10.1136/adc.85.1.29; Julu POO, 2005, BRAIN DEV-JPN, V27, pS43, DOI 10.1016/j.braindev.2005.02.012; Julu POO, 1997, ARCH DIS CHILD, V77, P464; JULU POO, 2001, RETT DISORDER DEV BR, P131; Kerr A, 1998, NEW DEVELOPMENTS IN CHILD NEUROLOGY, P191; NOMURA Y, 1992, BRAIN DEV-JPN, V14, pS21; NOMURA Y, 1985, BRAIN DEV-JPN, V7, P334, DOI 10.1016/S0387-7604(85)80040-1; Smeets EEJ, 2006, BRAIN DEV-JPN, V28, P625, DOI 10.1016/j.braindev.2006.04.010	10	45	45	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2008	371	9629					1981	1983		10.1016/S0140-6736(08)60849-1	http://dx.doi.org/10.1016/S0140-6736(08)60849-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312YY	18555901				2022-12-24	WOS:000256709500009
J	Frueh, DP; Arthanari, H; Koglin, A; Vosburg, DA; Bennett, AE; Walsh, CT; Wagner, G				Frueh, Dominique P.; Arthanari, Haribabu; Koglin, Alexander; Vosburg, David A.; Bennett, Andrew E.; Walsh, Christopher T.; Wagner, Gerhard			Dynamic thiolation-thioesterase structure of a non-ribosomal peptide synthetase	NATURE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID SYNTHASE; TRIPLE-RESONANCE EXPERIMENTS; ESCHERICHIA-COLI; MACROMOLECULAR STRUCTURE; C-13 MAGNETIZATION; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; SWISS-MODEL; RESOLUTION	Non-ribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) produce numerous secondary metabolites with various therapeutic/antibiotic properties(1). Like fatty acid synthases (FAS), these enzymes are organized in modular assembly lines in which each module, made of conserved domains, incorporates a given monomer unit into the growing chain. Knowledge about domain or module interactions may enable reengineering of this assembly line enzymatic organization and open avenues for the design of new bioactive compounds with improved therapeutic properties. So far, little structural information has been available on how the domains interact and communicate. This may be because of inherent interdomain mobility hindering crystallization, or because crystallized molecules may not represent the active domain orientations(2). In solution, the large size and internal dynamics of multidomain fragments (> 35 kilodaltons) make structure determination by nuclear magnetic resonance a challenge and require advanced technologies. Here we present the solution structure of the apo-thiolation-thioesterase (T-TE) di-domain fragment of the Escherichia coli enterobactin synthetase EntF NRPS subunit. In the holoenzyme, the T domain carries the growing chain tethered to a 4 '-phosphopantetheine whereas the TE domain catalyses hydrolysis and cyclization of the iron chelator enterobactin. The T-TE di-domain forms a compact but dynamic structure with a well-defined domain interface; the two active sites are at a suitable distance for substrate transfer from T to TE. We observe extensive interdomain and intradomain motions forwell-defined regions and show that these are modulated by interactions with proteins that participate in the biosynthesis. The T-TE interaction described here provides a model for NRPS, PKS and FAS function in general as T-TE-like di-domains typically catalyse the last step in numerous assembly-line chain-termination machineries.	[Frueh, Dominique P.; Arthanari, Haribabu; Koglin, Alexander; Vosburg, David A.; Bennett, Andrew E.; Walsh, Christopher T.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	dominique_frueh@hms.harvard.edu; christopher_walsh@hms.harvard.edu; gerhard_wagner@hms.harvard.edu	Frueh, Dominique P/A-6462-2008; Vosburg, David/P-3944-2019	Frueh, Dominique P/0000-0003-4605-3776; Vosburg, David/0000-0003-3424-5471; Arthanari, Haribabu/0000-0002-7281-1289	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066360, P01GM047467] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB002026-30, P41 EB002026-28, EB 002026, P41 EB002026, P41 EB002026-29, P41 EB002026-33, P41 EB002026-31, P41 EB002026-32] Funding Source: Medline; NIGMS NIH HHS [P41 GM066360, P41 GM066360-05, P01 GM047467-15, P01 GM047467, GM066360, P41 GM066360-04, P01 GM047467-110009, P01 GM047467-16, P01 GM047467-11, P01 GM047467-160012, P01 GM047467-13, P41 GM066360-01, P41 GM066360-02, P01 GM047467-12, P41 GM066360-03, GM47467, P01 GM047467-170012, P01 GM047467-14, P01 GM047467-17] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Frueh DP, 2006, J AM CHEM SOC, V128, P5757, DOI 10.1021/ja0584222; Frueh DP, 2006, J BIOMOL NMR, V34, P31, DOI 10.1007/s10858-005-5338-4; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hyberts SG, 2003, J BIOMOL NMR, V26, P335, DOI 10.1023/A:1024078926886; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Johnson MA, 2006, PROTEIN SCI, V15, P1030, DOI 10.1110/ps.051964606; Keller R., 2004, COMPUTER AIDED RESON, V1; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Medek A, 2000, J BIOMOL NMR, V18, P229, DOI 10.1023/A:1026544801001; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pervushin K, 2003, J BIOMOL NMR, V25, P147, DOI 10.1023/A:1022225711122; Roche ED, 2003, BIOCHEMISTRY-US, V42, P1334, DOI 10.1021/BI026867m; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; WAGNER G, 1995, NAT STRUCT BIOL, V2, P255, DOI 10.1038/nsb0495-255; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	46	127	129	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					903	U62		10.1038/nature07162	http://dx.doi.org/10.1038/nature07162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18704088	Green Accepted			2022-12-24	WOS:000258398600040
J	Jacobson, IG; Ryan, MAK; Hooper, TI; Smith, TC; Amoroso, PJ; Boyko, EJ; Gackstetter, GD; Wells, TS; Bell, NS				Jacobson, Isabel G.; Ryan, Margaret A. K.; Hooper, Tomoko I.; Smith, Tyler C.; Amoroso, Paul J.; Boyko, Edward J.; Gackstetter, Gary D.; Wells, Timothy S.; Bell, Nicole S.			Alcohol use and alcohol-related problems before and after military combat deployment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; MILLENNIUM COHORT; PROBLEM DRINKING; BINGE DRINKING; UNITED-STATES; PRIME-MD; CONSUMPTION; DEPENDENCE; ABUSE	Context High rates of alcohol misuse after deployment have been reported among personnel returning from past conflicts, yet investigations of alcohol misuse after return from the current wars in Iraq and Afghanistan are lacking. Objectives To determine whether deployment with combat exposures was associated with new-onset or continued alcohol consumption, binge drinking, and alcoholrelated problems. Design, Setting, and Participants Data were from Millennium Cohort Study participants who completed both a baseline (July 2001 to June 2003; n = 77 047) and followup (June 2004 to February 2006; n = 55 021) questionnaire (follow-up response rate = 71.4%). After we applied exclusion criteria, our analyses included 48 481 participants (active duty, n = 26 613; Reserve or National Guard, n = 21 868). Of these, 5510 deployed with combat exposures, 5661 deployed without combat exposures, and 37 310 did not deploy. Main Outcome Measures New- onset and continued heavy weekly drinking, binge drinking, and alcohol-related problems at follow-up. Results Baseline prevalence of heavy weekly drinking, binge drinking, and alcoholrelated problems among Reserve or National Guard personnel who deployed with combat exposures was 9.0%, 53.6%, and 15.2%, respectively; follow-up prevalence was 12.5%, 53.0%, and 11.9%, respectively; and new-onset rates were 8.8%, 25.6%, and 7.1%, respectively. Among active-duty personnel, new-onset rates were 6.0%, 26.6%, and 4.8%, respectively. Reserve and National Guard personnel who deployed and reported combat exposures were significantly more likely to experience new-onset heavy weekly drinking (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.36-1.96), binge drinking (OR, 1.46; 95% CI, 1.24-1.71), and alcohol-related problems (OR, 1.63; 95% CI, 1.33-2.01) compared with nondeployed personnel. The youngest members of the cohort were at highest risk for all alcohol-related outcomes. Conclusion Reserve and National Guard personnel and younger service members who deploy with reported combat exposures are at increased risk of new-onset heavy weekly drinking, binge drinking, and alcohol-related problems.	[Jacobson, Isabel G.; Ryan, Margaret A. K.; Smith, Tyler C.] US Dept Def, Ctr Deployment Hlth Res, Naval Hlth Res Ctr, San Diego, CA 92106 USA; [Hooper, Tomoko I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Amoroso, Paul J.] Madigan Army Med Ctr, Ft Lewis, WA USA; [Boyko, Edward J.] Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Wells, Timothy S.] Wright Patterson Air Force Base, Air Force Res Lab, Dayton, OH USA; [Gackstetter, Gary D.] Analyt Serv Inc, Arlington, VA USA; [Bell, Nicole S.] Social Sectors Dev Strategies Inc, Tacoma, WA USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Uniformed Services University of the Health Sciences - USA; Madigan Army Medical Center; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Jacobson, IG (corresponding author), US Dept Def, Ctr Deployment Hlth Res, Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	Isabel.Jacobson@med.navy.mil	Boyko, Edward J/G-2484-2017	Boyko, Edward J/0000-0002-3695-192X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013324] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Agrawal A, 2008, ADDICT BEHAV, V33, P1223, DOI 10.1016/j.addbeh.2008.04.003; Almeida-Filho N, 2004, REV SAUDE PUBL, V38, P45, DOI 10.1590/S0034-89102004000100007; American Association for Public Opinion Research, 2006, STAND DEF FIN DISP C, V4th; Ames GM, 2007, J STUD ALCOHOL DRUGS, V68, P336, DOI 10.15288/jsad.2007.68.336; Bell N S, 2001, Inj Prev, V7, P4, DOI 10.1136/ip.7.1.4; Bell NS, 2003, ALCOHOL CLIN EXP RES, V27, P826, DOI 10.1097/01.ALC.0000067978.27660.73; BRAY RM, 1991, AM J PUBLIC HEALTH, V81, P865, DOI 10.2105/AJPH.81.7.865; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Carlsson S, 2003, EUR J EPIDEMIOL, V18, P493, DOI 10.1023/A:1024694816036; Chilcoat HD, 1998, ADDICT BEHAV, V23, P827, DOI 10.1016/S0306-4603(98)00069-0; Coffman DL, 2007, PREV SCI, V8, P241, DOI 10.1007/s11121-007-0078-1; Costanzo PR, 2007, J STUD ALCOHOL DRUGS, V68, P727, DOI 10.15288/jsad.2007.68.727; Criqui MH, 1998, NOVART FDN SYMP, V216, P159; CRUM RM, 1992, AM J EPIDEMIOL, V135, P989, DOI 10.1093/oxfordjournals.aje.a116411; Crum Rosa M., 2000, Ethnicity and Disease, V10, P39; Cunradi CB, 2008, NICOTINE TOB RES, V10, P429, DOI 10.1080/14622200801889002; Dawson DA, 2006, J STUD ALCOHOL, V67, P195, DOI 10.15288/jsa.2006.67.195; Dawson DA, 2003, ALCOHOL RES HEALTH, V27, P18; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P902, DOI 10.1097/01.ALC.0000164544.45746.A7; Dawson DA, 1998, J SUBST ABUSE, V10, P321, DOI 10.1016/S0899-3289(99)00009-7; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; DILLMAN DA, 1978, MAIL TELEPHONE SURVE, P325; Engel CC, 1999, J OCCUP ENVIRON MED, V41, P384, DOI 10.1097/00043764-199905000-00006; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fernandez WG, 2006, MIL MED, V171, P538, DOI 10.7205/MILMED.171.6.538; Gilman SE, 2008, J EPIDEMIOL COMMUN H, V62, P224, DOI 10.1136/jech.2006.059022; Goldberg IJ, 2001, CIRCULATION, V103, P472; GOLDBERG J, 1990, AM J PUBLIC HEALTH, V80, P570, DOI 10.2105/AJPH.80.5.570; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heeb JL, 2005, ADDICT BEHAV, V30, P403, DOI 10.1016/j.addbeh.2004.04.022; Hobson CJ, 1998, INT J STRESS MANAGE, V5, P1, DOI 10.1023/A:1022978019315; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hussong AM, 2007, ADDICT BEHAV, V32, P1054, DOI 10.1016/j.addbeh.2006.07.011; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kozaric-Kovacic D, 2000, CROAT MED J, V41, P173; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lande RG, 2007, J AM OSTEOPATH ASSOC, V107, P401; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MANN CAL, 2007, HUM VACCIN, V3, P245; McFarlane AC, 1998, ADDICT BEHAV, V23, P813, DOI 10.1016/S0306-4603(98)00098-7; McLeod DS, 2001, J TRAUMA STRESS, V14, P259, DOI 10.1023/A:1011157800050; Micklewright S, 1996, J R Nav Med Serv, V82, P34; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; RICHARDS MS, 1989, AM J PUBLIC HEALTH, V79, P1011, DOI 10.2105/AJPH.79.8.1011; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; ROSS HE, 1995, DRUG ALCOHOL DEPEN, V39, P111, DOI 10.1016/0376-8716(95)01150-W; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Schuckit MA, 2006, DRUG ALCOHOL DEPEN, V82, P194, DOI 10.1016/j.drugalcdep.2005.09.006; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; SHEPHERD J, 1989, BRIT J ADDICT, V84, P1045; Shipherd JC, 2005, ADDICT BEHAV, V30, P595, DOI 10.1016/j.addbeh.2004.07.004; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Smith B, 2007, AM J PREV MED, V32, P347, DOI 10.1016/j.amepre.2006.12.015; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Smith TC, 2007, INT J ENVIRON HEAL R, V17, P271, DOI 10.1080/09603120701372243; Smith TC, 2007, ANN EPIDEMIOL, V17, P525, DOI 10.1016/j.annepidem.2006.12.002; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Ullman SE, 2006, ADDICT BEHAV, V31, P128, DOI 10.1016/j.addbeh.2005.04.002; Ullman SE, 2005, J STUD ALCOHOL, V66, P610, DOI 10.15288/jsa.2005.66.610; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; Vander Weg MW, 2006, MIL MED, V171, P177, DOI 10.7205/MILMED.171.2.177; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Werner MJ, 1996, J ADOLESCENT HEALTH, V18, P276, DOI 10.1016/1054-139X(95)00207-9; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x; WILLIAMS GD, 1985, J STUD ALCOHOL, V46, P223, DOI 10.15288/jsa.1985.46.223; Williams Jeffrey O, 2002, Work, V18, P141; Wynd CA, 1998, MIL MED, V163, P283, DOI 10.1093/milmed/163.5.283	79	473	476	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2008	300	6					663	675		10.1001/jama.300.6.663	http://dx.doi.org/10.1001/jama.300.6.663			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	336OM	18698065	Green Accepted			2022-12-24	WOS:000258374500019
J	Wilper, AP; Woolhandler, S; Lasser, KE; McCormick, D; Bor, DH; Himmelstein, DU				Wilper, Andrew P.; Woolhandler, Steffie; Lasser, Karen E.; McCormick, Danny; Bor, David H.; Himmelstein, David U.			A national study of chronic disease prevalence and access to care in uninsured US adults	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-INSURANCE COVERAGE; MORTALITY; OUTCOMES; DEATH; RISK	Background: No recent national studies have assessed chronic illness prevalence or access to care among persons without insurance in the United States. Objective: To compare reports of chronic conditions and access to care among U. S. adults, by self-reported insurance status. Design: Population-based survey. Setting: National Health and Nutritional Examination Survey (1999 2004). Participants: 12 486 patients age 18 to 64 years. Measurements: Estimates of national rates of cardiovascular disease, hypertension, diabetes, hypercholesterolemia, active asthma or chronic obstructive pulmonary disease, previous cancer, and measures of access to care. Results: On the basis of National Health and Nutrition Examination Survey (1999-2004) responses, an estimated 11.4 million (95% CI, 9.8 million to 13.0 million) working-age Americans with chronic conditions were uninsured, including 16.1% (CI, 12.6% to 19.6%) of the 7.8 million with cardiovascular disease, 15.5% (CI, 13.4% to 17.6%) of the 38.2 million with hypertension, and 16.6% (CI, 13.2% to 20.0%) of the 8.5 million with diabetes. After the authors controlled for age, sex, and race or ethnicity, chronically ill patients without insurance were more likely than those with coverage to have not visited a health professional (22.6% vs. 6.2%) and to not have a standard site for care (26.1% vs. 6.2%) but more likely to identify their standard site for care as an emergency department (7.1% vs. 1.1%) (P <0.001 for all comparisons). Limitation: The study was cross-sectional and used self-reported insurance and disease status. Conclusion: Millions of U.S. working-age adults with chronic conditions do not have insurance and have poorer access to medical care than their insured counterparts.	[Wilper, Andrew P.; Woolhandler, Steffie; Lasser, Karen E.; McCormick, Danny; Bor, David H.; Himmelstein, David U.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Cambridge, MA 02139 USA	Harvard University; Cambridge Health Alliance	Wilper, AP (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, 1493 Cambridge St, Cambridge, MA 02139 USA.	awilper@hsph.harvard.edu		Lasser, Karen/0000-0003-3777-6075	PHS HHS [5T32 HP110011] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1985, PREV MED, V14, P312; [Anonymous], 2006, AN REP GUID; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cannon M, 2004, COVER UNINSURED WEEK; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; COLLINS SR, 2006, GAPS HLTH INSURANCE; *EC REP PRES, TRANSM C FEBR 2004, P197; Fowler-Brown A, 2007, J GEN INTERN MED, V22, P502, DOI 10.1007/s11606-007-0127-2; Geynan JP, 2007, ANN FAM MED, V5, P257, DOI 10.1370/afm.649; *I MED, 2002, CAR COV TOO LITT TOO; KORN EL, 2009, ANAL HLTH SURVEYS; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; *NAT CTR HLTH STAT, SURV OP MAN BROCH CO; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; SWARTZ K, 2006, REINSURING HLTH WHY; *US BUR CENS CTR P, 2004, HLTH INS COV STAT TY; *US BUR CENS CTR P, 2002, HLTH INS COV STAT TY; *US BUR CES, CURR POP SURV 1988 2; *US BUR CES, CURR POP SURV 2000 2; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388; WESTERFIELD DL, 2003, INSURING UNINSURED A	30	137	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2008	149	3					170	176		10.7326/0003-4819-149-3-200808050-00006	http://dx.doi.org/10.7326/0003-4819-149-3-200808050-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336CW	18678844	Green Published			2022-12-24	WOS:000258342900003
J	Kamerow, D				Kamerow, Douglas			Should we screen for childhood dyslipidaemia?	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Manchester, Lancs, England	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Manchester, Lancs, England.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2008	337	7663							a886	10.1136/bmj.a886	http://dx.doi.org/10.1136/bmj.a886			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335EG	18650230				2022-12-24	WOS:000258273000035
J	Panesar, SS; Gatrad, R; Sheikh, A				Panesar, Sukhmeet Singh; Gatrad, Rashid; Sheikh, Aziz			Smokeless tobacco use by south Asian youth in the UK	LANCET			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland; [Panesar, Sukhmeet Singh] Whittington Hosp NHS Trust, London, England; [Gatrad, Rashid] Manor Hosp, Walsall, W Midlands, England	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				[Anonymous], 2002, TOB CONTROL, V11, P291, DOI 10.1136/tc.11.4.291; Bedi R, 1995, Prim Dent Care, V2, P39; Gatrad R, 2007, BMJ-BRIT MED J, V335, P20, DOI 10.1136/bmj.39227.409641.AD; Khan FA, 2000, J ORAL PATHOL MED, V29, P214, DOI 10.1034/j.1600-0714.2000.290504.x; Oakley E, 2005, B WORLD HEALTH ORGAN, V83, P656; Prabhu N T, 2001, Int J Paediatr Dent, V11, P18, DOI 10.1046/j.1365-263x.2001.00235.x; WARD W, 1999, UK PARLIAMENT CHILDR; Winstock AR, 2000, ADDICT BIOL, V5, P173, DOI 10.1080/13556210050003766	8	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2008	372	9633					97	98		10.1016/S0140-6736(08)61014-4	http://dx.doi.org/10.1016/S0140-6736(08)61014-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324XJ	18620935				2022-12-24	WOS:000257552400009
J	Watts, G				Watts, Geoff			How clean is your water?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*ASS PRESS, 2008, SEN BLAST EPA NEWS D; Collier AC, 2007, ECOHEALTH, V4, P164, DOI 10.1007/s10393-007-0105-5; DONN J, 2008, PHARM LURKING US DRI; *DRINK WAT INSP, 2001, PHARM RES DRINK WAT; *EUR MED AG, HUM MED EMEA PRES PR; Heberer T, 2002, J HYDROL, V266, P175, DOI 10.1016/S0022-1694(02)00165-8; Johnson AC, 2008, J HYDROL, V348, P167, DOI 10.1016/j.jhydrol.2007.09.054; Loos R, 2007, ANAL BIOANAL CHEM, V387, P1469, DOI 10.1007/s00216-006-1036-7; Pomati F, 2006, ENVIRON SCI TECHNOL, V40, P2442, DOI 10.1021/es051715a	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2008	337	7661							a237	10.1136/bmj.a237	http://dx.doi.org/10.1136/bmj.a237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18595920	Green Published			2022-12-24	WOS:000257961900029
J	Fazzio, TG; Huff, JT; Panning, B				Fazzio, Thomas G.; Huff, Jason T.; Panning, Barbara			An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity	CELL			English	Article							SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; INTERFERENCE; EXPRESSION; NANOG; OCT4; ACETYLATION; MAINTENANCE; DISRUPTION	Proper regulation of chromatin structure is necessary for the maintenance of cell type-specific gene expression patterns. The embryonic stem cell (ESC) expression pattern governs self-renewal and pluripotency. Here, we present an RNAi screen in mouse ESCs of 1008 loci encoding chromatin proteins. We identified 68 proteins that exhibit diverse phenotypes upon knockdown (KD), including seven subunits of the Tip60-p400 complex. Phenotypic analyses revealed that Tip60-p400 is necessary to maintain characteristic features of ESCs. We show that p400 localization to the promoters of both silent and active genes is dependent upon histone H3 lysine 4 trimethylation (H3K4me3). Furthermore, the Tip60-p400 KD gene expression profile is enriched for developmental regulators and significantly overlaps with that of the transcription factor Nanog. Depletion of Nanog reduces p400 binding to target promoters without affecting H3K4me3 levels. Together, these data indicate that Tip60-p400 integrates signals from Nanog and H3K4me3 to regulate gene expression in ESCs.	[Fazzio, Thomas G.; Huff, Jason T.; Panning, Barbara] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Fazzio, TG (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	thomas.fazzio@ucsf.edu; bpanning@biochem.ucsf.edu		Huff, Jason/0000-0002-0088-1640	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186, R01GM063671] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM085186, R01 GM063671, R01 GM085186-01A1, R01 GM63671] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Benanti JA, 2002, MOL CELL BIOL, V22, P7385, DOI 10.1128/MCB.22.21.7385-7397.2002; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Velkey JM, 2003, GENESIS, V37, P18, DOI 10.1002/gene.10218; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	327	330	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					162	174		10.1016/j.cell.2008.05.031	http://dx.doi.org/10.1016/j.cell.2008.05.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614019	Green Accepted, Bronze			2022-12-24	WOS:000257513100022
J	Stillman, MD				Stillman, Michael D.			Physicians behaving badly	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												michael.stillman@bmc.org						Moore C, 2007, ARCH INTERN MED, V167, P1305, DOI 10.1001/archinte.167.12.1305; Sijstermans R, 2007, INT J MED INFORM, V76, P336, DOI 10.1016/j.ijmedinf.2007.01.007	2	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2008	300	1					21	22		10.1001/jama.300.1.21	http://dx.doi.org/10.1001/jama.300.1.21			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320NW	18594028				2022-12-24	WOS:000257242800001
J	Sanders, GD; Bayoumi, AM; Holodnly, M; Owens, DK				Sanders, Gillian D.; Bayoumi, Ahmed M.; Holodnly, Mark; Owens, Douglas K.			Cost-effectiveness of HIV screening in patients older than 55 years of age	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR THERAPY; PLASMA VIRAL LOAD; CD4 CELL COUNT; LONG-TERM RESPONSE; RNA LEVELS; INFECTED PATIENTS; HETEROSEXUAL TRANSMISSION; PROGNOSTIC VALUE	Background: Although HIV infection is more prevalent in people younger than age 45 years, a substantial number of infections occur in older persons. Recent guidelines recommend HIV screening in patients age 13 to 64 years. The cost-effectiveness of HIV screening in patients age 55 to 75 years is uncertain. Objective: To examine the costs and benefits of HIV screening in patients age 55 to 75 years. Design: Markov model. Data Sources: Derived from the literature. Target Population: Patients age 55 to 75 years with unknown HIV status. Time Horizon: Lifetime. Perspective: Societal. Intervention: HIV screening program for patients age 55 to 75 years compared with current practice. Outcome Measures: Life-years, quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness. Results of Base-Case Analysis: For a 65-year-old patient, HIV screening using traditional counseling costs $55 440 per QALY compared with current practice when the prevalence of HIV was 0.5% and the patient did not have a sexual partner at risk. In sexually active patients, the incremental cost-effectiveness ratio was $30 020 per QALY. At a prevalence of 0.1%, HIV screening cost less than $60 000 per QALY for patients younger than age 75 years with a partner at risk if less costly streamlined counseling is used. Results of Sensitivity Analysis: Cost-effectiveness of HIV screening depended on HIV prevalence, age of the patient, counseling costs, and whether the patient was sexually active. Sensitivity analyses with other variables did not change the results substantially. Limitations: The effects of age on the toxicity and efficacy of highly active antiretroviral therapy and death from AIDS were uncertain. Sensitivity analyses exploring these variables did not qualitatively affect the results. Conclusion: If the tested population has an HIV prevalence of 0.1% or greater, HIV screening in persons from age 55 to 75 years reaches conventional levels of cost-effectiveness when counseling is streamlined and if the screened patient has a partner at risk. Screening patients with advanced age for HIV is economically attractive in many circumstances.	Duke Univ, Duke Clin Res Inst, Durham, NC 27715 USA; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Vet Affairs Palo Alto Hlth Care System, Palo Alto, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Duke University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Sanders, GD (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	gillian.sanders@duke.edu		Holodniy, Mark/0000-0002-6655-7982	NIA NIH HHS [P30 AG017253, P30-AG017253] Funding Source: Medline; NIDA NIH HHS [R01 DA015612-10, R01 DA015612, R01 DA15612-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2006, MMWR RECOMM REP; Bindman AB, 1998, JAMA-J AM MED ASSOC, V280, P1416, DOI 10.1001/jama.280.16.1416; Bonfanti P, 2000, J ACQ IMMUN DEF SYND, V23, P236; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1; Butcher D, 2000, ARCH INTERN MED, V160, P394, DOI 10.1001/archinte.160.3.394-a; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; *CDC, 1988, MMWR-MORBID MORTAL W, V36, P845; *CDC, 1988, MMWR-MORBID MORTAL W, V36, P833; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P538; *CDCP, 2001, HIV COUNS TEST PUBL; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, HIV AIDS SURV REP 20, V14; *CDCP, 2005, HIV AIDS SURV REP, V17; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P309; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Chene G, 1998, AIDS, V12, P2313, DOI 10.1097/00002030-199817000-00013; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Coombs RW, 1996, J INFECT DIS, V174, P704, DOI 10.1093/infdis/174.4.704; Cooper D, 1999, LANCET, V353, P2061, DOI 10.1016/S0140-6736(98)10391-4; D'Amato RM, 1998, ANTIVIR THER, V3, P147; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; DICLEMENTE RJ, 1995, JAMA-J AM MED ASSOC, V274, P1271, DOI 10.1001/jama.274.16.1271; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P358; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Erb P, 2000, ARCH INTERN MED, V160, P1134, DOI 10.1001/archinte.160.8.1134; ERICKSON B, 1990, SEX TRANSM DIS, V17, P194, DOI 10.1097/00007435-199010000-00009; Espinoza L, 2007, AM J PUBLIC HEALTH, V97, P144, DOI 10.2105/AJPH.2005.077461; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gable CB, 1996, J ACQ IMMUN DEF SYND, V12, P413, DOI 10.1097/00042560-199608010-00013; GalettoLacour A, 1996, J INFECT DIS, V173, P1388, DOI 10.1093/infdis/173.6.1388; Goetz MB, 2001, AIDS, V15, P1576, DOI 10.1097/00002030-200108170-00017; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Grimes RM, 2002, CLIN INFECT DIS, V34, P1530, DOI 10.1086/340404; Guardiola JM, 1999, ARCH INTERN MED, V159, P194, DOI 10.1001/archinte.159.2.194; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HARRIS RL, 1990, INFECT CONT HOSP EP, V11, P628; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hightow LB, 2003, AIDS EDUC PREV, V15, P282, DOI 10.1521/aeap.15.4.282.23826; *HITS 2000 INV, 2004, J ACQ IMMUN DEF SYND, V35, P511; *HIV COST SERV UT, 2001, NEW ENGL J MED, V344, P817; HOLMAN S, 1994, PUBLIC HEALTH REP, V109, P521; HONIDEN S, 2002, MED DECIS MAKING, V22, P560; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Ioannidis JPA, 1996, AIDS, V10, P255, DOI 10.1097/00002030-199603000-00003; Irwin K, 1996, ANN INTERN MED, V125, P471, DOI 10.7326/0003-4819-125-6-199609150-00007; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kassler WJ, 1997, AIDS, V11, P1045, DOI 10.1097/00002030-199708000-00014; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kaufmann GR, 1998, AIDS, V12, P1625, DOI 10.1097/00002030-199813000-00009; KEET IPM, 1992, AIDS, V6, P223, DOI 10.1097/00002030-199202000-00014; Keet IPM, 1997, J INFECT DIS, V176, P665, DOI 10.1086/514088; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; Keita-Perse O, 1998, AIDS, V12, pF175, DOI 10.1097/00002030-199815000-00002; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Kelen GD, 1996, ANN EMERG MED, V27, P687, DOI 10.1016/S0196-0644(96)70184-1; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Knobel H, 2001, AIDS, V15, P1591, DOI 10.1097/00002030-200108170-00025; Koblin BA, 1999, AM J EPIDEMIOL, V150, P1026, DOI 10.1093/oxfordjournals.aje.a009926; Kozak Lola Jean, 2004, Vital Health Stat 13, P1; LAUMAN EO, 1994, SOCIAL ORG SEXUALITY; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; LEMP GF, 1994, JAMA-J AM MED ASSOC, V272, P449, DOI 10.1001/jama.272.6.449; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; LOVEDAY C, 1995, LANCET, V345, P790, DOI 10.1016/S0140-6736(95)90668-1; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MACDONALD KL, 1989, ANN INTERN MED, V110, P617, DOI 10.7326/0003-4819-110-8-617; Maher K, 1999, J ACQ IMMUN DEF SYND, V22, P358; Manfredi R, 2004, AGEING RES REV, V3, P31, DOI 10.1016/j.arr.2003.07.001; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Mole L, 1999, PHARMACOECONOMICS, V16, P307, DOI 10.2165/00019053-199916030-00007; Monforte AD, 1998, AIDS, V12, P1631, DOI 10.1097/00002030-199813000-00010; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Montaner JSG, 1998, AIDS, V12, pF23, DOI 10.1097/00002030-199805000-00003; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; O'Brien TR, 1998, J ACQ IMMUN DEF SYND, V18, P155, DOI 10.1097/00042560-199806010-00007; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Orlando G, 2006, HIV MED, V7, P549, DOI 10.1111/j.1468-1293.2006.00420.x; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Paredes R, 1999, J ACQ IMMUN DEF SYND, V22, P132; Paris D, 1999, AIDS RES HUM RETROV, V15, P1631, DOI 10.1089/088922299309676; Pedersen C, 1997, J ACQ IMMUN DEF SYND, V16, P93, DOI 10.1097/00042560-199710010-00004; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Phillips AN, 2007, LANCET, V370, P1923, DOI 10.1016/S0140-6736(07)61815-7; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; *PRES US EX OFF, BUDG US GOV FISC YEA; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 1999, J ACQ IMMUN DEF SYND, V22, P260; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Reijers MHE, 2000, AIDS, V14, P59, DOI 10.1097/00002030-200001070-00007; REVICKI DA, 1995, MED CARE, V33, pAS173; Rhone SA, 1998, J INFECT DIS, V178, P662, DOI 10.1086/515365; Rhone SA, 1998, AIDS, V12, P619, DOI 10.1097/00002030-199806000-00011; Roca B, 1999, J INFECTION, V39, P141, DOI 10.1016/S0163-4453(99)90006-3; Roca B, 2000, AIDS, V14, P157, DOI 10.1097/00002030-200001280-00011; ROSENBERG PS, 1995, SCIENCE, V270, P1372, DOI 10.1126/science.270.5240.1372; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Salzberger B, 1999, Eur J Med Res, V4, P449; SAMUEL MC, 1993, J ACQ IMMUN DEF SYND, V6, P303; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; SCHWARTZ JS, 1990, JAMA-J AM MED ASSOC, V264, P1704, DOI 10.1001/jama.264.13.1704; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Sinclair M, 2004, INT J STD AIDS, V15, P33, DOI 10.1258/095646204322637236; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Spijkerman IJB, 1997, AIDS, V11, P1383, DOI 10.1097/00002030-199711000-00013; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; Staszewski S, 1998, AIDS, V12, P2360; Stuart JWTC, 1999, AIDS, V13, pF53, DOI 10.1097/00002030-199905070-00001; Sullivan AK, 1998, INT J STD AIDS, V9, P711, DOI 10.1258/0956462981921251; Tebas P, 1999, AIDS, V13, pF23, DOI 10.1097/00002030-199902040-00002; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tsevat J, 1996, MED CARE, V34, P44, DOI 10.1097/00005650-199601000-00004; Tsevat J, 1999, ANN INTERN MED, V131, P194, DOI 10.7326/0003-4819-131-3-199908030-00006; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; TURNER BJ, 1994, ARCH INTERN MED, V154, P1561, DOI 10.1001/archinte.154.14.1561; *US GEN ACC OFF, 1998, FUND IMPL NEW COMB T; Valdez H, 1999, ARCH INTERN MED, V159, P1771, DOI 10.1001/archinte.159.15.1771; van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Walensky R. P., 2004, Morbidity and Mortality Weekly Report, V53, P523; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Welch K, 2000, CLIN INFECT DIS, V30, P407, DOI 10.1086/313670; Welles SL, 1996, J INFECT DIS, V174, P696, DOI 10.1093/infdis/174.4.696; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Yerly S, 1998, ARCH INTERN MED, V158, P247, DOI 10.1001/archinte.158.3.247; Zingmond DS, 2003, JAIDS-J ACQ IMM DEF, V33, pS84, DOI 10.1097/00126334-200306012-00005; 2000, MED LETT DRUGS THER, V42, P1	164	57	60	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2008	148	12					889	+		10.7326/0003-4819-148-12-200806170-00002	http://dx.doi.org/10.7326/0003-4819-148-12-200806170-00002			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323DU	18559840	Green Accepted			2022-12-24	WOS:000257425000001
J	Ratcliff, F; Harrison, BD; Baulcombe, DC				Ratcliff, F; Harrison, BD; Baulcombe, DC			A similarity between viral defense and gene silencing in plants	SCIENCE			English	Article							BLACK RING VIRUS; NUCLEOTIDE-SEQUENCE; EXPRESSION; RESISTANCE; RNA	Gene silencing in plants, in which an endogenous gene is suppressed by introduction of a related transgene, has been used for crop improvement. Observations that viruses are potentially both initiators and targets of gene silencing suggested that this phenomenon may be related to natural defense against viruses. Supporting this idea, it was found that nepovirus infection of nontransgenic plants induces a resistance mechanism that is similar to transgene-induced gene silencing.	UNIV DUNDEE,DEPT BIOL SCI,DUNDEE DD1 4HN,SCOTLAND	University of Dundee				Baulcombe, David/0000-0003-0780-6878				Baulcombe DC, 1996, PLANT CELL, V8, P1833, DOI 10.1105/tpc.8.10.1833; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Baulcombe DC, 1996, CURR OPIN BIOTECH, V7, P173, DOI 10.1016/S0958-1669(96)80009-7; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Culver JN, 1996, VIROLOGY, V226, P228, DOI 10.1006/viro.1996.0650; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; GREIF C, 1988, J GEN VIROL, V69, P1517, DOI 10.1099/0022-1317-69-7-1517; HARRISON BD, 1958, J GEN MICROBIOL, V18, P450, DOI 10.1099/00221287-18-2-450; HUISMAN MJ, 1988, J GEN VIROL, V69, P1789, DOI 10.1099/0022-1317-69-8-1789; Jorgensen R, 1992, AGBIOTECH NEWS INFOR, V4, P265; JORGENSEN RA, 1995, SCIENCE, V268, P686, DOI 10.1126/science.268.5211.686; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; LE GALL O, 1995, J GEN VIROL, V76, P1279, DOI 10.1099/0022-1317-76-5-1279; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; LISTER RM, 1967, ANN APPL BIOL, V59, P49, DOI 10.1111/j.1744-7348.1967.tb04416.x; MATZKE MA, 1995, HOMOLOGOUS RECOMBINA, P271; MATZKE MA, 1995, PLANT PHYSIOL, V107, P6679; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; ROTT ME, 1995, J GEN VIROL, V76, P465, DOI 10.1099/0022-1317-76-2-465; RUIZ T, UNPUB; SHERWOOD JL, 1988, PLANT RESISTANCE VIR, P136; Sijen T, 1996, PLANT CELL, V8, P2277, DOI 10.1105/tpc.8.12.2277; SMITH HA, 1994, PLANT CELL, V6, P1441, DOI 10.1105/tpc.6.10.1441; Wingard SA, 1928, J AGRIC RES, V37, P0127	25	595	664	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 6	1997	276	5318					1558	1560		10.1126/science.276.5318.1558	http://dx.doi.org/10.1126/science.276.5318.1558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XC701	18610513				2022-12-24	WOS:A1997XC70100041
J	La Scola, B; Desnues, C; Pagnier, I; Robert, C; Barrassi, L; Fournous, G; Merchat, M; Suzan-Monti, M; Forterre, P; Koonin, E; Raoult, D				La Scola, Bernard; Desnues, Christelle; Pagnier, Isabelle; Robert, Catherine; Barrassi, Lina; Fournous, Ghislain; Merchat, Michele; Suzan-Monti, Marie; Forterre, Patrick; Koonin, Eugene; Raoult, Didier			The virophage as a unique parasite of the giant mimivirus	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; OCEAN SAMPLING EXPEDITION; BACTERIAL; VIRUSES	Viruses are obligate parasites of Eukarya, Archaea and Bacteria. Acanthamoeba polyphaga mimivirus ( APMV) is the largest known virus; it grows only in amoeba and is visible under the optical microscope. Mimivirus possesses a 1,185- kilobase double- stranded linear chromosome whose coding capacity is greater than that of numerous bacteria and archaea(1-3). Here we describe an icosahedral small virus, Sputnik, 50 nm in size, found associated with a new strain of APMV. Sputnik cannot multiply in Acanthamoeba castellanii but grows rapidly, after an eclipse phase, in the giant virus factory found in amoebae co- infected with APMV(4). Sputnik growth is deleterious to APMV and results in the production of abortive forms and abnormal capsid assembly of the host virus. The Sputnik genome is an 18.343- kilobase circular double- stranded DNA and contains genes that are linked to viruses infecting each of the three domains of life Eukarya, Archaea and Bacteria. Of the 21 predicted protein- coding genes, eight encode proteins with detectable homologues, including three proteins apparently derived from APMV, a homologue of an archaeal virus integrase, a predicted primase helicase, a packaging ATPase with homologues in bacteriophages and eukaryotic viruses, a distant homologue of bacterial insertion sequence transposase DNA- binding subunit, and a Zn- ribbon protein. The closest homologues of the last four of these proteins were detected in the Global Ocean Survey environmental data set(5), suggesting that Sputnik represents a currently unknown family of viruses. Considering its functional analogy with bacteriophages, we classify this virus as a virophage. The virophage could be a vehicle mediating lateral gene transfer between giant viruses.	[La Scola, Bernard; Desnues, Christelle; Pagnier, Isabelle; Robert, Catherine; Barrassi, Lina; Fournous, Ghislain; Suzan-Monti, Marie; Raoult, Didier] Univ Mediterranee, URMITE, Ctr Natl Rech Sci, Fac Med,UMR IRD 6236, F-13385 Marseille 5, France; [Merchat, Michele] Climespace, F-75012 Paris, France; [Forterre, Patrick] Univ Paris 11, Ctr Orsay, Inst Microbiol & Genet, F-91405 Orsay, France; [Forterre, Patrick] Inst Pasteur, Dept Microbiol, F-75724 Paris 15, France; [Koonin, Eugene] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; GDF Suez; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Raoult, D (corresponding author), Univ Mediterranee, URMITE, Ctr Natl Rech Sci, Fac Med,UMR IRD 6236, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	didier.raoult@gmail.com	Desnues, Christelle/B-1383-2010; RAOULT, Didier/A-8434-2008; Desnues, Christelle/ABG-2910-2021; LA SCOLA, Bernard/P-6477-2016	Desnues, Christelle/0000-0002-2178-0355; RAOULT, Didier/0000-0002-0633-5974; Desnues, Christelle/0000-0002-2178-0355; LA SCOLA, Bernard/0000-0001-8006-7704; Pagnier, Isabelle/0000-0002-1724-3450	Centre National de la Recherche Scientifique; CIFFRE fellowship; Intramural Research Program of the National Institutes of Health; National Library of Medicine; Institut Universitaire de France	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); CIFFRE fellowship; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Institut Universitaire de France	We thank X. de Lamballerie, S. Azza, P. de Clocquement, L. Espinosa, B. Campagna, N. Aldrovandi, V. Brice, A. Bernard, C. Ivars, B. Giumelli and Y. Wolf for expert assistance. This work was funded by the Centre National de la Recherche Scientifique (CNRS, credits recurrents). I. P. is funded by a CIFFRE fellowship, E. K. is supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, and P. F. is funded by the Institut Universitaire de France.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; De Silva FS, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-23; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAUQUET CM, 2005, VIRUS TAXONOMY, P1163; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-1; Koonin EV, 2005, CURR BIOL, V15, pR167, DOI 10.1016/j.cub.2005.02.042; Kowalczewska M, 2007, FUTURE MICROBIOL, V2, P631, DOI 10.2217/17460913.2.6.631; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; La Scola B, 2003, SCIENCE, V299, P2033; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; OLIVEIRA S, 1995, VIROLOGY, V207, P392, DOI 10.1006/viro.1995.1098; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456	27	373	412	7	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					100	U65		10.1038/nature07218	http://dx.doi.org/10.1038/nature07218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18690211				2022-12-24	WOS:000258890200045
J	Kurth, T; Schurks, M; Logroscino, G; Gaziano, JM; Buring, JE				Kurth, Tobias; Schurks, Markus; Logroscino, Giancarlo; Gaziano, J. Michael; Buring, Julie E.			Migraine, vascular risk, and cardiovascular events in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; ISCHEMIC-STROKE; DISEASE; HEADACHE; PREVENTION	Objectives To evaluate whether the association between migraine with aura and increased risk of cardiovascular disease is modified by vascular risk groups as measured by the Framingham risk score for coronary heart disease. Design Prospective cohort study. Setting Women's health study, United States. Participants 27 519 women who were free from cardiovascular disease at baseline with available information on the Framingham risk score and migraine status. Main outcome measures Time to major cardiovascular disease event (non-fatal myocardial infarction, non-fatal ischaemic stroke, death from ischaemic cardiovascular disease), myocardial infarction, and ischaemic stroke. Results At baseline, 3577 (13.0%) women reported, active migraine, of whom 1418 (39.6%) reported migraine with aura. During 11.9 years of follow-up, there were 697 cardiovascular disease events. We stratified participants based on 10 year risk of coronary heart disease estimated from the Framingham risk score (1%, 2-4%, 5-9%, and >= 10%). Compared with women without migraine, the age adjusted hazard ratios in women with active migraine with aura were 1.93 (95% confidence interval 1.45 to 2.56) for major cardiovascular disease, 1.80 (1.16 to 2.79) for ischaemic stroke, and 1.94 (1.27 to 2.95) for myocardial infarction. When stratified by Framingham risk score, the association between migraine with aura and major cardiovascular disease was strongest in the lowest risk score group. There was a diametric association pattern for ischaemic stroke and myocardial infarction. Compared with women without migraine, the age adjusted hazard ratios in women who reported migraine with aura in the lowest Framingham risk score group were 3.88 (1.87 to 8.08) for ischaemic stroke and 1.29 (0.40 to 4.21) for myocardial infarction. Hazard ratios in women with migraine with aura in the highest Framingham risk score group were 1.00 (0.24 to 4.14) for ischaemic stroke and 3.34 (1.50 to 7.46) for myocardial infarction. Women with migraine without aura were not at increased risk of ischaemic stroke or myocardial infarction in any of the Framingham risk score groups. Conclusion The association between migraine with aura and cardiovascular disease varies by vascular risk status. Information on history of migraine and vascular risk status might help to identify women at increased risk for specific future cardiovascular disease events. Trial registration Clinical trials NCT00000479.	[Kurth, Tobias; Schurks, Markus; Gaziano, J. Michael; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Gaziano, J. Michael; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Logroscino, Giancarlo] Univ Bari, Sch Med, Dept Neurol & Psychiat, Bari, Italy; [Gaziano, J. Michael] Boston VA Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Universita degli Studi di Bari Aldo Moro; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School	Kurth, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA.	tkurth@rics.bwh.harvard.edu	LOGROSCINO, GIANCARLO/K-5148-2016; Potter, Joseph E/A-3122-2008; Kurth, Tobias/A-9243-2012	LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Kurth, Tobias/0000-0001-7169-2620	National Heart. Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-47988]; Donald W Reynolds Foundation; Leducq Foundation; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart. Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Leducq Foundation(Leducq Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The women's health study is supported by grants and from the National Heart. Lung, and Blood Institute (HL-043851 and HL-080467). and the National Cancer Institute (CA-47988). The research for this work was supported by grants from the Donald W Reynolds Foundation, the Leducq Foundation, and the Doris Duke Charitable Foundation.	Ahmed B, 2006, AM J MED, V119, P670, DOI 10.1016/j.amjmed.2006.03.023; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bensenor IM, 2001, CEPHALALGIA, V21, P175, DOI 10.1046/j.0333-1024.2001.00194.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Goadsby PJ, 2002, CEPHALALGIA, V22, P107, DOI 10.1046/j.1468-2982.2002.00323.x; HENRICH JB, 1989, J CLIN EPIDEMIOL, V42, P773, DOI 10.1016/0895-4356(89)90075-9; *INT HEAD SOC HEAD, 1988, CEPHALALGIA S7, V8, pS1; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kurth T, 2008, CEPHALALGIA, V28, P49, DOI 10.1111/j.1468-2982.2007.01467.x; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Longoni M, 2006, NEUROL SCI, V27, pS107, DOI 10.1007/s10072-006-0582-2; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rose KM, 2007, NEUROLOGY, V68, P1694, DOI 10.1212/01.wnl.0000261916.42871.05; Rose KM, 2004, NEUROLOGY, V63, P2233, DOI 10.1212/01.WNL.0000147289.50605.DC; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; Tietjen GE, 2007, THROMB RES, V119, P217, DOI 10.1016/j.thromres.2005.12.020; Totaro R, 1997, CEPHALALGIA, V17, P191, DOI 10.1046/j.1468-2982.1997.1703191.x; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed	32	170	172	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2008	337	7666							a636	10.1136/bmj.a636	http://dx.doi.org/10.1136/bmj.a636			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340TZ	18687721	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000258669200024
J	Alder, NN; Jensen, RE; Johnson, AE				Alder, Nathan N.; Jensen, Robert E.; Johnson, Arthur E.			Fluorescence mapping of mitochondrial TM23 complex reveals a water-facing, substrate-interacting helix surface	CELL			English	Article							MULTIPLE CONDUCTANCE CHANNEL; TRANSLOCATION CONTACT SITES; TIME-RESOLVED FLUORESCENCE; PROTEIN IMPORT MOTOR; INNER MEMBRANE; PREPROTEIN TRANSLOCASE; ER MEMBRANE; PRESEQUENCE TRANSLOCASE; PERMEABILITY BARRIER; INTERMEMBRANE SPACE	Protein translocation across the mitochondrial inner membrane is mediated by the TIM23 complex. While its central component, Tim23, is believed to form a protein-conducting channel, the regions of this subunit that face the imported protein are unknown. To examine Tim23 structure and environment in intact membranes at high resolution, various derivatives, each with a single, environment-sensitive fluorescent probe positioned at a specific site, were assembled into functional TIM23 complexes in active mitochondria and analyzed by multiple spectral techniques. Probes placed sequentially throughout a transmembrane region that was identified by crosslinking as part of the protein-conducting channel revealed an a helix in an amphipathic environment. Probes on the aqueous-facing helical surface specifically underwent spectral changes during protein import, and their accessibility to hydrophilic quenching agents is considered in terms of channel gating. This approach has therefore provided an unprecedented view of a translocon channel structure in an intact, fully operational, membrane-embedded complex.	[Alder, Nathan N.; Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Jensen, Robert E.] Johns Hopkins Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Johns Hopkins University; Johns Hopkins Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu	Johnson, Arthur E/G-3457-2012	Alder, Nathan/0000-0003-4474-7803	National Institutes of Health (NIH) [GM64580, GM26494, GM54021]; NIH National Research Service Award [GM70266]; Robert A. Welch Foundation [BE-0017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064580, R01GM026494, F32GM070266] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Yiwei Miao and Yuanlong Shao for outstanding technical assistance, and to the members of the Johnson lab for helpful discussions. This work was supported by National Institutes of Health (NIH) grants GM64580 (to A.E.J. and R.E.J.), GM26494 (A.E.J.), and GM54021 (R.E.J.), NIH National Research Service Award grant GM70266 (N.N.A.), and by the Robert A. Welch Foundation (chair grant BE-0017).	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bomer U, 1997, EMBO J, V16, P2205, DOI 10.1093/emboj/16.9.2205; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Dattelbaum JD, 2005, PROTEIN SCI, V14, P284, DOI 10.1110/ps.041146005; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Futamura A, 2001, BIOCHEMISTRY-US, V40, P6680, DOI 10.1021/bi0029346; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Jittikoon J, 2007, BIOCHEMISTRY-US, V46, P10950, DOI 10.1021/bi7008213; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; JOHNSON AE, 1976, BIOCHEMISTRY-US, V15, P569, DOI 10.1021/bi00648a018; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; KUBRICH M, 1994, FEBS LETT, V349, P222, DOI 10.1016/0014-5793(94)00670-9; Kushnareva YE, 1999, ARCH BIOCHEM BIOPHYS, V366, P107, DOI 10.1006/abbi.1999.1190; LANCET D, 1977, BIOCHEMISTRY-US, V16, P5150, DOI 10.1021/bi00642a031; LIN S, 1991, PHOTOCHEM PHOTOBIOL, V54, P361, DOI 10.1111/j.1751-1097.1991.tb02028.x; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Meier S, 2005, J BIOL CHEM, V280, P7777, DOI 10.1074/jbc.M412158200; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Musse AA, 2006, J BIOL CHEM, V281, P885, DOI 10.1074/jbc.M511140200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; Reinhart G D, 1991, J Fluoresc, V1, P153, DOI 10.1007/BF00865362; Ryan KR, 1998, MOL CELL BIOL, V18, P178, DOI 10.1128/MCB.18.1.178; RYAN KR, 1993, J BIOL CHEM, V268, P23743; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Sirrenberg C, 1997, J BIOL CHEM, V272, P29963, DOI 10.1074/jbc.272.47.29963; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	59	80	80	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 8	2008	134	3					439	450		10.1016/j.cell.2008.06.007	http://dx.doi.org/10.1016/j.cell.2008.06.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692467	Bronze			2022-12-24	WOS:000258665500017
J	Rosengarten, M; Michael, M; Mykhalovskiy, E; Imrie, J				Rosengarten, Marsha; Michael, Mike; Mykhalovskiy, Eric; Imrie, John			The challenges of technological innovation in HIV	LANCET			English	Editorial Material							PREVENTION		[Rosengarten, Marsha; Michael, Mike] Univ London Goldsmiths Coll, Ctr Study Invent & Social Proc, Dept Sociol, London SE14 6NW, England; [Mykhalovskiy, Eric] York Univ, Dept Sociol, Toronto, ON M3J 2R7, Canada; [Rosengarten, Marsha; Imrie, John] Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia; [Imrie, John] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	University of London; Goldsmiths University London; York University - Canada; University of New South Wales Sydney; University of Kwazulu Natal	Rosengarten, M (corresponding author), Univ London Goldsmiths Coll, Ctr Study Invent & Social Proc, Dept Sociol, London SE14 6NW, England.	m.rosengarten@gold.ac.uk		rosengarten, marsha/0000-0003-3820-4810				Chesney M, 2003, AIDS PATIENT CARE ST, V17, P169, DOI 10.1089/108729103321619773; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Law John, 1999, ACTOR NETWORK THEORY; Michael Mike, 2000, RECONNECTING CULTURE; Mol Annemarie, 2003, BODY MULTIPLE ONTOLO; Mykhalovskiy Eric, 2004, SOCIAL THEORY HLTH, V2, P315, DOI DOI 10.1057/PALGRAVE.STH.8700037; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Stekler J, 2007, J INFECT DIS, V196, P336, DOI 10.1086/519173	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 2	2008	372	9636					357	358		10.1016/S0140-6736(08)61140-X	http://dx.doi.org/10.1016/S0140-6736(08)61140-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675674	Green Accepted, Green Submitted			2022-12-24	WOS:000258196000010
J	Hoegh-Guldberg, O; Hughes, L; McIntyre, S; Lindenmayer, DB; Parmesan, C; Possingham, HP; Thomas, CD				Hoegh-Guldberg, O.; Hughes, L.; McIntyre, S.; Lindenmayer, D. B.; Parmesan, C.; Possingham, H. P.; Thomas, C. D.			Assisted colonization and rapid climate change	SCIENCE			English	Editorial Material							EVOLUTIONARY RESPONSES; CORAL-REEFS; CONSEQUENCES; FORESTS; DEBATE; ERA		[Hoegh-Guldberg, O.] Univ Queensland, Ctr Marine Studies, Australian Res Council Ctr Excellence Reef Studie, St Lucia, Qld 4072, Australia; [Hoegh-Guldberg, O.] Univ Queensland, Coral Reef Targeted Res Project, St Lucia, Qld 4072, Australia; [Hughes, L.] Macquarie Univ, Sch Biol Sci, N Ryde, NSW 2109, Australia; [McIntyre, S.] CSIRO Sustainable Ecosyst, Canberra, ACT 2601, Australia; [Lindenmayer, D. B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Parmesan, C.] Univ Texas Austin, Austin, TX 78712 USA; [Possingham, H. P.] Univ Queensland, Ctr Ecol, Ctr Appl Environm Decis Anal, Brisbane, Qld 4072, Australia; [Thomas, C. D.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Queensland; University of Queensland; Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; University of Texas System; University of Texas Austin; University of Queensland; University of York - UK	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, Australian Res Council Ctr Excellence Reef Studie, St Lucia, Qld 4072, Australia.	oveh@uq.edu.au; lhughes@rna.bio.mq.edu.au; Sue.McIntyre@csiro.au; david.lindenmayer@anu.edu.au; parmesan@uts.cc.utexas.edu; h.possingham@uq.edu.au; cdt2@york.ac.uk	Possingham, Hugh/B-1337-2008; McIntyre, Sue/F-1885-2010; Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011; Parmesan, Camille/GVT-5674-2022; Thomas, Chris D/A-1894-2012; POSSINGHAM, HUGH/R-8310-2019; Lindenmayer, David B/P-7183-2017; Thomas, Chris D/A-1460-2014	Possingham, Hugh/0000-0001-7755-996X; McIntyre, Sue/0000-0002-0399-750X; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Thomas, Chris D/0000-0003-2822-1334; POSSINGHAM, HUGH/0000-0001-7755-996X; Lindenmayer, David B/0000-0002-4766-4088; Thomas, Chris D/0000-0003-2822-1334; Hughes, Lesley/0000-0003-0313-9780; Parmesan, Camille/0000-0002-1515-274X				Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Blumstein DT, 2002, J BIOGEOGR, V29, P685, DOI 10.1046/j.1365-2699.2002.00717.x; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Kingsolver JG, 2007, J EVOLUTION BIOL, V20, P892, DOI 10.1111/j.1420-9101.2007.01318.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Manning AD, 2007, CONSERV SCI PRACT, V1, P349; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rosenhead J., 1989, RATIONAL ANAL PROBLE, P193; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464	23	607	624	9	452	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					345	346		10.1126/science.1157897	http://dx.doi.org/10.1126/science.1157897			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635780				2022-12-24	WOS:000257713900025
J	Strathdee, SA; Magis-Rodriguez, C				Strathdee, Steffanie A.; Magis-Rodriguez, Carlos			Mexico's evolving HIV epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FEMALE SEX WORKERS; US BORDER CITIES; INFECTION; TIJUANA		[Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, Div Int Hlth & Cross Cultural Med, La Jolla, CA 92093 USA; [Magis-Rodriguez, Carlos] SIDA, Ctr Nacl Prevent & Control, Mexico City, DF, Mexico	University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Sch Med, Div Int Hlth & Cross Cultural Med, 9500 Gilman Dr,Mailstop 0622, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X	FOGARTY INTERNATIONAL CENTER [R25TW007500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA019829, R01DA019829, R21DA024381, R01DA023877] Funding Source: NIH RePORTER; FIC NIH HHS [R25TW0075, R25 TW007500-01A1, R25 TW007500] Funding Source: Medline; NIDA NIH HHS [R01 DA023877-01A1, R01 DA019829, R01 DA023877, R01DA019829, R37 DA019829, R01 DA019829-01A1, R21 DA024381, R21 DA024381-03] Funding Source: Medline; NIMH NIH HHS [R01MH065849, R01 MH065849] Funding Source: Medline; PHS HHS [R21024381] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bautista-Arredondo S, 2006, AIDS, V20, P101, DOI 10.1097/01.aids.0000198096.08444.53; Brouwer KC, 2006, J URBAN HEALTH, V83, P299, DOI 10.1007/s11524-005-9027-0; BROUWER KC, DEPORTATION US MEXIC; GAYET CMC, 2007, PRACTICAS SEXUALES P; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; Magis-Rodriguez C, 2004, JAIDS-J ACQ IMM DEF, V37, pS215, DOI 10.1097/01.qai.0000141252.16099.af; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; PATTERSON TL, 2008, 17 INT C AIDS AUG 3; RITIENI A, 2006, PREVALENCE HIV INFEC; *SECR SAL, 2007, PAN EP VIH SIDA ITS; STRATHDEE SA, 2008, 17 INT C AIDS AUG 3; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, SEX TRANSM DIS, V35, P263, DOI 10.1097/OLQ.0b013e31815b0; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001	15	100	100	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2008	300	5					571	573		10.1001/jama.300.5.571	http://dx.doi.org/10.1001/jama.300.5.571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333YG	18677029	Green Accepted			2022-12-24	WOS:000258188900018
J	Zlotorynski, E; Agami, R				Zlotorynski, Eitan; Agami, Reuven			A PASport to cellular proliferation	CELL			English	Editorial Material							MICRORNAS; MECHANISMS; EXPRESSION	The use of alternative polyadenylation sites produces mRNA isoforms with different 3' untranslated regions. A recent report in Science (Sandberg et al., 2008) suggests that alternative polyadenylation is connected to microRNA-mediated regulation of gene expression as part of a global program for cellular proliferation.	[Zlotorynski, Eitan; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1006 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1006 CX Amsterdam, Netherlands.	ragami@nki.nl	agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473				Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	10	7	7	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					208	210		10.1016/j.cell.2008.07.003	http://dx.doi.org/10.1016/j.cell.2008.07.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662535	Bronze			2022-12-24	WOS:000257891700009
J	Audero, E; Coppi, E; Mlinar, B; Rossetti, T; Caprioli, A; Al Banchaabouchi, M; Corradetti, R; Gross, C				Audero, Enrica; Coppi, Elisabetta; Mlinar, Boris; Rossetti, Tiziana; Caprioli, Antonio; Al Banchaabouchi, Mumna; Corradetti, Renato; Gross, Cornelius			Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition	SCIENCE			English	Article							BROWN ADIPOSE-TISSUE; DORSAL RAPHE NEURONS; BRAIN-STEM ABNORMALITIES; SINGLE-UNIT RESPONSES; NORMAL ANXIETY-LIKE; MEDULLARY RAPHE; CONSCIOUS RATS; MICE; THERMOGENESIS; RECEPTOR	Sudden infant death syndrome is the leading cause of death in the postneonatal period in developed countries. Postmortem studies show alterations in serotonin neurons in the brainstem of such infants. However, the mechanism by which altered serotonin homeostasis might cause sudden death is unknown. We investigated the consequences of altering the autoinhibitory capacity of serotonin neurons with the reversible overexpression of serotonin 1A autoreceptors in transgenic mice. Overexpressing mice exhibited sporadic bradycardia and hypothermia that occurred during a limited developmental period and frequently progressed to death. Moreover, overexpressing mice failed to activate autonomic target organs in response to environmental challenges. These findings show that excessive serotonin autoinhibition is a risk factor for catastrophic autonomic dysregulation and provide a mechanism for a role of altered serotonin homeostasis in sudden infant death syndrome.	[Audero, Enrica; Rossetti, Tiziana; Al Banchaabouchi, Mumna; Gross, Cornelius] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Coppi, Elisabetta; Mlinar, Boris; Corradetti, Renato] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Caprioli, Antonio] Sigma Tau Pharmaceut Co, Lab Behav Neuropharmacol, I-00040 Pomezia, Italy	European Molecular Biology Laboratory (EMBL); University of Florence; Leadiant Biosciences	Gross, C (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	Mlinar, Boris/A-7034-2008; Coppi, Elisabetta/K-6705-2016; Corradetti, Renato/A-1604-2008	Mlinar, Boris/0000-0001-9082-0827; Coppi, Elisabetta/0000-0003-4434-5919; Corradetti, Renato/0000-0002-2588-0484; Audero, Enrica/0000-0002-6138-244X	NIMH NIH HHS [MH64948] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH064948] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Erickson JT, 2007, RESP PHYSIOL NEUROBI, V159, P85, DOI 10.1016/j.resp.2007.06.002; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Guzman-Marin R, 2000, BRAIN RES, V875, P23, DOI 10.1016/S0006-8993(00)02561-0; Haddjeri N, 2004, NEUROPSYCHOPHARMACOL, V29, P1800, DOI 10.1038/sj.npp.1300489; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Heron Melonie, 2007, Natl Vital Stat Rep, V56, P1; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Liu RJ, 2005, EUR J NEUROSCI, V21, P945, DOI 10.1111/j.1460-9568.2005.03930.x; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Martin-Cora FJ, 2000, NEUROSCIENCE, V98, P301, DOI 10.1016/S0306-4522(00)00133-0; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; MENY RG, 1994, PEDIATRICS, V93, P44; Mlinar B, 2005, NEUROREPORT, V16, P1351, DOI 10.1097/01.wnr.0000175249.25535.bf; Morrison SF, 1999, AM J PHYSIOL-REG I, V276, pR962, DOI 10.1152/ajpregu.1999.276.4.R962; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Ootsuka Y, 2006, NEUROSCI LETT, V395, P170, DOI 10.1016/j.neulet.2005.10.062; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Richer M, 2002, EUR J PHARMACOL, V435, P195, DOI 10.1016/S0014-2999(01)01607-7; Taylor NC, 2005, J PHYSIOL-LONDON, V566, P543, DOI 10.1113/jphysiol.2005.083873; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	33	72	83	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					130	133		10.1126/science.1157871	http://dx.doi.org/10.1126/science.1157871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599790				2022-12-24	WOS:000257320800054
J	Daum, RS				Daum, Robert S.			Removing the golden coat of Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIONS		Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago	Daum, RS (corresponding author), Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA.							Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891	3	20	20	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					85	87		10.1056/NEJMcibr0803278	http://dx.doi.org/10.1056/NEJMcibr0803278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596277				2022-12-24	WOS:000257246000013
J	Bedri, A; Gudetta, B; Isehak, A; Kumbi, S; Lulseged, S; Mengistu, Y; Bhore, AV; Bhosale, R; Varadhrajan, V; Gupte, N; Sastry, J; Suryavanshi, N; Tripathy, S; Mmiro, F; Mubiru, M; Onyango, C; Taylor, A; Musoke, P; Nakabiito, C; Abashawl, A; Adamu, R; Antelman, G; Bollinger, RC; Bright, P; Chaudhary, MA; Coberly, J; Guay, L; Fowler, MG; Gupta, A; Hassen, E; Jackson, JB; Moulton, LH; Nayak, U; Omer, SB; Propper, L; Ram, M; Rexroad, V; Ruff, AJ; Shankar, A; Zwerski, S				Bedri, Abubaker; Gudetta, Berhanu; Isehak, Abdulhamid; Kumbi, Solomon; Lulseged, Sileshi; Mengistu, Yohannes; Bhore, Arvind V.; Bhosale, Ramesh; Varadhrajan, Venkat; Gupte, Nikhil; Sastry, Jayagowri; Suryavanshi, Nishi; Tripathy, Srikanth; Mmiro, Francis; Mubiru, Michael; Onyango, Carolyne; Taylor, Adrian; Musoke, Philippa; Nakabiito, Clemensia; Abashawl, Aida; Adamu, Rahel; Antelman, Gretchen; Bollinger, Robert C.; Bright, Patricia; Chaudhary, Mohammad A.; Coberly, Jacqueline; Guay, Laura; Fowler, Mary Glenn; Gupta, Amita; Hassen, Elham; Jackson, J. Brooks; Moulton, Lawrence H.; Nayak, Uma; Omer, Saad B.; Propper, Lidia; Ram, Malathi; Rexroad, Vivian; Ruff, Andrea J.; Shankar, Anita; Zwerski, Sheryl		Six Week Extended Dose Nevirapine	Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials	LANCET			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; SINGLE; INTRAPARTUM; ZIDOVUDINE; PROPHYLAXIS; RESISTANCE; LAMIVUDINE; VARIANTS; KAMPALA	Background UNICEF/WHO recommends that infants born to HIVinfected mothers who do not have access to acceptable, feasible, affordable, sustainable, and safe replacement feeding should be exclusively breastfed for at least 6 months. The aim of three trials in Ethiopia, India, and Uganda was to assess whether daily nevirapine given to breastfed infants through 6 weeks of age can decrease HIV transmission via breastfeeding. Methods HIV-infected women breastfeeding their infants were eligible for participation. Participants were randomly assigned to receive either single-dose nevirapine (nevirapine 200 mg to women in labour and nevirapine 2 mg/kg to newborns after birth) or 6 week extended-dose nevirapine (nevirapine 200 mg to women in labour and nevirapine 2 mg/kg to newborn babies after birth plus nevirapine 5 mg daily from days 8-42 for the infant). The randomisation sequences were generated by computer at a central data coordinating Centre. The primary endpoint was HIV infection at 6 months of age in infants who were HIV PCR negative at birth. Analyses were by modified intention to treat, excluding infants with missing specimens and those with indeterminate or confirmed HIV infection at birth. These studies are registered with ClinicalTrials.gov, numbers NCT00074399, NCT00061321, and NCT00639938. Findings 2024 liveborn infants randomised in the study had at least one specimen tested before 6 months of age (1047 infants in the single-dose group and 977 infants in the extended-dose group). The modified intention-to-treat population included 986 infants in the single-dose group and 901 in the extended-dose group. At 6 months, 87 children in the single-dose group and 62 in the extended-dose group were infected with HIV (relative risk 0.80, 95% CI 0 . 58.1. 10; p=0. 16). At 6 weeks of age, 54 children in the single-dose group and 25 in the extended-dose group were HIV positive (0.54, 0 . 34-0.85; p=0.009). 393 infants in the single-dose group and 346 in the extended-dose group experienced grade 3 or 4 serious adverse events during the study (p=0. 54). Interpretation Although a 6-week regimen of daily nevirapine might be associated with a reduction in the risk of HIV transmission at 6 weeks of age, the lack of a significant reduction in the primary endpoint-risk of HIV transmission at 6 months-suggests that a longer course of daily infant nevirapine to prevent HIV transmission via breast milk might be more effective where access to affordable and safe replacement feeding is not yet available and where the risks of replacement feeding are high. Funding US National Institutes of Health; US National Institute of Allergy and Infectious Diseases; Fogarty International Center.	[Abashawl, Aida; Adamu, Rahel; Antelman, Gretchen; Bollinger, Robert C.; Bright, Patricia; Chaudhary, Mohammad A.; Coberly, Jacqueline; Guay, Laura; Fowler, Mary Glenn; Gupta, Amita; Hassen, Elham; Jackson, J. Brooks; Moulton, Lawrence H.; Nayak, Uma; Omer, Saad B.; Propper, Lidia; Ram, Malathi; Rexroad, Vivian; Ruff, Andrea J.; Shankar, Anita] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Clin Global Hlth Educ, Baltimore, MD 21286 USA; [Zwerski, Sheryl] NIAID, Div Aids, NIH, Bethesda, MD USA; [Bedri, Abubaker; Gudetta, Berhanu; Isehak, Abdulhamid; Kumbi, Solomon; Lulseged, Sileshi; Mengistu, Yohannes] Univ Addis Ababa, Addis Ababa, Ethiopia; [Bhore, Arvind V.; Bhosale, Ramesh; Varadhrajan, Venkat] BJ Med Coll, Pune, Maharashtra, India; [Gupte, Nikhil; Sastry, Jayagowri; Suryavanshi, Nishi] Pune MIT, Pune, Maharashtra, India; [Tripathy, Srikanth] Natl AIDS Res Inst, Pune, Maharashtra, India; [Mmiro, Francis; Mubiru, Michael; Onyango, Carolyne; Taylor, Adrian] Makerere Univ, Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Nakabiito, Clemensia] Makerere Univ, Minist Hlth, Kampala, Uganda	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Addis Ababa University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Dr. Vishwanath Karad MIT World Peace University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Makerere University; Makerere University	Bollinger, RC (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Clin Global Hlth Educ, Phipps 540,600 N Wolfe St, Baltimore, MD 21286 USA.	rcb@jhmi.edu	Tefera, Endale/AAC-5030-2019; Bharadwaj, Renu/I-1979-2019; Omer, Saad B/K-1182-2012	Tefera, Endale/0000-0002-5053-6298; Bharadwaj, Renu/0000-0002-4286-7337; Omer, Saad B/0000-0002-5383-3474; Bollinger, Robert/0000-0002-6798-6834; Moulton, Lawrence/0000-0001-7041-7387; Gupta, Amita/0000-0001-7036-2718; Tripathy, Srikanth/0000-0002-8363-2606; Antelman, Gretchen/0000-0001-7906-9964; Kadam, Abhay/0000-0002-6972-853X; jackson, brooks/0000-0001-9458-135X	FIC NIH HHS [D43-TW0000] Funding Source: Medline; NIAID NIH HHS [R01AI45462, R01AI3857601A, R01AI34235] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [N01TW000000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034235, R01AI038576, R01AI045462] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARENDT V, 2007, 4 IAS C HIV PATH TRE; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Flys TS, 2006, JAIDS-J ACQ IMM DEF, V42, P610, DOI 10.1097/01.qai.0000221686.67810.20; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; KUMWENDA NI, 2008, N ENGL J MED    0604; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; NAM JM, 1992, BIOMETRICS, V48, P389, DOI 10.2307/2532298; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; *PER HIV GUID WORK, PHS TASK FORC REC US; Phadke MA, 2003, J NUTR, V133, P3153, DOI 10.1093/jn/133.10.3153; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Read JS, 2007, PEDIATRICS, V120, pE1547, DOI 10.1542/peds.2007-2951; Rollins N, 2004, JAIDS-J ACQ IMM DEF, V35, P188, DOI 10.1097/00126334-200402010-00014; Rothman K, 1986, MODERN EPIDEMIOLOGY; Saba J, 2002, LANCET, V359, P1178; Taha TE, 2004, JAMA-J AM MED ASSOC, V292, P202, DOI 10.1001/jama.292.2.202; Taha TE, 2003, LANCET, V362, P1171, DOI 10.1016/S0140-6736(03)14538-2; UNAIDS, 2006 REP GLOB AIDS E; VIOLARI A, 2007, 4 IAS C HIV PATH TRE; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2	29	199	202	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					300	313						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657709				2022-12-24	WOS:000258042800031
J	Gill, M				Gill, Mike			Why should doctors be interested in climate change?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Gill, M (corresponding author), Univ Surrey, Fac Med & Hlth Sci, Guildford GU2 7XH, Surrey, England.	mgilm1@gmail.com							0	13	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2008	336	7659					1506	1506		10.1136/bmj.39617.634190.59	http://dx.doi.org/10.1136/bmj.39617.634190.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583684	Green Published			2022-12-24	WOS:000257505900042
J	Lee, AH; Scapa, EF; Cohen, DE; Glimcher, LH				Lee, Ann-Hwee; Scapa, Erez F.; Cohen, David E.; Glimcher, Laurie H.			Regulation of hepatic lipogenesis by the transcription factor XBP1	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; STEAROYL-COA DESATURASE-1; PLASMA-CELL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; MICE; EXPRESSION; GENES; CARBOHYDRATE; BIOGENESIS	Dietary carbohydrates regulate hepatic lipogenesis by controlling the expression of critical enzymes in glycolytic and lipogenic pathways. We found that the transcription factor XBP1, a key regulator of the unfolded protein response, is required for the unrelated function of normal fatty acid synthesis in the liver. XBP1 protein expression in mice was elevated after feeding carbohydrates and corresponded with the induction of critical genes involved in fatty acid synthesis. Inducible, selective deletion of XBP1 in the liver resulted in marked hypocholesterolemia and hypotriglyceridemia, secondary to a decreased production of lipids from the liver. This phenotype was not accompanied by hepatic steatosis or compromise in protein secretory function. The identification of XBP1 as a regulator of lipogenesis has important implications for human dyslipidemias.	[Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Scapa, Erez F.; Cohen, David E.; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Scapa, Erez F.; Cohen, David E.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Lee, AH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ahlee@hsph.harvard.edu; lglimche@hsph.harvard.edu	Longo, Kenneth A/A-5631-2010		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296, R01AI032412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048873, R29DK048873, R01DK056626, R01DK048873] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32412, P01 AI56296, R01 AI032412, P01 AI056296] Funding Source: Medline; NIDDK NIH HHS [R01 DK048873, DK48873, R37 DK048873, DK56626, R29 DK048873, R01 DK056626] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHOTZ MC, 1957, AM J PHYSIOL, V188, P399, DOI 10.1152/ajplegacy.1957.188.2.399; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	21	708	748	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1492	1496		10.1126/science.1158042	http://dx.doi.org/10.1126/science.1158042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556558	Green Accepted			2022-12-24	WOS:000256676400044
J	He, XJ; Zhou, J; Bartlam, M; Zhang, RG; Ma, JY; Lou, ZY; Li, XM; Li, JJ; Joachimiak, A; Zeng, ZH; Ge, RW; Rao, ZH; Liu, YF				He, Xiaojing; Zhou, Jie; Bartlam, Mark; Zhang, Rongguang; Ma, Jianyuan; Lou, Zhiyong; Li, Xuemei; Li, Jingjing; Joachimiak, Andrzej; Zeng, Zonghao; Ge, Ruowen; Rao, Zihe; Liu, Yingfang			Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus	NATURE			English	Article							AMINO-ACID MUTATION; RNA-POLYMERASE; PA SUBUNIT; A VIRUS; PROMOTER-BINDING; MACROMOLECULAR STRUCTURES; PB1 PROTEIN; CAP-BINDING; MODEL; DOMAINS	The recent emergence of highly pathogenic avian influenza A virus strains with subtype H5N1 pose a global threat to human health(1). Elucidation of the underlying mechanisms of viral replication is critical for development of anti- influenza virus drugs(2). The influenza RNA- dependent RNA polymerase ( RdRp) heterotrimer has crucial roles in viral RNA replication and transcription. It contains three proteins: PA, PB1 and PB2. PB1 harbours polymerase and endonuclease activities and PB2 is responsible for cap binding(3,4); PA is implicated in RNA replication(5-10) and proteolytic activity(11-14), although its function is less clearly defined. Here we report the 2.9 angstrom structure of avian H5N1 influenza A virus PA ( PA(C), residues 257 - 716) in complex with the PA- binding region of PB1 ( PB1(N), residues 1 - 25). PA(C) has a fold resembling a dragon's head with PB1(N) clamped into its open 'jaws'. PB1(N) is a known inhibitor that blocks assembly of the polymerase heterotrimer and abolishes viral replication. Our structure provides details for the binding of PB1(N) to PA(C) at the atomic level, demonstrating a potential target for novel anti- influenza therapeutics. We also discuss a potential nucleotide binding site and the roles of some known residues involved in polymerase activity. Furthermore, to explore the role of PA in viral replication and transcription, we propose a model for the influenza RdRp heterotrimer by comparing PA(C) with the lambda 3 reovirus polymerase structure, and docking the PA(C) structure into an available low resolution electron microscopy map.	[He, Xiaojing; Zhou, Jie; Ma, Jianyuan; Li, Xuemei; Li, Jingjing; Zeng, Zonghao; Rao, Zihe; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin State Lab Prot Sci, Tianjin 300071, Peoples R China; [Zhang, Rongguang; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Zhang, Rongguang; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Lou, Zhiyong; Li, Xuemei; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Nankai University; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Tsinghua University; National University of Singapore	Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	raozh@xtal.tsinghua.edu.cn; liuy@ibp.ac.cn	Rao, Zihe/HCH-6944-2022; Ge, Ruowen/D-8352-2012; HE, XIAOJING/A-6040-2013	Ge, Ruowen/0000-0002-0750-7336; Bartlam, Mark/0000-0001-5173-5080; He, Xiaojing/0000-0003-3917-1133	National Natural Science Foundation of China [30599432, 30221003]; Ministry of Science and Technology International Cooperation Project [2006DFB32420]; Ministry of Science and Technology 863 Project [2006AA02A314, 2006AA02A322]; Ministry of Science and Technology 973 Project [2006CB504300, 2007CB914300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Cooperation Project; Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China); Ministry of Science and Technology 973 Project(National Basic Research Program of China)	We thank H. Chen and K. Yu for providing the A/goose/Guangdong/1/96 influenza PA gene; J. Ortin and O. Llorca for supplying electron microscopy maps; C. Yang, X. Su, F. Sun, L. Wang and R.- M. Xu for advice and technical assistance; and S. Harrison, P. Kuhn, X. Chen and T. Toyoda for discussion. This work was supported by the National Natural Science Foundation of China ( grant numbers 30599432 and 30221003), the Ministry of Science and Technology International Cooperation Project ( grant number 2006DFB32420), the Ministry of Science and Technology 863 Project ( grant numbers 2006AA02A314 and 2006AA02A322) and the Ministry of Science and Technology 973 Project ( grant numbers 2006CB504300 and 2007CB914300).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DELALUNA S, 1989, VIRUS RES, V13, P143, DOI 10.1016/0168-1702(89)90012-9; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P401; SUGIURA A, 1975, VIROLOGY, V65, P363, DOI 10.1016/0042-6822(75)90042-2; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	40	239	265	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1123	U51		10.1038/nature07120	http://dx.doi.org/10.1038/nature07120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18615018				2022-12-24	WOS:000258719600039
J	Truog, RD; Miller, FG				Truog, Robert D.; Miller, Franklin G.			The dead donor rule and organ transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BRAIN-DEATH		[Truog, Robert D.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; [Truog, Robert D.] Childrens Hosp, Div Crit Care Med, Boston, MA 02115 USA; [Miller, Franklin G.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.							[Anonymous], 1968, JAMA, V205, P337; BERNAT JL, 1981, ANN INTERN MED, V94, P389, DOI 10.1001/archinte.94.3.389; MILLER FG, IN PRESS HASTINGS CT; Shewmon DA, 1998, NEUROLOGY, V51, P1538, DOI 10.1212/WNL.51.6.1538; Truog RD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528024	5	128	130	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2008	359	7					674	675		10.1056/NEJMp0804474	http://dx.doi.org/10.1056/NEJMp0804474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336XE	18703469				2022-12-24	WOS:000258397900003
J	Loughlin, R; Riggs, B; Heald, R				Loughlin, Rose; Riggs, Blake; Heald, Rebecca			Snapshot: Motor proteins in spindle assembly	CELL			English	Editorial Material							DYNAMICS; LENGTH; ROLES		[Loughlin, Rose; Riggs, Blake; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Loughlin, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Heald, Rebecca/0000-0001-6671-6528				Brust-Mascher I, 2007, INT REV CYTOL, V259, P139, DOI 10.1016/S0074-7696(06)59004-7; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	8	11	11	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 8	2008	134	3					548	U17		10.1016/j.cell.2008.07.038	http://dx.doi.org/10.1016/j.cell.2008.07.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692476	Bronze			2022-12-24	WOS:000258665500027
J	Jia, SD; Liu, ZN; Zhang, S; Liu, PX; Zhang, L; Lee, SH; Zhang, J; Signoretti, S; Loda, M; Roberts, TM; Zhao, JJ				Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.			Essential roles of PI(3)K-p110 beta in cell growth, metabolism and tumorigenesis	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASES; LYSOPHOSPHATIDIC ACID; EMBRYONIC LETHALITY; P110-ALPHA SUBUNIT; CATALYTIC SUBUNIT; PROSTATE-CANCER; PI 3-KINASE; BETA-GAMMA	On activation by receptors, the ubiquitously expressed class IA isoforms (p110 alpha and p110 beta) of phosphatidylinositol-3-OH kinase (PI(3)K) generate lipid second messengers, which initiate multiple signal transduction cascades(1-5). Recent studies have demonstrated specific functions for p110 alpha in growth factor and insulin signalling(6-8). To probe for distinct functions of p110 beta, we constructed conditional knockout mice. Here we show that ablation of p110 beta in the livers of the resulting mice leads to impaired insulin sensitivity and glucose homeostasis, while having little effect on phosphorylation of Akt, suggesting the involvement of a kinase-independent role of p110 beta in insulin metabolic action. Using established mouse embryonic fibroblasts, we found that removal of p110 beta also had little effect on Akt phosphorylation in response to stimulation by insulin and epidermal growth factor, but resulted in retarded cell proliferation. Reconstitution of p110 beta-null cells with a wild-type or kinase-dead allele of p110 beta demonstrated that p110 beta possesses kinase-independent functions in regulating cell proliferation and trafficking. However, the kinase activity of p110 beta was required for G-protein-coupled receptor signalling triggered by lysophosphatidic acid and had a function in oncogenic transformation. Most strikingly, in an animal model of prostate tumour formation induced by Pten loss, ablation of p110 beta (also known as Pik3cb), but not that of p110 alpha (also known as Pik3ca), impeded tumorigenesis with a concomitant diminution of Akt phosphorylation. Taken together, our findings demonstrate both kinase-dependent and kinase-independent functions for p110 beta, and strongly indicate the kinase-dependent functions of p110 beta as a promising target in cancer therapy.	[Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Roberts, Thomas M.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Signoretti, Sabina; Loda, Massimo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhao, Jean J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Roberts, TM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	thomas_roberts@dfci.harvard.edu; jean_zhao@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA030002, P50CA090381, P01CA089021, R01CA134502, P01CA050661, R01CA131945, P50CA089393] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA089021-06A1, P01 CA089021, P50 CA090381-05, R01 CA134502-01, R01 CA131945, P01 CA050661, R01 CA030002-27, P50 CA089393-08S1, P50 CA089393, P01 CA050661-200001, R01 CA134502, P50 CA090381, R01 CA030002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Hazeki O, 1998, LIFE SCI, V62, P1555, DOI 10.1016/S0024-3205(98)00106-4; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu ZN, 2006, CELL CYCLE, V5, P675, DOI 10.4161/cc.5.7.2605; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ringel MD, 2001, CANCER RES, V61, P6105; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yart A, 2002, J BIOL CHEM, V277, P21167, DOI 10.1074/jbc.M110411200; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	34	546	586	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					776	U102		10.1038/nature07091	http://dx.doi.org/10.1038/nature07091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18594509	Green Accepted			2022-12-24	WOS:000258228000047
J	Romundstad, LB; Romundstad, PR; Sunde, A; von During, V; Skjaerven, R; Gunnell, D; Vatten, LJ				Romundstad, Liv Bente; Romundstad, Pal R.; Sunde, Arne; von During, Vidar; Skjaerven, Rolv; Gunnell, David; Vatten, Lars J.			Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study	LANCET			English	Article							IN-VITRO FERTILIZATION; BIRTH-WEIGHT; PREGNANCY OUTCOMES; INCREASED RISK; INFERTILITY; EMBRYO; SINGLETONS; DELIVERY; IVF/ICSI	Background Research suggests that singleton births following assisted fertilisation. are associated with adverse outcomes; however, these results might be confounded by factors that affect both fertility and pregnancy outcome. We therefore compared pregnancy outcomes in women who had singleton pregnancies conceived both spontaneously and after assisted fertilisation. Methods In a population-based cohort study, we assessed differences in birthweight, gestational age, and odds ratios (OR) of small for gestational age babies, premature births, and perinatal deaths in singletons (gestation >= 22 weeks or birthweigh >= 500 g) born to 2546 Norwegian women (> 20 years) who had conceived at least one child spontaneously and another after assisted fertilisation among 1200 922 births after spontaneous conception and 8229 after assisted fertilisation. Findings In the whole study population, assisted-fertilisation conceptions were associated with lower mean birthweight (difference 25 g, 95% CI 14 to 35), shorter duration of gestation (2 . 0 days, 1 . 6 to 2 . 3) and increased risks of small for gestational age (OR 1.26, 1.10 to 1.44), and perinatal death (1.31, 1.05 to 1.65) than were spontaneous conceptions. In the sibling-relationship comparisons, the spontaneous versus the assisted-fertilisation conceptions- showed a difference of only 9 g (-18 to 36) in birthweight and 0 . 6 days (-0 . 5 to 1. 7) in gestational age. For assisted fertilisation versus spontaneous conception in the sibling-relationship comparisons, the OR for small for gestational age was 0 . 99 (0.62 to 1. 57) and that for perinatal mortality was 0 . 36 (0 . 20 to 0 . 67). Interpretation Birthweight, gestational age, and risks of small for gestational age babies, and preterm delivery did not differ among infants of women who had conceived both spontaneously and after assisted fertilisation. The adverse outcomes of assisted fertilisation that we noted compared with those in the general population could therefore be attributable to the factors leading to infertility, rather than to factors related to the reproductive technology. Funding St Olavs University Hospital, Trondheim, Norway, and the Norwegian Research Council.	[Romundstad, Liv Bente; Sunde, Arne; von During, Vidar] St Olavs Univ Hosp, Dept Obstet & Gynaecol, IVF Unit, NO-7006 Trondheim, Norway; [Romundstad, Liv Bente; Romundstad, Pal R.; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Skjaerven, Rolv] Med Birth Registry Norway, Bergen, Norway; [Skjaerven, Rolv] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Vatten, Lars J.] Int Agcy Res Canc, F-69372 Lyon, France	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bristol; World Health Organization; International Agency for Research on Cancer (IARC)	Romundstad, LB (corresponding author), St Olavs Univ Hosp, Dept Obstet & Gynaecol, IVF Unit, NO-7006 Trondheim, Norway.	libero@ntnu.no	Vatten, Lars/AFK-2073-2022; Gunnell, David/ABE-6653-2020; Vatten, Lars/AAF-9380-2022	Gunnell, David/0000-0002-0829-6470; Romundstad, Pal Richard/0000-0003-2061-4336	St Olavs University Hospital, Trondheim, Norway; Norwegian Research Council	St Olavs University Hospital, Trondheim, Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was financially supported by St Olavs University Hospital, Trondheim, Norway, and the Norwegian Research Council.	Allen VM, 2006, J OBSTET GYNAECOL CA, V28, P220, DOI 10.1016/S1701-2163(16)32112-0; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Draper ES, 1999, LANCET, V353, P1746, DOI 10.1016/S0140-6736(98)08500-6; ERTZEID G, 1992, J REPROD FERTIL, V96, P649, DOI 10.1530/jrf.0.0960649; GHAZI HA, 1991, FERTIL STERIL, V55, P726; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Henriksen TB, 1997, OBSTET GYNECOL, V89, P594; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; McEvoy TG, 2001, REPRODUCTION, V122, P507, DOI 10.1530/rep.0.1220507; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Romundstad LB, 2006, HUM REPROD, V21, P2353, DOI 10.1093/humrep/del153; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Sutcliffe AG, 2007, LANCET, V370, P351, DOI 10.1016/S0140-6736(07)60456-5; WILLIAMS MA, 1991, FERTIL STERIL, V56, P668; World Health Organization, 2006, NEON PER MORT COUNTR; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	24	259	271	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2008	372	9640					737	743		10.1016/S0140-6736(08)61041-7	http://dx.doi.org/10.1016/S0140-6736(08)61041-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344YZ	18674812				2022-12-24	WOS:000258964500030
J	Pujol, B; Pannell, JR				Pujol, Benoit; Pannell, John R.			Reduced responses to selection after species range expansion	SCIENCE			English	Article							GENETIC-VARIATION; PLANT; POPULATION; POLLEN		[Pujol, Benoit; Pannell, John R.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Pannell, JR (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	john.pannell@plants.ox.ac.uk	Pujol, Benoit/N-1575-2019; Pujol, Benoit/A-8858-2011	Pujol, Benoit/0000-0001-9703-6760; Pujol, Benoit/0000-0001-9703-6760; Pannell, John/0000-0002-0098-7074	Natural Environment Research Council [NE/C511313/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Armbruster P, 1998, EVOLUTION, V52, P1697, DOI 10.1111/j.1558-5646.1998.tb02249.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; MEAGHER TR, 1991, AM NAT, V137, P738, DOI 10.1086/285191; Naciri-Graven Y, 2003, EVOLUTION, V57, P706, DOI 10.1111/j.0014-3820.2003.tb00284.x; Obbard DJ, 2006, AM NAT, V167, P354, DOI 10.1086/499546; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X	8	109	109	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					96	96		10.1126/science.1157570	http://dx.doi.org/10.1126/science.1157570			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599779				2022-12-24	WOS:000257320800043
J	Reed, TE; Daunt, F; Hall, ME; Phillips, RA; Wanless, S; Cunningham, EJA				Reed, T. E.; Daunt, F.; Hall, M. E.; Phillips, R. A.; Wanless, S.; Cunningham, E. J. A.			Parasite treatment affects maternal investment in sons	SCIENCE			English	Article							SEX-RATIO	Parasitism can be a major constraint on host condition and an important selective force. Theoretical and empirical evidence shows that maternal condition affects relative investment in sons and daughters; however, the effect of parasitism on sex ratio in vertebrates is seldom considered. We demonstrate experimentally that parasitism constrains the ability of mothers to rear sons in a long- lived seabird, the European shag Phalacrocorax aristotelis. The effect contributes to the decline in offspring survival as the breeding season progresses and hence has important population- level consequences for this, and potentially other, seasonal breeders.	[Reed, T. E.; Cunningham, E. J. A.] Univ Edinburgh, Inst Evolut Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Reed, T. E.; Daunt, F.; Wanless, S.] NERC Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Hall, M. E.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Phillips, R. A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Edinburgh; UK Centre for Ecology & Hydrology (UKCEH); University of Glasgow; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Reed, TE (corresponding author), Univ Edinburgh, Inst Evolut Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	tomreed@u.washington.edu	Cunningham, Emma/I-9190-2012; Hall, Maggie/C-7906-2009; Reed, Thomas E/A-5788-2012; Daunt, Francis/K-6688-2012; Wanless, Sarah/K-2338-2012	Reed, Thomas E/0000-0002-2993-0477; Daunt, Francis/0000-0003-4638-3388; Wanless, Sarah/0000-0002-2788-4606	University of Edinburgh; Royal Society; NERC CASE; The Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council [CEH010021, bas010017] Funding Source: researchfish; NERC [bas010017] Funding Source: UKRI	University of Edinburgh; Royal Society(Royal Society of London); NERC CASE(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The Association for the Study of Animal Behaviour (ASAB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Harris, M. Frederiksen, L. Kruuk, S. Reece, S. West, P. Monaghan, and A. Young for helpful discussion and A. Kiploks and M. Newell for invaluable field assistance. Thanks also to M. Melo, S. Preuss, and J. Pemberton (University of Edinburgh) and K. Griffiths and A. Adams (University of Glasgow) for help with molecular sexing; B. Craig and A. Meredith for advice on parasitology; and H.-P. Fagerholm, D. Gibson, and M. Blaxter for nematode identification. Special thanks to Scottish Natural Heritage for permission to work on the island and the Isle of May Bird Observatory for help maintaining the marked population of shags. This work was supported by a Principal's Studentship to T. E. R. from the University of Edinburgh, a fellowship to E. J. A. C. from the Royal Society, and a NERC CASE studentship to M. E. H. The Association for the Study of Animal Behaviour (ASAB) funded the logger work.	CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; Moller AP, 1998, OIKOS, V83, P301, DOI 10.2307/3546841; Moreno J, 1998, OECOLOGIA, V115, P312, DOI 10.1007/s004420050522; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90	8	28	28	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1681	1682		10.1126/science.1159466	http://dx.doi.org/10.1126/science.1159466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18687923				2022-12-24	WOS:000259300400037
J	Tammela, T; Zarkada, G; Wallgard, E; Murtomaki, A; Suchting, S; Wirzenius, M; Waltari, M; Hellstrom, M; Schomber, T; Peltonen, R; Freitas, C; Duarte, A; Isoniemi, H; Laakkonen, P; Christofori, G; Yla-Herttuala, S; Shibuya, M; Pytowski, B; Eichmann, A; Betsholtz, C; Alitalo, K				Tammela, Tuomas; Zarkada, Georgia; Wallgard, Elisabet; Murtomaki, Aino; Suchting, Steven; Wirzenius, Maria; Waltari, Marika; Hellstrom, Mats; Schomber, Tibor; Peltonen, Reetta; Freitas, Catarina; Duarte, Antonio; Isoniemi, Helena; Laakkonen, Pirjo; Christofori, Gerhard; Yla-Herttuala, Seppo; Shibuya, Masabumi; Pytowski, Bronislaw; Eichmann, Anne; Betsholtz, Christer; Alitalo, Kari			Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-3; INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; FACTOR-C; LYMPHATIC ENDOTHELIUM; LYMPHANGIOGENESIS; EXPRESSION; MOUSE; MICE; CANCER	Angiogenesis, the growth of new blood vessels from pre- existing vasculature, is a key process in several pathological conditions, including tumour growth and age- related macular degeneration(1). Vascular endothelial growth factors ( VEGFs) stimulate angiogenesis and lymphangiogenesis by activating VEGF receptor ( VEGFR) tyrosine kinases in endothelial cells(2). VEGFR- 3 ( also known as FLT- 4) is present in all endothelia during development, and in the adult it becomes restricted to the lymphatic endothelium(3). However, VEGFR- 3 is upregulated in the microvasculature of tumours and wounds(4,5). Here we demonstrate that VEGFR- 3 is highly expressed in angiogenic sprouts, and genetic targeting of VEGFR- 3 or blocking of VEGFR- 3 signalling with monoclonal antibodies results in decreased sprouting, vascular density, vessel branching and endothelial cell proliferation in mouse angiogenesis models. Stimulation of VEGFR- 3 augmented VEGF- induced angiogenesis and sustained angiogenesis even in the presence of VEGFR- 2 ( also known as KDR or FLK- 1) inhibitors, whereas antibodies against VEGFR- 3 and VEGFR- 2 in combination resulted in additive inhibition of angiogenesis and tumour growth. Furthermore, genetic or pharmacological disruption of the Notch signalling pathway led to widespread endothelial VEGFR- 3 expression and excessive sprouting, which was inhibited by blocking VEGFR- 3 signals. Our results implicate VEGFR- 3 as a regulator of vascular network formation. Targeting VEGFR- 3 may provide additional efficacy for anti- angiogenic therapies, especially towards vessels that are resistant to VEGF or VEGFR- 2 inhibitors.	[Tammela, Tuomas; Zarkada, Georgia; Murtomaki, Aino; Wirzenius, Maria; Waltari, Marika; Laakkonen, Pirjo; Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FIN-00014 Helsinki, Finland; [Tammela, Tuomas; Zarkada, Georgia; Murtomaki, Aino; Wirzenius, Maria; Waltari, Marika; Laakkonen, Pirjo; Alitalo, Kari] Univ Helsinki, Ludwig Inst Canc Res, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; [Tammela, Tuomas; Zarkada, Georgia; Murtomaki, Aino; Wirzenius, Maria; Waltari, Marika; Laakkonen, Pirjo; Alitalo, Kari] Univ Helsinki, Haartman Inst, FIN-00014 Helsinki, Finland; [Wallgard, Elisabet; Hellstrom, Mats; Betsholtz, Christer] Karolinska Inst, Div Matrix Biol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Suchting, Steven; Freitas, Catarina; Eichmann, Anne] Coll France, INSERM, U833, F-75005 Paris, France; [Schomber, Tibor; Christofori, Gerhard] Univ Basel, Ctr Biomed, Dept Clin Biol Sci, CH-4058 Basel, Switzerland; [Peltonen, Reetta; Isoniemi, Helena] Univ Helsinki, Cent Hosp, Dept Transplantat & Hepat Surg, Helsinki 00029, Finland; [Duarte, Antonio] Univ Tecn Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1300474 Lisbon, Portugal; [Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138519, Japan; [Pytowski, Bronislaw] ImClone Syst, New York, NY 10014 USA	University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Basel; University of Helsinki; Helsinki University Central Hospital; Universidade de Lisboa; University of Eastern Finland; Tokyo Medical & Dental University (TMDU); Eli Lilly	Alitalo, K (corresponding author), Univ Helsinki, Lab Mol Canc Biol, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	kari.alitalo@helsinki.fi	Duarte, Antonio/V-1178-2018; Alitalo, Kari K/J-5013-2014; Freitas, Catarina M/A-2555-2017	Duarte, Antonio/0000-0002-9255-3635; Alitalo, Kari K/0000-0002-7331-0902; Freitas, Catarina M/0000-0002-3393-5326; /0000-0003-3675-6961; Laakkonen, Pirjo/0000-0002-9620-095X; Hellstrom, Mats/0000-0002-7088-9533; Yla-Herttuala, Seppo/0000-0001-7593-2708	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NHLBI NIH HHS [5 R01 HL075183-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Enholm B, 2001, CIRC RES, V88, P623, DOI 10.1161/01.RES.88.6.623; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jussila L, 1998, CANCER RES, V58, P1599; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2001, CANCER RES, V61, P1786; Karpanen T, 2006, AM J PATHOL, V169, P708, DOI 10.2353/ajpath.2006.051200; Kiba A, 2003, BIOCHEM BIOPH RES CO, V301, P371, DOI 10.1016/S0006-291X(02)03033-4; Kozaki K, 2000, CANCER RES, V60, P2535; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; Prewett M, 1999, CANCER RES, V59, P5209; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; SAKAI K, 1987, J NATL CANCER I, V79, P923; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Zheng YJ, 2006, ARTERIOSCL THROM VAS, V26, P2019, DOI 10.1161/01.ATV.0000233336.53574.a1	50	614	640	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					656	U68		10.1038/nature07083	http://dx.doi.org/10.1038/nature07083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18594512				2022-12-24	WOS:000258026500051
J	Chen, CC; Carson, JJ; Feser, J; Tamburini, B; Zabaronick, S; Linger, J; Tyler, JK				Chen, Chin-Chuan; Carson, Joshua J.; Feser, Jason; Tamburini, Beth; Zabaronick, Susan; Linger, Jeffrey; Tyler, Jessica K.			Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair	CELL			English	Article							DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; S-PHASE; CHAPERONE ASF1; CELL-CYCLE; REPLICATION; RAD53; ADAPTATION; RECOVERY; H3	DNA damage causes checkpoint activation leading to cell cycle arrest and repair, during which the chromatin structure is disrupted. The mechanisms whereby chromatin structure and cell cycle progression are restored after DNA repair are largely unknown. We show that chromatin reassembly following double- strand break (DSB) repair requires the histone chaperone Asf1 and that absence of Asf1 causes cell death, as cells are unable to recover from the DNA damage checkpoint. We find that Asf1 contributes toward chromatin assembly after DSB repair by promoting acetylation of free histone H3 on lysine 56 (K56) via the histone acetyl transferase Rtt109. Mimicking acetylation of K56 bypasses the requirement for Asf1 for chromatin reassembly and checkpoint recovery, whereas mutations that prevent K56 acetylation block chromatin reassembly after repair. These results indicate that restoration of the chromatin following DSB repair is driven by acetylated H3 K56 and that this is a signal for the completion of repair.	[Chen, Chin-Chuan; Carson, Joshua J.; Feser, Jason; Tamburini, Beth; Zabaronick, Susan; Linger, Jeffrey; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jessica.tyler@uchsc.edu	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; Linger, Jeffrey/0000-0003-3935-751X; Tyler, Jessica/0000-0001-9765-1659	NCI NIH HHS [R01 CA095641-03, R01 CA095641-06, R01 CA095641-05A1, R01 CA095641-04, R01 CA095641, R01 CA095641-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lupardus PJ, 2004, CELL, V117, P555, DOI 10.1016/j.cell.2004.05.005; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Pasero P, 2003, CELL CYCLE, V2, P568, DOI 10.4161/cc.2.6.577; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Qin J, 2003, RADIAT RES, V159, P139, DOI 10.1667/0033-7587(2003)159[0139:MAOTDD]2.0.CO;2; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, CELL CYCLE, V3, P1383, DOI 10.4161/cc.3.11.1248; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005	56	310	319	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					231	243		10.1016/j.cell.2008.06.035	http://dx.doi.org/10.1016/j.cell.2008.06.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662539	Bronze, Green Accepted			2022-12-24	WOS:000257891700013
J	Xu, H; DeLuca, SZ; O'Farrell, PH				Xu, Hong; DeLuca, Steven Z.; O'Farrell, Patrick H.			Manipulating the metazoan mitochondrial genome with targeted restriction enzymesu	SCIENCE			English	Article							DNA MUTATIONS; DISEASE; CELLS	High copy number and random segregation confound genetic analysis of the mitochondrial genome. We developed an efficient selection for heritable mitochondrial genome ( mtDNA) mutations in Drosophila, thereby enhancing a metazoan model for study of mitochondrial genetics and mutations causing human mitochondrial disease. Targeting a restriction enzyme to mitochondria in the germline compromised fertility, but escaper progeny carried homoplasmic mtDNA mutations lacking the cleavage site. Among mutations eliminating a site in the cytochrome c oxidase gene, mt:Col(A302T) was healthy, mt:CoI(R301L) was male sterile but otherwise healthy, and mt: CoI(R301S) exhibited a wide range of defects, including growth retardation, neurodegeneration, muscular atrophy, male sterility, and reduced life span. Thus, germline expression of mitochondrial restriction enzymes creates a powerful selection and has allowed direct isolation of mitochondrial mutants in a metazoan.	[Xu, Hong; DeLuca, Steven Z.; O'Farrell, Patrick H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	O'Farrell, PH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ofarrell@cgl.ucsf.edu	Xu, Hong/H-9997-2016	Xu, Hong/0000-0003-1049-1184; DeLuca, Steven/0000-0003-0683-8413; O'Farrell, Patrick/0000-0003-0011-2734	NIAID NIH HHS [R01 AI060102, R01 AI060102-08] Funding Source: Medline; NIGMS NIH HHS [R01 GM086854, R01 GM037193-22, R01 GM037193, R01 GM086854-09A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086854, R01GM037193] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bayona-Bafaluy MP, 2002, MITOCHONDRION, V2, P3, DOI 10.1016/S1567-7249(02)00044-2; Bergstrom CT, 1998, GENETICS, V149, P2135; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	12	80	80	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					575	577		10.1126/science.1160226	http://dx.doi.org/10.1126/science.1160226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653897	Green Accepted			2022-12-24	WOS:000257888900052
J	Smith, AD; Bradley, DJ; Smith, V; Blaze, M; Behrens, RH; Chiodini, PL; Whitty, CJM				Smith, Adrian D.; Bradley, David J.; Smith, Valerie; Blaze, Marie; Behrens, Ron H.; Chiodini, Peter L.; Whitty, Christopher J. M.			Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006	BRITISH MEDICAL JOURNAL			English	Article							FALCIPARUM-MALARIA; TRAVELERS; PROPHYLAXIS; CHEMOPROPHYLAXIS; PREVENTION; KNOWLEDGE; COUNTRIES; MIGRANTS; FEATURES; DISEASE	Objective To examine temporal, geographic, and sociodemographic trends in case reporting and case fatality of malaria in the United Kingdom. Setting National malaria reference laboratory surveillance data in the UK. Design Observational study using prospectively gathered surveillance data and data on destinations from the international passenger survey. Participants 39 300 cases of proved malaria in the UK between 1987 and 2006. Main outcome measures Plasmodium species; sociodemographic details (including age, sex, and country of birth and residence); mortality; destination, duration, and purpose of international travel; and use of chemoprophylaxis. Results Reported cases of imported malaria increased significantly over the 20 years of the study; an increasing proportion was attributable to Plasmodium falciparum (P falciparum/P vivax reporting ratio 1.3:1 in 1987-91 and 5.4:1 in 2002-6). P vivax reports declined from 3954 in 1987-91 to 1244 in 2002-6. Case fatality of reported P falciparum malaria did not change over this period (7.4 deaths per 1000 reported cases). Travellers visiting friends and relatives, usually in a country in Africa or Asia from which members of their family migrated, accounted for 13 215/20 488 (64.5%) of all malaria reported, and reports were geographically concentrated in areas where migrants from Africa and South Asia to the UK have settled. People travelling for this purpose were at significantly higher risk of malaria than other travellers and were less likely to report the use of any chemoprophylaxis (odds ratio of reported chemoprophylaxis use 0.23, 95% confidence interval 0.21 to 0.25). Conclusions Despite the availability of highly effective preventive measures, the preventable burden from falciparum malaria has steadily increased in the UK while vivax malaria has decreased. Provision of targeted and appropriately delivered preventive messages and services for travellers from migrant families visiting friends and relatives should be a priority.	[Smith, Adrian D.; Bradley, David J.; Smith, Valerie; Blaze, Marie; Chiodini, Peter L.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, HPA Malaria Reference Lab, London WC1E 6AU, England; [Bradley, David J.; Behrens, Ron H.; Chiodini, Peter L.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 6AU, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Smith, AD (corresponding author), Univ Oxford, Div Publ Hlth & Primary Care, Oxford OX3 7LF, England.	adrian.smith@dphpc.ox.ac.uk	Smith, Adrian D/A-6336-2009; Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027; Smith, Adrian/0000-0003-0036-1490; Behrens, Ron/0000-0002-8166-2633				Angell SY, 2005, INFECT DIS CLIN N AM, V19, P49, DOI 10.1016/j.idc.2004.11.001; Badrinath P, 1998, BRIT MED J, V316, P1746, DOI 10.1136/bmj.316.7146.1746a; Behrens RH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-7; Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Bunn A, 2004, QJM-INT J MED, V97, P645, DOI 10.1093/qjmed/hch113; Casalino E, 2002, ARCH INTERN MED, V162, P1625, DOI 10.1001/archinte.162.14.1625; Chiodini P, 2007, GUIDELINES MALARIA P; DAVIDSON RN, 1993, J INFECTION, V26, P348, DOI 10.1016/0163-4453(93)96241-H; dos Santos CC, 1999, CAN MED ASSOC J, V160, P195; Evans MR, 1996, BRIT MED J, V313, P1554, DOI 10.1136/bmj.313.7071.1554b; General Register Office for Scotland, POP INF STAT; Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235; Leonard L, 2001, J Immigr Health, V3, P31, DOI 10.1023/A:1026610602073; Matteelli A, 1999, TROP MED INT HEALTH, V4, P653, DOI 10.1046/j.1365-3156.1999.00468.x; Moore DAJ, 2004, T ROY SOC TROP MED H, V98, P55, DOI 10.1016/S0035-9203(03)00007-5; Morgan M, 2005, ETHNIC HEALTH, V10, P355, DOI 10.1080/13557850500242035; *NO IR STAT RES AG, PUBL POP MIGR; Office for National Statistics, INT PASS SURV; PHILLIPSHOWARD PA, 1990, BMJ-BRIT MED J, V300, P499, DOI 10.1136/bmj.300.6723.499; Pistone T, 2007, T ROY SOC TROP MED H, V101, P990, DOI 10.1016/j.trstmh.2007.05.009; Reid AJC, 1998, BRIT MED J, V317, P1506, DOI 10.1136/bmj.317.7171.1506; *RES GROUP IMP INF, 2005, TROPNETEUROP SENT SU; Robinson P, 2001, J TRAVEL MED, V8, P76, DOI 10.2310/7060.2001.24309; Schlagenhauf P, 2003, J TRAVEL MED, V10, P106, DOI 10.2310/7060.2003.31764; Scolari C, 2002, J TRAVEL MED, V9, P160, DOI 10.2310/7060.2002.23177; Semaille C, 1999, J TRAVEL MED, V6, P3, DOI 10.2310/7060.1999.00002; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Van Hest NAH, 2002, EPIDEMIOL INFECT, V129, P371, DOI 10.1017/S0950268802007306; *WHO, 2007, MAL DIS BURD SEA REG; WHO UNICEF, 2005, WORLD MALARIA REPORT; *WORLD TOUR ORG, 2005, WTO WORLD TOUR BAR, V3	32	108	108	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2008	337	7661							a120	10.1136/bmj.a120	http://dx.doi.org/10.1136/bmj.a120			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SA	18599471	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000257961900036
J	Godar, S; Ince, TA; Bell, GW; Feldser, D; Donaher, JL; Bergh, J; Liu, A; Miu, K; Watnick, RS; Reinhardt, F; McAllister, SS; Jacks, T; Weinberg, RA				Godar, Samuel; Ince, Tan A.; Bell, George W.; Feldser, David; Donaher, Joana Liu; Bergh, Jonas; Liu, Anne; Miu, Kevin; Watnick, Randolph S.; Reinhardt, Ferenc; McAllister, Sandra S.; Jacks, Tyler; Weinberg, Robert A.			Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression	CELL			English	Article							LEUKEMIC STEM-CELLS; BREAST-CANCER CELLS; TRANSCRIPTIONAL REPRESSION; PATIENT SURVIVAL; EPITHELIAL-CELLS; IN-VIVO; GENE; P63; CARCINOMA; APOPTOSIS	The p53 tumor suppressor is a key mediator of cellular responses to various stresses. Here, we show that under conditions of basal physiologic and cellculture stress, p53 inhibits expression of the CD44 cell-surface molecule via binding to a noncanonical p53-binding sequence in the CD44 promoter. This interaction enables an untransformed cell to respond to stress- induced, p53- dependent cytostatic and apoptotic signals that would otherwise be blocked by the actions of CD44. In the absence of p53 function, the resulting derepressed CD44 expression is essential for the growth and tumor- initiating ability of highly tumorigenic mammary epithelial cells. In both tumorigenic and nontumorigenic cells, CD44' s expression is positively regulated by p63, a paralogue of p53. Our data indicate that CD44 is a key tumor-promoting agent in transformed tumor cells lacking p53 function. They also suggest that the derepression of CD44 resulting from inactivation of p53 can potentially aid the survival of immortalized, premalignant cells.	[Godar, Samuel; Ince, Tan A.; Bell, George W.; Donaher, Joana Liu; Liu, Anne; Miu, Kevin; Reinhardt, Ferenc; McAllister, Sandra S.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ince, Tan A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Womens & Perinatal Pathol,Dept Pathol, Boston, MA 02115 USA; [Feldser, David; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Bergh, Jonas] Karolinska Inst, Radiumhemmet & Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Bergh, Jonas] Univ Hosp, S-17176 Stockholm, Sweden; [Watnick, Randolph S.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Jacks, Tyler; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	McAllister, Sandra/J-7373-2012; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Ince, Tan/0000-0003-0315-6425; Bergh, Jonas/0000-0001-5526-1847	NCI NIH HHS [P01 CA080111-01, P01 CA080111-10, K08 CA092013-01, P50 CA089393-03, K08 CA092013, CA089393, P01 CA080111, CA092013, P50 CA089393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA092013, P50CA089393, P01CA080111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Barbour AP, 2003, CANCER RES, V63, P887; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dou J, 2007, CELL MOL IMMUNOL, V4, P467; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Endo K, 2000, J HEPATOL, V32, P78, DOI 10.1016/S0168-8278(00)80192-0; Gao AC, 1997, CANCER RES, V57, P846; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Piltti K, 2006, ONCOGENE, V25, P4880, DOI 10.1038/sj.onc.1209492; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SHTIVELMAN E, 1991, MOL CELL BIOL, V11, P5446, DOI 10.1128/MCB.11.11.5446; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weber GF, 2002, CANCER RES, V62, P2281; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zolota V, 2002, UROL ONCOL, V7, P13, DOI 10.1016/S1078-1439(01)00129-6	47	337	343	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					62	73		10.1016/j.cell.2008.06.006	http://dx.doi.org/10.1016/j.cell.2008.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614011	Bronze, Green Accepted			2022-12-24	WOS:000257513100014
J	Davis, BN; Hilyard, AC; Lagna, G; Hata, A				Davis, Brandi N.; Hilyard, Aaron C.; Lagna, Giorgio; Hata, Akiko			SMAD proteins control DROSHA-mediated microRNA maturation	NATURE			English	Article							TGF-BETA; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION SIGNATURE; BINDING-PROTEIN; CANCER; TARGETS; GENES; RNA; DIFFERENTIATION; INHIBITION	MicroRNAs ( miRNAs) are small non- coding RNAs that participate in the spatiotemporal regulation of messenger RNA and protein synthesis. Aberrant miRNA expression leads to developmental abnormalities and diseases, such as cardiovascular disorders and cancer; however, the stimuli and processes regulating miRNA biogenesis are largely unknown. The transforming growth factor beta ( TGF-beta) and bone morphogenetic protein ( BMP) family of growth factors orchestrates fundamental biological processes in development and in the homeostasis of adult tissues, including the vasculature. Here we show that induction of a contractile phenotype in human vascular smooth muscle cells by TGF-beta and BMPs is mediated by miR- 21. miR- 21 downregulates PDCD4 ( programmed cell death 4), which in turn acts as a negative regulator of smooth muscle contractile genes. Surprisingly, TGF-beta and BMP signalling promotes a rapid increase in expression of mature miR- 21 through a post- transcriptional step, promoting the processing of primary transcripts of miR- 21 ( pri- miR- 21) into precursor miR- 21 ( pre- miR- 21) by the DROSHA ( also known as RNASEN) complex. TGF-beta- and BMP- specific SMAD signal transducers are recruited to pri- miR- 21 in a complex with the RNA helicase p68 ( also known as DDX5), a component of the DROSHA microprocessor complex. The shared cofactor SMAD4 is not required for this process. Thus, regulation of miRNA biogenesis by ligand- specific SMAD proteins is critical for control of the vascular smooth muscle cell phenotype and potentially for SMAD4- independent responses mediated by the TGF-beta and BMP signalling pathways.	[Davis, Brandi N.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Davis, Brandi N.; Hilyard, Aaron C.; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Hata, A (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.	akiko.hata@tufts.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	NHLBI NIH HHS [R01 HL082854, R21 HL086572, HL086572, R21 HL086572-02, R01 HL082854-03, HL082854] Funding Source: Medline; NICHD NIH HHS [R01 HD042149, HD042149, R01 HD042149-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042149] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082854, R21HL086572] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Giehl K, 2007, CELLS TISSUES ORGANS, V185, P123, DOI 10.1159/000101313; Glick AB, 2004, CANCER BIOL THER, V3, P276, DOI 10.4161/cbt.3.3.849; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	1048	1106	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2008	454	7200					56	U2		10.1038/nature07086	http://dx.doi.org/10.1038/nature07086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18548003	Green Accepted			2022-12-24	WOS:000257308300034
J	Huang, ES; Zhang, Q; Gandra, N; Chin, MH; Meltzer, DO				Huang, Elbert S.; Zhang, Qi; Gandra, Niren; Chin, Marshall H.; Meltzer, David O.			The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; COST-EFFECTIVENESS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; UNITED-STATES; RISK-FACTORS; FOOT ULCERS; HEALTH; CARE; MODEL	Background: Physicians are uncertain about when to pursue intensive glucose control among older patients with diabetes. Objective: To assess the effect of comorbid illnesses and functional status, mediated through background mortality, on the expected benefits of intensive glucose control. Design: Decision analysis. Data Sources: Major clinical studies in diabetes and geriatrics. Target Population: Patients 60 to 80 years of age who have type 2 diabetes and varied life expectancies estimated from a mortality index that was validated at the population level. Time Horizon: Patient lifetime. Perspective: Health care system. Intervention: Intensive glucose control (hemoglobin A1c [HbA1c] level of 7.0) versus moderate glucose control (HbA1c level of 7.9). Outcome Measures: Lifetime differences in incidence of complications and average quality- adjusted days. Results of Base-Case Analysis: Healthy older patients of different age groups had expected benefits of intensive glucose control ranging from 51 to 116 quality-adjusted days. Within each age group, the expected benefits of intensive control steadily declined as the level of comorbid illness and functional impairment increased (mortality index score, 1 to 26 points). For patients 60 to 64 years of age with new-onset diabetes, the benefits declined from 106 days at baseline good health (life expectancy, 14.6 years) to 44 days with 3 additional index points (life expectancy, 9.7 years) and 8 days with 7 additional index points (life expectancy, 4.8 years). A similar decline in benefits occurred among patients with prolonged duration of diabetes. Results of Sensitivity Analysis: With alternative model assumptions (such as Framingham models), expected benefits of intensive control declined as mortality index scores increased. Limitations: Diabetes clinical trial data were lacking for frail, older patients. The mortality index was not validated for use in predicting individual- level life expectancies. Adverse effects of intensive control were not taken into account. Conclusion: Among older diabetic patients, the presence of multiple comorbid illnesses or functional impairments is a more important predictor of limited life expectancy and diminishing expected benefits of intensive glucose control than is age alone.	[Huang, Elbert S.] Univ Chicago, Chicago, IL 60637 USA; Old Dominion Univ, Norfolk, VA USA; Boston Univ, Sch Med, Boston, MA 02118 USA	University of Chicago; Old Dominion University; Boston University	Huang, ES (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	ehuang@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD056073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, K24DK071933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG021963] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG021963-04, K23 AG021963] Funding Source: Medline; NICHD NIH HHS [R03 HD056073] Funding Source: Medline; NIDDK NIH HHS [P60 DK20595, K24 DK071933, P60 DK020595] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrahamson MJ, 2007, JAMA-J AM MED ASSOC, V297, P196, DOI 10.1001/jama.297.2.196; *AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P40; American Diabetes Association, 2004, DIABETES CARE, V27, pS15; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON RN, 1999, NATL VITAL STAT REPO, V50; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1995, DIABETES AM; [Anonymous], 2007, DIABETES CARE, V30, pS4, DOI [10.2337/dc07-S004, DOI 10.2337/DC07-S004]; [Anonymous], MED DECIS MAK; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin MH, 2000, MED CARE, V38, P131, DOI 10.1097/00005650-200002000-00003; Chin MH, 2000, J GERONTOL A-BIOL, V55, pM601, DOI 10.1093/gerona/55.10.M601; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Durso SC, 2006, JAMA-J AM MED ASSOC, V295, P1935, DOI 10.1001/jama.295.16.1935; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Grant RW, 2004, ARCH INTERN MED, V164, P1134, DOI 10.1001/archinte.164.10.1134; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; HAYWARD RA, 2007, JAMA-J AM MED ASSOC, V297, P2196; Hayward RA, 2007, JAMA-J AM MED ASSOC, V297, P2195, DOI 10.1001/jama.297.20.2195-a; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; HUANG ES, 2007, HEALTH SERV RES, V42, P2294; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Petty GW, 1998, NEUROLOGY, V50, P208, DOI 10.1212/WNL.50.1.208; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Redekop W, 2004, DIABETES METAB, V30, P549, DOI 10.1016/S1262-3636(07)70154-4; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Rosen AB, 2005, ANN INTERN MED, V143, P89, DOI 10.7326/0003-4819-143-2-200507190-00007; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stafford RS, 2005, PLOS MED, V2, P1292, DOI 10.1371/journal.pmed.0020353; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Tennvall GR, 2001, DIABETOLOGIA, V44, P2077; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; United States Renal Data System, 1994, USRDS 1994 ANN DAT R; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	56	100	103	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					11	+		10.7326/0003-4819-149-1-200807010-00005	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323EZ	18591633	Green Accepted			2022-12-24	WOS:000257428200002
J	Zabow, G; Dodd, S; Moreland, J; Koretsky, A				Zabow, Gary; Dodd, Stephen; Moreland, John; Koretsky, Alan			Micro-engineered local field control for high-sensitivity multispectral MRI	NATURE			English	Article							IRON-OXIDE; CELLS; PARTICLES; SAFETY; AGENTS	In recent years, biotechnology and biomedical research have benefited from the introduction of a variety of specialized nanoparticles whose well-defined, optically distinguishable signatures enable simultaneous tracking of numerous biological indicators. Unfortunately, equivalent multiplexing capabilities are largely absent in the field of magnetic resonance imaging (MRI). Comparable magnetic-resonance labels have generally been limited to relatively simple chemically synthesized superparamagnetic microparticles that are, to a large extent, indistinguishable from one another. Here we show how it is instead possible to use a top-down microfabrication approach to effectively encode distinguishable spectral signatures into the geometry of magnetic microstructures. Although based on different physical principles from those of optically probed nanoparticles, these geometrically defined magnetic microstructures permit a multiplexing functionality in the magnetic resonance radio-frequency spectrum that is in many ways analogous to that permitted by quantum dots in the optical spectrum. Additionally, in situ modification of particle geometries may facilitate radio-frequency probing of various local physiological variables.	[Zabow, Gary; Dodd, Stephen; Koretsky, Alan] Natl Inst Neurol Disorders & Stroke, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Zabow, Gary; Moreland, John] NIST, Electromagnet Div, Boulder, CO 80305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Standards & Technology (NIST) - USA	Zabow, G (corresponding author), Natl Inst Neurol Disorders & Stroke, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA.	zabow@boulder.nist.gov	Koretsky, Alan P/C-7940-2015; Moreland, John/AAJ-1973-2020	Koretsky, Alan P/0000-0002-8085-4756; Zabow, Gary/0000-0002-1421-8540	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003047] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 NS003047-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; ASHKIN A, 1989, P NATL ACAD SCI USA, V86, P7914, DOI 10.1073/pnas.86.20.7914; Bozorth R.M., 1951, FERROMAGNETISM; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chikazumi S., 1997, PHYS FERROMAGNETISM; Cunningham CH, 2005, MAGNET RESON MED, V53, P999, DOI 10.1002/mrm.20477; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; GRAD J, 1990, J MAGN RESON, V90, P1, DOI 10.1016/0022-2364(90)90361-C; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hinds KA, 2003, BLOOD, V102, P867, DOI 10.1182/blood-2002-12-3669; Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8; Lanza GM, 2005, CURR TOP DEV BIOL, V70, P57, DOI 10.1016/S0070-2153(05)70003-X; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; MANSFIELD P, 1973, J PHYS C SOLID STATE, V6, pL422, DOI 10.1088/0022-3719/6/22/007; Mason W.T., 1999, FLUORESCENT LUMINESC; NELSON KL, 1995, TOP MAGN RESON IMAG, V7, P124; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; RUNGE VM, 1995, TOP MAGN RESON IMAG, V7, P181; SATO M, 1983, J CELL BIOL, V97, P1089, DOI 10.1083/jcb.97.4.1089; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shellock FG, 1999, J MAGN RESON IMAGING, V10, P477, DOI 10.1002/(SICI)1522-2586(199909)10:3<477::AID-JMRI33>3.0.CO;2-E; Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; Woods M, 2006, CHEM SOC REV, V35, P500, DOI 10.1039/b509907m; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; Zurkiya O, 2006, MAGN RESON MED, V56, P726, DOI 10.1002/mrm.21024	32	102	109	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1058	U2		10.1038/nature07048	http://dx.doi.org/10.1038/nature07048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563157	Green Accepted			2022-12-24	WOS:000256839900048
J	Polier, S; Dragovic, Z; Hartl, FU; Bracher, A				Polier, Sigrun; Dragovic, Zdravko; Hartl, F. Ulrich; Bracher, Andreas			Structural basis for the cooperation of Hsp70 and Hsp110 chaperones in protein folding	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; MARINESCO-SJOGREN-SYNDROME; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALLOSTERIC REGULATION; INTERDOMAIN LINKER; CRYSTAL-STRUCTURE; YEAST; GRPE; DNAK	Protein folding by Hsp70 is tightly controlled by cochaperones, including J-domain proteins that trigger ATP hydrolysis and nucleotide exchange factors (NEFs) that remove ADP from Hsp70. Here we present the crystal structure of the yeast NEF Sse1p (Hsp110) in complex with the nucleotide-binding domain (NBD) of Hsp70. Hsp110 proteins are homologous to Hsp70s and consist of an NBD, a beta sandwich domain, and a three helix bundle domain (3HBD). In the complex, the NBD of Sse1p is ATP bound, and together with the 3HBD it embraces the NBD of Hsp70, inducing opening and the release of bound ADP from Hsp70. Mutations that abolish NEF activity are lethal, thus defining nucleotide exchange on Hsp70 as an essential function of Sse1p. Our data suggest that Sse1p does not employ the nucleotide-dependent allostery and peptide-binding mode of canonical Hsp70s, and that direct interactions of substrate with Sse1p may support Hsp70-assisted protein folding in a cooperative process.	[Polier, Sigrun; Dragovic, Zdravko; Hartl, F. Ulrich; Bracher, Andreas] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; bracher@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019					Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; WILBANKS SM, 1995, J BIOL CHEM, V270, P2251, DOI 10.1074/jbc.270.5.2251; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	34	188	194	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					1068	1079		10.1016/j.cell.2008.05.022	http://dx.doi.org/10.1016/j.cell.2008.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555782	Bronze, Green Accepted			2022-12-24	WOS:000256693400021
J	Wang, B; Heath-Engel, H; Zhang, DL; Nguyen, N; Thomas, DY; Hanrahan, JW; Shore, GC				Wang, Bing; Heath-Engel, Hannah; Zhang, Donglei; Nguyen, Nhi; Thomas, David Y.; Hanrahan, John W.; Shore, Gordon C.			BAP31 interacts with Sec61 translocons and promotes retrotranslocation of CFTR Delta F508 via the Derlin-1 complex	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM MEMBRANE; ER-ASSOCIATED DEGRADATION; CLASS-I MOLECULES; PROTEIN TRANSLOCATION; UBIQUITIN-LIGASE; QUALITY-CONTROL; CYTOCHROME-C; CFTR; ASSOCIATION	BAP31 is an endoplasmic reticulum protein-sorting factor that associates with newly synthesized integral membrane proteins and controls their fate (i.e., egress, retention, survival, or degradation). BAP31 is itself an integral membrane protein and a constituent of several large protein complexes. Here, we show that a part of the BAP31 population interacts with two components of the Sec61 preprotein translocon, Sec61 beta and TRAM. BAP31 associates with the N terminus of one of its newly synthesized client proteins, the Delta F508 mutant of CFTR, and promotes its retrotranslocation from the ER and degradation by the cytoplasmic 26S proteasome system. Depletion of BAP31 reduces the proteasomal degradation of Delta F508 and permits a significant fraction of the surviving protein to reach the cell surface. Of note, BAP31 also associates physically and functionally with the Derlin-1 protein disclocation complex in the Delta F508 degradation pathway. Thus, BAP31 operates at early steps to deliver newly synthesized CFTR Delta F508 to its degradation pathway.	[Wang, Bing; Heath-Engel, Hannah; Zhang, Donglei; Nguyen, Nhi; Thomas, David Y.; Shore, Gordon C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Shore, Gordon C.] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Hanrahan, John W.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Shore, GC (corresponding author), McGill Univ, Dept Biochem, Mclntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	gordon.shore@mcgill.ca	Hanrahan, John/AGG-1926-2022; Thomas, David/M-7661-2017	Hanrahan, John/0000-0001-9080-2039; wang, bing/0000-0002-6549-8837; Thomas, David/0000-0002-8854-762X				Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ducret A, 2003, EUR J BIOCHEM, V270, P342, DOI 10.1046/j.1432-1033.2003.03395.x; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Greenfield JJA, 1999, J CELL SCI, V112, P1477; Hu D, 2006, J BIOCHEM MOL BIOL, V39, P677; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Szczesna-Skorupa E, 2006, J BIOL CHEM, V281, P4142, DOI 10.1074/jbc.M509522200; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; WARD CL, 1994, J BIOL CHEM, V269, P25710; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200	43	118	123	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					1080	1092		10.1016/j.cell.2008.04.042	http://dx.doi.org/10.1016/j.cell.2008.04.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555783	Bronze			2022-12-24	WOS:000256693400022
J	Sharp, D				Sharp, David			Healthy walking spoiled	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							FARAHMAND B, 2008, SCAND J MED SCI 0527; McGwin G, 2008, J TRAUMA, V64, P1562, DOI 10.1097/TA.0b013e3181238d39; Parkkari J, 2000, AM J MED, V109, P102, DOI 10.1016/S0002-9343(00)00455-1; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029; Wells Claudia, 2008, Health Stat Q, P6; 2008, GOLFING CAN BE GOOD	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2008	371	9631					2158	2158		10.1016/S0140-6736(08)60934-4	http://dx.doi.org/10.1016/S0140-6736(08)60934-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586161				2022-12-24	WOS:000257635800010
J	Ifa, DR; Manicke, NE; Dill, AL; Cooks, G				Ifa, Demian R.; Manicke, Nicholas E.; Dill, Allison L.; Cooks, Graham			Latent fingerprint chemical imaging by mass spectrometry	SCIENCE			English	Article							DESORPTION ELECTROSPRAY-IONIZATION; AMBIENT CONDITIONS		[Ifa, Demian R.; Manicke, Nicholas E.; Dill, Allison L.; Cooks, Graham] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Ifa, Demian R.; Manicke, Nicholas E.; Dill, Allison L.; Cooks, Graham] Purdue Univ, Ctr Analyt Instrumentat Dev, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cooks, G (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	cooks@purdue.edu	Cooks, R Graham/G-1051-2015; Ifa, Demian/D-3978-2012	Cooks, R Graham/0000-0002-9581-9603; 				Dorozhkin LM, 2004, SENSOR ACTUAT B-CHEM, V99, P568, DOI 10.1016/j.snb.2004.01.007; Ifa DR, 2007, INT J MASS SPECTROM, V259, P8, DOI 10.1016/j.ijms.2006.08.003; Leggett R, 2007, ANGEW CHEM INT EDIT, V46, P4100, DOI 10.1002/anie.200700217; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; Tahtouh M, 2007, J FORENSIC SCI, V52, P1089, DOI 10.1111/j.1556-4029.2007.00517.x; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404	6	293	304	7	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					805	805		10.1126/science.1157199	http://dx.doi.org/10.1126/science.1157199			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687956				2022-12-24	WOS:000258261000036
J	Suzuki, K; Verma, IM				Suzuki, Kotaro; Verma, Inder M.			Phosphorylation of SNAP-23 by I kappa B kinase 2 regulates mast cell degranulation	CELL			English	Article							MEMBRANE-FUSION; SIGNALING PATHWAYS; IMMUNE-RESPONSES; SNARE PROTEINS; LIPID RAFTS; PC12 CELLS; ACTIVATION; EXOCYTOSIS; COMPLEXES; MICE	Mast cells are known to play a pivotal role in allergic diseases. Cross-linking of the high-affinity receptor for IgE (Fc epsilon RI) leads to degranulation and allergic inflammation; however, the regulatory mechanisms of IgE-dependent exocytosis remain unknown. We show here that I kappa B kinase (IKK) 2 in mast cells plays critical roles in IgE-mediated anaphylaxis in vivo, and IgE-mediated degranulation in vitro, in an NF-kB-independent manner. Upon Fc epsilon RI stimulation, IKK2 phosphorylates SNAP-23, the target membrane soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor (SNARE), and ectopic expression of a phospho-mimetic mutant of SNAP-23 partially rescued the impaired IgE-mediated degranulation in IKK2-deficient mast cells. These results suggest that IKK2 phosphorylation of SNAP-23 leads to degranulation and anaphylactic reactions. While this reaction is NF-kB-independent, we additionally show that IKK2 also regulates late-phase allergic reactions promoted by the release of proinflammatory cytokines in an NF-kB-independent manner. The findings suggest that IKK2 is a central player in allergic reactions.	[Suzuki, Kotaro; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu			NIH; Leducq Foundation; Lustgarten Foundation; Ellison Medical Foundation; Francis C. Berger Foundation; National Institute of Allergy And Infectious Diseases [AI048034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048034, R37AI048034] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Lustgarten Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Francis C. Berger Foundation; National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are very grateful to Dr. P. A. Roche for SNAP-23 phosphorylation site-specific antibodies, Drs. Y. Tamori and M. Kasuga for murine SNAP-23 cDNA, R. Jacobs for electron microscopy, Dr. Y. Soda for making shRNA plasmids, Drs. Q. Li, H. Matsuzaki, Y. Xia, F. Liu, and T. Marumoto for valuable discussion and help in the preparation of the manuscript, and G. Estepa and N. Hoong for technical help. K. S. is supported by grants from the NIH and the Leducq Foundation. I. M. V. is an American Cancer Society Professor of Molecular Biology, and supported in part by grants from NIH, Leducq Foundation, Lustgarten Foundation, Ellison Medical Foundation, and the H. N. and Francis C. Berger Foundation. The project described was supported by Grant Number AI048034 from the National Institute of Allergy And Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy And Infectious Diseases or the National Institutes of Health.	Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Correa RG, 2005, CURR BIOL, V15, P1291, DOI 10.1016/j.cub.2005.06.023; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Peng YD, 2005, J LEUKOCYTE BIOL, V77, P975, DOI 10.1189/jlb.0204115; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027	40	116	117	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					485	495		10.1016/j.cell.2008.05.050	http://dx.doi.org/10.1016/j.cell.2008.05.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692471	Green Accepted, Bronze			2022-12-24	WOS:000258665500021
J	Tu, L; Tai, WCS; Chen, L; Banfield, DK				Tu, Linna; Tai, William C. S.; Chen, Lu; Banfield, David K.			Signal-mediated dynamic retention of glycosyltransferases in the Golgi	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; KIN RECOGNITION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; HELA-CELLS; LOCALIZATION; TRANSMEMBRANE; APPARATUS; PROTEOMICS; SEQUENCES	Golgi-resident glycosyltransferases are a family of enzymes that sequentially modify glycoproteins in a subcompartment-specific manner. These type II integral membrane proteins are characterized by a short cytoplasmically exposed amino-terminal tail and a luminal enzymatic domain. The cytoplasmic tails play a role in the localization of glycosyltransferases, and coat protein complex I (COPI) vesicle-mediated retrograde transport is also involved in their Golgi localization. However, the tails of these enzymes lack known COPI-binding motifs. Here, we found that Vps74p bound to a pentameric motif present in the cytoplasmic tails of the majority of yeast Golgi-localized glycosyltransferases, as well as to COPI. We propose that Vps74p maintains the steady-state localization of Golgi glycosyltransferases dynamically, by promoting their incorporation into COPI-coated vesicles.	[Tu, Linna; Tai, William C. S.; Chen, Lu; Banfield, David K.] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Banfield, DK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	bodkb@ust.hk		Tu, Linna/0000-0003-0162-2162; Tai, William Chi-Shing/0000-0002-0771-7894				BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; BURKE J, 1992, J BIOL CHEM, V267, P24433; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; LUSSIER M, 1995, J CELL BIOL, V131, P913, DOI 10.1083/jcb.131.4.913; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nagano-Ito M, 2007, GENE, V400, P82, DOI 10.1016/j.gene.2007.06.007; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Opat AS, 2001, BIOCHIMIE, V83, P763, DOI 10.1016/S0300-9084(01)01312-8; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Romero PA, 1999, GLYCOBIOLOGY, V9, P1045, DOI 10.1093/glycob/9.10.1045; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x	26	170	173	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					404	407		10.1126/science.1159411	http://dx.doi.org/10.1126/science.1159411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635803				2022-12-24	WOS:000257713900050
J	Keitt, TH				Keitt, Timothy H.			Coherent ecological dynamics induced by large-scale disturbance	NATURE			English	Article							COMPENSATORY DYNAMICS; COMMUNITY DYNAMICS; CURRENT KNOWLEDGE; BIODIVERSITY; ACIDIFICATION; VARIABILITY; SYNCHRONY; STABILITY; WAVELETS	Aggregate community- level response to disturbance is a principle concern in ecology because post- disturbance dynamics are integral to the ability of ecosystems to maintain function in an uncertain world. Community- level responses to disturbance can be arrayed along a spectrum ranging from synchronous oscillations where all species rise and fall together, to compensatory dynamics where total biomass remains relatively constant despite fluctuations in the densities of individual species(1). An important recent insight is that patterns of synchrony and compensation can vary with the timescale of analysis(2) and that spectral time series methods can enable detection of coherent dynamics that would otherwise be obscured by opposing patterns occurring at different scales(3). Here I show that application of wavelet analysis to experimentally manipulated plankton communities reveals strong synchrony after disturbance. The result is paradoxical because it is well established that these communities contain both disturbance- sensitive and disturbance- tolerant species leading to compensation within functional groups(4,5). Theory predicts that compensatory substitution of functionally equivalent species should stabilize ecological communities(6-10), yet I found at the whole- community level a large increase in seasonal biomass variation. Resolution of the paradox hinges on patterns of seasonality among species. The compensatory shift in community composition after disturbance resulted in a loss of cold- season dominants, which before disturbance had served to stabilize biomass throughout the year. Species dominating the disturbed community peaked coherently during the warm season, explaining the observed synchrony and increase in seasonal biomass variation. These results suggest that theory relating compensatory dynamics to ecological stability needs to consider not only complementarity in species responses to environmental change, but also seasonal complementarity among disturbance- tolerant and disturbance- sensitive species.	Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Keitt, TH (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	tkeitt@mail.utexas.edu	Keitt, Timothy/AAF-9787-2021	Keitt, Timothy/0000-0002-4587-1083				Benjamini Y, 2001, ANN STAT, V29, P1165; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Daubechies I., 1992, 10 LECT WAVELETS, V61; DOWNING AL, IN PRESS ECOLOGY; Ernest SKM, 2001, ECOLOGY, V82, P2118, DOI 10.2307/2680220; Fischer JM, 2001, ECOL APPL, V11, P1060, DOI 10.2307/3061012; FORST TM, 2005, LONG TERM DYNAMICS L; Frost TM, 2006, ECOL APPL, V16, P353, DOI 10.1890/04-1800; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Keitt TH, 2006, ECOLOGY, V87, P2895, DOI 10.1890/0012-9658(2006)87[2895:DOSCDU]2.0.CO;2; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Micheli F, 1999, OIKOS, V85, P161, DOI 10.2307/3546802; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PERCIVAL DB, 2002, CAMBRIDGE SERIES STA; Rao J. S., 2001, TOPICS CIRCULAR STAT; Solow AR, 2007, ECOSYSTEMS, V10, P1034, DOI 10.1007/s10021-007-9076-1; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Vasseur DA, 2007, ECOL LETT, V10, P1066, DOI 10.1111/j.1461-0248.2007.01099.x; Vasseur DA, 2007, ECOLOGY, V88, P2058, DOI 10.1890/06-1899.1	29	81	82	5	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					331	U39		10.1038/nature06935	http://dx.doi.org/10.1038/nature06935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633416				2022-12-24	WOS:000257665300038
J	Mackelprang, R; Rubin, EM				Mackelprang, Rachel; Rubin, Edward M.			Paleontology - New tricks with old bones	SCIENCE			English	Editorial Material							NEANDERTHAL GENOMIC DNA; MODERN HUMANS; SELECTION; AMPLIFICATION; SEQUENCES; GENE		[Mackelprang, Rachel; Rubin, Edward M.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Mackelprang, Rachel; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mackelprang, R (corresponding author), Dept Energy Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov						Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; BLOW MJ, 2008, GENOME RES; Coop G, 2008, MOL BIOL EVOL, V25, P1257, DOI 10.1093/molbev/msn091; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	16	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					211	212		10.1126/science.1161890	http://dx.doi.org/10.1126/science.1161890			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621660				2022-12-24	WOS:000257512900028
J	Wittemyer, G; Elsen, P; Bean, WT; Burton, ACO; Brashares, JS				Wittemyer, George; Elsen, Paul; Bean, William T.; Burton, A. Coleman O.; Brashares, Justin S.			Accelerated human population growth at protected area edges	SCIENCE			English	Article							CONSERVATION; WILDLIFE; POVERTY; PARKS; SIZE	Protected areas ( PAs) have long been criticized as creations of and for an elite few, where associated costs, but few benefits, are borne by marginalized rural communities. Contrary to predictions of this argument, we found that average human population growth rates on the borders of 306 PAs in 45 countries in Africa and Latin America were nearly double average rural growth, suggesting that PAs attract, rather than repel, human settlement. Higher population growth on PA edges is evident across ecoregions, countries, and continents and is correlated positively with international donor investment in national conservation programs and an index of park- related funding. These findings provide insight on the value of PAs for local people, but also highlight a looming threat to PA effectiveness and biodiversity conservation.	[Wittemyer, George; Elsen, Paul; Bean, William T.; Burton, A. Coleman O.; Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wittemyer, G (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	georgew@nature.berkeley.edu; brashares@nature.berkeley.edu	Burton, Cole/AAF-9234-2019; Burton, Cole/J-3184-2012; Wittemyer, George/AFQ-1840-2022; Bean, William/A-9399-2012; Elsen, Paul/H-9567-2019	Burton, Cole/0000-0002-8799-3847; Burton, Cole/0000-0002-8799-3847; Elsen, Paul/0000-0002-9953-7961; Bean, William T./0000-0001-6595-5885				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Cernea MM, 2006, WORLD DEV, V34, P1808, DOI 10.1016/j.worlddev.2006.02.008; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; de Sherbinin A, 2008, ORYX, V42, P26, DOI 10.1017/S0030605308000781; de Sherbinin Alex, 1998, Parks (Newbury), V8, P38; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; *GEF, 2006, GEF BIOD STRAT ACT; *GEF, 2008, GEF PROJ DAT; Hudak AT, 2004, AGR ECOSYST ENVIRON, V101, P307, DOI 10.1016/j.agee.2003.09.010; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; Karanth KK, 2006, BIOL CONSERV, V128, P147, DOI 10.1016/j.biocon.2005.09.024; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PELUSO NL, 1993, GLOBAL ENVIRON CHANG, V3, P199, DOI 10.1016/0959-3780(93)90006-7; Scherl L.M., 2004, OPPORTUNITIES LIMITA; Scholte P, 2003, AMBIO, V32, P58, DOI 10.1639/0044-7447(2003)032[0058:IAPTBU]2.0.CO;2; *UNEP, 2003, WORLD DAT PROT AR; *UNEP CIESIN, 2004, AFR POP DISTR DAT; *UNEP INT CTR TROP, 2004, LAT AM POP DISTR DAT; *UNEP WCMC, 2003, PROT NAT DES PROT AR; UNPD, 2007, WORLD URB PROSP 2007	26	407	432	6	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					123	126		10.1126/science.1158900	http://dx.doi.org/10.1126/science.1158900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599788				2022-12-24	WOS:000257320800052
J	Vyas, N; Goswami, D; Manonmani, A; Sharma, P; Ranganath, HA; VijayRaghavan, K; Shashidhara, LS; Sowdhamini, R; Mayor, S				Vyas, Neha; Goswami, Debanjan; Manonmani, A.; Sharma, Pranav; Ranganath, H. A.; VijayRaghavan, K.; Shashidhara, L. S.; Sowdhamini, R.; Mayor, Satyajit			Nanoscale organization of Hedgehog is essential for long-range signaling	CELL			English	Article							GPI-ANCHORED PROTEINS; SONIC HEDGEHOG; CHOLESTEROL MODIFICATION; LIPID MODIFICATIONS; DATA-BANK; DROSOPHILA; PALMITOYLATION; IDENTIFICATION; PROTEOGLYCANS; MICROSCOPY	Hedgehog (Hh) plays crucial roles in tissue-patterning and activates signaling in Patched (Ptc)-expressing cells. Paracrine signaling requires release and transport over many cell diameters away by a process that requires interaction with heparan sulfate proteoglycans (HSPGs). Here, we examine the organization of functional, fluorescently tagged variants in living cells by using optical imaging, FRET microscopy, and mutational studies guided by bioinformatics prediction. We find that cell-surface Hh forms suboptical oligomers, further concentrated in visible clusters colocalized with HSPGs. Mutation of a conserved Lys in a predicted Hh-protomer interaction interface results in an autocrine signaling-competent Hh isoform-incapable of forming dense nanoscale oligomers, interacting with HSPGs, or paracrine signaling. Thus, Hh exhibits a hierarchical organization from the nanoscale to visible clusters with distinct functions.	[Vyas, Neha; Goswami, Debanjan; Manonmani, A.; Sharma, Pranav; VijayRaghavan, K.; Sowdhamini, R.; Mayor, Satyajit] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Vyas, Neha; Ranganath, H. A.] Univ Mysore, Dept Studies Zool, Mysore 570006, Karnataka, India; [Shashidhara, L. S.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Mysore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Mayor, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bellary Rd, Bangalore 560065, Karnataka, India.	mayor@ncbs.res.in	Vyas, Neha/K-4015-2017	Vyas, Neha/0000-0002-8873-5751				Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; Dunbrack RL, 1997, FOLD DES, V2, pR27, DOI 10.1016/S1359-0278(97)00011-4; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Strigini M, 1997, DEVELOPMENT, V124, P4697; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	39	113	114	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1214	1227		10.1016/j.cell.2008.05.026	http://dx.doi.org/10.1016/j.cell.2008.05.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585355	Bronze			2022-12-24	WOS:000257144600018
J	Purves, D; Pacala, S				Purves, Drew; Pacala, Stephen			Predictive models of forest dynamics	SCIENCE			English	Editorial Material							LAND-USE HISTORY; ECOSYSTEMS; RANGE	Dynamic global vegetation models (DGVMs) have shown that forest dynamics could dramatically alter the response of the global climate system to increased atmospheric carbon dioxide over the next century. But there is little agreement between different DGVMs, making forest dynamics one of the greatest sources of uncertainty in predicting future climate. DGVM predictions could be strengthened by integrating the ecological realities of biodiversity and height-structured competition for light, facilitated by recent advances in the mathematics of forest modeling, ecological understanding of diverse forest communities, and the availability of forest inventory data.	[Purves, Drew] Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England; [Pacala, Stephen] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Microsoft; Princeton University	Purves, D (corresponding author), Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England.							Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Keeling HC, 2007, GLOBAL ECOL BIOGEOGR, V16, P618, DOI 10.1111/j.1466-8238.2007.00314.x; Landsberg J, 2003, CAN J FOREST RES, V33, P385, DOI 10.1139/X02-129; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Moorcroft PR, 2003, P ROY SOC B-BIOL SCI, V270, P1215, DOI 10.1098/rspb.2002.2251; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Okino MS, 1998, CHEM REV, V98, P391, DOI 10.1021/cr950223l; Oldfield S., 1998, WORLD LIST THREATENE; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Raupach MR, 2005, GLOBAL CHANGE BIOL, V11, P378, DOI 10.1111/j.1365-2486.2005.00917.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742	21	249	255	5	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1452	1453		10.1126/science.1155359	http://dx.doi.org/10.1126/science.1155359			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556548				2022-12-24	WOS:000256676400031
J	Nedjic, J; Aichinger, M; Emmerich, J; Mizushima, N; Klein, L				Nedjic, Jelena; Aichinger, Martin; Emmerich, Jan; Mizushima, Noboru; Klein, Ludger			Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-II PRESENTATION; CROHN-DISEASE; IN-VIVO; ANTIGEN; SELECTION; AIRE; MEDULLA; PROTEIN; VITRO	Recognition of self- antigen- derived epitopes presented by major histocompatibility complex class II ( MHC II) molecules on thymic epithelial cells ( TECs) is critical for the generation of a functional and self- tolerant CD4 T- cell repertoire. Whereas haematopoietic antigen- presenting cells generate MHC- II - peptide complexes predominantly through the processing of endocytosed polypeptides(1), it remains unknown if and how TECs use unconventional pathways of antigen presentation. Here we address the role of macroautophagy, a process that has recently been shown to allow for endogenous MHC II loading(2-6), in T- cell repertoire selection in the mouse thymus. In contrast to most other tissues, TECs had a high constitutive level of autophagy. Genetic interference with autophagy specifically in TECs led to altered selection of certain MHC-II-restricted T- cell specificities and resulted in severe colitis and multi- organ inflammation. Our findings indicate that autophagy focuses the MHC- II - peptide repertoire of TECs on their intracellular milieu, which notably comprises a wide array of otherwise strictly 'tissue-specific' self antigens(7,8). In doing so, it contributes to T- cell selection and is essential for the generation of a self- tolerant T- cell repertoire.	[Nedjic, Jelena; Aichinger, Martin; Emmerich, Jan; Klein, Ludger] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan; [Klein, Ludger] Univ Munich, Inst Immunol, D-80336 Munich, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Tokyo Medical & Dental University (TMDU); University of Munich	Klein, L (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	ludger.klein@med.lmu.de	Mizushima, Noboru/C-3635-2009; Klein, Ludger/G-8785-2011	Mizushima, Noboru/0000-0002-6258-6444; Klein, Ludger/0000-0003-2054-071X; Emmerich, Jan/0000-0002-7216-2231	Austrian National Science Fund [F023, Z58-B01]; European Union; FP6 Integrated Project Eurothymaide [LSHB-CT-2003-503410]; Boehringer Ingelheim	Austrian National Science Fund(Austrian Science Fund (FWF)); European Union(European Commission); FP6 Integrated Project Eurothymaide(European Commission); Boehringer Ingelheim(Boehringer Ingelheim)	We acknowledge support from the Austrian National Science Fund (Sonderforschungsbereich F023 and grant Z58-B01 'Wittgenstein Prize Meinrad Busslinger'; to J.N. and L. K.) and the European Union (FP6 Integrated Project 'Eurothymaide'; Contract LSHB-CT-2003-503410; to M.A., J.E. and L. K.). Research at the Research Institute of Molecular Pathology is funded by Boehringer Ingelheim. We thank C. Spona for technical assistance and M. Busslinger, M. S. Anderson, B. Kyewski and J. Derbinski for comments on the manuscript. We also thank H. Ploegh for discussions in the earliest phase of this project.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	32	373	394	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					396	U49		10.1038/nature07208	http://dx.doi.org/10.1038/nature07208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18701890				2022-12-24	WOS:000259265200046
J	Corrigan, JD; Cole, TB				Corrigan, John D.; Cole, Thomas B.			Substance use disorders and clinical management of traumatic brain injury and posttraumatic stress disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALCOHOL; PTSD; IRAQ		[Cole, Thomas B.] JAMA, Chicago, IL 60654 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Cole, TB (corresponding author), JAMA, 515 N State St, Chicago, IL 60654 USA.	tbcole@bellsouth.net	Corrigan, John D./E-2921-2011					Back SE, 2006, J NERV MENT DIS, V194, P690, DOI 10.1097/01.nmd.0000235794.12794.8a; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Corrigan JD, 2007, BRAIN INJURY, V21, P343, DOI 10.1080/02699050701253103; Drake RE, 2001, PSYCHIAT SERV, V52, P469, DOI 10.1176/appi.ps.52.4.469; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Ford Julian D, 2006, Am J Psychother, V60, P335; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P492	15	51	51	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2008	300	6					720	721		10.1001/jama.300.6.720	http://dx.doi.org/10.1001/jama.300.6.720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336OM	18698070				2022-12-24	WOS:000258374500024
J	Bishop, JL; Dobrea, EZN; McKeown, NK; Parente, M; Ehlmann, BL; Michalski, JR; Milliken, RE; Poulet, F; Swayze, GA; Mustard, JF; Murchie, SL; Bibring, JP				Bishop, Janice L.; Dobrea, Eldar Z. Noe; McKeown, Nancy K.; Parente, Mario; Ehlmann, Bethany L.; Michalski, Joseph R.; Milliken, Ralph E.; Poulet, Francois; Swayze, Gregg A.; Mustard, John F.; Murchie, Scott L.; Bibring, Jean-Pierre			Phyllosilicate diversity and past aqueous activity revealed at Mawrth Vallis, Mars	SCIENCE			English	Article							HYDROTHERMAL ALTERATION; INFRARED-SPECTROSCOPY; SMECTITES; BACTERIA; MINERALS; ORIGIN	Observations by the Mars Reconnaissance Orbiter/Compact Reconnaissance Imaging Spectrometer for Mars in the Mawrth Vallis region show several phyllosilicate species, indicating a wide range of past aqueous activity. Iron/magnesium (Fe/Mg)-smectite is observed in light-toned outcrops that probably formed via aqueous alteration of basalt of the ancient cratered terrain. This unit is overlain by rocks rich in hydrated silica, montmorillonite, and kaolinite that may have formed via subsequent leaching of Fe and Mg through extended aqueous events or a change in aqueous chemistry. A spectral feature attributed to an Fe2+ phase is present in many locations in the Mawrth Vallis region at the transition from Fe/Mg-smectite to aluminum/silicon (Al/Si)-rich units. Fe2+-bearing materials in terrestrial sediments are typically associated with microorganisms or changes in pH or cations and could be explained here by hydrothermal activity. The stratigraphy of Fe/Mg-smectite overlain by a ferrous phase, hydrated silica, and then Al-phyllosilicates implies a complex aqueous history.	[Bishop, Janice L.] SETI Inst, Mountain View, CA 94043 USA; [Bishop, Janice L.] NASA, Ames Res Ctr, Mountain View, CA 94043 USA; [Dobrea, Eldar Z. Noe; Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [McKeown, Nancy K.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Parente, Mario] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Ehlmann, Bethany L.; Mustard, John F.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Michalski, Joseph R.; Poulet, Francois; Bibring, Jean-Pierre] Inst Astrophys Spatiale, F-91405 Orsay, France; [Swayze, Gregg A.] US Geol Survey, Lakewood, CO 80225 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Santa Cruz; Stanford University; Brown University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; United States Department of the Interior; United States Geological Survey; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Bishop, JL (corresponding author), SETI Inst, Mountain View, CA 94043 USA.	jbishop@seti.org	Michalski, Joseph/AAU-5631-2020; Murchie, Scott L/E-8030-2015	Murchie, Scott L/0000-0002-1616-8751; Michalski, Joseph/0000-0002-4543-6452; Bishop, Janice/0000-0002-6681-9954	NASA [NNX13AK19A] Funding Source: Medline	NASA(National Aeronautics & Space Administration (NASA))		Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bishop J, 2002, CLAY MINER, V37, P607, DOI 10.1180/0009855023740063; Bishop J, 2002, CLAY MINER, V37, P617, DOI 10.1180/0009855023740064; Bishop JL, 2007, CLAY CLAY MINER, V55, P1, DOI 10.1346/CCMN.2007.0550101; BISHOP JL, 2005, LUN PLAN SCI C LUN P; BROCK TD, 1976, APPL ENVIRON MICROB, V32, P567, DOI 10.1128/AEM.32.4.567-571.1976; BROWNE PRL, 1978, ANNU REV EARTH PL SC, V6, P229, DOI 10.1146/annurev.ea.06.050178.001305; Chamley H., 1989, CLAY SEDIMENTOLOGY, DOI DOI 10.1007/978-3-642-85916-8; DOBREA EZ, 2008, LUN PLAN SCI C LUN P; JACKSON M. L., 1957, Proceedings. 6th nat. Conf. Clays & Clay Min., P133, DOI 10.1346/CCMN.1957.0060111; Loizeau D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002877; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Michalski JR, 2007, GEOLOGY, V35, P951, DOI 10.1130/G23854A.1; MICHALSKI JR, 2007, 7 INT MARS C PAS CA; MILLIKEN RE, IN PRESS GEOLOGY; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Nelson MJ, 2005, GEOCHIM COSMOCHIM AC, V69, P2701, DOI 10.1016/j.gca.2005.01.020; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; STUCKI JW, 1991, CLAY CLAY MINER, V39, P137, DOI 10.1346/CCMN.1991.0390204; Wray JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034385	23	294	294	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					830	833		10.1126/science.1159699	http://dx.doi.org/10.1126/science.1159699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687963	Green Accepted			2022-12-24	WOS:000258261000044
J	Yin, P; Hariadi, RF; Sahu, S; Choi, HMT; Park, SH; LaBean, TH; Reif, JH				Yin, Peng; Hariadi, Rizal F.; Sahu, Sudheer; Choi, Harry M. T.; Park, Sung Ha; LaBean, Thomas H.; Reif, John H.			Programming DNA tube circumferences	SCIENCE			English	Article							CONDUCTIVE NANOWIRES; NANOTUBES; DESIGN; NANOARCHITECTURES; NANOTECHNOLOGY; NANOSTRUCTURES; TEMPLATES; ASSEMBLE; CRYSTALS; 6-HELIX	Synthesizing molecular tubes with monodisperse, programmable circumferences is an important goal shared by nanotechnology, materials science, and supermolecular chemistry. We program molecular tube circumferences by specifying the complementarity relationships between modular domains in a 42-base single-stranded DNA motif. Single-step annealing results in the self-assembly of long tubes displaying monodisperse circumferences of 4, 5, 6, 7, 8, 10, or 20 DNA helices.	[Yin, Peng; Park, Sung Ha] CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA; [Yin, Peng; Choi, Harry M. T.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Yin, Peng] CALTECH, Ctr Biol Circuit Design, Pasadena, CA 91125 USA; [Hariadi, Rizal F.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Park, Sung Ha] CALTECH, Ctr Phys Informat, Pasadena, CA 91125 USA; [Sahu, Sudheer; LaBean, Thomas H.; Reif, John H.] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; [LaBean, Thomas H.] Duke Univ, Dept Chem, Durham, NC 27708 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Duke University; Duke University	Yin, P (corresponding author), CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA.	py@caltech.edu	Reif, John H/C-2684-2008; LaBean, Thomas H/G-2859-2011	LaBean, Thomas H/0000-0002-6739-2059; Choi, Harry/0000-0002-1530-0773; Hariadi, Rizal/0000-0001-7840-859X	Direct For Computer & Info Scie & Enginr [0829798] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [0829797] Funding Source: National Science Foundation	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Barish RD, 2005, NANO LETT, V5, P2586, DOI 10.1021/nl052038l; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Ke YG, 2006, J AM CHEM SOC, V128, P4414, DOI 10.1021/ja058145z; Kuzuya A, 2007, NANO LETT, V7, P1757, DOI 10.1021/nl070828k; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Park SH, 2005, NANO LETT, V5, P693, DOI 10.1021/nl050108i; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Reishus D, 2005, J AM CHEM SOC, V127, P17590, DOI 10.1021/ja0557177; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 1998, NANOTECHNOLOGY, V9, P257, DOI 10.1088/0957-4484/9/3/018; Sherman WB, 2006, BIOPHYS J, V90, P4546, DOI 10.1529/biophysj.105.080390; Wei B, 2005, BIOMACROMOLECULES, V6, P2528, DOI 10.1021/bm050230b; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451	25	358	387	3	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					824	826		10.1126/science.1157312	http://dx.doi.org/10.1126/science.1157312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687961				2022-12-24	WOS:000258261000042
J	Pham, CB; Shaughnessy, AF				Pham, Cung B.; Shaughnessy, Allen F.			Uncertainties page - Should we treat subclinical hypothyroidism?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; L-THYROXINE; THYROID-DISORDERS; ASSOCIATION; RISK		[Pham, Cung B.; Shaughnessy, Allen F.] Tufts Univ, Sch Med, Dept Publ Hlth & Family Med, Cambridge Hlth Alliance,Tufts Univ Family Med Res, Malden, MA 02148 USA	Harvard University; Cambridge Health Alliance; Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Family Med, Cambridge Hlth Alliance,Tufts Univ Family Med Res, 195 Canal St, Malden, MA 02148 USA.	Allen.Shaughnessy@Tufts.edu						[Anonymous], 2006, UK GUIDELINES USE TH; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Danese ND, 2000, J CLIN ENDOCR METAB, V85, P2993, DOI 10.1210/jcem.85.9.6841; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Gammage MD, 2007, ARCH INTERN MED, V167, P928, DOI 10.1001/archinte.167.9.928; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Ineck BA, 2003, ANN PHARMACOTHER, V37, P725, DOI 10.1345/aph.1C376; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; NYGAARD B, 2007, SUBCLINICAL HYPOTHYR; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Rodondi N, 2006, AM J MED, V119, P541, DOI 10.1016/j.amjmed.2005.09.028; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; *US PREV SERV TASK, 2004, REC STAT SCREEN THYR; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x	17	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2008	337	7664							a834	10.1136/bmj.a834	http://dx.doi.org/10.1136/bmj.a834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18632678				2022-12-24	WOS:000258561000032
J	Lee, TH; Emanuel, EJ				Lee, Thomas H.; Emanuel, Ezekiel J.			Tier 4 drugs and the fraying of the social compact	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER; COSTS		[Lee, Thomas H.] Partners Healthcare Syst, Boston, MA 02199 USA; [Emanuel, Ezekiel J.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	Partners Healthcare System; National Institutes of Health (NIH) - USA	Lee, TH (corresponding author), Partners Healthcare Syst, Boston, MA 02199 USA.							Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P947, DOI 10.1001/jama.299.8.947; KOLATA G, 2008, NY TIMES        0414; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Willey VJ, 2008, HEALTH AFFAIR, V27, P824, DOI 10.1377/hlthaff.27.3.824	5	53	53	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2008	359	4					333	335		10.1056/NEJMp0804261	http://dx.doi.org/10.1056/NEJMp0804261			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329FK	18650510				2022-12-24	WOS:000257852100001
J	Cain, KP; Benoit, SR; Winston, CA; Mac Kenzie, WR				Cain, Kevin P.; Benoit, Stephen R.; Winston, Carla A.; Mac Kenzie, William R.			Tuberculosis among foreign-born persons in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS ANALYSIS; RISK; POPULATION; PREVENTION; IMMIGRANTS; INFECTION; HEALTH; AGE	Context Foreign-born persons accounted for 57% of all tuberculosis (TB) cases in the United States in 2006. Current TB control strategies have not sufficiently addressed the high levels of TB disease and latent TB infection in this population. Objective To determine the risk of TB disease and drug-resistant TB among foreign-born populations and the potential impact of adding TB culture to overseas screening procedures for foreign-born persons entering the United States. Design, Setting, and Participants Descriptive epidemiologic analysis of foreign-born persons in the United States diagnosed with TB from 2001 through 2006. Main Outcome Measures TB case rates, stratified by time since US entry, country of origin, and age at US entry; anti-TB drug-resistance patterns; and characteristics of TB cases diagnosed within 3 months of US entry. Results A total of 46 970 cases of TB disease were reported among foreign-born persons in the United States from 2001 through 2006, of which 12 928 (28%) were among recent entrants (within 2 years of US entry). Among the foreign-born population overall, TB case rates declined with increasing time since US entry, but remained higher than among US-born persons - even more than 20 years after arrival. In total, 53% of TB cases among foreign-born persons occurred among the 22% of the foreign-born population born in sub-Saharan Africa and Southeast Asia. Isoniazid resistance was as high as 20% among recent entrants from Vietnam and 18% for recent entrants from Peru. On average, 250 individuals per year were diagnosed with smear-negative, culture-positive TB disease within 3 months of US entry; 46% of these were from the Philippines or Vietnam. Conclusion The relative yield of finding and treating latent TB infection is particularly high among individuals from most countries of sub-Saharan Africa and Southeast Asia.	[Cain, Kevin P.; Benoit, Stephen R.; Winston, Carla A.; Mac Kenzie, William R.] Ctr Dis Control, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Cain, KP (corresponding author), Ctr Dis Control, Div TB Eliminat, 1600 Clifton Rd,MS-E-10, Atlanta, GA 30333 USA.	kcain@cdc.gov	Kenzie, William R Mac/F-1528-2013	Kenzie, William R Mac/0000-0001-7723-0339				[Anonymous], [No title captured]; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; BLUM RN, 1993, CHEST, V103, P1670, DOI 10.1378/chest.103.6.1670; Cain KP, 2008, CLIN INFECT DIS, V46, P107, DOI 10.1086/523732; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; *CDCP, 2007, REP TUB US 2006; *CDCP, 2007 TECHN INSTR TUB; *CDCP, 2007, CDC IMM REQ TECHN IN; Centers for Disease Control and Prevention, 1991, 1991 TECHN INSTR MED; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Dasgupta K, 2005, EUR RESPIR J, V25, P1107, DOI 10.1183/09031936.05.00074004; Deardorff K, EVALUATING COMPONENT; GEITER L, 2000, ENDING NEGLECT ELIMI; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Goldberg SV, 2004, INT J TUBERC LUNG D, V8, P76; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Moran-Mendoza O, 2007, INT J TUBERC LUNG D, V11, P1014; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Parsyan AE, 2007, J INFECTION, V54, P262, DOI 10.1016/j.jinf.2006.04.010; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; ROSE DN, 1988, AM J PREV MED, V4, P102, DOI 10.1016/S0749-3797(18)31204-2; ROSE DN, 1986, JAMA-J AM MED ASSOC, V256, P2709, DOI 10.1001/jama.256.19.2709; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; SCHECHTER CB, 1990, AM J PREV MED, V6, P167, DOI 10.1016/S0749-3797(18)31022-5; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; *US BUR CENS, US CENS BUR AM FACTF; *US DEP HOM SEC, 2006, YB IMM STAT 2006; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	34	171	176	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					405	412		10.1001/jama.300.4.405	http://dx.doi.org/10.1001/jama.300.4.405			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647983	Bronze			2022-12-24	WOS:000257831200018
J	Gratwohl, A; Dohler, B; Stern, M; Opelz, G				Gratwohl, Alois; Doehler, Bernd; Stern, Martin; Opelz, Gerhard			H-Y as a minor histocompatibifity antigen in kidney transplantation: a retrospective cohort study	LANCET			English	Article							STEM-CELL TRANSPLANTATION; RENAL-TRANSPLANTATION; GRAFT-SURVIVAL; LYMPHOCYTES-T; DONOR GENDER; HLA; REJECTION; RISK; IMPACT; SEX	Background in haematopoietic stem-cell transplantation, male recipients of female grafts have an increased risk of graft-versus-host disease and female recipients have both an increased risk of rejection of male grafts and of specific T-cell and antibody reactivity against H-Y encoded gene products. By contrast, in kidney transplantation, the role of H-Y as a minor histocompatibility antigen has been disputed. We aimed to investigate whether an immunological H-Y effect occurs in kidney transplantation. Methods We did a retrospective cohort study between 1985 and 2004 in 195 516 recipients of allografts from deceased donors. We used multivariate statistical methods to compare graft survival and death-censored graft survival rates for female and male donor kidneys in female and male recipients at 1 and 10 years. Findings Graft loss was more common with kidneys from female donors than with those from male donors (p<0.001) after both 1 and 10 years. Female recipients had a lower rate of graft failure between the end of the first year and the end of the tenth year (p<0 . 001). Compared with all other combinations of sex, transplantation of male donor kidneys into female recipients was associated with an increased risk of graft failure during the first year (hazard ratio [HR] 1 .08, 95% CI 1.03-1.14, p=0.003; death censored HR 1.11, 1.04-1.19, p=0.003) and between 2 and 10 years (HR 1.06, 1.01-1.10, p=0.008; death censored HR 1.10, 1.05-1.16, p<0.001). Interpretation H-Y minor histocompatibility affects human kidney transplantation. Funding Swiss National Research Foundation; University of Heidelberg, Germany; European Leukemia Net.	[Gratwohl, Alois; Stern, Martin] Univ Basel Hosp, Dept Haematol, CH-4031 Basel, Switzerland; [Doehler, Bernd; Opelz, Gerhard] Heidelberg Univ, Dept Transplantat Immunol, D-6900 Heidelberg, Germany	University of Basel; Ruprecht Karls University Heidelberg	Gratwohl, A (corresponding author), Univ Basel Hosp, Dept Haematol, CH-4031 Basel, Switzerland.	hematology@uhbs.ch	Stern, Martin/C-9385-2012					Bohringer D, 2006, TRANSPLANTATION, V82, P1037, DOI 10.1097/01.tp.0000235908.54766.44; BRENNER BM, 1992, J AM SOC NEPHROL, V3, P162; BRENNER BM, 1993, AM J KIDNEY DIS, V21, P66, DOI 10.1016/0272-6386(93)70097-I; CANDINAS D, 1995, LANCET, V346, P1117, DOI 10.1016/S0140-6736(95)91797-7; COX DR, 1972, J R STAT SOC B, V34, P187; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; EICHWALD EJ, 1955, TRANSPLAN B, V2, P121; Gahrton G, 2005, BONE MARROW TRANSPL, V35, P609, DOI 10.1038/sj.bmt.1704861; GOULMY E, 1978, TRANSPLANTATION, V25, P315, DOI 10.1097/00007890-197806000-00007; GOULMY E, 1977, NATURE, V266, P544, DOI 10.1038/266544a0; GOULMY E, 1982, J EXP MED, V155, P1567, DOI 10.1084/jem.155.5.1567; Gratwohl A, 2003, LANCET, V362, P590, DOI 10.1016/S0140-6736(03)14207-9; Gratwohl A, 2001, Hematol J, V2, P363, DOI 10.1038/sj.thj.6200117; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAWAUCHI M, 1993, ANN THORAC SURG, V55, P716, DOI 10.1016/0003-4975(93)90281-L; Kim YS, 2001, LANCET, V357, P1180, DOI 10.1016/S0140-6736(00)04377-4; Koulack J, 1996, CLIN IMMUNOL IMMUNOP, V80, P273, DOI 10.1006/clin.1996.0123; Kwon OJ, 2004, TRANSPLANT P, V36, P2040, DOI 10.1016/j.transproceed.2004.07.046; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Nicholson ML, 2000, KIDNEY INT, V58, P390, DOI 10.1046/j.1523-1755.2000.00177.x; Oh CK, 2006, CLIN TRANSPLANT, V20, P163, DOI 10.1111/j.1399-0012.2005.00459.x; PFEFFER PF, 1982, TRANSPLANTATION, V33, P52, DOI 10.1097/00007890-198201000-00011; Poggio ED, 2006, AM J TRANSPLANT, V6, P616, DOI 10.1111/j.1600-6143.2005.01225.x; Prendergast TW, 1998, ANN THORAC SURG, V65, P88, DOI 10.1016/S0003-4975(97)01105-3; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Roberts DH, 2004, J HEART LUNG TRANSPL, V23, P1252, DOI 10.1016/j.healun.2003.09.014; SCHOLZ D, 1983, Z UROL NEPHROL, V76, P209; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Stern M, 2006, TRANSPLANTATION, V82, P218, DOI 10.1097/01.tp.0000226156.99206.d1; TAAL MW, 1998, TRANSPLANT REV, V12, P74; TERASAKI PI, 1994, TRANSPLANTATION, V57, P1450, DOI 10.1097/00007890-199405270-00008; *U HEID, COLL TRANSPL STUD; VOOGT PJ, 1990, LANCET, V335, P131, DOI 10.1016/0140-6736(90)90003-N; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	35	101	105	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 5	2008	372	9632					49	53		10.1016/S0140-6736(08)60992-7	http://dx.doi.org/10.1016/S0140-6736(08)60992-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XN	18603158				2022-12-24	WOS:000257339900031
J	Kramer, EM; Lewandowski, M; Beri, S; Bernard, J; Borkowski, M; Borkowski, MH; Burchfield, LA; Mathisen, B; Normanly, J				Kramer, Eric M.; Lewandowski, Michael; Beri, Satvik; Bernard, Jessica; Borkowski, Matthew; Borkowski, Michael H.; Burchfield, Laura Ann; Mathisen, Brenda; Normanly, Jennifer			Auxin gradients are associated with polarity changes in trees	SCIENCE			English	Article							PATTERN-FORMATION; MODEL; PHYLLOTAXIS		[Kramer, Eric M.; Beri, Satvik; Borkowski, Matthew; Borkowski, Michael H.; Burchfield, Laura Ann; Mathisen, Brenda] Bard Coll Simons Rock, Dept Phys, Great Barrington, MA 01230 USA; Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Lewandowski, Michael; Bernard, Jessica; Normanly, Jennifer] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Nottingham; University of Massachusetts System; University of Massachusetts Amherst	Kramer, EM (corresponding author), Bard Coll Simons Rock, Dept Phys, Great Barrington, MA 01230 USA.	ekramer@simons-rock.edu	Kramer, Eric M/B-9752-2008	Kramer, Eric/0000-0002-1424-2356				Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kramer EM, 2004, TREES-STRUCT FUNCT, V18, P493, DOI 10.1007/s00468-004-0322-2; Kramer EM, 2002, J THEOR BIOL, V216, P147, DOI 10.1006/jtbi.2002.2551; Kramer EM, 2006, J PLANT GROWTH REGUL, V25, P290, DOI 10.1007/s00344-006-0065-y; Larson, 1994, VASCULAR CAMBIUM; Mattheck C., 1995, WOOD INTERNAL OPTIMI; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Sztein AE, 2002, PLANT GROWTH REGUL, V36, P201, DOI 10.1023/A:1016586401506	8	20	21	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1610	1610		10.1126/science.1156130	http://dx.doi.org/10.1126/science.1156130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566279				2022-12-24	WOS:000256886700039
J	Olshansky, SJ; Perls, TT				Olshansky, S. Jay; Perls, Thomas T.			New developments in the illegal provision of growth hormone for "anti-aging" and bodybuilding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Olshansky, S. Jay] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60612 USA; [Perls, Thomas T.] Boston Univ, Sch Med, Dept Med, Geriatr Sect, Boston, MA 02118 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Boston University	Olshansky, SJ (corresponding author), Univ Illinois, Div Epidemiol & Biostat, 1603 W Taylor St,Room 885, Chicago, IL 60612 USA.	sjayo@uic.edu		Perls, Thomas/0000-0002-2492-4334				BRAVERMAN ER, 2005, ANTIAGING CLIN PROTO, P39; *COMM OV GOV REF, 2008, COMM HOLDS HEAR MYTH; Gharib Hossein, 2003, Endocr Pract, V9, P64; *HYM PHELPS MCN PC, 2007, FDA LAW BLOG SPEC PH; *INT HORM SOC BIOI, 2007, PRACT APPL TREAT AD; KLATZ RM, ANN INTERN MED  0118; Kwan AYM, 2007, PITUITARY, V10, P151, DOI 10.1007/s11102-007-0028-8; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; *OFF ALB COUNT DIS, OP WHICH DOCT; QUINN T, DAILY NEWS; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; *US FDA, 2007, IMP AL 66 71 DET PHY	14	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2792	2794		10.1001/jama.299.23.2792	http://dx.doi.org/10.1001/jama.299.23.2792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560007				2022-12-24	WOS:000256805200028
J	Kieffer, SW; Jakosky, BM				Kieffer, Susan W.; Jakosky, Bruce M.			Enceladus - Oasis or ice ball?	SCIENCE			English	Editorial Material							PLUME; ORIGIN		[Kieffer, Susan W.] Univ Illinois, Dept Geol, Urbana, IL 61802 USA; [Jakosky, Bruce M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; [Jakosky, Bruce M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Kieffer, SW (corresponding author), Univ Illinois, Dept Geol, Urbana, IL 61802 USA.	skieffer@uiuc.edu; bruce.jakosky@lasp.colorado.edu						Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Gioia G, 2007, P NATL ACAD SCI USA, V104, P13578, DOI 10.1073/pnas.0706018104; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Jakosky BM, 1998, J GEOPHYS RES-PLANET, V103, P19359, DOI 10.1029/98JE01892; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; SHOCK EL, 1990, ORIGINS LIFE EVOL B, V20, P331, DOI 10.1007/BF01808115; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; SULLIVAN W, 2007, PLANETS LIFE EMERGIN, P357; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	12	12	12	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1432	1433		10.1126/science.1159702	http://dx.doi.org/10.1126/science.1159702			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556539				2022-12-24	WOS:000256676400023
J	Pain, E				Pain, Elisabeth			Sustaining forests in a changing world	SCIENCE			English	Editorial Material																			0	1	1	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1514	1517		10.1126/science.320.5882.1514	http://dx.doi.org/10.1126/science.320.5882.1514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556562				2022-12-24	WOS:000256676400050
J	King, MC; Drivas, TG; Blobel, G				King, Megan C.; Drivas, Theodore G.; Blobel, Guenter			A network of nuclear envelope membrane proteins linking centromeres to microtubules	CELL			English	Article							SPINDLE-POLE BODY; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; MEIOTIC PROPHASE; DOMAIN PROTEINS; GENE; HETEROCHROMATIN; COMPLEX; CYTOSKELETON; ATTACHMENT	In the fission yeast S. pombe, nuclei are actively positioned at the cell center by microtubules. Here, we show that cytoplasmic microtubules are mechanically coupled to the nuclear heterochromatin through proteins embedded in the nuclear envelope. This includes an integral outer nuclear membrane protein of the KASH family ( Kms2) and two integral inner nuclear membrane proteins, the SUN-domain protein Sad1 and the previously uncharacterized protein Ima1. Ima1 specifically binds to heterochromatic regions and promotes the tethering of centromeric DNA to the SUN-KASH complex. In the absence of Ima1, or in cells harboring mutations in the centromeric Ndc80 complex, inefficient coupling of centromeric heterochromatin to Sad1 leads to striking defects in the ability of the nucleus to tolerate microtubule-dependent forces, leading to changes in nuclear shape, loss of spindle pole body components from the nuclear envelope, and partial dissociation of SUN-KASH complexes. This work highlights a framework for communication between cytoplasmic microtubules and chromatin.	[King, Megan C.; Drivas, Theodore G.; Blobel, Guenter] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	King, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10065 USA.	mking@rockefeller.edu		Drivas, Theodore/0000-0002-8717-0111	Kirschstein National Research Service; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077919] Funding Source: NIH RePORTER	Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Nurse lab and the Yeast Genomic Resource Center for strains, K. Sawin for the mCherry tagging template pKS390, R. Tsien for permission to use the mCherry fusion, H. Shio for technical support, and M. P. Rout for the anti-GFP antibody. We also thank F. Neumann for technical help and suggesting the "nut and bolt'' analogy and C. P. Lusk for critical reading of the manuscript. This work was supported by a Kirschstein National Research Service Award Fellowship and a Charles H. Revson Senior Fellowship in Biomedical Science (to M.C.K.) and the Howard Hughes Medical Institute (to G. B.).	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Asakawa H, 2005, MOL BIOL CELL, V16, P2325, DOI 10.1091/mbc.e04-11-0996; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Ekwall K, 1996, J CELL SCI, V109, P2637; Franco A, 2007, J CELL SCI, V120, P3345, DOI 10.1242/jcs.013698; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; HAGAN IM, 1990, J CELL BIOL, V110, P1617, DOI 10.1083/jcb.110.5.1617; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Miki F, 2004, MOL GENET GENOMICS, V270, P449, DOI 10.1007/s00438-003-0938-8; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nabetani A, 2001, CHROMOSOMA, V110, P322, DOI 10.1007/s004120100153; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Szabo B, 2004, CELL MOTIL CYTOSKEL, V59, P38, DOI 10.1002/cm.20022; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642	42	148	151	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					427	438		10.1016/j.cell.2008.06.022	http://dx.doi.org/10.1016/j.cell.2008.06.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692466	Bronze, Green Accepted			2022-12-24	WOS:000258665500016
J	Sugiyama, S; Di Nardo, AA; Aizawa, S; Matsuo, I; Volovitch, M; Prochiantz, A; Hensch, TK				Sugiyama, Sayaka; Di Nardo, Ariel A.; Aizawa, Shinichi; Matsuo, Isao; Volovitch, Michel; Prochiantz, Alain; Hensch, Takao K.			Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity	CELL			English	Article							OCULAR DOMINANCE PLASTICITY; CRITICAL PERIOD PLASTICITY; FACTOR 4E EIF4E; CEREBRAL-CORTEX; TENASCIN-R; MONOCULAR DEPRIVATION; CORTICAL INTERNEURONS; HOMEODOMAIN PROTEIN; NEUROTROPHIC FACTOR; PERINEURONAL NETS	Neural circuits are shaped by experience in early postnatal life. Distinct GABAergic connections within visual cortex determine the timing of the critical period for rewiring ocular dominance to establish visual acuity. We find that maturation of the parvalbumin (PV)-cell network that controls plasticity onset is regulated by a selective re-expression of the embryonic Otx2 homeoprotein. Visual experience promoted the accumulation of non-cell-autonomous Otx2 in PV-cells, and cortical infusion of exogenous Otx2 accelerated both PV-cell development and critical period timing. Conversely, conditional removal of Otx2 from non-PV cells or from the visual pathway abolished plasticity. Thus, the experience-dependent transfer of a homeoprotein may establish the physiological milieu for postnatal plasticity of a neural circuit.	[Di Nardo, Ariel A.; Volovitch, Michel; Prochiantz, Alain] Ecole Normale Super, CNRS, UMR 8542, F-75230 Paris 05, France; [Sugiyama, Sayaka; Hensch, Takao K.] RIKEN Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan; [Aizawa, Shinichi] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Matsuo, Isao] Osaka Med Ctr, Dept Mol Embryol, Osaka 5941101, Japan; [Matsuo, Isao] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Prochiantz, Alain] Coll France, F-75231 Paris, France; [Sugiyama, Sayaka; Hensch, Takao K.] Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hensch, Takao K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); RIKEN; RIKEN; Osaka Medical Center for Cancer & Cardiovascular Diseases; UDICE-French Research Universities; PSL Research University Paris; College de France; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University	Prochiantz, A (corresponding author), Ecole Normale Super, CNRS, UMR 8542, 46 Rue Ulm, F-75230 Paris 05, France.	prochian@biologie.ens.fr; hensch@mcb.harvard.edu	Sugiyama, Sayaka/AAQ-4489-2021; Di Nardo, Ariel A/P-4442-2017; Hensch, Takao/L-4182-2019	Sugiyama, Sayaka/0000-0002-2231-7880; Di Nardo, Ariel A/0000-0003-2944-488X; Matsuo, Isao/0000-0002-5916-6246; Volovitch, Michel/0000-0002-7488-764X	Human Frontiers Science Program HFSP [RGP0026/2002]; Fondation pour La Recherche Medicale (Longevite Cognitive et Sensorielle); Special Postdoctoral Research Program (RIKEN); Japanese Ministry of Science, Education and Technology MEXT [IBR 17021047]	Human Frontiers Science Program HFSP(Human Frontier Science Program); Fondation pour La Recherche Medicale (Longevite Cognitive et Sensorielle)(Fondation pour la Recherche Medicale); Special Postdoctoral Research Program (RIKEN); Japanese Ministry of Science, Education and Technology MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank D. Acampora and A. Simeone for graciously providing the Otx2-GFP mouse line and the original Otx2 plasmids; A. Ruiz i Altaba and M. Wassef for Otx2 antibody; S. Dupas for recombinant Otx2 protein; G. Corte for recombinant baculovirus; K. Moya, M. Beurdeley, and A. Scheuber for help in some experiments and discussion. Funded by the Human Frontiers Science Program (HFSP, RGP0026/2002), Fondation pour La Recherche Medicale (Longevite Cognitive et Sensorielle), and in part by the Special Postdoctoral Research Program (RIKEN) and Japanese Ministry of Science, Education and Technology (MEXT, IBR 17021047). S. S. is a Research Fellow of the Japan Society for the Promotion of Science (JSPS). A. A. D. is a fellow of the Canadian Institutes of Health Research (CIHR).	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Antonini A, 1999, J NEUROSCI, V19, P4388; Ba-Charvet KTN, 1998, DEVELOPMENT, V125, P4273; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Brunet I, 2007, TRENDS NEUROSCI, V30, P260, DOI 10.1016/j.tins.2007.03.010; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Butt SJB, 2007, J NEUROSCI, V27, P11847, DOI 10.1523/JNEUROSCI.3525-07.2007; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DAW N, 1995, VISUAL DEV; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Erisir A, 2005, J COMP NEUROL, V485, P11, DOI 10.1002/cne.20507; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; GAO B, 1994, EUR J NEUROSCI, V6, P837, DOI 10.1111/j.1460-9568.1994.tb00994.x; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Iwai Y, 2003, J NEUROSCI, V23, P6695; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joliot A, 1997, DEVELOPMENT, V124, P1865; JOLIOT AH, 1991, NEW BIOL, V3, P1121; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Liu LO, 2000, MOL BRAIN RES, V82, P150, DOI 10.1016/S0169-328X(00)00203-5; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mandolesi G, 2005, CURR BIOL, V15, P2119, DOI 10.1016/j.cub.2005.10.045; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Morales B, 2002, J NEUROSCI, V22, P8084; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Muratovska A, 2004, FEBS LETT, V558, P63, DOI 10.1016/S0014-5793(03)01505-9; Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; Nothias F, 1998, CURR BIOL, V8, P459, DOI 10.1016/S0960-9822(98)70189-7; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Rath MF, 2007, EXP EYE RES, V85, P65, DOI 10.1016/j.exer.2007.02.016; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Salinas PC, 2005, J NEUROBIOL, V64, P435, DOI 10.1002/neu.20159; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Sugiyama S, 2003, DEVELOPMENT, V130, P451, DOI 10.1242/dev.00232; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Topisirovic I, 2005, HISTOL HISTOPATHOL, V20, P1275, DOI 10.14670/HH-20.1275; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	75	336	343	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					508	520		10.1016/j.cell.2008.05.054	http://dx.doi.org/10.1016/j.cell.2008.05.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692473	Bronze			2022-12-24	WOS:000258665500023
J	Shcheprova, Z; Baldi, S; Frei, SB; Gonnet, G; Barral, Y				Shcheprova, Zhanna; Baldi, Sandro; Frei, Stephanie Buvelot; Gonnet, Gaston; Barral, Yves			A mechanism for asymmetric segregation of age during yeast budding	NATURE			English	Article							NUCLEAR-PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; GENE DELETION; PROTEIN; LOCALIZATION; DYNAMICS; COMPARTMENTALIZATION; PLASMID; MOTHER	Ageing and the mortality that ensues are sustainable for the species only if age is reset in newborns. In budding yeast, buds are made young whereas ageing factors, such as carbonylated proteins and DNA circles, remain confined to the ageing mother cell. The mechanisms of this confinement and their relevance are poorly understood. Here we show that a septin-dependent, lateral diffusion barrier forms in the nuclear envelope and limits the translocation of pre-existing nuclear pores into the bud. The retention of DNA circles within the mother cell depends on the presence of the diffusion barrier and on the anchorage of the circles to pores mediated by the nuclear basket. In accordance with the diffusion barrier ensuring the asymmetric segregation of nuclear age-determinants, the barrier mutant bud6 Delta fails to properly reset age in buds. Our data involve septin-dependent diffusion barriers in the confinement of ageing factors to one daughter cell during asymmetric cell division.	[Shcheprova, Zhanna; Baldi, Sandro; Frei, Stephanie Buvelot; Barral, Yves] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; [Gonnet, Gaston] ETH, Inst Computat Sci, Dept Comp Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Barral, Y (corresponding author), ETH, Inst Biochem, Dept Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch		Barral, Yves/0000-0002-0989-3373; Baldi, Sandro/0000-0002-9689-5317				Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; BARTON AA, 1950, J GEN MICROBIOL, V4, P84, DOI 10.1099/00221287-4-1-84; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Belgareh N, 1997, J CELL BIOL, V136, P747, DOI 10.1083/jcb.136.4.747; BREITENBACH M, 2003, TOPICS CURRENT GENET, V3, P61; Bucci M, 1997, J CELL BIOL, V136, P1185, DOI 10.1083/jcb.136.6.1185; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Falcon AA, 2003, J BIOL CHEM, V278, P41607, DOI 10.1074/jbc.M307025200; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gillespie CS, 2004, J THEOR BIOL, V229, P189, DOI 10.1016/j.jtbi.2004.03.015; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Guthrie C, 1991, GUIDE YEAST GENETICS; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Megee PC, 1999, SCIENCE, V285, P254, DOI 10.1126/science.285.5425.254; Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Oakes M, 1998, J CELL BIOL, V143, P23, DOI 10.1083/jcb.143.1.23; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Pruyne D, 2000, J CELL SCI, V113, P365; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scott-Drew S, 2002, CELL BIOL INT, V26, P393, DOI 10.1006/cbir.2002.0867; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141	47	238	242	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					728	U64		10.1038/nature07212	http://dx.doi.org/10.1038/nature07212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18660802				2022-12-24	WOS:000258228000037
J	Kerr, T; Montaner, J; Wood, E				Kerr, Thomas; Montaner, Julio; Wood, Evan			Supervised injecting facilities: time for scale-up?	LANCET			English	Editorial Material							HARM REDUCTION		St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					Beletsky L, 2008, AM J PUBLIC HEALTH, V98, P231, DOI 10.2105/AJPH.2006.103747; CLEMENT T, 2008, COMMUNICATION   0529; Csete J., 2007, CLOSED REASON INT NA; Expert Advisory Committee on Supervised Injection Site Research, 2008, VANC INS SERV OTH SU; *INT NARC CONTR BO, 2008, REP INT NARC CONTR B; Kimber J, 2003, DRUG ALCOHOL REV, V22, P227, DOI 10.1080/095952301000116951; Lloyd C, 2007, INT J DRUG POLICY, V18, P5, DOI 10.1016/j.drugpo.2006.12.010; *MSIC COMM, 2003, FIN REP SYDN MED SUP; PIPER B, 2007, DRUG POLICY NEW 1107; Scotland's Future Forum, 2008, APPR ALC DRUGS SCOTL; Strathdee SA, 2007, ADDICTION, V102, P848, DOI 10.1111/j.1360-0443.2007.01859.x; UNAIDS, 2005, INT HIV PREV UNAIDS; *WHO, 2005, POL PROGR GUID HIV A; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; 2008, BBC NEWS        0530	15	17	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					354	355		10.1016/S0140-6736(08)61138-1	http://dx.doi.org/10.1016/S0140-6736(08)61138-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	334AZ	18675672				2022-12-24	WOS:000258196000008
J	Carlson, ME; Hsu, M; Conboy, IM				Carlson, Morgan E.; Hsu, Michael; Conboy, Irina M.			Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells	NATURE			English	Article							SKELETAL-MUSCLE; PROLIFERATION; P16(INK4A); ARREST; MICE	Adult skeletal muscle robustly regenerates throughout an organism's life, but as the muscle ages, its ability to repair diminishes and eventually fails(1,2). Previous work suggests that the regenerative potential of muscle stem cells (satellite cells) is not triggered in the old muscle because of a decline in Notch activation, and that it can be rejuvenated by forced local activation of Notch(3). Here we report that, in addition to the loss of Notch activation, old muscle produces excessive transforming growth factor (TGF)-beta (but not myostatin), which induces unusually high levels of TGF-beta pSmad3 in resident satellite cells and interferes with their regenerative capacity. Importantly, endogenous Notch and pSmad3 antagonize each other in the control of satellite-cell proliferation, such that activation of Notch blocks the TGF-beta-dependent upregulation of the cyclin-dependent kinase (CDK) inhibitors p15, p16, p21 and p27, whereas inhibition of Notch induces them. Furthermore, in muscle stem cells, Notch activity determines the binding of pSmad3 to the promoters of these negative regulators of cell-cycle progression. Attenuation of TGF-beta/pSmad3 in old, injured muscle restores regeneration to satellite cells in vivo. Thus a balance between endogenous pSmad3 and active Notch controls the regenerative competence of muscle stem cells, and deregulation of this balance in the old muscle microniche interferes with regeneration.	[Carlson, Morgan E.; Hsu, Michael; Conboy, Irina M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Conboy, IM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	iconboy@berkeley.edu		Hsu, Mike/0000-0001-7086-1808	NIA NIH HHS [R21 AG27892, R21 AG027892, R01 AG027252] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG027252, R21AG027892] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barcellos-Hoff MH, 1996, J MAMMARY GLAND BIOL, V1, P353, DOI 10.1007/BF02017391; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; CARLSON ME, 2007, AGING CELL; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lin J, 2003, BIOCHEM BIOPH RES CO, V300, P938, DOI 10.1016/S0006-291X(02)02949-2; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morgan JE, 2002, J CELL BIOL, V157, P693, DOI 10.1083/jcb.200108047; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Olson NE, 2000, J BIOL CHEM, V275, P11270, DOI 10.1074/jbc.275.15.11270; Rao P, 2003, MOL CELL BIOL, V23, P6694, DOI 10.1128/MCB.23.18.6694-6701.2003; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021	30	345	353	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					528	U9		10.1038/nature07034	http://dx.doi.org/10.1038/nature07034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18552838	Green Accepted, Green Submitted			2022-12-24	WOS:000257860300054
J	Polizzotto, ML; Kocar, BD; Benner, SG; Sampson, M; Fendorf, S				Polizzotto, Matthew L.; Kocar, Benjamin D.; Benner, Shawn G.; Sampson, Michael; Fendorf, Scott			Near-surface wetland sediments as a source of arsenic release to ground water in Asia	NATURE			English	Article							REDUCING BACTERIA; ORGANIC-MATTER; DRINKING-WATER; BANGLADESH; MEKONG; CONTAMINATION; MOBILITY; CAMBODIA; DELTA; EXTRACTION	Tens of millions of people in south and southeast Asia routinely consume ground water that has unsafe arsenic levels(1,2). Arsenic is naturally derived from eroded Himalayan sediments, and is believed to enter solution following reductive release from solid phases under anaerobic conditions. However, the processes governing aqueous concentrations and locations of arsenic release to pore water remain unresolved, limiting our ability to predict arsenic concentrations spatially (between wells) and temporally (future concentrations) and to assess the impact of human activities on the arsenic problem(3-9). This uncertainty is partly attributed to a poor understanding of groundwater flow paths altered by extensive irrigation pumping in the Ganges-Brahmaputra delta(10), where most research has focused. Here, using hydrologic and (bio)geochemical measurements, we show that on the minimally disturbed Mekong delta of Cambodia, arsenic is released from near-surface, river-derived sediments and transported, on a centennial timescale, through the underlying aquifer back to the river. Owing to similarities in geologic deposition, aquifer source rock and regional hydrologic gradients(11-15), our results represent a model for understanding pre-disturbance conditions for other major deltas in Asia. Furthermore, the observation of strong hydrologic influence on arsenic behaviour indicates that release and transport of arsenic are sensitive to continuing and impending anthropogenic disturbances. In particular, groundwater pumping for irrigation, changes in agricultural practices, sediment excavation, levee construction and upstream dam installations will alter the hydraulic regime and/or arsenic source material and, by extension, influence groundwater arsenic concentrations and the future of this health problem.	[Polizzotto, Matthew L.; Kocar, Benjamin D.; Fendorf, Scott] Stanford Univ, Sch Earth & Atmospher Sci, Stanford, CA 94305 USA; [Benner, Shawn G.] Boise State Univ, Dept Geosci, Boise, ID 83705 USA; [Sampson, Michael] Resource Dev Int Cambodia, Phnom Penh, Cambodia	Stanford University; Idaho; Boise State University	Fendorf, S (corresponding author), Stanford Univ, Sch Earth & Atmospher Sci, Stanford, CA 94305 USA.	fendorf@stanford.edu	张, 楠/B-1010-2010; Benner, Shawn/A-2557-2012	Benner, Shawn/0000-0003-4024-5777; Fendorf, Scott/0000-0002-9177-1809				Aggarwal PK, 2003, SCIENCE, V300, p584B, DOI 10.1126/science.1081789; Berg M, 2001, ENVIRON SCI TECHNOL, V35, P2621, DOI 10.1021/es010027y; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Harvey CF, 2006, CHEM GEOL, V228, P112, DOI 10.1016/j.chemgeo.2005.11.025; Harvey CF, 2003, SCIENCE, V300, p584D, DOI 10.1126/science.1082685; Harvey CF, 2002, SCIENCE, V298, P1602, DOI 10.1126/science.1076978; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; *JAP INT COOP AG, 2002, STUD GROUNDW DEV SO; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; McArthur JM, 2004, APPL GEOCHEM, V19, P1255, DOI 10.1016/j.apgeochem.2004.02.001; Nguyen VL, 2000, J ASIAN EARTH SCI, V18, P427; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Pederick RL, 2007, J ENVIRON SCI HEAL A, V42, P1763, DOI 10.1080/10934520701564269; Polizzotto ML, 2005, P NATL ACAD SCI USA, V102, P18819, DOI 10.1073/pnas.0509539103; Polya DA, 2005, MINERAL MAG, V69, P807, DOI 10.1180/0026461056950290; Postma D, 2007, GEOCHIM COSMOCHIM AC, V71, P5054, DOI 10.1016/j.gca.2007.08.020; Rowland HAL, 2007, GEOBIOLOGY, V5, P281, DOI 10.1111/j.1472-4669.2007.00100.x; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Stanger G, 2005, ENVIRON GEOCHEM HLTH, V27, P341, DOI 10.1007/s10653-005-3991-x; STUTE M, IN PRESS WAT RESOUR; Swartz CH, 2004, GEOCHIM COSMOCHIM AC, V68, P4539, DOI 10.1016/j.gca.2004.04.020; Ta TKO, 2002, QUATERNARY SCI REV, V21, P1807, DOI 10.1016/S0277-3791(02)00007-0; Tamura T, 2007, J ASIAN EARTH SCI, V29, P585, DOI 10.1016/j.jseaes.2006.03.009; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2003, SCIENCE, V300, p584C, DOI 10.1126/science.1081057; Yu WH, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001327	28	438	458	13	441	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					505	U5		10.1038/nature07093	http://dx.doi.org/10.1038/nature07093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650922				2022-12-24	WOS:000257860300048
J	Greenhalgh, T				Greenhalgh, Trisha			Anyone for Club Med?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a677	10.1136/bmj.a677	http://dx.doi.org/10.1136/bmj.a677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18614468	Green Published			2022-12-24	WOS:000257962000048
J	Moster, D; Lie, RT; Markestad, T				Moster, Dag; Lie, Rolv Terje; Markestad, Trond			Long-term medical and social consequences of preterm birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-ADULTS BORN; QUALITY-OF-LIFE; SCHOOL-AGED CHILDREN; WEIGHT INFANTS; BEHAVIORAL OUTCOMES; CEREBRAL-PALSY; PREVALENCE; RISK; ASSOCIATION; DISORDERS	Background: Advances in perinatal care have increased the number of premature babies who survive. There are concerns, however, about the ability of these children to cope with the demands of adulthood. Methods: We linked compulsory national registries in Norway to identify children of different gestational-age categories who were born between 1967 and 1983 and to follow them through 2003 in order to document medical disabilities and outcomes reflecting social performance. Results: The study included 903,402 infants who were born alive and without congenital anomalies (1822 born at 23 to 27 weeks of gestation, 2805 at 28 to 30 weeks, 7424 at 31 to 33 weeks, 32,945 at 34 to 36 weeks, and 858,406 at 37 weeks or later). The proportions of infants who survived and were followed to adult life were 17.8%, 57.3%, 85.7%, 94.6%, and 96.5%, respectively. Among the survivors, the prevalence of having cerebral palsy was 0.1% for those born at term versus 9.1% for those born at 23 to 27 weeks of gestation (relative risk for birth at 23 to 27 weeks of gestation, 78.9; 95% confidence interval [CI], 56.5 to 110.0); the prevalence of having mental retardation, 0.4% versus 4.4% (relative risk, 10.3; 95% CI, 6.2 to 17.2); and the prevalence of receiving a disability pension, 1.7% versus 10.6% (relative risk, 7.5; 95% CI, 5.5 to 10.0). Among those who did not have medical disabilities, the gestational age at birth was associated with the education level attained, income, receipt of Social Security benefits, and the establishment of a family, but not with rates of unemployment or criminal activity. Conclusions: In this cohort of people in Norway who were born between 1967 and 1983, the risks of medical and social disabilities in adulthood increased with decreasing gestational age at birth.	[Moster, Dag; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Markestad, Trond] Univ Bergen, Sect Pediat, Dept Clin Med, N-5020 Bergen, Norway; [Moster, Dag; Markestad, Trond] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Lie, Rolv Terje] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH)	Moster, D (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, POB 7804, N-5020 Bergen, Norway.	dag.moster@smis.uib.no	Fahimifar, Sepideh/M-5303-2019					Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Allin M, 2006, J NEUROL NEUROSUR PS, V77, P495, DOI 10.1136/jnnp.2005.075465; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bjerager M, 1995, ACTA PAEDIATR, V84, P1339, DOI 10.1111/j.1651-2227.1995.tb13565.x; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; Dinesen SJ, 2001, ARCH DIS CHILD-FETAL, V85, pF165, DOI 10.1136/fn.85.3.F165; Elgen I, 2002, ARCH DIS CHILD-FETAL, V87, pF128, DOI 10.1136/fn.87.2.F128; Ericson A, 1998, ARCH DIS CHILD-FETAL, V78, pF171, DOI 10.1136/fn.78.3.F171; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; HACK M, 1992, J DEV BEHAV PEDIATR, V13, P412; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hille ETM, 2001, LANCET, V357, P1641, DOI 10.1016/S0140-6736(00)04818-2; HUNT JV, 1988, PEDIATRICS, V82, P596; Indredavik MS, 2004, ARCH DIS CHILD-FETAL, V89, pF445, DOI 10.1136/adc.2003.038943; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; LEE J, 1994, INT J EPIDEMIOL, V23, P201, DOI 10.1093/ije/23.1.201; Lefebvre F, 2005, ACTA PAEDIATR, V94, P733, DOI 10.1080/08035250510025987; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Lindstrom K, 2007, PEDIATRICS, V120, P936, DOI 10.1542/peds.2007-2439; Lindstrom K, 2007, PEDIATRICS, V120, P70, DOI 10.1542/peds.2006-3260; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; *MIN JUST POL, 2003, KRIM PERS POL PAT BE; *MIN LAB SOC INCL, 2008, FIN SOC ASS; *MIN LAB SOC INCL, 2008, NORW SOC INS SCHEM; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; Platt MJ, 2007, LANCET, V369, P43, DOI 10.1016/S0140-6736(07)60030-0; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; *STAT NORW, 2007, STAT NORW I COUNTS; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Wilson-Costello D, 2007, SEMIN FETAL NEONAT M, V12, P344, DOI 10.1016/j.siny.2007.06.010; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; World Health Organisation, 2008, INT CLASS DIS ICD	40	876	913	1	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2008	359	3					262	273		10.1056/NEJMoa0706475	http://dx.doi.org/10.1056/NEJMoa0706475			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KD	18635431	Bronze			2022-12-24	WOS:000257656600006
J	Damasio, A; Meyer, K				Damasio, Antonio; Meyer, Kaspar			Behind the looking-glass	NATURE			English	Editorial Material							CORTICAL CONNECTIONS; RECOGNITION; PREMOTOR; MONKEY; AREAS		[Damasio, Antonio; Meyer, Kaspar] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Southern California	Damasio, A (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.		Damasio, Antonio/AAD-1342-2019					Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; FOGASSI L, 1998, SOC NEUR ABSTR, V24, P257; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; KEYERS C, 2004, TRENDS COGN SCI, V8, P501; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; ROCKLAND KS, 1981, BRAIN RES, V212, P249, DOI 10.1016/0006-8993(81)90461-3; VANHOESEN GW, 1982, TRENDS NEUROSCI, V5, P345, DOI 10.1016/0166-2236(82)90201-6	10	47	54	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					167	168		10.1038/454167a	http://dx.doi.org/10.1038/454167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615070				2022-12-24	WOS:000257466900027
J	Bainbridge, KE; Hoffman, HJ; Cowie, CC				Bainbridge, Kathleen E.; Hoffman, Howard J.; Cowie, Catherine C.			Diabetes and hearing impairment in the United States: Audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; INNER-EAR; EPIDEMIOLOGY; ADULTS; NOISE; ASSOCIATION; POPULATION; PREVALENCE; MANAGEMENT; THRESHOLD	Background: Diabetes might affect the vasculature and neural system of the inner ear, leading to hearing impairment. Objective: To determine whether hearing impairment is more prevalent among U. S. adults with diabetes. Design: Cross-sectional analysis of nationally representative data. Setting: National Health and Nutrition Examination Survey, 1999 to 2004. Participants: 5140 noninstitutionalized adults age 20 to 69 years who had audiometric testing. Measurements: Hearing impairment was assessed from the pure tone average of thresholds over low or mid-frequencies (500, 1000, and 2000 Hz) and high frequencies (3000, 4000, 6000, and 8000 Hz) and was defined as mild or greater severity (pure tone average > 25 decibels hearing level [dB HL]) and moderate or greater severity (pure tone average > 40 dB HL). Results: Hearing impairment was more prevalent among adults with diabetes. Age-adjusted prevalence of low-or mid-frequency hearing impairment of mild or greater severity in the worse ear was 21.3% (95% CI, 15.0% to 27.5%) among 399 adults with diabetes compared with 9.4% (CI, 8.2% to 10.5%) among 4741 adults without diabetes. Similarly, age-adjusted prevalence of high-frequency hearing impairment of mild or greater severity in the worse ear was 54.1% (CI, 45.9% to 62.3%) among those with diabetes compared with 32.0% (CI, 30.5% to 33.5%) among those without diabetes. The association between diabetes and hearing impairment was independent of known risk factors for hearing impairment, such as noise exposure, ototoxic medication use, and smoking (adjusted odds ratios for low- or mid-frequency and high-frequency hearing impairment were 1.82 [CI, 1.27 to 2.60] and 2.16 [CI, 1.47 to 3.18], respectively). Limitations: The diagnosis of diabetes was based on self-report. The investigators could not distinguish between type 1 and type 2 diabetes. Noise exposure was based on participant recall. Conclusion: Hearing impairment is common in adults with diabetes, and diabetes seems to be an independent risk factor for the condition.	[Bainbridge, Kathleen E.] Social & Sci Syst, Silver Spring, MD 20910 USA; Natl Inst Deafness & Other Commun Disorders, Bethesda, MD USA; NIDDK, Bethesda, MD USA	Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bainbridge, KE (corresponding author), Social & Sci Syst, 8757 Georgia Ave,12th Floor, Silver Spring, MD 20910 USA.	kbainbridge@s-3.com		Hoffman, Howard/0000-0003-4105-0808	NIAAA NIH HHS [HHSN267200700001C] Funding Source: Medline; NIDDK NIH HHS [GS1-0F-00381L, N001 DK12478] Funding Source: Medline; NLM NIH HHS [HHSN267200700001G] Funding Source: Medline; PHS HHS [HHSN 26720070000 1G] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Axelsson A, 1978, Acta Otolaryngol Suppl, V356, P1; AXELSSON A, 1995, EAR HEARING, V16, P245, DOI 10.1097/00003446-199506000-00001; Bagai A, 2006, JAMA-J AM MED ASSOC, V295, P416, DOI 10.1001/jama.295.4.416; Bogardus ST, 2003, JAMA-J AM MED ASSOC, V289, P1986, DOI 10.1001/jama.289.15.1986; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cruickshanks KJ, 2003, ARCH OTOLARYNGOL, V129, P1041, DOI 10.1001/archotol.129.10.1041; Cruickshanks KJ, 1998, JAMA-J AM MED ASSOC, V279, P1715, DOI 10.1001/jama.279.21.1715; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540; Dalton DS, 2001, AUDIOLOGY, V40, P1; Erdem T, 2003, EUR ARCH OTO-RHINO-L, V260, P62, DOI 10.1007/s00405-002-0519-1; FRIEDMAN SA, 1975, ARCH INTERN MED, V135, P573, DOI 10.1001/archinte.135.4.573; Fukushima H, 2005, OTOLARYNG HEAD NECK, V133, P100, DOI 10.1016/j.otohns.2005.02.004; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gates GA, 2000, HEARING RES, V141, P220, DOI 10.1016/S0378-5955(99)00223-3; GELFAND S, 2001, ESSENTIALS AUDIOLOGY; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; ISHII EK, 1992, SCI TOTAL ENVIRON, V127, P155, DOI 10.1016/0048-9697(92)90474-7; JORGENSEN MB, 1961, ARCHIV OTOLARYNGOL, V74, P373; Kasemsuwan Lalida, 2001, Journal of the Medical Association of Thailand, V84, P1389; KURIEN M, 1989, J LARYNGOL OTOL, V103, P164, DOI 10.1017/S0022215100108345; Ma FC, 1998, J LARYNGOL OTOL, V112, P835, DOI 10.1017/S0022215100141842; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; MAKISHIMA K, 1971, ANN OTO RHINOL LARYN, V80, P218, DOI 10.1177/000348947108000208; Makishima K, 1978, OTOLARYNGOLOGY, V86; Marshall JD, 2007, EUR J HUM GENET, V15, P1193, DOI 10.1038/sj.ejhg.5201933; Minton JAL, 2003, REV ENDOCR METAB DIS, V4, P53, DOI 10.1023/A:1021875403463; Muhr P, 2006, INT J AUDIOL, V45, P247, DOI 10.1080/14992020500190052; *NAT DIAB DAT GROU, 1995, NIH PUBL NAT I DIAB; National Institute of Diabetes and Digestive and Kidney Diseases, 2005, NAT DIAB STAT FACT S; PLEIS JR, 2007, VITAL HLTH STAT, V10, P1; Sakuta H, 2007, DIABETES RES CLIN PR, V75, P229, DOI 10.1016/j.diabres.2006.06.029; Sasso FC, 1999, METABOLISM, V48, P1346, DOI 10.1016/S0026-0495(99)90141-5; Strawbridge WJ, 1996, AM J EPIDEMIOL, V144, P135, DOI 10.1093/oxfordjournals.aje.a008900; Tambs K, 2003, INT J AUDIOL, V42, P89, DOI 10.3109/14992020309078340; TAYLOR IG, 1978, J LARYNGOL OTOL, V92, P99, DOI 10.1017/S0022215100085108; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976	39	252	270	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					1	+		10.7326/0003-4819-149-1-200807010-00231	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00231			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18559825	Green Accepted			2022-12-24	WOS:000257428200001
J	Kamerow, D				Kamerow, Douglas			Placebo pills for children	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 14	2008	336	7657					1339	1339		10.1136/bmj.39603.698889.59	http://dx.doi.org/10.1136/bmj.39603.698889.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316YB	18556311	Green Published			2022-12-24	WOS:000256984700034
J	Westaby, S				Westaby, Stephen			Advanced heart failure - an "off-the-shelf" solution?	LANCET			English	Editorial Material									Oxford Heart Ctr, Oxford OX3 9DU, England		Westaby, S (corresponding author), Oxford Heart Ctr, Oxford OX3 9DU, England.	swestaby@AHF.org.uk						BOYLE AJ, 2008, J AM COLL CARDIO SA, V51, pA69; Cadeiras Martin, 2007, Heart Fail Clin, V3, P321, DOI 10.1016/j.hfc.2007.04.004; DANDEL M, 2008, J AM COLL CARDIOL  S, V51, pA68; Lietz K, 2007, J AM COLL CARDIOL, V50, P1282, DOI 10.1016/j.jacc.2007.04.099; MCALISTER FA, 2007, JAMA-J AM MED ASSOC, V297, P2505; MOORE SA, 2008, J AM COLL CARDIOL  S, V51, pA68; Redfield MM, 2002, NEW ENGL J MED, V347, P1442, DOI 10.1056/NEJMe020115; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; ROSE EA, 2007, CIRCULATION, V116; Thekkudan J, 2008, J HEART LUNG TRANSPL, V27, pS122, DOI 10.1016/j.healun.2007.11.179; Vaidya V, 2008, J AM COLL CARDIOL, V51, pA258; Westaby S, 2000, LANCET, V356, P900, DOI 10.1016/S0140-6736(00)02680-5; 2008, HANSARD, V699, P265	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2008	371	9628					1898	1900		10.1016/S0140-6736(08)60813-2	http://dx.doi.org/10.1016/S0140-6736(08)60813-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310OI	18539210				2022-12-24	WOS:000256538500010
J	Ker, K; Perel, P; Blackhall, K; Roberts, I				Ker, Katharine; Perel, Pablo; Blackhall, Karen; Roberts, Ian			Uncertainties page - How effective are some common treatments for traumatic brain injury?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE HEAD-INJURY; INTENSIVE-CARE; YOUNG-PEOPLE; MANNITOL; MANAGEMENT; DISABILITY; CENTERS; BURDEN; ADULTS; COMA		[Ker, Katharine; Perel, Pablo; Blackhall, Karen; Roberts, Ian] Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Ker, K (corresponding author), Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, Keppel St, London WC1E 7HT, England.	Katharine.Ker@lshtm.ac.uk		/0000-0002-2342-301X; Ker, Katharine/0000-0002-1514-5005				BOHN DJ, 1989, CRIT CARE MED S, V118, P17; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Fraade-Blanar L, 2007, REV PANAM SALUD PUBL, V22, P254, DOI 10.1590/S1020-49892007000900005; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts I, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000033; Roberts I, 2007, BRIT MED J, V334, P392, DOI 10.1136/bmj.39118.480023.BE; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Schierhout G, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000566, 10.1002/14651858. CD000566]; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; *WHO AD HOC COMM H, 1996, INV HLTH RES DEV; Yamey G, 2007, BMJ-BRIT MED J, V335, P269, DOI 10.1136/bmj.39281.645035.80	24	9	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a865	10.1136/bmj.a865	http://dx.doi.org/10.1136/bmj.a865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18703657	Green Accepted			2022-12-24	WOS:000259797600044
J	Piot, P; Bartos, M; Larson, H; Zewdie, D; Mane, P				Piot, Peter; Bartos, Michael; Larson, Heidi; Zewdie, Debrework; Mane, Purnima			HIV prevention 6 - Coming to terms with complexity: a call to action for HIV prevention	LANCET			English	Article							SEXUAL-BEHAVIOR; HIV/AIDS; REDUCTION; HEALTH; IMPACT	A quarter of a century of AIDS responses has created a huge body of knowledge about HIV transmission and how to prevent it, yet every day, around the world, nearly 7000 people become infected with the virus. Although HIV prevention is complex, it ought not to be mystifying. Local and national achievements in curbing the epidemic have been myriad, and have created a body of evidence about what works, but these successful approaches have not yet been fully applied. Essential programmes and services have not had sufficient coverage; they have often lacked the funding to be applied with sufficient quality and intensity. Action and funding have not necessarily been directed to where the epidemic is or to what drives it. Few programmes address vulnerability to HIV and structural determinants of the epidemic. A prevention constituency has not been adequately mobilised to stimulate the demand for HIV prevention. Confident and unified leadership has not emerged to assert what is needed in HIV prevention and how to overcome the political, sociocultural, and logistic barriers in getting there. We discuss the combination of solutions which are needed to intensify HIV prevention, using the existing body of evidence and the lessons from our successes and failures in HIV prevention.	[Piot, Peter; Bartos, Michael] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland; [Larson, Heidi] Clark Univ, Dept Int Dev Community & Environm, Worcester, MA 01610 USA; [Larson, Heidi] Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Zewdie, Debrework] World Bank, Washington, DC 20433 USA; [Mane, Purnima] United Nations Populat Fund UNFPA, New York, NY USA	UNAIDS; Clark University; Harvard University; Harvard T.H. Chan School of Public Health; The World Bank; United Nations Population Fund	Bartos, M (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	bartosm@unaids.org	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				*AIDS2031 CONS, 2008, DEV AG FUT ANT 50 YE; ALEXANDER A, 2007, GLOB HLTH COUNC C WA; ANDERSON RM, 1996, AIDS WORLD, V2, P71; BAXTER D, 2006, HIV AUSTR, V5, P6; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; BERTOZZI SM, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60889-2; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cohen J, 2004, SCIENCE, V304, P509, DOI 10.1126/science.304.5670.509; *COMM PREV HIV INF, 2006, PREV HIV INF INJ DRU; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Compston Alastair, LANCET, V372, P1502, DOI [DOI 10.1016/S0140-6736(08)60885-5, 10.1016/S0140-6736(08)61620-7, DOI 10.1016/S0140-6736(08)61620-7]; Crimp D., 1988, AIDS CULTURAL ANAL C; DEGENHARDT L, 2008, GLOBAL EPIDEMIOLOGY; DEWALQUE D, 2006, 3956 WORLD BANK; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; *FED DEM REP ETH, 2008, REP PROGR IMPL UN DE; *FED MIN HLTH, 2005, ACC ACC HIV AIDS PRE; Galvao J, 2005, AM J PUBLIC HEALTH, V95, P1110, DOI 10.2105/AJPH.2004.044313; Garnett GP, 2007, SEX TRANSM DIS, V34, P737, DOI 10.1097/OLQ.0b013e3181559c5c; *GOV SWED, 2006, C STOCKH SWED MAY; Grunseit A, 1997, J ADOLESCENT RES, V12, P421, DOI 10.1177/0743554897124002; GUPTA GR, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60887-9; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Hankins C, 2004, LANCET, V364, P1915, DOI 10.1016/S0140-6736(04)17488-6; HELGUERA G, 1990, INT C AIDS, V6, P294; *HLTH POL IN, 2006, INT CONS MAL SEX HLT; *INT TASK TEAM PRE, 2007, GUID GLOB SCAL UP PR; *IRIN AFR, 2007, W AFR IMP LOW RISK M; IZAZOLALICEA JA, 2002, FINANCING EXPENDITUR; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jitsuiki D, 2006, J HYPERTENS, V24, P68; LINGAPPA JR, 2008, REGIONAL DIFFERENCES; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; MERSON MH, 2008, LANCET          0806, DOI DOI 10.1016/S0140-6736(08)60884-3; Mesquita Fabio, 2007, Harm Reduct J, V4, P9, DOI 10.1186/1477-7517-4-9; *MIN PUBL HLTH THA, 2006, UN ACC 2010 THAIL NA; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Piot P, 2007, AM J PUBLIC HEALTH, V97, P1934, DOI 10.2105/AJPH.2007.121418; Piot P, 2006, LANCET, V368, P526, DOI 10.1016/S0140-6736(06)69161-7; *PMTCT GLOB PARTN, 2007, CONS STAT ACH UN ACC; *POP COUNC, 2008, ENG COMM SUPP HIV PR; PRIEUR A, 1990, AIDS EDUC PREV, V2, P101; Rogers E. M., 2005, INNOVATION J PUBLIC, V10, P1, DOI DOI 10.1002/9781118785317.WE0M120209]; Saigal Saroj, LANCET, V371, P261, DOI [10.1016/S0140-6736(08)60136-1, DOI 10.1016/S0140-6736(08)60886-7, DOI 10.1016/S0140-6736(08)60136-1]; SAMUELS F, 2008, ENGAGING COMMUNITIES; SCHLEIFER R, 2006, RHETORIC RISK HUMAN; *SOUL CIT RES UN, 2007, HIV PREV MULT CONC S; Southern African Development Community (SADC), 2006, EXP THINK TANK M HIV; [State Council HIV/AIDS Working Committee UN Theme Group on HIV/AIDS in China], 2004, JOINT ASS HIV AIDS P; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; *TRAV RES CTR INDR, 2008, INT COORD INF SERV D; *TREATM ACT CAMP, 2006, MAK HIV PREV WORK; *UN GEN ASS, 2008, DECL COMM HIV AIDS P; *UNAIDS, 2004, 3 1S KEY PRINC; *UNAIDS, 2001, GLOB STRAT FRAM HIV; *UNAIDS, 2004, AIDS AFR 3 SCEN 2025; *UNAIDS, 2008, UNAIDS REP IN PRESS; UNAIDS, 2007, FIN RES REQ ACH UN A; *UNAIDS, 2007, INF DASHB; UNAIDS, 2005, INT HIV PREV UNAIDS; UNAIDS, 1998, EXP GLOB RESP HIV AI; *UNAIDS, 2007, PRACT GUID INT HIV P; *UNAIDS E EUR CENT, 2008, AIDS EP UPD REG SUMM; *UNAIDS E SO AFR R, 2007, REV HIV PREV RESP UN; *UNFPA, 2004, CULT MATT WORK COMM; *UNICEF UNAIDS WHO, 2008, CHILDR AIDS 2 STOCKT; *UNODC, 2007, 2007 WORLD DRUG REP; *US CDC, 2008, UPD COMP EV BAS INT; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; VANGRIENSVEN F, 2007, 8 INT C AIDS AS PAC; Vernazza P, 2008, B MED SUISSES, V89, P165; WABRIREMANGEN F, 2006, RAPID ASSESSMENT TRE; WATNEY S, 1990, IDENTITY COMMUNITY C, P157; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Whiteside A., 2007, REV EMERGENCIES SWAZ; WHITSIDE A, 2008, HIV AIDS VERY SHORT; *WHO UNODC UNAIDS, 2008, DRAFT TECHN GUID COU; World Health Organization, 2008, UN ACC SCAL PRIOR HI	81	182	187	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					845	859		10.1016/S0140-6736(08)60888-0	http://dx.doi.org/10.1016/S0140-6736(08)60888-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	347FB	18687458				2022-12-24	WOS:000259124900027
J	Raghavan, S; Manzanillo, P; Chan, K; Dovey, C; Cox, JS				Raghavan, Sridharan; Manzanillo, Paolo; Chan, Kaman; Dovey, Cole; Cox, Jeffery S.			Secreted transcription factor controls Mycobacterium tuberculosis virulence	NATURE			English	Article							BACILLUS-CALMETTE-GUERIN; PSEUDOMONAS-AERUGINOSA; ESAT-6 SECRETION; GENE-EXPRESSION; SYSTEM; INFECTION; ANTIGEN; PROTEIN; MACROPHAGES; VACCINATION	Bacterial pathogens trigger specialized virulence factor secretion systems on encountering host cells. The ESX-1 protein secretion system of Mycobacterium tuberculosis - the causative agent of the human disease tuberculosis - delivers bacterial proteins into host cells during infection and is critical for virulence, but how it is regulated is unknown. Here we show that EspR (also known as Rv3849) is a key regulator of ESX-1 that is required for secretion and virulence in mice. EspR activates transcription of an operon that includes three ESX-1 components, Rv3616c-Rv3614c, whose expression in turn promotes secretion of ESX-1 substrates. EspR directly binds to and activates the Rv3616c-Rv3614c promoter and, unexpectedly, is itself secreted from the bacterial cell by the ESX-1 system that it regulates. Efflux of the DNA-binding regulator results in reduced Rv3616c-Rv3614c transcription, and thus reduced ESX-1 secretion. Our results reveal a direct negative feedback loop that regulates the activity of a secretion system essential for virulence. As the virulence factors secreted by the ESX-1 system are highly antigenic, fine control of secretion may be critical to successful infection.	[Raghavan, Sridharan; Manzanillo, Paolo; Chan, Kaman; Dovey, Cole; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, 600 16th St,Campus Box 2200, San Francisco, CA 94143 USA.	Jeffery.Cox@ucsf.edu			NIAID NIH HHS [P01 AI063302, R01 AI051667-06, P01 AI063302-040001, P01 AI063302-020001, P01 AI063302-050001, P01 AI063302-010001, AI63302, R01 AI051667-08, R01 AI051667-07, P01 AI063302-030001, R01 AI051667, AI51667] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051667, P01AI063302] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Colangeli R, 2000, INFECT IMMUN, V68, P990, DOI 10.1128/IAI.68.2.990-993.2000; Coler RN, 2001, J IMMUNOL, V166, P6227, DOI 10.4049/jimmunol.166.10.6227; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lewis RJ, 1996, FEBS LETT, V378, P98, DOI 10.1016/0014-5793(95)01432-2; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maizel A, 2002, DEVELOPMENT, V129, P3545; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh B, 2003, CLIN EXP IMMUNOL, V134, P70, DOI 10.1046/j.1365-2249.2003.02258.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367	40	146	169	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					717	U49		10.1038/nature07219	http://dx.doi.org/10.1038/nature07219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685700	Green Accepted			2022-12-24	WOS:000258228000035
J	Rawstron, AC; Bennett, FL; O'Connor, SJM; Kwok, M; Fenton, JAL; Plummer, M; de Tute, R; Owen, RG; Richards, SJ; Jack, AS; Hillmen, P				Rawstron, Andy C.; Bennett, Fiona L.; O'Connor, Sheila J. M.; Kwok, Marwan; Fenton, James A. L.; Plummer, Marieth; de Tute, Ruth; Owen, Roger G.; Richards, Stephen J.; Jack, Andrew S.; Hillmen, Peter			Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE MUTATION STATUS; EXPRESSION; PROGRESSION; EXPANSIONS; GUIDELINES; DIAGNOSIS; FREQUENT; BLOOD	Background: A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over 5000 circulating CLL-phenotype cells per cubic millimeter. Asymptomatic persons with fewer CLL-phenotype cells have monoclonal B-cell lymphocytosis (MBL). The goal of this study was to investigate the relation between MBL and CLL. Methods: We investigated 1520 subjects who were 62 to 80 years of age with a normal blood count and 2228 subjects with lymphocytosis (>4000 lymphocytes per cubic millimeter) for the presence of MBL, using flow cytometry. Monoclonal B cells were further characterized by means of cytogenetic and molecular analyses. A representative cohort of 185 subjects with CLL-phenotype MBL and lymphocytosis were monitored for a median of 6.7 years (range, 0.2 to 11.8). Results: Monoclonal CLL-phenotype B cells were detected in 5.1% of subjects (78 of 1520) with a normal blood count and 13.9% (309 of 2228) with lymphocytosis. CLL-phenotype MBL had a frequency of 13q14 deletion and trisomy 12 similar to that of CLL and showed a skewed repertoire of the immunoglobulin heavy variable group (IGHV) genes. Among 185 subjects presenting with lymphocytosis, progressive lymphocytosis occurred in 51 (28%), progressive CLL developed in 28 (15%), and chemotherapy was required in 13 (7%). The absolute B-cell count was the only independent prognostic factor associated with progressive lymphocytosis. During follow-up over a median of 6.7 years, 34% of subjects (62 of 185) died, but only 4 of these deaths were due to CLL. Age above 68 years and hemoglobin level below 12.5 g per deciliter were the only independent prognostic factors for death. Conclusions: The CLL-phenotype cells found in the general population and in subjects with lymphocytosis have features in common with CLL cells. CLL requiring treatment develops in subjects with CLL-phenotype MBL and with lymphocytosis at the rate of 1.1% per year.	[Rawstron, Andy C.] St James Inst Oncol, HMDS, Dept Haematol, Leeds LS9 7TF, W Yorkshire, England; Leeds Teaching Hosp, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Rawstron, AC (corresponding author), St James Inst Oncol, HMDS, Dept Haematol, Bexley Wing,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	andy.rawstron@hmds.org.uk	Kwok, Marwan/AAG-7558-2019	Kwok, Marwan/0000-0002-3985-5079; Richards, Stephen/0000-0002-8421-5353; Rawstron, Andy/0000-0003-0798-9790				Bennett FL, 2004, BRIT J HAEMATOL, V125, P6; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fung SS, 2007, LEUKEMIA LYMPHOMA, V48, P1087, DOI 10.1080/10428190701321277; Ghia P, 2004, BLOOD, V103, P2337, DOI 10.1182/blood-2003-09-3277; *HAEM MAL RES NETW, ANN EST INC MON B CE; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin BJ, 2000, BLOOD, V95, P2455, DOI 10.1182/blood.V95.7.2455.007a43c_2455_2457; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Marti GE, 2003, CYTOM PART B-CLIN CY, V52B, P1, DOI 10.1002/cyto.b.10013; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; McCarthy B, 2006, J INVEST MED, V54, pS386; (NCI) NCI, SURV EP END RES SEER; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Rawstron AC, 2002, BLOOD, V100, P2289, DOI 10.1182/blood-2002-03-0892; Rawstron AC, 2001, BLOOD, V98, P29, DOI 10.1182/blood.V98.1.29; Shanafelt TD, 2008, LEUKEMIA RES, V32, P1458, DOI 10.1016/j.leukres.2007.11.030; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948	24	391	409	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					575	583		10.1056/NEJMoa075290	http://dx.doi.org/10.1056/NEJMoa075290			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687638	Bronze			2022-12-24	WOS:000258216700005
J	Sokol, DK				Sokol, Daniel K.			Clarifying best interests - What should doctors consider when determining what's best for their patients?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, St Georges, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, St Georges, London WC1E 7HU, England.	daniel.sokol@talk21.com							0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2008	337	7664							a994	10.1136/bmj.a994	http://dx.doi.org/10.1136/bmj.a994			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339EN	18667474				2022-12-24	WOS:000258561000025
J	Wilson, JAP				Wilson, Joanne A. P.			Tumor necrosis factor alpha and colitis-associated colon cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; THERAPY		Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27710 USA	Duke University	Wilson, JAP (corresponding author), Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27710 USA.							Chan EP, 2006, GASTROENTEROL CLIN N, V35, P675, DOI 10.1016/j.gtc.2006.07.003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rutgeerts P, 2006, NEW ENGL J MED, V354, P2200; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7	6	24	28	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2008	358	25					2733	2734		10.1056/NEJMcibr0803116	http://dx.doi.org/10.1056/NEJMcibr0803116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314NC	18565868				2022-12-24	WOS:000256815100013
J	O'Brien, SJ				O'Brien, Stephen J.			The platypus genome unraveled	CELL			English	Editorial Material							EVOLUTION	The genome of the platypus has been sequenced, assembled, and annotated by an international genomics team. Like the animal itself the platypus genome contains an amalgam of mammal, reptile, and bird-like features.	NCI, Lab Gen Divers, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Brien, SJ (corresponding author), NCI, Lab Gen Divers, Frederick, MD 21702 USA.	obrien@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				[Anonymous], 1999, WALKERS MAMMALS WORL; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; JACOB K. T., 1940, BOT GAZ, V102, P143, DOI 10.1086/334941; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; O'Brien SJ, 2001, SCIENCE, V292, P2264, DOI 10.1126/science.1059393; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; VEYRUNES F, 2008, GENOME RES; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wilson D. E., 2005, MAMMAL SPECIES WORLD	10	8	8	2	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					953	955		10.1016/j.cell.2008.05.038	http://dx.doi.org/10.1016/j.cell.2008.05.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555772	Bronze			2022-12-24	WOS:000256693400011
J	Boasso, A; Shearer, GM; Clerici, M				Boasso, Adriano; Shearer, Gene M.; Clerici, Mario			The hunt for an HIV vaccine: time to rethink recent failures	LANCET			English	Editorial Material							INFECTION		[Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, I-20100 Milan, Italy; [Clerici, Mario] Fdn Don C Gnocchi, I-20100 Milan, Italy; [Boasso, Adriano] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England; [Shearer, Gene M.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Clerici, M (corresponding author), Univ Milan, Dept Biomed Sci & Technol, I-20100 Milan, Italy.	mario.clerici@unimi.it		Boasso, Adriano/0000-0001-9673-6319; Clerici, Mario/0000-0001-5920-6191	NATIONAL CANCER INSTITUTE [ZIABC009267, Z01BC009267] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2007, Nature, V449, P390; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Boasso A, 2007, CURR DRUG METAB, V8, P217, DOI 10.2174/138920007780362527; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Chirmule N, 1996, MICROBIOL REV, V60, P386, DOI 10.1128/MMBR.60.2.386-406.1996; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Franchini G, 2002, VACCINE, V20, pA52, DOI 10.1016/S0264-410X(02)00388-2; Herbeuval JP, 2006, AIDS REV, V8, P3; Munier ML, 2007, IMMUNOL CELL BIOL, V85, P6, DOI 10.1038/sj.icb.7100015	10	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 7	2008	371	9628					1897	1898		10.1016/S0140-6736(08)60812-0	http://dx.doi.org/10.1016/S0140-6736(08)60812-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310OI	18539209				2022-12-24	WOS:000256538500009
J	Christiaen, L; Davidson, B; Kawashima, T; Powell, W; Nolla, H; Vranizan, K; Levine, M				Christiaen, Lionel; Davidson, Brad; Kawashima, Takeshi; Powell, Weston; Nolla, Hector; Vranizan, Karen; Levine, Michael			The transcription/migration interface in heart precursors of Ciona intestinalis	SCIENCE			English	Article							SIMPLE CHORDATE; ACTIN; MIGRATION; RHO; LAMELLIPODIA; NETWORKS	Gene regulatory networks direct the progressive determination of cell fate during embryogenesis, but how they control cell behavior during morphogenesis remains largely elusive. Cell sorting, microarrays, and targeted molecular manipulations were used to analyze cardiac cell migration in the ascidian Ciona intestinalis. The heart network regulates genes involved in most cellular activities required for migration, including adhesion, cell polarity, and membrane protrusions. We demonstrated that fibroblast growth factor signaling and the forkhead transcription factor FoxF directly upregulate the small guanosine triphosphatase RhoDF, which synergizes with Cdc42 to contribute to the protrusive activity of migrating cells. Moreover, RhoDF induces membrane protrusions independently of other cellular activities required for migration. We propose that transcription regulation of specific effector genes determines the coordinated deployment of discrete cellular modules underlying migration.	[Christiaen, Lionel; Davidson, Brad; Powell, Weston; Levine, Michael] Univ Calif Berkeley, Ctr Integrat Genom, Div Genet Genom & Dev, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kawashima, Takeshi] Dept Energy, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Nolla, Hector] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Vranizan, Karen] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Christiaen, L (corresponding author), Univ Calif Berkeley, Ctr Integrat Genom, Div Genet Genom & Dev, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	lionelchristiaen@berkeley.edu; mlevine@berkeley.edu	Kawashima, Takeshi/M-4510-2015; Powell, Weston/I-6961-2019	Christiaen, Lionel/0000-0001-5930-5667; Davidson, Brad/0000-0001-5082-7872; Levine, Michael/0000-0001-7629-0081; Powell, Weston/0000-0002-1555-1425	PHS HHS [18B-106681] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Randazzo PA, 2003, DEV CELL, V4, P287, DOI 10.1016/S1534-5807(03)00067-4; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Veeman MT, 2008, DEVELOPMENT, V135, P33, DOI 10.1242/dev.010892; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	22	99	100	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1349	1352		10.1126/science.1158170	http://dx.doi.org/10.1126/science.1158170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535245				2022-12-24	WOS:000256441100047
J	Zimmermann, MB; Jooste, PL; Pandav, CS				Zimmermann, Michael B.; Jooste, Pieter L.; Pandav, Chandrakant S.			Iodine-deficiency disorders	LANCET			English	Review							SCHOOL-AGE-CHILDREN; IODIZED SALT; GOITER PREVALENCE; UNITED-STATES; REPRODUCTIVE FAILURE; DEVELOPING-COUNTRIES; THYROID-DEFICIENCY; ENDEMIC GOITER; DIETARY IODINE; BOSTON-AREA	2 billion individuals worldwide have insufficient iodine intake, with those in south Asia and sub-Saharan Africa particularly affected. Iodine deficiency has many adverse effects on growth and development. These effects are due to inadequate production of thyroid hormone and are termed iodine-deficiency disorders. Iodine deficiency is the most common cause of preventable mental impairment worldwide. Assessment methods include urinary iodine concentration, goitre, newborn thyroid-stimulating hormone, and blood thyroglobulin. In nearly all countries, the best strategy to control iodine deficiency is iodisation of salt, which is one of the most cost-effective ways to contribute to economic and social development. When iodisation of salt is not possible, iodine supplements can be given to susceptible groups. Introduction of iodised salt to regions of chronic iodine-deficiency disorders might transiently increase the proportion of thyroid disorders, but overall the small risks of iodine excess are far outweighed by the substantial risks of iodine deficiency. International efforts to control iodine-deficiency disorders are slowing, and reaching the third of the worldwide population that remains deficient poses major challenges.	[Zimmermann, Michael B.] Swiss Fed Inst Technol, Human Nutr Lab, CH-8092 Zurich, Switzerland; [Zimmermann, Michael B.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [Jooste, Pieter L.] MRC, Nutr Intervent Res Unit, Cape Town, South Africa; [Pandav, Chandrakant S.] All India Inst Med Sci, Ctr Community Med, New Delhi, India	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; All India Institute of Medical Sciences (AIIMS) New Delhi	Zimmermann, MB (corresponding author), Swiss Fed Inst Technol, Human Nutr Lab, Schmelzbergstr 7,LFV E19, CH-8092 Zurich, Switzerland.	michael.zimmermann@ilw.agrl.ethz.ch	Zimmermann, Michael B/C-3062-2016					Abuye C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-316; Aguayo VM, 2003, PUBLIC HEALTH NUTR, V6, P653, DOI 10.1079/PHN2003484; Andersen S, 2008, BRIT J NUTR, V99, P813, DOI 10.1017/S0007114507842292; Andersson M, 2007, PUBLIC HEALTH NUTR, V10, P1606, DOI 10.1017/S1368980007361004; [Anonymous], WORLD POP PROSP 2004; [Anonymous], WHO GLOB DAT IOD DEF; Assey VD, 2006, FOOD NUTR BULL, V27, P292, DOI 10.1177/156482650602700402; Atego EA, 2005, IDD NEWSLETTER, V21, P1; BENMILOUD M, 1994, J CLIN ENDOCR METAB, V79, P20, DOI 10.1210/jc.79.1.20; Bleichrodt N., 1987, PREVENTION CONTROL I, P65; Brauer VFH, 2006, EUR J ENDOCRINOL, V155, P807, DOI 10.1530/eje.1.02302; Braverman LE, 2007, THYROID, V17, P819, DOI 10.1089/thy.2007.0105; Caldwell KL, 2005, ACCREDIT QUAL ASSUR, V10, P356, DOI 10.1007/s00769-005-0003-x; Caldwell KL, 2005, THYROID, V15, P692, DOI 10.1089/thy.2005.15.692; CAO XY, 1994, NEW ENGL J MED, V331, P1739, DOI 10.1056/NEJM199412293312603; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chavasit V, 2002, J FOOD COMPOS ANAL, V15, P265, DOI 10.1006/jfca.2002.1054; Chen ZP., 2007, IDD NEWSLETTER, V23, P18; CHOW CC, 1991, CLIN ENDOCRINOL, V34, P413, DOI 10.1111/j.1365-2265.1991.tb00314.x; Cobra C, 1997, J NUTR, V127, P574, DOI 10.1093/jn/127.4.574; CONNOLLY KJ, 1979, LANCET, V2, P1149; Corvilain B, 1998, THYROID, V8, P107, DOI 10.1089/thy.1998.8.107; De Benoist B, FOOD NUTR B IN PRESS; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Delange F, 2002, THYROID, V12, P915, DOI 10.1089/105072502761016557; Delange F, 1999, THYROID, V9, P545, DOI 10.1089/thy.1999.9.545; DELANGE F, THYROID ITS DIS; DeLong GR, 1997, LANCET, V350, P771, DOI 10.1016/S0140-6736(96)12365-5; Dillon JC, 2000, BRIT J OBSTET GYNAEC, V107, P631, DOI 10.1111/j.1471-0528.2000.tb13305.x; Diosady L. L., 1998, Food and Nutrition Bulletin, V19, P240; Diosady L. L., 1997, Food and Nutrition Bulletin, V18, P388; *DIS CONTR PRIOR P, IOD DEF CHILDR AG 5; Doerge DR, 2002, J CHROMATOGR B, V777, P269, DOI 10.1016/S1570-0232(02)00214-3; Dunn JT, 2000, THYROID, V10, P681, DOI 10.1089/10507250050137752; Dunn JT, 2003, J NUTR, V133, p3008S, DOI 10.1093/jn/133.9.3008S; Egbuta J, 2003, PUBLIC HEALTH NUTR, V6, P169, DOI 10.1079/PHN2002413; El-Ghawi UM, 2006, BIOL TRACE ELEM RES, V111, P31, DOI 10.1385/BTER:111:1:31; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; *EUR COMM HACPD GS, 2002, OP SCI COMM FOOD TOL; Glinoer D, 2006, THYROID, V16, P947, DOI 10.1089/thy.2006.16.947; *GOV IND MIN HLTH, 2007, 2005 06 NAT FAM HLTH; Haddow JE, 2007, J CLIN ENDOCR METAB, V92, P1019, DOI 10.1210/jc.2006-2156; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003; Horton S, 2006, J NUTR, V136, P1068, DOI 10.1093/jn/136.4.1068; IBRAHIM M, 2006, COCHRANE DB SYST REV, V2; Jooste PL, 2001, B WORLD HEALTH ORGAN, V79, P534; Knudsen N, 2000, EUR J CLIN NUTR, V54, P361, DOI 10.1038/sj.ejcn.1600935; KOPP P, 1994, J CLIN ENDOCR METAB, V79, P134, DOI 10.1210/jc.79.1.134; Laurberg P, 2004, J CLIN ENDOCR METAB, V89, P181, DOI 10.1210/jc.2003-030829; LAURBERG P, 1991, J INTERN MED, V229, P415, DOI 10.1111/j.1365-2796.1991.tb00368.x; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P219, DOI 10.1530/eje.1.02210; Li M, 2006, MED J AUSTRALIA, V184, P165, DOI 10.5694/j.1326-5377.2006.tb00177.x; Mason J. B., 2002, Food and Nutrition Bulletin, V23, P292; McGuire J., 1994, ENRICHING LIVES OVER; *NAT AC DIET I MED, 2001, REF INT VIT A VIT K; Nazaimoon WMW, 1996, CLIN ENDOCRINOL, V45, P79, DOI 10.1046/j.1365-2265.1996.00785.x; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; Okosieme OE, 2006, J ROY SOC MED, V99, P396, DOI 10.1258/jrsm.99.8.396; Pearce EN, 2007, J CLIN ENDOCR METAB, V92, P1673, DOI 10.1210/jc.2006-2738; Pearce EN, 2004, J CLIN ENDOCR METAB, V89, P3421, DOI 10.1210/jc.2003-032002; Pedersen IB, 2007, J CLIN ENDOCR METAB, V92, P3122, DOI 10.1210/jc.2007-0732; Pedersen IB, 2006, J CLIN ENDOCR METAB, V91, P3830, DOI 10.1210/jc.2006-0652; PHAROAH POD, 1971, LANCET, V1, P308; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; Pop VJ, 2005, LANCET, V365, P1604, DOI 10.1016/S0140-6736(05)66489-6; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Qian M, 2005, ASIA PAC J CLIN NUTR, V14, P32; ROUSSET BA, THYROID ITS DIS; Sack Joseph, 2003, Pediatr Endocrinol Rev, V1 Suppl 2, P170; Sankar R, 2005, NATL MED J INDIA, V18, P169; Sartelet H, 1996, NUTRITION, V12, P100, DOI 10.1016/0899-9007(96)90707-8; Seal JA, 2007, MED J AUSTRALIA, V186, P69, DOI 10.5694/j.1326-5377.2007.tb00803.x; Sehestedt T, 2006, CLIN ENDOCRINOL, V65, P229, DOI 10.1111/j.1365-2265.2006.02580.x; SQUATRITO S, 1986, J CLIN ENDOCR METAB, V63, P368, DOI 10.1210/jcem-63-2-368; Sullivan KM, 1997, J NUTR, V127, P55, DOI 10.1093/jn/127.1.55; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Thomson BM, 2008, BRIT J NUTR, V99, P614, DOI 10.1017/S0007114507812001; Todd CH, 1998, AM J CLIN NUTR, V67, P1279, DOI 10.1093/ajcn/67.6.1279; *UNICEF, STAT WORLDS CHILDR 2; *UNICEF, FACT SHEET IDD ACH C; *UNICEF NUTR SECT, 2007, PROT CHILDR BRAIN DE, P1; United Nations, MILL DEV GOALS MDGS; Untoro J, 2006, AM J CLIN NUTR, V84, P1208, DOI 10.1093/ajcn/84.5.1208; Utiger RD, 2006, NEW ENGL J MED, V354, P2819, DOI 10.1056/NEJMe068092; Vanderpas J, 2006, ANNU REV NUTR, V26, P293, DOI 10.1146/annurev.nutr.26.010506.103810; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; *WHO INT COUNC CON, 2001, WHONHD011 INT COUNC; Yang F, 2007, EUR J ENDOCRINOL, V156, P403, DOI 10.1530/EJE-06-0651; Zimmermann M, 2000, EUR J ENDOCRINOL, V143, P727, DOI 10.1530/eje.0.1430727; Zimmermann MB, 2006, AM J CLIN NUTR, V83, P108; Zimmermann MB, 2005, AM J CLIN NUTR, V82, P388, DOI 10.1093/ajcn/82.2.388; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P840, DOI 10.1093/ajcn/81.4.840; Zimmermann MB, 2004, J NUTR, V134, P1673, DOI 10.1093/jn/134.7.1673; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P642; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P231; Zimmermann MB, 2003, AM J CLIN NUTR, V77, P663, DOI 10.1093/ajcn/77.3.663; Zimmermann MB, 2007, THYROID, V17, P829, DOI 10.1089/thy.2007.0108; Zimmermann MB, 2007, AM J CLIN NUTR, V86, P1040, DOI 10.1093/ajcn/86.4.1040; Zimmermann MB, 2007, J CLIN ENDOCR METAB, V92, P3436, DOI 10.1210/jc.2007-1082; Zimmermann MB, 2007, J CLIN ENDOCR METAB, V92, P437, DOI 10.1210/jc.2006-1901; Zimmermann MB, 2006, J CLIN ENDOCR METAB, V91, P4881, DOI 10.1210/jc.2006-1370; Zimmermann MB, 2006, ANNU REV NUTR, V26, P367, DOI 10.1146/annurev.nutr.26.061505.111236	104	580	618	3	86	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1251	1262		10.1016/S0140-6736(08)61005-3	http://dx.doi.org/10.1016/S0140-6736(08)61005-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357YB	18676011				2022-12-24	WOS:000259882000031
J	Lipp, JS; Morono, Y; Inagaki, F; Hinrichs, KU				Lipp, Julius S.; Morono, Yuki; Inagaki, Fumio; Hinrichs, Kai-Uwe			Significant contribution of Archaea to extant biomass in marine subsurface sediments	NATURE			English	Article							SUBSEAFLOOR SEDIMENTS; MICROBIAL COMMUNITIES; PACIFIC-OCEAN; PROKARYOTES; SEA; BIOMARKERS; BIOSPHERE; BACTERIA; ECOLOGY; LIPIDS	Deep drilling into the marine sea floor has uncovered a vast sedimentary ecosystem of microbial cells(1,2). Extrapolation of direct counts of stained microbial cells to the total volume of habitable marine subsurface sediments suggests that between 56 Pg ( ref. 1) and 303 Pg ( ref. 3) of cellular carbon could be stored in this largely unexplored habitat. From recent studies using various cultureindependent techniques, no clear picture has yet emerged as to whether Archaea or Bacteria are more abundant in this extensive ecosystem(4-7). Here we show that in subsurface sediments buried deeper than 1 m in a wide range of oceanographic settings at least 87% of intact polar membrane lipids, biomarkers for the presence of live cells(7,8), are attributable to archaeal membranes, suggesting that Archaea constitute a major fraction of the biomass. Results obtained from modified quantitative polymerase chain reaction and slot- blot hybridization protocols support the lipid- based evidence and indicate that these techniques have previously underestimated archaeal biomass. The lipid concentrations are proportional to those of total organic carbon. On the basis of this relationship, we derived an independent estimate of amounts of cellular carbon in the global marine subsurface biosphere. Our estimate of 90 Pg of cellular carbon is consistent, within an order of magnitude, with previous estimates, and underscores the importance of marine subsurface habitats for global biomass budgets.	[Lipp, Julius S.; Hinrichs, Kai-Uwe] Univ Bremen, Organ Geochem Grp, Dept Geosci, D-28334 Bremen, Germany; [Lipp, Julius S.; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Morono, Yuki; Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nanko Ku, Kochi 7838502, Japan	University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Hinrichs, KU (corresponding author), Univ Bremen, Organ Geochem Grp, Dept Geosci, POB 330 440, D-28334 Bremen, Germany.	khinrichs@uni-bremen.de	Hinrichs, Kai-Uwe/C-7675-2009; Inagaki, Fumio/AAI-1156-2019	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Inagaki, Fumio/0000-0003-2887-6525; Morono, Yuki/0000-0001-8928-4254	Integrated Ocean Drilling Program [301, 311]; Ocean Drilling Program [201, 204, 207]; US National Science Foundation; Deutsche Forschungsgemeinschaft; IODP/ODP [Hi616-4]; JAMSTEC Multidisciplinary Research Promotion Award	Integrated Ocean Drilling Program; Ocean Drilling Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); US National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IODP/ODP; JAMSTEC Multidisciplinary Research Promotion Award	Samples for this research were provided by the Integrated Ocean Drilling Program (IODP, expeditions 301 and 311), the Ocean Drilling Program (ODP, legs 201, 204 and 207; sponsored by the US National Science Foundation and participating countries under the Joint Oceanographic Institutions, Inc.), and cruises Sonne SO147, Kaiyo KY04-11, Professor Logatchev TTR15 and Chikyu Shakedown Expedition CK06-06. We thank the participating crews and scientists for sample recovery and data; U. Proske and N. Buchs for assistance with lipid extraction and sample preparation; J. M. Hayes and A. Teske for comments on an earlier version of this manuscript; H. F. Fredricks and F. Schubotz for discussion of data; V. Heuer, A. Schippers and T. Toki for sample donation; B. Kockisch for TOC analysis; and T. Terada and N. Masui for DNA extraction and analyses. This work was supported by Deutsche Forschungsgemeinschaft ( through MARUM Center for Marine Environmental Sciences and grant Hi616-4 from the priority program IODP/ODP) and JAMSTEC Multidisciplinary Research Promotion Award 2007 ( to Y. M. and F. I.). This is MARUM publication number 0585.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Arnosti C, 2006, GEOMICROBIOL J, V23, P551, DOI 10.1080/01490450600897336; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; CARDACE D, 2006, P ODP SCI RES, V205; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; FREDRICKS HF, 2007, P ODP SCI RES, V207; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Mauclaire L, 2004, GEOBIOLOGY, V2, P217, DOI 10.1111/j.1472-4677.2004.00035.x; MIDDELBURG JJ, 1993, GLOBAL PLANET CHANGE, V8, P47, DOI 10.1016/0921-8181(93)90062-S; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Rutters H, 2002, J MICROBIOL METH, V48, P149, DOI 10.1016/S0167-7012(01)00319-0; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Seiter K, 2004, DEEP-SEA RES PT I, V51, P2001, DOI 10.1016/j.dsr.2004.06.014; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; SUMMIT M, 2000, P ODP SCI RES, V169; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Teske AP, 2006, GEOMICROBIOL J, V23, P357, DOI 10.1080/01490450600875613; Thiel V, 2007, GEOBIOLOGY, V5, P413, DOI 10.1111/j.1472-4669.2007.00119.x; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; White D., 1979, ASTM STP, V673, P87; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zink KG, 2003, ORG GEOCHEM, V34, P755, DOI 10.1016/S0146-6380(03)00041-X	30	433	462	2	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					991	994		10.1038/nature07174	http://dx.doi.org/10.1038/nature07174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18641632				2022-12-24	WOS:000258591000038
J	Warne, T; Serrano-Vega, MJ; Baker, JG; Moukhametzianov, R; Edwards, PC; Henderson, R; Leslie, AGW; Tate, CG; Schertler, GFX				Warne, Tony; Serrano-Vega, Maria J.; Baker, Jillian G.; Moukhametzianov, Rouslan; Edwards, Patricia C.; Henderson, Richard; Leslie, Andrew G. W.; Tate, Christopher G.; Schertler, Gebhard F. X.			Structure of a beta(1)-adrenergic G-protein-coupled receptor	NATURE			English	Article							2ND EXTRACELLULAR LOOP; BETA-ADRENERGIC-RECEPTORS; HIGH-AFFINITY BINDING; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; BETA-1-ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR; AGONIST ACTIVATION; PROVIDE EVIDENCE; AMINO-ACIDS	G-protein-coupled receptors have a major role in transmembrane signalling in most eukaryotes and many are important drug targets. Here we report the 2.7 angstrom resolution crystal structure of a beta(1)-adrenergic receptor in complex with the high-affinity antagonist cyanopindolol. The modified turkey (Meleagris gallopavo) receptor was selected to be in its antagonist conformation and its thermostability improved by earlier limited mutagenesis. The ligand-binding pocket comprises 15 side chains from amino acid residues in 4 transmembrane alpha-helices and extracellular loop 2. This loop defines the entrance of the ligand-binding pocket and is stabilized by two disulphide bonds and a sodium ion. Binding of cyanopindolol to the beta(1)-adrenergic receptor and binding of carazolol to the beta(2)-adrenergic receptor involve similar interactions. A short well-defined helix in cytoplasmic loop 2, not observed in either rhodopsin or the beta(2)-adrenergic receptor, directly interacts by means of a tyrosine with the highly conserved DRY motif at the end of helix 3 that is essential for receptor activation.	[Warne, Tony; Serrano-Vega, Maria J.; Moukhametzianov, Rouslan; Edwards, Patricia C.; Henderson, Richard; Leslie, Andrew G. W.; Tate, Christopher G.; Schertler, Gebhard F. X.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Baker, Jillian G.] Univ Nottingham, Inst Cell Signalling, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England	MRC Laboratory Molecular Biology; University of Nottingham	Tate, CG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	cgt@mrc-lmb.cam.ac.uk; gfx@mrc-lmb.cam.ac.uk	Schertler, Gebhard/M-9512-2014; soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Tate, Christopher/0000-0002-2008-9183; Warne, Tony/0000-0001-9646-6080; Schertler, Gebhard F.X./0000-0002-5846-6810; baker, jillian/0000-0003-2371-8202	MRC [MC_U105178937, MC_U105184322, MC_U105184325] Funding Source: UKRI; Medical Research Council [MC_U105184322, MC_U105184325, U.1051.04.020(78937), MC_U105178937] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BLACK JW, 1989, ANGEW CHEM INT EDIT, V28, P886, DOI 10.1002/anie.198908861; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DONALDSON J, 1988, BIOCHEM PHARMACOL, V37, P715, DOI 10.1016/0006-2952(88)90146-3; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Isogaya M, 1998, MOL PHARMACOL, V54, P616; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lattion AL, 1999, FEBS LETT, V457, P302, DOI 10.1016/S0014-5793(99)01064-9; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARKER EM, 1991, J BIOL CHEM, V266, P519; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Sato T, 1999, BRIT J PHARMACOL, V128, P272, DOI 10.1038/sj.bjp.0702813; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Sugimoto Y, 2002, J PHARMACOL EXP THER, V301, P51, DOI 10.1124/jpet.301.1.51; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; WESS J, 1990, MOL PHARMACOL, V38, P517; WONG SKF, 1994, J BIOL CHEM, V269, P18968; WONG SKF, 1990, J BIOL CHEM, V265, P6219; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795	52	1195	1240	3	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					486	491		10.1038/nature07101	http://dx.doi.org/10.1038/nature07101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18594507	Green Accepted			2022-12-24	WOS:000257860300044
J	Thibault, P; Dierolf, M; Menzel, A; Bunk, O; David, C; Pfeiffer, F				Thibault, Pierre; Dierolf, Martin; Menzel, Andreas; Bunk, Oliver; David, Christian; Pfeiffer, Franz			High-resolution scanning x-ray diffraction microscopy	SCIENCE			English	Article							PHASE-RETRIEVAL	Coherent diffractive imaging (CDI) and scanning transmission x-ray microscopy (STXM) are two popular microscopy techniques that have evolved quite independently. CDI promises to reach resolutions below 10 nanometers, but the reconstruction procedures put stringent requirements on data quality and sample preparation. In contrast, STXM features straightforward data analysis, but its resolution is limited by the spot size on the specimen. We demonstrate a ptychographic imaging method that bridges the gap between CDI and STXM by measuring complete diffraction patterns at each point of a STXM scan. The high penetration power of x-rays in combination with the high spatial resolution will allow investigation of a wide range of complex mesoscopic life and material science specimens, such as embedded semiconductor devices or cellular networks.	[Thibault, Pierre; Dierolf, Martin; Menzel, Andreas; Bunk, Oliver; David, Christian; Pfeiffer, Franz] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Pfeiffer, Franz] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Thibault, P (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	pierre.thibault@psi.ch	Thibault, Pierre/B-2656-2010; Bunk, Oliver/B-7602-2013; Dierolf, Martin J/B-9816-2008; Menzel, Andreas/C-4388-2012	Thibault, Pierre/0000-0003-1278-8846; Bunk, Oliver/0000-0001-6563-4053; Dierolf, Martin J/0000-0001-5150-2949; Menzel, Andreas/0000-0002-0489-609X				Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Chapman HN, 1996, ULTRAMICROSCOPY, V66, P153, DOI 10.1016/S0304-3991(96)00084-8; Eisebitt S, 2004, NATURE, V432, P885, DOI 10.1038/nature03139; Elser V, 2007, P NATL ACAD SCI USA, V104, P418, DOI 10.1073/pnas.0606359104; Elser V, 2003, J OPT SOC AM A, V20, P40, DOI 10.1364/JOSAA.20.000040; Faulkner HML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023903; HEGERL R, 1970, BERICH BUNSEN GESELL, V74, P1148, DOI 10.1002/bbpc.19700741112; Hornberger B, 2007, ULTRAMICROSCOPY, V107, P644, DOI 10.1016/j.ultramic.2006.12.006; Jefimovs K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.264801; MCNULTY I, 1992, SCIENCE, V256, P1009, DOI 10.1126/science.256.5059.1009; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Mimura H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2436469; MORRISON G, 2005, IPAP C SERIES, V7, P377; NELLIST PD, 1995, NATURE, V374, P630, DOI 10.1038/374630a0; Quiney HM, 2006, NAT PHYS, V2, P101, DOI 10.1038/nphys218; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Rodenburg JM, 2007, ULTRAMICROSCOPY, V107, P227, DOI 10.1016/j.ultramic.2006.07.007; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; RODENBURG JM, 1992, PHILOS T R SOC A, V339, P521, DOI 10.1098/rsta.1992.0050; Sayre D, 2008, ACTA CRYSTALLOGR A, V64, P33, DOI 10.1107/S010876730705550X; Schroer CG, 2003, APPL PHYS LETT, V82, P1485, DOI 10.1063/1.1556960; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Williams GJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.175501	26	928	978	15	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					379	382		10.1126/science.1158573	http://dx.doi.org/10.1126/science.1158573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635796				2022-12-24	WOS:000257713900042
J	Hamada, FN; Rosenzweig, M; Kang, K; Pulver, SR; Ghezzi, A; Jegla, TJ; Garrity, PA				Hamada, Fumika N.; Rosenzweig, Mark; Kang, Kyeongjin; Pulver, Stefan R.; Ghezzi, Alfredo; Jegla, Timothy J.; Garrity, Paul A.			An internal thermal sensor controlling temperature preference in Drosophila	NATURE			English	Article							ION CHANNELS; ANTENNAL LOBE; NEURONS; THERMOSENSATION; MELANOGASTER; THERMOTAXIS; SENSATION; GENETICS; FLY	Animals from flies to humans are able to distinguish subtle gradations in temperature and show strong temperature preferences(1-4). Animals move to environments of optimal temperature and some manipulate the temperature of their surroundings, as humans do using clothing and shelter. Despite the ubiquitous influence of environmental temperature on animal behaviour, the neural circuits and strategies through which animals select a preferred temperature remain largely unknown. Here we identify a small set of warmth- activated anterior cell ( AC) neurons located in the Drosophila brain, the function of which is critical for preferred temperature selection. AC neuron activation occurs just above the fly's preferred temperature and depends on dTrpA1, an ion channel that functions as amolecular sensor of warmth. Flies that selectively express dTrpA1 in the AC neurons select normal temperatures, whereas flies in which dTrpA1 function is reduced or eliminated choose warmer temperatures. This internal warmth- sensing pathway promotes avoidance of slightly elevated temperatures and acts together with a distinct pathway for cold avoidance to set the fly's preferred temperature. Thus, flies select a preferred temperature by using a thermal sensing pathway tuned to trigger avoidance of temperatures that deviate even slightly from the preferred temperature. This provides a potentially general strategy for robustly selecting a narrow temperature range optimal for survival.	[Hamada, Fumika N.; Rosenzweig, Mark; Kang, Kyeongjin; Pulver, Stefan R.; Ghezzi, Alfredo; Garrity, Paul A.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Jegla, Timothy J.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Jegla, Timothy J.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Brandeis University; Scripps Research Institute; Scripps Research Institute	Garrity, PA (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Natl Ctr Behav Genom, MS-008,415 South St, Waltham, MA 02454 USA.	pgarrity@brandeis.edu	Ghezzi, Alfredo/I-4620-2012	Ghezzi, Alfredo/0000-0001-9176-1320; Pulver, Stefan/0000-0001-5170-7522; Jegla, Timothy/0000-0001-8616-2390; Kang, KyeongJin/0000-0003-0446-469X; Garrity, Paul/0000-0002-8274-6564	NCRR NIH HHS [RR16780] Funding Source: Medline; NEI NIH HHS [R01 EY013874-06, R01 EY013874, R01 EY13874] Funding Source: Medline; NIMH NIH HHS [R01 MH067284, R01 MH067284-05] Funding Source: Medline; NINDS NIH HHS [P01 NS044232, P01 NS044232-070002, P30 NS045713S10, P30 NS045713-069006, P30 NS045713, P01 NS044232-060002] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; BROWN AWA, 1951, NATURE, V167, P202, DOI 10.1038/167202a0; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; FANGER PO, 1974, EUR J APPL PHYSIOL O, V33, P255, DOI 10.1007/BF00430233; Fischer H, 2002, J COMP PHYSIOL A, V188, P643, DOI 10.1007/s00359-002-0339-1; FRAENKEL GS, 1940, ORIENTATION ANIMALS; FRIEND WG, 1977, ANNU REV ENTOMOL, V22, P309, DOI 10.1146/annurev.en.22.010177.001521; Heinrich B., 1993, HOT BLOODED INSECTS; Ito K, 1998, LEARN MEMORY, V5, P52; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KITAMOTO T, 1995, J NEUROBIOL, V28, P70, DOI 10.1002/neu.480280107; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; SIDDIQUI WH, 1972, ANN ENTOMOL SOC AM, V65, P993, DOI 10.1093/aesa/65.5.993; STEVENSON RD, 1985, AM NAT, V125, P102, DOI 10.1086/284330; Tayler TD, 2004, DEVELOPMENT, V131, P5935, DOI 10.1242/dev.01465; Tichy H., 2001, ECOLOGY SENSING, P271, DOI [10.1007/978-3-662-22644-5_14, DOI 10.1007/978-3-662-22644-5_14]; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306	28	647	655	5	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 10	2008	454	7201					217	U55		10.1038/nature07001	http://dx.doi.org/10.1038/nature07001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18548007	Green Accepted			2022-12-24	WOS:000257466900044
J	Coleman, JR; Papamichail, D; Skiena, S; Futcher, B; Wimmer, E; Mueller, S				Coleman, J. Robert; Papamichail, Dimitris; Skiena, Steven; Futcher, Bruce; Wimmer, Eckard; Mueller, Steffen			Virus attenuation by genome-scale changes in codon pair bias	SCIENCE			English	Article							POLIOVIRUS; RNA; DEOPTIMIZATION; STRATEGY	As a result of the redundancy of the genetic code, adjacent pairs of amino acids can be encoded by as many as 36 different pairs of synonymous codons. A species- specific "codon pair bias" provides that some synonymous codon pairs are used more or less frequently than statistically predicted. We synthesized de novo large DNA molecules using hundreds of over- or underrepresented synonymous codon pairs to encode the poliovirus capsid protein. Underrepresented codon pairs caused decreased rates of protein translation, and polioviruses containing such amino acid- independent changes were attenuated in mice. Polioviruses thus customized were used to immunize mice and provided protective immunity after challenge. This "death by a thousand cuts" strategy could be generally applicable to attenuating many kinds of viruses.	[Coleman, J. Robert; Futcher, Bruce; Wimmer, Eckard; Mueller, Steffen] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Papamichail, Dimitris; Skiena, Steven] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wimmer, E (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	ewimmer@ms.cc.sunysb.edu	Papamichail, Dimitris/A-5712-2010; Mueller, Steffen/HGE-0738-2022	Mueller, Steffen/0000-0003-2660-258X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015122, R01AI015122, R01AI075219] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075219-01A1, R01 AI075219, R37 AI015122-34, R37 AI015122, AI075219, AI15122] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Fedorov A, 2002, NUCLEIC ACIDS RES, V30, P1192, DOI 10.1093/nar/30.5.1192; Flanagan EB, 2001, J VIROL, V75, P6107, DOI 10.1128/JVI.75.13.6107-6114.2001; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Jiang P, 2007, P NATL ACAD SCI USA, V104, P9457, DOI 10.1073/pnas.0700451104; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOIKE S, 1994, COLD SPRING HARBOR M, P463; Landsteiner K., 1909, Z IMMUNITATSFORSCH, V2, P377; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Toyoda H, 2007, CANCER RES, V67, P2857, DOI 10.1158/0008-5472.CAN-06-3713; VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Zhao WD, 2001, J VIROL, V75, P3719, DOI 10.1128/JVI.75.8.3719-3730.2001	18	433	477	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1784	1787		10.1126/science.1155761	http://dx.doi.org/10.1126/science.1155761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583614	Green Accepted			2022-12-24	WOS:000257121200041
J	Hackett, SJ; Kimball, RT; Reddy, S; Bowie, RCK; Braun, EL; Braun, MJ; Chojnowski, JL; Cox, WA; Han, KL; Harshman, J; Huddleston, CJ; Marks, BD; Miglia, KJ; Moore, WS; Sheldon, FH; Steadman, DW; Witt, CC; Yuri, T				Hackett, Shannon J.; Kimball, Rebecca T.; Reddy, Sushma; Bowie, Rauri C. K.; Braun, Edward L.; Braun, Michael J.; Chojnowski, Jena L.; Cox, W. Andrew; Han, Kin-Lan; Harshman, John; Huddleston, Christopher J.; Marks, Ben D.; Miglia, Kathleen J.; Moore, William S.; Sheldon, Frederick H.; Steadman, David W.; Witt, Christopher C.; Yuri, Tamaki			A phylogenomic study of birds reveals their evolutionary history	SCIENCE			English	Article							EXPLOSIVE EVOLUTION; DIVERGENCES; SEQUENCES; CHARACTERS; UTILITY; GENES; TAXA	Deep avian evolutionary relationships have been difficult to resolve as a result of a putative explosive radiation. Our study examined similar to 32 kilobases of aligned nuclear DNA sequences from 19 independent loci for 169 species, representing all major extant groups, and recovered a robust phylogeny from a genome- wide signal supported by multiple analytical methods. We documented well- supported, previously unrecognized interordinal relationships ( such as a sister relationship between passerines and parrots) and corroborated previously contentious groupings ( such as flamingos and grebes). Our conclusions challenge current classifications and alter our understanding of trait evolution; for example, some diurnal birds evolved from nocturnal ancestors. Our results provide a valuable resource for phylogenetic and comparative studies in birds.	[Kimball, Rebecca T.; Braun, Edward L.; Chojnowski, Jena L.; Cox, W. Andrew; Han, Kin-Lan; Yuri, Tamaki] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Hackett, Shannon J.; Reddy, Sushma; Bowie, Rauri C. K.; Harshman, John] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Bowie, Rauri C. K.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Bowie, Rauri C. K.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Bowie, Rauri C. K.] Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7602 Matieland, South Africa; [Bowie, Rauri C. K.] Univ Stellenbosch, Dept Bot & Zool, ZA-7602 Matieland, South Africa; [Braun, Michael J.; Han, Kin-Lan; Huddleston, Christopher J.; Yuri, Tamaki] Smithsonian Inst, Dept Vertebrate Zool, Suitland, MD 20746 USA; [Braun, Edward L.; Han, Kin-Lan] Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA; [Marks, Ben D.; Sheldon, Frederick H.; Witt, Christopher C.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Miglia, Kathleen J.; Moore, William S.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Steadman, David W.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Witt, Christopher C.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Witt, Christopher C.] Univ New Mexico, Museum SW Biol, Albuquerque, NM 87131 USA	State University System of Florida; University of Florida; Field Museum of Natural History (Chicago); University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Research Foundation - South Africa; Stellenbosch University; Smithsonian Institution; University System of Maryland; University of Maryland College Park; Louisiana State University System; Louisiana State University; Wayne State University; State University System of Florida; University of Florida; University of New Mexico; University of New Mexico	Kimball, RT (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	rkimball@ufl.edu	Kimball, Rebecca T/C-2290-2009; Bowie, Rauri/H-9165-2019; Han, Kin-Lan/G-7121-2011; Kimball, Rebecca/Q-6862-2019; Witt, Christopher/D-8587-2012	Bowie, Rauri/0000-0001-8328-6021; Kimball, Rebecca/0000-0001-5449-5481; Witt, Christopher/0000-0003-2781-1543; Reddy, Sushma/0000-0001-7263-0763; Yuri, Tamaki/0000-0001-6394-5755; Braun, Edward/0000-0003-1643-5212; Cox, William/0000-0002-1205-5979				Braun EL, 2002, SYST BIOL, V51, P614, DOI 10.1080/10635150290102294; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Chubb AL, 2004, MOL PHYLOGENET EVOL, V30, P140, DOI 10.1016/S1055-7903(03)00159-3; Cracraft J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P143; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2004, EVOLUTION, V58, P2558; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; GRIFFITHS CS, 1994, AUK, V111, P787, DOI 10.2307/4088811; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mindell DP, 1999, SYST BIOL, V48, P138, DOI 10.1080/106351599260490; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Peters J.L., 1931, CHECK LIST BIRDS WOR, V1; Poe S, 2004, EVOLUTION, V58, P404, DOI 10.1111/j.0014-3820.2004.tb01655.x; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Sibley CG, 1990, DISTRIBUTION TAXONOM; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; Zwickl D., 2006, GARLI GENETIC ALGORI; [No title captured]; [No title captured]	31	1440	1482	9	570	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1763	1768		10.1126/science.1157704	http://dx.doi.org/10.1126/science.1157704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583609				2022-12-24	WOS:000257121200035
J	Wang, NC; Maggioni, AP; Konstam, MA; Zannad, F; Krasa, HB; Burnett, JC; Grinfeld, L; Swedberg, K; Udelson, JE; Cook, T; Traver, B; Zimmer, C; Orlandi, C; Gheorghiade, M				Wang, Norman C.; Maggioni, Aldo P.; Konstam, Marvin A.; Zannad, Faiez; Krasa, Holly B.; Burnett, John C., Jr.; Grinfeld, Liliana; Swedberg, Karl; Udelson, James E.; Cook, Thomas; Traver, Brian; Zimmer, Christopher; Orlandi, Cesare; Gheorghiade, Mihai		Efficacy Vasopressin Antagonism He	Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BUNDLE-BRANCH BLOCK; CARDIAC-RESYNCHRONIZATION THERAPY; LONG-TERM MORTALITY; DILATED CARDIOMYOPATHY; ELDERLY PATIENTS; CONDUCTION; PROGNOSIS; OUTCOMES; TRIAL; DEFIBRILLATOR	Context Hospitalization for heart failure is associated with high postdischarge mortality and morbidity. The predictive value of the QRS duration during admission for heart failure has not been well studied. Objective To investigate the predictive value of the QRS duration in patients hospitalized for heart failure with reduced left ventricular ejection fraction ( LVEF). Design, Setting, and Participants Retrospective, post hoc analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan ( EVEREST), an event- driven, randomized, double- blind, placebo- controlled study in patients hospitalized for heart failure and having an LVEF of 40% or less. A total of 4133 patients were enrolled at 359 North American, South American, and European sites between October 7, 2003, and February 3, 2006. After excluding 1029 patients with a pacemaker, implantable cardioverter- defibrillator, or both at enrollment and 142 patients without a reported baseline QRS duration, 2962 patients were included in the analysis: 1641 had a normal QRS duration ( < 120 ms) and 1321 had a prolonged QRS duration ( < 120 ms). Main Outcome Measures Dual primary end points were all- cause mortality and the composite of cardiovascular death or hospitalization for heart failure. Results During a median follow- up of 9.9 months, all- cause mortality was 18.7% for patients with a normal baseline QRS duration and 28.1% for patients with a prolonged baseline QRS duration ( hazard ratio [ HR], 1.61; 95% confidence interval [ CI], 1.38- 1.87). The composite of cardiovascular death or hospitalization for heart failure was 32.4% for patients with a baseline QRS duration less than 120 ms and 41.6% for patients with a baseline QRS duration of 120 ms or greater ( HR, 1.40; 95% CI, 1.24-1.58). The increased risk associated with prolonged QRS duration was confirmed after adjusting for multiple variables for all- cause mortality ( HR, 1.24; 95% CI, 1.02-1.50) and the composite of cardiovascular death or hospitalization for heart failure ( HR, 1.28; 95% CI, 1.10- 1.49). Only 105 patients ( 3.6%) who presented with a prolonged baseline QRS duration had a normal QRS duration on their last inpatient electrocardiogram. Conclusion A prolonged QRS duration appears common in patients with reduced LVEF who are hospitalized for heart failure and is an independent predictor of high postdischarge morbidity and mortality.	[Wang, Norman C.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Maggioni, Aldo P.] ANMCO Res Ctr, Florence, Italy; [Konstam, Marvin A.; Udelson, James E.] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA; [Zannad, Faiez] CHU Nancy, CIC, INSERM, Nancy, France; [Krasa, Holly B.; Zimmer, Christopher; Orlandi, Cesare] Otsuka Pharmaceut Co Ltd, Rockville, MD USA; [Burnett, John C., Jr.] Mayo Clin, Rochester, MN USA; [Grinfeld, Liliana] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Swedberg, Karl] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; [Cook, Thomas; Traver, Brian] Univ Wisconsin, Madison, WI USA	Northwestern University; Feinberg School of Medicine; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Tufts Medical Center; Tufts University; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Otsuka Pharmaceutical; Mayo Clinic; Hospital Italiano de Buenos Aires; University of Buenos Aires; Sahlgrenska University Hospital; University of Wisconsin System; University of Wisconsin Madison	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, 201 E Huron St,Galter Pavil 10-240, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Swedberg, Karl/B-2475-2008; Zannad, Faiez/K-4649-2019; Maggioni, Aldo Pietro/AAL-5334-2020	Maggioni, Aldo Pietro/0000-0003-2764-6779				Abraham WT, 2006, J AM COLL CARDIOL, V47, p19A; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Aranda JM, 2002, AM J CARDIOL, V90, P335, DOI 10.1016/S0002-9149(02)02479-7; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Barsheshet A, 2008, AM J CARDIOL, V101, P1303, DOI 10.1016/j.amjcard.2007.12.035; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Bleeker GB, 2004, J CARDIOVASC ELECTR, V15, P544, DOI 10.1046/j.1540-8167.2004.03604.x; Breidthardt T, 2007, HEART, V93, P1093, DOI 10.1136/hrt.2006.102319; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; BROPHY JM, 1994, CAN J CARDIOL, V10, P543; Buxton AE, 2005, J AM COLL CARDIOL, V46, P310, DOI 10.1016/j.jacc.2005.03.060; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2001, EUR J HEART FAIL, V3, P481, DOI 10.1016/S1388-9842(01)00176-3; Danciu SC, 2006, AM J CARDIOL, V97, P256, DOI 10.1016/j.amjcard.2005.08.031; Fonarow GC, 2007, ARCH INTERN MED, V167, P1493, DOI 10.1001/archinte.167.14.1493; FRANZ MR, 1992, CIRCULATION, V86, P968, DOI 10.1161/01.CIR.86.3.968; Gheorghiade M, 2005, J CARD FAIL, V11, P260, DOI 10.1016/j.cardfail.2005.03.009; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Grigioni F, 2002, J HEART LUNG TRANSPL, V21, P899, DOI 10.1016/S1053-2498(02)00431-X; Higgins SL, 2000, J AM COLL CARDIOL, V36, P824, DOI 10.1016/S0735-1097(00)00795-6; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Leclercq C, 1998, J AM COLL CARDIOL, V32, P1825, DOI 10.1016/S0735-1097(98)00492-6; McCullough PA, 2005, INT J CARDIOL, V102, P303, DOI 10.1016/j.ijcard.2004.10.008; Mueller C, 2006, J INTERN MED, V260, P421, DOI 10.1111/j.1365-2796.2006.01703.x; Nelson GS, 2000, CIRCULATION, V102, P3053; Nelson GS, 2000, CIRCULATION, V101, P2703, DOI 10.1161/01.CIR.101.23.2703; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Shamim W, 2002, HEART, V88, P47, DOI 10.1136/heart.88.1.47; Shenkman HJ, 2002, CHEST, V122, P528, DOI 10.1378/chest.122.2.528; SILVERMAN ME, 1995, AM J CARDIOL, V75, P460, DOI 10.1016/S0002-9149(99)80581-5; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Tabrizi F, 2007, EUR HEART J, V28, P2449, DOI 10.1093/eurheartj/ehm262; Taneja T, 2001, PACE, V24, P16, DOI 10.1046/j.1460-9592.2001.00016.x; Ukkonen H, 2003, CIRCULATION, V107, P28, DOI 10.1161/01.CIR.0000047068.02226.95; WILLEMS JL, 1985, J AM COLL CARDIOL, V5, P1261, DOI 10.1016/S0735-1097(85)80335-1; Xiao HB, 1996, INT J CARDIOL, V53, P163, DOI 10.1016/0167-5273(95)02502-2; Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32	42	142	156	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2008	299	22					2656	2666		10.1001/jama.299.22.2656	http://dx.doi.org/10.1001/jama.299.22.2656			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311FN	18544725	Bronze			2022-12-24	WOS:000256586200022
J	Douma, S; Petidis, K; Doumas, M; Papaefthimiou, P; Triantafyllou, A; Kartali, N; Papadopoulos, N; Vogiatzis, K; Zamboulis, C				Douma, Stella; Petidis, Konstantinos; Doumas, Michael; Papaefthimiou, Panagiota; Triantafyllou, Areti; Kartali, Niki; Papadopoulos, Nikolaos; Vogiatzis, Konstantinos; Zamboulis, Chrysanthos			Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study	LANCET			English	Article							PRIMARY ALDOSTERONISM; SECONDARY HYPERTENSION; UNRECOGNIZED EPIDEMIC; DIAGNOSIS; OUTCOMES; PATIENT; FORMS; RATIO	Background Results of several studies published since 1999 suggest that primary hyperaldosteronism (also known as Conn's syndrome) affects more than 10% of people with hypertension; however, such a high prevalence has also been disputed. Experts generally agree that resistant hypertension has the highest prevalence of primary hyperaldosteronism, on the basis of small studies. We aimed to assess the prevalence of primary hyperaldosteronism in a large group of patients with resistant hypertension. Methods Patients with resistant hypertension (blood pressure >140/90 mm Hg despite a three drug regimen, including a diuretic) who attended our outpatient clinic were assessed for primary hyperaldosteronism. Serum aldosterone and plasma renin activity were determined and their ratio was calculated. Patients with a positive test (ratio >65.16 and aldosterone concentrations >416 pmol/L) underwent salt suppression tests with intravenous saline and fludrocortisone. Diagnosis of primary hyperaldosteronism was further confirmed by the response to treatment with spironolactone. Findings Over 20 years, we studied 1616 patients with resistant hypertension. 338 patients (20.9%) had a ratio of more than 65.16 and aldosterone concentrations of more than 416 pmol/L. On the basis of salt suppression tests, 182 (11.3%) patients had primary hyperaldosteronism, and response to spironolactone treatment further confirmed this diagnosis. Hypokalaemia was seen only in 83 patients with primary hyperaldosteronism (45.6%). Interpretation Although the prevalence of Primary hyperaldosteronism in patients with resistant hypertension was high, it was substantially lower than previously reported. On the basis of this finding, we could assume that the prevalence of primary hyperaldosteronism in the general unselected hypertensive population is much lower than currently reported. Thus, the notion of an epidemic of primary hyperaldosteronism is not supported. Funding None.	[Douma, Stella; Petidis, Konstantinos; Doumas, Michael; Papaefthimiou, Panagiota; Triantafyllou, Areti; Kartali, Niki; Papadopoulos, Nikolaos; Vogiatzis, Konstantinos; Zamboulis, Chrysanthos] Aristotle Univ Thessaloniki, Hippokratio Gen Hosp, Propedeut Dept Internal Med 2, Thessaloniki 54643, Greece	Aristotle University of Thessaloniki	Doumas, M (corresponding author), Aristotle Univ Thessaloniki, Hippokratio Gen Hosp, Propedeut Dept Internal Med 2, Thessaloniki 54643, Greece.	michalisdoumas@yahoo.co.uk	N.G., Papadopoulos/L-8670-2013; Douma, Stella/O-2904-2013	N.G., Papadopoulos/0000-0002-4448-3468; Kartali, Nikoleta/0000-0003-3750-4782; Doumas, Michael/0000-0002-7269-8044; Triantafyllou, Areti/0000-0001-7644-0684				ANDERSEN GS, 1988, J HUM HYPERTENS, V2, P187; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Calhoun DA, 2002, CURR HYPERTENS REP, V4, P221, DOI 10.1007/s11906-002-0011-8; Calhoun DA, 2007, HYPERTENSION, V50, P447, DOI 10.1161/HYPERTENSIONAHA.106.086116; Catena C, 2008, ARCH INTERN MED, V168, P80, DOI 10.1001/archinternmed.2007.33; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CONN JW, 1955, J LAB CLIN MED, V45, P3; Eide IK, 2004, J HYPERTENS, V22, P2217, DOI 10.1097/00004872-200411000-00026; Gallay BJ, 2001, AM J KIDNEY DIS, V37, P699, DOI 10.1016/S0272-6386(01)80117-7; GIFFORD RW, 1969, MILBANK FUND Q, V47, P170, DOI 10.2307/3349261; KAPLAN NM, 1967, ANN INTERN MED, V66, P1079, DOI 10.7326/0003-4819-66-6-1079; Kaplan NM, 2007, HYPERTENSION, V50, P454, DOI 10.1161/HYPERTENSIONAHA.106.086124; Lim PO, 1999, LANCET, V353, P40, DOI 10.1016/S0140-6736(05)74868-6; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Martell N, 2003, BLOOD PRESSURE, V12, P149, DOI 10.1080/08037050310009950; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Mulatero P, 2002, HYPERTENSION, V40, P897, DOI 10.1161/01.HYP.0000038478.59760.41; Mulatero P, 2005, TRENDS ENDOCRIN MET, V16, P114, DOI 10.1016/j.tem.2005.02.007; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Schwartz GL, 2005, CLIN CHEM, V51, P386, DOI 10.1373/clinchem.2004.041780; Sechi LA, 2006, JAMA-J AM MED ASSOC, V295, P2638, DOI 10.1001/jama.295.22.2638; SETARO JF, 1992, NEW ENGL J MED, V327, P543; SINCLAIR AM, 1987, ARCH INTERN MED, V147, P1289, DOI 10.1001/archinte.147.7.1289; Stowasser M, 2001, J RENIN-ANGIO-ALDO S, V2, P156, DOI 10.3317/jraas.2001.022; Stowasser M, 2003, J HYPERTENS, V21, P2149, DOI 10.1097/00004872-200311000-00025; Stowasser M, 2005, J CLIN ENDOCR METAB, V90, P5070, DOI 10.1210/jc.2005-0681; Stowasser M, 2004, MOL CELL ENDOCRINOL, V217, P33, DOI 10.1016/j.mce.2003.10.006; Strauch B, 2003, J HUM HYPERTENS, V17, P349, DOI 10.1038/sj.jhh.1001554; Strauch B, 2006, AM J HYPERTENS, V19, P909, DOI 10.1016/j.amjhyper.2006.02.002; SWALES JD, 1982, LANCET, V1, P894; Tanabe A, 1997, Hypertens Res, V20, P85, DOI 10.1291/hypres.20.85; Umpierrez GE, 2007, DIABETES CARE, V30, P1699, DOI 10.2337/dc07-0031; Weinberger MH, 2006, AM J HYPERTENS, V19, P628, DOI 10.1016/j.amjhyper.2006.01.002; Young WF, 2003, ENDOCRINOLOGY, V144, P2208, DOI 10.1210/en.2003-0279	37	368	387	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2008	371	9628					1921	1926		10.1016/S0140-6736(08)60834-X	http://dx.doi.org/10.1016/S0140-6736(08)60834-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310OI	18539224				2022-12-24	WOS:000256538500028
J	Vermeij, GJ; Roopnarine, PD				Vermeij, Geerat J.; Roopnarine, Peter D.			The coming Arctic invasion	SCIENCE			English	Editorial Material									[Vermeij, Geerat J.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Roopnarine, Peter D.] Calif Acad Sci, Dept Invertebrate Zool & Geol, San Francisco, CA 94118 USA	University of California System; University of California Davis; California Academy of Sciences	Vermeij, GJ (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	vermeij@geology.ucdavis.edu; proopnarine@calacademy.org		Roopnarine, Peter/0000-0002-9811-1176				Andersen O.G.N., 1989, P147; CARTER LD, 1986, GEOLOGY, V14, P675, DOI 10.1130/0091-7613(1986)14<675:LCAOSI>2.0.CO;2; Dayton P.K., 1990, P631; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Krylov AA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001497; STOCKLI R, 2006, EOS T AM GEOPHYS UN, V87, P49, DOI DOI 10.1029/2006EO050002; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617	8	75	79	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2008	321	5890					780	781		10.1126/science.1160852	http://dx.doi.org/10.1126/science.1160852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687946				2022-12-24	WOS:000258261000026
J	Jackson, ML; Nelson, JC; Weiss, NS; Neuzil, KM; Barlow, W; Jackson, LA				Jackson, Michael L.; Nelson, Jennifer C.; Weiss, Noel S.; Neuzil, Kathleen M.; Barlow, William; Jackson, Lisa A.			Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study	LANCET			English	Article							PREVENTING HOSPITALIZATION; COST-EFFECTIVENESS; MORTALITY; EFFICACY; REDUCTION; BENEFITS; IMPACT; OLDER	Background Pneumonia is a common complication of influenza infection in elderly individuals and could therefore potentially be prevented by influenza vaccination. In studies with data from administrative sources, vaccinated elderly people had a reduced risk of admission for pneumonia compared with unvaccinated seniors; however, these findings could have been biased by underlying differences in health between the groups. Furthermore, since most individuals with pneumonia are not treated in hospital, such studies should include both outpatient and inpatient events. We therefore assessed whether influenza vaccination is associated with a reduced risk of community-acquired pneumonia in immunocompetent elderly people after controlling for health status indicators. Methods We did a population-based, nested case-control study in immunocompetent elderly people aged 65-94 years (cases and controls) enrolled in Group Health (a health maintenance organisation) during the 2000, 2001, and 2002 preinfluenza periods and influenza seasons. Cases were individuals with an episode of outpatient or inpatient community-acquired pneumonia (validated by review of medical records or chest radiograph reports). We randomly selected two age-matched and sex-matched controls for each case. The exposure of interest was influenza vaccination. We reviewed medical records to define potential confounders, including smoking history, presence and severity of lung and heart disease, and frailty indicators. Findings 1173 cases and 2346 controls were included in the study. After we adjusted for the presence and severity of comorbidities, as defined by chart review, influenza vaccination was not associated with a reduced risk of community-acquired pneumonia (odds ratio 0 . 92, 95% CI 0 . 77-1. 10) during the influenza season. Interpretation The effect of influenza vaccination on the risk of pneumonia in elderly people during influenza seasons might be less than previously estimated. Funding Group Health Center for Health Studies internal funds and Group Health Community Foundation fellowship grant.	[Jackson, Michael L.; Nelson, Jennifer C.; Barlow, William; Jackson, Lisa A.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Nelson, Jennifer C.; Barlow, William] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Weiss, Noel S.; Jackson, Lisa A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Neuzil, Kathleen M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Weiss, Noel S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Neuzil, Kathleen M.] PATH, Seattle, WA USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Jackson, ML (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave Suite 1600, Seattle, WA 98101 USA.	mlj3@cornell.edu						[Anonymous], 2001, Morbidity and Mortality Weekly Report, V50, P532; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P516; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P466; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P1019; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P503; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1045; Crocetti E, 2001, EUR J EPIDEMIOL, V17, P163, DOI 10.1023/A:1017978420601; Davidson A.C., 1997, BOOTSTRAP METHODS TH; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohmit SE, 1995, INT J EPIDEMIOL, V24, P1240, DOI 10.1093/ije/24.6.1240; PuigBarbera J, 1997, J EPIDEMIOL COMMUN H, V51, P526, DOI 10.1136/jech.51.5.526; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Wang ST, 2005, VACCINE, V23, P1973, DOI 10.1016/j.vaccine.2004.10.011	30	140	143	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2008	372	9636					398	405		10.1016/S0140-6736(08)61160-5	http://dx.doi.org/10.1016/S0140-6736(08)61160-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334AZ	18675690				2022-12-24	WOS:000258196000031
J	Ishikawa, HO; Takeuchi, H; Haltiwanger, RS; Irvine, KD				Ishikawa, Hiroyuki O.; Takeuchi, Hideyuki; Haltiwanger, Robert S.; Irvine, Kenneth D.			Four-jointed is a Golgi kinase that phosphorylates a subset of cadherin domains	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; PLANAR POLARITY; FAT; DROSOPHILA; GROWTH; ENCODES; PATHWAY; YORKIE; MEMBER; SITES	The atypical cadherin Fat acts as a receptor for a signaling pathway that regulates growth, gene expression, and planar cell polarity. Genetic studies in Drosophila identified the four-jointed gene as a regulator of Fat signaling. We show that four-jointed encodes a protein kinase that phosphorylates serine or threonine residues within extracellular cadherin domains of Fat and its transmembrane ligand, Dachsous. Four-jointed functions in the Golgi and is the first molecularly defined kinase that phosphorylates protein domains destined to be extracellular. An acidic sequence motif (Asp-Asn-Glu) within Four-jointed was essential for its kinase activity in vitro and for its biological activity in vivo. Our results indicate that Four-jointed regulates Fat signaling by phosphorylating cadherin domains of Fat and Dachsous as they transit through the Golgi.	[Ishikawa, Hiroyuki O.; Irvine, Kenneth D.] Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; [Ishikawa, Hiroyuki O.; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Takeuchi, Hideyuki/AAZ-9210-2020		Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA123071, CA123071, R01 CA123071-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM078620-02, GM078620, R01 GM078620, R01 GM061126-08, R01 GM061126, GM061126] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078620, R01GM061126] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Rock R, 2005, DEV DYNAM, V234, P602, DOI 10.1002/dvdy.20553; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Yamaguchi K, 2006, DEV DYNAM, V235, P3085, DOI 10.1002/dvdy.20946; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	28	174	182	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					401	404		10.1126/science.1158159	http://dx.doi.org/10.1126/science.1158159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635802	Green Accepted			2022-12-24	WOS:000257713900049
J	Trock, BJ; Han, M; Freedland, SJ; Humphreys, EB; DeWeese, TL; Partin, AW; Walsh, PC				Trock, Bruce J.; Han, Misop; Freedland, Stephen J.; Humphreys, Elizabeth B.; DeWeese, Theodore L.; Partin, Alan W.; Walsh, Patrick C.			Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIGEN DOUBLING TIME; RADIATION-THERAPY; BREAST-CANCER; POSTOPERATIVE RADIOTHERAPY; LOCAL RECURRENCE; FAILURE; SURGERY; PSA	Context Biochemical disease recurrence after radical prostatectomy often prompts salvage radiotherapy, but no studies to date have had sufficient numbers of patients or follow-up to determine whether radiotherapy improves survival, and if so, the sub-group of men most likely to benefit. Objectives To quantify the relative improvement in prostate cancer-specific survival of salvage radiotherapy vs no therapy after biochemical recurrence following prostatectomy, and to identify subgroups for whom salvage treatment is most beneficial. Design, Setting, and Patients Retrospective analysis of a cohort of 635 US men undergoing prostatectomy from 1982-2004, followed up through December 28, 2007, who experienced biochemical and/or local recurrence and received no salvage treatment (n = 397), salvage radiotherapy alone (n = 160), or salvage radiotherapy combined with hormonal therapy (n = 78). Main Outcome Measure Prostate cancer-specific survival defined from time of recurrence until death from disease. Results With a median follow-up of 6 years after recurrence and 9 years after prostatectomy, 116 men (18%) died from prostate cancer, including 89 (22%) who received no salvage treatment, 18 (11%) who received salvage radiotherapy alone, and 9 (12%) who received salvage radiotherapy and hormonal therapy. Salvage radiotherapy alone was associated with a significant 3-fold increase in prostate cancer-specific survival relative to those who received no salvage treatment (hazard ratio [HR], 0.32 [95% confidence interval {CI}, 0.19-0.54]; P <.001). Addition of hormonal therapy to salvage radiotherapy was not associated with any additional increase in prostate cancer-specific survival (HR, 0.34 [95% CI, 0.17-0.69]; P = .003). The increase in prostate cancer-specific survival associated with salvage radiotherapy was limited to men with a prostate-specific antigen doubling time of less than 6 months and remained after adjustment for pathological stage and other established prognostic factors. Salvage radiotherapy initiated more than 2 years after recurrence provided no significant increase in prostate cancer-specific survival. Men whose prostate-specific antigen level never became undetectable after salvage radiotherapy did not experience a significant increase in prostate cancer-specific survival. Salvage radiotherapy also was associated with a significant increase in overall survival. Conclusions Salvage radiotherapy administered within 2 years of biochemical recurrence was associated with a significant increase in prostate cancer-specific survival among men with a prostate-specific antigen doubling time of less than 6 months, independent of other prognostic features such as pathological stage or Gleason score. These preliminary findings should be validated in other settings, and ultimately, in a randomized controlled trial.	[Trock, Bruce J.; Han, Misop; Humphreys, Elizabeth B.; Partin, Alan W.; Walsh, Patrick C.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [DeWeese, Theodore L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA; [Freedland, Stephen J.] Durham Vet Affairs Med Ctr, Surg Sect, Durham, NC USA; [Freedland, Stephen J.] Duke Univ, Sch Med, Duke Prostate Ctr, Dept Surg, Durham, NC USA; [Freedland, Stephen J.] Duke Univ, Sch Med, Duke Prostate Ctr, Dept Pathol, Durham, NC USA	Johns Hopkins University; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Trock, BJ (corresponding author), Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, 600 N Wolfe St,546 Phipps Bldg, Baltimore, MD 21287 USA.	btrock@jhmi.edu			NATIONAL CANCER INSTITUTE [P50CA058236, P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [CA58236, P30 CA006973, P50 CA058236, P50 CA058236-13] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V366, P2087; Anscher MS, 2000, INT J RADIAT ONCOL, V48, P369, DOI 10.1016/S0360-3016(00)00645-3; Boccon-Gibod L, 2007, EUR UROL SUPPL, V6, P521, DOI 10.1016/j.eursup.2007.01.026; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Chawla AK, 2002, UROLOGY, V59, P726, DOI 10.1016/S0090-4295(02)01540-6; Choo R, 2006, BJU INT, V98, P773, DOI 10.1111/j.1464-410X.2006.06423.x; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Harrell FE, 2001, REGRESSION MODELING; Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043; Leventis AK, 2001, J CLIN ONCOL, V19, P1030, DOI 10.1200/JCO.2001.19.4.1030; Liauw SL, 2003, UROLOGY, V61, P1204, DOI 10.1016/S0090-4295(03)00044-X; Maffezzini M, 2007, EUR UROL, V51, P605, DOI 10.1016/j.eururo.2006.10.062; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5; Penson DF, 2007, J UROLOGY, V177, P2020, DOI 10.1016/j.juro.2007.01.121; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Song DY, 2002, UROLOGY, V60, P281, DOI 10.1016/S0090-4295(02)01709-0; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Ward JF, 2005, NAT CLIN PRACT UROL, V2, P174, DOI 10.1038/ncpuro0145; Ward JF, 2004, J UROLOGY, V172, P2244, DOI 10.1097/01.ju.0000145262.34748.2b	25	514	524	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2008	299	23					2760	2769		10.1001/jama.299.23.2760	http://dx.doi.org/10.1001/jama.299.23.2760			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314JH	18560003	Green Accepted, Bronze			2022-12-24	WOS:000256805200024
J	Petit, RJ; Hu, FS; Dick, CW				Petit, Remy J.; Hu, Feng Sheng; Dick, Christopher W.			Forests of the past: A window to future changes	SCIENCE			English	Editorial Material							RAPID CLIMATE-CHANGE; EVOLUTIONARY RESPONSES; WHITE SPRUCE; TREE FLORA; DIVERSITY; PHYLOGEOGRAPHY; CONSEQUENCES; RICHNESS; PATTERNS; ICE	The study of past forest change provides a necessary historical context for evaluating the outcome of human-induced climate change and biological invasions. Retrospective analyses based on fossil and genetic data greatly advance our understanding of tree colonization, adaptation, and extinction in response to past climatic change. For instance, these analyses reveal cryptic refugia near or north of continental ice sheets, leading to reevaluation of postglacial tree migration rates. Species extinctions appear to have occurred primarily during periods of high climatic variability. Transoceanic dispersal and colonization in the tropics were widespread at geological time scales, inconsistent with the idea that tropical forests are particularly resistant to biological invasions.	[Petit, Remy J.] INRA Biodivers Genes & Communities, UMR1202, F-33612 Cestas, France; [Petit, Remy J.] Univ Bordeaux 1, UMR1202, F-33612 Cestas, France; [Hu, Feng Sheng] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Hu, Feng Sheng] Univ Illinois, Dept Geol, Urbana, IL 61801 USA; [Hu, Feng Sheng] Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA; [Dick, Christopher W.] Univ Michigan, Dept Ecol & Evolut Biol, Ann Arbor, MI 48103 USA; [Dick, Christopher W.] Univ Michigan, Herbarium, Ann Arbor, MI 48103 USA; [Dick, Christopher W.] Smithsonian Trop Res Inst, Balboa, Panama	INRAE; UDICE-French Research Universities; Universite de Bordeaux; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian Tropical Research Institute	Petit, RJ (corresponding author), INRA Biodivers Genes & Communities, UMR1202, 69 Route Arcachon, F-33612 Cestas, France.	petit@pierroton.inra.fr	Petit, Remy/AAD-9078-2019; Petit, Rémy/A-8842-2008	Petit, Rémy/0000-0002-4809-1453				Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Dick CW, 2007, MOL ECOL, V16, P3039, DOI 10.1111/j.1365-294X.2007.03341.x; Huntley B., 1983, ATLAS PRESENT POLLEN; Jackson ST, 1999, P NATL ACAD SCI USA, V96, P13847, DOI 10.1073/pnas.96.24.13847; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; Lloyd AH, 2005, ECOLOGY, V86, P1687, DOI 10.1890/03-0786; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pennington RT, 2004, PHILOS T R SOC B, V359, P1611, DOI 10.1098/rstb.2004.1532; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2004, FOREST ECOL MANAG, V197, P117, DOI 10.1016/j.foreco.2004.05.009; RITCHIE JC, 1986, J BIOGEOGR, V13, P527, DOI 10.2307/2844816; Shepherd LD, 2007, MOL ECOL, V16, P4536, DOI 10.1111/j.1365-294X.2007.03451.x; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2007, ECOL LETT, V10, P673, DOI 10.1111/j.1461-0248.2007.01056.x	23	201	209	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1450	1452		10.1126/science.1155457	http://dx.doi.org/10.1126/science.1155457			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556547	Green Submitted			2022-12-24	WOS:000256676400030
J	Heng, JIT; Nguyen, L; Castro, DS; Zimmer, C; Wildner, H; Armant, O; Skowronska-Krawczyk, D; Bedogni, F; Matter, JM; Hevner, R; Guillemot, F				Heng, Julian Ik-Tsen; Nguyen, Laurent; Castro, Diogo S.; Zimmer, Celine; Wildner, Hendrik; Armant, Olivier; Skowronska-Krawczyk, Dorota; Bedogni, Francesco; Matter, Jean-Marc; Hevner, Robert; Guillemot, Francois			Neurogenin 2 controls cortical neuron migration through regulation of Rnd2	NATURE			English	Article							CEREBRAL-CORTEX; PYRAMIDAL NEURONS; CELL-MIGRATION; PRONEURAL BHLH; RHO FAMILY; DIFFERENTIATION; NEOCORTEX; PROTEINS; SPECIFICATION; HIPPOCAMPUS	Motility is a universal property of newly generated neurons. How cell migration is coordinately regulated with other aspects of neuron production is not well understood. Here we show that the proneural protein neurogenin 2 ( Neurog2), which controls neurogenesis in the embryonic cerebral cortex(1,2), directly induces the expression of the small GTP- binding protein Rnd2 ( ref. 3) in newly generated mouse cortical neurons before they initiate migration. Rnd2 silencing leads to a defect in radial migration of cortical neurons similar to that observed when the Neurog2 gene is deleted. Remarkably, restoring Rnd2 expression in Neurog2- mutant neurons is sufficient to rescue their ability to migrate. Our results identify Rnd2 as a novel essential regulator of neuronal migration in the cerebral cortex and demonstrate that Rnd2 is a major effector of Neurog2 function in the promotion of migration. Thus, a proneural protein controls the complex cellular behaviour of cell migration through a remarkably direct pathway involving the transcriptional activation of a small GTP- binding protein.	[Heng, Julian Ik-Tsen; Nguyen, Laurent; Castro, Diogo S.; Zimmer, Celine; Wildner, Hendrik; Armant, Olivier; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England; [Skowronska-Krawczyk, Dorota; Matter, Jean-Marc] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Bedogni, Francesco; Hevner, Robert] Univ Washington, Harborview Med Ctr, Sch Med, Dept Pathol, Seattle, WA 98104 USA	MRC National Institute for Medical Research; University of Geneva; Harborview Medical Center; University of Washington; University of Washington Seattle	Guillemot, F (corresponding author), Natl Inst Med Res, Div Mol Neurobiol, Mill Hill, London NW7 1AA, England.	fguille@nimr.mrc.ac.uk	Guillemot, Francois/AAV-1482-2021; Castro, Diogo S/I-6217-2016	Castro, Diogo S/0000-0001-8178-9565; armant, olivier/0000-0001-7101-9209; Nguyen, Laurent/0000-0002-8560-3008; bedogni, francesco/0000-0002-6651-0041; Heng, Julian Ik-Tsen/0000-0002-0378-7078	Australian CJ Martin Fellowship [310616]; Medical Research Council career development fellowship; European Molecular Biology Organization; Medical Research Council career development fellowships; European Commission 6th Framework Programme for Research and Technological Development; Medical Research Council; Medical Research Council [MC_U117570528] Funding Source: researchfish; MRC [MC_U117570528] Funding Source: UKRI	Australian CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council career development fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Medical Research Council career development fellowships(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission 6th Framework Programme for Research and Technological Development(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to S. Wood for technical assistance in generating transgenic embryos. Wethank members of the Guillemot laboratory for suggestions on the manuscript, and F. Polleux (University of North Carolina) for the pNeuroD1 plasmid and D. Anderson (California Institute of Technology) for the anti- Neurog2 antibody. J.I.-T.H. is supported by an Australian CJ Martin Fellowship (grant number 310616) and a Medical Research Council career development fellowship (UK), L.N. and H.W. by postdoctoral fellowships awarded by the European Molecular Biology Organization, and D.S.C. and C.Z. by Medical Research Council career development fellowships ( UK). This work was supported by grants from the European Commission 6th Framework Programme for Research and Technological Development to F.G. and by institutional funds from the Medical Research Council ( UK).	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chardin P, 2003, CURR BIOL, V13, pR702, DOI 10.1016/j.cub.2003.08.042; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fode C, 2000, GENE DEV, V14, P67; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Kakimoto T, 2004, J BIOL CHEM, V279, P14104, DOI 10.1074/jbc.M312763200; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Nakamura K, 2006, NEUROSCI RES, V54, P149, DOI 10.1016/j.neures.2005.10.008; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; SEO S, 2007, EMBO J; Tabata H, 2003, J NEUROSCI, V23, P9996; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016	30	207	208	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					114	U82		10.1038/nature07198	http://dx.doi.org/10.1038/nature07198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18690213				2022-12-24	WOS:000258890200048
J	Ko, HC; Stoykovich, MP; Song, JZ; Malyarchuk, V; Choi, WM; Yu, CJ; Geddes, JB; Xiao, JL; Wang, SD; Huang, YG; Rogers, JA				Ko, Heung Cho; Stoykovich, Mark P.; Song, Jizhou; Malyarchuk, Viktor; Choi, Won Mook; Yu, Chang-Jae; Geddes, Joseph B., III; Xiao, Jianliang; Wang, Shuodao; Huang, Yonggang; Rogers, John A.			A hemispherical electronic eye camera based on compressible silicon optoelectronics	NATURE			English	Article							SPHERICAL SURFACES; SOFT LITHOGRAPHY; STAMP COLLAPSE; FABRICATION; MICROSTRUCTURES; ARRAYS	The human eye is a remarkable imaging device, with many attractive design features(1,2). Prominent among these is a hemispherical detector geometry, similar to that found in many other biological systems, that enables a wide field of view and low aberrations with simple, few-component imaging optics(3-5). This type of configuration is extremely difficult to achieve using established optoelectronics technologies, owing to the intrinsically planar nature of the patterning, deposition, etching, materials growth and doping methods that exist for fabricating such systems. Here we report strategies that avoid these limitations, and implement them to yield high-performance, hemispherical electronic eye cameras based on single-crystalline silicon. The approach uses wafer-scale optoelectronics formed in unusual, two-dimensionally compressible configurations and elastomeric transfer elements capable of transforming the planar layouts in which the systems are initially fabricated into hemispherical geometries for their final implementation. In a general sense, these methods, taken together with our theoretical analyses of their associated mechanics, provide practical routes for integrating well-developed planar device technologies onto the surfaces of complex curvilinear objects, suitable for diverse applications that cannot be addressed by conventional means.	[Ko, Heung Cho; Stoykovich, Mark P.; Choi, Won Mook; Yu, Chang-Jae; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Song, Jizhou; Rogers, John A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Malyarchuk, Viktor; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Geddes, Joseph B., III; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Xiao, Jianliang; Wang, Shuodao; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	y-huang@northwestern.edu; jrogers@uiuc.edu	huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Rogers, John/L-2798-2016; Wang, Shuodao/H-6014-2011; Song, Jizhou/B-1935-2008; Xiao, Jianliang/B-4535-2008	Wang, Shuodao/0000-0002-0481-7902; Song, Jizhou/0000-0003-2821-9429; 				Boncheva M, 2005, P NATL ACAD SCI USA, V102, P3924, DOI 10.1073/pnas.0500807102; Boncheva M, 2005, ADV MATER, V17, P553, DOI 10.1002/adma.200400940; Born M, 1999, PRINCIPLES OPTICS, V461; Childs WR, 2004, ADV MATER, V16, P1323, DOI 10.1002/adma.200400592; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Grayson TP, 2002, P SOC PHOTO-OPT INS, V4849, P269, DOI 10.1117/12.460757; Hsu PHI, 2004, IEEE T ELECTRON DEV, V51, P371, DOI 10.1109/TED.2003.822873; Hsu PI, 2004, J APPL PHYS, V95, P705, DOI 10.1063/1.1634370; Huang YGY, 2005, LANGMUIR, V21, P8058, DOI 10.1021/la0502185; JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Land MF, 2002, ANIMAL EYES; Lee KJ, 2005, ADV FUNCT MATER, V15, P557, DOI 10.1002/adfm.200400189; Lima O, 2007, J VAC SCI TECHNOL B, V25, P2412, DOI 10.1116/1.2804428; Miller SM, 2002, J VAC SCI TECHNOL B, V20, P2320, DOI 10.1116/1.1520554; Paul KE, 2003, ADV FUNCT MATER, V13, P259, DOI 10.1002/adfm.200304255; Radtke D, 2007, OPT EXPRESS, V15, P1167, DOI 10.1364/OE.15.001167; Ruchhoeft P, 2000, J VAC SCI TECHNOL B, V18, P3185, DOI 10.1116/1.1319842; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; Swain P, 2004, P SOC PHOTO-OPT INS, V5499, P281, DOI 10.1117/12.554840; WALTHER A, 1995, RAY WAVE THEORY LENS; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Zheng W, 2004, P NATL ACAD SCI USA, V101, P12814, DOI 10.1073/pnas.0404437101; Zhou W, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149513	25	981	1095	29	560	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					748	753		10.1038/nature07113	http://dx.doi.org/10.1038/nature07113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18685704				2022-12-24	WOS:000258228000041
J	Manzoni, S; Jackson, RB; Trofymow, JA; Porporato, A				Manzoni, Stefano; Jackson, Robert B.; Trofymow, John A.; Porporato, Amilcare			The global stoichiometry of litter nitrogen mineralization	SCIENCE			English	Article							OLD-GROWTH FOREST; BACTERIAL-GROWTH; CARBON; SOIL; DYNAMICS; DECOMPOSITION; TRANSFORMATIONS; IMMOBILIZATION; EFFICIENCY; PATTERNS	Plant residue decomposition and the nutrient release to the soil play a major role in global carbon and nutrient cycling. Although decomposition rates vary strongly with climate, nitrogen immobilization into litter and its release in mineral forms are mainly controlled by the initial chemical composition of the residues. We used a data set of similar to 2800 observations to show that these global nitrogen- release patterns can be explained by fundamental stoichiometric relationships of decomposer activity. We show how litter quality controls the transition from nitrogen accumulation into the litter to release and alters decomposers' respiration patterns. Our results suggest that decomposers lower their carbon- use efficiency to exploit residues with low initial nitrogen concentration, a strategy used broadly by bacteria and consumers across trophic levels.	[Manzoni, Stefano; Porporato, Amilcare] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; [Jackson, Robert B.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Jackson, Robert B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Trofymow, John A.] Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC V8Z 1M5, Canada	Duke University; Duke University; Duke University; Natural Resources Canada; Canadian Forest Service	Porporato, A (corresponding author), Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA.	amilcare@duke.edu	Manzoni, Stefano/C-5330-2009	Manzoni, Stefano/0000-0002-5960-5712; Jackson, Robert/0000-0001-8846-7147				ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Agren GI, 1996, THEORETICAL ECOSYSTE; BERG B, 1983, ECOLOGY, V64, P63, DOI 10.2307/1937329; Berg B., 2003, DECOMPOSITION PROCES; BOSATTA E, 1982, OIKOS, V39, P143, DOI 10.2307/3544478; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; HARMON ME, 2007, LONG TERM ECOLOGICAL, P23513; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Hart SC, 1999, ECOLOGY, V80, P1385, DOI 10.1890/0012-9658(1999)080[1385:NTIFTB]2.0.CO;2; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Krankina ON, 1999, CAN J FOREST RES, V29, P20, DOI 10.1139/cjfr-29-1-20; Manzoni S, 2007, SOIL BIOL BIOCHEM, V39, P1542, DOI 10.1016/j.soilbio.2007.01.006; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McGill W. B., 1981, Ecological Bulletins, P49; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; PANDIAN TJ, 1986, FRESHWATER BIOL, V16, P93, DOI 10.1111/j.1365-2427.1986.tb00950.x; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Seneviratne G, 2000, BIOL FERT SOILS, V31, P60, DOI 10.1007/s003740050624; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Swift M. J., 1979, STUDIES ECOLOGY, V5; TROFYMOW JA, 1998, BCX378 PAC FOR CTR; Waksman SA, 1924, J AGR SCI, V14, P555, DOI 10.1017/S0021859600003981	29	449	515	28	465	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					684	686		10.1126/science.1159792	http://dx.doi.org/10.1126/science.1159792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18669860				2022-12-24	WOS:000258077700042
J	Davis, S; Trapman, P; Leirs, H; Begon, M; Heesterbeek, JAP				Davis, S.; Trapman, P.; Leirs, H.; Begon, M.; Heesterbeek, J. A. P.			The abundance threshold for plague as a critical percolation phenomenon	NATURE			English	Article							WILDLIFE DISEASE; EPIDEMIC; NETWORKS; MODELS; POPULATIONS; PARAMETERS; INFECTION; SERENGETI; KAZAKSTAN; INVASION	Percolation theory is most commonly associated with the slow flow of liquid through a porous medium, with applications to the physical sciences(1). Epidemiological applications have been anticipated for disease systems where the host is a plant or volume of soil(2,3), and hence is fixed in space. However, no natural examples have been reported. The central question of interest in percolation theory(4), the possibility of an infinite connected cluster, corresponds in infectious disease to a positive probability of an epidemic. Archived records of plague ( infection with Yersinia pestis) in populations of great gerbils ( Rhombomys opimus) in Kazakhstan have been used to show that epizootics only occur when more than about 0.33 of the burrow systems built by the host are occupied by family groups(5). The underlying mechanism for this abundance threshold is unknown. Here we present evidence that it is a percolation threshold, which arises from the difference in scale between the movements that transport infectious fleas between family groups and the vast size of contiguous landscapes colonized by gerbils. Conventional theory predicts that abundance thresholds for the spread of infectious disease arise when transmission between hosts is density dependent such that the basic reproduction number ( R(0)) increases with abundance, attaining 1 at the threshold. Percolation thresholds, however, are separate, spatially explicit thresholds that indicate long- range connectivity in a system and do not coincide with R(0) = 1. Abundance thresholds are the theoretical basis for attempts to manage infectious disease by reducing the abundance of susceptibles, including vaccination and the culling of wildlife(6-8). This first natural example of a percolation threshold in a disease system invites a re- appraisal of other invasion thresholds, such as those for epidemic viral infections in African lions ( Panthera leo), and of other disease systems such as bovine tuberculosis ( caused by Mycobacterium bovis) in badgers ( Meles meles).	[Davis, S.; Heesterbeek, J. A. P.] Univ Utrecht, Fac Vet Med, NL-3584 CL Utrecht, Netherlands; [Trapman, P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Leirs, H.] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Leirs, H.] Univ Aarhus, Danish Pest Infestat Lab, Fac Agr Sci, Dept Integrated Pest Management, DK-2800 Lyngby, Denmark; [Begon, M.] Univ Liverpool, Host Parasite Biol Res Grp, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Antwerp; Aarhus University; University of Liverpool	Davis, S (corresponding author), Univ Utrecht, Fac Vet Med, Yalelaan 7, NL-3584 CL Utrecht, Netherlands.	S.A.Davis@uu.nl	Leirs, Herwig/B-8197-2008	Leirs, Herwig/0000-0002-7612-5024; Heesterbeek, Hans/0000-0001-8537-6418; Begon, Mike/0000-0003-1715-5327	Natural Environment Research Council [NE/E007899/1] Funding Source: researchfish; NERC [NE/E007899/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Artois M, 2001, VET J, V162, P141, DOI 10.1053/tvjl.2001.0601; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Begon M, 2006, EMERG INFECT DIS, V12, P268; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2007, J R SOC INTERFACE, V4, P649, DOI 10.1098/rsif.2006.0208; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grimmett G. R., 1999, PERCOLATION; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; KESTEN H, 1980, COMMUN MATH PHYS, V74, P41, DOI 10.1007/BF01197577; Korneyev G.A., 1968, QUANTITATIVE CHARACT; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Otten W, 2004, NEW PHYTOL, V163, P125, DOI 10.1111/j.1469-8137.2004.01086.x; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; RUDENCHIK Yu. V., 1967, ZOOL ZH, V46, P117; SAHIMI M, 1994, APPL PERCOLATION THE; TRAPMAN P, 2006, THESIS VRIJE U AMSTE; Trapman P, 2007, THEOR POPUL BIOL, V71, P160, DOI 10.1016/j.tpb.2006.11.002	27	133	133	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2008	454	7204					634	637		10.1038/nature07053	http://dx.doi.org/10.1038/nature07053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18668107	Green Published			2022-12-24	WOS:000258026500046
J	Kadaba, NS; Kaiser, JT; Johnson, E; Lee, A; Rees, DC				Kadaba, Neena S.; Kaiser, Jens T.; Johnson, Eric; Lee, Allen; Rees, Douglas C.			The high-affinity E-coli methionine ABC transporter: Structure and allosteric regulation	SCIENCE			English	Article							BINDING-PROTEIN; ATP-BINDING; SUBUNIT INTERACTIONS; MEMBRANE-PROTEINS; ACT DOMAIN; ARCHITECTURE; SYSTEMS; SUPERFAMILY; PERMEASES; MECHANISM	The crystal structure of the high- affinity Escherichia coli MetNI methionine uptake transporter, a ember of the adenosine triphosphate ( ATP)- binding cassette ( ABC) family, has been solved to 3.7 angstrom resolution. The overall architecture of MetNI reveals two copies of the adenosine triphosphatase ( ATPase) MetN in complex with two copies of the transmembrane domain MetI, with the transporter adopting an inward- facing conformation exhibiting widely separated nucleotide binding domains. Each MetI subunit is organized around a core of five transmembrane helices that correspond to a subset of the helices observed in the larger membrane- spanning subunits of the molybdate ( ModBC) and maltose ( MalFGK) ABC transporters. In addition to the conserved nucleotide binding domain of the ABC family, MetN contains a carboxyl- terminal extension with a ferredoxin- like fold previously assigned to a conserved family of regulatory ligand- binding domains. These domains separate the nucleotide binding domains and would interfere with their association required for ATP binding and hydrolysis. Methionine binds to the dimerized carboxyl- terminal domain and is shown to inhibit ATPase activity. These observations are consistent with an allosteric regulatory mechanism operating at the level of transport activity, where increased intracellular levels of the transported ligand stabilize an inward- facing, ATPase- inactive state of MetNI to inhibit further ligand translocation into the cell.	[Kadaba, Neena S.; Kaiser, Jens T.; Johnson, Eric; Lee, Allen; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kadaba, Neena S.; Kaiser, Jens T.; Johnson, Eric; Lee, Allen; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu		Johnson, Eric/0000-0002-2909-865X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045162, R01GM045162] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM045162-18, R01 GM045162, GM45162, R37 GM045162] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I.B., 2003, ABC PROTEINS BACTERI, P647; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; KADNER RJ, 1977, J BACTERIOL, V129, P207, DOI 10.1128/JB.129.1.207-216.1977; KADNER RJ, 1975, J BACTERIOL, V122, P110, DOI 10.1128/JB.122.1.110-119.1975; KADNER RJ, 1974, J BACTERIOL, V117, P232, DOI 10.1128/JB.117.1.232-241.1974; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Neijssel OM, 1996, ESCHERICHIA COLI SAL, V2, P1683; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stouthamer A. H., 1979, INT REV BIOCHEM, V21, P1; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	41	164	170	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 11	2008	321	5886					250	253		10.1126/science.1157987	http://dx.doi.org/10.1126/science.1157987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621668	Green Accepted			2022-12-24	WOS:000257512900040
J	Wilson, DP; Law, MG; Grulich, AE; Cooper, DA; Kaldor, JM				Wilson, David P.; Law, Matthew G.; Grulich, Andrew E.; Cooper, David A.; Kaldor, John M.			Relation between HIV viral load and infectiousness: a model-based analysis	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; REDUCING HETEROSEXUAL TRANSMISSION; SEXUAL-BEHAVIOR; RISK-FACTORS; PREGNANT-WOMEN; COITAL ACT; MEN; PREVALENCE; COUPLES	Background A consensus statement released on behalf of the Swiss Federal Commission for HIV/AIDS suggests that people receiving effective antiretroviral therapy-ie, those with undetectable plasma HIV RNA (<40 copies per mL)-are sexually non-infectious. We analysed the implications of this statement at a population level. Methods We used a simple mathematical model to estimate the cumulative risk of HIV transmission from effectively treated HIV-infected patients (HIV RNA <10 copies per mL) over a prolonged period. We investigated the risk of unprotected sexual transmission per act and cumulatively over many exposures, within couples initially discordant for HIV status. Findings Assuming that each couple had 100 sexual encounters per year, the cumulative probability of transmission to the serodiscordant partner each year is 0.0022 (uncertainty bounds 0.0008-0.0058) for female-to-male transmission, 0.0043 (0.0016-0.0115) for male-to-female transmission, and 0.043 (0.0159-0.1097) for male-to-male transmission. In a population of 10000 serodiscordant partnerships, over 10 years the expected number of seroconversions would be 215 (80-564) for female-to-male transmission, 425 (159-1096) for male-to-female transmission, and 3524 (1477-6871) for male-to-male transmission, corresponding to an increase in incidence of four times compared with incidence under current rates of condom use. Interpretation Our analyses suggest that the risk of HIV transmission in heterosexual partnerships in the presence of effective treatment is low but non-zero and that the transmission risk in male homosexual partnerships is high over repeated exposures. If the claim of non-infectiousness in effectively treated patients was widely accepted, and condom use subsequently declined, then there is the potential for substantial increases in HIV incidence. Funding Australian Research Council.	[Wilson, David P.; Law, Matthew G.; Grulich, Andrew E.; Cooper, David A.; Kaldor, John M.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Wilson, DP (corresponding author), Level 2,376 Victoria St, Darlinghurst, NSW 2010, Australia.	Dwilson@nchecr.unsw.edu.au	Wilson, David P/G-4614-2013; Kaldor, John M/D-4545-2011	Law, Matthew/0000-0002-3540-8837				Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; BLOWER SM, 1993, J ACQ IMMUN DEF SYND, V6, P1347; Burris S, 2007, ARIZONA STATE LAW J; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Dougan S, 2007, SEX TRANSM INFECT, V83, P120, DOI 10.1136/sti.2006.021428; Dukers NHTM, 2002, AIDS, V16, pF19, DOI 10.1097/00002030-200207050-00001; ELLIOT R, 1996, CRIMINAL LAW HIV AID; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Fitch JT, 2002, SEX TRANSM DIS, V29, P811, DOI 10.1097/00007435-200212000-00013; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GRIERSON J, 2006, MONOGRAPH SERIES LAT, V60; GRULICH AE, 2007, SEX HEALTH, V5, P113; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Jin FY, 2007, JAIDS-J ACQ IMM DEF, V46, P245, DOI 10.1097/QAI.0b013e3181565db5; Kalichman SC, 2008, SEX TRANSM DIS, V35, P55, DOI 10.1097/OLQ.0b013e318141fe9b; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lazzarini Z, 2002, J LAW MED ETHICS, V30, P239, DOI 10.1111/j.1748-720X.2002.tb00390.x; LeGoff J, 2007, INT J STD AIDS, V18, P593, DOI 10.1258/095646207781568457; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MCCUSKER J, 1988, AM J PUBLIC HEALTH, V78, P462, DOI 10.2105/AJPH.78.4.462; *NAT CTR HIV SOC R, 2006, ANN REP TRENDS BEH; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Phillips AN, 2004, AIDS, V18, P1795, DOI 10.1097/00002030-200409030-00008; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rangsin R, 2004, JAIDS-J ACQ IMM DEF, V36, P622, DOI 10.1097/00126334-200405010-00011; Read TRH, 2007, SEX HEALTH, V4, P35, DOI 10.1071/SH06043; Rodriguez RJ, 1997, J ACQ IMMUN DEF SYND, V15, P49, DOI 10.1097/00042560-199705010-00008; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Smith CJ, 2005, J INFECT DIS, V192, P1387, DOI 10.1086/466534; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; *UK COLL GROUP HIV, 2005, MAPP ISS HIV OTH SEX; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Van de Ven P, 2005, AIDS, V19, P179, DOI 10.1097/00002030-200501280-00010; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WELLER SC, 1993, SOC SCI MED, V36, P1653; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105; Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103; Wilson DP, 2008, MATH MODELS INVESTIG; Yahya-Malima KI, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-75; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	60	260	268	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2008	372	9635					314	320		10.1016/S0140-6736(08)61115-0	http://dx.doi.org/10.1016/S0140-6736(08)61115-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657710				2022-12-24	WOS:000258042800032
J	Budanov, AV; Karin, M				Budanov, Andrei V.; Karin, Michael			p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling	CELL			English	Article							ACTIVATED PROTEIN-KINASE; S6 KINASE; TUBEROUS-SCLEROSIS; TUMOR-SUPPRESSOR; CELL-GROWTH; MAMMALIAN TARGET; RAPAMYCIN; TRANSLATION; PATHWAY; TSC2	The tumor suppressor p53 is activated upon genotoxic and oxidative stress and in turn inhibits cell proliferation and growth through induction of specific target genes. Cell growth is positively regulated by mTOR, whose activity is inhibited by the TSC1: TSC2 complex. Although genotoxic stress has been suggested to inhibit mTOR via p53-mediated activation of mTOR inhibitors, the precise mechanism of this link was unknown. We now demonstrate that the products of two p53 target genes, Sestrin1 and Sestrin2, activate the AMP-responsive protein kinase ( AMPK) and target it to phosphorylate TSC2 and stimulate its GAP activity, thereby inhibiting mTOR. Correspondingly, Sestrin2-deficient mice fail to inhibit mTOR signaling upon genotoxic challenge. Sestrin1 and Sestrin2 therefore provide an important link between genotoxic stress, p53 and the mTOR signaling pathway.	[Budanov, Andrei V.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Budanov, Andrei V/HGD-5487-2022	Budanov, Andrei V/0000-0002-7943-1000	Tobacco Related Disease Research Program TRDRPW [15RT-0197]; National Institute of Environmental Health Science [5RO1 ES06376, 5R37 ES04151]; Superfund Basic Research Program [5P42 ES010337]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R37ES004151, R01ES006376] Funding Source: NIH RePORTER	Tobacco Related Disease Research Program TRDRPW(University of California System); National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Superfund Basic Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank D.J. Kwiatkowski (Department of Medicine, Brigham and Women's Hospital, Harvard Medical School) for Tsc2<SUP>-/-</SUP> and Tsc2<SUP>+/+</SUP> fibroblasts, E. Feinstein (Quark Biotech) for Sesn2 antibodies, N. Sonenberg (McGill University), K. L. Guan (UCSD), P. M. Chumakov (Lerner Research Institute, The Cleveland Clinic Foundation), J. Blenis (Department of Cell Biology, Harvard Medical School), G. Thomas (Genome Research Institute, University of Cincinnati), N. Hay (Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago), M. J. Birnbaum (Howard Hughes Medical Institute and Department of Medicine, University of Pennsylvania School of Medicine), S. W. Lowe ( Cold Spring Harbor Laboratory), and R. J. Shaw for gifts of plasmids and antibodies. We also thank W. E. Naugler for protein and cDNA samples from DEN-treated mice, J. Wang for p53 knockout mice, P. H. Tseng for help with gel filtration experiments, and V. Temkin for help with fluorescent-activated cell sorter analysis. Work was supported by grants from the Tobacco Related Disease Research Program (TRDRPW; 15RT-0197), the National Institute of Environmental Health Science (5RO1 ES06376 and 5R37 ES04151), and the Superfund Basic Research Program (5P42 ES010337). A. B. was supported by a postdoctoral fellowship from the Tobacco-Related Disease Research Program.	Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; BUHLER R, 1992, EUR J BIOCHEM, V204, P407, DOI 10.1111/j.1432-1033.1992.tb16650.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Soliman GA, 2005, CURR OPIN LIPIDOL, V16, P317, DOI 10.1097/01.mol.0000169352.35642.06; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thomas GV, 2006, CURR OPIN GENET DEV, V16, P78, DOI 10.1016/j.gde.2005.12.003; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	953	1004	2	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					451	460		10.1016/j.cell.2008.06.028	http://dx.doi.org/10.1016/j.cell.2008.06.028			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692468	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000258665500018
J	Lape, R; Colquhoun, D; Sivilotti, LG				Lape, Remigijus; Colquhoun, David; Sivilotti, Lucia G.			On the nature of partial agonism in the nicotinic receptor superfamily	NATURE			English	Article							GLYCINE RECEPTORS; ION CHANNELS; END-PLATE; ACETYLCHOLINE; BINDING; ACTIVATION; MECHANISM; CURRENTS	Partial agonists are ligands that bind to receptors but produce only a small maximum response even at concentrations where all receptors are occupied. In the case of ligand-activated ion channels, it has been supposed since 1957 that partial agonists evoke a small response because they are inefficient at eliciting the change of conformation between shut and open states of the channel. We have investigated partial agonists for two members of the nicotinic superfamily - the muscle nicotinic acetylcholine receptor and the glycine receptor - and find that the open-shut reaction is similar for both full and partial agonists, but the response to partial agonists is limited by an earlier conformation change ('flipping') that takes place while the channel is still shut. This has implications for the interpretation of structural studies, and in the future, for the design of partial agonists for therapeutic use.	[Lape, Remigijus; Colquhoun, David; Sivilotti, Lucia G.] UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, Dept Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England.	d.colquhoun@ucl.ac.uk	Colquhoun, David/C-1664-2008; Sivilotti, Lucia/D-8919-2011; Lape, Remigijus/C-6175-2008	Colquhoun, David/0000-0002-4263-017X; Sivilotti, Lucia/0000-0003-2510-8424; Lape, Remigijus/0000-0002-6604-0828	MRC [G0400869] Funding Source: UKRI; Medical Research Council [G0400869, G0400869(72542)] Funding Source: Medline; Wellcome Trust [074491] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ADAMS PR, 1977, J PHYSIOL-LONDON, V268, P291, DOI 10.1113/jphysiol.1977.sp011858; Andersen OS, 1999, J GEN PHYSIOL, V114, P589; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Colquhoun D, 2003, J PHYSIOL-LONDON, V547, P699, DOI 10.1113/jphysiol.2002.034165; COLQUHOUN D, 2003, DRUG DISCOVERY DRUG, P357; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; GARDNER P, 1984, NATURE, V309, P160, DOI 10.1038/309160a0; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Han NLR, 2004, J BIOL CHEM, V279, P19559, DOI 10.1074/jbc.M400548200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hatton CJ, 2003, J PHYSIOL-LONDON, V547, P729, DOI 10.1113/jphysiol.2002.034173; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; WYMAN J, 1951, J POLYM SCI, V7, P499, DOI 10.1002/pol.1951.120070506; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	26	270	273	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					722	U56		10.1038/nature07139	http://dx.doi.org/10.1038/nature07139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18633353	Green Accepted			2022-12-24	WOS:000258228000036
J	Guang, S; Bochner, AF; Pavelec, DM; Burkhart, KB; Harding, S; Lachowiec, J; Kennedy, S				Guang, Shouhong; Bochner, Aaron F.; Pavelec, Derek M.; Burkhart, Kirk B.; Harding, Sandra; Lachowiec, Jennifer; Kennedy, Scott			An Argonaute transports siRNAs from the cytoplasm to the nucleus	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; RNA INTERFERENCE; PATHWAYS; REVEALS; TARGET; LIN-15; DCR-1	Ribonucleoprotein complexes consisting of Argonaute- like proteins and small regulatory RNAs function in a wide range of biological processes. Many of these small regulatory RNAs are predicted to act, at least in part, within the nucleus. We conducted a genetic screen to identify factors essential for RNA interference ( RNAi) in nuclei of Caenorhabditis elegans and identified the Argonaute protein NRDE- 3. In the absence of small interfering RNAs ( siRNAs), NRDE- 3 resides in the cytoplasm. NRDE- 3 binds siRNAs generated by RNA- dependent RNA polymerases acting on messenger RNA templates in the cytoplasm and redistributes to the nucleus. Nuclear redistribution of NRDE- 3 requires a functional nuclear localization signal, is required for nuclear RNAi, and results in NRDE- 3 association with nuclear- localized nascent transcripts. Thus, specific Argonaute proteins can transport specific classes of small regulatory RNAs to distinct cellular compartments to regulate gene expression.	[Guang, Shouhong; Bochner, Aaron F.; Pavelec, Derek M.; Burkhart, Kirk B.; Harding, Sandra; Lachowiec, Jennifer; Kennedy, Scott] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Bochner, Aaron F.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Pavelec, Derek M.] Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Burkhart, Kirk B.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, S (corresponding author), Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.	sgkennedy@wisc.edu	guang, shouhong/F-1127-2010; Lachowiec, Jennifer/ABF-5182-2021	Lachowiec, Jennifer/0000-0003-2962-6448; Kennedy, Scott/0000-0002-7974-8155	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133, R01GM088289, R01GM076619] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007133-25, R01 GM076619, T32 GM007133-26, R01 GM076619-03, T32 GM007133-24, T32 GM007133-27, R01 GM076619-02, R01 GM088289, T32 GM007133, R01 GM088289-01, R01 GM076619-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Bosher JM, 1999, GENETICS, V153, P1245; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; CLARK SG, 1994, GENETICS, V137, P987; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	16	239	273	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					537	541		10.1126/science.1157647	http://dx.doi.org/10.1126/science.1157647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653886	Green Accepted			2022-12-24	WOS:000257888900040
J	Lee, I; Schindelin, H				Lee, Imsang; Schindelin, Hermann			Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes	CELL			English	Article							CRYSTAL-STRUCTURE; PROTEIN-ACTIVATION; MECHANISM; COMPLEX; NEDD8; E2; E1; IDENTIFICATION; HETERODIMER; MUTAGENESIS	Ubiquitin (Ub) and ubiquitin-like proteins (Ubls) are conjugated to their targets by specific cascades involving three classes of enzymes, E1, E2, and E3. Each E1 adenylates the C terminus of its cognate Ubl, forms a E1 similar to Ubl thioester intermediate, and ultimately generates a thioester-linked E2 similar to Ubl product. We have determined the crystal structure of yeast Uba1, revealing a modular architecture with individual domains primarily mediating these specific activities. The negatively charged C-terminal ubiquitin-fold domain (UFD) is primed for binding of E2s and recognizes their positively charged first a helix via electrostatic interactions. In addition, a mobile loop from the domain harboring the E1 catalytic cysteine contributes to E2 binding. Significant, experimentally observed motions in the UFD around a hinge in the linker connecting this domain to the rest of the enzyme suggest a conformation-dependent mechanism for the transthioesterification function of Uba1; however, this mechanism clearly differs from that of other E1 enzymes.	[Lee, Imsang; Schindelin, Hermann] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Schindelin, Hermann] Univ Wurzburg, Inst Biol Struct, D-97078 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg; University of Wurzburg	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	hermann.schindelin@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019		NIDDK NIH HHS [DK54835] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	37	177	183	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					268	278		10.1016/j.cell.2008.05.046	http://dx.doi.org/10.1016/j.cell.2008.05.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662542	Bronze			2022-12-24	WOS:000257891700016
J	Obayashi, E; Yoshida, H; Kawai, F; Shibayama, N; Kawaguchi, A; Nagata, K; Tame, JRH; Park, SY				Obayashi, Eiji; Yoshida, Hisashi; Kawai, Fumihiro; Shibayama, Naoya; Kawaguchi, Atsushi; Nagata, Kyosuke; Tame, Jeremy R. H.; Park, Sam-Yong			The structural basis for an essential subunit interaction in influenza virus RNA polymerase	NATURE			English	Article							AMINO-ACID MUTATION; A VIRUS; PA SUBUNIT; CAP-BINDING; PROTEIN; REPLICATION; COMPLEX; DESIGN; TRANSCRIPTION; INHIBITORS	Influenza A virus is a major human and animal pathogen with the potential to cause catastrophic loss of life. The virus reproduces rapidly, mutates frequently and occasionally crosses species barriers. The recent emergence in Asia of avian influenza related to highly pathogenic forms of the human virus has highlighted the urgent need for new effective treatments(1). Here we demonstrate the importance to viral replication of a subunit interface in the viral RNA polymerase, thereby providing a new set of potential drug binding sites entirely independent of surface antigen type. No current medication targets this heterotrimeric polymerase complex. All three subunits, PB1, PB2 and PA, are required for both transcription and replication(2-4). PB1 carries the polymerase active site, PB2 includes the capped- RNA recognition domain, and PA is involved in assembly of the functional complex(5-7), but so far very little structural information has been reported for any of them(8-11). We describe the crystal structure of a large fragment of one subunit ( PA) of influenza A RNA polymerase bound to a fragment of another subunit ( PB1). The carboxy- terminal domain of PA forms a novel fold, and forms a deep, highly hydrophobic groove into which the amino- terminal residues of PB1 can fit by forming a 3(10) helix.	[Obayashi, Eiji; Yoshida, Hisashi; Kawai, Fumihiro; Tame, Jeremy R. H.; Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Shibayama, Naoya] Jichi Med Univ, Dept Physiol, Div Biophys, Shimotsuke, Tochigi 3290498, Japan; [Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Dept Infect Biol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan	Yokohama City University; Jichi Medical University; University of Tsukuba; University of Tsukuba	Park, SY (corresponding author), Yokohama City Univ, Prot Design Lab, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	park@tsurumi.yokohama-cu.ac.jp	Kawai, Fumihiro/O-2712-2018	Kawaguchi, Atsushi/0000-0002-5485-1578; Shibayama, Naoya/0000-0002-2208-1126; Yoshida, Hisashi/0000-0003-0374-2600; Kawai, Fumihiro/0000-0003-0909-0789; Tame, Jeremy/0000-0002-9341-7280	ISS applied research partnership program	ISS applied research partnership program	We thank the staff at the SPring-8 BL41XU and Photon Factory BL5A beamlines for assistance with data collection, and M. Yao and Y. Zhou for help with data processing. This work was supported in part by the ISS applied research partnership program (S.-Y.P.).	[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAAM J, 1983, CELL, V34, P609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; Elton D, 2005, CURRENT TOPICS INFLU, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; HORISBERGER MA, 1980, VIROLOGY, V107, P302, DOI 10.1016/0042-6822(80)90296-2; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu Y, 2007, CURR MED CHEM, V14, P2872, DOI 10.2174/092986707782360024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	42	212	234	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1127	U57		10.1038/nature07225	http://dx.doi.org/10.1038/nature07225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18660801				2022-12-24	WOS:000258719600040
J	Peters, NC; Egen, JG; Secundino, N; Debrabant, A; Kimblin, N; Kamhawi, S; Lawyer, P; Fay, MP; Germain, RN; Sacks, D				Peters, Nathan C.; Egen, Jackson G.; Secundino, Nagila; Debrabant, Alain; Kimblin, Nicola; Kamhawi, Shaden; Lawyer, Phillip; Fay, Michael P.; Germain, Ronald N.; Sacks, David			In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies	SCIENCE			English	Article							MAJOR INFECTION; MICE; CELLS; MACROPHAGE; APOPTOSIS; SKIN; GRANULOCYTES; RECRUITMENT; MODULATION; CLEARANCE	Infection with the obligate intracellular protozoan Leishmania is thought to be initiated by direct parasitization of macrophages, but the early events following transmission to the skin by vector sand flies have been difficult to examine directly. Using dynamic intravital microscopy and flow cytometry, we observed a rapid and sustained neutrophilic infiltrate at localized sand fly bite sites. Invading neutrophils efficiently captured Leishmania major ( L. m.) parasites early after sand fly transmission or needle inoculation, but phagocytosed L. m. remained viable and infected neutrophils efficiently initiated infection. Furthermore, neutrophil depletion reduced, rather than enhanced, the ability of parasites to establish productive infections. Thus, L. m. appears to have evolved to both evade and exploit the innate host response to sand fly bite in order to establish and promote disease.	[Egen, Jackson G.; Germain, Ronald N.] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Peters, Nathan C.; Secundino, Nagila; Kimblin, Nicola; Kamhawi, Shaden; Lawyer, Phillip; Sacks, David] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; [Debrabant, Alain] US FDA, Lab Bacterial Parasit & Unconvent Agents, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Fay, Michael P.] NIAID, Biostat Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Egen, JG (corresponding author), NIAID, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA.	jegen@niaid.nih.gov; dsacks@nih.gov	Okpebholo, Love/A-8163-2010; Germain, Ronald N./Z-1945-2019; Secundino, Nagila/AAM-4553-2020; Germain, Ronald/ABE-7090-2020; Peters, Nathan/AAW-8289-2020; Fay, Michael P/A-2974-2008	Peters, Nathan/0000-0002-2548-9581; Fay, Michael P/0000-0002-8643-9625; Egen, Jackson/0000-0003-2053-0837	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000494, ZIAAI000256, ZIAAI001034] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000256-26, Z01 AI000494-21] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Belkaid Y, 2000, P NATL ACAD SCI USA, V97, P6704, DOI 10.1073/pnas.97.12.6704; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Chen L, 2005, PARASITOL INT, V54, P109, DOI 10.1016/j.parint.2005.02.001; Faust N, 2000, BLOOD, V96, P719; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Ribeiro-Gomes FL, 2006, PARASITOLOGY, V132, pS61, DOI 10.1017/S0031182006000862; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; Teixeira CR, 2005, J IMMUNOL, V175, P8346, DOI 10.4049/jimmunol.175.12.8346; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005	26	571	581	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					970	974		10.1126/science.1159194	http://dx.doi.org/10.1126/science.1159194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18703742	Green Accepted			2022-12-24	WOS:000258436700041
J	Faham, S; Watanabe, A; Besserer, GM; Cascio, D; Specht, A; Hirayama, BA; Wright, EM; Abramson, J				Faham, Salem; Watanabe, Akira; Besserer, Gabriel Mercado; Cascio, Duilio; Specht, Alexandre; Hirayama, Bruce A.; Wright, Ernest M.; Abramson, Jeff			The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na(+)/sugar symport	SCIENCE			English	Article							NA+/GLUCOSE COTRANSPORTER SGLT1; X-RAY STRUCTURE; ESCHERICHIA-COLI; NA+/I-SYMPORTER; MOLECULAR CHARACTERIZATION; CONFORMATIONAL-CHANGES; MEMBRANE; BINDING; SELECTIVITY; PROTEINS	Membrane transporters that use energy stored in sodium gradients to drive nutrients into cells constitute a major class of proteins. We report the crystal structure of a member of the solute sodium symporters (SSS), the Vibrio parahaemolyticus sodium/galactose symporter (vSGLT). The similar to 3.0 angstrom structure contains 14 transmembrane (TM) helices in an inward-facing conformation with a core structure of inverted repeats of 5 TM helices (TM2 to TM6 and TM7 to TM11). Galactose is bound in the center of the core, occluded from the outside solutions by hydrophobic residues. Surprisingly, the architecture of the core is similar to that of the leucine transporter (LeuT) from a different gene family. Modeling the outward-facing conformation based on the LeuT structure, in conjunction with biophysical data, provides insight into structural rearrangements for active transport.	[Faham, Salem; Watanabe, Akira; Besserer, Gabriel Mercado; Hirayama, Bruce A.; Wright, Ernest M.; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Cascio, Duilio] Univ Calif Los Angeles, UCLA Dept Energy Inst Genom & Proteom, Los Angeles, CA 90095 USA; [Specht, Alexandre] Univ Strasbourg 1, Chim Bioorgan Lab, CNRS, Fac Pharm,UMR 7175, F-67401 Illkirch Graffenstaden, France	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wright, EM (corresponding author), Univ Calif Los Angeles, Dept Physiol, David Geffen Sch Med, Los Angeles, CA 90095 USA.	ewright@mednet.ucla.edu; jabramson@mednet.ucla.edu	SPECHT, Alexandre/K-9736-2018	SPECHT, Alexandre/0000-0001-5056-5278	NIDDK NIH HHS [R01 DK019567, DK19567, DK44602, R01 DK044602] Funding Source: Medline; NIGMS NIH HHS [GM07844, R01 GM078844-01, R01 GM078844, R01 GM078844-02, R01 GM078844-03] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019567, R01DK044602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; CRANE RK, 1961, MEMBRANE TRANSPORT M, P439; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; EDWAR N, 2006, CURR PROTOC BIOINF S, V15; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; Panayotova-Heiermann M, 1998, BIOCHEMISTRY-US, V37, P10522, DOI 10.1021/bi9800395; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Reed-Tsur MD, 2008, ENDOCRINOLOGY, V149, P3077, DOI 10.1210/en.2008-0027; SCHULTZ SG, 1970, PHYSIOL REV, V50, P637, DOI 10.1152/physrev.1970.50.4.637; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 2006, BIOCHEMISTRY-US, V45, P1470, DOI 10.1021/bi052160z; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Veenstra M, 2004, BIOCHEMISTRY-US, V43, P3620, DOI 10.1021/bi0357210; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2004, PHYSIOLOGY, V19, P370, DOI 10.1152/physiol.00026.2004; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549	33	413	417	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					810	814		10.1126/science.1160406	http://dx.doi.org/10.1126/science.1160406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18599740	Green Accepted			2022-12-24	WOS:000258261000038
J	Umbach, JL; Kramer, MF; Jurak, I; Karnowski, HW; Coen, DM; Cullen, BR				Umbach, Jennifer Lin; Kramer, Martha F.; Jurak, Igor; Karnowski, Heather W.; Coen, Donald M.; Cullen, Bryan R.			MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs	NATURE			English	Article							HERPES-SIMPLEX-VIRUS; READING-FRAME-P; TYPE-1 LATENCY; NEURONAL SURVIVAL; GENE-EXPRESSION; SENSORY NEURONS; TRANSCRIPT; REACTIVATION; CELLS; ICP0	Herpesviruses are characterized by their ability to maintain lifelong latent infections in their animal hosts. However, the mechanisms that allow establishment and maintenance of the latent state remain poorly understood. Herpes simplex virus 1 (HSV-1) establishes latency in neurons of sensory ganglia, where the only abundant viral gene product is a non-coding RNA, the latency associated transcript (LAT)(1,2). Here we show that LAT functions as a primary microRNA (miRNA) precursor that encodes four distinct miRNAs in HSV-1 infected cells. One of these miRNAs, miR-H2-3p, is transcribed in an antisense orientation to ICP0-a viral immediate-early transcriptional activator that is important for productive HSV-1 replication and thought to have a role in reactivation from latency(3). We show that miR-H2-3p is able to reduce ICP0 protein expression, but does not significantly affect ICP0 messenger RNA levels. We also identified a fifth HSV-1 miRNA in latently infected trigeminal ganglia, miR-H6, which derives from a previously unknown transcript distinct from LAT. miR-H6 shows extended seed complementarity to the mRNA encoding a second HSV-1 transcription factor, ICP4, and inhibits expression of ICP4, which is required for expression of most HSV-1 genes during productive infection(4). These results may explain the reported ability of LAT to promote latency(5-9). Thus, HSV-1 expresses at least two primary miRNA precursors in latently infected neurons that may facilitate the establishment and maintenance of viral latency by post-transcriptionally regulating viral gene expression.	[Umbach, Jennifer Lin; Karnowski, Heather W.; Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Umbach, Jennifer Lin; Karnowski, Heather W.; Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA; [Kramer, Martha F.; Jurak, Igor; Coen, Donald M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Duke University; Duke University; Harvard University; Harvard Medical School	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	culle002@mc.duke.edu	Jurak, Igor/Q-7042-2018	Jurak, Igor/0000-0002-7271-2643	NCI NIH HHS [T32 CA009111] Funding Source: Medline; NIAID NIH HHS [R01 AI067968-02, R01 AI067968-03, R01 AI067968] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067968] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvira MR, 1999, J VIROL, V73, P3866, DOI 10.1128/JVI.73.5.3866-3876.1999; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloom DC, 2004, INT REV IMMUNOL, V23, P187, DOI 10.1080/08830180490265592; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SH, 2002, J VIROL, V76, P4764, DOI 10.1128/JVI.76.10.4764-4772.2002; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; COEN DM, 1985, J VIROL, V53, P477, DOI 10.1128/JVI.53.2.477-488.1985; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; FARRELL MJ, 1991, P NATL ACAD SCI USA, V88, P790, DOI 10.1073/pnas.88.3.790; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; Garber DA, 1997, J VIROL, V71, P5885, DOI 10.1128/JVI.71.8.5885-5893.1997; GOLDIN AL, 1981, J VIROL, V38, P50, DOI 10.1128/JVI.38.1.50-58.1981; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Kang W, 2006, VIROLOGY, V356, P106, DOI 10.1016/j.virol.2006.07.033; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Perng GC, 2002, J VIROL, V76, P8003, DOI 10.1128/JVI.76.16.8003-8010.2002; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; PRESTON CM, 1979, J VIROL, V29, P275, DOI 10.1128/JVI.29.1.275-284.1979; Randall G, 1997, J VIROL, V71, P7750, DOI 10.1128/JVI.71.10.7750-7757.1997; SAWTELL NM, 1992, J VIROL, V66, P2157, DOI 10.1128/JVI.66.4.2157-2169.1992; Sawtell NM, 1997, J VIROL, V71, P5423, DOI 10.1128/JVI.71.7.5423-5431.1997; SEKULOVICH RE, 1988, J VIROL, V62, P4510, DOI 10.1128/JVI.62.12.4510-4522.1988; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 2003, J VIROL, V77, P12319, DOI 10.1128/JVI.77.22.12319-12330.2003; Thompson RL, 1997, J VIROL, V71, P5432, DOI 10.1128/JVI.71.7.5432-5440.1997; Thompson RL, 2001, J VIROL, V75, P6660, DOI 10.1128/JVI.75.14.6660-6675.2001; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; YEH L, 1993, J VIROL, V67, P7373, DOI 10.1128/JVI.67.12.7373-7382.1993	37	489	540	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					780	U108		10.1038/nature07103	http://dx.doi.org/10.1038/nature07103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18596690	Green Accepted			2022-12-24	WOS:000258228000048
J	Park, JH; Scheerer, P; Hofmann, KP; Choe, HW; Ernst, OP				Park, Jung Hee; Scheerer, Patrick; Hofmann, Klaus Peter; Choe, Hui-Woog; Ernst, Oliver Peter			Crystal structure of the ligand-free G-protein-coupled receptor opsin	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; TRANSMEMBRANE HELICES; METARHODOPSIN-III; BOVINE RHODOPSIN; DARK-ADAPTATION; ACTIVATION; BINDING; CRYSTALLOGRAPHY; INTERMEDIATE; TRANSDUCIN	In the G- protein- coupled receptor ( GPCR) rhodopsin, the inactivating ligand 11- cis- retinal is bound in the seven- transmembrane helix ( TM) bundle and is cis/ trans isomerized by light to form active metarhodopsin II. With metarhodopsin II decay, all- trans- retinal is released, and opsin is reloaded with new 11- cis- retinal. Here we present the crystal structure of ligand- free native opsin from bovine retinal rod cells at 2.9 angstrorm (angstrom) resolution. Compared to rhodopsin, opsin shows prominent structural changes in the conserved E(D)RY and NPxxY(x)(5,6)F regions and in TM5 - TM7. At the cytoplasmic side, TM6 is tilted outwards by 6 - 7 angstrom, whereas the helix structure of TM5 is more elongated and close to TM6. These structural changes, some of which were attributed to an active GPCR state, reorganize the empty retinal- binding pocket to disclose two openings that may serve the entry and exit of retinal. The opsin structure sheds new light on ligand binding to GPCRs and on GPCR activation.	[Park, Jung Hee; Scheerer, Patrick; Hofmann, Klaus Peter; Choe, Hui-Woog; Ernst, Oliver Peter] Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Jeonbuk National University	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	klaus_peter.hofmann@charite.de; hwchoe@chonbuk.ac.kr; oliver.ernst@charite.de	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Scheerer, Patrick/0000-0001-5028-2075				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bartl FJ, 2007, PHYS CHEM CHEM PHYS, V9, P1648, DOI 10.1039/b616365c; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sachs K, 2000, METHOD ENZYMOL, V315, P238; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z	52	758	768	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					183	U33		10.1038/nature07063	http://dx.doi.org/10.1038/nature07063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18563085	Green Submitted			2022-12-24	WOS:000257466900036
J	Tsuda, H; Han, SM; Yang, YF; Tong, C; Lin, YQ; Mohan, K; Haueter, C; Zoghbi, A; Harati, Y; Kwan, J; Miller, MA; Bellen, HJ				Tsuda, Hiroshi; Han, Sung Min; Yang, Youfeng; Tong, Chao; Lin, Yong Qi; Mohan, Kriti; Haueter, Claire; Zoghbi, Anthony; Harati, Yadollah; Kwan, Justin; Miller, Michael A.; Bellen, Hugo J.			The Amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors	CELL			English	Article							OOCYTE MEIOTIC MATURATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; MOTOR-NEURON DEGENERATION; C-ELEGANS; CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEIN; TYROSINE KINASE; NEUROMUSCULAR-JUNCTION; BINDING-PROTEIN	VAP proteins (human VAPB/ALS8, Drosophila VAP33, and C. elegans VPR-1) are homologous proteins with an amino-terminal major sperm protein (MSP) domain and a transmembrane domain. The MSP domain is named for its similarity to the C. elegans MSP protein, a sperm-derived hormone that binds to the Eph receptor and induces oocyte maturation. A point mutation (P56S) in the MSP domain of human VAPB is associated with Amyotrophic lateral sclerosis (ALS), but the mechanisms underlying the pathogenesis are poorly understood. Here we show that the MSP domains of VAP proteins are cleaved and secreted ligands for Eph receptors. The P58S mutation in VAP33 leads to a failure to secrete the MSP domain as well as ubiquitination, accumulation of inclusions in the endoplasmic reticulum, and an unfolded protein response. We propose that VAP MSP domains are secreted and act as diffusible hormones for Eph receptors. This work provides insight into mechanisms that may impact the pathogenesis of ALS.	[Tsuda, Hiroshi; Tong, Chao; Mohan, Kriti; Zoghbi, Anthony; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Han, Sung Min; Yang, Youfeng; Miller, Michael A.] Univ Alabama, Sch Med, Dept Cell Biol, Birmingham, AL 35294 USA; [Lin, Yong Qi; Haueter, Claire; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Yang, Youfeng/E-2252-2011	Yang, Youfeng/0000-0003-0736-2680; Zoghbi, Anthony William/0000-0002-3441-440X; Tong, Chao/0000-0001-6521-5465; Miller, Michael/0000-0003-4872-7121; Bellen, Hugo/0000-0001-5992-5989	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Baker AME, 2002, J MOL BIOL, V319, P491, DOI 10.1016/S0022-2836(02)00294-2; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bottino D, 2002, J CELL SCI, V115, P367; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; BRENNER S, 1974, GENETICS, V77, P71; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Chin-Sang ID, 2002, DEVELOPMENT, V129, P5499, DOI 10.1242/dev.00122; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Corrigan C, 2005, DEVELOPMENT, V132, P5225, DOI 10.1242/dev.02083; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Govindan JA, 2006, CURR BIOL, V16, P1257, DOI 10.1016/j.cub.2006.05.020; Harris JE, 2006, DEV BIOL, V299, P105, DOI 10.1016/j.ydbio.2006.07.013; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kosinski M, 2005, DEVELOPMENT, V132, P3357, DOI 10.1242/dev.01916; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lai KO, 2001, MOL CELL NEUROSCI, V17, P1034, DOI 10.1006/mcne.2001.0997; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Magal E, 1996, J NEUROSCI RES, V43, P735, DOI 10.1002/(SICI)1097-4547(19960315)43:6<735::AID-JNR10>3.0.CO;2-X; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; PESACRETA TC, 1989, J CELL BIOL, V108, P1697, DOI 10.1083/jcb.108.5.1697; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Talbot K, 2006, HUM MOL GENET, V15, pR182, DOI 10.1093/hmg/ddl202; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; WARD S, 1988, J MOL BIOL, V199, P1, DOI 10.1016/0022-2836(88)90374-9; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Whitten SJ, 2007, DEV BIOL, V301, P432, DOI 10.1016/j.ydbio.2006.08.038; Yamamoto I, 2006, DEV DYNAM, V235, P571, DOI 10.1002/dvdy.20662; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	66	168	177	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					963	977		10.1016/j.cell.2008.04.039	http://dx.doi.org/10.1016/j.cell.2008.04.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555774	Green Accepted, Bronze			2022-12-24	WOS:000256693400013
J	Dunkle, KL; Stephenson, R; Karita, E; Chomba, E; Kayitenkore, K; Vwalika, C; Greenberg, L; Allen, S				Dunkle, Kristin L.; Stephenson, Rob; Karita, Etienne; Chomba, Elwyn; Kayitenkore, Kayitesi; Vwalika, Cheswa; Greenberg, Lauren; Allen, Susan			New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data	LANCET			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; DISCORDANT COUPLES; HIV-1-DISCORDANT COUPLES; SEXUAL-BEHAVIOR; COITAL ACT; TRANSMISSION; UGANDA; RATES; RISK	Background Sub-Saharan Africa has a high rate of HIV infection, most of which is attributable to heterosexual transmission. Few attempts have been made to assess the extent of HIV transmission within marriages, and HIV-prevention efforts remain focused on abstinence and non-marital sex. We aimed to estimate the proportion of heterosexual transmission of HIV which occurs within married or cohabiting couples in urban Zambia and Rwanda each year. Methods We used population-based data from Demographic and Health Surveys (DHS) on heterosexual behaviour in Zambia in 2001-02 and in Rwanda in 2005. We also used data on the HIV serostatus of married or cohabiting couples and non-cohabiting couples that was collected through a voluntary counselling and testing service for urban couples in Lusaka, in Zambia, and Kigali, in Rwanda. We estimated the probability that an individual would acquire an incident HIV infection from a cohabiting or non-cohabiting sexual partner, and then the proportion of total heterosexual HIV transmission which occurs within married or cohabiting couples in these settings each year. Findings We analysed DHS data from 1739 Zambian women, 540 Zambian men, 1176 Rwandan women, and 606 Rwandan men. Under our base model, we estimated that 55 . 1% to 92.7% of new heterosexually acquired HIV infections among adults in urban Zambia and Rwanda occurred within serodiscordant marital or cohabiting relationships, depending on the sex of the index partner and on location. Under our extended model, which incorporated the higher rates of reported condom use that we found with non-cohabiting partners, we estimated that 60.3% to 94.2% of new heterosexually acquired infections occurred within marriage or cohabitation. We estimated that an intervention for couples which reduced transmission in serodiscordant urban cohabiting couples from 20% to 7% every year could avert 35.7% to 60.3% of heterosexually transmitted HIV infections that would otherwise occur. Interpretation Since most heterosexual HIV transmission for both men and women in urban Zambia and Rwanda takes place within marriage or cohabitation, voluntary counselling and testing for couples should be promoted, as should other evidence-based interventions that target heterosexual couples. Funding US National Institute of Mental Health, National Institute of Child Health and Human Development, National Institute of Allergy and Infectious Diseases, Fogarty AIDS International Training and Research Program, Emory Center for AIDS Research, and the International AIDS Vaccine Initiative.	[Dunkle, Kristin L.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Dunkle, Kristin L.] Emory Univ, Emory Ctr AIDS Res, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Stephenson, Rob; Greenberg, Lauren; Allen, Susan] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Karita, Etienne; Kayitenkore, Kayitesi; Allen, Susan] Rwanda Zambia HIV Res Grp, Projet San Francisco, Kigali, Rwanda; [Chomba, Elwyn; Vwalika, Cheswa; Allen, Susan] Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Dunkle, KL (corresponding author), Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, 1520 Clifton Rd NE, Atlanta, GA 30322 USA.	kdunkle@sph.emory.edu	Dunkle, Kristin/AAU-5488-2020; Stephenson, Rob/J-9876-2012	Dunkle, Kristin/0000-0003-3071-5544; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040125] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, P30AI027767, R01AI040951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER; FIC NIH HHS [FIC 2D43 TW001042] Funding Source: Medline; NIAID NIH HHS [P30 AI27767, P30 AI027767, P30 AI050409, R01 AI40951] Funding Source: Medline; NICHD NIH HHS [R01 HD040125, R01 HD 40125] Funding Source: Medline; NIMH NIH HHS [R01 MH 66767, R01 MH066767] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Centers for Disease Control and Prevention, 2007, COUPL HIV COUNS TEST; *CENTR STAT OFRF C, 2003, ZAMB DEM HLTH SURV 2; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Clark S, 2006, INT FAM PLAN PERSPEC, V32, P79, DOI 10.1363/3207906; *CSO ORC MACR, 2007, ZIMB DEM HLTH SURV 2; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; El-Bassel N, 2003, AM J PUBLIC HEALTH, V93, P963, DOI 10.2105/AJPH.93.6.963; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P83; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; *INSR ORC MACR, 2006, RWAND DEM HLTH SURV; Kakimoto K, 2007, AIDS CARE, V19, P381, DOI 10.1080/09540120500520998; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; *MOHSW BOS ORC MAC, 2005, LES DEM HLTH SURV 20; Painter TM, 2007, AJAR-AFR J AIDS RES, V6, P25, DOI 10.2989/16085900709490396; Parikh SA, 2007, AM J PUBLIC HEALTH, V97, P1198, DOI 10.2105/AJPH.2006.088682; Sagay A S, 2006, Afr J Med Med Sci, V35 Suppl, P125; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Stephenson R, 2008, AIDS CARE, V20, P395, DOI 10.1080/09540120701593497; *TACAIDS NBS ORC M, 2005, TANZ HIV AIDS IND SU; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; *UNAIDS, 2006, REP GLOB AIDS EP 200; Wardlow H, 2007, AM J PUBLIC HEALTH, V97, P1006, DOI 10.2105/AJPH.2006.088559; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28	38	370	377	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2008	371	9631					2183	2191		10.1016/S0140-6736(08)60953-8	http://dx.doi.org/10.1016/S0140-6736(08)60953-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326CP	18586173				2022-12-24	WOS:000257635800025
J	Huo, FW; Zheng, ZJ; Zheng, GF; Giam, LR; Zhang, H; Mirkin, CA				Huo, Fengwei; Zheng, Zijian; Zheng, Gengfeng; Giam, Louise R.; Zhang, Hua; Mirkin, Chad A.			Polymer pen lithography	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SOFT LITHOGRAPHY; NANOLITHOGRAPHY; PARALLEL; RESOLUTION; PATTERNS; STAMP	We report a low- cost, high- throughput scanning probe lithography method that uses a soft elastomeric tip array, rather than tips mounted on individual cantilevers, to deliver inks to a surface in a "direct write" manner. Polymer pen lithography merges the feature size control of dip- pen nanolithography with the large- area capability of contact printing. Because ink delivery is time and force dependent, features on the nanometer, micrometer, and macroscopic length scales can be formed with the same tip array. Arrays with as many as about 11 million pyramid- shaped pens can be brought into contact with substrates and readily leveled optically to ensure uniform pattern development.	[Huo, Fengwei; Zheng, Zijian; Zheng, Gengfeng; Zhang, Hua; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Huo, Fengwei; Zheng, Zijian; Zheng, Gengfeng; Giam, Louise R.; Zhang, Hua; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Giam, Louise R.; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Zhang, Hua/A-1302-2009; Zheng, Gengfeng/G-7023-2011; ZHENG, ZIJIAN/B-4012-2009; Mirkin, Chad A/E-3911-2010; Huo, Fengwei/A-2243-2011; huo, fengwei/A-2243-2011	Zhang, Hua/0000-0001-9518-740X; Zheng, Gengfeng/0000-0002-1803-6955; ZHENG, ZIJIAN/0000-0002-6653-7594; Huo, Fengwei/0000-0003-0904-6008; huo, fengwei/0000-0001-8990-6973; Mirkin, Chad/0000-0002-6634-7627	U. S. Air Force Office of Scientific Research (AFOSR); Defense Advanced Research Projects Agency (DARPA); NSF (Nanoscale Science and Engineering Center program); NIH Director's Pioneer Award; National Security Science and Engineering Faculty Fellowship; NSF for a Graduate Research Fellowship	U. S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF (Nanoscale Science and Engineering Center program)(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Security Science and Engineering Faculty Fellowship; NSF for a Graduate Research Fellowship(National Science Foundation (NSF))	C. A. M. acknowledges the U. S. Air Force Office of Scientific Research (AFOSR), the Defense Advanced Research Projects Agency (DARPA), and NSF (Nanoscale Science and Engineering Center program) for support of this research. C. A. M. is grateful for a NIH Director's Pioneer Award and a National Security Science and Engineering Faculty Fellowship from the U. S. Department of Defense. L. R. G. acknowledges the NSF for a Graduate Research Fellowship.	Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; Demers LM, 2002, SCIENCE, V296, P1836, DOI 10.1126/science.1071480; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835; Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Kramer S, 2003, CHEM REV, V103, P4367, DOI 10.1021/cr020704m; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Lenhert S, 2007, SMALL, V3, P71, DOI 10.1002/smll.200600431; Loo YL, 2002, J AM CHEM SOC, V124, P7654, DOI 10.1021/ja026355v; Maoz R, 1999, ADV MATER, V11, P55, DOI 10.1002/(SICI)1521-4095(199901)11:1<55::AID-ADMA55>3.0.CO;2-8; Mirkin CA, 2007, ACS NANO, V1, P79, DOI 10.1021/nn700228m; Odom TW, 2002, LANGMUIR, V18, P5314, DOI 10.1021/la020169l; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Qi MH, 2004, NATURE, V429, P538, DOI 10.1038/nature02575; Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39; Salaita K, 2006, ANGEW CHEM INT EDIT, V45, P7220, DOI 10.1002/anie.200603142; Schmid H, 2000, MACROMOLECULES, V33, P3042, DOI 10.1021/ma982034l; Wang XF, 2003, LANGMUIR, V19, P8951, DOI 10.1021/la034858o; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Xu S, 1999, LANGMUIR, V15, P7244, DOI 10.1021/la9906727; Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898; Zhang H, 2004, NANO LETT, V4, P1649, DOI 10.1021/nl049185o; Zheng ZJ, 2006, J AM CHEM SOC, V128, P7730, DOI 10.1021/ja061636e	27	426	450	8	401	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1658	1660		10.1126/science.1162193	http://dx.doi.org/10.1126/science.1162193			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18703709	Green Accepted			2022-12-24	WOS:000259300400029
J	Gomez-Roldan, V; Fermas, S; Brewer, PB; Puech-Pages, V; Dun, EA; Pillot, JP; Letisse, F; Matusova, R; Danoun, S; Portais, JC; Bouwmeester, H; Becard, G; Beveridge, CA; Rameau, C; Rochange, SF				Gomez-Roldan, Victoria; Fermas, Soraya; Brewer, Philip B.; Puech-Pages, Virginie; Dun, Elizabeth A.; Pillot, Jean-Paul; Letisse, Fabien; Matusova, Radoslava; Danoun, Saida; Portais, Jean-Charles; Bouwmeester, Harro; Becard, Guillaume; Beveridge, Christine A.; Rameau, Catherine; Rochange, Soizic F.			Strigolactone inhibition of shoot branching	NATURE			English	Article							ARBUSCULAR-MYCORRHIZAL FUNGI; ROOT PARASITIC PLANTS; GERMINATION STIMULANTS; PHOSPHORUS DEFICIENCY; SEED-GERMINATION; APICAL DOMINANCE; RMS1 MUTANT; ARABIDOPSIS; PEA; SIGNAL	A carotenoid- derived hormonal signal that inhibits shoot branching in plants has long escaped identification. Strigolactones are compounds thought to be derived from carotenoids and are known to trigger the germination of parasitic plant seeds and stimulate symbiotic fungi. Here we present evidence that carotenoid cleavage dioxygenase 8 shoot branching mutants of pea are strigolactone deficient and that strigolactone application restores the wild- type branching phenotype to ccd8 mutants. Moreover, we show that other branching mutants previously characterized as lacking a response to the branching inhibition signal also lack strigolactone response, and are not deficient in strigolactones. These responses are conserved in Arabidopsis. In agreement with the expected properties of the hormonal signal, exogenous strigolactone can be transported in shoots and act at low concentrations. We suggest that endogenous strigolactones or related compounds inhibit shoot branching in plants. Furthermore, ccd8 mutants demonstrate the diverse effects of strigolactones in shoot branching, mycorrhizal symbiosis and parasitic weed interaction.	[Fermas, Soraya; Pillot, Jean-Paul; Rameau, Catherine] Inst JP Bourgin, Genet & Ameliorat Plantes Stn, INRA, UR254, F-78000 Versailles, France; [Gomez-Roldan, Victoria; Puech-Pages, Virginie; Danoun, Saida; Becard, Guillaume; Rochange, Soizic F.] Univ Toulouse 1, F-31326 Castanet Tolosan, France; [Gomez-Roldan, Victoria; Puech-Pages, Virginie; Danoun, Saida; Becard, Guillaume; Rochange, Soizic F.] UPS, F-31326 Castanet Tolosan, France; [Gomez-Roldan, Victoria; Puech-Pages, Virginie; Danoun, Saida; Becard, Guillaume; Rochange, Soizic F.] CNRS, F-31326 Castanet Tolosan, France; [Brewer, Philip B.; Dun, Elizabeth A.; Beveridge, Christine A.] Univ Queensland, ARC Ctr Excellence Integrat Legume Res, Brisbane, Qld 4072, Australia; [Letisse, Fabien; Portais, Jean-Charles] INSA Toulouse, CNRS, UMR5504, UMR792,INRA, F-31400 Toulouse, France; [Matusova, Radoslava; Bouwmeester, Harro] Plant Res Int, NL-6700 AA Wageningen, Netherlands; [Bouwmeester, Harro] Univ Wageningen & Res Ctr, Lab Plant Physiol, NL-6703 BD Wageningen, Netherlands; [Beveridge, Christine A.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse 1 Capitole; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Wageningen University & Research; University of Queensland	Rameau, C (corresponding author), Inst JP Bourgin, Genet & Ameliorat Plantes Stn, INRA, UR254, F-78000 Versailles, France.	becard@scsv.ups-tlse.fr; rameau@versailles.inra.fr	Brewer, Philip B/C-6562-2008; Beveridge, Christine Anne/B-3514-2009; Matusova, Radoslava/A-1886-2017; Bouwmeester, Harro J/C-1414-2008; Dun, Elizabeth/A-1283-2010; Gomez, Maria M/H-5391-2018	Brewer, Philip B/0000-0003-4871-9260; Beveridge, Christine Anne/0000-0003-0878-3110; Matusova, Radoslava/0000-0001-9181-295X; Dun, Elizabeth/0000-0003-4068-0349; Gomez, Maria M/0000-0002-8428-1588; Bouwmeester, Harro/0000-0003-0907-2732; Portais, Jean-Charles/0000-0002-3480-0933; Fabien, Letisse/0000-0002-1490-0152	French Ministry of Research and Higher Education; ANR; The Netherlands Organisation for Scientific Research (NWO; VICI-grant)	French Ministry of Research and Higher Education; ANR(French National Research Agency (ANR)); The Netherlands Organisation for Scientific Research (NWO; VICI-grant)(Netherlands Organization for Scientific Research (NWO))	V.G.-R. was supported by the French Ministry of Research and Higher Education. S. F. was supported by a grant from ANR. H.B. and R.M. were supported by a grant from The Netherlands Organisation for Scientific Research (NWO; VICI-grant). The authors are grateful to A. Marion-Poll for discussions, H.M.O. Leyser for supply of the Arabidopsis max4 seed, K. Yoneyama for the gift of orobanchyl acetate, and D. M. Joel for providing O. crenata seeds. The UPLC/QTOF mass spectrometer was made available to us by the Institut des Technologies Avancees du Vivant (Toulouse, France). We thank K. Condon for plant husbandry, the ARC Centre of Excellence for Integrative Legume Research and the European Union FP6 Grain Legumes Integrated Project for financial support.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arumingtyas EL, 1992, PISUM GENET, V24, P17; Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Berleth T, 2004, CURR OPIN PLANT BIOL, V7, P553, DOI 10.1016/j.pbi.2004.07.016; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Beveridge CA, 2006, CURR OPIN PLANT BIOL, V9, P35, DOI 10.1016/j.pbi.2005.11.006; Beveridge CA, 1997, PLANT PHYSIOL, V115, P1251, DOI 10.1104/pp.115.3.1251; Beveridge CA, 1996, PLANT PHYSIOL, V110, P859, DOI 10.1104/pp.110.3.859; Beveridge CA, 2000, PLANT PHYSIOL, V123, P689, DOI 10.1104/pp.123.2.689; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Booker J, 2003, PLANT CELL, V15, P495, DOI 10.1105/tpc.007542; Bouvier F, 2005, TRENDS PLANT SCI, V10, P187, DOI 10.1016/j.tplants.2005.02.007; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Brachmann A, 2006, PLOS BIOL, V4, P1111, DOI 10.1371/journal.pbio.0040239; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Dodd IC, 2008, PLANT CELL PHYSIOL, V49, P791, DOI 10.1093/pcp/pcn052; Doust AN, 2007, CURR OPIN PLANT BIOL, V10, P21, DOI 10.1016/j.pbi.2006.11.015; Dun EA, 2006, PLANT PHYSIOL, V142, P812, DOI 10.1104/pp.106.086868; Foo E, 2005, PLANT CELL, V17, P464, DOI 10.1105/tpc.104.026716; Foo E, 2001, PLANT PHYSIOL, V126, P203, DOI 10.1104/pp.126.1.203; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Goldwasser Y, 2008, PLANT GROWTH REGUL, V55, P21, DOI 10.1007/s10725-008-9253-z; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Li CJ, 1999, PHYSIOL PLANTARUM, V106, P415, DOI 10.1034/j.1399-3054.1999.106409.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Morris SE, 2001, PLANT PHYSIOL, V126, P1205, DOI 10.1104/pp.126.3.1205; Mouchel CF, 2007, CURR OPIN PLANT BIOL, V10, P473, DOI 10.1016/j.pbi.2007.08.005; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; NEHAUSER JL, 2004, PLOS BIOL, V2, pE258; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Strader LC, 2008, NAT CHEM BIOL, V4, P337, DOI 10.1038/nchembio0608-337; Symons G. M., 1997, Pisum Genetics, V29, P1; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Xie X, 2008, PHYTOCHEMISTRY, V69, P427, DOI 10.1016/j.phytochem.2007.07.017; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1	51	1398	1531	36	696	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					189	U22		10.1038/nature07271	http://dx.doi.org/10.1038/nature07271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18690209				2022-12-24	WOS:000259090800039
J	Meissner, A; Mikkelsen, TS; Gu, HC; Wernig, M; Hanna, J; Sivachenko, A; Zhang, XL; Bernstein, BE; Nusbaum, C; Jaffe, DB; Gnirke, A; Jaenisch, R; Lander, ES				Meissner, Alexander; Mikkelsen, Tarjei S.; Gu, Hongcang; Wernig, Marius; Hanna, Jacob; Sivachenko, Andrey; Zhang, Xiaolan; Bernstein, Bradley E.; Nusbaum, Chad; Jaffe, David B.; Gnirke, Andreas; Jaenisch, Rudolf; Lander, Eric S.			Genome-scale DNA methylation maps of pluripotent and differentiated cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; DISTINCT; CANCER; GENES; HYPERMETHYLATION; SIGNATURES; PROMOTERS; PATTERNS; DISPLAY	DNA methylation is essential for normal development(1-3) and has been implicated in many pathologies including cancer(4,5). Our knowledge about the genome-wide distribution of DNA methylation, how it changes during cellular differentiation and how it relates to histone methylation and other chromatin modifications in mammals remains limited. Here we report the generation and analysis of genome-scale DNA methylation profiles at nucleotide resolution in mammalian cells. Using high-throughput reduced representation bisulphite sequencing(6) and single-molecule-based sequencing, we generated DNA methylation maps covering most CpG islands, and a representative sampling of conserved non-coding elements, transposons and other genomic features, for mouse embryonic stem cells, embryonic-stem-cell-derived and primary neural cells, and eight other primary tissues. Several key findings emerge from the data. First, DNA methylation patterns are better correlated with histone methylation patterns than with the underlying genome sequence context. Second, methylation of CpGs are dynamic epigenetic marks that undergo extensive changes during cellular differentiation, particularly in regulatory regions outside of core promoters. Third, analysis of embryonic-stem-cell-derived and primary cells reveals that 'weak' CpG islands associated with a specific set of developmentally regulated genes undergo aberrant hypermethylation during extended proliferation in vitro, in a pattern reminiscent of that reported in some primary tumours. More generally, the results establish reduced representation bisulphite sequencing as a powerful technology for epigenetic profiling of cell populations relevant to developmental biology, cancer and regenerative medicine.	[Meissner, Alexander; Wernig, Marius; Hanna, Jacob; Jaenisch, Rudolf; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Meissner, Alexander; Mikkelsen, Tarjei S.; Gu, Hongcang; Sivachenko, Andrey; Zhang, Xiaolan; Bernstein, Bradley E.; Nusbaum, Chad; Jaffe, David B.; Gnirke, Andreas; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Jaenisch, Rudolf; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; lander@broad.mit.edu	Hu, Ruogu/B-2203-2008; Mikkelsen, Tarjei S/A-1306-2007; Hanna, Jacob/K-1339-2012	Mikkelsen, Tarjei S/0000-0002-8133-3135; Hanna, Jacob/0000-0003-2042-9974; Gu, Hongcang/0000-0002-1439-7606	NHGRI NIH HHS [R01 HG004401, R01 HG004401-02, U54 HG003067-06, U54 HG003067-04, U54 HG003067] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG004401] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; JONES PA, 1990, PHILOS T R SOC B, V326, P277, DOI 10.1098/rstb.1990.0011; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104	30	1830	1921	2	324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					766	U91		10.1038/nature07107	http://dx.doi.org/10.1038/nature07107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18600261	Green Accepted			2022-12-24	WOS:000258228000045
J	Limaye, AP; Kirby, KA; Rubenfeld, GD; Leisenring, WM; Bulger, EM; Neff, MJ; Gibran, NS; Huang, ML; Hayes, TKS; Corey, L; Boeckh, M				Limaye, Ajit P.; Kirby, Katharine A.; Rubenfeld, Gordon D.; Leisenring, Wendy M.; Bulger, Eileen M.; Neff, Margaret J.; Gibran, Nicole S.; Huang, Meei-Li; Hayes, Tracy K. Santo; Corey, Lawrence; Boeckh, Michael			Cytomegalovirus reactivation in critically ill immunocompetent patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	103rd International Conference of the American-Thoracic-Society	MAY 18-23, 2007	San Francisco, CA	Amer Thorac Soc			ORGAN-TRANSPLANT RECIPIENTS; PULMONARY CYTOMEGALOVIRUS; RENAL-TRANSPLANTATION; SURGICAL-PATIENTS; INFECTION; DISEASE; IMPACT; GANCICLOVIR; MORTALITY; MODELS	Context Cytomegalovirus (CMV) infection is associated with adverse clinical outcomes in immunosuppressed persons, but the incidence and association of CMV reactivation with adverse outcomes in critically ill persons lacking evidence of immunosuppression have not been well defined. Objective To determine the association of CMV reactivation with intensive care unit (ICU) and hospital length of stay in critically ill immunocompetent persons. Design, Setting, and Participants We prospectively assessed CMV plasma DNA-emia by thrice-weekly real-time polymerase chain reaction (PCR) and clinical outcomes in a cohort of 120 CMV-seropositive, immunocompetent adults admitted to 1 of 6 ICUs at 2 separate hospitals at a large US tertiary care academic medical center between 2004 and 2006. Clinical measurements were assessed by personnel blinded to CMV PCR results. Risk factors for CMV reactivation and association with hospital and ICU length of stay were assessed by multivariable logistic regression and proportional odds models. Main Outcome Measures Association of CMV reactivation with prolonged hospital length of stay or death. Results The primary composite end point of continued hospitalization (n=35) or death (n=10) by 30 days occurred in 45 (35%) of the 120 patients. Cytomegalovirus viremia at any level occurred in 33% (39/120; 95% confidence interval [CI], 24%-41%) at a median of 12 days (range, 3-57 days) and CMV viremia greater than 1000 copies/ mL occurred in 20% (24/120; 95% CI, 13%-28%) at a median of 26 days (range, 9-56 days). By logistic regression, CMV infection at any level (adjusted odds ratio [OR], 4.3; 95% CI, 1.6-11.9; P=.005) and at greater than 1000 copies/mL (adjusted OR, 13.9; 95% CI, 3.2-60; P < .001) and the average CMV area under the curve (AUC) in log(10) copies per milliliter (adjusted OR, 2.1; 95% CI, 1.3-3.2; P < .001) were independently associated with hospitalization or death by 30 days. In multivariable partial proportional odds models, both CMV 7-day moving average (OR, 5.1; 95% CI, 2.9-9.1; P < .001) and CMV AUC (OR, 3.2; 95% CI, 2.1-4.7; P < .001) were independently associated with a hospital length of stay of at least 14 days. Conclusions These preliminary findings suggest that reactivation of CMV occurs frequently in critically ill immunocompetent patients and is associated with prolonged hospitalization or death. A controlled trial of CMV prophylaxis in this setting is warranted.	[Limaye, Ajit P.; Hayes, Tracy K. Santo] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [Limaye, Ajit P.; Rubenfeld, Gordon D.; Neff, Margaret J.; Corey, Lawrence; Boeckh, Michael] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Leisenring, Wendy M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bulger, Eileen M.; Gibran, Nicole S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Huang, Meei-Li; Corey, Lawrence; Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA; [Kirby, Katharine A.; Leisenring, Wendy M.] Fred Hutchinson Canc Res Ctr, Program Clin Stat, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Limaye, AP (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	limaye@u.washington.edu	Corey, Lawrence/AAE-1796-2020; Boeckh, Michael/AAA-1607-2022	Corey, Lawrence/0000-0002-2179-2436; Kirby, Katharine/0000-0003-0876-8113	NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA018029-279016, P01 CA018029, CA-18029] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BALE JF, 1990, INFECT CONT HOSP EP, V11, P17; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; CHASTRE J, 1995, AM J RESP CRIT CARE, V152, P231, DOI 10.1164/ajrccm.152.1.7599829; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2006, CRIT CARE MED, V34, P842, DOI 10.1097/01.CCM.0000201876.11059.05; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2002, J INFECT DIS, V185, P1395, DOI 10.1086/340508; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; DOMART Y, 1990, CHEST, V97, P18, DOI 10.1378/chest.97.1.18; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Kalil AC, 2005, ANN INTERN MED, V143, P870, DOI 10.7326/0003-4819-143-12-200512200-00005; Kalil RSN, 2003, AM J TRANSPLANT, V3, P79, DOI 10.1034/j.1600-6143.2003.30114.x; Kealey G P, 1987, J Burn Care Rehabil, V8, P543, DOI 10.1097/00004630-198708060-00017; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Limaye AP, 2006, TRANSPLANTATION, V81, P1645, DOI 10.1097/01.tp.0000226071.12562.1a; Lowance D, 1999, NEW ENGL J MED, V340, P1462, DOI 10.1056/NEJM199905133401903; Manez R, 1997, J INFECT DIS, V176, P1462, DOI 10.1086/514142; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Munoz-Price LS, 2004, CLIN INFECT DIS, V39, P1293, DOI 10.1086/425002; PETERSON B, 1990, APPL STAT-J ROY ST C, V39, P205; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Small LN, 2006, CLIN INFECT DIS, V43, P869, DOI 10.1086/507337; Strippoli GFM, 2006, TRANSPLANTATION, V81, P139, DOI 10.1097/01.tp.0000183970.71366.da; Valantine HA, 1999, CIRCULATION, V100, P61, DOI 10.1161/01.CIR.100.1.61; von Muller L, 2006, EMERG INFECT DIS, V12, P1517, DOI 10.3201/eid1210.060411	35	400	413	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2008	300	4					413	422		10.1001/jama.300.4.413	http://dx.doi.org/10.1001/jama.300.4.413			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328XJ	18647984	Green Accepted, Bronze			2022-12-24	WOS:000257831200019
J	Rabinovich, M; Huerta, R; Laurent, G				Rabinovich, Misha; Huerta, Ramon; Laurent, Gilles			Neuroscience - Transient dynamics for neural processing	SCIENCE			English	Editorial Material							ODOR REPRESENTATIONS		[Rabinovich, Misha; Huerta, Ramon] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA; [Laurent, Gilles] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Diego; California Institute of Technology	Rabinovich, M (corresponding author), Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA.	laurentg@caltech.edu	Huerta, Ramon/J-4316-2012; Laurent, Gilles/A-4583-2012; Huerta, Ramon/C-9296-2013	Huerta, Ramon/0000-0003-3925-5169; Laurent, Gilles/0000-0002-2296-114X; Huerta, Ramon/0000-0003-3925-5169; Rabinovich, Mikhail I./0000-0003-4499-5348				Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Jones M., 2007, P NATL ACAD SCI USA, V104, P18772; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; LINDSTROM T, 1993, J MATH BIOL, V31, P541, DOI 10.1007/BF00161198; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142	15	304	306	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					48	50		10.1126/science.1155564	http://dx.doi.org/10.1126/science.1155564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599763				2022-12-24	WOS:000257320800027
J	Kepecs, A; Uchida, N; Zariwala, HA; Mainen, ZF				Kepecs, Adam; Uchida, Naoshige; Zariwala, Hatim A.; Mainen, Zachary F.			Neural correlates, computation and behavioural impact of decision confidence	NATURE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; MATCHING BEHAVIOR; REWARD PREFERENCE; NEURONAL-ACTIVITY; UNCERTAINTY; REPRESENTATION; MODELS; PERFORMANCE; AMYGDALA	Humans and other animals must often make decisions on the basis of imperfect evidence(1,2). Statisticians use measures such as P values to assign degrees of confidence to propositions, but little is known about how the brain computes confidence estimates about decisions. We explored this issue using behavioural analysis and neural recordings in rats in combination with computational modelling. Subjects were trained to perform an odour categorization task that allowed decision confidence to be manipulated by varying the distance of the test stimulus to the category boundary. To understand how confidence could be computed along with the choice itself, using standard models of decision-making(3-6), we defined a simple measure that quantified the quality of the evidence contributing to a particular decision. Here we show that the firing rates of many single neurons in the orbitofrontal cortex match closely to the predictions of confidence models and cannot be readily explained by alternative mechanisms, such as learning stimulus - outcome associations(7-10). Moreover, when tested using a delayed reward version of the task, we found that rats' willingness to wait for rewards increased with confidence, as predicted by the theoretical model. These results indicate that confidence estimates, previously suggested to require 'metacognition'(11,12) and conscious awareness(13,14), are available even in the rodent brain, can be computed with relatively simple operations, and can drive adaptive behaviour. We suggest that confidence estimation may be a fundamental and ubiquitous component of decision- making.	[Kepecs, Adam; Uchida, Naoshige; Zariwala, Hatim A.; Mainen, Zachary F.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Uchida, Naoshige] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Zariwala, Hatim A.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Mainen, Zachary F.] Gulbenkian Inst Sci, Champalimaud Neurosci Programme, P-2780901 Oeiras, Portugal	Cold Spring Harbor Laboratory; Harvard University; Harvard University; Allen Institute for Brain Science; Fundacao Champalimaud	Kepecs, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	kepecs@cshl.edu; zmainen@igc.gulbenkian.pt		Uchida, Naoshige/0000-0002-5755-9409; Kepecs, Adam/0000-0003-0049-8120; Mainen, Zachary/0000-0001-7913-9109	National Institutes of Health (NIDCD); Center for the Neural Mechanisms of Cognition at Cold Spring Harbor Laboratory; Swartz Foundation	National Institutes of Health (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Center for the Neural Mechanisms of Cognition at Cold Spring Harbor Laboratory; Swartz Foundation	We thank J. Paton, A. Pouget, S. Raghavachari, G. Turner and members of the Mainen laboratory for comments on the manuscript. Support was provided by the National Institutes of Health (NIDCD) (Z.F.M.), the Center for the Neural Mechanisms of Cognition at Cold Spring Harbor Laboratory (Z.F.M.), and the Swartz Foundation (A.K., N.U., Z.F.M).	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Davidson A.C., 1997, BOOTSTRAP METHODS TH; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Efron B., 1994, INTRO BOOTSTRAP; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Foote AL, 2007, CURR BIOL, V17, P551, DOI 10.1016/j.cub.2007.01.061; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Hampton RR, 2001, P NATL ACAD SCI USA, V98, P5359, DOI 10.1073/pnas.071600998; Hansen P.C., 1998, RANK DEFICIENT DISCR; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kahneman D., 1982, JUDGMENT UNCERTAINTY; Keren G, 1997, J BEHAV DECIS MAKING, V10, P269, DOI 10.1002/(SICI)1099-0771(199709)10:3<269::AID-BDM281>3.0.CO;2-L; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koch C, 2007, NAT NEUROSCI, V10, P140, DOI 10.1038/nn0207-140; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Simmons JM, 2007, ANN NY ACAD SCI, V1121, P376, DOI 10.1196/annals.1401.028; Smith J.D., 2003, BEHAV BRAIN SCI, V26, P340; Smith JD, 2003, BEHAV BRAIN SCI, V26, P317; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	43	509	513	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					227	U55		10.1038/nature07200	http://dx.doi.org/10.1038/nature07200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18690210				2022-12-24	WOS:000259090800048
J	Llewellyn, ME; Barretto, RPJ; Delp, SL; Schnitzer, MJ				Llewellyn, Michael E.; Barretto, Robert P. J.; Delp, Scott L.; Schnitzer, Mark J.			Minimally invasive high-speed imaging of sarcomere contractile dynamics in mice and humans	NATURE			English	Article							IN-VIVO; 2ND-HARMONIC GENERATION; MUSCLE; MICROSCOPY; FLUORESCENCE; PROTEINS; MOUSE; CELLS	Sarcomeres are the basic contractile units of striated muscle. Our knowledge about sarcomere dynamics has primarily come from in vitro studies of muscle fibres(1) and analysis of optical diffraction patterns obtained from living muscles(2,3). Both approaches involve highly invasive procedures and neither allows examination of individual sarcomeres in live subjects. Here we report direct visualization of individual sarcomeres and their dynamical length variations using minimally invasive optical microendoscopy(4) to observe second-harmonic frequencies of light generated in the muscle fibres(5,6) of live mice and humans. Using microendoscopes as small as 350 mm in diameter, we imaged individual sarcomeres in both passive and activated muscle. Our measurements permit in vivo characterization of sarcomere length changes that occur with alterations in body posture and visualization of local variations in sarcomere length not apparent in aggregate length determinations. High-speed data acquisition enabled observation of sarcomere contractile dynamics with millisecond-scale resolution. These experiments point the way to in vivo imaging studies demonstrating how sarcomere performance varies with physical conditioning and physiological state, as well as imaging diagnostics revealing how neuromuscular diseases affect contractile dynamics.	[Llewellyn, Michael E.; Barretto, Robert P. J.; Delp, Scott L.; Schnitzer, Mark J.] Stanford Univ, Bio X Program, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA	Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, Bio X Program, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.	mschnitz@stanford.edu		Delp, Scott/0000-0002-9643-7551	NINDS NIH HHS [R01 NS050533, R01 NS050533-01, R01NS050533] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050533] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chu SW, 2004, BIOPHYS J, V86, P3914, DOI 10.1529/biophysj.103.034595; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; CUTTS A, 1988, J ANAT, V160, P79; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Goulding D, 1997, J MUSCLE RES CELL M, V18, P465, DOI 10.1023/A:1018650915751; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; LIEBER RL, 1994, J NEUROPHYSIOL, V71, P874, DOI 10.1152/jn.1994.71.3.874; Lieber RL, 2005, J HAND SURG-AM, V30A, P273, DOI 10.1016/j.jhsa.2004.10.003; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; Moreaux L, 2001, BIOPHYS J, V80, P1568, DOI 10.1016/S0006-3495(01)76129-2; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Perreault EJ, 2003, J NEUROPHYSIOL, V89, P738, DOI 10.1152/jn.00168.2002; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; PLOTNIKOV SV, IN PRESS J BIOMED OP; Ponten E, 2007, MUSCLE NERVE, V36, P47, DOI 10.1002/mus.20780; Rothstein EC, 2005, BIOPHYS J, V88, P2165, DOI 10.1529/biophysj.104.053165; Schurmann S, 2007, PROC SPIE, V6442, DOI 10.1117/12.700917; Telley IA, 2007, J MUSCLE RES CELL M, V28, P89, DOI 10.1007/s10974-007-9107-8; YEH Y, 1980, BIOPHYS J, V29, P509, DOI 10.1016/S0006-3495(80)85149-6; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	30	228	237	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2008	454	7205					784	788		10.1038/nature07104	http://dx.doi.org/10.1038/nature07104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18600262	Green Accepted			2022-12-24	WOS:000258228000049
J	Barrera, NP; Di Bartolo, N; Booth, PJ; Robinson, CV				Barrera, Nelson P.; Di Bartolo, Natalie; Booth, Paula J.; Robinson, Carol V.			Micelles protect membrane complexes from solution to vacuum	SCIENCE			English	Article							IONIZATION MASS-SPECTROMETRY; MACROMOLECULAR ASSEMBLIES; GAS-PHASE; ESCHERICHIA-COLI; DISSOCIATION; STOICHIOMETRY; ARCHITECTURE; MECHANISM; ORIGIN	The ability to maintain interactions between soluble protein subunits in the gas phase of a mass spectrometer gives critical insight into the stoichiometry and interaction networks of protein complexes. Conversely, for membrane protein complexes in micelles, the transition into the gas phase usually leads to the disruption of interactions, particularly between cytoplasmic and membrane subunits, and a mass spectrum dominated by large aggregates of detergent molecules. We show that by applying nanoelectrospray to a micellar solution of a membrane protein complex, the heteromeric adenosine 5'- triphosphate ( ATP)- binding cassette transporter BtuC(2)D(2), we can maintain the complex intact in the gas phase of a mass spectrometer. Dissociation of either transmembrane ( BtuC) or cytoplasmic ( BtuD) subunits uncovers modifications to the transmembrane subunits and cooperative binding of ATP. By protecting a membrane protein complex within a n-dodecyl-beta-D-maltoside micelle, we demonstrated a powerful strategy that will enable the subunit stoichiometry and ligand- binding properties of membrane complexes to be determined directly, by precise determination of the masses of intact complexes and dissociated subunits.	[Barrera, Nelson P.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Di Bartolo, Natalie; Booth, Paula J.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Cambridge; University of Bristol	Robinson, CV (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk	Booth, Paula/A-9644-2011	Barrera, Nelson/0000-0001-7825-1406; Booth, Paula Jane/0000-0003-3893-360X; robinson, carol/0000-0001-7829-5505	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Benesch JLP, 2006, CHEM BIOL, V13, P597, DOI 10.1016/j.chembiol.2006.04.006; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.3.CO;2-I; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Chapman HN, 2007, NATURE, V448, P676, DOI 10.1038/nature06049; Demmers JAA, 2003, FEBS LETT, V541, P28, DOI 10.1016/S0014-5793(03)00282-5; DRUMMOND CJ, 1985, J PHYS CHEM-US, V89, P2103, DOI 10.1021/j100256a060; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Felitsyn N, 2001, ANAL CHEM, V73, P4647, DOI 10.1021/ac0103975; Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hanson CL, 2003, BIOPHYS J, V85, P3802, DOI 10.1016/S0006-3495(03)74795-X; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Ilag LL, 2004, J AM CHEM SOC, V126, P14362, DOI 10.1021/ja0450307; Jarrold MF, 2007, PHYS CHEM CHEM PHYS, V9, P1659, DOI 10.1039/b612615d; Jurchen JC, 2003, J AM CHEM SOC, V125, P2817, DOI 10.1021/ja0211508; Kaltashov IA, 2005, ANAL CHEM, V77, P5370, DOI 10.1021/ac050511+; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lengqvist J, 2004, J BIOL CHEM, V279, P13311, DOI 10.1074/jbc.M310958200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo JA, 1997, MASS SPECTROM REV, V16, P1; LOO RRO, 1994, PROTEIN SCI, V3, P1975, DOI 10.1002/pro.5560031109; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Rundlett KL, 1996, ANAL CHEM, V68, P3493, DOI 10.1021/ac960472p; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Sharon M, 2007, J AM CHEM SOC, V129, P8740, DOI 10.1021/ja067820h; SIUZDAK G, 1995, ANGEW CHEM INT EDIT, V34, P2053, DOI 10.1002/anie.199520531; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Versluis C, 2001, J AM SOC MASS SPECTR, V12, P329, DOI 10.1016/S1044-0305(00)00227-0	35	277	279	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					243	246		10.1126/science.1159292	http://dx.doi.org/10.1126/science.1159292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18556516				2022-12-24	WOS:000257512900038
J	Harvey, CD; Yasuda, R; Zhong, HN; Svoboda, K				Harvey, Christopher D.; Yasuda, Ryohei; Zhong, Haining; Svoboda, Karel			The spread of Ras activity triggered by activation of a single dendritic spine	SCIENCE			English	Article							LONG-TERM POTENTIATION; CELLS; TRAFFICKING; INTEGRATION; PLASTICITY; RECEPTORS; CYCLE	In neurons, individual dendritic spines isolate N- methyl- D- aspartate ( NMDA) receptor- mediated calcium ion ( Ca(2+)) accumulations from the dendrite and other spines. However, the extent to which spines compartmentalize signaling events downstream of Ca(2+) influx is not known. We combined two- photon fluorescence lifetime imaging with two- photon glutamate uncaging to image the activity of the small guanosine triphosphatase Ras after NMDA receptor activation at individual spines. Induction of long- term potentiation ( LTP) triggered robust Ca(2+)- dependent Ras activation in single spines that decayed in similar to 5 minutes. Ras activity spread over similar to 10 micrometers of dendrite and invaded neighboring spines by diffusion. The spread of Ras- dependent signaling was necessary for the local regulation of the threshold for LTP induction. Thus, Ca(2+)- dependent synaptic signals can spread to couple multiple synapses on short stretches of dendrite.	[Harvey, Christopher D.; Yasuda, Ryohei; Zhong, Haining; Svoboda, Karel] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Harvey, Christopher D.; Zhong, Haining; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Duke University	Yasuda, R (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	yasuda@neuro.duke.edu; svobodak@janelia.hhmi.org	Yasuda, Ryohei/E-7726-2011	Zhong, Haining/0000-0002-7109-4724; Yasuda, Ryohei/0000-0001-6263-9297	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH080047, R01 MH080047-01] Funding Source: Medline; Autism Speaks [AS1398] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Speaks		Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PISTON DW, 1992, TIME RESOLVED LASER, V3, P379; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	28	293	302	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					136	140		10.1126/science.1159675	http://dx.doi.org/10.1126/science.1159675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18556515	Green Accepted			2022-12-24	WOS:000257320800056
J	Blair, KM; Turner, L; Winkelman, JT; Berg, HC; Kearns, DB				Blair, Kris M.; Turner, Linda; Winkelman, Jared T.; Berg, Howard C.; Kearns, Daniel B.			A molecular clutch disables flagella in the Bacillus subtilis biofilm	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ROTOR PROTEIN FLIG; ESCHERICHIA-COLI; BACTERIAL FLAGELLA; TORQUE GENERATION; OPTICAL TWEEZERS; MASTER REGULATOR; MOTOR; COMPONENT; RESIDUES	Biofilms are multicellular aggregates of sessile bacteria encased by an extracellular matrix and are important medically as a source of drug- resistant microbes. In Bacillus subtilis, we found that an operon required for biofilm matrix biosynthesis also encoded an inhibitor of motility, EpsE. EpsE arrested flagellar rotation in a manner similar to that of a clutch, by disengaging motor force-generating elements in cells embedded in the biofilm matrix. The clutch is a simple, rapid, and potentially reversible form of motility control.	[Blair, Kris M.; Winkelman, Jared T.; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Turner, Linda; Berg, Howard C.] Rowland Inst Sci Inc, Cambridge, MA 02142 USA; [Berg, Howard C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Indiana University System; Indiana University Bloomington; Harvard University	Kearns, DB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dbkearns@indiana.edu		Kearns, Daniel/0000-0002-3460-8378; Blair, Kris/0000-0002-2887-5592	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065540] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; BLOCK SM, 1991, CYTOMETRY, V12, P492, DOI 10.1002/cyto.990120605; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Garinot-Schneider C, 2000, J BIOL CHEM, V275, P31407, DOI 10.1074/jbc.M004524200; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Marykwas DL, 1996, J MOL BIOL, V256, P564, DOI 10.1006/jmbi.1996.0109; Mashimo T, 2007, J BACTERIOL, V189, P5153, DOI 10.1128/JB.00061-07; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	23	219	223	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1636	1638		10.1126/science.1157877	http://dx.doi.org/10.1126/science.1157877			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566286				2022-12-24	WOS:000256886700048
J	Acosta, JC; O'Loghlen, A; Banito, A; Guijarro, MV; Augert, A; Raguz, S; Fumagalli, M; Da Costa, M; Brown, C; Popov, N; Takatsu, Y; Melamed, J; di Fagagna, FD; Bernard, D; Hernando, E; Gil, J				Acosta, Juan C.; O'Loghlen, Ana; Banito, Ana; Guijarro, Maria V.; Augert, Arnaud; Raguz, Selina; Fumagalli, Marzia; Da Costa, Marco; Brown, Celia; Popov, Nikolay; Takatsu, Yoshihiro; Melamed, Jonathan; di Fagagna, Fabrizio d'Adda; Bernard, David; Hernando, Eva; Gil, Jesus			Chemokine signaling via the CXCR2 receptor reinforces senescence	CELL			English	Article							SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; REPLICATIVE SENESCENCE; CANCER-CELLS; P53; FIBROBLASTS; GROWTH; TUMORIGENESIS; INTERLEUKIN-8; TRANSFORMATION	Cells enter senescence, a state of stable proliferative arrest, in response to a variety of cellular stresses, including telomere erosion, DNA damage, and oncogenic signaling, which acts as a barrier against malignant transformation in vivo. To identify genes controlling senescence, we conducted an unbiased screen for small hairpin RNAs that extend the life span of primary human fibroblasts. Here, we report that knocking down the chemokine receptor CXCR2 (IL8RB) alleviates both replicative and oncogene-induced senescence (OIS) and diminishes the DNA-damage response. Conversely, ectopic expression of CXCR2 results in premature senescence via a p53-dependent mechanism. Cells undergoing OIS secrete multiple CXCR2-binding chemokines in a program that is regulated by the NF-kappa B and C/EBP beta transcription factors and coordinately induce CXCR2 expression. CXCR2 upregulation is also observed in preneoplastic lesions in vivo. These results suggest that senescent cells activate a self-amplifying secretory network in which CXCR2-binding chemokines reinforce growth arrest.	[Acosta, Juan C.; O'Loghlen, Ana; Banito, Ana; Raguz, Selina; Da Costa, Marco; Brown, Celia; Popov, Nikolay; Takatsu, Yoshihiro; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Clin Sci Ctr,Cell Proliferat Grp, London W12 0NN, England; [Guijarro, Maria V.; Melamed, Jonathan; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Augert, Arnaud; Bernard, David] Univ Lille 1, CNRS, Inst Biol, UMR 8161, Lille, France; [Augert, Arnaud; Bernard, David] Univ Lille 2, Inst Pasteur, IFR 142, Lille, France; [Fumagalli, Marzia; di Fagagna, Fabrizio d'Adda] Mol Oncol Fdn, IFOM Fdn, FIRC Inst, I-20139 Milan, Italy	Imperial College London; New York University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; IFOM - FIRC Institute of Molecular Oncology	Gil, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Clin Sci Ctr,Cell Proliferat Grp, Hammersmith Campus, London W12 0NN, England.	jesus.gil@csc.mrc.ac.uk	d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Gil, Jesus/C-7739-2012; Melamed, Jonathan/AAV-3769-2020; Acosta, Juan/AAE-6320-2021; O'Loghlen, Ana/K-9965-2014; Banito, Ana/P-6168-2017; Bernard, David/D-6265-2018	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Gil, Jesus/0000-0002-4303-6260; Melamed, Jonathan/0000-0003-2844-7990; Acosta, Juan/0000-0002-7989-7329; Banito, Ana/0000-0003-2188-0003; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; O'Loghlen, Ana/0000-0002-8141-1965; Bernard, David/0000-0002-1557-2074; Hernando, Eva/0000-0003-1023-0312; Fumagalli, Marzia/0000-0002-2036-4544	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; MRC [MC_U120085810] Funding Source: UKRI; Medical Research Council [MC_U120085810] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; BORDONI R, 1990, J CELL BIOCHEM, V44, P207, DOI 10.1002/jcb.240440403; Burger M, 1999, J IMMUNOL, V163, P2017; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mason DX, 2006, CARCINOGENESIS, V27, P350, DOI 10.1093/carcin/bgi264; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579	41	1139	1164	8	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					1006	1018		10.1016/j.cell.2008.03.038	http://dx.doi.org/10.1016/j.cell.2008.03.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555777	Bronze			2022-12-24	WOS:000256693400016
J	Gegear, RJ; Casselman, A; Waddell, S; Reppert, SM				Gegear, Robert J.; Casselman, Amy; Waddell, Scott; Reppert, Steven M.			Cryptochrome mediates light-dependent magnetosensitivity in Drosophila	NATURE			English	Article							MAGNETIC-FIELD DETECTION; MAGNETORECEPTION; MECHANISM; MODEL; PHOTORECEPTOR; ORIENTATION; ANIMALS; BIRDS	Although many animals use the Earth's magnetic field for orientation and navigation(1,2), the precise biophysical mechanisms underlying magnetic sensing have been elusive. One theoretical model proposes that geomagnetic fields are perceived by chemical reactions involving specialized photoreceptors(3). However, the specific photoreceptor involved in such magnetoreception has not been demonstrated conclusively in any animal. Here we show that the ultraviolet-A/blue-light photoreceptor cryptochrome ( Cry) is necessary for light- dependent magnetosensitive responses in Drosophila melanogaster. In a binary- choice behavioural assay for magnetosensitivity, wild- type flies show significant naive and trained responses to a magnetic field under full- spectrum light (similar to 300-700 nm) but do not respond to the field when wavelengths in the Cry- sensitive, ultraviolet- A/ blue- light part of the spectrum (<420 nm) are blocked. Notably, Cry- deficient cry(0) and cry(b) flies do not show either naive or trained responses to a magnetic field under full- spectrum light. Moreover, Cry- dependent magnetosensitivity does not require a functioning circadian clock. Our work provides, to our knowledge, the first genetic evidence for a Cry-based magnetosensitive system in any animal.	[Gegear, Robert J.; Casselman, Amy; Waddell, Scott; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Chan, Ryan/AAP-1584-2020	Gegear, Robert/0000-0001-9886-1324; Waddell, Scott/0000-0003-4503-6229	NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Zhu for the protein work in Fig. 4b, c; L. Foley for assistance; J. C. Hall for the cry<SUP>0</SUP> flies; P. Emery for the Per and Cry antibodies; and P. Emery, P. Perrat, B. Leung, S. DasGupta, M. Krashes and H. Zhu for discussions. This work was supported by grants from the NIH.	Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; PHILLIPS JB, 1993, J COMP PHYSIOL A, V172, P303, DOI 10.1007/BF00216612; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; WEHNER R, 1970, EXPERIENTIA, V26, P967, DOI 10.1007/BF02114135; Wiltschko R, 2006, BIOESSAYS, V28, P157, DOI 10.1002/bies.20363; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	30	287	304	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					1014	U61		10.1038/nature07183	http://dx.doi.org/10.1038/nature07183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18641630	Green Accepted			2022-12-24	WOS:000258591000043
J	Navarro, L; Jay, F; Nomura, K; He, SY; Voinnet, O				Navarro, Lionel; Jay, Florence; Nomura, Kinya; He, Sheng Yang; Voinnet, Olivier			Suppression of the microRNA pathway by bacterial effector proteins	SCIENCE			English	Article							ARABIDOPSIS INNATE IMMUNITY; PSEUDOMONAS-SYRINGAE; PLANT IMMUNITY; SMALL RNAS; DEFENSE; BAK1; METHYLATION; RESISTANCE; INHIBITOR; SECRETION	Plants and animals sense pathogen- associated molecular patterns ( PAMPs) and in turn differentially regulate a subset of microRNAs ( miRNAs). However, the extent to which the miRNA pathway contributes to innate immunity remains unknown. Here, we show that miRNA- deficient mutants of Arabidopsis partly restore growth of a type III secretion- defective mutant of Pseudomonas syringae. These mutants also sustained growth of nonpathogenic Pseudomonas fluorescens and Escherichia coli strains, implicating miRNAs as key components of plant basal defense. Accordingly, we have identified P. syringae effectors that suppress transcriptional activation of some PAMP- responsive miRNAs or miRNA biogenesis, stability, or activity. These results provide evidence that, like viruses, bacteria have evolved to suppress RNA silencing to cause disease.	[Navarro, Lionel; Jay, Florence; Voinnet, Olivier] Univ Strasbourg 1, Inst Biol Mol Plantes, CNRS, UPR 2353, F-67084 Strasbourg, France; [Nomura, Kinya; He, Sheng Yang] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Michigan State University	Voinnet, O (corresponding author), Univ Strasbourg 1, Inst Biol Mol Plantes, CNRS, UPR 2353, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr	Bruening, Stefan/B-8505-2011	JAY, Florence/0000-0001-7353-8299; Voinnet, Olivier/0000-0001-6982-9544	NIAID NIH HHS [5R01AI060761, R01 AI060761-03, R01 AI060761] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060761] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	29	265	293	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					964	967		10.1126/science.1159505	http://dx.doi.org/10.1126/science.1159505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18703740	Green Accepted			2022-12-24	WOS:000258436700039
J	Bays, PM; Husain, M				Bays, Paul M.; Husain, Masud			Dynamic shifts of limited working memory resources in human vision	SCIENCE			English	Article							SHORT-TERM-MEMORY; VISUAL-ATTENTION; EYE-MOVEMENTS; POPULATION CODES; PARIETAL CORTEX; INFORMATION; CAPACITY; CONJUNCTIONS; PERCEPTION; FEATURES	Our ability to remember what we have seen is very limited. Most current views characterize this limit as a fixed number of items-only four objects-that can be held in visual working memory. We show that visual memory capacity is not fixed by the number of objects, but rather is a limited resource that is shared out dynamically between all items in the visual scene. This resource can be shifted flexibly between objects, with allocation biased by selective attention and toward targets of upcoming eye movements. The proportion of resources allocated to each item determines the precision with which it is remembered, a relation that we show is governed by a simple power law, allowing quantitative estimates of resource distribution in a scene.	[Bays, Paul M.; Husain, Masud] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Bays, Paul M.; Husain, Masud] UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Bays, PM (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.bays@ion.ucl.ac.uk	Bays, Paul/B-3999-2009; Ca, Ma/AAW-6714-2021; Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Bays, Paul/0000-0003-4684-4893	Wellcome Trust [061140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N., 1995, ATTENTION MEMORY INT; DAVIDSON ML, 1973, PERCEPT PSYCHOPHYS, V14, P110, DOI 10.3758/BF03198624; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; ERIKSEN CW, 1973, PERCEPT PSYCHOPHYS, V14, P155, DOI 10.3758/BF03198630; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; PALMER J, 1990, J EXP PSYCHOL HUMAN, V16, P332, DOI 10.1037/0096-1523.16.2.332; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; WICKENS TD, 2002, ELEMENTARY SIGNAL DE; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	33	734	759	12	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					851	854		10.1126/science.1158023	http://dx.doi.org/10.1126/science.1158023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687968	Green Accepted			2022-12-24	WOS:000258261000050
J	Palamidessi, A; Frittoli, E; Garre, M; Faretta, M; Mione, M; Testa, I; Diaspro, A; Lanzetti, L; Scita, G; Di Fiore, PP				Palamidessi, Andrea; Frittoli, Emanuela; Garre, Massimiliano; Faretta, Mario; Mione, Marina; Testa, Ilaria; Diaspro, Alberto; Lanzetti, Letizia; Scita, Giorgio; Di Fiore, Pier Paolo			Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration	CELL			English	Article							LIVING CELLS; RHO-GTPASES; MEMBRANE; CANCER; PROTEINS; INTEGRIN; INVASION; POLARITY; INTERNALIZATION; LOCALIZATION	The small GTPases, Rab5 and Rac, are essential for endocytosis and actin remodeling, respectively. Coordination of these processes is critical to achieve spatial restriction of intracellular signaling, which is essential for a variety of polarized functions. Here, we show that clathrin- and Rab5- mediated endocytosis are required for the activation of Rac induced by motogenic stimuli. Rac activation occurs on early endosomes, where the RacGEF Tiam1 is also recruited. Subsequent recycling of Rac to the plasma membrane ensures localized signaling, leading to the formation of actin- based migratory protrusions. Thus, membrane trafficking of Rac is required for the spatial resolution of Rac-dependent motogenic signals. We further demonstrate that a Rab5-to-Rac circuitry controls the morphology of motile mammalian tumor cells and primordial germinal cells during zebrafish development, suggesting that this circuitry is relevant for the regulation of migratory programs in various cells, in both in vitro settings and whole organisms.	[Palamidessi, Andrea; Frittoli, Emanuela; Garre, Massimiliano; Faretta, Mario; Mione, Marina; Scita, Giorgio; Di Fiore, Pier Paolo] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Garre, Massimiliano; Faretta, Mario; Di Fiore, Pier Paolo] Ist Europeo Oncol, Dipartimento Oncol Sperimentale, I-20141 Milan, Italy; [Testa, Ilaria; Diaspro, Alberto] Univ Genoa, Dept Phys, LAMBS MicroScoBio, I-16146 Genoa, Italy; [Lanzetti, Letizia] Univ Turin, Ist Ric & Cura Cancro, Dipartimento Sci Oncol, I-10060 Turin, Italy; [Scita, Giorgio; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Genoa; University of Turin; University of Milan	Scita, G (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Via Adamello 16, I-20139 Milan, Italy.	giorgio.scita@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Mione, Maria Caterina/ABG-9926-2021; Mione, Maria Caterina/I-3073-2013; Di Fiore, Pier Paolo/K-2130-2012; Faretta, Mario/H-8946-2012; Diaspro, Alberto/E-7833-2010; Palamidessi, Andrea/F-1203-2018; Scita, Giorgio/J-9670-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Faretta, Mario/0000-0003-1678-5781; Diaspro, Alberto/0000-0002-4916-5928; Scita, Giorgio/0000-0001-7984-1889; Garre', Massimiliano/0000-0001-9332-0270; Testa, Ilaria/0000-0003-4005-4997; LANZETTI, Letizia/0000-0001-7541-5524; Mione, Maria Caterina/0000-0002-9040-3705; palamidessi, andrea/0000-0002-7134-7023	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Arvelo Francisco, 2006, Invest. clín, V47, P185; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Drummond AH, 1999, ANN NY ACAD SCI, V878, P228, DOI 10.1111/j.1749-6632.1999.tb07688.x; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukui Y, 2002, CELL BIOL INT, V26, P933, DOI 10.1006/cbir.2002.0959; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich D, 2002, CURR OPIN CELL BIOL, V14, P563, DOI 10.1016/S0955-0674(02)00374-5; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	41	332	338	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					135	147		10.1016/j.cell.2008.05.034	http://dx.doi.org/10.1016/j.cell.2008.05.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614017	Bronze			2022-12-24	WOS:000257513100020
J	Stagg, SM; LaPointe, P; Razvi, A; Gurkan, C; Potter, CS; Carragher, B; Balch, WE				Stagg, Scott M.; LaPointe, Paul; Razvi, Abbas; Gurkan, Cemal; Potter, Clinton S.; Carragher, Bridget; Balch, William E.			Structural basis for cargo regulation of COPII coat assembly	CELL			English	Article							ENDOPLASMIC-RETICULUM; VESICLE FORMATION; MEMBRANE CURVATURE; TRANSPORT; PROTEINS; GOLGI; CAGE; SELECTION; GTPASE; ER	Using cryo-electron microscopy, we have solved the structure of an icosidodecahedral COPII coat involved in cargo export from the endoplasmic reticulum ( ER) coassembled from purified cargo adaptor Sec23-24 and Sec13-31 lattice-forming complexes. The coat structure shows a tetrameric assembly of the Sec23-24 adaptor layer that is well positioned beneath the vertices and edges of the Sec13-31 lattice. Fitting the known crystal structures of the COPII proteins into the density map reveals a flexible hinge region stemming from interactions between WD40 beta-propeller domains present in Sec13 and Sec31 at the vertices. The structure shows that the hinge region can direct geometric cage expansion to accommodate a wide range of bulky cargo, including procollagen and chylomicrons, that is sensitive to adaptor function in inherited disease. The COPII coat structure leads us to propose a mechanism by which cargo drives cage assembly and membrane curvature for budding from the ER.	[Stagg, Scott M.; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Nat Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Stagg, Scott M.; LaPointe, Paul; Razvi, Abbas; Gurkan, Cemal; Potter, Clinton S.; Carragher, Bridget; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Stagg, Scott M.; LaPointe, Paul; Razvi, Abbas; Gurkan, Cemal; Potter, Clinton S.; Carragher, Bridget; Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Gurkan, Cemal] Cyprus Inst Neurol & Genet, Dept Electron Microscopy & Mol Pathol, Nicosia, Cyprus; [Stagg, Scott M.] Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; State University System of Florida; Florida State University	Carragher, B (corresponding author), Scripps Res Inst, Nat Resource Automated Mol Microscopy, La Jolla, CA 92037 USA.	bcarr@scripps.edu; webalch@scripps.edu	Gurkan, Cemal/S-5751-2016	Gurkan, Cemal/0000-0001-7379-4559; LaPointe, Paul/0000-0002-5465-1795; Carragher, Bridget/0000-0002-0624-5020	National Institutes of Health (NIH); National Center for Research Resources' P41 program [RR17573]; NIH [GM42336, GM073509]; Cystic Fibrosis Foundation Consortium [NIH R33EB00798, NSF EIA0121282]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB000798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, F32GM073509] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources' P41 program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health (NIH) though the National Center for Research Resources' P41 program (RR17573) with additional NIH support to W. E. B. (GM42336) and S. S. (GM073509). P. L., A. R., and C. G. were supported by fellowships from the Cystic Fibrosis Foundation Consortium. We acknowledge Dr. Arthur J. Olson (NIH R33EB00798 and NSF EIA0121282 to A. Olson) for construction and use of tangible interface (3D) models for analysis of structural features of the COPII coat.	Antonny B, 2005, BIOCHEM SOC T, V33, P619, DOI 10.1042/BST0330619; Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Shoulders CC, 2004, CURR OPIN LIPIDOL, V15, P191, DOI 10.1097/00041433-200404000-00012; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006	37	197	203	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					474	484		10.1016/j.cell.2008.06.024	http://dx.doi.org/10.1016/j.cell.2008.06.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692470	Green Accepted, Bronze			2022-12-24	WOS:000258665500020
J	Holmes, C; Boche, D; Wilkinson, D; Yadegarfar, G; Hopkins, V; Bayer, A; Jones, RW; Bullock, R; Love, S; Neal, JW; Zotova, E; Nicoll, JAR				Holmes, Clive; Boche, Delphine; Wilkinson, David; Yadegarfar, Ghasem; Hopkins, Vivienne; Bayer, Anthony; Jones, Roy W.; Bullock, Roger; Love, Seth; Neal, James W.; Zotova, Elina; Nicoll, James A. R.			Long-term effects of A beta(42) immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial	LANCET			English	Article							AMYLOID-BETA PROTEIN; A-BETA-42 IMMUNIZATION; PEPTIDE; AD; IMMUNOTHERAPY; VACCINATION; ANTIBODIES; DEMENTIA; MEMORY; AN1792	Background Immunisation of patients with Alzheimer's disease with full-length amyloid-beta peptide (A beta(42)) can clear amyloid plaques from the brain. Our aim was to assess the relation between A beta(42) immune response, degree of plaque removal, and long-term clinical outcomes. Methods In June, 2003, consent for long-term clinical follow-up, post-mortem neuropathological examination, or both, was sought from 80 patients (or their carers) who had entered a phase I randomised, placebo-controlled trial of immunisation with A beta(42) (AN1792, Elan Pharmaceuticals) in September, 2000. The follow-up study was completed in September, 2006. Plaques were assessed in terms of the percentage area of the cortex with A beta immunostaining (A beta load) and in terms of characteristic histological features reflecting plaque removal. Survival of all 80 individuals until severe dementia or death was assessed with a Cox proportional hazard model. Findings 20 participants-15 in the AN1792 group, five in the placebo group-died before follow-up started. A further 22 patients-19 in the AN1792 group, three in the placebo group-died during follow-up. Nine of the deceased patients, all in the AN1792 group, had given consent for post-mortem analysis; one of these who did not die with Alzheimer's disease was excluded. in the remaining eight participants who received immunisation and who were examined neuropathologically, mean A beta load was lower than in an unimmunised control group that was matched for age at death (2.1% [SE 0.7] in treated participants vs 5.1% [0.9] in controls; mean difference 3.0%, 95% CI 0.6-5.4; p=0.02). Although there was considerable variation in A beta load and degree of plaque removal among immunised participants, the degree of plaque removal varied significantly with mean antibody response attained during the treatment study period (Kruskal-Wallis p=0.02). Seven of the eight immunised patients who underwent post-mortem assessment, including those with virtually complete plaque removal, had severe end stage dementia before death. In the whole cohort, there was no evidence of improved survival (hazard ratio 0.93, 95% CI 0.43-3.11; p=0.86) or of an improvement in the time to severe dementia (1.18, 0.45-3.11; p=0.73) in the AN1792 group versus the placebo group. Interpretation Although immunisation with A beta(42) resulted in clearance of amyloid plaques in patients with Alzheimer's disease, this clearance did not prevent progressive neurodegeneration.	[Holmes, Clive; Wilkinson, David; Hopkins, Vivienne] Moorgreen Hosp, Hampshire Partnership Trust, Memory Assessment & Res Ctr, Southampton SO30 3JB, Hants, England; [Holmes, Clive; Boche, Delphine; Wilkinson, David; Zotova, Elina; Nicoll, James A. R.] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [Yadegarfar, Ghasem] Univ Southampton, Sch Med, Publ Hlth Sci & Med Stat Grp RDSU, Southampton, Hants, England; [Nicoll, James A. R.] Southampton Univ Hosp NHS Trust, Dept Cellular Pathol, Southampton, Hants, England; [Yadegarfar, Ghasem] Isfahan Univ Med Sci, Dept Epidemiol & Biostat, Sch Hlth Sci, Esfahan, Iran; [Bayer, Anthony; Neal, James W.] Univ Wales Coll Cardiff, Dept Geriatr Med, Cardiff, Wales; [Bayer, Anthony; Neal, James W.] Univ Wales Coll Cardiff, Dept Pathol, Cardiff, Wales; [Jones, Roy W.] Royal United Hosp, Res Inst Care Elderly, Bath BA1 3NG, Avon, England; [Bullock, Roger] Victoria Hosp, Kingshill Res Ctr, Swindon, Wilts, England; [Love, Seth] Univ Bristol, Dept Neuropathol, Bristol, Avon, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Isfahan University Medical Science; Cardiff University; Cardiff University; University of Bristol	Holmes, C (corresponding author), Moorgreen Hosp, Hampshire Partnership Trust, Memory Assessment & Res Ctr, Botley Rd, Southampton SO30 3JB, Hants, England.	ch4@soton.ac.uk	Bayer, Antony/H-4434-2019; Love, Seth/E-6545-2012; Boche, Delphine/A-7589-2011; Yadegarfar, Ghasem G/G-3016-2017; Bayer, Antony/H-4376-2019; Nicoll, James/I-9253-2017	Bayer, Antony/0000-0002-7514-248X; Boche, Delphine/0000-0002-5884-130X; Yadegarfar, Ghasem G/0000-0002-5331-3890; Holmes, Clive/0000-0003-1999-6912; Nicoll, James/0000-0002-9444-7246; Love, Seth/0000-0001-8683-3625	Alzheimers Research UK [ART-PG2006-4, ART-ESG2005-3] Funding Source: researchfish; Medical Research Council [G0501033] Funding Source: Medline; MRC [G0501033] Funding Source: UKRI	Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Bombois S, 2007, ARCH NEUROL-CHICAGO, V64, P583, DOI 10.1001/archneur.64.4.583; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Esiri MM, 2001, LANCET, V357, P169; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 1997, Int Psychogeriatr, V9 Suppl 1, P163, DOI 10.1017/S1041610297004857; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mattson MP, 2003, SCIENCE, V301, P1847, DOI 10.1126/science.301.5641.1847; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; PRIDE MW, 2004, INT C ALZH DIS REL D; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Smith MA, 2002, LANCET, V359, P1864, DOI 10.1016/S0140-6736(02)08695-6; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Wilcock DM, 2007, NEUROSCIENCE, V144, P950, DOI 10.1016/j.neuroscience.2006.10.020; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; World Health Organisation, 1993, ICD 10 CLASS MENT BE	32	1083	1170	1	167	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2008	372	9634					216	223		10.1016/S0140-6736(08)61075-2	http://dx.doi.org/10.1016/S0140-6736(08)61075-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327YH	18640458				2022-12-24	WOS:000257763900031
J	Skotheim, JM; Di Talia, S; Siggia, ED; Cross, FR				Skotheim, Jan M.; Di Talia, Stefano; Siggia, Eric D.; Cross, Frederick R.			Positive feedback of G1 cyclins ensures coherent cell cycle entry	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; G1-SPECIFIC TRANSCRIPTION; FLUORESCENT PROTEIN; GENE-EXPRESSION; BUDDING YEAST; CDK ACTIVITY; CLN3; START; DIVISION	In budding yeast, Saccharomyces cerevisiae, the Start checkpoint integrates multiple internal and external signals into an all- or- none decision to enter the cell cycle. Here we show that Start behaves like a switch due to systems- level feedback in the regulatory network. In contrast to current models proposing a linear cascade of Start activation, transcriptional positive feedback of the G1 cyclins Cln1 and Cln2 induces the near- simultaneous expression of the similar to 200- gene G1/ S regulon. Nuclear Cln2 drives coherent regulon expression, whereas cytoplasmic Cln2 drives efficient budding. Cells with the CLN1 and CLN2 genes deleted frequently arrest as unbudded cells, incurring a large fluctuation- induced fitness penalty due to both the lack of cytoplasmic Cln2 and insufficient G1/ S regulon expression. Thus, positive- feedback- amplified expression of Cln1 and Cln2 simultaneously drives robust budding and rapid, coherent regulon expression. A similar G1/ S regulatory network in mammalian cells, comprised of non- orthologous genes, suggests either conservation of regulatory architecture or convergent evolution.	[Skotheim, Jan M.; Di Talia, Stefano; Siggia, Eric D.; Cross, Frederick R.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA	Rockefeller University	Skotheim, JM (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	skotheim@stanford.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820; Di Talia, Stefano/0000-0001-9758-7925	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078153, F32GM078769] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078153-01, F32 GM078769-01, F32 GM078769, R01 GM078153-02, F32 GM078769-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Edgington NP, 2001, J CELL SCI, V114, P4599; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kato M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r56; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; LORD PG, 1981, J CELL SCI, V50, P361; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; SIMCHEN G, 1972, EXP CELL RES, V75, P207, DOI 10.1016/0014-4827(72)90538-1; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	43	251	254	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					291	U12		10.1038/nature07118	http://dx.doi.org/10.1038/nature07118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18633409	Green Accepted			2022-12-24	WOS:000257665300029
J	Ly, A; Nikolaev, A; Suresh, G; Zheng, YF; Tessier-Lavigne, M; Stein, E				Ly, Alice; Nikolaev, Anatoly; Suresh, Geetha; Zheng, Yufang; Tessier-Lavigne, Marc; Stein, Elke			DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1	CELL			English	Article							AXON GUIDANCE; COMMISSURAL AXONS; NERVOUS-SYSTEM; DOWN-SYNDROME; SPINAL-CORD; MOLECULAR DIVERSITY; SELF-AVOIDANCE; SONIC HEDGEHOG; REQUIRE DSCAM; DROSOPHILA	During nervous system development, spinal commissural axons project toward and across the ventral midline. They are guided in part by netrin-1, made by midline cells, which attracts the axons by activating the netrin receptor DCC. However, previous studies suggest that additional receptor components are required. Here, we report that the Down's syndrome Cell Adhesion Molecule (DSCAM), a candidate gene implicated in the mental retardation phenotype of Down's syndrome, is expressed on spinal commissural axons, binds netrin-1, and is necessary for commissural axons to grow toward and across the midline. DSCAM and DCC can each mediate a turning response of these neurons to netrin-1. Similarly, Xenopus spinal neurons exogenously expressing DSCAM can be attracted by netrin-1 independently of DCC. These results show that DSCAM is a receptor that can mediate turning responses to netrin-1 and support a key role for netrin/DSCAM signaling in commissural axon guidance in vertebrates.	[Ly, Alice; Suresh, Geetha; Zheng, Yufang; Stein, Elke] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Stein, Elke] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Stein, Elke] Yale Univ, Interdisciplinary Neurosci Program, New Haven, CT 06520 USA; [Stein, Elke] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Nikolaev, Anatoly; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA	Yale University; Yale University; Yale University; Yale University; Roche Holding; Genentech	Stein, E (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 266 Whitney Ave, New Haven, CT 06520 USA.	elke.stein@yale.edu	Stein, Elke/E-8107-2013; Zheng, Yufang/F-1091-2011	Stein, Elke/0000-0001-8965-5692; Zheng, Yufang/0000-0002-0488-2624; Nikolaev, Anatoly/0000-0003-2818-5839	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [S10 RR022636-01A1, S10-RR22636, S10 RR022636] Funding Source: Medline; NIGMS NIH HHS [T32-GM07499, T32 GM007499] Funding Source: Medline; NIMH NIH HHS [R01 MH071404-03, R01 MH071404] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071404] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Barlow GM, 2002, BIOCHEM BIOPH RES CO, V293, P881, DOI 10.1016/S0006-291X(02)00307-8; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ding YQ, 2005, DEVELOPMENT, V132, P2047, DOI 10.1242/dev.01798; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; ZHANG JQ, 1994, NATURE, V368, P140; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	39	194	201	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1241	1254		10.1016/j.cell.2008.05.030	http://dx.doi.org/10.1016/j.cell.2008.05.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585357	Bronze, Green Accepted			2022-12-24	WOS:000257144600020
J	Zubkov, MV; Tarran, GA				Zubkov, Mikhail V.; Tarran, Glen A.			High bacterivory by the smallest phytoplankton in the North Atlantic Ocean	NATURE			English	Article							AMINO-ACID-UPTAKE; PLANKTONIC PROTISTS; SURFACE WATERS; FLOW-CYTOMETRY; FOOD WEBS; MIXOTROPHY; BACTERIOPLANKTON; CYANOBACTERIA; ASSIMILATION; ENUMERATION	Planktonic algae, <5 mu m in size are major fixers of inorganic carbon in the ocean(1). They dominate phytoplankton biomass in post-bloom, stratified oceanic temperate waters(2). Traditionally, large and small algae are viewed as having a critical growth dependence on inorganic nutrients, which the latter can better acquire at lower ambient concentrations owing to their higher surface area to volume ratios(3,4). Nonetheless, recent phosphate tracer experiments in the oligotrophic ocean(5) have suggested that small algae obtain inorganic phosphate indirectly, possibly through feeding on bacterioplankton. There have been numerous microscopy- based studies of algae feeding mixotrophically(6,7) in the laboratory(8-10) and field(11-14), as well as mathematical modelling of the ecological importance of mixotrophy(15). However, because of methodological limitations(16) there has not been a direct comparison of obligate heterotrophic and mixotrophic bacterivory. Here we present direct evidence that small algae carry out 40 - 95% of the bacterivory in the euphotic layer of the temperate North Atlantic Ocean in summer. A similar range of 37 - 70% was determined in the surface waters of the tropical North- East Atlantic Ocean, suggesting the global significance of mixotrophy. This finding reveals that even the smallest algae have less dependence on dissolved inorganic nutrients than previously thought, obtaining a quarter of their biomass from bacterivory. This has important implications for how we perceive nutrient acquisition and limitation of carbon- fixing protists as well as control of bacterioplankton in the ocean.	[Zubkov, Mikhail V.] Natl Ocean Ctr, Southampton SO14 3ZH, Hants, England; [Tarran, Glen A.] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	NERC National Oceanography Centre; Plymouth Marine Laboratory	Zubkov, MV (corresponding author), Natl Ocean Ctr, Southampton SO14 3ZH, Hants, England.	mvz@noc.soton.ac.uk	Zubkov, Mikhail/AAW-9674-2020	Zubkov, Mikhail/0000-0001-7723-6810	UK Natural Environment Research Council (NERC); Oceans 2025 core programmes of the National Oceanography Centre; Southampton and Plymouth Marine Laboratory; NERC thematic programme Surface Ocean Low Atmosphere Study (SOLAS); NERC [soc010012, soc010008, NE/E016138/1, pml010002] Funding Source: UKRI; Natural Environment Research Council [soc010012, pml010002, NE/C001931/1, NE/E016138/1, soc010008] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Oceans 2025 core programmes of the National Oceanography Centre; Southampton and Plymouth Marine Laboratory; NERC thematic programme Surface Ocean Low Atmosphere Study (SOLAS)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We gratefully acknowledge the captain, officers and crew aboard the RRS Discovery for their help during the cruises, M. Moore for sharing chlorophyll concentration measurements, P. Hill for helping with setting up experiments on the second cruise, and P. Warwick for his help with radiotracer measurements ashore. We thank M. Sleigh, A. Martin and R. Leakey for their critical comments on the earlier drafts of the paper. We thank H. Ducklow for constructive criticism of the earlier version of this paper. This study was supported by the UK Natural Environment Research Council (NERC) through the Oceans 2025 core programmes of the National Oceanography Centre, Southampton and Plymouth Marine Laboratory. The second cruise was supported by the NERC thematic programme Surface Ocean Low Atmosphere Study (SOLAS).	ARENOVSKI AL, 1995, J PLANKTON RES, V17, P801, DOI 10.1093/plankt/17.4.801; BIRD DF, 1986, SCIENCE, V231, P493, DOI 10.1126/science.231.4737.493; CARON DA, 2000, MICROBIAL ECOLOGY OC, P495, DOI DOI 10.1175/1520-0493(2000)1281993:SOOTWJ2.0.CO;2; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Hansen PJ, 2002, MAR BIOL, V141, P975, DOI 10.1007/s00227-002-0879-5; Jones RI, 2000, FRESHWATER BIOL, V45, P219, DOI 10.1046/j.1365-2427.2000.00672.x; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; MALONE TC, 1980, PHYSL ECOLOGY PHYTOP, P433; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Mary I, 2008, FEMS MICROBIOL ECOL, V63, P36, DOI 10.1111/j.1574-6941.2007.00414.x; Olson R.J., 2018, HDB METHODS AQUATIC, P175, DOI DOI 10.1201/9780203752746; Rothhaupt KO, 1996, ECOLOGY, V77, P716, DOI 10.2307/2265496; SHERR BF, 1987, APPL ENVIRON MICROB, V53, P958, DOI 10.1128/AEM.53.5.958-965.1987; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Stibor H, 2003, PROTIST, V154, P91, DOI 10.1078/143446103764928512; Tarran GA, 2001, DEEP-SEA RES PT II, V48, P963, DOI 10.1016/S0967-0645(00)00104-1; Thingstad TF, 1996, ECOLOGY, V77, P2108, DOI 10.2307/2265705; Tittel J, 2003, P NATL ACAD SCI USA, V100, P12776, DOI 10.1073/pnas.2130696100; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; VAQUE D, 1994, MAR ECOL PROG SER, V109, P263, DOI 10.3354/meps109263; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x; Zubkov MV, 2006, CYTOM PART A, V69A, P1010, DOI 10.1002/cyto.a.20332; Zubkov M, 2007, J PLANKTON RES, V29, P79; Zubkov MV, 2004, FEMS MICROBIOL ECOL, V50, P153, DOI 10.1016/j.femsec.2004.06.009; Zubkov MV, 2005, FEMS MICROBIOL ECOL, V54, P281, DOI 10.1016/j.femsec.2005.04.001; Zubkov MV, 1998, FEMS MICROBIOL ECOL, V27, P85, DOI 10.1111/j.1574-6941.1998.tb00527.x; ZUBKOV MV, 1995, MICROBIAL ECOL, V30, P157, DOI 10.1007/BF00172571	28	254	258	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					224	U48		10.1038/nature07236	http://dx.doi.org/10.1038/nature07236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18690208				2022-12-24	WOS:000259090800047
J	Sakamoto, T; Webb, MR; Forgacs, E; White, HD; Sellers, JR				Sakamoto, Takeshi; Webb, Martin R.; Forgacs, Eva; White, Howard D.; Sellers, James R.			Direct observation of the mechanochemical coupling in myosin Va during processive movement	NATURE			English	Article							SINGLE-MOLECULE; KINETIC MECHANISM; NECK LENGTH; ADP; ATP; MOTOR	Myosin Va transports intracellular cargoes along actin filaments in cells(1). This processive, two- headed motor takes multiple 36- nm steps in which the two heads swing forward alternately towards the barbed end of actin driven by ATP hydrolysis(2). The ability of myosin Va to move processively is a function of its long lever arm, the high duty ratio of its kinetic cycle and the gating of the kinetics between the two heads such that ADP release from the lead head is greatly retarded(3-10). Mechanical studies at the multiple- and the single- molecule level suggest that there is tight coupling ( that is, one ATP is hydrolysed per power stroke), but this has not been directly demonstrated(4,5,11). We therefore investigated the coordination between the ATPase mechanism of the two heads of myosin Va and directly visualized the binding and dissociation of single fluorescently labelled nucleotide molecules, while simultaneously observing the stepping motion of the fluorescently labelled myosin Va as it moved along an actin filament. Here we show that preferential ADP dissociation from the trail head of mouse myosin Va is followed by ATP binding and a synchronous 36- nm step. Even at low ATP concentrations, the myosin Va molecule retained at least one nucleotide ( ADP in the lead head position) when moving. Thus, we directly demonstrate tight coupling between myosin Va movement and the binding and dissociation of nucleotidebysimultaneouslyimagingwithnearnanometreprecision.	[Sakamoto, Takeshi; Sellers, James R.] NHLBI, Lab Mol Physiol, Bethesda, MD 20892 USA; [Webb, Martin R.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Forgacs, Eva; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MRC National Institute for Medical Research; Eastern Virginia Medical School	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, Bldg 10, Bethesda, MD 20892 USA.	Sellersj@mail.nih.gov		Webb, Martin/0000-0002-0134-9621	Medical Research Council, UK; National Heart, Lung and Blood Intramural Program; NIH [EB00209]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung and Blood Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. Zhang, A. Smith and G. Reid for technical assistance; E. Yokoi for the TIRF illuminator to combine two optical cables; C. Fanghella for technical help in the calculation of the number of photons; and C. Weaver for help with Metamorph. We are appreciative of the critical comments on the manuscript made by P.J. Knight and E. Homsher. M.R.W. was supported by the Medical Research Council, UK. J.R.S. and T.S. were supported by the National Heart, Lung and Blood Intramural Program. H. D. W. and E. F. were supported by NIH EB00209 and a postdoctoral fellowship from the American Heart Association.	Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Ishijima A, 1996, BIOPHYS J, V70, P383, DOI 10.1016/S0006-3495(96)79582-6; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oiwa K, 2000, BIOPHYS J, V78, P3048, DOI 10.1016/S0006-3495(00)76843-3; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; SELLERS JR, 2008, MYOSINS SUPERFAMILY, V7, P289; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	27	97	98	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					128	U99		10.1038/nature07188	http://dx.doi.org/10.1038/nature07188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668042	Green Accepted			2022-12-24	WOS:000258890200051
J	Gong, Y; Cao, P; Yu, HJ; Jiang, T				Gong, Yong; Cao, Peng; Yu, Hong-jun; Jiang, Tao			Crystal structure of the neurotrophin-3 and p75(NTR) symmetrical complex	NATURE			English	Article							NERVE GROWTH-FACTOR; RECEPTORS; BINDING; ACTIVATION; TRKA; P75	Neurotrophins (NTs) are important regulators for the survival, differentiation and maintenance of different peripheral and central neurons. NTs bind to two distinct classes of glycosylated receptor: the p75 neurotrophin receptor (p75(NTR)) and tyrosine kinase receptors (Trks). Whereas p75(NTR) binds to all NTs, the Trk subtypes are specific for each NT1,2. The question of whether NTs stimulate p75(NTR) by inducing receptor homodimerization is still under debate. Here we report the 2.6-angstrom resolution crystal structure of neurotrophin-3 (NT-3) complexed to the ectodomain of glycosylated p75(NTR). In contrast to the previously reported asymmetric complex structure, which contains a dimer of nerve growth factor (NGF) bound to a single ectodomain of deglycosylated p75(NTR) (ref. 3), we show that NT-3 forms a central homodimer around which two glycosylated p75(NTR) molecules bind symmetrically. Symmetrical binding occurs along the NT-3 interfaces, resulting in a 2:2 ligand-receptor cluster. A comparison of the symmetrical and asymmetric structures reveals significant differences in ligand receptor interactions and p75(NTR) conformations. Biochemical experiments indicate that both NT-3 and NGF bind to p75(NTR) with 2:2 stoichiometry in solution, whereas the 2:1 complexes are the result of artificial deglycosylation. We therefore propose that the symmetrical 2:2 complex reflects a native state of p75(NTR) activation at the cell surface. These results provide a model for NTs-p75(NTR) recognition and signal generation, as well as insights into coordination between p75(NTR) and Trks.	[Gong, Yong; Cao, Peng; Yu, Hong-jun; Jiang, Tao] Chinese Acad Sci, Natl Key Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Jiang, T (corresponding author), Chinese Acad Sci, Natl Key Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	tjiang@ibp.ac.cn		, Peng/0000-0002-2044-3074; Yu, Hongjun/0000-0002-1483-2962				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARIBAULT TJ, 1985, J NEUROSCI RES, V14, P49, DOI 10.1002/jnr.490140105; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McInnes C, 1997, BIOPOLYMERS, V43, P339, DOI 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schweigreiter R, 2006, BIOESSAYS, V28, P583, DOI 10.1002/bies.20419; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705	28	91	97	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2008	454	7205					789	U114		10.1038/nature07089	http://dx.doi.org/10.1038/nature07089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334NH	18596692				2022-12-24	WOS:000258228000050
J	Tsukamoto, S; Kuma, A; Murakami, M; Kishi, C; Yamamoto, A; Mizushima, N				Tsukamoto, Satoshi; Kuma, Akiko; Murakami, Mirei; Kishi, Chieko; Yamamoto, Akitsugu; Mizushima, Noboru			Autophagy is essential for preimplantation development of mouse embryos	SCIENCE			English	Article							SELF-DIGESTION; CELLS; TRANSITION; MARKER; LC3; DEGRADATION; INHIBITION; OOCYTES; DISEASE; MICE	After fertilization, maternal proteins in oocytes are degraded and new proteins encoded by the zygotic genome are synthesized. We found that autophagy, a process for the degradation of cytoplasmic constituents in the lysosome, plays a critical role during this period. Autophagy was triggered by fertilization and up- regulated in early mouse embryos. Autophagy- defective oocytes derived from oocyte- specific Atg5 ( autophagy- related 5) knockout mice failed to develop beyond the four- and eight- cell stages if they were fertilized by Atg5- null sperm, but could develop if they were fertilized by wild- type sperm. Protein synthesis rates were reduced in the autophagy- null embryos. Thus, autophagic degradation within early embryos is essential for preimplantation development in mammals.	[Tsukamoto, Satoshi; Kuma, Akiko; Murakami, Mirei; Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Kuma, Akiko; Mizushima, Noboru] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Tsukamoto, Satoshi/0000-0001-7063-8825				BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MERZ EA, 1981, J REPROD FERTIL, V61, P415, DOI 10.1530/jrf.0.0610415; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697	23	409	431	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					117	120		10.1126/science.1154822	http://dx.doi.org/10.1126/science.1154822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599786				2022-12-24	WOS:000257320800050
J	McAllister, SS; Gifford, AM; Greiner, AL; Kelleher, SP; Saelzler, MP; Ince, TA; Reinhardt, F; Harris, LN; Hylander, BL; Repasky, EA; Weinberg, RA				McAllister, Sandra S.; Gifford, Ann M.; Greiner, Ashley L.; Kelleher, Stephen P.; Saelzler, Matthew P.; Ince, Tan A.; Reinhardt, Ferenc; Harris, Lyndsay N.; Hylander, Bonnie L.; Repasky, Elizabeth A.; Weinberg, Robert A.			Systemic endocrine instigation of indolent tumor growth requires osteopontin	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; BREAST-CANCER; GENE-EXPRESSION; STROMAL FIBROBLASTS; TRANSGENIC MICE; MYELOID CELLS; IN-VITRO; ANGIOGENESIS; PROGENITORS	The effects of primary tumors on the host systemic environment and resulting contributions of the host to tumor growth are poorly understood. Here, we find that human breast carcinomas instigate the growth of otherwise-indolent tumor cells, micrometastases, and human tumor surgical specimens located at distant anatomical sites. This systemic instigation is accompanied by incorporation of bone-marrow cells (BMCs) into the stroma of the distant, once-indolent tumors. We find that BMCs of hosts bearing instigating tumors are functionally activated prior to their mobilization; hence, when coinjected with indolent cells, these activated BMCs mimic the systemic effects imparted by instigating tumors. Secretion of osteopontin by instigating tumors is necessary for BMC activation and the subsequent outgrowth of the distant otherwise-indolent tumors. These results reveal that outgrowth of indolent tumors can be governed on a systemic level by endocrine factors released by certain instigating tumors, and hold important experimental and therapeutic implications.	[McAllister, Sandra S.; Gifford, Ann M.; Greiner, Ashley L.; Kelleher, Stephen P.; Saelzler, Matthew P.; Ince, Tan A.; Reinhardt, Ferenc; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Greiner, Ashley L.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Kelleher, Stephen P.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Saelzler, Matthew P.; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ince, Tan A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Div Womens & Perinatal Pathol, Boston, MA 02115 USA; [Harris, Lyndsay N.] Yale Univ, Med Ctr, Dept Med Oncol, New Haven, CT 06510 USA; [Hylander, Bonnie L.; Repasky, Elizabeth A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Weinberg, Robert A.] MIT Ludwig Ctr Mol Oncol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Boston University; Williams College; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Roswell Park Cancer Institute; Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	McAllister, Sandra/J-7373-2012	Ince, Tan/0000-0003-0315-6425	NATIONAL CANCER INSTITUTE [K08CA092013, P01CA080111] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA080111, K08 CA092013, P0-CA080111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; Direkze NC, 2006, HEMATOL ONCOL, V24, P189, DOI 10.1002/hon.788; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Feng F, 2000, BREAST CANCER RES TR, V63, P71, DOI 10.1023/A:1006466516192; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; Gohongi T, 1999, NAT MED, V5, P1203, DOI 10.1038/13524; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Klarmann K, 2003, BLOOD, V102, P3120, DOI 10.1182/blood-2003-04-1249; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Naka T, 2002, CANCER RES, V62, P5800; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Olumi AF, 1999, CANCER RES, V59, P5002; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ramankulov A, 2007, J CANCER RES CLIN, V133, P643, DOI 10.1007/s00432-007-0215-z; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	45	327	336	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					994	1005		10.1016/j.cell.2008.04.045	http://dx.doi.org/10.1016/j.cell.2008.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555776	Green Accepted, Bronze			2022-12-24	WOS:000256693400015
J	Lata, S; Schoehn, G; Jain, A; Pires, R; Piehler, J; Gottlinger, HG; Weissenhorn, W				Lata, Suman; Schoehn, Guy; Jain, Ankur; Pires, Ricardo; Piehler, Jacob; Goettlinger, Heinrich G.; Weissenhorn, Winfried			Helical structures of ESCRT-III are disassembled by VPS4	SCIENCE			English	Article							LATE-BUDDING DOMAINS; PROTEINS; CYTOKINESIS; AUTOINHIBITION; TRAFFICKING; RECOGNITION; MACHINERY; FILAMENTS; RELEASE; CHMP3	During intracellular membrane trafficking and remodeling, protein complexes known as the ESCRTs ( endosomal sorting complexes required for transport) interact with membranes and are required for budding processes directed away from the cytosol, including the budding of intralumenal vesicles to form multivesicular bodies; for the budding of some enveloped viruses; and for daughter cell scission in cytokinesis. We found that the ESCRT- III proteins CHMP2A and CHMP3 ( charged multivesicular body proteins 2A and 3) could assemble in vitro into helical tubular structures that expose their membrane interaction sites on the outside of the tubule, whereas the AAA- type adenosine triphosphatase VPS4 could bind on the inside of the tubule and disassemble the tubes upon adenosine triphosphate hydrolysis. CHMP2A and CHMP3 copolymerized in solution, and their membrane targeting was cooperatively enhanced on planar lipid bilayers. Such helical CHMP structures could thus assemble within the neck of an inwardly budding vesicle, catalyzing late steps in budding under the control of VPS4.	[Lata, Suman; Schoehn, Guy; Pires, Ricardo; Weissenhorn, Winfried] Univ Grenoble 1, European Mol Biol Lab, CNRS, Unit Viral Host Cell Interact,UMR 5233, F-38042 Grenoble 9, France; [Schoehn, Guy] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct UMR 5075, F-38027 Grenoble 1, France; [Jain, Ankur; Piehler, Jacob] Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Goettlinger, Heinrich G.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Program Mol Med, Worcester, MA 01605 USA	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Goethe University Frankfurt; University of Massachusetts System; University of Massachusetts Worcester	Weissenhorn, W (corresponding author), Univ Grenoble 1, European Mol Biol Lab, CNRS, Unit Viral Host Cell Interact,UMR 5233, 6 Rue Jules Horowitz, F-38042 Grenoble 9, France.	weissenhorn@embl.fr	Vieira-Pires, Ricardo/J-5232-2013	Vieira-Pires, Ricardo/0000-0003-1830-3715; Gottlinger, Heinrich/0000-0003-4124-5824; Schoehn, Guy/0000-0002-1459-3201	Deutsche Forschungsgemeinschaft [SPP 1175]; Agence Nationale de la Recherche sur le SIDA; Universite Joseph Fourier; Agence Nationale de la Recherche; CNRS; NIH [AI29873]; European Molecular Biology Organization; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029873, R37AI029873] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence Nationale de la Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Universite Joseph Fourier; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Siebert (Institut de Biologie Structurale) for advice on UROX. This work was supported by Deutsche Forschungsgemeinschaft (SPP 1175) (W.W.), the Agence Nationale de la Recherche sur le SIDA (W.W.) Universite Joseph Fourier (W.W.), the Agence Nationale de la Recherche (G.S.) the CNRS (G.S.), the NIH (grant AI29873, H.G.), and by postdoctoral fellowships from the European Molecular Biology Organization (S.L.) and the International Human Frontier Science Program Organization (S.L.). The EM map has been deposited at the European Bioinformatics Institute accession code EMD-1536.	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	26	238	244	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1354	1357		10.1126/science.1161070	http://dx.doi.org/10.1126/science.1161070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18687924	Green Accepted			2022-12-24	WOS:000258914300050
J	Kumar, P; Ban, HS; Kim, SS; Wu, HQ; Pearson, T; Greiner, DL; Laouar, A; Yao, JH; Haridas, V; Habiro, K; Yang, YG; Jeong, JH; Lee, KY; Kim, YH; Kim, SW; Peipp, M; Fey, GH; Manjunath, N; Shultz, LD; Lee, SK; Shankar, P				Kumar, Priti; Ban, Hong-Seok; Kim, Sang-Soo; Wu, Haoquan; Pearson, Todd; Greiner, Dale L.; Laouar, Amale; Yao, Jiahong; Haridas, Viraga; Habiro, Katsuyoshi; Yang, Yong-Guang; Jeong, Ji-Hoon; Lee, Kuen-Yong; Kim, Yong-Hee; Kim, Sung Wan; Peipp, Matthias; Fey, Georg H.; Manjunath, N.; Shultz, Leonard D.; Lee, Sang-Kyung; Shankar, Premlata			T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice	CELL			English	Article							SMALL INTERFERING RNA; LENTIVIRAL VECTOR; CHAIN IMMUNOTOXIN; MOUSE MODEL; HU MICE; IN-VIVO; C-MYB; ANTIBODY; INHIBITION; THERAPY	Evaluation of the therapeutic potential of RNAi for HIV infection has been hampered by the challenges of siRNA delivery and lack of suitable animal models. Using a delivery method for T cells, we show that siRNA treatment can dramatically suppress HIV infection. A CD7-specific single-chain antibody was conjugated to oligo-9-arginine peptide (scFvCD79R) for T cell-specific siRNA delivery in NOD/SCIDIL2r gamma(-/-) mice reconstituted with human lymphocytes (Hu-PBL) or CD34(+) hematopoietic stem cells (Hu-HSC). In HIV-infected Hu-PBL mice, treatment with anti-CCR5 (viral coreceptor) and antiviral siRNAs complexed to scFvCD7-9R controlled viral replication and prevented the disease-associated CD4 T cell loss. This treatment also suppressed endogenous virus and restored CD4 T cell counts in mice reconstituted with HIV+ peripheral blood mononuclear cells. Moreover, scFvCD7-9R could deliver antiviral siRNAs to naive T cells in Hu-HSC mice and effectively suppress viremia in infected mice. Thus, siRNA therapy for HIV infection appears to be feasible in a preclinical animal model.	[Ban, Hong-Seok; Lee, Kuen-Yong; Kim, Yong-Hee; Lee, Sang-Kyung] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea; [Ban, Hong-Seok; Lee, Kuen-Yong; Kim, Yong-Hee; Lee, Sang-Kyung] Hanyang Univ, Hanyang Fus Mat Program, Seoul 133791, South Korea; [Kumar, Priti; Kim, Sang-Soo; Wu, Haoquan; Laouar, Amale; Yao, Jiahong; Haridas, Viraga; Manjunath, N.; Shankar, Premlata] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Kumar, Priti; Kim, Sang-Soo; Wu, Haoquan; Laouar, Amale; Yao, Jiahong; Haridas, Viraga; Manjunath, N.; Shankar, Premlata] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Pearson, Todd; Greiner, Dale L.] Univ Massachusetts, Sch Med, Dept Med, Div Diabet, Worcester, MA 01605 USA; [Habiro, Katsuyoshi; Yang, Yong-Guang] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02129 USA; [Jeong, Ji-Hoon; Kim, Sung Wan] Univ Utah, Ctr Controlled Chem Delivery, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Peipp, Matthias] Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, D-24105 Kiel, Germany; [Fey, Georg H.] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	Hanyang University; Hanyang University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Utah System of Higher Education; University of Utah; University of Kiel; University of Erlangen Nuremberg; Jackson Laboratory	Lee, SK (corresponding author), Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.	sangkyunglee@hanyang.ac.kr; premlata.shankar@ttuhsc.edu	Kumar, Priti/C-5699-2009; Laouar, Amale/AAO-2903-2020; Peipp, Matthias/A-8775-2013; Ban, Hyun Seung/F-9526-2014; kim, sang-soo/C-6573-2009	Ban, Hyun Seung/0000-0002-2698-6037; Kim, Sang-Soo/0000-0002-9135-380X; Yang, Yong-Guang/0000-0003-4985-1247; Lee, Kuen Yong/0000-0002-5759-5952; Peipp, Matthias/0000-0002-5088-3804; Wu, Haoquan/0000-0001-9386-3187	NIH/National Institute of Allergy and Infectious Diseases [RO1 A1071882, R21 AI06532, AI075419]; Korea Ministry of Education and Science Technology [R01-2006-000-10506-0, F104AA010005-07A0101-00510]; Seoul RBD [CR070027]; CFAR [P30 A060354]; NIH [CA34196]; Juvenile Diabetes Research Foundation; MOEHRD [KRF-2006-352-D00070]; Wilhelm Sander Foundation; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075419, R01AI071882, P30AI060354] Funding Source: NIH RePORTER	NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Korea Ministry of Education and Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul RBD(Seoul RBD program); CFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); MOEHRD(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Wilhelm Sander Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Changseon Choi and Nahyun Kim for technical assistance and Luke Jasenosky for editing the manuscript. This work was supported by the following grants: NIH/National Institute of Allergy and Infectious Diseases RO1 A1071882 and R21 AI06532 to P. S., Korea Ministry of Education and Science Technology R01-2006-000-10506-0 and F104AA010005-07A0101-00510 and Seoul R&BD CR070027 to S. K. L., CFAR fellowship P30 A060354 to P. K., NIH/NIAID Autoimmunity Prevention Center grant to D. L. G., NIH CA34196 to L. D. S., Juvenile Diabetes Research Foundation to D. L. G., L. D. S., and T. P., MOEHRD KRF-2006-352-D00070 to S. S. K., NIH/NIAID UO1 AI075419 to M. N., a Wilhelm Sander Foundation research grant to G. H. F, and the Seoul Fellowship to H. S. B.	Anderson J, 2007, MOL THER, V15, P1182, DOI 10.1038/sj.mt.6300157; Banerjea A, 2003, MOL THER, V8, P62, DOI 10.1016/S1525-0016(03)00140-0; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Bonilla FA, 1997, INT IMMUNOL, V9, P1875, DOI 10.1093/intimm/9.12.1875; Bremer E, 2005, CANCER RES, V65, P3380, DOI 10.1158/0008-5472.CAN-04-2756; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Fais S, 1999, J VIROL, V73, P6453, DOI 10.1128/JVI.73.8.6453-6459.1999; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Frankel AE, 1997, LEUKEMIA LYMPHOMA, V26, P287, DOI 10.3109/10428199709051778; Goffinet C, 2006, FASEB J, V20, P500, DOI 10.1096/fj.05-4651fje; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x; Hogrefe RI, 2006, NUCLEOS NUCLEOT NUCL, V25, P889, DOI 10.1080/15257770600793885; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; LAZAROVITS AI, 1993, J IMMUNOL, V150, P5163; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; LIPSICK JS, 1987, MOL CELL BIOL, V7, P3358, DOI 10.1128/MCB.7.9.3358; Manjunath N, 2006, TRENDS IMMUNOL, V27, P328, DOI 10.1016/j.it.2006.05.006; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Nakata H, 2005, J VIROL, V79, P2087, DOI 10.1128/JVI.79.4.2087-2096.2005; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Peipp M, 2002, CANCER RES, V62, P2848; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Shacklett BL, 2008, PLOS MED, V5, P16, DOI 10.1371/journal.pmed.0050013; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Surabhi RM, 2002, J VIROL, V76, P12963, DOI 10.1128/JVI.76.24.12963-12973.2002; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Wan L, 2006, PROTEIN EXPRES PURIF, V48, P307, DOI 10.1016/j.pep.2006.02.005; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zeng F, 2006, NAT PROTOC, V1, P920, DOI 10.1038/nprot.2006.81	47	467	507	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2008	134	4					577	586		10.1016/j.cell.2008.06.034	http://dx.doi.org/10.1016/j.cell.2008.06.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18691745	Green Accepted, Bronze			2022-12-24	WOS:000258665800012
J	Bjornsson, HT; Sigurdsson, MI; Fallin, MD; Irizarry, RA; Aspelund, T; Cui, HM; Yu, WQ; Rongione, MA; Ekstrom, TJ; Harris, TB; Launer, LJ; Eiriksdottir, G; Leppert, MF; Sapienza, C; Gudnason, V; Feinberg, AP				Bjornsson, Hans T.; Sigurdsson, Martin I.; Fallin, M. Daniele; Irizarry, Rafael A.; Aspelund, Thor; Cui, Hengmi; Yu, Wenqiang; Rongione, Michael A.; Ekstrom, Tomas J.; Harris, Tamara B.; Launer, Lenore J.; Eiriksdottir, Gudny; Leppert, Mark F.; Sapienza, Carmen; Gudnason, Vilmundur; Feinberg, Andrew P.			Intra-individual change over time in DNA methylation with familial clustering	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIGENETICS; CANCER	Context Changes over time in epigenetic marks, which are modifications of DNA such as by DNA methylation, may help explain the late onset of common human diseases. However, changes in methylation or other epigenetic marks over time in a given individual have not yet been investigated. Objectives To determine whether there are longitudinal changes in global DNA methylation in individuals and to evaluate whether methylation maintenance demonstrates familial clustering. Design, Setting, and Participants We measured global DNA methylation by luminometric methylation assay, a quantitative measurement of genome- wide DNA methylation, on DNA sampled at 2 visits on average 11 years apart in 111 individuals from an Icelandic cohort ( 1991 and 2002- 2005) and on average 16 years apart in 126 individuals from a Utah sample ( 1982- 1985 and 1997- 2005). Main Outcome Measure Global methylation changes over time. Results Twenty- nine percent of Icelandic individuals showed greater than 10% methylation change over time ( P <. 001). The family- based Utah sample also showed intra-individual changes over time, and further demonstrated familial clustering of methylation change ( P=. 003). The family showing the greatest global methylation loss also demonstrated the greatest loss of gene- specific methylation by a separate methylation assay. Conclusion These data indicate that methylation changes over time and suggest that methylation maintenance may be under genetic control.	[Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Hjartavernd, IS-201 Kopavogur, Iceland; [Bjornsson, Hans T.; Sigurdsson, Martin I.; Cui, Hengmi; Yu, Wenqiang; Rongione, Michael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Fallin, M. Daniele] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Fallin, M. Daniele; Irizarry, Rafael A.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Bjornsson, Hans T.; Sigurdsson, Martin I.; Fallin, M. Daniele; Irizarry, Rafael A.; Cui, Hengmi; Yu, Wenqiang; Rongione, Michael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Ctr Epigenet, Baltimore, MD USA; [Ekstrom, Tomas J.] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Leppert, Mark F.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Leppert, Mark F.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Sapienza, Carmen] Temple Univ, Sch Med, Fels Inst Canc Res, Philadelphia, PA 19122 USA; [Sapienza, Carmen] Temple Univ, Sch Med, Dept Pathol, Philadelphia, PA 19122 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gudnason, V (corresponding author), Hjartavernd, Holtasmari 1, IS-201 Kopavogur, Iceland.	v.gudnason@hjarta.is; afeinberg@jhu.edu	Aspelund, Thor/F-4826-2011; Feinberg, Andrew/AAY-7666-2020; Launer, Lenore J/A-8218-2010; Bjornsson, Hans T/A-2964-2013; Aspelund, Thor/C-5983-2008; Ekström, Tomas/B-7764-2013; Bjornsson, Hans/GSN-3911-2022; Sigurdsson, Martin Ingi/I-9655-2016; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019	Bjornsson, Hans T/0000-0001-6635-6753; Aspelund, Thor/0000-0002-7998-5433; Bjornsson, Hans/0000-0001-6635-6753; Sigurdsson, Martin Ingi/0000-0001-7054-0844; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Feinberg, Andrew/0000-0002-8364-1991	NATIONAL INSTITUTE ON AGING [ZIAAG007380] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG007380-02] Funding Source: Medline; NCRR NIH HHS [R01 RR021967-02, M01 RR000064, R01 RR021967, M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [P50-HG003233, P50 HG003233] Funding Source: Medline; NIA NIH HHS [N01AG12100] Funding Source: Medline; NIEHS NIH HHS [R01-ES015211, R01 ES015211] Funding Source: Medline; NIGMS NIH HHS [R01 GM083084, R01 GM083084-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2001, CANCER RES, V61, P4947; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; *SAGE, 2006, COMP PROGR VERS 5 2; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; SANO H, 1985, J CLIN INVEST, V76, P1314, DOI 10.1172/JCI112105; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484	30	509	557	3	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2008	299	24					2877	2883		10.1001/jama.299.24.2877	http://dx.doi.org/10.1001/jama.299.24.2877			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317LN	18577732	Green Accepted, Bronze			2022-12-24	WOS:000257021800025
J	Emerson, JJ; Cardoso-Moreira, M; Borevitz, JO; Long, M				Emerson, J. J.; Cardoso-Moreira, Margarida; Borevitz, Justin O.; Long, Manyuan			Natural selection shapes genome-wide patterns of copy-number polymorphism in Drosophila melanogaster	SCIENCE			English	Article							EVOLUTION; DNA; DUPLICATIONS; POPULATIONS; SEQUENCES; INFERENCE; HISTORY; MODEL	The role that natural selection plays in governing the locations and early evolution of copy- number mutations remains largely unexplored. We used high- density full- genome tiling arrays to create a fine- scale genomic map of copy- number polymorphisms ( CNPs) in Drosophila melanogaster. We inferred a total of 2658 independent CNPs, 56% of which overlap genes. These include CNPs that are likely to be under positive selection, most notably high- frequency duplications encompassing toxin- response genes. The locations and frequencies of CNPs are strongly shaped by purifying selection, with deletions under stronger purifying selection than duplications. Among duplications, those overlapping exons or introns, as well as those falling on the X chromosome, seem to be subject to stronger purifying selection.	[Emerson, J. J.; Cardoso-Moreira, Margarida; Borevitz, Justin O.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Emerson, J. J.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Cardoso-Moreira, Margarida] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Cardoso-Moreira, Margarida] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal	University of Chicago; Academia Sinica - Taiwan; Universidade do Porto; Universidade do Porto	Emerson, JJ (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jje@uchicago.edu; mmoreira@uchicago.edu	Moreira, Margarida M Cardoso/A-7749-2012; Cardoso-Moreira, Margarida/L-8294-2019; Borevitz, Justin/B-5423-2012; Emerson, J.J./D-8955-2011	Cardoso-Moreira, Margarida/0000-0001-6639-3597; Borevitz, Justin/0000-0001-8408-3699; Emerson, James/0000-0001-9474-0891				Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; ASHBURNER M, 1994, DEVELOPMENT, V120, P2077; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Biemar F, 2005, P NATL ACAD SCI USA, V102, P15907, DOI 10.1073/pnas.0507817102; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiston-Lavier AS, 2007, GENOME RES, V17, P1458, DOI 10.1101/gr.6208307; Gordo I, 2001, CURR BIOL, V11, pR684, DOI 10.1016/S0960-9822(01)00408-0; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Lipatov M, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-24; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Otto SP, 2002, ADV GENET, V46, P451; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Pool JE, 2006, GENETICS, V174, P915, DOI 10.1534/genetics.106.058693; Pritchard JK, 2000, GENETICS, V155, P945; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	26	205	212	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2008	320	5883					1629	1631		10.1126/science.1158078	http://dx.doi.org/10.1126/science.1158078			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18535209				2022-12-24	WOS:000256886700046
J	King, AA; Ionides, EL; Pascual, M; Bouma, MJ				King, Aaron A.; Ionides, Edward L.; Pascual, Mercedes; Bouma, Menno J.			Inapparent infections and cholera dynamics	NATURE			English	Article							VIBRIO-CHOLERAE; ENDEMIC CHOLERA; CLIMATE; ENVIRONMENT; BANGLADESH; EPIDEMICS; DISEASE	In many infectious diseases, an unknown fraction of infections produce symptoms mild enough to go unrecorded, a fact that can seriously compromise the interpretation of epidemiological records. This is true for cholera, a pandemic bacterial disease, where estimates of the ratio of asymptomatic to symptomatic infections have ranged from 3 to 100 (refs 1-5). In the absence of direct evidence, understanding of fundamental aspects of cholera transmission, immunology and control has been based on assumptions about this ratio and about the immunological consequences of inapparent infections. Here we show that a model incorporating high asymptomatic ratio and rapidly waning immunity, with infection both from human and environmental sources, explains 50 yr of mortality data from 26 districts of Bengal, the pathogen's endemic home. We find that the asymptomatic ratio in cholera is far higher than had been previously supposed and that the immunity derived from mild infections wanes much more rapidly than earlier analyses have indicated. We find, too, that the environmental reservoir(5,6) (free-living pathogen) is directly responsible for relatively few infections but that it may be critical to the disease's endemicity. Our results demonstrate that inapparent infections can hold the key to interpreting the patterns of disease outbreaks. New statistical methods(7), which allow rigorous maximum likelihood inference based on dynamical models incorporating multiple sources and outcomes of infection, seasonality, process noise, hidden variables and measurement error, make it possible to test more precise hypotheses and obtain unexpected results. Our experience suggests that the confrontation of time-series data with mechanistic models is likely to revise our understanding of the ecology of many infectious diseases.	[King, Aaron A.; Pascual, Mercedes] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Ionides, Edward L.] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bouma, Menno J.] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; The Santa Fe Institute; University of London; London School of Hygiene & Tropical Medicine	King, AA (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	kingaa@umich.edu	King, Aaron A/B-8092-2012; Ibrahim, Essam Hassan/G-1960-2018	King, Aaron A/0000-0001-6159-3207; Ibrahim, Essam Hassan/0000-0003-0130-2257				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Barndorff-Nielsen O. E., 1994, INFERENCE ASYMPTOTIC; Bouma MJ, 2001, HYDROBIOLOGIA, V460, P147, DOI 10.1023/A:1013165215074; Burnham KP, 2002, MULTIMODEL INFERENCE; Casella G., 2021, STAT INFERENCE; CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45; CASH RA, 1974, J INFECT DIS, V130, P325, DOI 10.1093/infdis/130.4.325; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Feachem R G, 1982, Trop Dis Bull, V79, P1; GLASS RI, 1983, J INFECT DIS, V148, P998, DOI 10.1093/infdis/148.6.998; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; Glass Roger I., 1992, P129; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; Hilborn Ray, 1997, V28; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; ISLAM MS, 1993, J DIARRHOEAL DIS RES, V11, P197; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kloeden P.E., 1999, NUMERICAL SOLUTION S; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Le vine MM, 1981, ACUTE ENTERIC INFECT, P443; MCCORMACK WM, 1969, AM J EPIDEMIOL, V89, P658, DOI 10.1093/oxfordjournals.aje.a120979; McCullagh P, 1989, GEN LINEAR MODELS; R Development Core Team, 2007, R LANG ENV STAT COMP; Rice JA, 1988, MATH STAT DATA ANAL; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sack RB, 2003, J INFECT DIS, V187, P96, DOI 10.1086/345865; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SIDDIQUE AK, 1991, LANCET, V337, P1125, DOI 10.1016/0140-6736(91)92789-5; VANDELINDE PA, 1965, B WORLD HEALTH ORGAN, V32, P515; *WHO, 1950, WKL EP REC	36	289	293	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					877	U29		10.1038/nature07084	http://dx.doi.org/10.1038/nature07084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18704085	Green Published			2022-12-24	WOS:000258398600034
J	Martick, M; Horan, LH; Noller, HF; Scott, WG				Martick, Monika; Horan, Lucas H.; Noller, Harry F.; Scott, William G.			A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA	NATURE			English	Article							GENE-EXPRESSION; CLEAVAGE; LECTIN; FAMILY; TRANSCRIPTS; ALIGNMENT; SEQUENCE; GENOME; DECAY	Structured RNAs embedded in the untranslated regions (UTRs) of messenger RNAs can regulate gene expression. In bacteria, control of a metabolite gene is mediated by the self-cleaving activity of a ribozyme embedded in its 59 UTR1. This discovery has raised the question of whether gene-regulating ribozymes also exist in eukaryotic mRNAs. Here we show that highly active hammerhead ribozymes(2,3) are present in the 3 ' UTRs of rodent C-type lectin type II (Clec2) genes(4-7). Using a hammerhead RNA motif search with relaxed delimitation of the non-conserved regions, we detected ribozyme sequences in which the invariant regions, in contrast to the previously identified continuous hammerheads(8-10), occur as two fragments separated by hundreds of nucleotides. Notably, a fragment pair can assemble to form an active hammerhead ribozyme structure between the translation termination and the polyadenylation signals within the 3 ' UTR. We demonstrate that this hammerhead structure can self-cleave both in vitro and in vivo, and is able to reduce protein expression in mouse cells. These results indicate that an unrecognized mechanism of post-transcriptional gene regulation involving association of discontinuous ribozyme sequences within an mRNA may be modulating the expression of several CLEC2 proteins that function in bone remodelling and the immune response of several mammals.	[Martick, Monika; Horan, Lucas H.; Noller, Harry F.; Scott, William G.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Martick, M (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	mmartick@yahoo.com		Horan, Lucas/0000-0002-9143-7667; Scott, William/0000-0002-9273-3564	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087721] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI043393-09, R01 AI043393] Funding Source: Medline; NIGMS NIH HHS [R01 GM087721] Funding Source: Medline; PHS HHS [R01043393] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Eddy S, 2008, RNABOB PROGRAM SEARC; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Flores R, 2001, METHOD ENZYMOL, V341, P540, DOI 10.1016/S0076-6879(01)41175-X; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lockyer AE, 2003, PARASITOLOGY, V126, P203, DOI 10.1017/S0031182002002792; MARTICK M, 2007, THESIS U CALIFORNIA; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Osborne EM, 2005, RNA, V11, P187, DOI 10.1261/rna.7950605; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Przybilski R, 2005, PLANT CELL, V17, P1877, DOI 10.1105/tpc.105.032730; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; STERN S, 1988, METHOD ENZYMOL, V164, P481; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	29	120	124	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					899	U57		10.1038/nature07117	http://dx.doi.org/10.1038/nature07117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18615019	Green Accepted			2022-12-24	WOS:000258398600039
J	Langan, SM; Smeeth, L; Hubbard, R; Fleming, KM; Smith, CJP; West, J				Langan, S. M.; Smeeth, L.; Hubbard, R.; Fleming, K. M.; Smith, C. J. P.; West, J.			Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; DATABASE; REGION; RISK	Objective To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgaris in the United kingdom. Design Retrospective historical cohort study. Setting Computerised medical records from the health improvement network, a large population based UK general practice database. Participants Patients with pemphigus vulgaris and bullous pemphigoid diagnostic codes and age, sex, and practice matched controls. Main outcome measures incidence and mortality compared with the control population by calendar period, age group, sex, geographical region, and degree of social deprivation. Results 869 people with bullous pemphigoid and 138 people with pemphigus vulgaris were identified. The median age at presentation for bullous pemphigoid was 80 (range 23-102) years, and 534 (61%) patients were female. The median age at presentation for pemphigus vulgaris was 71 (21-102) years, and 91 (66%) patients were female. Incidences of bullous pemphigoid and pemphigus vulgaris were 4.3 (95% confidence interval 4.0 to 4.6) and 0.7 (0.6 to 0.8) per 100 000 person years. The incidence of bullous pemphigoid increased overtime; the average yearly increase was 17% (incidence rate ratio=1.2, 95% confidence interval 1.1 to 1.2). An average yearly increase in incidence of pemphigus vulgaris of 11% (incidence rate ratio=1.1, 1.0 to 1.2) occurred. The risk of death for patients with bullous pemphigoid was twice as, great as for controls (adjusted hazard ratio=2.3, 95% confidence interval 2.0 to 2.7). For pemphigus vulgaris, the risk of death was three times greater than for controls (adjusted hazard ratio=3.3, 2.2 to 5.2). Conclusions Incidences of bullous pemphigoid and pemphigus vulgaris are increasing. The reasons for the changes in incidence are not clearly understood but have implications for identifying causative factors. Both disorders are associated with a high risk of death. Previous estimates may have underestimated the risk of death associated with these diseases.	[Langan, S. M.] Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England; [Smeeth, L.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Ctr Populat Studies Noncommun Dis Epidemiol, London WC1, England; [Hubbard, R.; Fleming, K. M.; Smith, C. J. P.; West, J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham	Langan, SM (corresponding author), Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England.	sinead.langan@nottingham.ac.uk	West, Joe/I-6637-2012; Fleming, Kate M/A-6475-2010; West, Joe/M-3867-2019; Smeeth, Liam/X-5862-2018	West, Joe/0000-0002-1135-9356; Fleming, Kate M/0000-0002-6572-5016; West, Joe/0000-0002-1135-9356; Langan, Sinead/0000-0002-7022-7441; Smeeth, Liam/0000-0002-9168-6022	British Lung Foundation [C05/01] Funding Source: researchfish; Wellcome Trust [082178] Funding Source: Medline; Department of Health Funding Source: Medline	British Lung Foundation; Wellcome Trust(Wellcome Trust); Department of Health		ADAM BA, 1992, INT J DERMATOL, V31, P42, DOI 10.1111/j.1365-4362.1992.tb03519.x; Bath-Hextall F, 2007, INT J CANCER, V121, P2105, DOI 10.1002/ijc.22952; Colbert RL, 2004, J INVEST DERMATOL, V122, P1091, DOI 10.1111/j.0022-202X.2004.22504.x; Garcia-Doval I, 2006, BRIT J DERMATOL, V155, P820, DOI 10.1111/j.1365-2133.2006.07411.x; GELLIS S, 1941, ARCH DERMATOL SYPHIO, P44; Gudi VS, 2005, BRIT J DERMATOL, V153, P424, DOI 10.1111/j.1365-2133.2005.06662.x; HIETANEN J, 1982, ACTA DERM-VENEREOL, V62, P491; Joly P, 2005, J INVEST DERMATOL, V124, P664, DOI 10.1111/j.0022-202X.2005.23626.x; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Jung M, 1999, J AM ACAD DERMATOL, V41, P266, DOI 10.1016/S0190-9622(99)70061-7; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; NALDI L, 1993, INT J DERMATOL, V32, P424, DOI 10.1111/j.1365-4362.1993.tb02813.x; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Roujeau JC, 1998, ARCH DERMATOL, V134, P465, DOI 10.1001/archderm.134.4.465; RYAN JG, 1971, ARCH DERMATOL, V104, P14, DOI 10.1001/archderm.104.1.14; Salmanpour R, 2006, INT J DERMATOL, V45, P103, DOI 10.1111/j.1365-4632.2004.02374.x; Uzun S, 2006, INT J DERMATOL, V45, P523, DOI 10.1111/j.1365-4632.2004.02533.x; V'lckova-Laskoska MT, 2007, INT J DERMATOL, V46, P253, DOI 10.1111/j.1365-4632.2006.03010.x	20	405	411	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2008	337	7662							a180	10.1136/bmj.a180	http://dx.doi.org/10.1136/bmj.a180			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330SB	18614511	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000257962000042
J	Tsai, TYC; Choi, YS; Ma, WZ; Pomerening, JR; Tang, C; Ferrell, JE				Tsai, Tony Yu-Chen; Choi, Yoon Sup; Ma, Wenzhe; Pomerening, Joseph R.; Tang, Chao; Ferrell, James E., Jr.			Robust, tunable biological oscillations from interlinked positive and negative feedback loops	SCIENCE			English	Article							CELL-CYCLE OSCILLATOR; CIRCADIAN CLOCK; BUDDING YEAST; XENOPUS; PHOSPHORYLATION; MODEL; HYSTERESIS; ACTIVATION; MECHANISMS; EXTRACTS	A simple negative feedback loop of interacting genes or proteins has the potential to generate sustained oscillations. However, many biological oscillators also have a positive feedback loop, raising the question of what advantages the extra loop imparts. Through computational studies, we show that it is generally difficult to adjust a negative feedback oscillator's frequency without compromising its amplitude, whereas with positive- plus- negative feedback, one can achieve a widely tunable frequency and near- constant amplitude. This tunability makes the latter design suitable for biological rhythms like heartbeats and cell cycles that need to provide a constant output over a range of frequencies. Positive- plus- negative oscillators also appear to be more robust and easier to evolve, rationalizing why they are found in contexts where an adjustable frequency is unimportant.	[Tsai, Tony Yu-Chen; Choi, Yoon Sup; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Choi, Yoon Sup] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea; [Ma, Wenzhe; Tang, Chao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Ma, Wenzhe; Tang, Chao] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Pomerening, Joseph R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Stanford University; Pohang University of Science & Technology (POSTECH); Peking University; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	Ma, Wenzhe/N-3320-2017	Tang, Chao/0000-0003-1474-3705; Tsai, Tony/0000-0003-1121-9406; Pomerening, Joseph/0000-0003-4120-9081	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077544, R01GM061276] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM77544, GM61726, R01 GM061276, R01 GM061276-08, R01 GM077544-01, R01 GM077544-02, R01 GM061276-07, R01 GM077544, R01 GM061276-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; HAHN HS, 1974, P NATL ACAD SCI USA, V71, P4067, DOI 10.1073/pnas.71.10.4067; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P15760, DOI 10.1073/pnas.0407111101; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Levine K, 1995, Prog Cell Cycle Res, V1, P101; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Mara A, 2007, TRENDS CELL BIOL, V17, P593, DOI 10.1016/j.tcb.2007.09.005; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NAVE CR, 1995, HYPERPHYSICS; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; NOVAK B, 1993, J CELL SCI, V106, P1153; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ruoff P, 1996, NATURWISSENSCHAFTEN, V83, P514, DOI 10.1007/BF01141953; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; STROGATZ SH, 1994, ONLINEAR DYNAMICS CH; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; van der Pol B, 1928, PHILOS MAG, V6, P763	45	496	504	6	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					126	129		10.1126/science.1156951	http://dx.doi.org/10.1126/science.1156951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599789	Green Accepted			2022-12-24	WOS:000257320800053
J	Bennett, MR; Pang, WL; Ostroff, NA; Baumgartner, BL; Nayak, S; Tsimring, LS; Hasty, J				Bennett, Matthew R.; Pang, Wyming Lee; Ostroff, Natalie A.; Baumgartner, Bridget L.; Nayak, Sujata; Tsimring, Lev S.; Hasty, Jeff			Metabolic gene regulation in a dynamically changing environment	NATURE			English	Article							MESSENGER-RNA DECAY; SACCHAROMYCES-CEREVISIAE; FLUCTUATING ENVIRONMENTS; GLUCOSE REPRESSION; SOFT LITHOGRAPHY; YEAST; EXPRESSION; BIOLOGY; NETWORKS; PROTEINS	Natural selection dictates that cells constantly adapt to dynamically changing environments in a context- dependent manner. Gene- regulatory networks often mediate the cellular response to perturbation(1-3), and an understanding of cellular adaptation will require experimental approaches aimed at subjecting cells to a dynamic environment that mimics their natural habitat(4-9). Here we monitor the response of Saccharomyces cerevisiae metabolic gene regulation to periodic changes in the external carbon source by using a microfluidic platform that allows precise, dynamic control over environmental conditions. We show that the metabolic system acts as a low- pass filter that reliably responds to a slowly changing environment, while effectively ignoring fast fluctuations. The sensitive low- frequency response was significantly faster than in predictions arising from our computational modelling, and this discrepancy was resolved by the discovery that two key galactose transcripts possess half- lives that depend on the carbon source. Finally, to explore how induction characteristics affect frequency response, we compare two S. cerevisiae strains and show that they have the same frequency response despite having markedly different induction properties. This suggests that although certain characteristics of the complex networks may differ when probed in a static environment, the system has been optimized for a robust response to a dynamically changing environment.	[Bennett, Matthew R.; Pang, Wyming Lee; Ostroff, Natalie A.; Baumgartner, Bridget L.; Nayak, Sujata; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bennett, Matthew R.; Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu	Bennett, Matthew/B-3700-2008	Bennett, Matthew/0000-0002-4975-8854; Tsimring, Lev/0000-0003-0709-3548	National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082168] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Groisman for useful discussions regarding microfluidic design; D. Volfson and C. Grilly for aid in development and testing of image segmentation and tracking algorithms, and M. Ferry for his suggestions on microbiology. This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health.	Andrade RP, 2005, BIOCHEM BIOPH RES CO, V332, P254, DOI 10.1016/j.bbrc.2005.04.119; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; de Atauri P., 2004, Systems Biology, V1, P28, DOI 10.1049/sb:20045013; de la Cruz BJ, 2002, YEAST, V19, P887, DOI 10.1002/yea.884; Demir O, 2006, COMPUT BIOL CHEM, V30, P179, DOI 10.1016/j.compbiolchem.2006.02.004; DOUGLAS HC, 1966, GENETICS, V54, P911; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Scheffler IE, 1998, INT J BIOCHEM CELL B, V30, P1175, DOI 10.1016/S1357-2725(98)00086-7; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2; Verma M, 2005, BIOCHEM J, V388, P843, DOI 10.1042/BJ20041883; Whitesides GM, 2004, ABSTR PAP AM CHEM S, V227, pU113; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	27	229	234	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1119	1122		10.1038/nature07211	http://dx.doi.org/10.1038/nature07211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18668041	Green Accepted			2022-12-24	WOS:000258719600038
J	Herrero, JL; Roberts, MJ; Delicato, LS; Gieselmann, MA; Dayan, P; Thiele, A				Herrero, J. L.; Roberts, M. J.; Delicato, L. S.; Gieselmann, M. A.; Dayan, P.; Thiele, A.			Acetylcholine contributes through muscarinic receptors to attentional modulation in V1	NATURE			English	Article							PRIMARY VISUAL-CORTEX; CHOLINERGIC MODULATION; SELECTIVE ATTENTION; PARIETAL CORTEX; MACAQUE MONKEY; AREAS V1; PERFORMANCE; RELEASE; CELLS; V4	Attention exerts a strong influence over neuronal processing in cortical areas(1,2). It selectively increases firing rates(2-4) and affects tuning properties(1,5), including changing receptive field locations and sizes(3,6). Although these effects are well studied, their cellular mechanisms are poorly understood. To study the cellular mechanisms, we combined iontophoretic pharmacological analysis of cholinergic receptors with single cell recordings in V1 while rhesus macaque monkeys ( Macaca mulatta) performed a task that demanded top- down spatial attention. Attending to the receptive field of the V1 neuron under study caused an increase in firing rates. Here we show that this attentional modulation was enhanced by low doses of acetylcholine. Furthermore, applying the muscarinic antagonist scopolamine reduced attentional modulation, whereas the nicotinic antagonist mecamylamine had no systematic effect. These results demonstrate that muscarinic cholinergic mechanisms play a central part in mediating the effects of attention in V1.	[Herrero, J. L.; Roberts, M. J.; Delicato, L. S.; Gieselmann, M. A.; Thiele, A.] Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dayan, P.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	Newcastle University - UK; University of London; University College London	Thiele, A (corresponding author), Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	Delicato, Louise/AAT-1921-2020; Roberts, Mark/C-7011-2018	Delicato, Louise/0000-0001-8271-2324; Thiele, Alexander/0000-0003-4894-0213; Roberts, Mark/0000-0001-7513-1281; Dayan, Peter/0000-0003-3476-1839	BBSRC [BBS/B/09325]; Wellcome Trust [070380/Z/03/Z]; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BBS/B/09325, BB/F021399/1] Funding Source: researchfish; BBSRC [BB/F021399/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the BBSRC (BBS/B/09325), the Wellcome Trust (070380/Z/03/Z) and the Gatsby Charitable Foundation.	Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davidson MC, 2000, J NEUROPHYSIOL, V83, P1536, DOI 10.1152/jn.2000.83.3.1536; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Furey ML, 2008, NEUROPSYCHOPHARMACOL, V33, P913, DOI 10.1038/sj.npp.1301461; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; Nobili L, 1997, VISION RES, V37, P3559, DOI 10.1016/S0042-6989(97)00076-X; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; RUSSCHEN FT, 1985, J COMP NEUROL, V242, P1, DOI 10.1002/cne.902420102; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	30	325	327	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1110	1114		10.1038/nature07141	http://dx.doi.org/10.1038/nature07141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18633352	Green Accepted			2022-12-24	WOS:000258719600036
J	Boxem, M; Maliga, Z; Klitgord, N; Li, N; Lemmens, I; Mana, M; de Lichtervelde, L; Mul, JD; van de Peut, D; Devos, M; Simonis, N; Yildirim, MA; Cokol, M; Kao, HL; de Smet, AS; Wang, HD; Schlaitz, AL; Hao, T; Milstein, S; Fan, CY; Tipsword, M; Drew, K; Galli, M; Rhrissorrakrai, K; Drechsel, D; Koller, D; Roth, FP; Iakoucheva, LM; Dunker, AK; Bonneau, R; Gunsalus, KC; Hill, DE; Piano, F; Tavernier, J; van den Heuvel, S; Hyman, AA; Vidal, M				Boxem, Mike; Maliga, Zoltan; Klitgord, Niels; Li, Na; Lemmens, Irma; Mana, Miyeko; de Lichtervelde, Lorenzo; Mul, Joram D.; van de Peut, Diederik; Devos, Maxime; Simonis, Nicolas; Yildirim, Muhammed A.; Cokol, Murat; Kao, Huey-Ling; de Smet, Anne-Sophie; Wang, Haidong; Schlaitz, Anne-Lore; Hao, Tong; Milstein, Stuart; Fan, Changyu; Tipsword, Mike; Drew, Kevin; Galli, Matilde; Rhrissorrakrai, Kahn; Drechsel, David; Koller, Daphne; Roth, Frederick P.; Iakoucheva, Lilia M.; Dunker, A. Keith; Bonneau, Richard; Gunsalus, Kristin C.; Hill, David E.; Piano, Fabio; Tavernier, Jan; van den Heuvel, Sander; Hyman, Anthony A.; Vidal, Marc			A protein domain-based interactome network for C-elegans early embryogenesis	CELL			English	Article							NUCLEAR-PORE COMPLEX; CENTROSOME MATURATION; INTERACTION MAP; GENOME; RESOURCE; IDENTIFICATION; ARCHITECTURE; CENTRIOLAR; REQUIRE; MODELS	Many protein-protein interactions are mediated through independently folding modular domains. Proteome-wide efforts to model protein-protein interaction or "interactome'' networks have largely ignored this modular organization of proteins. We developed an experimental strategy to efficiently identify interaction domains and generated a domain-based interactome network for proteins involved in C. elegans early-embryonic cell divisions. Minimal interacting regions were identified for over 200 proteins, providing important information on their domain organization. Furthermore, our approach increased the sensitivity of the two-hybrid system, resulting in amore complete interactome network. This interactome modeling strategy revealed insights into C. elegans centrosome function and is applicable to other biological processes in this and other organisms.	[Boxem, Mike; Klitgord, Niels; Li, Na; de Lichtervelde, Lorenzo; Mul, Joram D.; van de Peut, Diederik; Devos, Maxime; Simonis, Nicolas; Yildirim, Muhammed A.; Hao, Tong; Milstein, Stuart; Fan, Changyu; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, CCSB, Boston, MA 02115 USA; [Boxem, Mike; Klitgord, Niels; Li, Na; de Lichtervelde, Lorenzo; Mul, Joram D.; van de Peut, Diederik; Devos, Maxime; Simonis, Nicolas; Yildirim, Muhammed A.; Hao, Tong; Milstein, Stuart; Fan, Changyu; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Boxem, Mike; Klitgord, Niels; Li, Na; de Lichtervelde, Lorenzo; Mul, Joram D.; van de Peut, Diederik; Devos, Maxime; Simonis, Nicolas; Yildirim, Muhammed A.; Hao, Tong; Milstein, Stuart; Fan, Changyu; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Boxem, Mike] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Maliga, Zoltan; de Smet, Anne-Sophie; Tipsword, Mike; Drechsel, David; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Lemmens, Irma; de Smet, Anne-Sophie; Tavernier, Jan] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lemmens, Irma; de Smet, Anne-Sophie; Tavernier, Jan] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium; [Cokol, Murat; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Mana, Miyeko; Kao, Huey-Ling; Drew, Kevin; Rhrissorrakrai, Kahn; Bonneau, Richard; Gunsalus, Kristin C.; Piano, Fabio] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA; [Wang, Haidong; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Galli, Matilde; van den Heuvel, Sander] Univ Utrecht, Fac Sci, Div Dev Biol, NL-3584 CH Utrecht, Netherlands; [Iakoucheva, Lilia M.] Rockefeller Univ, Lab Stat Genet, New York, NY 10065 USA; [Dunker, A. Keith] Indiana Univ, Sch Med & Informat, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Harvard University; Harvard Medical School; New York University; Stanford University; Utrecht University; Rockefeller University; Indiana University System; Indiana University-Purdue University Indianapolis	Boxem, M (corresponding author), Harvard Univ, Sch Med, CCSB, Boston, MA 02115 USA.	mboxem@partners.org; hyman@mpi-cbg.de; marc_vidal@dfci.harvard.edu	Yildirim, Muhammed/J-3695-2014; Hyman, Anthony A/B-3917-2017; Bonneau, Richard/GZL-2900-2022; van den Heuvel, Sander J.L./B-8892-2011; Hill, David E/B-6617-2011; Simonis, Nicolas/E-5124-2010; Roth, Frederick P/H-6308-2011; Tavernier, Jan/AAG-3636-2019; Klitgord, Niels/B-5121-2009; Hyman, Tony/F-1923-2011; Boxem, Mike/B-8857-2011; Bonneau, Richard/ABD-6737-2021; Mul, Joram/C-3125-2011	Yildirim, Muhammed/0000-0003-2826-1766; Hyman, Anthony A/0000-0003-3664-154X; van den Heuvel, Sander J.L./0000-0001-9015-7463; Drew, Kevin/0000-0002-1260-4413; Galli, Matilde/0000-0002-2861-7032; Mul, Joram/0000-0003-0453-2568; Mana, Miyeko/0000-0002-5516-4008; Roth, Frederick/0000-0002-6628-649X; Iakoucheva, Lilia/0000-0002-4542-5219	Leukemia Research Foundation; W. M. Keck foundation; National Institutes of Health [R21RR023114, R01HG001715, R33CA105405, R33CA81658, R21CA113711, U54 CA011295, CA95281]; United States Army Medical Research Acquisition Activity [W23RYX-3275-N605]; New York State Foundation of Science, Technology; Academic Research [C040066]; National Science Foundation [MCB 0444818, BDI-0345474, IUAP-P6:28, UG-GOA12051401, FWO-G.0031.06]; NATIONAL CANCER INSTITUTE [R21CA113711, P01CA095281, R33CA081658, U54CA112952, R33CA105405] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR023114] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER	Leukemia Research Foundation; W. M. Keck foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research Acquisition Activity; New York State Foundation of Science, Technology; Academic Research; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to X. Xin and C. Boone for sharing of the cDNA library and yeast strains, to Joe Hargitai for unparalleled parallel computing support, to IBM's World Community Grid (http://www.wcgrid.org), and to M. Cusick for critical reading of the manuscript. Support was provided by the Leukemia Research Foundation to M. B., the W. M. Keck foundation to M. V., the FWO-V to I.L., National Institutes of Health grants R21RR023114 (M.B. P.I.), R01HG001715 ( M.V. P.I.), R33CA105405 (M.V. P.I.), R33CA81658 (M.V. P.I.), R21CA113711 (L.M.I. P.I.), U54 CA011295 (J. Nevins, PI; M.V. subcontract), and CA95281 (S.v.d.H.), United States Army Medical Research Acquisition Activity grant W23RYX-3275-N605 (K.C.G.), New York State Foundation of Science, Technology, and Academic Research grant C040066 (K.C.G.), National Science Foundation grants MCB 0444818 to L. M. I. and BDI-0345474 to D. K. and grants IUAP-P6:28, UG-GOA12051401, and FWO-G.0031.06 to J. T. M. V. is a "Chercheur Qualifie Honoraire'' from the Fonds de la Recherche Scientifique (FRS-FNRS, French Community of Belgium).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fromont-Racine M, 2002, METHOD ENZYMOL, V350, P513, DOI 10.1016/S0076-6879(02)50982-4; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Liu JF, 2004, PROTEINS, V55, P678, DOI 10.1002/prot.20095; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Praitis V, 2001, GENETICS, V157, P1217; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Trifonov EN, 2003, CURR OPIN STRUC BIOL, V13, P110, DOI 10.1016/S0959-440X(03)00005-8; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Walhout AJM, 1999, GENOME RES, V9, P1128, DOI 10.1101/gr.9.11.1128; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang HD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r192; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	59	155	162	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					534	545		10.1016/j.cell.2008.07.009	http://dx.doi.org/10.1016/j.cell.2008.07.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692475	Green Accepted, Bronze			2022-12-24	WOS:000258665500025
J	Marson, A; Levine, SS; Cole, MF; Frampton, GM; Brambrink, T; Johnstone, S; Guenther, MG; Johnston, WK; Wernig, M; Newman, J; Calabrese, JM; Dennis, LM; Volkert, TL; Gupta, S; Love, J; Hannett, N; Sharp, PA; Bartel, DP; Jaenisch, R; Young, RA				Marson, Alexander; Levine, Stuart S.; Cole, Megan F.; Frampton, Garrett M.; Brambrink, Tobias; Johnstone, Sarah; Guenther, Matthew G.; Johnston, Wendy K.; Wernig, Marius; Newman, Jamie; Calabrese, J. Mauro; Dennis, Lucas M.; Volkert, Thomas L.; Gupta, Sumeet; Love, Jennifer; Hannett, Nancy; Sharp, Phillip A.; Bartel, David P.; Jaenisch, Rudolf; Young, Richard A.			Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells	CELL			English	Article							SELF-RENEWAL; DEVELOPMENTAL REGULATORS; EXPRESSION; PLURIPOTENCY; PROMOTERS; NETWORK; DICER; DIFFERENTIATION; BIOGENESIS; SIGNATURE	MicroRNAs (miRNAs) are crucial for normal embryonic stem (ES) cell self-renewal and cellular differentiation, but how miRNA gene expression is controlled by the key transcriptional regulators of ES cells has not been established. We describe here the transcriptional regulatory circuitry of ES cells that incorporates protein-coding and miRNA genes based on high-resolution ChIP-seq data, systematic identification of miRNA promoters, and quantitative sequencing of short transcripts in multiple cell types. We find that the key ES cell transcription factors are associated with promoters for miRNAs that are preferentially expressed in ES cells and with promoters for a set of silent miRNA genes. This silent set of miRNA genes is co-occupied by Polycomb group proteins in ES cells and shows tissue-specific expression in differentiated cells. These data reveal how key ES cell transcription factors promote the ES cell miRNA expression program and integrate miRNAs into the regulatory circuitry controlling ES cell identity.	[Marson, Alexander; Levine, Stuart S.; Cole, Megan F.; Frampton, Garrett M.; Brambrink, Tobias; Johnstone, Sarah; Guenther, Matthew G.; Johnston, Wendy K.; Wernig, Marius; Newman, Jamie; Dennis, Lucas M.; Volkert, Thomas L.; Gupta, Sumeet; Love, Jennifer; Hannett, Nancy; Bartel, David P.; Jaenisch, Rudolf; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Marson, Alexander; Cole, Megan F.; Frampton, Garrett M.; Johnstone, Sarah; Newman, Jamie; Calabrese, J. Mauro; Dennis, Lucas M.; Sharp, Phillip A.; Bartel, David P.; Jaenisch, Rudolf; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Johnstone, Sarah; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Calabrese, J. Mauro; Sharp, Phillip A.] MIT, Koch Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Frampton, Garrett/0000-0002-2361-2750; Levine, Stuart/0000-0001-7363-562X	NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869, HG002668]; Whitehead Institute; Cancer Center Support (Core); NCI [P30-CA14051]; NATIONAL CANCER INSTITUTE [R37CA084198, P30CA014051, R01CA087869] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Institute; Cancer Center Support (Core); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Young, Jaenisch, and Bartel laboratories, especially T. Lee, for discussions and critical review of the manuscript. We also thank A. Ravi and A. Seila for their help and A. Smith for providing the ZHBTc4 cells. We are grateful to L. A. Boyer, B. Chevalier, R. Kumar, and T. Lee who were instrumental in performing location analysis in hES cells. We also thank Biology and Research Computing (BaRC), especially Tom DiCesare, for computational and technical support and graphic assistance. This work was supported in part by NIH grants 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869 to R.J. and by NIH grant HG002668 and a grant from the Whitehead Institute to R.A.Y and partially by a Cancer Center Support (Core) grant P30-CA14051 from the NCI. R.A.Y. consults for Agilent Technologies.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; YI F, 2008, STEM CELLS; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	58	1116	1191	2	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					521	533		10.1016/j.cell.2008.07.020	http://dx.doi.org/10.1016/j.cell.2008.07.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692474	Bronze, Green Accepted			2022-12-24	WOS:000258665500024
J	Dasen, JS; De Camilli, A; Wang, B; Tucker, PW; Jessell, TM				Dasen, Jeremy S.; De Camilli, Alessandro; Wang, Bin; Tucker, Philip W.; Jessell, Thomas M.			Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1	CELL			English	Article							ETS GENE PEA3; POOL IDENTITY; EARLY VERTEBRATES; SUBTYPE IDENTITY; SKELETAL-MUSCLES; NERVOUS-SYSTEM; SPECIFICATION; EXPRESSION; EVOLUTION; LIMB	The precision with which motor neurons innervate target muscles depends on a regulatory network of Hox transcription factors that translates neuronal identity into patterns of connectivity. We show that a single transcription factor, FoxP1, coordinates motor neuron subtype identity and connectivity through its activity as a Hox accessory factor. FoxP1 is expressed in Hox-sensitive motor columns and acts as a dose-dependent determinant of columnar fate. Inactivation of Foxp1 abolishes the output of the motor neuron Hox network, reverting the spinal motor system to an ancestral state. The loss of FoxP1 also changes the pattern of motor neuron connectivity, and in the limb motor axons appear to select their trajectories and muscle targets at random. Our findings show that FoxP1 is a crucial determinant of motor neuron diversification and connectivity, and clarify how this Hox regulatory network controls the formation of a topographic neural map.	[Dasen, Jeremy S.; De Camilli, Alessandro] NYU, Sch Med, Dept Physiol & Neurosci, Smilow Neurosci Program, New York, NY 10016 USA; [Wang, Bin; Tucker, Philip W.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Biochem, New York, NY 10032 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Mol Biophys, New York, NY 10032 USA	New York University; University of Texas System; University of Texas Austin; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Dasen, JS (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Smilow Neurosci Program, New York, NY 10016 USA.	jeremy.dasen@nyumc.org; tmj1@columbia.edu			NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA031534] Funding Source: Medline; PHS HHS [5R01033245] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Force A, 2002, J EXP ZOOL, V294, P30, DOI 10.1002/jez.10091; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Funakoshi K, 2007, BRAIN BEHAV EVOLUT, V69, P105, DOI 10.1159/000095199; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kusakabe R, 2005, DEV DYNAM, V234, P824, DOI 10.1002/dvdy.20587; Landgraf M, 2006, SEMIN CELL DEV BIOL, V17, P3, DOI 10.1016/j.semcdb.2005.11.007; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; RPICE SR, 2002, CELL, V109, P205; Shah V, 2004, DEV DYNAM, V231, P43, DOI 10.1002/dvdy.20103; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tamura S, 2003, GENE EXPR PATTERNS, V3, P193, DOI 10.1016/S1567-133X(03)00003-6; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Turney BW, 2003, J ANAT, V202, P83, DOI 10.1046/j.1469-7580.2003.00131.x; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225	45	255	257	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					304	316		10.1016/j.cell.2008.06.019	http://dx.doi.org/10.1016/j.cell.2008.06.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662545	Bronze			2022-12-24	WOS:000257891700019
J	Alroy, J; Aberhan, M; Bottjer, DJ; Foote, M; Fursich, FT; Harries, PJ; Hendy, AJW; Holland, SM; Ivany, LC; Kiessling, W; Kosnik, MA; Marshall, CR; McGowan, AJ; Miller, AI; Olszewski, TD; Patzkowsky, ME; Peters, SE; Villier, L; Wagner, PJ; Bonuso, N; Borkow, PS; Brenneis, B; Clapham, ME; Fall, LM; Ferguson, CA; Hanson, VL; Krug, AZ; Layou, KM; Leckey, EH; Nurnberg, S; Powers, CM; Sessa, JA; Simpson, C; Tomasovych, A; Visaggi, CC				Alroy, John; Aberhan, Martin; Bottjer, David J.; Foote, Michael; Fuersich, Franz T.; Harries, Peter J.; Hendy, Austin J. W.; Holland, Steven M.; Ivany, Linda C.; Kiessling, Wolfgang; Kosnik, Matthew A.; Marshall, Charles R.; McGowan, Alistair J.; Miller, Arnold I.; Olszewski, Thomas D.; Patzkowsky, Mark E.; Peters, Shanan E.; Villier, Loic; Wagner, Peter J.; Bonuso, Nicole; Borkow, Philip S.; Brenneis, Benjamin; Clapham, Matthew E.; Fall, Leigh M.; Ferguson, Chad A.; Hanson, Victoria L.; Krug, Andrew Z.; Layou, Karen M.; Leckey, Erin H.; Nuernberg, Sabine; Powers, Catherine M.; Sessa, Jocelyn A.; Simpson, Carl; Tomasovych, Adam; Visaggi, Christy C.			Phanerozoic trends in the global diversity of marine invertebrates	SCIENCE			English	Article							TAXONOMIC DIVERSITY; SAMPLING-STANDARDIZATION; MASS EXTINCTIONS; ANIMAL DIVERSITY; ALPHA-DIVERSITY; FOSSIL RECORD; DIVERSIFICATION; COMMUNITIES; EVENNESS; INCREASE	It has previously been thought that there was a steep Cretaceous and Cenozoic radiation of marine invertebrates. This pattern can be replicated with a new data set of fossil occurrences representing 3.5 million specimens, but only when older analytical protocols are used. Moreover, analyses that employ sampling standardization and more robust counting methods show a modest rise in diversity with no clear trend after the mid- Cretaceous. Globally, locally, and at both high and low latitudes, diversity was less than twice as high in the Neogene as in the mid- Paleozoic. The ratio of global to local richness has changed little, and a latitudinal diversity gradient was present in the early Paleozoic.	[Alroy, John] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Aberhan, Martin; Kiessling, Wolfgang; Brenneis, Benjamin; Nuernberg, Sabine] Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; [Bottjer, David J.; Bonuso, Nicole; Clapham, Matthew E.; Powers, Catherine M.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Foote, Michael; Peters, Shanan E.; Hanson, Victoria L.; Krug, Andrew Z.; Simpson, Carl; Tomasovych, Adam] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Fuersich, Franz T.] Univ Erlangen Nurnberg, Geozentrum Nordbayern, D-91054 Erlangen, Germany; [Harries, Peter J.] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Hendy, Austin J. W.; Miller, Arnold I.; Ferguson, Chad A.; Layou, Karen M.; Sessa, Jocelyn A.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Hendy, Austin J. W.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Holland, Steven M.; Hanson, Victoria L.; Layou, Karen M.] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Ivany, Linda C.; Visaggi, Christy C.] Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; [Kosnik, Matthew A.; Wagner, Peter J.] Smithsonian Inst, Dept Paleobiol, Washington, DC 20013 USA; [Marshall, Charles R.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [McGowan, Alistair J.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Olszewski, Thomas D.; Fall, Leigh M.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Olszewski, Thomas D.; Fall, Leigh M.] Texas A&M Univ, Fac Ecol & Evolutionary Biol, College Stn, TX 77843 USA; [Patzkowsky, Mark E.; Krug, Andrew Z.; Sessa, Jocelyn A.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Peters, Shanan E.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Villier, Loic] Univ Aix Marseille 1, Ctr Sedimentol Paleontol, F-13331 Marseille 3, France; [Bonuso, Nicole] Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92834 USA; [Borkow, Philip S.] Hamilton Local Sch Dist, Dept Sci, Columbus, OH 43207 USA; [Clapham, Matthew E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Layou, Karen M.] Coll William & Mary, Dept Geol, Williamsburg, VA 23187 USA; [Leckey, Erin H.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Simpson, Carl] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Tomasovych, Adam] Slovak Acad Sci, Inst Geol, Bratislava 84005 45, Slovakia; [Visaggi, Christy C.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Southern California; University of Chicago; University of Erlangen Nuremberg; State University System of Florida; University of South Florida; University System of Ohio; University of Cincinnati; Yale University; University System of Georgia; University of Georgia; Syracuse University; Smithsonian Institution; Smithsonian National Museum of Natural History; Harvard University; Natural History Museum London; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Wisconsin System; University of Wisconsin Madison; UDICE-French Research Universities; Aix-Marseille Universite; California State University System; California State University Fullerton; University of California System; University of California Santa Cruz; William & Mary; University of Colorado System; University of Colorado Boulder; Duke University; Slovak Academy of Sciences; University of North Carolina; University of North Carolina Wilmington	Alroy, J (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	alroy@nceas.ucsb.edu	Kosnik, Matthew A./P-9632-2019; Clapham, Matthew E./A-4294-2015; Peters, Shanan E/A-5620-2013; Tomasovych, Adam/C-9623-2010; Kiessling, Wolfgang/E-2259-2015; Simpson, Carl/E-7140-2010; Kosnik, Matthew/G-2312-2010; Nürnberg, Sabine/D-5217-2013; Hendy, Austin J/C-1279-2013; Alroy, John/B-4585-2009; Holland, Steven/A-8557-2008	Kosnik, Matthew A./0000-0001-5380-7041; Clapham, Matthew E./0000-0003-4867-7304; Peters, Shanan E/0000-0002-3346-4317; Tomasovych, Adam/0000-0002-0471-9480; Kiessling, Wolfgang/0000-0002-1088-2014; Kosnik, Matthew/0000-0001-5380-7041; Hendy, Austin J/0000-0002-9818-1158; Alroy, John/0000-0002-9882-2111; Holland, Steven/0000-0002-4527-9370; Harries, Peter/0000-0001-8320-9114; Simpson, Carl/0000-0003-0719-4437; Sessa, Jocelyn A./0000-0003-1509-5519				Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; AUSICH WI, 1982, SCIENCE, V216, P173, DOI 10.1126/science.216.4542.173; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; BAMBACH RK, 1983, BIOTIC INTERACTIONS, P719; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Bush AM, 2004, PALEOBIOLOGY, V30, P666, DOI 10.1666/0094-8373(2004)030<0666:RBFDCT>2.0.CO;2; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Miller AI, 1996, PALEOBIOLOGY, V22, P304, DOI 10.1017/S0094837300016237; Miller AI, 2000, PALEOBIOLOGY, V26, P53, DOI 10.1666/0094-8373(2000)26[53:CAPGD]2.0.CO;2; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Peters SE, 2004, PALEOBIOLOGY, V30, P325, DOI 10.1666/0094-8373(2004)030<0325:EOCBMC>2.0.CO;2; Powell MG, 2005, GEOLOGY, V33, P381, DOI 10.1130/G21155.1; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; RAUP D M, 1976, Paleobiology, V2, P289; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; SIMPSON GG, 1960, EVOLUTION DARWIN, V1, P117; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Streel M, 2000, EARTH-SCI REV, V52, P121, DOI 10.1016/S0012-8252(00)00026-X; Valentine J. W., 1969, Palaeontology, V12, P684; Van valen L, 1976, EVOL THEORY, V1, P179; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795	35	501	530	8	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					97	100		10.1126/science.1156963	http://dx.doi.org/10.1126/science.1156963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599780				2022-12-24	WOS:000257320800044
J	Levy, ED; Erba, EB; Robinson, CV; Teichmann, SA				Levy, Emmanuel D.; Erba, Elisabetta Boeri; Robinson, Carol V.; Teichmann, Sarah A.			Assembly reflects evolution of protein complexes	NATURE			English	Article							MACROMOLECULAR ASSEMBLIES; NETWORKS; SYMMETRY; SUBUNIT	A homomer is formed by self- interacting copies of a protein unit. This is functionally important(1,2), as in allostery(3-5), and structurally crucial because mis- assembly of homomers is implicated in disease(6,7). Homomers are widespread, with 50 - 70% of proteins with a known quaternary state assembling into such structures(8,9). Despite their prevalence, their role in the evolution of cellular machinery(10,11) and the potential for their use in the design of new molecular machines(12,13), little is known about the mechanisms that drive formation of homomers at the level of evolution and assembly in the cell(9,14). Here we present an analysis of over 5,000 unique atomic structures and show that the quaternary structure of homomers is conserved in over 70% of protein pairs sharing as little as 30% sequence identity. Where quaternary structure is not conserved among the members of a protein family, a detailed investigation revealed well- defined evolutionary pathways by which proteins transit between different quaternary structure types. Furthermore, we show by perturbing subunit interfaces within complexes and by mass spectrometry analysis(15), that the ( dis) assembly pathway mimics the evolutionary pathway. These data represent a molecular analogy to Haeckel's evolutionary paradigm of embryonic development, where an intermediate in the assembly of a complex represents a form that appeared in its own evolutionary history. Our model of self- assembly allows reliable prediction of evolution and assembly of a complex solely from its crystal structure.	[Levy, Emmanuel D.; Teichmann, Sarah A.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Erba, Elisabetta Boeri; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	MRC Laboratory Molecular Biology; University of Cambridge	Levy, ED (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	homomers@mrc-lmb.cam.ac.uk	Erba, Elisabetta Boeri/J-1058-2014	Erba, Elisabetta Boeri/0000-0002-5910-4707; Teichmann, Sarah/0000-0002-6294-6366; robinson, carol/0000-0001-7829-5505	Medical Research Council [MC_U105161047, U.1051.04.025(78835)] Funding Source: Medline; MRC [MC_U105161047] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bahadur RP, 2007, J MOL BIOL, V367, P574, DOI 10.1016/j.jmb.2006.12.054; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Cabezon E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200; Cheesman C, 2004, BIOCHEMISTRY-US, V43, P1609, DOI 10.1021/bi0354987; CLAVERIE P, 1968, CR ACAD SCI D NAT, V266, P1616; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Iber D, 2006, NATURE, V441, P371, DOI 10.1038/nature04666; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Janin J, 2008, SCIENCE, V319, P165, DOI 10.1126/science.1152930; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Luke K, 2006, ARCH BIOCHEM BIOPHYS, V456, P8, DOI 10.1016/j.abb.2006.10.003; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1968, NOB S, V11; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Powers ET, 2003, BIOPHYS J, V85, P3587, DOI 10.1016/S0006-3495(03)74777-8; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552	28	311	312	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1262	U66		10.1038/nature06942	http://dx.doi.org/10.1038/nature06942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18563089	Green Accepted			2022-12-24	WOS:000257075800048
J	Ago, T; Liu, T; Zhai, P; Chen, W; Li, H; Molkentin, JD; Vatner, SF; Sadoshima, J				Ago, Tetsuro; Liu, Tong; Zhai, Peiyong; Chen, Wei; Li, Hong; Molkentin, Jeffery D.; Vatner, Stephen F.; Sadoshima, Junichi			A redox-dependent pathway for regulating class IIHDACs and cardiac hypertrophy	CELL			English	Article							HISTONE DEACETYLASE; NUCLEAR-FACTOR; THIOREDOXIN; ACTIVATION; HEART; INHIBITION; PROTEIN-1; PHENOTYPE; APOPTOSIS; STRESS	Thioredoxin 1 (Trx1) facilitates the reduction of signaling molecules and transcription factors by cysteine thiol-disulfide exchange, thereby regulating cell growth and death. Here we studied the molecular mechanism by which Trx1 attenuates cardiac hypertrophy. Trx1 upregulates DnaJb5, a heat shock protein 40, and forms a multiple-protein complex with DnaJb5 and class II histone deacetylases (HDACs), master negative regulators of cardiac hypertrophy. Both Cys-274/Cys-276 in DnaJb5 and Cys-667/Cys-669 in HDAC4 are oxidized and form intramolecular disulfide bonds in response to reactive oxygen species (ROS)-generating hypertrophic stimuli, such as phenylephrine, whereas they are reduced by Trx1. Whereas reduction of Cys-274/Cys-276 in DnaJb5 is essential for interaction between DnaJb5 and HDAC4, reduction of Cys-667/Cys-669 in HDAC4 inhibits its nuclear export, independently of its phosphorylation status. Our study reveals a novel regulatory mechanism of cardiac hypertrophy through which the nucleocytoplasmic shuttling of class II HDACs is modulated by their redox modification in a Trx1-sensitive manner.	[Ago, Tetsuro; Zhai, Peiyong; Vatner, Stephen F.; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Liu, Tong; Chen, Wei; Li, Hong] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Canc, Ctr Adv Prote Res, Newark, NJ 07103 USA; [Liu, Tong; Chen, Wei; Li, Hong] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Canc, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Sadoshima, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	sadoshju@umdnj.edu	Li, Hong/K-8436-2013	Ago, Tetsuro/0000-0003-4560-6594; Molkentin, Jeffery/0000-0002-3558-6529; Li, Hong/0000-0001-5731-5335; Sadoshima, Junichi/0000-0003-3724-4132	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069020, R01HL067727, R01HL091469, P01HL059139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039, R01AG028787] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL059139, HL 59139, HL67727, P01 HL069020, HL69020, HL91469] Funding Source: Medline; NIA NIH HHS [R01 AG028787, AG28787, AG23039] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ago T, 2006, ANTIOXID REDOX SIGN, V8, P1635, DOI 10.1089/ars.2006.8.1635; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Choi HI, 2006, FREE RADICAL BIO MED, V40, P651, DOI 10.1016/j.freeradbiomed.2005.09.018; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1; Li GQ, 1997, AM J PHYSIOL-HEART C, V273, pH1090, DOI 10.1152/ajpheart.1997.273.3.H1090; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Tang W, 2001, BIOCHEMISTRY-US, V40, P14985, DOI 10.1021/bi0107593; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700	24	274	277	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					978	993		10.1016/j.cell.2008.04.041	http://dx.doi.org/10.1016/j.cell.2008.04.041			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555775	Green Submitted, Bronze			2022-12-24	WOS:000256693400014
J	Basto, R; Brunk, K; Vinadogrova, T; Peel, N; Franz, A; Khodjakov, A; Raff, JW				Basto, Renata; Brunk, Kathrin; Vinadogrova, Tatiana; Peel, Nina; Franz, Anna; Khodjakov, Alexey; Raff, Jordan W.			Centrosome amplification can initiate tumorigenesis in flies	CELL			English	Article							ASYMMETRIC CELL-DIVISION; REGULATES SPINDLE ORIENTATION; NEUROBLAST SELF-RENEWAL; NEURAL STEM-CELLS; CENTRIOLE DUPLICATION; TUMOR-SUPPRESSOR; DROSOPHILA-MELANOGASTER; CHROMOSOME INSTABILITY; CYCLE PROGRESSION; CORTICAL POLARITY	Centrosome amplification is a common feature of many cancer cells, and it has been previously proposed that centrosome amplification can drive genetic instability and so tumorigenesis. To test this hypothesis, we generated Drosophila lines that have extra centrosomes in similar to 60% of their somatic cells. Many cells with extra centrosomes initially form multipolar spindles, but these spindles ultimately become bipolar. This requires a delay in mitosis that is mediated by the spindle assembly checkpoint (SAC). As a result of this delay, there is no dramatic increase in genetic instability in flies with extra centrosomes, and these flies maintain a stable diploid genome over many generations. The asymmetric division of the larval neural stem cells, however, is compromised in the presence of extra centrosomes, and larval brain cells with extra centrosomes can generate metastatic tumors when transplanted into the abdomens of wild-type hosts. Thus, centrosome amplification can initiate tumorigenesis in flies.	[Basto, Renata; Brunk, Kathrin; Peel, Nina; Franz, Anna; Raff, Jordan W.] Gurdon Inst, Cambridge CB2 1QN, England; [Vinadogrova, Tatiana; Khodjakov, Alexey] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Vinadogrova, Tatiana; Khodjakov, Alexey] SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; [Peel, Nina] NIDDK, NIH, Lab Biochem & Genet, Bethesda, MD 20892 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Basto, R (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, Paris 05, France.	renata.basto@curie.fr; j.raff@gurdon.cam.ac.uk		Franz, Anna/0000-0002-2070-326X; Peel, Nina/0000-0002-4277-4106	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; NIGMS NIH HHS [R01 GM059363, R01 GM059363-10] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Baker JD, 2004, DEVELOPMENT, V131, P3411, DOI 10.1242/dev.01229; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brinkley BR, 1998, CELL MOTIL CYTOSKEL, V41, P281, DOI 10.1002/(SICI)1097-0169(1998)41:4<281::AID-CM1>3.0.CO;2-C; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Endow SA, 1998, J CELL SCI, V111, P2487; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Karpova N, 2006, CELL MOTIL CYTOSKEL, V63, P301, DOI 10.1002/cm.20124; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; LEE HS, 1988, MOL CELL BIOL, V8, P4727, DOI 10.1128/MCB.8.11.4727; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; RING D, 1982, J CELL BIOL, V94, P549, DOI 10.1083/jcb.94.3.549; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; Sluder G, 1997, J CELL SCI, V110, P421; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Woodhouse E, 1998, DEV GENES EVOL, V207, P542, DOI 10.1007/s004270050145; Wunderlich V, 2002, J MOL MED, V80, P545, DOI 10.1007/s00109-002-0374-y; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016	61	402	408	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					1032	1042		10.1016/j.cell.2008.05.039	http://dx.doi.org/10.1016/j.cell.2008.05.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555779	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000256693400018
J	Harder, JL; Margolis, B				Harder, Jennifer L.; Margolis, Ben			SnapShot: Tight and adherens junction signaling	CELL			English	Editorial Material							CELL-ADHESION; CYTOSKELETON		[Harder, Jennifer L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Harder, JL (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069605] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Kohler K, 2005, BIOL CELL, V97, P659; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008	9	13	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6							e2	10.1016/j.cell.2008.06.002	http://dx.doi.org/10.1016/j.cell.2008.06.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555786	Bronze			2022-12-24	WOS:000256693400025
J	Lange, OF; Lakomek, NA; Fares, C; Schroder, GF; Walter, KFA; Becker, S; Meiler, J; Grubmuller, H; Griesinger, C; de Groot, BL				Lange, Oliver F.; Lakomek, Nils-Alexander; Fares, Christophe; Schroeder, Gunnar F.; Walter, Korvin F. A.; Becker, Stefan; Meiler, Jens; Grubmueller, Helmut; Griesinger, Christian; de Groot, Bert L.			Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution	SCIENCE			English	Article							RESIDUAL DIPOLAR COUPLINGS; PROTEIN BACKBONE MOTION; N-15 NMR RELAXATION; MODEL-FREE APPROACH; ORDER PARAMETERS; BINDING DOMAINS; SPECTROSCOPY; CATALYSIS; INFORMATION; ENTROPY	Protein dynamics are essential for protein function, and yet it has been challenging to access the underlying atomic motions in solution on nanosecond-to-microsecond time scales. We present a structural ensemble of ubiquitin, refined against residual dipolar couplings (RDCs), comprising solution dynamics up to microseconds. The ensemble covers the complete structural heterogeneity observed in 46 ubiquitin crystal structures, most of which are complexes with other proteins. Conformational selection, rather than induced-fit motion, thus suffices to explain the molecular recognition dynamics of ubiquitin. Marked correlations are seen between the flexibility of the ensemble and contacts formed in ubiquitin complexes. A large part of the solution dynamics is concentrated in one concerted mode, which accounts for most of ubiquitin's molecular recognition heterogeneity and ensures a low entropic complex formation cost.	[Lakomek, Nils-Alexander; Fares, Christophe; Walter, Korvin F. A.; Becker, Stefan; Griesinger, Christian] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Lange, Oliver F.; Schroeder, Gunnar F.; Grubmueller, Helmut; de Groot, Bert L.] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37212 USA	Max Planck Society; Max Planck Society; Vanderbilt University	Griesinger, C (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	cigr@nmr.mpibpc.mpg.de; bgroot@gwdg.de	Lakomek, Nils A/K-6568-2016; Fares, Christophe/G-2481-2011; Schröder, Gunnar F/H-5261-2013; Lange, Oliver/B-2861-2009; Lange, Oliver/G-1366-2010; Lange, Oliver/K-5749-2012	Lakomek, Nils A/0000-0002-4285-6339; Schröder, Gunnar F/0000-0003-1803-5431; Lange, Oliver/0000-0002-4018-7020; Meiler, Jens/0000-0001-8945-193X				AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Bouvignies G, 2006, J AM CHEM SOC, V128, P15100, DOI 10.1021/ja066704b; Briggman KB, 2003, J AM CHEM SOC, V125, P10164, DOI 10.1021/ja035904+; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Chang SL, 2005, J MAGN RESON, V174, P43, DOI 10.1016/j.jmr.2005.01.008; CLARKSON T, 1995, SCIENCE, V267, P383; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; Lakomek NA, 2006, J BIOMOL NMR, V34, P101, DOI 10.1007/s10858-005-5686-0; Lakomek NA, 2005, ANGEW CHEM INT EDIT, V44, P7776, DOI 10.1002/anie.200502573; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; Massi F, 2005, PROTEIN SCI, V14, P735, DOI 10.1110/ps.041139505; Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Ottiger M, 1998, J AM CHEM SOC, V120, P12334, DOI 10.1021/ja9826791; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Peti W, 2002, J AM CHEM SOC, V124, P5822, DOI 10.1021/ja011883c; Richter B, 2007, J BIOMOL NMR, V37, P117, DOI 10.1007/s10858-006-9117-7; Ruan K, 2005, J AM CHEM SOC, V127, P15032, DOI 10.1021/ja055520e; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Tolman JR, 2002, J AM CHEM SOC, V124, P12020, DOI 10.1021/ja0261123; Wang LC, 2001, P NATL ACAD SCI USA, V98, P7684, DOI 10.1073/pnas.121069998; Yang DW, 1997, J MOL BIOL, V272, P790, DOI 10.1006/jmbi.1997.1285	44	806	816	2	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1471	1475		10.1126/science.1157092	http://dx.doi.org/10.1126/science.1157092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556554	Green Published			2022-12-24	WOS:000256676400038
J	Drummond, DA; Wilke, CO				Drummond, D. Allan; Wilke, Claus O.			Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolution	CELL			English	Article							SYNONYMOUS CODON USAGE; TRANSFER-RNA SYNTHETASE; GENE-EXPRESSION; SUBSTITUTION RATES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL ACCURACY; MUTATION-RATE; SELECTION; DROSOPHILA	Strikingly consistent correlations between rates of coding-sequence evolution and gene expression levels are apparent across taxa, but the biological causes behind the selective pressures on coding-sequence evolution remain controversial. Here, we demonstrate conserved patterns of simple covariation between sequence evolution, codon usage, and mRNA level in E. coli, yeast, worm, fly, mouse, and human that suggest that all observed trends stem largely from a unified underlying selective pressure. In metazoans, these trends are strongest in tissues composed of neurons, whose structure and lifetime confer extreme sensitivity to protein misfolding. We propose, and demonstrate using a molecular-level evolutionary simulation, that selection against toxicity of misfolded proteins generated by ribosome errors suffices to create all of the observed covariation. The mechanistic model of molecular evolution that emerges yields testable biochemical predictions, calls into question the use of nonsynonymous-to-synonymous substitution ratios (Ka/Ks) to detect functional selection, and suggests how mistranslation may contribute to neurodegenerative disease.	[Drummond, D. Allan] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Wilke, Claus O.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA	Harvard University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Drummond, DA (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	dadrummond@cgr.harvard.edu	Wilke, Claus O./B-4643-2008; Drummond, D. Allan/A-1250-2015	Drummond, D. Allan/0000-0001-7018-7059; Wilke, Claus/0000-0002-7470-9261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM068763-05, P50 GM068763] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKASHI H, 1994, GENETICS, V136, P927; Anfinsen Christian B., 1959, MOL BASIS EVOLUTION; Bacher JM, 2007, P NATL ACAD SCI USA, V104, P1907, DOI 10.1073/pnas.0610835104; Bierne N, 2003, GENETICS, V165, P1587; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Choi JK, 2007, GENETICS, V175, P199, DOI 10.1534/genetics.106.066027; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Koonin EV, 2006, CURR OPIN BIOTECH, V17, P481, DOI 10.1016/j.copbio.2006.08.003; Kourie JI, 2002, CLIN EXP PHARMACOL P, V29, P741, DOI 10.1046/j.1440-1681.2002.03737.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; LI WH, 1985, MOL BIOL EVOL, V2, P150; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Marais G, 2004, J MOL EVOL, V59, P771, DOI 10.1007/s00239-004-2671-2; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Parmley JL, 2007, PLOS BIOL, V5, P343, DOI 10.1371/journal.pbio.0050014; Popescu CE, 2006, GENETICS, V172, P1567, DOI 10.1534/genetics.105.047399; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2007, NEUROSCIENTIST, V13, P519, DOI 10.1177/1073858407303428; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Wilke CO, 2006, GENETICS, V173, P473, DOI 10.1534/genetics.105.051300; Wilke CO, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-25; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Wright SI, 2004, MOL BIOL EVOL, V21, P1719, DOI 10.1093/molbev/msh191; Wyckoff GJ, 2005, TRENDS GENET, V21, P381, DOI 10.1016/j.tig.2005.05.005; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974; ZUCKERKANDL E, 1976, J MOL EVOL, V7, P167, DOI 10.1007/BF01731487	68	739	758	2	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					341	352		10.1016/j.cell.2008.05.042	http://dx.doi.org/10.1016/j.cell.2008.05.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662548	Green Accepted, Bronze			2022-12-24	WOS:000257891700022
J	Li, Q; Zhou, H; Wurtele, H; Davies, B; Horazdovsky, B; Verreault, A; Zhang, ZG				Li, Qing; Zhou, Hui; Wurtele, Hugo; Davies, Brian; Horazdovsky, Bruce; Verreault, Alain; Zhang, Zhiguo			Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly	CELL			English	Article							DNA-REPLICATION; EPIGENETIC INHERITANCE; S-PHASE; CHROMATIN; H3; ASF1; H4; YEAST; COMPLEX; HETEROCHROMATIN	Chromatin assembly factor 1 (CAF-1) and Rtt106 participate in the deposition of newly synthesized histones onto replicating DNA to form nucleosomes. This process is critical for the maintenance of genome stability and inheritance of functionally specialized chromatin structures in proliferating cells. However, the molecular functions of the acetylation of newly synthesized histones in this DNA replication-coupled nucleosome assembly pathway remain enigmatic. Here we show that histone H3 acetylated at lysine 56 (H3K56Ac) is incorporated onto replicating DNA and, by increasing the binding affinity of CAF-1 and Rtt106 for histone H3, H3K56Ac enhances the ability of these histone chaperones to assemble DNA into nucleosomes. Genetic analysis indicates that H3K56Ac acts in a nonredundant manner with the acetylation of the N-terminal residues of H3 and H4 in nucleosome assembly. These results reveal a mechanism by which H3K56Ac regulates replication-coupled nucleosome assembly mediated by CAF-1 and Rtt106.	[Wurtele, Hugo; Verreault, Alain] IRIC, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Li, Qing; Zhou, Hui; Davies, Brian; Horazdovsky, Bruce; Zhang, Zhiguo] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Universite de Montreal; Mayo Clinic	Verreault, A (corresponding author), IRIC, Dept Pathol & Biol Cellulaire, POB 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	alain.verreault@umontreal.ca; zhang.zhiguo@mayo.edu			NIGMS NIH HHS [R01 GM081838, R01 GM081838-01A1, R01 GM072719, R01 GM072719-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838, R01GM072719] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Falbo KB, 2006, J CELL BIOCHEM, V97, P684, DOI 10.1002/jcb.20752; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shibahara K, 2000, P NATL ACAD SCI USA, V97, P7766, DOI 10.1073/pnas.97.14.7766; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	46	328	334	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					244	255		10.1016/j.cell.2008.06.018	http://dx.doi.org/10.1016/j.cell.2008.06.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662540	Green Accepted, Bronze			2022-12-24	WOS:000257891700014
J	Shima, S; Pilak, O; Vogt, S; Schick, M; Stagni, MS; Meyer-Klaucke, W; Warkentin, E; Thauer, RK; Ermler, U				Shima, Seigo; Pilak, Oliver; Vogt, Sonja; Schick, Michael; Stagni, Marco S.; Meyer-Klaucke, Wolfram; Warkentin, Eberhard; Thauer, Rudolf K.; Ermler, Ulrich			The crystal structure of [Fe]-hydrogenase reveals the geometry of the active site	SCIENCE			English	Article							CLUSTER-FREE HYDROGENASE; FE-ONLY HYDROGENASE; METAL-FREE HYDROGENASE; DESULFOVIBRIO-DESULFURICANS; CLOSTRIDIUM-PASTEURIANUM; METHANOGENIC ARCHAEA; CARBON-MONOXIDE; COORDINATION CHEMISTRY; LIGHT-INACTIVATION; NIFE HYDROGENASES	Biological formation and consumption of molecular hydrogen (H(2)) are catalyzed by hydrogenases, of which three phylogenetically unrelated types are known: [ NiFe]- hydrogenases, [ FeFe]- hydrogenases, and [ Fe]- hydrogenase. We present a crystal structure of [ Fe]- hydrogenase at 1.75 angstrom resolution, showing a mononuclear iron coordinated by the sulfur of cysteine 176, two carbon monoxide ( CO) molecules, and the sp(2)- hybridized nitrogen of a 2- pyridinol compound with back- bonding properties similar to those of cyanide. The three- dimensional arrangement of the ligands is similar to that of thiolate, CO, and cyanide ligated to the low- spin iron in binuclear [ NiFe]- and [ FeFe]- hydrogenases, although the enzymes have evolved independently and the CO and cyanide ligands are not found in any other metalloenzyme. The related iron ligation pattern of hydrogenases exemplifies convergent evolution and presumably plays an essential role in H(2) activation. This finding may stimulate the ongoing synthesis of catalysts that could substitute for platinum in applications such as fuel cells.	[Shima, Seigo; Pilak, Oliver; Vogt, Sonja; Schick, Michael; Thauer, Rudolf K.] Univ Marburg, Max Planck Inst Terr Microbiol, Fachbereich Biol, D-35043 Marburg, Germany; [Shima, Seigo; Pilak, Oliver; Vogt, Sonja; Schick, Michael; Thauer, Rudolf K.] Univ Marburg, Mikrobiol Lab, Fachbereich Biol, D-35043 Marburg, Germany; [Stagni, Marco S.; Meyer-Klaucke, Wolfram] EMBL Hamburg, D-22603 Hamburg, Germany; [Warkentin, Eberhard; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society; Philipps University Marburg; Philipps University Marburg; European Molecular Biology Laboratory (EMBL); Max Planck Society	Shima, S (corresponding author), Univ Marburg, Max Planck Inst Terr Microbiol, Fachbereich Biol, Karl von Frisch Str, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de; ulermler@mpibp-frankfurt.mpg.de	Salomone-Stagni, Marco/F-4458-2010; Meyer-Klaucke, Wolfram/G-1148-2010					Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Buurman G, 2000, FEBS LETT, V485, P200, DOI 10.1016/S0014-5793(00)02225-0; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; HEINEKEY DM, 1993, CHEM REV, V93, P913, DOI 10.1021/cr00019a004; Hu XL, 2007, J AM CHEM SOC, V129, P8988, DOI 10.1021/ja067876b; Justice AK, 2007, INORG CHEM, V46, P1655, DOI 10.1021/ic0618706; Korbas M, 2006, J BIOL CHEM, V281, P30804, DOI 10.1074/jbc.M605306200; Kubas GJ, 2005, CATAL LETT, V104, P79, DOI 10.1007/s10562-005-7440-3; Lemon BJ, 1999, BIOCHEMISTRY-US, V38, P12969, DOI 10.1021/bi9913193; Liu TB, 2007, J AM CHEM SOC, V129, P7008, DOI 10.1021/ja071851a; Lyon EJ, 2004, EUR J BIOCHEM, V271, P195, DOI 10.1046/j.1432-1033.2003.03920.x; Lyon EJ, 2004, J AM CHEM SOC, V126, P14239, DOI 10.1021/ja046818s; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; RAWSON JM, 1995, COORDIN CHEM REV, V139, P313, DOI 10.1016/0010-8545(94)01117-T; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Shima S, 2004, ANGEW CHEM INT EDIT, V43, P2547, DOI 10.1002/anie.200353763; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Silakov A, 2007, J AM CHEM SOC, V129, P11447, DOI 10.1021/ja072592s; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vogt S, 2008, J BIOL INORG CHEM, V13, P97, DOI 10.1007/s00775-007-0302-2; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wolfe S, 2007, THEOR CHEM ACC, V118, P265, DOI 10.1007/s00214-007-0321-7	31	446	455	5	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					572	575		10.1126/science.1158978	http://dx.doi.org/10.1126/science.1158978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653896				2022-12-24	WOS:000257888900051
J	Hasselmann, M; Gempe, T; Schiott, M; Nunes-Silva, CG; Otte, M; Beye, M				Hasselmann, Martin; Gempe, Tanja; Schiott, Morten; Nunes-Silva, Carlos Gustavo; Otte, Marianne; Beye, Martin			Evidence for the evolutionary nascence of a novel sex determination pathway in honeybees	NATURE			English	Article							TRANSFORMER GENE; APIS-MELLIFERA; DROSOPHILA; SELECTION; RNA; RECOMBINATION; DIVERSITY; PROTEINS; INSIGHTS; INSECTS	Sex determination in honeybees (Apis mellifera) is governed by heterozygosity at a single locus harbouring the complementary sex determiner (csd) gene(1), in contrast to the well-studied sex chromosome system of Drosophila melanogaster(2). Bees heterozygous at csd are females, whereas homozygotes and hemizygotes (haploid individuals) are males. Although at least 15 different csd alleles are known among natural bee populations(3), the mechanisms linking allelic interactions to switching of the sexual development programme are still obscure. Here we report a new component of the sex-determining pathway in honeybees, encoded 12 kilobases upstream of csd. The gene feminizer (fem) is the ancestrally conserved progenitor gene from which csd arose and encodes an SR-type protein, harbouring an Arg/Ser-rich domain. Fem shares the same arrangement of Arg/Ser- and proline-rich-domain with the Drosophila principal sex-determining gene transformer (tra), but lacks conserved motifs except for a 30-amino-acid motif that Fem shares only with Tra of another fly, Ceratitis capitata(4). Like tra, the fem transcript is alternatively spliced. The male-specific splice variant contains a premature stop codon and yields no functional product, whereas the female-specific splice variant encodes the functional protein. We show that RNA interference (RNAi)-induced knockdowns of the female-specific fem splice variant result in male bees, indicating that the fem product is required for entire female development. Furthermore, RNAi- induced knockdowns of female allelic csd transcripts result in the male-specific fem splice variant, suggesting that the fem gene implements the switch of developmental pathways controlled by heterozygosity at csd. Comparative analysis of fem and csd coding sequences from five bee species indicates a recent origin of csd in the honeybee lineage from the fem progenitor and provides evidence for positive selection at csd accompanied by purifying selection at fem. The fem locus in bees uncovers gene duplication and positive selection as evolutionary mechanisms underlying the origin of a novel sex determination pathway.	[Hasselmann, Martin; Gempe, Tanja; Schiott, Morten; Otte, Marianne; Beye, Martin] Univ Dusseldorf, Dept Genet, D-40225 Dusseldorf, Germany; [Schiott, Morten] Univ Copenhagen, Ctr Social Evolut, Dept Biol, DK-2100 Copenhagen, Denmark; [Nunes-Silva, Carlos Gustavo] INPA, GPA, BR-69060001 Manaus, Amazonas, Brazil	Heinrich Heine University Dusseldorf; University of Copenhagen; Institute Nacional de Pesquisas da Amazonia	Beye, M (corresponding author), Univ Dusseldorf, Dept Genet, Universitaetsstr 1, D-40225 Dusseldorf, Germany.	martin.beye@uni-duesseldorf.de	Hasselmann, Martin/ABB-6485-2021; Schiøtt, Morten/H-4118-2012; Nunes-Silva, Carlos Gustavo/D-8760-2013; Hasselmann, Martin/E-7681-2014; Schiøtt, Morten/AAJ-8945-2021	Hasselmann, Martin/0000-0003-3305-4024; Schiøtt, Morten/0000-0002-4309-8090; Nunes-Silva, Carlos Gustavo/0000-0003-2276-838X; Schiøtt, Morten/0000-0002-4309-8090; Otte, Marianne/0000-0001-7433-2444				BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; Beye M, 2004, BIOESSAYS, V26, P1131, DOI 10.1002/bies.20098; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Blencowe BJ, 1999, BIOCHEM CELL BIOL, V77, P277, DOI 10.1139/bcb-77-4-277; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Bull J. J., 1983, EVOLUTION SEX DETERM; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; BUTLER B, 1986, EMBO J, V5, P3607, DOI 10.1002/j.1460-2075.1986.tb04689.x; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; Engel MS, 2001, P NATL ACAD SCI USA, V98, P1661, DOI 10.1073/pnas.98.4.1661; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Grimaldi David, 2005, pi; Hasselmann M, 2004, P NATL ACAD SCI USA, V101, P4888, DOI 10.1073/pnas.0307147101; Hasselmann M, 2006, GENETICS, V174, P1469, DOI 10.1534/genetics.106.062018; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; KERR WE, 1987, INSECT SOC, V34, P274, DOI 10.1007/BF02224359; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; Kulathinal RJ, 2003, MOL BIOL EVOL, V20, P441, DOI 10.1093/molbev/msg053; Lewis D, 1942, BIOL REV CAMB PHILOS, V17, P46, DOI 10.1111/j.1469-185X.1942.tb00431.x; NEI M, 2000, MOL EVOLUTION PHYLOG, P216; NOTHIGER R, 1985, COLD SPRING HARB SYM, V50, P615, DOI 10.1101/SQB.1985.050.01.074; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pane A, 2002, DEVELOPMENT, V129, P3715; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113	30	176	189	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					519	U7		10.1038/nature07052	http://dx.doi.org/10.1038/nature07052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18594516				2022-12-24	WOS:000257860300052
J	Carroll, SB				Carroll, Sean B.			Evo-devo and an expanding evolutionary synthesis: A genetic theory of morphological evolution	CELL			English	Review							HOMEOTIC GENES; HOX PROTEIN; TRANSCRIPTIONAL NETWORK; REGULATORY EVOLUTION; PARALLEL EVOLUTION; DROSOPHILA EMBRYOS; PATTERN-FORMATION; PELVIC REDUCTION; EYELESS GENE; TARGET GENES	Biologists have long sought to understand which genes and what kinds of changes in their sequences are responsible for the evolution of morphological diversity. Here, I outline eight principles derived from molecular and evolutionary developmental biology and review recent studies of species divergence that have led to a genetic theory of morphological evolution, which states that (1) form evolves largely by altering the expression of functionally conserved proteins, and (2) such changes largely occur through mutations in the cis-regulatory sequences of pleiotropic developmental regulatory loci and of the target genes within the vast networks they control.	Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Mol Biol Lab, Madison, WI 53706 USA.	sbcarrol@wisc.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adachi Y, 2003, MECH DEVELOP, V120, P1113, DOI 10.1016/j.mod.2003.08.007; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BURKE AC, 1995, DEVELOPMENT, V121, P333; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, REG GEN GEN REG; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; GELBART WM, 1989, DEVELOPMENT, V107, P65; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gould S. J., 1994, HENS TEETH HORSES TO; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Grens A, 1995, DEVELOPMENT, V121, P4027; HADORN E, 1961, DEV GENETICS LETHAL; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hall BK, 2003, INT J DEV BIOL, V47, P491; Han W, 1998, MOL CELL BIOL, V18, P3384, DOI 10.1128/MCB.18.6.3384; Hinman VF, 2007, DEV BIOL, V312, P584, DOI 10.1016/j.ydbio.2007.09.006; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hittinger CT, 2005, DEVELOPMENT, V132, P5261, DOI 10.1242/dev.02146; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LAWRENCE PA, 1984, CELL, V36, P570, DOI 10.1016/0092-8674(84)90333-7; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lynch VJ, 2004, P ROY SOC B-BIOL SCI, V271, P2201, DOI 10.1098/rspb.2004.2848; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ohno S., 1970, EVOLUTION GENE DUPLI; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; RICHARDSON Michael K, 2003, NAT GENET, V34, P351; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; STENT GS, 1984, CELL, V36, P567, DOI 10.1016/0092-8674(84)90332-5; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; VanderZwan-Butler CJ, 2007, DEV BIOL, V301, P350, DOI 10.1016/j.ydbio.2006.10.027; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595; Zhao YX, 2001, DEVELOPMENT, V128, P3197; Zinzen RP, 2006, DEV CELL, V11, P895, DOI 10.1016/j.devcel.2006.10.012; ZUCKERKANDL E, 1968, HEMOGLOBINS HAECKELS, P256; ZUCKERKANDL E, 1965, EVOLVING GENES PROTE, V5, P97	99	1235	1270	11	408	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					25	36		10.1016/j.cell.2008.06.030	http://dx.doi.org/10.1016/j.cell.2008.06.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614008	Bronze			2022-12-24	WOS:000257513100011
J	Lenoir, J; Gegout, JC; Marquet, PA; de Ruffray, P; Brisse, H				Lenoir, J.; Gegout, J. C.; Marquet, P. A.; de Ruffray, P.; Brisse, H.			A significant upward shift in plant species optimum elevation during the 20th century	SCIENCE			English	Article							CLIMATE-CHANGE; UPHILL SHIFTS; ALPINE PLANTS; GLOBAL CHANGE; RANGE; FINGERPRINTS; BUTTERFLIES; RESPONSES; MARGIN; EXTENT	Spatial fingerprints of climate change on biotic communities are usually associated with changes in the distribution of species at their latitudinal or altitudinal extremes. By comparing the altitudinal distribution of 171 forest plant species between 1905 and 1985 and 1986 and 2005 along the entire elevation range ( 0 to 2600 meters above sea level) in west Europe, we show that climate warming has resulted in a significant upward shift in species optimum elevation averaging 29 meters per decade. The shift is larger for species restricted to mountain habitats and for grassy species, which are characterized by faster population turnover. Our study shows that climate change affects the spatial core of the distributional range of plant species, in addition to their distributional margins, as previously reported.	[Lenoir, J.; Gegout, J. C.] Lab Etud Ressources Foret Bois LERFoB, AgroParisTech, UMR 1092, F-54000 Nancy, France; [Marquet, P. A.] Pontificia Univ Catolica Chile, CASEB, Dept Ecol, Santiago 6513677, Chile; [Marquet, P. A.] IEB, Santiago, Chile; [Marquet, P. A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [de Ruffray, P.] Univ Strasbourg 1, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Brisse, H.] Fac Sci & Tech St Jerome, CNRS, IMEP, UMR 6116, F-34397 Marseille 20, France	AgroParisTech; Pontificia Universidad Catolica de Chile; The Santa Fe Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lenoir, J (corresponding author), Lab Etud Ressources Foret Bois LERFoB, AgroParisTech, UMR 1092, 14 Rue Girardet, F-54000 Nancy, France.	jonathan.lenoir@agroparistech.fr	Lenoir, Jonathan/AAE-8441-2019; Marquet, Pablo A/B-7732-2009	Lenoir, Jonathan/0000-0003-0638-9582; Marquet, Pablo A/0000-0001-6369-9339; Gegout, Jean-Claude/0000-0002-5760-9920				Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chapin FS, 2004, AMBIO, V33, P361, DOI 10.1639/0044-7447(2004)033[0361:GCATBF]2.0.CO;2; Coudun C, 2006, ECOL MODEL, V199, P164, DOI 10.1016/j.ecolmodel.2006.05.024; DAMBRINE E, 1994, FOREST DECLINE ATMOS, P177; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Keller F, 2000, REG ENVIRON CHANGE, V1, P70, DOI 10.1007/PL00011535; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Lavergne S, 2006, GLOBAL CHANGE BIOL, V12, P1466, DOI 10.1111/j.1365-2486.2006.01183.x; Lesica P, 2004, J VEG SCI, V15, P679, DOI 10.1111/j.1654-1103.2004.tb02310.x; Moisselin J.M., 2002, METEOROLOGIE, V38, P45, DOI DOI 10.4267/2042/36233; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tryjanowski P, 2005, DIVERS DISTRIB, V11, P219, DOI 10.1111/j.1366-9516.2005.00140.x; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	30	1348	1450	23	705	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2008	320	5884					1768	1771		10.1126/science.1156831	http://dx.doi.org/10.1126/science.1156831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583610				2022-12-24	WOS:000257121200036
J	Putnam, NH; Butts, T; Ferrier, DEK; Furlong, RF; Hellsten, U; Kawashima, T; Robinson-Rechavi, M; Shoguchi, E; Terry, A; Yu, JK; Benito-Gutierrez, E; Dubchak, I; Garcia-Fernandez, J; Gibson-Brown, JJ; Grigoriev, IV; Horton, AC; de Jong, PJ; Jurka, J; Kapitonov, VV; Kohara, Y; Kuroki, Y; Lindquist, E; Lucas, S; Osoegawa, K; Pennacchio, LA; Salamov, AA; Satou, Y; Sauka-Spengler, T; Schmutz, J; Shin-I, T; Toyoda, A; Bronner-Fraser, M; Fujiyama, A; Holland, LZ; Holland, PWH; Satoh, N; Rokhsar, DS				Putnam, Nicholas H.; Butts, Thomas; Ferrier, David E. K.; Furlong, Rebecca F.; Hellsten, Uffe; Kawashima, Takeshi; Robinson-Rechavi, Marc; Shoguchi, Eiichi; Terry, Astrid; Yu, Jr-Kai; Benito-Gutierrez, Elia; Dubchak, Inna; Garcia-Fernandez, Jordi; Gibson-Brown, Jeremy J.; Grigoriev, Igor V.; Horton, Amy C.; de Jong, Pieter J.; Jurka, Jerzy; Kapitonov, Vladimir V.; Kohara, Yuji; Kuroki, Yoko; Lindquist, Erika; Lucas, Susan; Osoegawa, Kazutoyo; Pennacchio, Len A.; Salamov, Asaf A.; Satou, Yutaka; Sauka-Spengler, Tatjana; Schmutz, Jeremy; Shin-I, Tadasu; Toyoda, Atsushi; Bronner-Fraser, Marianne; Fujiyama, Asao; Holland, Linda Z.; Holland, Peter W. H.; Satoh, Nori; Rokhsar, Daniel S.			The amphioxus genome and the evolution of the chordate karyotype	NATURE			English	Article							GENE DUPLICATIONS; REVEALS; VERTEBRATES; ORIGINS; RECONSTRUCTION; INSIGHTS; CHROMOSOMES; DIVERGENCE; PHYLOGENY; INFERENCE	Lancelets ('amphioxus') are the modern survivors of an ancient chordate lineage, with a fossil record dating back to the Cambrian period. Here we describe the structure and gene content of the highly polymorphic similar to 520-megabase genome of the Florida lancelet Branchiostoma floridae, and analyse it in the context of chordate evolution. Whole-genome comparisons illuminate the murky relationships among the three chordate groups (tunicates, lancelets and vertebrates), and allow not only reconstruction of the gene complement of the last common chordate ancestor but also partial reconstruction of its genomic organization, as well as a description of two genome-wide duplications and subsequent reorganizations in the vertebrate lineage. These genome-scale events shaped the vertebrate genome and provided additional genetic variation for exploitation during vertebrate evolution.	[Putnam, Nicholas H.; Hellsten, Uffe; Terry, Astrid; Dubchak, Inna; Grigoriev, Igor V.; Lindquist, Erika; Lucas, Susan; Pennacchio, Len A.; Salamov, Asaf A.; Rokhsar, Daniel S.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Putnam, Nicholas H.; Kawashima, Takeshi; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Butts, Thomas; Furlong, Rebecca F.; Holland, Linda Z.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Ferrier, David E. K.] Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; [Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Robinson-Rechavi, Marc] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Shoguchi, Eiichi; Satou, Yutaka; Satoh, Nori] Kyoto Univ, Dept Zool, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Yu, Jr-Kai; Sauka-Spengler, Tatjana; Bronner-Fraser, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Benito-Gutierrez, Elia] Natl Inst Med Res, London NW7 1AA, England; [Garcia-Fernandez, Jordi] Univ Barcelona, Dept Genet, Fac Biol, E-08028 Barcelona, Spain; [Gibson-Brown, Jeremy J.; Horton, Amy C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [de Jong, Pieter J.; Osoegawa, Kazutoyo] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Jurka, Jerzy; Kapitonov, Vladimir V.] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kohara, Yuji; Shin-I, Tadasu] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Kuroki, Yoko; Toyoda, Atsushi; Fujiyama, Asao] RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Schmutz, Jeremy] JGI Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Holland, Peter W. H.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Oxford; University of St Andrews; University of Lausanne; Swiss Institute of Bioinformatics; Kyoto University; California Institute of Technology; MRC National Institute for Medical Research; University of Barcelona; Washington University (WUSTL); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of California System; University of California San Diego; Scripps Institution of Oceanography	Rokhsar, DS (corresponding author), Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA.	satoh@ascidian.zool.kyoto-u.ac.jp; dsrokhsar@yahoo.com	Yu, Jr-Kai/H-4822-2019; Putnam, Nicholas/B-9968-2008; Gutierrez, Elia Benito/ABG-6788-2021; Kawashima, Takeshi/M-4510-2015; Satou, Yutaka/K-7131-2012; Schmutz, Jeremy/N-3173-2013; Satou, Yutaka/AAJ-2194-2021; Terry, Astrid/A-2538-2011; Garcia-Fernandez, Jordi/B-3839-2013; Robinson-Rechavi, Marc/E-9727-2011; Ferrier, David/D-7595-2013	Yu, Jr-Kai/0000-0001-8591-0529; Putnam, Nicholas/0000-0002-1315-782X; Gutierrez, Elia Benito/0000-0003-2435-0948; Satou, Yutaka/0000-0001-5193-0708; Schmutz, Jeremy/0000-0001-8062-9172; Satou, Yutaka/0000-0001-5193-0708; Butts, Thomas/0000-0002-1781-5287; Bronner, Marianne/0000-0003-4274-1862; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Pennacchio, Len/0000-0002-8748-3732; Terry, Astrid/0000-0002-5234-1224; Holland, Peter/0000-0003-1533-9376; Rokhsar, Daniel/0000-0002-8704-2224; Horton, Amy/0000-0003-2148-5636; Furlong, Rebecca/0000-0002-8451-6471; Garcia-Fernandez, Jordi/0000-0001-5677-5970; Grigoriev, Igor/0000-0002-3136-8903; Robinson-Rechavi, Marc/0000-0002-3437-3329; Ferrier, David/0000-0003-3247-6233	Biotechnology and Biological Sciences Research Council [BBS/B/12067, BBS/B/12067/2] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Castro LFC, 2004, IMMUNOGENETICS, V55, P782, DOI 10.1007/s00251-004-0642-9; Castro LFC, 2003, EVOL DEV, V5, P459, DOI 10.1046/j.1525-142X.2003.03052.x; Castro LFC, 2002, ZOOL SCI, V19, P1349, DOI 10.2108/zsj.19.1349; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; COSTA OG, 1834, CENNI ZOOLOGICI OSSI, P49; Danchin EGJ, 2004, TRENDS GENET, V20, P587, DOI 10.1016/j.tig.2004.09.009; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Edvardsen RB, 2004, J MOL EVOL, V59, P448, DOI 10.1007/s00239-004-2636-5; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; HOLLAND PWH, 1994, DEVELOPMENT, P125; HOWELL WM, 1971, EXPERIENTIA, V27, P1495, DOI 10.1007/BF02154315; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; IVANOVAKAZAS OM, 1995, T SANKT PETERBURGSKO, V84, P1; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; KOWALEVSKY A, 1866, MEM ACAD IMP SCI SAI, V11, P1; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Lundin Lars-Gustav, 2003, Journal of Structural and Functional Genomics, V3, P53, DOI 10.1023/A:1022600813840; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MORRIS SC, 1979, SCI AM, V241, P122, DOI 10.1038/scientificamerican0779-122; Nachman MW, 2000, GENETICS, V156, P297; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Ohno S., 1970, P1; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Popovici C, 2001, BIOCHEM BIOPH RES CO, V288, P362, DOI 10.1006/bbrc.2001.5794; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Robinson-Rechavi M, 2004, MOL BIOL EVOL, V21, P580, DOI 10.1093/molbev/msh046; SCHMIDTKE J, 1977, NATURE, V266, P532, DOI 10.1038/266532a0; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stokes MD, 1998, AM SCI, V86, P552, DOI 10.1511/1998.43.799; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; *U WASH, SEA LAMPR GEN PROJ; Valentine JW, 2000, PALEOBIOLOGY, V26, P513, DOI 10.1666/0094-8373(2000)026<0513:TGPTTE>2.0.CO;2; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; YARRELL W, 1836, HIST BRIT FISHES, P468; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	79	1172	1253	5	182	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1064	U3		10.1038/nature06967	http://dx.doi.org/10.1038/nature06967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18563158	Green Submitted, hybrid, Green Accepted			2022-12-24	WOS:000256839900049
J	Skerker, JM; Perchuk, BS; Siryaporn, A; Lubin, EA; Ashenberg, O; Goulian, M; Laub, MT				Skerker, Jeffrey M.; Perchuk, Barrett S.; Siryaporn, Albert; Lubin, Emma A.; Ashenberg, Orr; Goulian, Mark; Laub, Michael T.			Rewiring the specificity of two-component signal transduction systems	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; ESCHERICHIA-COLI K-12; HISTIDINE-KINASE; MOLECULAR RECOGNITION; RESPONSE REGULATOR; PHOSPHORELAY; DOMAINS; SENSOR; INFORMATION; SEQUENCE	Two-component signal transduction systems are the predominant means by which bacteria sense and respond to environmental stimuli. Bacteria often employ tens or hundreds of these paralogous signaling systems, comprised of histidine kinases (HKs) and their cognate response regulators (RRs). Faithful transmission of information through these signaling pathways and avoidance of detrimental crosstalk demand exquisite specificity of HK-RR interactions. To identify the determinants of two-component signaling specificity, we examined patterns of amino acid co-evolution in large, multiple sequence alignments of cognate kinase-regulator pairs. Guided by these results, we demonstrate that a subset of the coevolving residues is sufficient, when mutated, to completely switch the substrate specificity of the kinase EnvZ. Our results shed light on the basis of molecular discrimination in two-component signaling pathways, provide a general approach for the rational rewiring of these pathways, and suggest that analyses of coevolution may facilitate the reprogramming of other signaling systems and protein-protein interactions.	[Skerker, Jeffrey M.; Perchuk, Barrett S.; Lubin, Emma A.; Ashenberg, Orr; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Siryaporn, Albert; Goulian, Mark] Univ Penn, Dept Phys, Philadelphia, PA 19104 USA; [Goulian, Mark] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; University of Pennsylvania	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu		Laub, Michael/0000-0002-8288-7607	NIGMS NIH HHS [R01 GM082899-01, P50 GM068763-05, P50 GM068763, R01 GM080279, R01 GM080279-02, R01 GM082899] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM080279, R01GM082899] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Batchelor E, 2005, J BACTERIOL, V187, P5723, DOI 10.1128/JB.187.16.5723-5731.2005; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fersht A., 1985, ENZYME STRUCTURE MEC; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Janiak-Spens F, 2000, MOL MICROBIOL, V37, P136, DOI 10.1046/j.1365-2958.2000.01973.x; Jiang M, 1999, MOL MICROBIOL, V33, P389, DOI 10.1046/j.1365-2958.1999.01481.x; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Miller J. H., 1992, LAB MANUAL HDB ESCHE; Miyashiro T, 2007, P NATL ACAD SCI USA, V104, P16305, DOI 10.1073/pnas.0700025104; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Qin L, 2003, J BACTERIOL, V185, P3429, DOI 10.1128/JB.185.11.3429-3435.2003; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhu Y, 2004, J BIOL CHEM, V279, P48152, DOI 10.1074/jbc.M401024200	44	348	360	3	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					1043	1054		10.1016/j.cell.2008.04.040	http://dx.doi.org/10.1016/j.cell.2008.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555780	Bronze, Green Accepted			2022-12-24	WOS:000256693400019
J	Rehmann, H; Arias-Palomo, E; Hadders, MA; Schwede, F; Llorca, O; Bos, JL				Rehmann, Holger; Arias-Palomo, Ernesto; Hadders, Michael A.; Schwede, Frank; Llorca, Oscar; Bos, Johannes L.			Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B	NATURE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; DEPENDENT PROTEIN-KINASE; ELECTRON-MICROSCOPY; REGULATORY SUBUNIT; BINDING PROTEINS; ACTIVATION; RAS; PROGRAM; FAMILY; VISUALIZATION	Epac proteins are activated by binding of the second messenger cAMP and then act as guanine nucleotide exchange factors for Rap proteins(1,2). The Epac proteins are involved in the regulation of cell adhesion(3) and insulin secretion(4). Here we have determined the structure of Epac2 in complex with a cAMP analogue (Sp-cAMPS) and RAP1B by X- ray crystallography and single particle electron microscopy. The structure represents the cAMP activated state of the Epac2 protein with the RAP1B protein trapped in the course of the exchange reaction. Comparison with the inactive conformation reveals that cAMP binding causes conformational changes that allow the cyclic nucleotide binding domain to swing from a position blocking the Rap binding site towards a docking site at the Ras exchange motif domain.	[Rehmann, Holger; Bos, Johannes L.] Univ Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [Rehmann, Holger; Bos, Johannes L.] Univ Med Ctr, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Arias-Palomo, Ernesto; Llorca, Oscar] CSIC, CIB, Spanish Natl Res Council, E-28040 Madrid, Spain; [Hadders, Michael A.] Univ Utrecht, Bijvoet Ctr, Dept Crystal & Struct Chem, NL-3584 CH Utrecht, Netherlands; [Schwede, Frank] BIOLOG Life Sci Inst, D-28199 Bremen, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Utrecht University	Rehmann, H (corresponding author), Univ Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, Universiteitsweg 100, NL-3584 CG Utrecht, Netherlands.	h.rehmann@UMCutrecht.nl	Llorca, Oscar/P-2784-2019; Llorca, Oscar/K-1144-2014; Bustelo, Xose R./A-9526-2010; Arias Palomo, Ernesto/L-1853-2017; Garcia, Pedro/L-2808-2017	Llorca, Oscar/0000-0001-5705-0699; Llorca, Oscar/0000-0001-5705-0699; Bustelo, Xose R./0000-0001-9398-6072; Garcia, Pedro/0000-0001-6717-8717; Arias-Palomo, Ernesto/0000-0002-2706-7411	Autonomous Region of Madrid; Bremer Innovationsagentur; Spanish Ministry of Education and Science (MEC); Red Tematica de Investigacion cooperativa en Cancer (RTICC); Chemical Sciences and the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO)	Autonomous Region of Madrid; Bremer Innovationsagentur; Spanish Ministry of Education and Science (MEC)(Spanish Government); Red Tematica de Investigacion cooperativa en Cancer (RTICC); Chemical Sciences and the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank P. Gros for access to crystallization robots, M. Rensen- De Leeuw for technical assistance, A. Wittinghofer for reading the manuscript, the European Synchrotron Radiation Facility for providing synchrotron facilities, the scientists at ID23-1 for help with data collection, and the Galicia Supercomputer Centre (CESGA) and the Barcelona Supercomputing Centre for computing resources. H. R. is a recipient of the Hendrik Casimir-Karl Ziegler-Forschungspreis of the Nordrhein-Westfalischen Akademie der Wissenschaften and the Koninklijke Nederlandse Akademie van Wetenschappen. E.A.-P. and O.L. are supported by the Autonomous Region of Madrid, F. S. by the Bremer Innovationsagentur, O.L. by the Spanish Ministry of Education and Science (MEC) and the Red Tematica de Investigacion cooperativa en Cancer (RTICC), and J.L.B. by the Chemical Sciences and the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SCHOMBURG D, 1988, J MOL GRAPHICS, V6, P161, DOI 10.1016/0263-7855(88)80069-9; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; YAGURA TS, 1981, BIOCHEMISTRY-US, V20, P879, DOI 10.1021/bi00507a035; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	35	144	150	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					124	U93		10.1038/nature07187	http://dx.doi.org/10.1038/nature07187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18660803				2022-12-24	WOS:000258890200050
J	Arenz, A; Silver, RA; Schaefer, AT; Margrie, TW				Arenz, Alexander; Silver, R. Angus; Schaefer, Andreas T.; Margrie, Troy W.			The contribution of single synapses to sensory representation in vivo	SCIENCE			English	Article							RAPID BEHAVIORAL MODIFICATION; CEREBELLAR GRANULE CELLS; VESTIBULOOCULAR REFLEX; VESTIBULAR SYSTEM; PRIMATE FLOCCULUS; HEAD ROTATION; EYE-MOVEMENT; TRANSMISSION; MONKEY; NEURONS	The extent to which synaptic activity can signal a sensory stimulus limits the information available to a neuron. We determined the contribution of individual synapses to sensory representation by recording excitatory postsynaptic currents ( EPSCs) in cerebellar granule cells during a time- varying, quantifiable vestibular stimulus. Vestibular- sensitive synapses faithfully reported direction and velocity, rather than position or acceleration of whole- body motion, via bidirectional modulation of EPSC frequency. The lack of short- term synaptic dynamics ensured a highly linear relationship between velocity and charge transfer, and as few as 100 synapses provided resolution approaching psychophysical limits. This indicates that highly accurate stimulus representation can be achieved by small networks and even within single neurons.	[Arenz, Alexander; Silver, R. Angus; Schaefer, Andreas T.; Margrie, Troy W.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England	University of London; University College London	Margrie, TW (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Univ St, London WC1E 6JJ, England.	t.margrie@ucl.ac.uk		Schaefer, Andreas/0000-0002-4677-8788; Silver, Robin/0000-0002-5480-6638	BBSRC [BB/F005490/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005490/1] Funding Source: Medline; Medical Research Council [MC_U117597156] Funding Source: Medline; Wellcome Trust [072292, 064413] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; CALVIN WH, 1967, SCIENCE, V155, P842, DOI 10.1126/science.155.3764.842; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dino MR, 2001, EXP BRAIN RES, V140, P162, DOI 10.1007/s002210100790; Eccles JC, 1967, CEREBELLUM NEURONAL; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mergner T, 1993, J Vestib Res, V3, P41; NODA H, 1979, J PHYSIOL-LONDON, V294, P349, DOI 10.1113/jphysiol.1979.sp012934; NODA H, 1981, ANN NY ACAD SCI, V374, P465, DOI 10.1111/j.1749-6632.1981.tb30892.x; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007	25	147	147	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					977	980		10.1126/science.1158391	http://dx.doi.org/10.1126/science.1158391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18703744	Green Accepted			2022-12-24	WOS:000258436700043
J	Schaefer, AL; Greenberg, EP; Oliver, CM; Oda, Y; Huang, JJ; Bittan-Banin, G; Peres, CM; Schmidt, S; Juhaszova, K; Sufrin, JR; Harwood, CS				Schaefer, Amy L.; Greenberg, E. P.; Oliver, Colin M.; Oda, Yasuhiro; Huang, Jean J.; Bittan-Banin, Gili; Peres, Caroline M.; Schmidt, Silke; Juhaszova, Katarina; Sufrin, Janice R.; Harwood, Caroline S.			A new class of homoserine lactone quorum-sensing signals	NATURE			English	Article							IDENTIFICATION; AUTOINDUCER; GENES	Quorum sensing is a term used to describe cell- to- cell communication that allows cell- density- dependent gene expression. Many bacteria use acyl- homoserine lactone ( acyl- HSL) synthases to generate fatty acyl- HSL quorum- sensing signals, which function with signal receptors to control expression of specific genes. The fatty acyl group is derived from fatty acid biosynthesis and provides signal specificity, but the variety of signals is limited. Here we show that the photosynthetic bacterium Rhodopseudomonas palustris uses an acyl- HSL synthase to produce p- coumaroyl- HSL by using environmental p- coumaric acid rather than fatty acids from cellular pools. The bacterium has a signal receptor with homology to fatty acyl- HSL receptors that responds to p- coumaroyl- HSL to regulate global gene expression. We also found that p- coumaroyl- HSL is made by other bacteria including Bradyrhizobium sp. and Silicibacter pomeroyi. This discovery extends the range of possibilities for acyl- HSL quorum sensing and raises fundamental questions about quorum sensing within the context of environmental signalling.	[Schaefer, Amy L.; Greenberg, E. P.; Oda, Yasuhiro; Huang, Jean J.; Bittan-Banin, Gili; Juhaszova, Katarina; Harwood, Caroline S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Oliver, Colin M.; Sufrin, Janice R.] SUNY Buffalo, Roswell Pk Canc Inst, Mol Pharmacol & Canc Therapeut Program, Buffalo, NY 14263 USA; [Peres, Caroline M.] Danisco Genencor, Palo Alto, CA 94304 USA; [Schmidt, Silke] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany	University of Washington; University of Washington Seattle; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Goethe University Frankfurt	Harwood, CS (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	csh5@u.washington.edu	Schaefer, Amy/AAU-8576-2020; Albers, Pieter/I-2563-2017	Schaefer, Amy/0000-0003-0581-054X; Greenberg, Everett/0000-0001-9474-8041	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059026] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buchan A, 2004, APPL ENVIRON MICROB, V70, P1658, DOI 10.1128/AEM.70.3.1658-1668.2004; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Fuqua C, 1998, CURR OPIN MICROBIOL, V1, P183, DOI 10.1016/S1369-5274(98)80009-X; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; HARRISON FH, 2005, THESIS U IOWA; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Minogue TD, 2002, MOL MICROBIOL, V44, P1625, DOI 10.1046/j.1365-2958.2002.02987.x; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; MORENOHAGELSIEB G, 2002, BIOINFORMATICS S, V1, pS329; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Oda Y, 2005, J BACTERIOL, V187, P7784, DOI 10.1128/JB.187.22.7784-7794.2005; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Peng X, 2003, APPL ENVIRON MICROB, V69, P1417, DOI 10.1128/AEM.69.3.1417-1427.2003; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904	30	268	286	9	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					595	U6		10.1038/nature07088	http://dx.doi.org/10.1038/nature07088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18563084				2022-12-24	WOS:000258026500037
J	Asher, G; Gatfield, D; Stratmann, M; Reinke, H; Dibner, C; Kreppel, F; Mostoslavsky, R; Alt, FW; Schibler, U				Asher, Gad; Gatfield, David; Stratmann, Markus; Reinke, Hans; Dibner, Charna; Kreppel, Florian; Mostoslavsky, Raul; Alt, Frederick W.; Schibler, Ueli			SIRT1 regulates circadian clock gene expression through PER2 deacetylation	CELL			English	Article							HISTONE ACETYLATION; TRANSCRIPTION; PROTEIN; LIVER; MECHANISMS; REVEALS; NPAS2; MOUSE; CRYPTOCHROME; COORDINATION	The mammalian circadian timing system is composed of a central pacemaker in the suprachiasmatic nucleus of the brain that synchronizes countless subsidiary oscillators in peripheral tissues. The rhythm-generating mechanism is thought to rely on a feedback loop involving positively and negatively acting transcription factors. BMAL1 and CLOCK activate the expression of Period (Per) and Cryptochrome (Cry) genes, and once PER and CRY proteins accumulate to a critical level they form complexes with BMAL1-CLOCK heterodimers and thereby repress the transcription of their own genes. Here, we show that SIRT1, an NAD(+)- dependent protein deacetylase, is required for high-magnitude circadian transcription of several core clock genes, including Bmal1, Ror gamma, Per2, and Cry1. SIRT1 binds CLOCK-BMAL1 in a circadian manner and promotes the deacetylation and degradation of PER2. Given the NAD(+) dependence of SIRT1 deacetylase activity, it is likely that SIRT1 connects cellular metabolism to the circadian core clockwork circuitry.	[Asher, Gad; Gatfield, David; Stratmann, Markus; Reinke, Hans; Dibner, Charna; Schibler, Ueli] Univ Geneva, Dept Mol Biol Sci 3, CH-1211 Geneva 4, Switzerland; [Kreppel, Florian] Univ Ulm, Div Gene Therapy, D-89081 Ulm, Germany; [Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Ctr Blood Res, Boston, MA 02115 USA; [Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Geneva; Ulm University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol Sci 3, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	ueli.schibler@molbio.unige.ch	Jansen, Heiko T./A-5770-2008; Gatfield, David/C-2354-2011; ASHER, GAD/K-1333-2012	Jansen, Heiko T./0000-0003-0178-396X; Gatfield, David/0000-0001-5114-2824; Asher, Gad/0000-0001-9403-7856	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Dzhagalov I, 2004, CELL MOL IMMUNOL, V1, P401; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Preitner Nicolas, 2003, Novartis Found Symp, V253, P89; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker JR, 2005, METHOD ENZYMOL, V393, P366, DOI 10.1016/S0076-6879(05)93016-4; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	65	932	983	3	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					317	328		10.1016/j.cell.2008.06.050	http://dx.doi.org/10.1016/j.cell.2008.06.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662546	Bronze			2022-12-24	WOS:000257891700020
J	Schermelleh, L; Carlton, PM; Haase, S; Shao, L; Winoto, L; Kner, P; Burke, B; Cardoso, MC; Agard, DA; Gustafsson, MGL; Leonhardt, H; Sedat, JW				Schermelleh, Lothar; Carlton, Peter M.; Haase, Sebastian; Shao, Lin; Winoto, Lukman; Kner, Peter; Burke, Brian; Cardoso, M. Cristina; Agard, David A.; Gustafsson, Mats G. L.; Leonhardt, Heinrich; Sedat, John W.			Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy	SCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; PORE COMPLEX; CRYOELECTRON TOMOGRAPHY; INTERPHASE; ENVELOPE; RESOLUTION; NANOSCOPY; CHROMATIN; FRACTION; CHANNEL	Fluorescence light microscopy allows multicolor visualization of cellular components with high specificity, but its utility has until recently been constrained by the intrinsic limit of spatial resolution. We applied three- dimensional structured illumination microscopy ( 3D- SIM) to circumvent this limit and to study the mammalian nucleus. By simultaneously imaging chromatin, nuclear lamina, and the nuclear pore complex ( NPC), we observed several features that escape detection by conventional microscopy. We could resolve single NPCs that colocalized with channels in the lamin network and peripheral heterochromatin. We could differentially localize distinct NPC components and detect double- layered invaginations of the nuclear envelope in prophase as previously seen only by electron microscopy. Multicolor 3D- SIM opens new and facile possibilities to analyze subcellular structures beyond the diffraction limit of the emitted light.	[Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Dept Biol, Ctr Integrated Prot Sci, D-82152 Planegg Martinsried, Germany; [Carlton, Peter M.; Haase, Sebastian; Shao, Lin; Winoto, Lukman; Kner, Peter; Agard, David A.; Sedat, John W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Burke, Brian] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Haase, Sebastian; Cardoso, M. Cristina] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Gustafsson, Mats G. L.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Gustafsson, Mats G. L.] Univ Calif San Francisco, Bioengn Program, San Francisco, CA 94143 USA	University of Munich; University of California System; University of California San Francisco; State University System of Florida; University of Florida; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Leonhardt, H (corresponding author), Univ Munich, Dept Biol, Ctr Integrated Prot Sci, D-82152 Planegg Martinsried, Germany.	h.leonhardt@lmu.de; sedat@msg.ucsf.edu	Carlton, Peter/AAD-2403-2021; Cardoso, M. Cristina/F-5215-2011; Leonhardt, Heinrich/B-2791-2014; Schermelleh, Lothar/H-4588-2019	Carlton, Peter/0000-0002-5320-6024; Schermelleh, Lothar/0000-0002-1612-9699	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025101] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-2501-25, R01 GM025101, R01 GM025101-25] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI 10.1007/ BF02956173; AGARD DA, 1989, METHOD CELL BIOL, V30, P353; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Born M., 1998, PRINCIPLE OPTICS; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; GERACE L, 1978, J CELL BIOL, V79, P546, DOI 10.1083/jcb.79.2.546; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; PADDY MR, 1990, CELL, V62, P89, DOI 10.1016/0092-8674(90)90243-8; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Tonini R, 1999, FASEB J, V13, P1395, DOI 10.1096/fasebj.13.11.1395; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119	28	816	850	13	325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1332	1336		10.1126/science.1156947	http://dx.doi.org/10.1126/science.1156947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535242	Green Accepted, Green Submitted			2022-12-24	WOS:000256441100043
J	Soroceanu, L; Akhavan, A; Cobbs, CS				Soroceanu, Liliana; Akhavan, Armin; Cobbs, Charles S.			Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection	NATURE			English	Article							NF-KAPPA-B; GLYCOPROTEIN-B; SOLUBLE FORM; NEUTRALIZING ANTIBODIES; SIGNAL-TRANSDUCTION; CELLULAR RECEPTOR; VIRAL REPLICATION; PERMISSIVE CELLS; UP-REGULATION; ENTRY	Human cytomegalovirus ( HCMV) is a ubiquitous human herpesvirus that can cause life- threatening disease in the fetus and the immunocompromised host(1). Upon attachment to the cell, the virus induces robust inflammatory, interferon- and growth- factor-like signalling(2-9). The mechanisms facilitating viral entry and gene expression are not clearly understood(4). Here we show that platelet- derived growth factor-alpha receptor (PDGFR-alpha) is specifically phosphorylated by both laboratory and clinical isolates of HCMV in various human cell types, resulting in activation of the phosphoinositide-3-kinase (PI(3)K) signalling pathway. Upon stimulation by HCMV, tyrosine- phosphorylated PDGFR-alpha associated with the p85 regulatory subunit of PI( 3) K and induced protein kinase B ( also known as Akt) phosphorylation, similar to the genuine ligand, PDGF-AA. Cells in which PDGFR-alpha was genetically deleted(10) or functionally blocked were non- permissive to HCMV entry, viral gene expression or infectious virus production. Re- introducing human PDGFRA gene into knockout cells restored susceptibility to viral entry and essential viral gene expression. Blockade of receptor function with a humanized PDGFR-alpha blocking antibody (IMC-3G3)(11) or targeted inhibition of its kinase activity with a small molecule (Gleevec)(12) completely inhibited HCMV viral internalization and gene expression in human epithelial, endothelial and fibroblast cells. Viral entry in cells harbouring endogenous PDGFR-alpha was competitively inhibited by pretreatment with PDGF-AA. We further demonstrate that HCMV glycoprotein B directly interacts with PDGFR-alpha, resulting in receptor tyrosine phosphorylation, and that glycoprotein B neutralizing antibodies(13) inhibit HCMV- induced PDGFR-alpha phosphorylation. Taken together, these data indicate that PDGFR-alpha is a critical receptor required for HCMV infection, and thus a target for novel anti- viral therapies.	[Soroceanu, Liliana; Akhavan, Armin; Cobbs, Charles S.] Calif Pacific Med Ctr, Res Inst, Dept Neurosci, San Francisco, CA 94107 USA; [Cobbs, Charles S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Cobbs, CS (corresponding author), Calif Pacific Med Ctr, Res Inst, Dept Neurosci, Suite 220,475 Brannan St, San Francisco, CA 94107 USA.	charles.cobbs@gmail.com			California Pacific Medical Center Research Institute; Arthur Flaming Foundation	California Pacific Medical Center Research Institute; Arthur Flaming Foundation	We thank M. Tallquist for the PDGFR-alpha knockout mouse fibroblasts, C. Heldin for the human PDGFR-alpha cDNA, D. Diamond for providing the soluble glycoprotein B, and N. Loizos (ImClone) for the IMC-3G3 antibody. We are grateful to W. Britt (University of Alabama at Birmingham) for viruses, glycoprotein B neutralizing antibodies and discussions. This study was supported by an institutional grant from California Pacific Medical Center Research Institute and by the Arthur Flaming Foundation.	Andreoni KA, 2002, J MED VIROL, V67, P33, DOI 10.1002/jmv.2189; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; Britt WJ, 2005, J VIROL, V79, P4066, DOI 10.1128/JVI.79.7.4066-4079.2005; BRITT WJ, 1984, VIROLOGY, V135, P369, DOI 10.1016/0042-6822(84)90193-4; BRITT WJ, 1996, FIELDS VIROLOGY; Carlson C, 1997, VIROLOGY, V239, P198, DOI 10.1006/viro.1997.8892; Chan G, 2004, BIOL REPROD, V71, P797, DOI 10.1095/biolreprod.104.028118; Cobbs CS, 2007, J NEURO-ONCOL, V85, P271, DOI 10.1007/s11060-007-9423-2; Compton T, 2004, TRENDS CELL BIOL, V14, P5, DOI 10.1016/j.tcb.2003.10.009; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; English EP, 2006, J BIOL CHEM, V281, P2661, DOI 10.1074/jbc.M508485200; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Gredmark S, 2007, J VIROL, V81, P5112, DOI 10.1128/JVI.02197-06; HUANG ES, 1973, J VIROL, V12, P1473, DOI 10.1128/JVI.12.6.1473-1481.1973; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; Isomura H, 2003, J VIROL, V77, P3602, DOI 10.1128/JVI.77.6.3602-3614.2003; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; LI L, 1995, J VIROL, V69, P6047, DOI 10.1128/JVI.69.10.6047-6053.1995; Loizos N, 2005, MOL CANCER THER, V4, P369; MAR EC, 1983, ANTIMICROB AGENTS CH, V24, P518, DOI 10.1128/AAC.24.4.518; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Netterwald JR, 2004, J VIROL, V78, P6688, DOI 10.1128/JVI.78.12.6688-6691.2004; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Sandler C, 2006, BIOCHEM BIOPH RES CO, V347, P31, DOI 10.1016/j.bbrc.2006.06.052; Shimamura M, 2006, J VIROL, V80, P4591, DOI 10.1128/JVI.80.9.4591-4600.2006; Simmen KA, 2001, P NATL ACAD SCI USA, V98, P7140, DOI 10.1073/pnas.121177598; THOMAS B, 1993, VIRUSES CELLULAR IMM; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Wang ZD, 2004, J VIROL, V78, P3965, DOI 10.1128/JVI.78.8.3965-3976.2004; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985	36	223	237	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					391	U43		10.1038/nature07209	http://dx.doi.org/10.1038/nature07209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18701889				2022-12-24	WOS:000259265200045
J	Baek, D; Villen, J; Shin, C; Camargo, FD; Gygi, SP; Bartel, DP				Baek, Daehyun; Villen, Judit; Shin, Chanseok; Camargo, Fernando D.; Gygi, Steven P.; Bartel, David P.			The impact of microRNAs on protein output	NATURE			English	Article							GROWTH-FACTOR-I; MESSENGER-RNAS; MIRNA TARGETS; CELL-CULTURE; CATHEPSIN-B; AMINO-ACIDS; C. ELEGANS; IDENTIFICATION; EXPRESSION; DETERMINANTS	MicroRNAs are endogenous similar to 23-nucleotide RNAs that can pair to sites in the messenger RNAs of protein- coding genes to downregulate the expression from these messages. MicroRNAs are known to influence the evolution and stability of many mRNAs, but their global impact on protein output had not been examined. Here we use quantitative mass spectrometry to measure the response of thousands of proteins after introducing microRNAs into cultured cells and after deleting mir- 223 in mouse neutrophils. The identities of the responsive proteins indicate that targeting is primarily through seed- matched sites located within favourable predicted contexts in 39 untranslated regions. Hundreds of genes were directly repressed, albeit each to a modest degree, by individual microRNAs. Although some targets were repressed without detectable changes in mRNA levels, those translationally repressed by more than a third also displayed detectable mRNA destabilization, and, for the more highly repressed targets, mRNA destabilization usually comprised the major component of repression. The impact of microRNAs on the proteome indicated that for most interactions microRNAs act as rheostats to make fine- scale adjustments to protein output.	[Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Baek, Daehyun; Shin, Chanseok; Camargo, Fernando D.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Baek, Daehyun; Shin, Chanseok; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Baek, Daehyun; Shin, Chanseok; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; dbartel@wi.mit.edu		Villen, Judit/0000-0002-1005-1739	Damon Runyon postdoctoral fellowship; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	Damon Runyon postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.-J. Hong, T. Brummelkamp and S. Stehling-Sun for discussions, C. Bakalarski for writing and implementing the Vista algorithm for automated protein quantification, W. Johnston for technical assistance, and P. Wisniewski for cell sorting. This was supported by a Damon Runyon postdoctoral fellowship (C.S.) and grants from the NIH (D.P.B and S.P.G). D.P.B. is an investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BJERKNES R, 1995, J CLIN ENDOCR METAB, V80, P1948, DOI 10.1210/jc.80.6.1948; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FU YK, 1991, J IMMUNOL, V146, P1602; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	48	2811	2921	4	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					64	U38		10.1038/nature07242	http://dx.doi.org/10.1038/nature07242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668037	Green Accepted			2022-12-24	WOS:000258890200037
J	Brouns, SJJ; Jore, MM; Lundgren, M; Westra, ER; Slijkhuis, RJH; Snijders, APL; Dickman, MJ; Makarova, KS; Koonin, EV; van der Oost, J				Brouns, Stan J. J.; Jore, Matthijs M.; Lundgren, Magnus; Westra, Edze R.; Slijkhuis, Rik J. H.; Snijders, Ambrosius P. L.; Dickman, Mark J.; Makarova, Kira S.; Koonin, Eugene V.; van der Oost, John			Small CRISPR RNAs guide antiviral defense in prokaryotes	SCIENCE			English	Article							PROVIDES ACQUIRED-RESISTANCE; STREPTOCOCCUS-THERMOPHILUS; REPEATS; IDENTIFICATION; ELEMENTS; DNA; EVOLUTIONARY; SEQUENCE; VIRUSES; SYSTEM	Prokaryotes acquire virus resistance by integrating short fragments of viral nucleic acid into clusters of regularly interspaced short palindromic repeats ( CRISPRs). Here we show how virus- derived sequences contained in CRISPRs are used by CRISPR- associated ( Cas) proteins from the host to mediate an antiviral response that counteracts infection. After transcription of the CRISPR, a complex of Cas proteins termed Cascade cleaves a CRISPR RNA precursor in each repeat and retains the cleavage products containing the virus- derived sequence. Assisted by the helicase Cas3, these mature CRISPR RNAs then serve as small guide RNAs that enable Cascade to interfere with virus proliferation. Our results demonstrate that the formation of mature guide RNAs by the CRISPR RNA endonuclease subunit of Cascade is a mechanistic requirement for antiviral defense.	[Brouns, Stan J. J.; Jore, Matthijs M.; Lundgren, Magnus; Westra, Edze R.; Slijkhuis, Rik J. H.; van der Oost, John] Univ Wageningen & Res Ctr, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Snijders, Ambrosius P. L.; Dickman, Mark J.] Univ Sheffield, Dept Chem & Proc Engn, Sheffield S1 3JD, S Yorkshire, England; [Makarova, Kira S.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Wageningen University & Research; University of Sheffield; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	van der Oost, J (corresponding author), Univ Wageningen & Res Ctr, Dept Agrotechnol & Food Sci, Microbiol Lab, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands.	john.vanderoost@wur.nl	van+der+Oost, John/Y-2548-2019; Jore, Matthijs/F-7852-2018	Jore, Matthijs/0000-0002-0686-370X; Dickman, Mark/0000-0002-9236-0788; Brouns, Stan/0000-0002-9573-1724; Snijders, Bram/0000-0002-5416-8592	Engineering and Physical Sciences Research Council [EP/E036252/1, EP/D033713/1] Funding Source: researchfish; EPSRC [EP/E036252/1, EP/D033713/1] Funding Source: UKRI; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 LM000061-14] Funding Source: Medline	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kim J., COMMUNICATION; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x	20	1552	1800	30	648	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					960	964		10.1126/science.1159689	http://dx.doi.org/10.1126/science.1159689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18703739	Green Accepted			2022-12-24	WOS:000258436700038
J	Clauset, A; Erwin, DH				Clauset, Aaron; Erwin, Douglas H.			The evolution and distribution of species body size	SCIENCE			English	Article							COPES RULE; EXTINCTION; MASS	The distribution of species body size within taxonomic groups exhibits a heavy right tail extending over many orders of magnitude, where most species are much larger than the smallest species. We provide a simple model of cladogenetic diffusion over evolutionary time that omits explicit mechanisms for interspecific competition and other microevolutionary processes, yet fully explains the shape of this distribution. We estimate the model's parameters from fossil data and find that it robustly reproduces the distribution of 4002 mammal species from the late Quaternary. The observed fit suggests that the asymmetric distribution arises from a fundamental trade-off between the short-term selective advantages (Cope's rule) and long-term selective risks of increased species body size in the presence of a taxon-specific lower limit on body size.	[Clauset, Aaron; Erwin, Douglas H.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Erwin, Douglas H.] Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA	The Santa Fe Institute; Smithsonian Institution; Smithsonian National Museum of Natural History	Clauset, A (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	aaronc@santafe.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; ALROY J, 2008, PALEOBIOLOGY DATABAS; Brown J. H., 1995, MACROECOLOGY; Brown JH, 1996, AM NAT, V147, P1092, DOI 10.1086/285895; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Deperet C.J.J., 1909, TRANSFORMATIONS ANIM; DIAL KP, 1988, ECOLOGY, V69, P1620, DOI 10.2307/1941660; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Gaudin Timothy J., 2006, P1; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kozlowski J, 2002, FUNCT ECOL, V16, P540, DOI 10.1046/j.1365-2435.2002.00647.x; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Ludwig D, 1996, ECOL APPL, V6, P1067, DOI 10.2307/2269591; McKinney M.L., 1990, P75; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; PEARSON OP, 1948, SCIENCE, V108, P44, DOI 10.1126/science.108.2793.44; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; SMITH FA, 2007, MACROECOLOGICAL DATA; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; VANVALEN L, 1973, EVOLUTION, V27, P27, DOI 10.1111/j.1558-5646.1973.tb05914.x; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799	27	118	118	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					399	401		10.1126/science.1157534	http://dx.doi.org/10.1126/science.1157534			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635801	Green Submitted			2022-12-24	WOS:000257713900048
J	Kjelstrup, KB; Solstad, T; Brun, VH; Hafting, T; Leutgeb, S; Witter, MP; Moser, EI; Moser, MB				Kjelstrup, Kirsten Brun; Solstad, Trygve; Brun, Vegard Heimly; Hafting, Torkel; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Finite scale of spatial representation in the hippocampus	SCIENCE			English	Article							PARAHIPPOCAMPAL REGION; VENTRAL HIPPOCAMPUS; ENTORHINAL CORTEX; FUNCTIONAL NEUROANATOMY; ENSEMBLE CODE; ORGANIZATION; RAT; DYNAMICS; MEMORY; MAP	To determine how spatial scale is represented in the pyramidal cell population of the hippocampus, we recorded neural activity at multiple longitudinal levels of this brain area while rats ran back and forth on an 18- meter- long linear track. CA3 cells had well- defined place fields at all levels. The scale of representation increased almost linearly from <1 meter at the dorsal pole to similar to 10 meters at the ventral pole. The results suggest that the place- cell map includes the entire hippocampus and that environments are represented in the hippocampus at a topographically graded but finite continuum of scales.	[Kjelstrup, Kirsten Brun; Solstad, Trygve; Brun, Vegard Heimly; Hafting, Torkel; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Kjelstrup, Kirsten Brun; Solstad, Trygve; Brun, Vegard Heimly; Hafting, Torkel; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway; [Witter, Menno P.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Neurosci Res Inst, NL-1007 MB Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Brun, Vegard Heimly/ADZ-5405-2022	Brun, Vegard Heimly/0000-0002-4136-3073; Hafting, Torkel/0000-0002-0928-3487				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jackson W.B., 1982, P1077; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Maurer AP, 2006, HIPPOCAMPUS, V16, P785, DOI 10.1002/hipo.20202; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MOSER E, 1993, J NEUROSCI, V13, P3916; MOSER EI, IN PRESS ANN REV NEU, V31; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; POUCET B, 1994, NEUROREPORT, V5, P2045, DOI 10.1097/00001756-199410270-00014; SOLSTAD T, 2007, SOC NEUR ABSTR, V33; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; STROUD DC, 1982, J MAMMAL, V63, P151, DOI 10.2307/1380682; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	33	414	419	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					140	143		10.1126/science.1157086	http://dx.doi.org/10.1126/science.1157086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599792				2022-12-24	WOS:000257320800057
J	Marrazzo, JM; Thomas, KK; Fiedler, TL; Ringwood, K; Fredricks, DN				Marrazzo, Jeanne M.; Thomas, Katherine K.; Fiedler, Tina L.; Ringwood, Kathleen; Fredricks, David N.			Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women	ANNALS OF INTERNAL MEDICINE			English	Article							0.75-PERCENT METRONIDAZOLE GEL; INTRAVAGINAL METRONIDAZOLE; THERAPY; PCR; SUSCEPTIBILITY; IDENTIFICATION; CLINDAMYCIN; RECURRENCE; VAGINITIS; EFFICACY	Background: Bacterial vaginosis frequently persists after treatment. The role of newly defined bacterial vaginosis-associated bacteria (BVAB), which have a specificity for this condition of 97% or greater, has not been assessed. Objective: To define risks for bacterial vaginosis persistence, including pretreatment detection of specific vaginal bacteria, among women reporting sex with women. Design: Observational cohort study. Setting: University-based research clinic. Patients: 335 women age 16 to 29 years reporting sex with at least 1 woman in the past year. Participants were recruited through advertisements and provider referral. Intervention: Bacterial vaginosis was treated with intravaginal metronidazole gel (0.75%), 37.5 mg nightly for 5 nights. Measurements: Species-specific 16S recombinant DNA polymerase chain reaction assays targeting 17 bacterial species were applied to vaginal fluid obtained at baseline. Test of cure by clinical criteria and Gram stain analysis and repeated polymerase chain reaction assays of vaginal fluid were performed 1 month after treatment, and interim behaviors were assessed by using computer-assisted self-interview. Results: Of 335 women, 24% of whom also reported sex with men within 3 months before enrollment, 131 (39%) had bacterial vaginosis. In the 120 (92%) women who returned for follow- up, the incidence of persistent bacterial vaginosis was 26% and was statistically significantly higher in women with baseline detection of 3 Clostridiales bacteria, designated as BVAB1 (risk ratio, 2.0 [95% CI, 1.1 to 4.0]), BVAB2 (risk ratio, 8.7 [CI, 2.5 to infinity]), or BVAB3 (risk ratio, 3.1 [CI, 1.7 to 5.8]); Peptoniphilus lacrimalis (risk ratio, 3.5 [CI, 1.6 to 15.5]); and Megasphaera phylotype 2 (risk ratio, 3.4 [CI, 1.4 to 5.5]). Persistence was lower with treatment adherence ( risk ratio, 0.4 [0.2 to 0.9]). Detection of these bacteria at the test- of- cure visit was associated with persistence, whereas posttreatment sexual activity was not. Limitations: Findings may not be generalizable to women who have sex only with men, or to women whose bacterial vaginosis is treated with oral antibiotics. The study may be too small and may involve a population that is too highly selected to draw definitive conclusions about associations of persistent infection with posttreatment sexual behaviors. Conclusion: Persistent bacterial vaginosis is associated with several bacteria in the Clostridiales order, Megasphaera phylotype 2, and P. lacrimalis, suggesting that vaginal microbiology at diagnosis may determine risk for antibiotic failure.	[Marrazzo, Jeanne M.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Marrazzo, JM (corresponding author), Univ Washington, Harborview Med Ctr, Mailbox 359931,325 9th Ave, Seattle, WA 98104 USA.	jmm2@u.washington.edu		Thomas, Katherine K/0000-0002-7024-468X; Fredricks, David/0000-0003-2735-6800; Marrazzo, Jeanne/0000-0002-9277-7364	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI053250, R01AI061628, R01AI052228] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI061628-03, R01 AI061628, R01 AI052228-05, R03 AI053250-02, R01 AI052228] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGNEW KJ, 1995, SEX TRANSM DIS, V22, P269, DOI 10.1097/00007435-199509000-00001; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Beigi RH, 2004, AM J OBSTET GYNECOL, V191, P1124, DOI 10.1016/j.ajog.2004.05.033; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; De Backer E, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-51; EFRON B, 1986, INTRO BOOSTRAP; Ezaki T, 2001, INT J SYST EVOL MICR, V51, P1521, DOI 10.1099/00207713-51-4-1521; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks David N, 2005, Curr Infect Dis Rep, V7, P463, DOI 10.1007/s11908-005-0049-2; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003; Hanson JM, 2000, J REPROD MED, V45, P889; HILLER SL, 2008, SEXUALLY TE IN PRESS; HILLIER SL, 1993, OBSTET GYNECOL, V81, P963; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Limaye AP, 2001, J INFECT DIS, V183, P1669, DOI 10.1086/320711; Livengood CH, 1999, SEX TRANSM DIS, V26, P137, DOI 10.1097/00007435-199903000-00003; LIVENGOOD CH, 1994, AM J OBSTET GYNECOL, V170, P759, DOI 10.1016/S0002-9378(94)70278-0; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; MELTZER MC, 2008, SEX TRANSM DIS; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NG LK, 1989, FEMS MICROBIOL LETT, V61, P47, DOI 10.1111/j.1574-6968.1989.tb03550.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nyirjesy P, 2006, AM J OBSTET GYNECOL, V194, P1277, DOI 10.1016/j.ajog.2005.11.006; Nyirjesy P, 2007, SEX TRANSM DIS, V34, P197, DOI 10.1097/01.olq.0000235152.98601.d7; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; SKARIN A, 1983, SCAND J INFECT DIS, P81; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; Song YL, 2003, MICROBIOL-SGM, V149, P1719, DOI 10.1099/mic.0.26227-0; SPIEGEL CA, 1983, J INFECT DIS, V148, P817, DOI 10.1093/infdis/148.5.817; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; THOMAS KK, 2007, 17 M INT SOC SEX TRA; Tohill Beth C, 2004, Infect Dis Obstet Gynecol, V12, P121, DOI 10.1080/10647440400020711	42	92	103	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2008	149	1					20	+		10.7326/0003-4819-149-1-200807010-00006	http://dx.doi.org/10.7326/0003-4819-149-1-200807010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323EZ	18591634	Green Accepted			2022-12-24	WOS:000257428200003
J	Moeller, S; Freiwald, WA; Tsao, DY				Moeller, Sebastian; Freiwald, Winrich A.; Tsao, Doris Y.			Patches with links: A unified system for processing faces in the macaque temporal lobe	SCIENCE			English	Article							INFEROTEMPORAL AREA TE; CORTICAL CONNECTIONS; OBJECT RECOGNITION; FRONTAL-CORTEX; MONKEYS; PROJECTIONS; FMRI; REPRESENTATIONS; ORGANIZATION; PERCEPTION	The brain processes objects through a series of regions along the ventral visual pathway, but the circuitry subserving the analysis of specific complex forms remains unknown. One complex form category, faces, selectively activates six patches of cortex in the macaque ventral pathway. To identify the connectivity of these face patches, we used electrical microstimulation combined with simultaneous functional magnetic resonance imaging. Stimulation of each of four targeted face patches produced strong activation, specifically within a subset of the other face patches. Stimulation outside the face patches produced an activation pattern that spared the face patches. These results suggest that the face patches form a strongly and specifically interconnected hierarchical network.	[Moeller, Sebastian; Freiwald, Winrich A.; Tsao, Doris Y.] Univ Bremen, Inst Brain Res, D-28334 Bremen, Germany; [Moeller, Sebastian; Freiwald, Winrich A.; Tsao, Doris Y.] Univ Bremen, Ctr Adv Imaging, D-28334 Bremen, Germany	University of Bremen; University of Bremen	Tsao, DY (corresponding author), Univ Bremen, Inst Brain Res, POB 330440, D-28334 Bremen, Germany.	doris@nmr.mgh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bosking WH, 1997, J NEUROSCI, V17, P2112; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Cheng K, 1997, J NEUROSCI, V17, P7902; Cohen JD, 2001, SCIENCE, V293, P2405, DOI 10.1126/science.1066018; EKSTROM LB, 2005, SOC NEUR ANN M WASH; EPSHTEIN B, 2006, IEEE COMP SOC C COMP; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Felleman DJ, 1997, J NEUROSCI, V17, P3185; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Saleem KS, 1996, J NEUROSCI, V16, P4757; SALEEM KS, 1993, CEREB CORTEX, V3, P454, DOI 10.1093/cercor/3.5.454; Saleem KS, 2000, J NEUROSCI, V20, P5083; Saleem KS, 2007, COMBINED MRI HISTOLO; SELTZER B, 1989, J COMP NEUROL, V290, P451, DOI 10.1002/cne.902900402; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Suzuki W, 2000, J COMP NEUROL, V422, P206, DOI 10.1002/(SICI)1096-9861(20000626)422:2<206::AID-CNE5>3.0.CO;2-0; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WEBSTER MJ, 1991, J NEUROSCI, V11, P1095; WEBSTER MJ, 1993, J COMP NEUROL, V335, P73, DOI 10.1002/cne.903350106	32	290	292	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1355	1359		10.1126/science.1157436	http://dx.doi.org/10.1126/science.1157436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535247	Green Accepted			2022-12-24	WOS:000256441100049
J	Gutierrez, OM; Mannstadt, M; Isakova, T; Rauh-Hain, JA; Tamez, H; Shah, A; Smith, K; Lee, H; Thadhani, R; Juppner, H; Wolf, M				Gutierrez, Orlando M.; Mannstadt, Michael; Isakova, Tamara; Rauh-Hain, Jose Alejandro; Tamez, Hector; Shah, Anand; Smith, Kelsey; Lee, Hang; Thadhani, Ravi; Juppner, Harald; Wolf, Myles			Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; VITAMIN-D; VASCULAR CALCIFICATION; ONCOGENIC OSTEOMALACIA; MINERAL METABOLISM; PHOSPHATE; SURVIVAL; FGF23; RACE	Background: Fibroblast growth factor 23 (FGF-23) is a hormone that increases the rate of urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxyvitamin D, thus helping to mitigate hyperphosphatemia in patients with kidney disease. Hyperphosphatemia and low 1,25-dihydroxyvitamin D levels are associated with mortality among patients with chronic kidney disease, but the effect of the level of FGF-23 on mortality is unknown. Methods: We examined mortality according to serum phosphate levels in a prospective cohort of 10,044 patients who were beginning hemodialysis treatment and then analyzed FGF-23 levels and mortality in a nested case-control sample of 200 subjects who died and 200 who survived during the first year of hemodialysis treatment. We hypothesized that increased FGF-23 levels at the initiation of hemodialysis would be associated with increased mortality. Results: Serum phosphate levels in the highest quartile (>5.5 mg per deciliter [1.8 mmol per liter]) were associated with a 20% increase in the multivariable adjusted risk of death, as compared with normal levels (3.5 to 4.5 mg per deciliter [1.1 to 1.4 mmol per liter]) (hazard ratio, 1.2; 95% confidence interval [CI], 1.1 to 1.4). Median C-terminal FGF-23 (cFGF-23) levels were significantly higher in case subjects than in controls (2260 vs. 1406 reference units per milliliter, P<0.001). Multivariable adjusted analyses showed that increasing FGF-23 levels were associated with a monotonically increasing risk of death when examined either on a continuous scale (odds ratio per unit increase in log-transformed cFGF-23 values, 1.8; 95% CI, 1.4 to 2.4) or in quartiles, with quartile 1 as the reference category (odds ratio for quartile 2, 1.6 [95% CI, 0.8 to 3.3]; for quartile 3, 4.5 [95% CI, 2.2 to 9.4]; and for quartile 4, 5.7 [95% CI, 2.6 to 12.6]). Conclusions: Increased FGF-23 levels appear to be independently associated with mortality among patients who are beginning hemodialysis treatment. Future studies might investigate whether FGF-23 is a potential biomarker that can be used to guide strategies for the management of phosphorus balance in patients with chronic kidney disease.	[Gutierrez, Orlando M.; Isakova, Tamara; Rauh-Hain, Jose Alejandro; Tamez, Hector; Shah, Anand; Smith, Kelsey; Thadhani, Ravi; Wolf, Myles] Massachusetts Gen Hosp, Renal Unit, Boston, MA 02114 USA; [Mannstadt, Michael; Juppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Juppner, Harald] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Juppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wolf, M (corresponding author), Univ Miami, Div Nephrol & Hypertens, Miller Sch Med, 1120 NW 14th St, Miami, FL 33136 USA.	mwolf2@med.miami.edu	Mannstadt, Michael/AAO-1124-2020	Mannstadt, Michael/0000-0003-0867-9778	NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR017376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046718, K08DK081669, R01DK076116, R21DK071674] Funding Source: NIH RePORTER; NCRR NIH HHS [K23 RR017376, K30RR02229207, K23RR017376] Funding Source: Medline; NIDDK NIH HHS [R21 DK071674, R01 DK076116, K08 DK081669, R37 DK046718, R01DK076116, R21DK071674, R37 DK046718-17] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Foley RN, 2007, J AM SOC NEPHROL, V18, P2575, DOI 10.1681/ASN.2006121411; Frankenfield DL, 2003, J AM SOC NEPHROL, V14, P180, DOI 10.1097/01.ASN.0000037400.83593.E6; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, KIDNEY INT, V73, P956, DOI 10.1038/ki.2008.4; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Koiwa F, 2005, THER APHER DIAL, V9, P336, DOI 10.1111/j.1744-9987.2005.00293.x; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; RITZ E, 1973, KIDNEY INT, V4, P116, DOI 10.1038/ki.1973.90; Robinson BM, 2006, J AM SOC NEPHROL, V17, P2910, DOI 10.1681/ASN.2005101078; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Shigematsu T, 2004, AM J KIDNEY DIS, V44, P250, DOI 10.1053/j.ajkd.2004.04.029; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tonelli, 2007, CIRCULATION, V116, pE556, DOI 10.1161/CIRCULATIONAHA.107.187927; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; *US REN DAT SYST, 2004, USRDS 2003 ANN DAT R; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	39	1303	1364	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2008	359	6					584	592		10.1056/NEJMoa0706130	http://dx.doi.org/10.1056/NEJMoa0706130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334IY	18687639	Green Accepted			2022-12-24	WOS:000258216700006
J	Mocumbi, AO; Ferreira, MB; Sidi, D; Yacoub, MH				Mocumbi, Ana Olga; Ferreira, Maria Beatriz; Sidi, Daniel; Yacoub, Magdi H.			A population study of endomyocardial fibrosis in a rural area of mozambique	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATIC HEART-DISEASE; GEOGRAPHICAL-DISTRIBUTION; SURGICAL-TREATMENT; UGANDA; SURGERY; DIAGNOSIS; EMF	Background: Endomyocardial fibrosis is the most common restrictive cardiomyopathy worldwide. It has no specific treatment and carries a poor prognosis, since most patients present with advanced heart failure. On the basis of clinical series, regional variations in distribution have been reported within several countries in Africa, Asia, and South America, but large-scale data are lacking on the epidemiologic features and early stages of the disease. Methods: We used transthoracic echocardiography to determine the prevalence of endomyocardial fibrosis in a rural area of Mozambique. We screened a random sample of 1063 subjects of all age groups selected by clustering. Major and minor diagnostic criteria were defined, and a severity score was developed and applied. Cases were classified according to the distribution and severity of the lesions in the heart. Results: The estimated overall prevalence of endomyocardial fibrosis was 19.8%, or 211 of 1063 subjects (95% confidence interval [CI], 17.4 to 22.2). The prevalence was highest among persons 10 to 19 years of age (28.1%, or 73 of 260 subjects [95% CI, 22.6 to 33.6]) and was higher among male than among female subjects (23.0% vs. 17.5%, P=0.03). The most common form was biventricular endomyocardial fibrosis (a prevalence of 55.5%, or 117 of 211 subjects [95% CI, 48.8 to 62.2]), followed by right-sided endomyocardial fibrosis (a prevalence of 28.0%, or 59 of 211 subjects [95% CI, 21.9 to 34.1]). Most affected subjects had mild-to-moderate structural and functional echocardiographic abnormalities. Only 48 persons with endomyocardial fibrosis (22.7%) were symptomatic. The frequency of familial occurrence was high. Conclusions: Endomyocardial fibrosis is common in a rural area of Mozambique. By using echocardiography, we were able to detect early, asymptomatic stages of the disease. These findings may aid in the study of the pathogenesis of the disease and in the development of new management strategies.	[Mocumbi, Ana Olga; Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, London, England; [Mocumbi, Ana Olga; Ferreira, Maria Beatriz; Sidi, Daniel; Yacoub, Magdi H.] Inst Coracao, Maputo, Mozambique; [Sidi, Daniel] Hop Necker Enfants Malad, Paris, France	Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Yacoub, MH (corresponding author), Harefield Hosp, Magdi Yacoub Inst, Harefield UB9 6JH, Middx, England.	m.yacoub@imperial.ac.uk	Ferreira, Maria Beatriz C/G-6561-2012	Mocumbi, Ana/0000-0002-9564-2860				Andy JJ, 1998, ACTA TROP, V69, P127, DOI 10.1016/S0001-706X(97)00125-3; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berensztein CS, 2000, J AM SOC ECHOCARDIOG, V13, P385, DOI 10.1016/S0894-7317(00)70008-3; BIJLSMA F, 1979, T ROY SOC TROP MED H, V73, P661, DOI 10.1016/0035-9203(79)90015-4; CHERIAN G, 1983, AM HEART J, V105, P659, DOI 10.1016/0002-8703(83)90491-X; CONNOR DH, 1967, AM HEART J, V74, P687, DOI 10.1016/0002-8703(67)90509-1; Ferreira B, 2002, B SOC PATHOL EXOT, V95, P276; Ferreira M B, 1992, Rev Port Cardiol, V11, P841; FERREIRA MB, 2000, THESIS PARIS 5 U REN; GONZALEZLAVIN L, 1983, AM HEART J, V105, P699, DOI 10.1016/0002-8703(83)90508-2; Hakim J. G., 1996, Central African Journal of Medicine, V42, P262; Hassan WM, 2005, CHEST, V128, P3985, DOI 10.1378/chest.128.6.3985; Kartha CC, 1995, CARDIOVASC RES, V30, P636, DOI 10.1016/S0008-6363(96)88509-9; KRISHNA S, 1978, 8 WORLD C CARD TOK S; Kutty VR, 1996, INT J EPIDEMIOL, V25, P1202, DOI 10.1093/ije/25.6.1202; LOWENTHAL MN, 1978, MED J ZAMBIA, V12, P2; Mady Charles, 2005, Arq. Bras. Cardiol., V84, P241, DOI 10.1590/S0066-782X2005000300009; METRAS D, 1985, CIRCULATION, V72, P274; Mocumbi AO, 2008, HEART, V94, P384, DOI 10.1136/hrt.2007.136101; Moraes F, 1999, EUR J CARDIO-THORAC, V15, P309, DOI 10.1016/S1010-7940(99)00027-5; Niino Tetsuya, 2002, Ann Thorac Cardiovasc Surg, V8, P173; PATEL AK, 1971, BRIT MED J, V4, P331, DOI 10.1136/bmj.4.5783.331; Rutakingirwa M, 1999, TROP MED INT HEALTH, V4, P229, DOI 10.1046/j.1365-3156.1999.43376.x; Salemi V M C, 2005, Heart, V91, P1399, DOI 10.1136/hrt.2005.063610; Schneider U, 1998, HEART, V79, P362, DOI 10.1136/hrt.79.4.362; SHAPER AG, 1970, PATHOL MICROBIOL, V35, P26, DOI 10.1159/000162195; SHAPER AG, 1968, BRIT HEART J, V30, P391; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; VALIATHAN MS, 1987, ANN THORAC SURG, V43, P68, DOI 10.1016/S0003-4975(10)60169-5; Yacoub S, 2008, NAT CLIN PRACT CARD, V5, P176, DOI 10.1038/ncpcardio1129; Yie Kilsoo, 2004, Interact Cardiovasc Thorac Surg, V3, P86, DOI 10.1016/S1569-9293(03)00189-0; Yin Ruixing, 2000, Chinese Medical Sciences Journal, V15, P55	32	122	126	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 3	2008	359	1					43	49		10.1056/NEJMoa0708629	http://dx.doi.org/10.1056/NEJMoa0708629			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320PB	18596273				2022-12-24	WOS:000257246000006
J	Sandberg, R; Neilson, JR; Sarma, A; Sharp, PA; Burge, CB				Sandberg, Rickard; Neilson, Joel R.; Sarma, Arup; Sharp, Phillip A.; Burge, Christopher B.			Proliferating cells express mRNAs with shortened 3 ' untranslated regions and fewer microRNA target sites	SCIENCE			English	Article							ALTERNATIVE POLYADENYLATION; FACTOR CSTF-64; STIMULATORY FACTOR; GENE-EXPRESSION; EVENTS; DIFFERENTIATION; TRANSITION; SELECTION; SUBUNIT; BINDING	Messenger RNA ( mRNA) stability, localization, and translation are largely determined by sequences in the 3' untranslated region ( 3'UTR). We found a conserved increase in expression of mRNAs terminating at upstream polyadenylation sites after activation of primary murine CD4(+) T lymphocytes. This program, resulting in shorter 3' UTRs, is a characteristic of gene expression during immune cell activation and correlates with proliferation across diverse cell types and tissues. Forced expression of full- length 3' UTRs conferred reduced protein expression. In some cases the reduction in protein expression could be reversed by deletion of predicted microRNA target sites in the variably included region. Our data indicate that gene expression is coordinately regulated, such that states of increased proliferation are associated with widespread reductions in the 3' UTR- based regulatory capacity of mRNAs.	[Sandberg, Rickard; Sharp, Phillip A.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Neilson, Joel R.; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sarma, Arup] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu; cburge@mit.edu	Burge, Christopher B./AAH-2177-2020	Sandberg, Rickard/0000-0001-6473-1740; Neilson, Joel R./0000-0002-3408-608X	NCI NIH HHS [P30-CA14051, K99 CA131474, P01 CA042063-22, P01-CA42063, P30 CA014051, P01 CA042063] Funding Source: Medline; NHGRI NIH HHS [R01-HG002439, R01 HG002439, R01 HG002439-07] Funding Source: Medline; NIAID NIH HHS [U19 AI056900, U19 AI056900-010001] Funding Source: Medline; NIGMS NIH HHS [R01 GM034277, R01 GM034277-23, R01-GM34277] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051, K99CA131474] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ara T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-189; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; PEATTIE DA, 1994, GENE, V150, P251, DOI 10.1016/0378-1119(94)90434-0; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	21	969	994	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1643	1647		10.1126/science.1155390	http://dx.doi.org/10.1126/science.1155390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566288	Green Accepted			2022-12-24	WOS:000256886700050
J	Seki, A; Coppinger, JA; Jang, CY; Yates, JR; Fang, GW				Seki, Akiko; Coppinger, Judith A.; Jang, Chang-Young; Yates, John R., III; Fang, Guowei			Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control mitotic entry	SCIENCE			English	Article							POLO-LIKE KINASE; SCF-BETA-TRCP; CELL-CYCLE; PLX1; DOMAIN; POLO-LIKE-KINASE-1; PHOSPHORYLATION; PURIFICATION; PATHWAY; MITOSIS	A central question in the study of cell proliferation is, what controls cell- cycle transitions? Although the accumulation of mitotic cyclins drives the transition from the G(2) phase to the M phase in embryonic cells, the trigger for mitotic entry in somatic cells remains unknown. We report that the synergistic action of Bora and the kinase Aurora A ( Aur- A) controls the G(2)- M transition. Bora accumulates in the G(2) phase and promotes Aur- A- mediated activation of Polo- like kinase 1 ( Plk1), leading to the activation of cyclin- dependent kinase 1 and mitotic entry. Mechanistically, Bora interacts with Plk1 and controls the accessibility of its activation loop for phosphorylation and activation by Aur- A. Thus, Bora and Aur- A control mitotic entry, which provides a mechanism for one of the most important yet ill- defined events in the cell cycle.	[Seki, Akiko; Jang, Chang-Young; Fang, Guowei] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Coppinger, Judith A.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Stanford University; Scripps Research Institute	Fang, GW (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	gwfang@stanford.edu		coppinger, judith/0000-0001-6813-9840	NCRR NIH HHS [P41 RR011823, RR11823-10, P41 RR011823-10] Funding Source: Medline; NHLBI NIH HHS [R01 HL079442-04, HL079442, R01 HL079442] Funding Source: Medline; NIGMS NIH HHS [GM062852, R01 GM062852-05, R01 GM062852] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062852] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Eliassen A, 2003, NORW J GEOL, V83, P299; Erikson E, 2004, J BIOL CHEM, V279, P32219, DOI 10.1074/jbc.M403840200; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu JJ, 2005, ONCOGENE, V24, P238, DOI 10.1038/sj.onc.1208220; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	25	438	447	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1655	1658		10.1126/science.1157425	http://dx.doi.org/10.1126/science.1157425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566290	Green Accepted			2022-12-24	WOS:000256886700053
J	Chen, X; Xu, H; Yuan, P; Fang, F; Huss, M; Vega, VB; Wong, E; Orlov, YL; Zhang, WW; Jiang, JM; Loh, YH; Yeo, HC; Yeo, ZX; Narang, V; Govindarajan, KR; Leong, B; Shahab, A; Ruan, YJ; Bourque, G; Sung, WK; Clarke, ND; Wei, CL; Ng, HH				Chen, Xi; Xu, Han; Yuan, Ping; Fang, Fang; Huss, Mikael; Vega, Vinsensius B.; Wong, Eleanor; Orlov, Yuriy L.; Zhang, Weiwei; Jiang, Jianming; Loh, Yuin-Han; Yeo, Hock Chuan; Yeo, Zhen Xuan; Narang, Vipin; Govindarajan, Kunde Ramamoorthy; Leong, Bernard; Shahab, Atif; Ruan, Yijun; Bourque, Guillaume; Sung, Wing-Kin; Clarke, Neil D.; Wei, Chia-Lin; Ng, Huck-Hui			Integration of external signaling pathways with the core transcriptional network in embryonic stem cells	CELL			English	Article							SELF-RENEWAL; BINDING-SITES; DEVELOPMENTAL REGULATORS; C-MYC; PLURIPOTENT; GENOME; NANOG; DIFFERENTIATION; FIBROBLASTS; ACTIVATION	Transcription factors (TFs) and their specific interactions with targets are crucial for specifying gene-expression programs. To gain insights into the transcriptional regulatory networks in embryonic stem (ES) cells, we use chromatin immunoprecipitation coupled with ultra-high-throughput DNA sequencing (ChIP-seq) to map the locations of 13 sequence-specific TFs (Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, n-Myc, Klf4, Esrrb, Tcfcp2l1, E2f1, and CTCF) and 2 transcription regulators (p300 and Suz12). These factors are known to play different roles in ES-cell biology as components of the LIF and BMP signaling pathways, self-renewal regulators, and key reprogramming factors. Our study provides insights into the integration of the signaling pathways into the ES-cell-specific transcription circuitries. Intriguingly, we find specific genomic regions extensively targeted by different TFs. Collectively, the comprehensive mapping of TF-binding sites identifies important features of the transcriptional regulatory networks that define ES-cell identity.	[Wong, Eleanor; Ruan, Yijun; Wei, Chia-Lin] Genome Inst Singapore, Genome Technol & Biol Grp, Singapore 138672, Singapore; [Chen, Xi; Yuan, Ping; Fang, Fang; Zhang, Weiwei; Jiang, Jianming; Loh, Yuin-Han; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Chen, Xi; Fang, Fang; Zhang, Weiwei; Jiang, Jianming; Loh, Yuin-Han; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Orlov, Yuriy L.; Yeo, Hock Chuan; Yeo, Zhen Xuan; Clarke, Neil D.] Genome Inst Singapore, Computat & Syst Biol Grp, Singapore 138672, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Wei, CL (corresponding author), Genome Inst Singapore, Genome Technol & Biol Grp, Singapore 138672, Singapore.	weicl@gis.a-star.edu.sg; nghh@gis.a-star.edu.sg	Orlov, Yuriy L/F-1520-2013; Chen, Xi/C-6889-2012; Xu, Han/H-1963-2012; jiang, jianming/B-3421-2012; Huss, Mikael/B-1300-2009; Ramamoorthy, Govindarajan Kunde/AAK-6866-2020; Ng, Huck Hui/A-1135-2009; Loh, Yuin-Han/E-1096-2014; Clarke, Neil/D-9613-2014; Fang, Fang/G-7679-2016; Bourque, Guillaume/AFR-2927-2022	Orlov, Yuriy L/0000-0003-0587-1609; jiang, jianming/0000-0003-3251-2716; Loh, Yuin-Han/0000-0002-4715-6454; Bourque, Guillaume/0000-0002-3933-9656; Fang, Fang/0000-0002-5272-302X; Chen, Xi/0000-0002-7995-6202; Yuan, Ping/0000-0001-7243-3487; Yeo, Hock Chuan/0000-0001-5176-8800; Narang, Vipin/0000-0001-8669-9964; Huss, Mikael/0000-0003-0839-2451; Wong, Eleanor/0000-0001-7094-7679; Sung, Wing-Kin/0000-0001-7806-7086	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003521] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01HG003521-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	50	1870	1929	6	272	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 13	2008	133	6					1106	1117		10.1016/j.cell.2008.04.043	http://dx.doi.org/10.1016/j.cell.2008.04.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555785	Bronze			2022-12-24	WOS:000256693400024
J	Belin, D; Mar, AC; Dalley, JW; Robbins, TW; Everitt, BJ				Belin, David; Mar, Adam C.; Dalley, Jeffrey W.; Robbins, Trevor W.; Everitt, Barry J.			High impulsivity predicts the switch to compulsive cocaine-taking	SCIENCE			English	Article							SUBSTANCE USE DISORDERS; DRUG-ADDICTION; PERSONALITY; BEHAVIOR; REINFORCEMENT; VULNERABILITY; AMPHETAMINE; STRIATUM; STIMULI; SEEKING	Both impulsivity and novelty- seeking have been suggested to be behavioral markers of the propensity to take addictive drugs. However, their relevance for the vulnerability to compulsively seek and take drugs, which is a hallmark feature of addiction, is unknown. We report here that, whereas high reactivity to novelty predicts the propensity to initiate cocaine self- administration, high impulsivity predicts the development of addiction- like behavior in rats, including persistent or compulsive drug- taking in the face of aversive outcomes. This study shows experimental evidence that a shift from impulsivity to compulsivity occurs during the development of addictive behavior, which provides insights into the genesis and neural mechanisms of drug addiction.	[Belin, David; Mar, Adam C.; Dalley, Jeffrey W.; Robbins, Trevor W.; Everitt, Barry J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Belin, David; Mar, Adam C.; Dalley, Jeffrey W.; Robbins, Trevor W.; Everitt, Barry J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Belin, D (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Downing St, Cambridge CB2 3EB, England.	bdb26@cam.ac.uk; bje10@cam.ac.uk	Belin, David/E-1231-2014; Mar, Adam/A-3455-2013; Robbins, Trevor W/A-7551-2008	Belin, David/0000-0002-7383-372X; Mar, Adam/0000-0002-2095-2936; Dalley, Jeffrey/0000-0002-2282-3660; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G0600196] Funding Source: UKRI; Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0600196, G0600196(77608), G0001354] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dom G, 2006, ADDICTION, V101, P50, DOI 10.1111/j.1360-0443.2005.01270.x; Evenden J, 1999, PSYCHOPHARMACOLOGY, V143, P111, DOI 10.1007/s002130050926; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Haber SN, 2000, J NEUROSCI, V20, P2369; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Perry JL, 2005, PSYCHOPHARMACOLOGY, V178, P193, DOI 10.1007/s00213-004-1994-4; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Poulos CX, 1995, BEHAV PHARMACOL, V6, P810; Rikoon SH, 2006, J SUBST ABUSE TREAT, V31, P17, DOI 10.1016/j.jsat.2006.03.003; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; White TL, 2006, NEUROPSYCHOPHARMACOL, V31, P1064, DOI 10.1038/sj.npp.1300939; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6; Zilberman ML, 2007, J ADDICT DIS, V26, P79, DOI 10.1300/J069v26n01_10	26	693	708	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1352	1355		10.1126/science.1158136	http://dx.doi.org/10.1126/science.1158136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535246	Green Accepted			2022-12-24	WOS:000256441100048
J	Laurberg, M; Asahara, H; Korostelev, A; Zhu, JY; Trakhanov, S; Noller, HF				Laurberg, Martin; Asahara, Haruichi; Korostelev, Andrei; Zhu, Jianyu; Trakhanov, Sergei; Noller, Harry F.			Structural basis for translation termination on the 70S ribosome	NATURE			English	Article							STOP CODON RECOGNITION; PEPTIDE-BOND FORMATION; TRANSFER-RNA; RELEASE FACTORS; GGQ MOTIF; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHAIN TERMINATION; DECODING CENTER; HUMAN ERF1	At termination of protein synthesis, type I release factors promote hydrolysis of the peptidyl-transfer RNA linkage in response to recognition of a stop codon. Here we describe the crystal structure of the Thermus thermophilus 70S ribosome in complex with the release factor RF1, tRNA and a messenger RNA containing a UAA stop codon, at 3.2 angstrom resolution. The stop codon is recognized in a pocket formed by conserved elements of RF1, including its PxT recognition motif, and 16S ribosomal RNA. The codon and the 30S subunit A site undergo an induced fit that results in stabilization of a conformation of RF1 that promotes its interaction with the peptidyl transferase centre. Unexpectedly, the main-chain amide group of Gln 230 in the universally conserved GGQ motif of the factor is positioned to contribute directly to peptidyl-tRNA hydrolysis.	[Laurberg, Martin; Asahara, Haruichi; Korostelev, Andrei; Zhu, Jianyu; Trakhanov, Sergei; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Laurberg, Martin; Asahara, Haruichi; Korostelev, Andrei; Zhu, Jianyu; Trakhanov, Sergei; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		Korostelev, Andrei/0000-0003-1588-717X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106105] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CAPECCHI MR, 1969, COLD SPRING HARB SYM, V34, P469, DOI 10.1101/SQB.1969.034.01.053; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Nakamura Y, 2002, FEBS LETT, V514, P30, DOI 10.1016/S0014-5793(02)02330-X; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SCOLNICK EM, 1969, P NATL ACAD SCI USA, V64, P1235, DOI 10.1073/pnas.64.4.1235; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Seit-Nebi A, 2000, MOL BIOL+, V34, P764, DOI 10.1007/BF02759621; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; VOGEL Z, 1969, BIOCHEMISTRY-US, V8, P5161, DOI 10.1021/bi00840a070; Youngman EM, 2006, COLD SPRING HARB SYM, V71, P545, DOI 10.1101/sqb.2006.71.036; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zoldak G, 2007, NUCLEIC ACIDS RES, V35, P1343, DOI 10.1093/nar/gkl696	43	268	275	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					852	857		10.1038/nature07115	http://dx.doi.org/10.1038/nature07115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18596689				2022-12-24	WOS:000258398600028
J	Conrad, MN; Lee, CY; Chao, G; Shinohara, M; Kosaka, H; Shinohara, A; Conchello, JA; Dresser, ME				Conrad, Michael N.; Lee, Chih-Ying; Chao, Gene; Shinohara, M.; Kosaka, H.; Shinohara, A.; Conchello, J. -A.; Dresser, Michael E.			Rapid telomere movement in meiotic prophase is promoted by NDJ1, MPS3, and CSM4 and is modulated by recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; NUCLEAR-ENVELOPE; FISSION YEAST; CROSSOVER INTERFERENCE; ECTOPIC RECOMBINATION; BOUQUET FORMATION	Haploidization of the genome in meiosis requires that chromosomes be sorted exclusively into pairs stabilized by synaptonemal complexes (SCs) and crossovers. This sorting and pairing is accompanied by active chromosome positioning in meiotic prophase in which telomeres cluster near the spindle pole to form the bouquet before dispersing around the nuclear envelope. We now describe telomere-led rapid prophase movements (RPMs) that frequently exceed 1 mu m/s and persist throughout meiotic prophase. Bouquet formation and RPMs depend on NDJ1, MPS3, and a new member of this pathway, CSM4, which encodes a meiosis-specific nuclear envelope protein required specifically for telomere mobility. RPMs initiate independently of recombination but differ quantitatively in mutants that fail to complete recombination, suggesting that RPMs respond to recombination status. Together with recombination defects described for ndj1, our observations suggest that RPMs and SCs balance the disruption and stabilization of recombinational interactions, respectively, to regulate crossing over.	[Conrad, Michael N.; Lee, Chih-Ying; Chao, Gene; Conchello, J. -A.; Dresser, Michael E.] Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, Oklahoma City, OK 73104 USA; [Lee, Chih-Ying; Dresser, Michael E.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Shinohara, M.; Kosaka, H.; Shinohara, A.] Osaka Univ, Div Integrated Prot Funct, Inst Prot Res, Osaka 4, Japan; [Conchello, J. -A.] Univ Oklahoma, Dept Elect Engn, Norman, OK 73019 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Osaka University; University of Oklahoma System; University of Oklahoma - Norman	Dresser, ME (corresponding author), Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	dresserm@omrf.ouhsc.edu	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235				Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Berg, 2018, RANDOM WALKS BIOL; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Cha RS, 2000, GENE DEV, V14, P493; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Conchello JA, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2812554; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dresser ME, 1997, GENETICS, V147, P533; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goldman ASH, 2000, P NATL ACAD SCI USA, V97, P9537, DOI 10.1073/pnas.97.17.9537; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hayashi A, 1998, GENES CELLS, V3, P587, DOI 10.1046/j.1365-2443.1998.00215.x; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jaspersen SL, 2006, J CELL BIOL, V174, P665, DOI 10.1083/jcb.200601062; Kateneva AV, 2005, J CELL BIOL, V171, P241, DOI 10.1083/jcb.200505020; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; Miki F, 2004, MOL GENET GENOMICS, V270, P449, DOI 10.1007/s00438-003-0938-8; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; PARVINEN M, 1976, NATURE, V260, P534, DOI 10.1038/260534a0; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Schlecht HB, 2004, GENETICS, V168, P1189, DOI 10.1534/genetics.104.029157; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Villasante A, 2007, P NATL ACAD SCI USA, V104, P10542, DOI 10.1073/pnas.0703808104; White EJ, 2004, GENETICS, V167, P51, DOI 10.1534/genetics.167.1.51; XU LZ, 1995, MOL CELL BIOL, V15, P6572; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	59	156	159	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1175	1187		10.1016/j.cell.2008.04.047	http://dx.doi.org/10.1016/j.cell.2008.04.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585352	Bronze			2022-12-24	WOS:000257144600015
J	Shih, C; Museth, AK; Abrahamsson, M; Blanco-Rodriguez, AM; Di Bilio, AJ; Sudhamsu, J; Crane, BR; Ronayne, KL; Towrie, M; Vlcek, A; Richards, JH; Winkler, JR; Gray, HB				Shih, Crystal; Museth, Anna Katrine; Abrahamsson, Malin; Blanco-Rodriguez, Ana Maria; Di Bilio, Angel J.; Sudhamsu, Jawahar; Crane, Brian R.; Ronayne, Kate L.; Towrie, Mike; Vlcek, Antonin, Jr.; Richards, John H.; Winkler, Jay R.; Gray, Harry B.			Tryptophan-accelerated electron flow through proteins	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA AZURINS; RIBONUCLEOTIDE REDUCTASE; OXIDATION; RADICALS; DYNAMICS; TYROSINE; CURRENTS; PROTON; BONDS; WATER	Energy flow in biological structures often requires submillisecond charge transport over long molecular distances. Kinetics modeling suggests that charge- transfer rates can be greatly enhanced by multistep electron tunneling in which redox- active amino acid side chains act as intermediate donors or acceptors. We report transient optical and infrared spectroscopic experiments that quantify the extent to which an intervening tryptophan residue can facilitate electron transfer between distant metal redox centers in a mutant Pseudomonas aeruginosa azurin. Cu-1 oxidation by a photoexcited Re-1- diimine at position 124 on a histidine( 124)- glycine( 123)- tryptophan( 122)-methionine( 121) beta strand occurs in a few nanoseconds, fully two orders of magnitude faster than documented for single- step electron tunneling at a 19 angstrom donor- acceptor distance.	[Sudhamsu, Jawahar; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Shih, Crystal; Museth, Anna Katrine; Abrahamsson, Malin; Di Bilio, Angel J.; Richards, John H.; Winkler, Jay R.; Gray, Harry B.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Blanco-Rodriguez, Ana Maria; Vlcek, Antonin, Jr.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Ronayne, Kate L.; Towrie, Mike] STFC Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England	Cornell University; California Institute of Technology; University of London; Queen Mary University London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu; a.vlcek@qmul.ac.uk; jhr@caltech.edu; winklerj@caltech.edu; hbgray@caltech.edu	Vlcek, Antonin/G-3908-2014; Sudhamsu, Jawahar/A-8751-2012; Winkler, Jay R/B-7372-2009	Towrie, Mike/0000-0002-1305-701X	NIDDK NIH HHS [DK19038] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019038, R01DK019038] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berlin YA, 2003, J PHYS CHEM A, V107, P3970, DOI 10.1021/jp034225i; Blanco-Rodriguez AM, 2006, J AM CHEM SOC, V128, P4365, DOI 10.1021/ja057451+; Cannizzo A, 2008, J AM CHEM SOC, V130, P8967, DOI 10.1021/ja710763w; Chang MCY, 2004, J AM CHEM SOC, V126, P16702, DOI 10.1021/ja044124d; Connick WB, 1995, INORG CHIM ACTA, V240, P169, DOI 10.1016/0020-1693(95)04532-5; Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FREY PA, 1990, CHEM REV, V90, P1343, DOI 10.1021/cr00105a014; Gabrielsson A, 2006, J AM CHEM SOC, V128, P4253, DOI 10.1021/ja0539802; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Kobayashi C, 2003, J CHEM PHYS, V119, P3550, DOI 10.1063/1.1588293; LANGEN R, 1995, SCIENCE, V268, P1733, DOI 10.1126/science.7792598; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Prytkova TR, 2007, SCIENCE, V315, P622, DOI 10.1126/science.1134862; REGAN JJ, 1995, CHEM BIOL, V2, P489, DOI 10.1016/1074-5521(95)90266-X; Sjoberg BM, 1997, STRUCT BOND, V88, P139; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; Skov LK, 1998, J AM CHEM SOC, V120, P1102, DOI 10.1021/ja972540a; SOLAR S, 1991, J PHYS CHEM-US, V95, P3639, DOI 10.1021/j100162a038; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stuchebrukhov AA, 1996, J CHEM PHYS, V105, P10819, DOI 10.1063/1.472890; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Winkler JR, 1999, PURE APPL CHEM, V71, P1753, DOI 10.1351/pac199971091753	28	344	348	1	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1760	1762		10.1126/science.1158241	http://dx.doi.org/10.1126/science.1158241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583608				2022-12-24	WOS:000257121200034
J	Umehara, M; Hanada, A; Yoshida, S; Akiyama, K; Arite, T; Takeda-Kamiya, N; Magome, H; Kamiya, Y; Shirasu, K; Yoneyama, K; Kyozuka, J; Yamaguchi, S				Umehara, Mikihisa; Hanada, Atsushi; Yoshida, Satoko; Akiyama, Kohki; Arite, Tomotsugu; Takeda-Kamiya, Noriko; Magome, Hiroshi; Kamiya, Yuji; Shirasu, Ken; Yoneyama, Koichi; Kyozuka, Junko; Yamaguchi, Shinjiro			Inhibition of shoot branching by new terpenoid plant hormones	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; GERMINATION STIMULANTS; PHOSPHORUS DEFICIENCY; APICAL-DOMINANCE; GIBBERELLIC-ACID; PARASITIC PLANTS; ROOT PARASITES; ARABIDOPSIS; RICE; STRIGOL	Shoot branching is a major determinant of plant architecture and is highly regulated by endogenous and environmental cues. Two classes of hormones, auxin and cytokinin, have long been known to have an important involvement in controlling shoot branching. Previous studies using a series of mutants with enhanced shoot branching suggested the existence of a third class of hormone( s) that is derived from carotenoids, but its chemical identity has been unknown. Here we show that levels of strigolactones, a group of terpenoid lactones, are significantly reduced in some of the branching mutants. Furthermore, application of strigolactones inhibits shoot branching in these mutants. Strigolactones were previously found in root exudates acting as communication chemicals with parasitic weeds and symbiotic arbuscular mycorrhizal fungi. Thus, we propose that strigolactones act as a new hormone class - or their biosynthetic precursors - in regulating above- ground plant architecture, and also have a function in underground communication with other neighbouring organisms.	[Umehara, Mikihisa; Hanada, Atsushi; Yoshida, Satoko; Takeda-Kamiya, Noriko; Magome, Hiroshi; Kamiya, Yuji; Shirasu, Ken; Yamaguchi, Shinjiro] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Akiyama, Kohki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Osaka 5998531, Japan; [Arite, Tomotsugu; Kyozuka, Junko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan; [Yoneyama, Koichi] Utsunomiya Univ, Weed Sci Ctr, Utsunomiya, Tochigi 3218505, Japan	RIKEN; University of Tokyo; Utsunomiya University	Yamaguchi, S (corresponding author), RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan.	shinjiro@postman.riken.jp	Yoshida, Satoko/AAZ-4757-2021; Kyozuka, Junko/E-7844-2012; Yoshida, Satoko/G-5003-2010; Yamaguchi, Shinjiro/F-9684-2010; Yoneyama, Koichi/A-9819-2012; yoshida, satoko/AAO-4892-2020; Kamiya, Yuji/F-9420-2010; Shirasu, Ken/A-4455-2010; Akiyama, Kohki/B-4668-2012; Shirasu, Ken/ABF-5306-2020; Umehara, M/D-2416-2011	Yoshida, Satoko/0000-0002-9999-7861; Yoneyama, Koichi/0000-0002-4930-035X; yoshida, satoko/0000-0002-9999-7861; Kamiya, Yuji/0000-0003-4415-520X; Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; Kyozuka, Junko/0000-0003-2242-7171; Akiyama, Kohki/0000-0002-9171-9058	MEXT of Japan [1820810, 19678001, 19780040]; MAFF of Japan (Genomics for Agricultural Innovation) [IPG0001]; RIKEN Special Postdoctoral Researchers Program	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MAFF of Japan (Genomics for Agricultural Innovation); RIKEN Special Postdoctoral Researchers Program	We are grateful to S. Ishikawa for sequencing the d17-1 allele; K. Fujiwara for assistance in preparing plant materials; N. Makita and H. Sakakibara for their advice on rice hydroponic culture; and Y. Tsuchiya for advice on germination assays. We thank the Salk Institute and the Arabidopsis Biological Resource Center for providing Arabidopsis T-DNA insertion lines; T. Yokota, K. Yoneyama and X. Xie for sharing information on strigolactone analysis; M. Maekawa for propagating rice seeds; and K. Mori, P. McCourt and A. Gabar Babiker for providing (+)-strigol and 2 '-epi-orobanchol, (+)-GR24, and S. hermonthica seeds, respectively. This work was supported in part by grants from the MEXT of Japan ( 1820810 to K. Y., 19678001 to K. S. and 19780040 to Sa. Y.) and the MAFF of Japan (Genomics for Agricultural Innovation, IPG0001 to J.K.). M. U. is supported by the RIKEN Special Postdoctoral Researchers Program.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Beveridge CA, 1996, PLANT PHYSIOL, V110, P859, DOI 10.1104/pp.110.3.859; BEVERIDGE CA, 1994, PLANT PHYSIOL, V104, P953, DOI 10.1104/pp.104.3.953; Beveridge CA, 2000, PLANT PHYSIOL, V123, P689, DOI 10.1104/pp.123.2.689; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; BRADOW JM, 1988, J PLANT GROWTH REGUL, V7, P227, DOI 10.1007/BF02025265; BRADOW JM, 1990, J PLANT GROWTH REGUL, V9, P35, DOI 10.1007/BF02041939; CLINE MG, 1991, BOT REV, V57, P318, DOI 10.1007/BF02858771; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; Goldstick D, 2008, RATIO, V21, P28, DOI 10.1111/j.1467-9329.2007.00382.x; Gressel J, 2004, CROP PROT, V23, P661, DOI 10.1016/j.cropro.2003.11.014; Gurney AL, 2006, NEW PHYTOL, V169, P199, DOI 10.1111/j.1469-8137.2005.01560.x; Humphrey AJ, 2006, PHYTOCHEMISTRY, V67, P636, DOI 10.1016/j.phytochem.2005.12.026; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Joel DM, 2000, CROP PROT, V19, P753, DOI 10.1016/S0261-2194(00)00100-9; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; KAMACHI K, 1991, PLANT PHYSIOL, V96, P411, DOI 10.1104/pp.96.2.411; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1230, DOI 10.1021/jf00019a031; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Simons JL, 2007, PLANT PHYSIOL, V143, P697, DOI 10.1104/pp.106.087957; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Sugimoto Y, 2008, PHYTOCHEMISTRY, V69, P212, DOI 10.1016/j.phytochem.2007.06.011; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	44	1310	1434	33	604	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					195	U29		10.1038/nature07272	http://dx.doi.org/10.1038/nature07272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	346SZ	18690207				2022-12-24	WOS:000259090800040
J	Valle, L; Serena-Acedo, T; Liyanarachchi, S; Hampel, H; Comeras, I; Li, ZY; Zeng, QH; Zhang, HT; Pennison, MJ; Sadim, M; Pasche, B; Tanner, SM; de la Chapelle, A				Valle, Laura; Serena-Acedo, Tarsicio; Liyanarachchi, Sandya; Hampel, Heather; Comeras, Ilene; Li, Zhongyuan; Zeng, Qinghua; Zhang, Hong-Tao; Pennison, Michael J.; Sadim, Maureen; Pasche, Boris; Tanner, Stephan M.; de la Chapelle, Albert			Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer	SCIENCE			English	Article							HUMAN GENE-EXPRESSION; BETA RECEPTOR; TGFBR1-ASTERISK-6A; SMAD3; PREDISPOSITION; SUSCEPTIBILITY; TUMORIGENESIS; DEFICIENCY; KINDREDS; VARIANT	Much of the genetic predisposition to colorectal cancer (CRC) in humans is unexplained. Studying a Caucasian- dominated population in the United States, we showed that germline allele- specific expression ( ASE) of the gene encoding transforming growth factor-beta (TGF-beta) type I receptor, TGFBR1, is a quantitative trait that occurs in 10 to 20% of CRC patients and 1 to 3% of controls. ASE results in reduced expression of the gene, is dominantly inherited, segregates in families, and occurs in sporadic CRC cases. Although subtle, the reduction in constitutive TGFBR1 expression alters SMAD- mediated TGF-beta signaling. Two major TGFBR1 haplotypes are predominant among ASE cases, which suggests ancestral mutations, but causative germline changes have not been identified. Conservative estimates suggest that ASE confers a substantially increased risk of CRC ( odds ratio, 8.7; 95% confidence interval, 2.6 to 29.1), but these estimates require confirmation and will probably show ethnic differences.	[Zeng, Qinghua; Zhang, Hong-Tao; Pennison, Michael J.; Sadim, Maureen; Pasche, Boris] Northwestern Univ, Canc Genet Program, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; [Zeng, Qinghua; Zhang, Hong-Tao; Pennison, Michael J.; Sadim, Maureen; Pasche, Boris] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Valle, Laura; Serena-Acedo, Tarsicio; Liyanarachchi, Sandya; Hampel, Heather; Comeras, Ilene; Li, Zhongyuan; Tanner, Stephan M.; de la Chapelle, Albert] Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Pasche, B (corresponding author), Northwestern Univ, Canc Genet Program, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA.	b-pasche@northwestern.edu; Stephan.Tanner@osumc.edu; Albert.delaChapelle@osumc.edu	Valle, Laura/H-8118-2012; Zhang, Hong-Tao/P-9661-2017; Hampel, Heather/AAV-4041-2020	Valle, Laura/0000-0003-0371-0844; Zhang, Hong-Tao/0000-0003-4182-421X; Hampel, Heather/0000-0001-7558-9794; Edsall, Lee Elizabeth/0000-0002-0326-2829	NIH [CA67941, CA16058, CA112520, CA108741]; Walter S. Mander Foundation; Jeannik M. Littlefield-American Association for Cancer Research Grant in Metastatic Colon Cancer Research; Fundacion Ramon Areces.; NATIONAL CANCER INSTITUTE [R01CA067941, P30CA016058, U01CA067941, R01CA112520, R01CA108741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter S. Mander Foundation; Jeannik M. Littlefield-American Association for Cancer Research Grant in Metastatic Colon Cancer Research; Fundacion Ramon Areces.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. He, K. Sotamaa, and W. Frankel for help. This work was supported by NIH grants CA67941, CA16058, CA112520, and CA108741; grants from the Walter S. Mander Foundation, Chicago, IL; and the Jeannik M. Littlefield-American Association for Cancer Research Grant in Metastatic Colon Cancer Research. L. V. was supported by a fellowship from the Fundacion Ramon Areces.	Bian Y, 2005, J CLIN ONCOL, V23, P3074, DOI 10.1200/JCO.2005.00.281; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Kemp ZE, 2006, CANCER RES, V66, P5003, DOI 10.1158/0008-5472.CAN-05-4074; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003; Pasche B, 1999, CANCER RES, V59, P5678; Pasche B, 2005, JAMA-J AM MED ASSOC, V294, P1634, DOI 10.1001/jama.294.13.1634; Pasche B, 1998, CANCER RES, V58, P2727; Pasche B, 2004, J CLIN ONCOL, V22, P756, DOI 10.1200/JCO.2004.99.271; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skoglund J, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.033928; Skoglund J, 2007, CLIN CANCER RES, V13, P3748, DOI 10.1158/1078-0432.CCR-06-2865; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	30	119	124	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1361	1365		10.1126/science.1159397	http://dx.doi.org/10.1126/science.1159397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18703712	Green Accepted			2022-12-24	WOS:000258914300052
J	Tsai, SY; Opavsky, R; Sharma, N; Wu, LZ; Naidu, S; Nolan, E; Feria-Arias, E; Timmers, C; Opavska, J; de Bruin, A; Chong, JL; Trikha, P; Fernandez, SA; Stromberg, P; Rosol, TJ; Leone, G				Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Naidu, Shan; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Fernandez, Soledad A.; Stromberg, Paul; Rosol, Thomas J.; Leone, Gustavo			Mouse development with a single E2F activator	NATURE			English	Article							TRANSCRIPTION FACTOR; CELL-CYCLE; PROLIFERATION; MICE; RB; IDENTIFICATION; SPECIFICITY; MATURATION; MECHANISM; BINDING	The E2F family is conserved from Caenorhabditis elegans to mammals, with some family members having transcription activation functions and others having repressor functions(1,2). Whereas C. elegans(3) and Drosophila melanogaster(4,5) have a single E2F activator protein and repressor protein, mammals have at least three activator and five repressor proteins(1,2,6). Why such genetic complexity evolved in mammals is not known. To begin to evaluate this genetic complexity, we targeted the inactivation of the entire subset of activators, E2f1, E2f2, E2f3a and E2f3b, singly or in combination in mice. We demonstrate that E2f3a is sufficient to support mouse embryonic and postnatal development. Remarkably, expression of E2f3b or E2f1 from the E2f3a locus ( E2f3a(3bki) or E2f3a(1ki), respectively) suppressed all the postnatal phenotypes associated with the inactivation of E2f3a. We conclude that there is significant functional redundancy among activators and that the specific requirement for E2f3a during postnatal development is dictated by regulatory sequences governing its selective spatiotemporal expression and not by its intrinsic protein functions. These findings provide a molecular basis for the observed specificity among E2F activators during development.	[Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Naidu, Shan; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Tsai, Shih-Yin; Opavsky, Rene; Sharma, Nidhi; Wu, Lizhao; Naidu, Shan; Nolan, Eric; Feria-Arias, Enrique; Timmers, Cynthia; Opavska, Jana; de Bruin, Alain; Chong, Jean-Leon; Trikha, Prashant; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Coll Med, Columbus, OH 43210 USA; [Naidu, Shan; Stromberg, Paul; Rosol, Thomas J.] Ohio State Univ, Dept Vet Biosci, Coll Vet Med, Columbus, OH 43210 USA; [Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Leone, G (corresponding author), Ohio State Univ, Dept Mol Genet, Coll Biol Sci, 484 W 12Th Ave, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	de Bruin, Alain/AAL-9195-2020; Trikha, Prashant/B-5897-2012; Rosol, Thomas/G-9585-2011	Rosol, Thomas/0000-0003-3737-1190; Tsai, Shih-Yin/0000-0002-2834-6383; de Bruin, Alain/0000-0001-8579-2649	NIH [R01CA85619, R01HD042619, R01CA121275, R01HD047470, P01CA097189, K01CA102328]; DoD awards [BC0300893, BC061730]; T32 fellowship [CA106196]; Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470, R01HD042619] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA121275, R01CA085619, T32CA106196, K01CA102328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD awards; T32 fellowship; Pew Charitable Trusts Scholar Award; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Moffitt and L. Rawahneh for histology expertise. We also thank J. Nevins, C. Bock and A. Otoshi for support in the generation of the E2f3a, E2f3b, E2f3a<SUP>3bki</SUP> and E2f3a<SUP>1ki</SUP> mice, and the Mouse Metabolic Phenotyping center at the University of Cincinnati for advice on the analysis of E2f1<SUP>-/-</SUP>E2f3a<SUP>-/-</SUP> mice. We are grateful to D. Guttridge, M. Ostrowski and M. Simcox for critically reading the manuscript and helpful suggestions. This work was funded by NIH grants to G. L. (R01CA85619, R01HD042619, R01CA121275, R01HD047470, P01CA097189), to L. W. ( K01CA102328), DoD awards to A.d.B. (BC0300893) and J.-L.C. (BC061730), and a T32 fellowship (CA106196) to R.O.G.L. is the recipient of the Pew Charitable Trusts Scholar Award and the Leukemia and Lymphoma Society Scholar Award.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; DeGregori J, 2006, CURR MOL MED, V6, P739; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; DYNLACHT BD, 1994, P NATL ACAD SCI USA, V91, P6359, DOI 10.1073/pnas.91.14.6359; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Humbert PO, 2000, GENE DEV, V14, P690; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Sawado T, 1998, BIOCHEM BIOPH RES CO, V251, P409, DOI 10.1006/bbrc.1998.9407; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	26	75	75	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1137	U69		10.1038/nature07066	http://dx.doi.org/10.1038/nature07066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18594513	Green Accepted, Green Published			2022-12-24	WOS:000258719600042
J	Shen, WX; Flajolet, M; Greengard, P; Surmeier, DJ				Shen, Weixing; Flajolet, Marc; Greengard, Paul; Surmeier, D. James			Dichotomous dopaminergic control of striatal synaptic plasticity	SCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM DEPRESSION; MEDIUM SPINY NEURONS; BASAL GANGLIA; STRIATOPALLIDAL NEURONS; DENDRITIC EXCITABILITY; MODULATION; INTERNEURONS; TRANSMISSION; ACTIVATION	At synapses between cortical pyramidal neurons and principal striatal medium spiny neurons (MSNs), postsynaptic D1 and D2 dopamine (DA) receptors are postulated to be necessary for the induction of long-term potentiation and depression, respectively-forms of plasticity thought to underlie associative learning. Because these receptors are restricted to two distinct MSN populations, this postulate demands that synaptic plasticity be unidirectional in each cell type. Using brain slices from DA receptor transgenic mice, we show that this is not the case. Rather, DA plays complementary roles in these two types of MSN to ensure that synaptic plasticity is bidirectional and Hebbian. In models of Parkinson's disease, this system is thrown out of balance, leading to unidirectional changes in plasticity that could underlie network pathology and symptoms.	[Shen, Weixing; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Northwestern University; Feinberg School of Medicine; Rockefeller University	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu		Greengard, Paul/0000-0002-4437-0893	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-05, P50 MH074866, MH074866] Funding Source: Medline; NINDS NIH HHS [NS 34696, R01 NS034696, R37 NS034696, R01 NS034696-06] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Dujardin K, 2003, CURR OPIN NEUROL, V16, pS11, DOI 10.1097/00019052-200312002-00003; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GONAN F, 1997, J NEUROSCI, V17, P5972; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	28	786	797	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2008	321	5890					848	851		10.1126/science.1160575	http://dx.doi.org/10.1126/science.1160575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334ZQ	18687967	Green Accepted			2022-12-24	WOS:000258261000049
J	Bensinger, SJ; Bradley, MN; Joseph, SB; Zelcer, N; Janssen, EM; Hausner, MA; Shih, R; Parks, JS; Edwards, PA; Jamieson, BD; Tontonoz, P				Bensinger, Steven J.; Bradley, Michelle N.; Joseph, Sean B.; Zelcer, Noam; Janssen, Edith M.; Hausner, Mary Ann; Shih, Roger; Parks, John S.; Edwards, Peter A.; Jamieson, Beth D.; Tontonoz, Peter			LXR signaling couples sterol metabolism to proliferation in the acquired immune response	CELL			English	Article							LIVER-X-RECEPTORS; CHOLESTEROL EFFLUX; NUCLEAR RECEPTORS; CELL-GROWTH; IDENTIFICATION; INHIBITION; PATHWAYS; BINDING; LYMPHOCYTES; ACTIVATION	Cholesterol is essential for membrane synthesis; however, the mechanisms that link cellular lipid metabolism to proliferation are incompletely understood. We demonstrate here that cellular cholesterol levels in dividing T cells are maintained in part through reciprocal regulation of the LXR and SREBP transcriptional programs. T cell activation triggers induction of the oxysterol- metabolizing enzyme SULT2B1, consequent suppression of the LXR pathway for cholesterol transport, and promotion of the SREBP pathway for cholesterol synthesis. Ligation of LXR during T cell activation inhibits mitogen- driven expansion, whereas loss of LXRb confers a proliferative advantage. Inactivation of the sterol transporter ABCG1 uncouples LXR signaling from proliferation, directly linking sterol homeostasis to the antiproliferative action of LXR. Mice lacking LXRb exhibit lymphoid hyperplasia and enhanced responses to antigenic challenge, indicating that proper regulation of LXR- dependent sterol metabolism is important for immune responses. These results implicate LXR signaling in a metabolic checkpoint that modulates cell proliferation and immunity.	[Hausner, Mary Ann; Shih, Roger; Jamieson, Beth D.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90049 USA; [Edwards, Peter A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90049 USA; [Janssen, Edith M.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Parks, John S.] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; La Jolla Institute for Immunology; Wake Forest University		ptontonoz@mednet.ucla.edu	Zelcer, Noam/C-6393-2009	Zelcer, Noam/0000-0001-6935-7532; Joseph, Sean/0000-0002-2602-8517; janssen, edith/0000-0001-7881-6307	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA-16042, P30 CA016042] Funding Source: Medline; NCRR NIH HHS [RR021975, K01 RR021975] Funding Source: Medline; NHLBI NIH HHS [HL049373, HL30568, P01 HL030568, R01 HL066088, R01 HL066088-07, P01 HL049373] Funding Source: Medline; NIAID NIH HHS [AI-28697, P30 AI028697] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR021975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, P01HL030568, R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Beadling Carol, 2002, Med Immunol, V1, P2, DOI 10.1186/1476-9433-1-2; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; CHAKRABARTI R, 1991, J BIOL CHEM, V266, P12216; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHEN HW, 1975, P NATL ACAD SCI USA, V72, P1950, DOI 10.1073/pnas.72.5.1950; CHEN HW, 1974, NATURE, V251, P419, DOI 10.1038/251419a0; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fuda H, 2007, J LIPID RES, V48, P1343, DOI 10.1194/jlr.M700018-JLR200; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACDONALD HR, 1979, J IMMUNOL, V122, P1067; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; Martinez-Botas J, 1999, FASEB J, V13, P1359, DOI 10.1096/fasebj.13.11.1359; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Toes REM, 1998, J IMMUNOL, V160, P4449; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886	49	478	494	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					97	111		10.1016/j.cell.2008.04.052	http://dx.doi.org/10.1016/j.cell.2008.04.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614014	Green Accepted, Bronze			2022-12-24	WOS:000257513100017
J	Crockett, MJ; Clark, L; Tabibnia, G; Lieberman, MD; Robbins, TW				Crockett, Molly J.; Clark, Luke; Tabibnia, Golnaz; Lieberman, Matthew D.; Robbins, Trevor W.			Serotonin modulates behavioral reactions to unfairness	SCIENCE			English	Article							ECONOMIC DECISION-MAKING; ULTIMATUM GAME; DEPLETION; FAIRNESS		[Crockett, Molly J.; Clark, Luke; Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Crockett, Molly J.; Clark, Luke; Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Tabibnia, Golnaz; Lieberman, Matthew D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of Cambridge; University of Cambridge; University of California System; University of California Los Angeles	Crockett, MJ (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	mc536@cam.ac.uk	Lieberman, Matthew/ABD-8197-2020; Crockett, Molly/F-8217-2014; Robbins, Trevor W/A-7551-2008	Lieberman, Matthew/0000-0002-4447-7359; Crockett, Molly/0000-0001-8800-410X; Robbins, Trevor/0000-0003-0642-5977; Clark, Luke/0000-0003-1103-2422; Tabibnia, Golnaz/0000-0003-3898-2313	Medical Research Council [G0001354] Funding Source: Medline; Wellcome Trust [076244, 076274] Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Evers EAT, 2006, PSYCHOPHARMACOLOGY, V187, P200, DOI 10.1007/s00213-006-0411-6; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x	7	273	283	3	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1739	1739		10.1126/science.1155577	http://dx.doi.org/10.1126/science.1155577			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18535210	Green Submitted, Green Accepted			2022-12-24	WOS:000257121200028
J	Murzin, AG				Murzin, Alexey G.			Biochemistry - Metamorphic proteins	SCIENCE			English	Editorial Material							T7 RNA-POLYMERASE; STRUCTURAL BASIS; TRANSCRIPTION; TRANSITION; FOLDS		MRC Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Murzin, AG (corresponding author), MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	agm@mrc-lmb.cam.ac.uk			Medical Research Council [MC_U105192716] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roessler CG, 2008, P NATL ACAD SCI USA, V105, P2343, DOI 10.1073/pnas.0711589105; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	12	162	162	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2008	320	5884					1725	1726		10.1126/science.1158868	http://dx.doi.org/10.1126/science.1158868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318VP	18583598				2022-12-24	WOS:000257121200022
J	Pan, XX; Luhrmann, A; Satoh, A; Laskowski-Arce, MA; Roy, CR				Pan, Xiaoxiao; Luhrmann, Anja; Satoh, Ayano; Laskowski-Arce, Michelle A.; Roy, Craig R.			Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA; COXIELLA-BURNETII; WOLBACHIA-PIPIENTIS; SECRETION SYSTEMS; PATHOGENESIS; GENOME; ARCHITECTURE; INFECTION; ENDOSOMES; TRANSPORT	Specialized secretion systems are used by many bacteria to deliver effector proteins into host cells that can either mimic or disrupt the function of eukaryotic factors. We found that the intracellular pathogens Legionella pneumophila and Coxiella burnetii use a type IV secretion system to deliver into eukaryotic cells a large number of different bacterial proteins containing ankyrin repeat homology domains called Anks. The L. pneumophila AnkX protein prevented microtubule- dependent vesicular transport to interfere with fusion of the L. pneumophila- containing vacuole with late endosomes after infection of macrophages, which demonstrates that Ank proteins have effector functions important for bacterial infection of eukaryotic host cells.	[Pan, Xiaoxiao; Luhrmann, Anja; Laskowski-Arce, Michelle A.; Roy, Craig R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Satoh, Ayano] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu	Satoh, Ayano/B-2423-2011	Satoh, Ayano/0000-0003-3736-1283; Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [R01 AI041699-12, R01 AI041699, AI041699, R01 AI064559, R01 AI064559-03, AI064559] Funding Source: Medline; NIA NIH HHS [AG030101] Funding Source: Medline; NIGMS NIH HHS [GM060919] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064559, R56AI064559, R37AI041699, R01AI041699, R29AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG030101] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	20	298	306	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1651	1654		10.1126/science.1158160	http://dx.doi.org/10.1126/science.1158160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566289	Green Accepted			2022-12-24	WOS:000256886700052
J	Weaver, M; Krasnow, MA				Weaver, Molly; Krasnow, Mark A.			Dual origin of tissue-specific progenitor cells in Drosophila tracheal remodeling	SCIENCE			English	Article							BRANCHING MORPHOGENESIS; STEM-CELLS; SYSTEM; METAMORPHOSIS; MELANOGASTER; DISTINCT; LARVAL; FATE; GENE; FGF	During Drosophila metamorphosis, most larval cells die. Pupal and adult tissues form from imaginal cells, tissue- specific progenitors allocated in embryogenesis that remain quiescent during embryonic and larval life. Clonal analysis and fate mapping of single, identified cells show that tracheal system remodeling at metamorphosis involves a classical imaginal cell population and a population of differentiated, functional larval tracheal cells that reenter the cell cycle and regain developmental potency. In late larvae, both populations are activated and proliferate, spread over and replace old branches, and diversify into various stalk and coiled tracheolar cells under control of fibroblast growth factor signaling. Thus, Drosophila pupal/ adult tissue progenitors can arise both by early allocation of multipotent cells and late return of differentiated cells to a multipotent state, even within a single tissue.	[Weaver, Molly; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Weaver, Molly; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	krasnow@cmgm.stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM047735] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047735] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias A.M., 1993, DEV DROSOPHILA, P609; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Dor Y, 2004, CELL CYCLE, V3, P1104; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fuse N, 1996, DEVELOPMENT, V122, P1059; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Guha A, 2005, DEV BIOL, V287, P192, DOI 10.1016/j.ydbio.2005.09.005; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Harbecke R, 1996, INT J DEV BIOL, V40, P197; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Klapper R, 2000, MECH DEVELOP, V95, P47, DOI 10.1016/S0925-4773(00)00328-2; Kylsten P, 1997, DEV BIOL, V192, P509, DOI 10.1006/dbio.1997.8770; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; PIHAN J C, 1968, Archives de Zoologie Experimentale et Generale, V109, P287; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025; SHAFIQ SA, 1963, Q J MICROSC SCI, V104, P135; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Whitten J., 1980, Genetics and Biology of Drosophila, V2d, P499; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zelzer E, 2000, BIOESSAYS, V22, P219, DOI 10.1002/(SICI)1521-1878(200003)22:3<219::AID-BIES3>3.0.CO;2-A	26	48	50	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1496	1499		10.1126/science.1158712	http://dx.doi.org/10.1126/science.1158712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18669822	Green Accepted			2022-12-24	WOS:000259121800043
J	Liu, J; Bartesaghi, A; Borgnia, MJ; Sapiro, G; Subramaniam, S				Liu, Jun; Bartesaghi, Alberto; Borgnia, Mario J.; Sapiro, Guillermo; Subramaniam, Sriram			Molecular architecture of native HIV-1 gp120 trimers	NATURE			English	Article							ENVELOPE GLYCOPROTEIN; IMMUNODEFICIENCY; NEUTRALIZATION; REPLICATION; RECEPTOR; COMPLEX; LACKING; EPITOPE; V1; V2	The envelope glycoproteins (Env) of human and simian immunodeficiency viruses ( HIV and SIV, respectively) mediate virus binding to the cell surface receptor CD4 on target cells to initiate infection(1). Env is a heterodimer of a transmembrane glycoprotein (gp41) and a surface glycoprotein ( gp120), and forms trimers on the surface of the viral membrane. Using cryo- electron tomography combined with three- dimensional image classification and averaging, we report the three- dimensional structures of trimeric Env displayed on native HIV- 1 in the unliganded state, in complex with the broadly neutralizing antibody b12 and in a ternary complex with CD4 and the 17b antibody. By fitting the known crystal structures(2,3) of the monomeric gp120 core in the b12- and CD4/17b-bound conformations into the density maps derived by electron tomography, we derive molecular models for the native HIV- 1 gp120 trimer in unliganded and CD4- bound states. We demonstrate that CD4 binding results in a major reorganization of the Env trimer, causing an outward rotation and displacement of each gp120 monomer. This appears to be coupled with a rearrangement of the gp41 region along the central axis of the trimer, leading to closer contact between the viral and target cell membranes. Our findings elucidate the structure and conformational changes of trimeric HIV- 1 gp120 relevant to antibody neutralization and attachment to target cells.	[Liu, Jun; Bartesaghi, Alberto; Borgnia, Mario J.; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sapiro, Guillermo] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	ss1@nih.gov		Subramaniam, Sriram/0000-0003-4231-4115; Borgnia, Mario/0000-0001-9159-1413	National Cancer Institute; National Science Foundation and the Department of Defense; NATIONAL CANCER INSTITUTE [ZIABC010825, ZIABC010412] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation and the Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Bess and J. Lifson for providing purified, AT-2 treated HIV-1 BaL virus; P. Kwong for providing purified preparations of Fab fragments of the neutralizing antibodies b12 and 17b; S. Fellini and colleagues for assistance with use of the high- performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov); E. Tyler for assistance with figures; T. M. Chou for assistance with microscope maintenance; and A. Bennett, J. Milne and T. White for comments on the manuscript. This work was supported by funds from the intramural programme of the National Cancer Institute (to S.S.), and from the National Science Foundation and the Department of Defense (to G.S.).	Ashish, 2008, J BIOL CHEM, V283, P2761, DOI 10.1074/jbc.M708325200; Bartesaghi A, 2008, J STRUCT BIOL, V162, P436, DOI 10.1016/j.jsb.2008.02.008; Bennett A, 2007, J BIOL CHEM, V282, P27754, DOI 10.1074/jbc.M702025200; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Johnson WE, 2002, J VIROL, V76, P2075, DOI 10.1128/JVI.76.5.2075-2086.2002; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Subramaniam S, 2005, CURR OPIN MICROBIOL, V8, P316, DOI 10.1016/j.mib.2005.04.012; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443	30	603	637	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					109	U76		10.1038/nature07159	http://dx.doi.org/10.1038/nature07159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668044	Green Accepted			2022-12-24	WOS:000258890200047
J	Rodriguez, JJL; Ferri, CP; Acosta, D; Guerra, M; Huang, YG; Jacob, KS; Krishnamoorthy, ES; Salas, A; Sosa, AL; Acosta, I; Dewey, ME; Gaona, C; Jotheeswaran, AT; Li, SR; Rodriguez, D; Rodriguez, G; Kumar, PS; Valhuerdi, A; Prince, M				Rodriguez, Juan J. Llibre; Ferri, Cleusa P.; Acosta, Daisy; Guerra, Mariella; Huang, Yueqin; Jacob, K. S.; Krishnamoorthy, E. S.; Salas, Aquiles; Sosa, Ana Luisa; Acosta, Isaac; Dewey, Michael E.; Gaona, Ciro; Jotheeswaran, A. T.; Li, Shuran; Rodriguez, Diana; Rodriguez, Guillermina; Kumar, P. Senthil; Valhuerdi, Adolfo; Prince, Martin		10-66 Dementia Res Grp	Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey	LANCET			English	Article							ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEVELOPING-COUNTRY; MENTAL-HEALTH; 2 COMMUNITIES; MORTALITY; SUBTYPES; YORUBA; CARE; AGE	Background Studies have suggested that the prevalence of dementia is lower in developing than in developed regions. We investigated the prevalence and severity of dementia in sites in low-income and middle-income countries according to two definitions of dementia diagnosis. Methods We undertook one-phase cross-sectional surveys of all residents aged 65 years and older (n=14 960) in 11 sites in seven low-income and middle-income countries (China, India, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). Dementia diagnosis was made according to the culturally and educationally sensitive, 10/66 dementia diagnostic algorithm, which had been prevalidated in 25 Latin American, Asian, and African centres; and by computerised application of the dementia criterion from the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). We also compared prevalence of DSM-IV dementia in each of the study sites with that from estimates in European studies. Findings The prevalence of DSM-IV dementia varied widely, from 0.3% (95% CI 0.1-0.5) in rural India to 6.3% (5.0-7.7) in Cuba. After standardisation for age and sex, DSM-IV prevalence in urban Latin American sites was four-fifths of that in Europe (standardised morbidity ratio 80 [95% CI 70-91]), but in China the prevalence was only half (56 [32-91] in rural China), and in India and rural Latin America a quarter or less of the European prevalence (18 [5-34] in rural India). 10/66 dementia prevalence was higher than that of DSM-IV dementia, and more consistent across sites, varying between 5.6% (95% CI 4.2-7.0) in rural China and 11.7% (10.3-13.1) in the Dominican Republic. The validity of the 847 of 1345 cases of 10/66 dementia not confirmed by DSM-IV was supported by high levels of associated disability (mean WHO Disability Assessment Schedule II score 33.7 [SD 28.6]). Interpretation As compared with the 10/66 dementia algorithm, the DSM-IV dementia criterion might underestimate dementia prevalence, especially in regions with low awareness of this emerging public-health problem. Funding Wellcome Trust (UK); WHO; the US Alzheimer's Association; and Fondo Nacional De Ciencia, Y Tecnologia, Consejo De Desarrollo Cientifico Y Humanistico, and Universidad Central De Venezuela (Venezuela).	[Ferri, Cleusa P.; Dewey, Michael E.; Prince, Martin] Kings Coll London, Ctr Publ Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London SE5 8AF, England; [Valhuerdi, Adolfo] Univ Hosp, Faustino Perez, Matanzas, Cuba; [Rodriguez, Guillermina] Minist Protecc Social 6th Dist, Direcc Gen Salud Publ, Santo Domingo, Dominican Rep; [Guerra, Mariella; Rodriguez, Diana] Inst Mem & Desordenes Relacionados, Lima, Peru; [Rodriguez, Juan J. Llibre] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Acosta, Daisy] Univ Nacl Pedro Henriquez Urena, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Mariella] Univ Peruana Cayetano Heredia, Lima, Peru; [Huang, Yueqin; Li, Shuran] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.; Kumar, P. Senthil] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India; [Krishnamoorthy, E. S.; Jotheeswaran, A. T.] Ctr Clin Neurosci, Inst Neurol Sci, Voluntary Hlth Serv, Madras, Tamil Nadu, India; [Salas, Aquiles] Cent Univ Venezuela, Dept Med, Caracas Univ Hosp, Fac Med, Caracas, Venezuela; [Sosa, Ana Luisa; Acosta, Isaac] Univ Nacl Autonoma Mexico, Cognit & Behav Unit, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico; [Gaona, Ciro] Clin Loira, Caracas, Venezuela	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Universidad Peruana Cayetano Heredia; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Central Venezuela; Universidad Nacional Autonoma de Mexico	Prince, M (corresponding author), Kings Coll London, Ctr Publ Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, De Crespigny Pk, London SE5 8AF, England.	Martin.Prince@iop.kcl.ac.uk	Rodriguez, Juan J Llibre/D-2380-2010; Dewey, Michael E/E-2049-2010; Castillo, Gilberto Isaac Acosta/CAA-2728-2022; Sosa, Ana L/A-8593-2012; Castillo, Gilberto Isaac Acosta/AAY-5476-2020; Guerra, Mariella/E-3582-2010; Prince, Martin J/A-9170-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Ferri, Cleusa Pinheiro/B-2922-2010	Rodriguez, Juan J Llibre/0000-0002-8215-3160; Dewey, Michael E/0000-0002-7522-3677; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Prince, Martin J/0000-0003-1379-7146; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Guerra, Mariella/0000-0001-8923-349X; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; GAONA MD, MSc, CIRO/0000-0002-8839-5531	Wellcome Trust [GR08002, GR066133, 080002, 066133] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; BALDERESCHI M, 1994, NEUROLOGY, V44, P239, DOI 10.1212/WNL.44.2.239; Chandra V, 1998, NEUROLOGY, V51, P1000, DOI 10.1212/WNL.51.4.1000; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Ferri CP, 2004, INT PSYCHOGERIATR, V16, P441, DOI 10.1017/S1041610204000833; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Ganguli M, 1996, Int Psychogeriatr, V8, P507, DOI 10.1017/S1041610296002852; HALL KS, 1993, INT J METHOD PSYCH, V3, P1; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacob KS, 2007, INT PSYCHOGERIATR, V19, P669, DOI 10.1017/S1041610207005297; Lobo A, 2000, NEUROLOGY, V54, pS4; Molero AE, 2007, NEUROEPIDEMIOLOGY, V29, P107, DOI 10.1159/000109824; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nitrini R, 2005, INT J GERIATR PSYCH, V20, P247, DOI 10.1002/gps.1274; OConnor DW, 1996, NEUROLOGY, V47, P1194, DOI 10.1212/WNL.47.5.1194; Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098; Perkins AJ, 2002, INT J GERIATR PSYCH, V17, P566, DOI 10.1002/gps.643; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M, 2003, INT J EPIDEMIOL, V32, P1078, DOI 10.1093/ije/dyg321; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2000, INT J GERIATR PSYCH, V15, P21, DOI 10.1002/(SICI)1099-1166(200001)15:1<21::AID-GPS71>3.0.CO;2-5; Prince M, 1997, TROP MED INT HEALTH, V2, P993, DOI 10.1046/j.1365-3156.1997.d01-156.x; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2007, WORLD PSYCHIATRY, V6, P5; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Rehm J., 1999, INT J METH PSYCH RES, V8, P110, DOI DOI 10.1002/MPR.61; REISBERG B, 2007, DIAGNOSTIC ISSUES DE, P27; RITCHIE K, 1992, INT J EPIDEMIOL, V21, P763, DOI 10.1093/ije/21.4.763; Scazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625; Shaji KS, 2003, INT J GERIATR PSYCH, V18, P1, DOI 10.1002/gps.649; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Zhou DF, 2006, ACTA NEUROL SCAND, V114, P273, DOI 10.1111/j.1600-0404.2006.00641.x	37	213	238	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2008	372	9637					464	474		10.1016/S0140-6736(08)61002-8	http://dx.doi.org/10.1016/S0140-6736(08)61002-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335OD	18657855	Green Published			2022-12-24	WOS:000258299000030
J	Tanovic, A; Samel, SA; Essen, LO; Marahiel, MA				Tanovic, Alan; Samel, Stefan A.; Essen, Lars-Oliver; Marahiel, Mohamed A.			Crystal structure of the termination module of a nonribosomal peptide synthetase	SCIENCE			English	Article							FATTY-ACID SYNTHASE; PROTEIN INTERACTIONS; DOMAINS; BIOSYNTHESIS; ARCHITECTURE; ANTIBIOTICS; CYCLIZATION; POLYKETIDE; RESOLUTION	Nonribosomal peptide synthetases ( NRPSs) are modular multidomain enzymes that act as an assembly line to catalyze the biosynthesis of complex natural products. The crystal structure of the 144- kilodalton Bacillus subtilis termination module SrfA- C was solved at 2.6 angstrom resolution. The adenylation and condensation domains of SrfA- C associate closely to form a catalytic platform, with their active sites on the same side of the platform. The peptidyl carrier protein domain is flexibly tethered to this platform and thus can move with its substrate- loaded 4'-phosphopantetheine arm between the active site of the adenylation domain and the donor side of the condensation domain. The SrfA- C crystal structure has implications for the rational redesign of NRPSs as a means of producing novel bioactive peptides.	[Tanovic, Alan; Samel, Stefan A.; Essen, Lars-Oliver; Marahiel, Mohamed A.] Univ Marburg, Dept Chem, D-35032 Marburg, Germany	Philipps University Marburg	Essen, LO (corresponding author), Univ Marburg, Dept Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de; marahiel@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026				Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sieber SA, 2002, CHEM BIOL, V9, P997, DOI 10.1016/S1074-5521(02)00214-4; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751	19	246	252	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2008	321	5889					659	663		10.1126/science.1159850	http://dx.doi.org/10.1126/science.1159850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18583577				2022-12-24	WOS:000258077700035
J	Ben-Shahar, TR; Heeger, S; Lehane, C; East, P; Flynn, H; Skehel, M; Uhlmann, F				Ben-Shahar, Tom Rolef; Heeger, Sebastian; Lehane, Chris; East, Philip; Flynn, Helen; Skehel, Mark; Uhlmann, Frank			Eco1-dependent cohesin acetylation during establishment of sister chromatid cohesion	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; ATP HYDROLYSIS; FISSION YEAST; S-PHASE; CHROMOSOMES; PROTEIN; ASSOCIATION; RESOLUTION; STABILITY	Replicated chromosomes are held together by the chromosomal cohesin complex from the time of their synthesis in S phase onward. This requires the replication fork- associated acetyl transferase Eco1, but Eco1's mechanism of action is not known. We identified spontaneous suppressors of the thermosensitive eco1-1 allele in budding yeast. An acetylation- mimicking mutation of a conserved lysine in cohesin's Smc3 subunit makes Eco1 dispensable for cell growth, and we show that Smc3 is acetylated in an Eco1- dependent manner during DNA replication to promote sister chromatid cohesion. A second set of eco1-1 suppressors inactivate the budding yeast ortholog of the cohesin destabilizer Wapl. Our results indicate that Eco1 modifies cohesin to stabilize sister chromatid cohesion in parallel with a cohesion establishment reaction that is in principle Eco1- independent.	[Ben-Shahar, Tom Rolef; Heeger, Sebastian; Lehane, Chris; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [East, Philip] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England; [Flynn, Helen; Skehel, Mark] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK; Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619; East, Philip/0000-0001-5801-5713; Flynn, Helen/0000-0001-7002-9130				Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876	28	358	361	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					563	566		10.1126/science.1157774	http://dx.doi.org/10.1126/science.1157774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653893				2022-12-24	WOS:000257888900048
J	Sudarsan, N; Lee, ER; Weinberg, Z; Moy, RH; Kim, JN; Link, KH; Breaker, RR				Sudarsan, N.; Lee, E. R.; Weinberg, Z.; Moy, R. H.; Kim, J. N.; Link, K. H.; Breaker, R. R.			Riboswitches in eubacteria sense the second messenger cyclic di-GMP	SCIENCE			English	Article							VIBRIO-CHOLERAE; DIGUANYLATE CYCLASE; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; MOTILITY; BACTERIA; RECEPTOR; DOMAIN	Cyclic di-guanosine monophosphate (di-GMP) is a circular RNA dinucleotide that functions as a second messenger in diverse species of bacteria to trigger wide-ranging physiological changes, including cell differentiation, conversion between motile and biofilm lifestyles, and virulence gene expression. However, the mechanisms by which cyclic di-GMP regulates gene expression have remained a mystery. We found that cyclic di-GMP in many bacterial species is sensed by a riboswitch class in messenger RNA that controls the expression of genes involved in numerous fundamental cellular processes. A variety of cyclic di-GMP regulons are revealed, including some riboswitches associated with virulence gene expression, pilus formation, and flagellum biosynthesis. In addition, sequences matching the consensus for cyclic di-GMP riboswitches are present in the genome of a bacteriophage.	[Sudarsan, N.; Link, K. H.; Breaker, R. R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Lee, E. R.; Weinberg, Z.; Kim, J. N.; Breaker, R. R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Moy, R. H.; Breaker, R. R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Moy, Ryan/0000-0002-0507-8590; Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR19895-02, S10 RR019895] Funding Source: Medline; NHLBI NIH HHS [N01HV28186, HV28186] Funding Source: Medline; NIDDK NIH HHS [R33 DK07027] Funding Source: Medline; NIGMS NIH HHS [GM 068819, T32 GM007223, R01 GM068819, T32GM007223] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM068819] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Beyhan S, 2007, MOL MICROBIOL, V63, P995, DOI 10.1111/j.1365-2958.2006.05568.x; Breaker RR, 2008, SCIENCE, V319, P1795, DOI 10.1126/science.1152621; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07	22	508	548	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					411	413		10.1126/science.1159519	http://dx.doi.org/10.1126/science.1159519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635805	Green Accepted			2022-12-24	WOS:000257713900052
J	Haering, CH; Farcas, AM; Arumugam, P; Metson, J; Nasmyth, K				Haering, Christian H.; Farcas, Ana-Maria; Arumugam, Prakash; Metson, Jean; Nasmyth, Kim			The cohesin ring concatenates sister DNA molecules	NATURE			English	Article							SMC PROTEINS; PROTEASE; ARCHITECTURE; COMPLEXES; CLEAVAGE; YEAST; HINGE	Sister chromatid cohesion, which is essential for mitosis, is mediated by a multi- subunit protein complex called cohesin. Cohesin's Scc1, Smc1 and Smc3 subunits form a tripartite ring structure, and it has been proposed that cohesin holds sister DNA molecules together by trapping them inside its ring. To test this, we used site- specific crosslinking to create chemical connections at the three interfaces between the three constituent polypeptides of the ring, thereby creating covalently closed cohesin rings. As predicted by the ring entrapment model, this procedure produced dimeric DNA - cohesin structures that are resistant to protein denaturation. We conclude that cohesin rings concatenate individual sister minichromosome DNA molecules.	[Haering, Christian H.; Farcas, Ana-Maria; Arumugam, Prakash; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Arumugam, Prakash/AAZ-6422-2020	Arumugam, Prakash/0000-0001-6217-8128; Haering, Christian/0000-0001-8301-1722; Nasmyth, Kim/0000-0001-7030-4403	Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bausch C, 2007, MOL CELL BIOL, V27, P8522, DOI 10.1128/MCB.01007-07; Dhar G, 2004, CELL, V119, P33, DOI 10.1016/j.cell.2004.09.010; ESWAR N, 2006, CURR PROTOC BIOINF S, V15; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hwang DC, 2000, MOL CELLS, V10, P505, DOI 10.1007/s10059-000-0505-7; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; KIM JS, 1995, ANAL BIOCHEM, V225, P174, DOI 10.1006/abio.1995.1131; Milutinovich M, 2003, SCIENCE, V300, P1101, DOI 10.1126/science.1084478; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6	17	332	335	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					297	U19		10.1038/nature07098	http://dx.doi.org/10.1038/nature07098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18596691	Green Submitted			2022-12-24	WOS:000257665300030
J	Kuilman, T; Michaloglou, C; Vredeveld, LCW; Douma, S; van Doom, R; Desmet, CJ; Aarden, LA; Mooi, WJ; Peeper, DS				Kuilman, Thomas; Michaloglou, Chrysiis; Vredeveld, Liesbeth C. W.; Douma, Sirith; van Doom, Remco; Desmet, Christophe J.; Aarden, Lucien A.; Mooi, Wolter J.; Peeper, Daniel S.			Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network	CELL			English	Article							RAS-INDUCED SENESCENCE; CELLULAR SENESCENCE; TUMOR SUPPRESSION; HUMAN-CELLS; REPLICATIVE SENESCENCE; C/EBP-BETA; CANCER; P53; TUMORIGENESIS; GROWTH	Oncogene-induced cellular senescence (OIS) is emerging as a potent cancer-protective response to oncogenic events, serving to eliminate early neoplastic cells from the proliferative pool. Using combined genetic and bioinformatic analysis, we find that OIS is linked specifically to the activation of an inflammatory transcriptome. Induced genes included the pleiotropic cytokine interleukin-6 (IL-6), which upon secretion by senescent cells acted mitogenically in a paracrine fashion. Unexpectedly, IL-6 was also required for the execution of OIS, but in a cell-autonomous mode. Its depletion caused the inflammatory network to collapse and abolished senescence entry and maintenance. Furthermore, we demonstrate that the transcription factor C/EBP beta cooperates with IL-6 to amplify the activation of the inflammatory network, including IL-8. In human colon adenomas, IL-8 specifically colocalized with arrested, p16(INK4A)-positive epithelium. We propose a model in which the context-dependent cytostatic and promitogenic functions of specific interleukins contribute to connect senescence with an inflammatory phenotype and cancer.	[Kuilman, Thomas; Michaloglou, Chrysiis; Vredeveld, Liesbeth C. W.; Douma, Sirith; van Doom, Remco; Desmet, Christophe J.; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Aarden, Lucien A.] Sanquin AMC Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Mooi, Wolter J.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Vrije Universiteit Amsterdam	Peeper, DS (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	Kuilman, Thomas/0000-0001-6724-6767; van Doorn, Remco/0000-0002-7019-6673				Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; HIRANO T, 1989, RES CLIN LAB, V19, P1; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Kalai M, 1997, EUR J BIOCHEM, V249, P690, DOI 10.1111/j.1432-1033.1997.t01-2-00690.x; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; LU C, 1993, J CELL BIOL, V120, P1281, DOI 10.1083/jcb.120.5.1281; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mason DX, 2004, ONCOGENE, V23, P9238, DOI 10.1038/sj.onc.1208172; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Tremain R, 2000, ONCOGENE, V19, P1698, DOI 10.1038/sj.onc.1203471; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034	52	1328	1361	6	104	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 13	2008	133	6					1019	1031		10.1016/j.cell.2008.03.039	http://dx.doi.org/10.1016/j.cell.2008.03.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	312TJ	18555778	Bronze			2022-12-24	WOS:000256693400017
J	Kukar, TL; Ladd, TB; Bann, MA; Fraering, PC; Narlawar, R; Maharvi, GM; Healy, B; Chapman, R; Welzel, AT; Price, RW; Moore, B; Rangachari, V; Cusack, B; Eriksen, J; Jansen-West, K; Verbeeck, C; Yager, D; Eckman, C; Ye, WJ; Sagi, S; Cottrell, BA; Torpey, J; Rosenberry, TL; Fauq, A; Wolfe, MS; Schmidt, B; Walsh, DM; Koo, EH; Golde, TE				Kukar, Thomas L.; Ladd, Thomas B.; Bann, Maralyssa A.; Fraering, Patrick C.; Narlawar, Rajeshwar; Maharvi, Ghulam M.; Healy, Brent; Chapman, Robert; Welzel, Alfred T.; Price, Robert W.; Moore, Brenda; Rangachari, Vijayaraghavan; Cusack, Bernadette; Eriksen, Jason; Jansen-West, Karen; Verbeeck, Christophe; Yager, Debra; Eckman, Christopher; Ye, Wenjuan; Sagi, Sarah; Cottrell, Barbara A.; Torpey, Justin; Rosenberry, Terrone L.; Fauq, Abdul; Wolfe, Michael S.; Schmidt, Boris; Walsh, Dominic M.; Koo, Edward H.; Golde, Todd E.			Substrate-targeting gamma-secretase modulators	NATURE			English	Article							AMYLOID-BETA-PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRECURSOR PROTEIN; IN-VIVO; A-BETA-42; OLIGOMERIZATION; INHIBITORS; NSAIDS; SITE; ACETYLCHOLINESTERASE	Selective lowering of A beta 42 levels ( the 42- residue isoform of the amyloid-beta peptide) with small- molecule gamma-secretase modulators ( GSMs), such as some non- steroidal anti- inflammatory drugs, is a promising therapeutic approach for Alzheimer's disease(1). To identify the target of these agents we developed biotinylated photo-activatable GSMs. GSM photoprobes did not label the core proteins of the gamma- secretase complex, but instead labelled the beta- amyloid precursor protein ( APP), APP carboxy- terminal fragments and amyloid-beta peptide in human neuroglioma H4 cells. Substrate labelling was competed by other GSMs, and labelling of an APP gamma- secretase substrate was more efficient than a Notch substrate. GSM interaction was localized to residues 28 - 36 of amyloid-beta, a region critical for aggregation. We also demonstrate that compounds known to interact with this region of amyloid- beta act as GSMs, and some GSMs alter the production of cell- derived amyloid- beta oligomers. Furthermore, mutation of the GSM binding site in the APP alters the sensitivity of the substrate to GSMs. These findings indicate that substrate targeting by GSMs mechanistically links two therapeutic actions: alteration in A beta 42 production and inhibition of amyloid- beta aggregation, which may synergistically reduce amyloid- beta deposition in Alzheimer's disease. These data also demonstrate the existence and feasibility of 'substrate targeting' by small- molecule effectors of proteolytic enzymes, which if generally applicable may significantly broaden the current notion of 'druggable' targets(2).	[Kukar, Thomas L.; Ladd, Thomas B.; Bann, Maralyssa A.; Maharvi, Ghulam M.; Healy, Brent; Chapman, Robert; Price, Robert W.; Moore, Brenda; Rangachari, Vijayaraghavan; Cusack, Bernadette; Eriksen, Jason; Jansen-West, Karen; Verbeeck, Christophe; Yager, Debra; Eckman, Christopher; Rosenberry, Terrone L.; Fauq, Abdul; Golde, Todd E.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Brain Mind Inst, CH-1025 Lausanne, Switzerland; [Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, CH-1025 Lausanne, Switzerland; [Fraering, Patrick C.; Ye, Wenjuan; Wolfe, Michael S.] Harvard Univ, Sch Med, Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Narlawar, Rajeshwar; Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, D-64287 Darmstadt, Germany; [Welzel, Alfred T.; Walsh, Dominic M.] Univ Coll Dublin, Lab Neurodegenerat Res, Conway Inst, Dublin 4, Ireland; [Sagi, Sarah; Cottrell, Barbara A.; Torpey, Justin; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Mayo Clinic; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Technical University of Darmstadt; University College Dublin; University of California System; University of California San Diego	Kukar, TL (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	kukar.thomas@mayo.edu; golde.todd@mayo.edu	Eriksen, Jason/A-8054-2008; Kukar, Thomas/AAW-2612-2021; Narlawar, Rajeshwar/E-4981-2010; Cusack, Bernadette/D-4606-2013; Schmidt, Boris/M-7886-2019; Rangachari, vijay/K-1420-2015; Schmidt, Boris/D-3293-2009	Eriksen, Jason/0000-0003-1549-4165; Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392; Moore, Brenda/0000-0002-9685-6561; Bann, Maralyssa/0000-0002-5893-950X; Fraering, Patrick/0000-0002-5841-5327; Kukar, Thomas/0000-0002-3750-6262	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206, R01AG017574] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG020206, P01 AG020206-010002, R01 AG017574, R01 AG017574-09, R01 AG017574-08] Funding Source: Medline; NINDS NIH HHS [R01 NS041355, R01 NS041355-07, R01 NS041355-06A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Christensen Daniel D, 2007, Prim Care Companion J Clin Psychiatry, V9, P32; De Ferrari GV, 2001, J BIOL CHEM, V276, P23282, DOI 10.1074/jbc.M009596200; Dong DL, 1999, CHEM BIOL, V6, P133, DOI 10.1016/S1074-5521(99)89005-X; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Ferrao-Gonzales AD, 2005, J BIOL CHEM, V280, P34747, DOI 10.1074/jbc.M501651200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Grziwa B, 2003, J BIOL CHEM, V278, P6803, DOI 10.1074/jbc.M210047200; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Johnson JL, 2003, BIOCHEMISTRY-US, V42, P5438, DOI 10.1021/bi027065u; Kodadek T, 2002, BIOPOLYMERS, V66, P134, DOI 10.1002/bip.10233; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar T, 2008, CURR TOP MED CHEM, V8, P47, DOI 10.2174/156802608783334042; Kukar T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-54; Leuchtenberger S, 2006, J NEUROCHEM, V96, P355, DOI 10.1111/j.1471-4159.2005.03553.x; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P5428, DOI 10.1016/j.bmcl.2007.07.044; Narlawar R, 2006, J MED CHEM, V49, P7588, DOI 10.1021/jm0610200; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; SAGI SA, 2004, 26410 SOC NEUR; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977	32	254	266	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2008	453	7197					925	U62		10.1038/nature07055	http://dx.doi.org/10.1038/nature07055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	311WV	18548070	Green Submitted, Green Accepted			2022-12-24	WOS:000256632000045
J	Guthrie, B; Saultz, JW; Freeman, GK; Haggerty, JL				Guthrie, Bruce; Saultz, John W.; Freeman, George K.; Haggerty, Jeannie L.			Continuity of care matters	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-CARE		[Guthrie, Bruce] Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland; [Saultz, John W.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Freeman, George K.] Univ London St Georges Hosp, Community Hlth Sci Div, London, England; [Haggerty, Jeannie L.] Univ Sherbrooke, Dept Sci Sante Communautaire, Quebec City, PQ, Canada; [Haggerty, Jeannie L.] Univ Sherbrooke, Dept Family Med, Quebec City, PQ, Canada	University of Dundee; Oregon Health & Science University; St Georges University London; University of Sherbrooke; University of Sherbrooke	Guthrie, B (corresponding author), Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022; Haggerty, Jeannie/GSD-7271-2022	Guthrie, Bruce/0000-0003-4191-4880	Harkness fellowship from the Commonwealth Fund	Harkness fellowship from the Commonwealth Fund	All four authors have researched continuity in primary and secondary care. BG, JWS, and GKF are practising family physicians. The paper draws on their knowledge of the research literature, including systematic and narrative reviews conducted by them (JWS, JLH, GKF), policy and research scoping work (JLH, GKF), and review and summary of multiproject research programmes in the UK and Canada (BG, JLH, GKF). BG wrote the first draft, which was separately revised by JWS, JLH, and GKF, with BG coordinating rewriting and agreement of the final article. BG is the guarantor During the initial writing, BG was supported by a Harkness fellowship from the Commonwealth Fund, The views presented here are those of the authors.	Adair CE, 2005, PSYCHIAT SERV, V56, P1061, DOI 10.1176/appi.ps.56.9.1061; Balint M., 1957, DOCTOR; BARR M, 2006, ADV MED HOME PATIENT; Boulton M, 2006, BRIT J GEN PRACT, V56, P749; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Guthrie Bruce, 2006, BMC Fam Pract, V7, P11, DOI 10.1186/1471-2296-7-11; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Kearley KE, 2001, BRIT J GEN PRACT, V51, P712; Lester H, 2007, BRIT MED J, V335, P1130, DOI 10.1136/bmj.39385.406192.AD; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; *ROYAL COLL GEN PR, 2004, FUT ACC GEN PRACT BA; Royal College of General Practitioners, 2004, FUT GEN PRACT; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Schers H, 2002, BRIT J GEN PRACT, V52, P459; Solberg LI, 2006, ANN FAM MED, V4, P109, DOI 10.1370/afm.424; Starfield B, 2004, PEDIATRICS, V113, P1493; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Windridge K, 2004, BRIT J GEN PRACT, V54, P364	19	107	109	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2008	337	7669							a867	10.1136/bmj.a867	http://dx.doi.org/10.1136/bmj.a867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351JP	18687724				2022-12-24	WOS:000259420900031
J	Kruger, M; Moser, M; Ussar, S; Thievessen, I; Luber, CA; Forner, F; Schmidt, S; Zanivan, S; Fassler, R; Mann, M				Krueger, Marcus; Moser, Markus; Ussar, Siegfried; Thievessen, Ingo; Luber, Christian A.; Forner, Francesca; Schmidt, Sarah; Zanivan, Sara; Faessler, Reinhard; Mann, Matthias			SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function	CELL			English	Article							SITE-SPECIFIC PHOSPHORYLATION; AMINO-ACIDS; PROTEIN-TURNOVER; STABLE-ISOTOPES; CULTURE SILAC; INTEGRIN ACTIVATION; SIGNALING NETWORKS; MEMBRANE SKELETON; MASS-SPECTROMETRY; IN-VIVO	Stable isotope labeling by amino acids in cell culture (SILAC) has become a versatile tool for quantitative, mass spectrometry (MS)-based proteomics. Here, we completely label mice with a diet containing either the natural or the (13)C(6)-substituted version of lysine. Mice were labeled over four generations with the heavy diet, and development, growth, and behavior were not affected. MS analysis of incorporation levels allowed for the determination of incorporation rates of proteins from blood cells and organs. The F2 generation was completely labeled in all organs tested. SILAC analysis from various organs lacking expression of beta 1 integrin, beta-Parvin, or the integrin tail-binding protein Kindlin-3 confirmed their absence and disclosed a structural defect of the red blood cell membrane skeleton in Kindlin-3-deficient erythrocytes. The SILAC-mouse approach is a versatile tool by which to quantitatively compare proteomes from knockout mice and thereby determine protein functions under complex in vivo conditions.	[Moser, Markus; Ussar, Siegfried; Thievessen, Ingo; Schmidt, Sarah; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Krueger, Marcus; Luber, Christian A.; Forner, Francesca; Zanivan, Sara; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de; mmann@biochem.mpg.de	Ussar, Siegfried/AAL-4331-2021; Zanivan, Sara/GOV-5505-2022; Mann, Matthias/A-3454-2013; Zanivan, Sara/C-4340-2008	Ussar, Siegfried/0000-0001-7575-0920; Mann, Matthias/0000-0003-1292-4799; Zanivan, Sara/0000-0002-9880-9099				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Benevenga NJ, 1995, NUTR REQUIREMENTS LA, P192; BERLIN NI, 1959, PHYSIOL REV, V39, P577, DOI 10.1152/physrev.1959.39.3.577; Beynon RJ, 2005, MOL CELL PROTEOMICS, V4, P857, DOI 10.1074/mcp.R400010-MCP200; Bier DM, 1997, EUR J PEDIATR, V156, pS2, DOI 10.1007/PL00014265; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Coffman R L, 1982, Immunol Rev, V69, P5; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; DELAUNAY J, 1995, FEBS LETT, V369, P34, DOI 10.1016/0014-5793(95)00460-Q; DIETZ WH, 1982, METABOLISM, V31, P749, DOI 10.1016/0026-0495(82)90070-1; Doherty MK, 2006, EXPERT REV PROTEOMIC, V3, P97, DOI 10.1586/14789450.3.1.97; Doherty MK, 2005, PROTEOMICS, V5, P522, DOI 10.1002/pmic.200400959; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; GREGG CT, 1973, LIFE SCI, V13, P775, DOI 10.1016/0024-3205(73)90068-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishihama Y, 2005, NAT BIOTECHNOL, V23, P617, DOI 10.1038/nbt1086; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; Moebius J, 2005, MOL CELL PROTEOMICS, V4, P1754, DOI 10.1074/mcp.M500209-MCP200; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; MOORE S, 1958, FED PROC, V17, P1107; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Peters LL, 1998, GENOMICS, V54, P348, DOI 10.1006/geno.1998.5537; Pratt JM, 2002, PROTEOMICS, V2, P157, DOI 10.1002/1615-9861(200202)2:2<157::AID-PROT157>3.0.CO;2-M; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RYBICKI AC, 1995, BLOOD, V86, P3583, DOI 10.1182/blood.V86.9.3583.bloodjournal8693583; Schoenheimer R, 1935, Science, V82, P156, DOI 10.1126/science.82.2120.156; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Southgate CD, 1996, NAT GENET, V14, P227, DOI 10.1038/ng1096-227; Taouatas N, 2008, NAT METHODS, V5, P405, DOI 10.1038/NMETH.1204; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Wolfe RR., 2005, ISOTOPE TRACERS META, V2; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Zhang YL, 2007, NUCLEIC ACIDS RES, V35, pD771, DOI 10.1093/nar/gkl784	56	514	532	2	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					353	364		10.1016/j.cell.2008.05.033	http://dx.doi.org/10.1016/j.cell.2008.05.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662549	Bronze, Green Accepted			2022-12-24	WOS:000257891700023
J	Unal, E; Heidinger-Pauli, JM; Kim, W; Guacci, V; Onn, I; Gygi, SP; Koshland, DE				Unal, Elcin; Heidinger-Pauli, Jill M.; Kim, Woong; Guacci, Vincent; Onn, Itay; Gygi, Steven P.; Koshland, Douglas E.			A molecular determinant for the establishment of sister chromatid cohesion	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; PROTEINS; BINDING; REPAIR; ACETYLTRANSFERASE; CONDENSATION; RESOLUTION; COMPLEXES	Chromosome segregation, transcriptional regulation, and repair of DNA double- strand breaks require the cohesin protein complex. Cohesin holds the replicated chromosomes ( sister chromatids) together to mediate sister chromatid cohesion. The mechanism of how cohesion is established is unknown. We found that in budding yeast, the head domain of the Smc3p subunit of cohesin is acetylated by the Eco1p acetyltransferase at two evolutionarily conserved residues, promoting the chromatin- bound cohesin to tether sister chromatids. Smc3p acetylation is induced in S phase after the chromatin loading of cohesin and is suppressed in G(1) and G(2)/M. Smc3 head acetylation and its cell cycle regulation provide important insights into the biology and mechanism of cohesion establishment.	[Unal, Elcin; Heidinger-Pauli, Jill M.; Guacci, Vincent; Onn, Itay; Koshland, Douglas E.] Carnegie Inst, Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Unal, Elcin; Heidinger-Pauli, Jill M.; Guacci, Vincent; Onn, Itay; Koshland, Douglas E.] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Unal, Elcin; Heidinger-Pauli, Jill M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Kim, Woong; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Carnegie Institution for Science; Johns Hopkins University; Harvard University; Harvard Medical School	Koshland, DE (corresponding author), Carnegie Inst, Howard Hughes Med Inst, 3520 San Martin Dr, Baltimore, MD 21218 USA.	koshland@ciwemb.edu	Onn, Itay/AAA-7949-2020	Onn, Itay/0000-0002-7689-5520; Unal, Elcin/0000-0002-6768-609X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Brands A, 2005, CURR BIOL, V15, pR50, DOI 10.1016/j.cub.2004.12.052; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Noble D, 2006, CELL CYCLE, V5, P2528, DOI 10.4161/cc.5.21.3405; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	30	324	328	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					566	569		10.1126/science.1157880	http://dx.doi.org/10.1126/science.1157880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653894				2022-12-24	WOS:000257888900049
J	Maier, AG; Rug, M; O'Neill, MT; Brown, M; Chakravorty, S; Szestak, T; Chesson, J; Wu, Y; Hughes, K; Coppel, RL; Newbold, C; Beeson, JG; Craig, A; Crabb, BS; Cowman, AF				Maier, Alexander G.; Rug, Melanie; O'Neill, Matthew T.; Brown, Monica; Chakravorty, Srabasti; Szestak, Tadge; Chesson, Joanne; Wu, Yang; Hughes, Katie; Coppel, Ross L.; Newbold, Chris; Beeson, James G.; Craig, Alister; Crabb, Brendan S.; Cowman, Alan F.			Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes	CELL			English	Article							RED-BLOOD-CELL; TARGETED GENE DELETION; NEGATIVE SELECTION; MALARIA VIRULENCE; CYTOADHERENCE; MEMBRANE; SURFACE; PARASITE; ANTIGEN; SIGNAL	A major part of virulence for Plasmodium falciparum malaria infection, the most lethal parasitic disease of humans, results from increased rigidity and adhesiveness of infected host red cells. These changes are caused by parasite proteins exported to the erythrocyte using novel trafficking machinery assembled in the host cell. To understand these unique modifications, we used a large-scale gene knockout strategy combined with functional screens to identify proteins exported into parasite-infected erythrocytes and involved in remodeling these cells. Eight genes were identified encoding proteins required for export of the parasite adhesin PfEMP1 and assembly of knobs that function as physical platforms to anchor the adhesin. Additionally, we show that multiple proteins play a role in generating increased rigidity of infected erythrocytes. Collectively these proteins function as a pathogen secretion system, similar to bacteria and may provide targets for anti-virulence based therapies to a disease responsible for millions of deaths annually.	[Maier, Alexander G.; Rug, Melanie; O'Neill, Matthew T.; Brown, Monica; Chesson, Joanne; Beeson, James G.; Crabb, Brendan S.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Chakravorty, Srabasti; Szestak, Tadge; Wu, Yang; Hughes, Katie; Craig, Alister] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Newbold, Chris] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Walter & Eliza Hall Institute; Liverpool School of Tropical Medicine; University of Liverpool; Monash University; University of Oxford	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Rug, Melanie/A-9504-2011; Crabb, Brendan/F-5287-2013; Maier, Alex G/A-6499-2009; Cowman, Alan F/C-7642-2013; Rug, Melanie/B-5417-2015; Coppel, Ross L/A-6626-2008	Maier, Alex G/0000-0001-7369-1058; Cowman, Alan F/0000-0001-5145-9004; Coppel, Ross L/0000-0002-4476-9124; Craig, Alister/0000-0003-0914-6164; Newbold, Chris/0000-0002-9274-3789; Hughes, Katie/0000-0002-3597-1056	MRC [G0400417] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044008] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G0400417] Funding Source: Medline; NIAID NIH HHS [R01 AI44008, R01 AI044008] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust)		Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; BARNWELL JW, 1989, EXP PARASITOL, V69, P407, DOI 10.1016/0014-4894(89)90190-2; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; BOZDECH Z, 2003, TRANSCRIPTOME INTRAE; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hardeman MR, 1998, SCAND J CLIN LAB INV, V58, P617, DOI 10.1080/00365519850186049; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kun JFJ, 1997, MOL BIOCHEM PARASIT, V85, P41, DOI 10.1016/S0166-6851(96)02805-8; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MATTEI D, 1992, GENE, V110, P71, DOI 10.1016/0378-1119(92)90446-V; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; RAVENTOSSUAREZ C, 1985, P NATL ACAD SCI USA, V82, P3829, DOI 10.1073/pnas.82.11.3829; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; STAHL HD, 1987, MOL BIOL MED, V4, P199; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	45	347	351	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 11	2008	134	1					48	61		10.1016/j.cell.2008.04.051	http://dx.doi.org/10.1016/j.cell.2008.04.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614010	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000257513100013
J	Laakso, JM; Lewis, JH; Shuman, H; Ostap, EM				Laakso, Joseph M.; Lewis, John H.; Shuman, Henry; Ostap, E. Michael			Myosin I can act as a molecular force sensor	SCIENCE			English	Article							LOAD-DEPENDENT KINETICS; HAIR-CELLS; ADAPTATION; MUSCLE; BINDING; DOMAIN; MYO1B; STEPS; MOTOR	The ability to sense molecular tension is crucial for a wide array of cellular processes, including the detection of auditory stimuli, control of cell shape, and internalization and transport of membranes. We show that myosin I, a motor protein that has been implicated in powering key steps in these processes, dramatically alters its motile properties in response to tension. We measured the displacement generated by single myosin I molecules, and we determined the actin-attachment kinetics with varying tensions using an optical trap. The rate of myosin I detachment from actin decreases > 75- fold under tension of 2 piconewtons or less, resulting in myosin I transitioning from a low (< 0.2) to a high (> 0.9) duty- ratio motor. This impressive tension sensitivity supports a role for myosin I as a molecular force sensor.	[Laakso, Joseph M.; Lewis, John H.; Shuman, Henry; Ostap, E. Michael] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Laakso, Joseph M.; Lewis, John H.; Shuman, Henry; Ostap, E. Michael] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ostap, EM (corresponding author), Univ Penn, Sch Med, Dept Physiol, B400 Richards Bldg, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu		LEWIS, JOHN/0000-0003-0210-341X; Laakso, Joseph/0000-0002-1991-0229	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247, R37GM057247] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR051174, P01 AR051174-050003, P01 AR051174] Funding Source: Medline; NIGMS NIH HHS [R01 GM057247-10, GM057247, R01 GM057247] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Batters C, 2004, PHILOS T R SOC B, V359, P1895, DOI 10.1098/rstb.2004.1559; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Lin TM, 2005, J BIOL CHEM, V280, P41562, DOI 10.1074/jbc.M508653200; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tsygankov D, 2007, P NATL ACAD SCI USA, V104, P19321, DOI 10.1073/pnas.0709911104; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200	23	162	162	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 4	2008	321	5885					133	136		10.1126/science.1159419	http://dx.doi.org/10.1126/science.1159419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599791	Green Accepted			2022-12-24	WOS:000257320800055
J	Tadross, MR; Dick, IE; Yue, DT				Tadross, Michael R.; Dick, Ivy E.; Yue, David T.			Mechanism of local and global Ca2+ sensing by calmodulin in complex with a Ca2+ channel	CELL			English	Article							STOPPED-FLOW FLUORESCENCE; AUDITORY HAIR-CELLS; CA2+-DEPENDENT INACTIVATION; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; DECODING CALCIUM; GENE-EXPRESSION; KINASE-II; FREQUENCY; RECEPTOR	Calmodulin (CaM) in complex with Ca2+ channels constitutes a prototype for Ca2+ sensors that are intimately colocalized with Ca2+ sources. The C-lobe of CaM senses local, large Ca2+ oscillations due to Ca2+ influx from the host channel, and the N-lobe senses global, albeit diminutive Ca2+ changes arising from distant sources. Though biologically essential, the mechanism underlying global Ca2+ sensing has remained unknown. Here, we advance a theory of how global selectivity arises, and we experimentally validate this proposal with methodologies enabling millisecond control of Ca2+ oscillations seen by the CaM/channel complex. We find that global selectivity arises from rapid Ca2+ release from CaM combined with greater affinity of the channel for Ca2+-free versus Ca2+-bound CaM. The emergence of complex decoding properties from the juxtaposition of common elements, and the techniques developed herein, promise generalization to numerous molecules residing near Ca2+ sources.	[Tadross, Michael R.; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; [Tadross, Michael R.; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Dick, Ivy/0000-0002-7253-6846	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, T32DC000023] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL076795] Funding Source: Medline; NIDCD NIH HHS [T32 DC000023, P30 DC005211] Funding Source: Medline; NIMH NIH HHS [R01 MH065531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Black DJ, 2005, AM J PHYSIOL-CELL PH, V288, pC669, DOI 10.1152/ajpcell.00191.2004; Bootman MD, 2001, J CELL SCI, V114, P2213; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chaudhuri D, 2005, J NEUROSCI, V25, P8282, DOI 10.1523/JNEUROSCI.2253-05.2005; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARTIN SR, 1985, EUR J BIOCHEM, V151, P543, DOI 10.1111/j.1432-1033.1985.tb09137.x; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Myers BR, 2007, NEURON, V54, P847, DOI 10.1016/j.neuron.2007.06.011; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; STILES J, 2001, COMPUTATION NEUROSCI; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Winslow MM, 2005, SCIENCE, V307, P56, DOI 10.1126/science.1108163; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; YANG PS, 2007, BIOPHYS J A S, V20, P1669; Zhang S, 1999, METH MOL B, V128, P103	51	149	153	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1228	1240		10.1016/j.cell.2008.05.025	http://dx.doi.org/10.1016/j.cell.2008.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585356	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000257144600019
J	Chazdon, RL				Chazdon, Robin L.			Beyond deforestation: Restoring forests and ecosystem services on degraded lands	SCIENCE			English	Editorial Material							BIODIVERSITY; CONSERVATION; RESTORATION	Despite continued forest conversion and degradation, forest cover is increasing in countries across the globe. New forests are regenerating on former agricultural land, and forest plantations are being established for commercial and restoration purposes. Plantations and restored forests can improve ecosystem services and enhance biodiversity conservation, but will not match the composition and structure of the original forest cover. Approaches to restoring forest ecosystems depend strongly on levels of forest and soil degradation, residual vegetation, and desired restoration outcomes. Opportunities abound to combine ambitious forest restoration and regeneration goals with sustainable rural livelihoods and community participation. New forests will require adaptive management as dynamic, resilient systems that can withstand stresses of climate change, habitat fragmentation, and other anthropogenic effects.	[Chazdon, Robin L.] Univ Connecticut, Dept Ecol & Evolut Biol, Storrs, CT 06269 USA	University of Connecticut	Chazdon, RL (corresponding author), Univ Connecticut, Dept Ecol & Evolut Biol, Storrs, CT 06269 USA.	chazdon@uconn.edu	Chazdon, Robin/O-9766-2018	Chazdon, Robin/0000-0002-7349-5687				Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chokkalingam Unna, 2005, P405, DOI 10.1007/0-387-29112-1_58; Ciccarese L, 2005, IN ST WA MA, V3, P111; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; FAO, 2006, 147 FAO; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; ITTO-International Tropical Timber Organization, 2002, POLICY DEV SERIES, V13; Jordan WR., 2003, SUNFLOWER FOREST ECO; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Lindenmayer DB, 2004, BIOL CONSERV, V119, P151, DOI 10.1016/j.biocon.2003.10.028; Monela G. C., 2004, STUDY SOCIAL EC ENV; Poffenberger M, 2006, INT J ENVIRON SUSTAI, V5, P57, DOI 10.1504/IJESD.2006.008683; Prach K, 2007, LINKING RESTORATION, P121, DOI DOI 10.1007/978-0-387-35303-6; Sabogal Cesar, 2005, P361, DOI 10.1007/0-387-29112-1_52; Sampaio AB, 2007, RESTOR ECOL, V15, P462, DOI 10.1111/j.1526-100X.2007.00242.x; *STAT FOR ADM, 2005, CHIN FOR DEV REP; Walker Lawrence R., 2007, P1, DOI 10.1007/978-0-387-35303-6_1; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070; Zimmerman J. K., 2007, OLD FIELDS DYNAMICS, P51	26	987	1042	37	849	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1458	1460		10.1126/science.1155365	http://dx.doi.org/10.1126/science.1155365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556551				2022-12-24	WOS:000256676400034
J	Kaldor, JM; Delpech, V; Guy, RJ				Kaldor, Jolin M.; Delpech, Valerie; Guy, Rebecca J.			AIDS case reporting: do we still need it?	LANCET			English	Editorial Material							IMPACT		[Kaldor, Jolin M.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia; [Delpech, Valerie] Hlth Protect Agcy, Ctr Infect, London, England; [Guy, Rebecca J.] Burnet Inst, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Health Protection Agency; Burnet Institute	Kaldor, JM (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia.	jkaldor@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011	delpech, valerie/0000-0002-9952-8109; Guy, Rebecca/0000-0002-2929-4634				ANCELLEPARK RA, 1995, LANCET, V345, P789, DOI 10.1016/S0140-6736(95)90667-3; Australian Government Department of Health, 2004, AUSTR NAT NOT DIS CA; Brannstrom J, 2005, INT J STD AIDS, V16, P702, DOI 10.1258/095646205774357262; BROOKMEYER R, 1989, STAT MED, V8, P23, DOI 10.1002/sim.4780080105; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P19; *CDCP, 2007, HIV AIDS SURV REP 20, V17; Centers for Disease Control and Prevention, 1982, MMWR-MORBID MORTAL W, V31, P507; CURRAN JW, 1984, NEW ENGL J MED, V310, P69, DOI 10.1056/NEJM198401123100201; Diaz T, 2005, AIDS, V19, pS31, DOI 10.1097/01.aids.0000172875.67262.21; *EUROHIV, 2007, 74 EURHIV EUR CTR EP; Forbes Anna, 1996, AIDS Policy Law, VBonus Report, P1; KEGELES SM, 1990, AIDS, V4, P585, DOI 10.1097/00002030-199006000-00016; Law M, 2003, HIV Med, V4, P1, DOI 10.1046/j.1468-1293.2003.00138.x; *MAP, 2004, AIDS AS FAC FACTS CO; McDonald AM, 2003, AUST NZ J PUBL HEAL, V27, P608, DOI 10.1111/j.1467-842X.2003.tb00607.x; *NAT CTR HIV EP CL, 2006, HIV AIDS VIR HEP SEX; Sladden Tim, 2005, Pac Health Dialog, V12, P23; *UK COLL GROUP HIV, 2007, TEST TIM HIV OTH SEX; *US PRES EM PLAN A, 2006, BRING HOP SUPPL ANT; *WHO, 1994, WKLY EPIDEMIOL REC, V69, P273; *WHO, 2006, PROGR GLOB ACC HIV A; *WHO, 2007, GUID PROV IN HIV TES; *WHO REG OFF AFR, HIV AIDS EP SURV REP; World Health Organization, 1997, Weekly Epidemiological Record, V72, P357; 1996, COMMUN DIS REP CDR R, V6, pR1	26	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					181	183		10.1016/S0140-6736(08)61006-5	http://dx.doi.org/10.1016/S0140-6736(08)61006-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	18684500				2022-12-24	WOS:000262340900033
J	Kulp, TR; Hoeft, SE; Asao, M; Madigan, MT; Hollibaugh, JT; Fisher, JC; Stolz, JF; Culbertson, CW; Miller, LG; Oremland, RS				Kulp, T. R.; Hoeft, S. E.; Asao, M.; Madigan, M. T.; Hollibaugh, J. T.; Fisher, J. C.; Stolz, J. F.; Culbertson, C. W.; Miller, L. G.; Oremland, R. S.			Arsenic(III) fuels anoxygenic photosynthesis in hot spring biofilms from Mono Lake, California	SCIENCE			English	Article							ARSENITE OXIDASE GENES; MICROBIAL MATS; FERROUS IRON; ECTOTHIORHODOSPIRA; HYPERSALINE; METABOLISM; OXIDATION; BACTERIA	Phylogenetic analysis indicates that microbial arsenic metabolism is ancient and probably extends back to the primordial Earth. In microbial biofilms growing on the rock surfaces of anoxic brine pools fed by hot springs containing arsenite and sulfide at high concentrations, we discovered lightdependent oxidation of arsenite [ As( III)] to arsenate [ As( V)] occurring under anoxic conditions. The communities were composed primarily of Ectothiorhodospira- like purple bacteria or Oscillatoria- like cyanobacteria. A pure culture of a photosynthetic bacterium grew as a photoautotroph when As( III) was used as the sole photosynthetic electron donor. The strain contained genes encoding a putative As( V) reductase but no detectable homologs of the As( III) oxidase genes of aerobic chemolithotrophs, suggesting a reverse functionality for the reductase. Production of As( V) by anoxygenic photosynthesis probably opened niches for primordial Earth's first As( V)- respiring prokaryotes.	[Kulp, T. R.; Hoeft, S. E.; Miller, L. G.; Oremland, R. S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Asao, M.; Madigan, M. T.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Hollibaugh, J. T.; Fisher, J. C.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Stolz, J. F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Culbertson, C. W.] US Geol Survey, Water Sci Ctr, Augusta, ME 04330 USA	United States Department of the Interior; United States Geological Survey; Southern Illinois University System; Southern Illinois University; University System of Georgia; University of Georgia; Duquesne University; United States Department of the Interior; United States Geological Survey	Oremland, RS (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	roremlan@usgs.gov	张, 楠/B-1010-2010	Miller, Laurence/0000-0002-7807-3475				Bosak T, 2007, GEOBIOLOGY, V5, P119, DOI 10.1111/j.1472-4669.2007.00104.x; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Budinoff CR, 2008, ISME J, V2, P340, DOI 10.1038/ismej.2007.115; CASTENHOLZ RW, 1990, FEMS MICROBIOL ECOL, V74, P325, DOI 10.1111/j.1574-6968.1990.tb04079.x; CLOERN JE, 1983, LIMNOL OCEANOGR, V28, P1049, DOI 10.4319/lo.1983.28.6.1049; COHEN Y, 1975, J BACTERIOL, V123, P855, DOI 10.1128/JB.123.3.855-861.1975; CULVER DA, 1969, LIMNOL OCEANOGR, V14, P862, DOI 10.4319/lo.1969.14.6.0862; D'Imperio S, 2007, APPL ENVIRON MICROB, V73, P7067, DOI 10.1128/AEM.01161-07; DesMarais DJ, 1995, ADV MICROB ECOL, V14, P251; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; Griffin BM, 2007, SCIENCE, V316, P1870, DOI 10.1126/science.1139478; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Jackson CR, 2001, ENVIRON MICROBIOL, V3, P532, DOI 10.1046/j.1462-2920.2001.00221.x; Kulp TR, 2006, APPL ENVIRON MICROB, V72, P6514, DOI 10.1128/AEM.01066-06; OREMLAND RS, 1987, GEOCHIM COSMOCHIM AC, V51, P2915, DOI 10.1016/0016-7037(87)90367-X; Oremland RS, 2005, SCIENCE, V308, P1305, DOI 10.1126/science.1110832; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Rashby SE, 2007, P NATL ACAD SCI USA, V104, P15099, DOI 10.1073/pnas.0704912104; RAYMOND JC, 1969, ARCH MIKROBIOL, V69, P121, DOI 10.1007/BF00409756; Rhine ED, 2007, BIOCHEM BIOPH RES CO, V354, P662, DOI 10.1016/j.bbrc.2007.01.004; Santini JM, 2000, APPL ENVIRON MICROB, V66, P92, DOI 10.1128/AEM.66.1.92-97.2000; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0	26	157	169	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2008	321	5891					967	970		10.1126/science.1160799	http://dx.doi.org/10.1126/science.1160799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18703741				2022-12-24	WOS:000258436700040
J	Herry, C; Ciocchi, S; Senn, V; Demmou, L; Muller, C; Luthi, A				Herry, Cyril; Ciocchi, Stephane; Senn, Verena; Demmou, Lynda; Mueller, Christian; Luethi, Andreas			Switching on and off fear by distinct neuronal circuits	NATURE			English	Article							HIPPOCAMPAL INACTIVATION DISRUPTS; MEDIAL PREFRONTAL CORTEX; LATERAL AMYGDALA NEURONS; BASOLATERAL AMYGDALA; EXTINCTION; MEMORY; RESPONSES; CONTEXT; ACQUISITION; MODULATION	Switching between exploratory and defensive behaviour is fundamental to survival of many animals, but how this transition is achieved by specific neuronal circuits is not known. Here, using the converse behavioural states of fear extinction and its context- dependent renewal as a model in mice, we show that bi- directional transitions between states of high and low fear are triggered by a rapid switch in the balance of activity between two distinct populations of basal amygdala neurons. These two populations are integrated into discrete neuronal circuits differentially connected with the hippocampus and the medial prefrontal cortex. Targeted and reversible neuronal inactivation of the basal amygdala prevents behavioural changes without affecting memory or expression of behaviour. Our findings indicate that switching between distinct behavioural states can be triggered by selective activation of specific neuronal circuits integrating sensory and contextual information. These observations provide a new framework for understanding context- dependent changes of fear behaviour.	[Herry, Cyril; Ciocchi, Stephane; Senn, Verena; Demmou, Lynda; Mueller, Christian; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	cyril.herry@fmi.ch; andreas.luthi@fmi.ch	Herry, Cyril/AAP-9902-2020	Herry, Cyril/0000-0003-2973-0843; Ciocchi, Stephane/0000-0002-5701-9250				Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; FALLS WA, 1992, J NEUROSCI, V12, P854; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jing J, 2000, J NEUROPHYSIOL, V83, P1346, DOI 10.1152/jn.2000.83.3.1346; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rodriguez BI, 1999, BEHAV RES THER, V37, P845, DOI 10.1016/S0005-7967(98)00106-5; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Stalnaker TA, 2007, NAT NEUROSCI, V10, P949, DOI 10.1038/nn1931; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	50	665	715	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2008	454	7204					600	U28		10.1038/nature07166	http://dx.doi.org/10.1038/nature07166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	331QC	18615015				2022-12-24	WOS:000258026500038
J	Nakahata, Y; Kaluzova, M; Grimaldi, B; Sahar, S; Hirayama, J; Chen, D; Guarente, LP; Sassone-Corsi, P				Nakahata, Yasukazu; Kaluzova, Milota; Grimaldi, Benedetto; Sahar, Saurabh; Hirayama, Jun; Chen, Danica; Guarente, Leonard P.; Sassone-Corsi, Paolo			The NAD(+)-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control	CELL			English	Article							HISTONE ACETYLATION; GENE-EXPRESSION; REGULATOR CLOCK; MAMMALIAN CLOCK; PROTEIN SIR2; LIFE-SPAN; TRANSCRIPTION; METABOLISM; MOUSE; YEAST	Circadian rhythms govern a large array of metabolic and physiological functions. The central clock protein CLOCK has HAT properties. It directs acetylation of histone H3 and of its dimerization partner BMAL1 at Lys537, an event essential for circadian function. We show that the HDAC activity of the NAD(+)- dependent SIRT1 enzyme is regulated in a circadian manner, correlating with rhythmic acetylation of BMAL1 and H3 Lys9/Lys14 at circadian promoters. SIRT1 associates with CLOCK and is recruited to the CLOCK: BMAL1 chromatin complex at circadian promoters. Genetic ablation of the Sirt1 gene or pharmacological inhibition of SIRT1 activity lead to disturbances in the circadian cycle and in the acetylation of H3 and BMAL1. Finally, using liver-specific SIRT1 mutant mice we show that SIRT1 contributes to circadian control in vivo. We propose that SIRT1 functions as an enzymatic rheostat of circadian function, transducing signals originated by cellular metabolites to the circadian clock.	[Nakahata, Yasukazu; Kaluzova, Milota; Grimaldi, Benedetto; Sahar, Saurabh; Hirayama, Jun; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Chen, Danica; Guarente, Leonard P.] MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT)	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Nakahata, Yasukazu/0000-0003-3814-5822; Hirayama, Jun/0000-0002-8485-3320; Grimaldi, Benedetto/0000-0002-2589-9302	NIA NIH HHS [R37 AG011119-18, R37 AG011119] Funding Source: Medline; NIGMS NIH HHS [R01-GM081634-01, R01 GM081634] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011119] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chopra VS, 2005, BIOESSAYS, V27, P119, DOI 10.1002/bies.20191; Collis SJ, 2007, CHROMOSOMA, V116, P331, DOI 10.1007/s00412-007-0108-6; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grimaldi B, 2007, COLD SPRING HARB SYM, V72, P105, DOI 10.1101/sqb.2007.72.049; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hardin PE, 2006, CELL, V125, P424, DOI 10.1016/j.cell.2006.04.010; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wade PA, 1997, CURR BIOL, V7, pR82, DOI 10.1016/S0960-9822(06)00042-X; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	74	988	1032	2	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2008	134	2					329	340		10.1016/j.cell.2008.07.002	http://dx.doi.org/10.1016/j.cell.2008.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662547	Bronze, Green Accepted			2022-12-24	WOS:000257891700021
J	Trotter, JA; Williams, IS; Barnes, CR; Lecuyer, C; Nicoll, RS				Trotter, Julie A.; Williams, Ian S.; Barnes, Christopher R.; Lecuyer, Christophe; Nicoll, Robert S.			Did cooling oceans trigger Ordovician biodiversification? Evidence from conodont thermometry	SCIENCE			English	Article							OXYGEN ISOTOPIC COMPOSITION; ATMOSPHERIC CO2; BRACHIOPODS; DELTA-O-18; EVOLUTION; SEAWATER; GEOCHEMISTRY; GLACIATION; PHOSPHATE; CALCITE	The Ordovician Period, long considered a supergreenhouse state, saw one of the greatest radiations of life in Earth's history. Previous temperature estimates of up to similar to 70 degrees C have spawned controversial speculation that the oxygen isotopic composition of seawater must have evolved over geological time. We present a very different global climate record determined by ion microprobe oxygen isotope analyses of Early Ordovician- Silurian conodonts. This record shows a steady cooling trend through the Early Ordovician reaching modern equatorial temperatures that were sustained throughout the Middle and Late Ordovician. This favorable climate regime implies not only that the oxygen isotopic composition of Ordovician seawater was similar to that of today, but also that climate played an overarching role in promoting the unprecedented increases in biodiversity that characterized this period.	[Trotter, Julie A.; Williams, Ian S.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Trotter, Julie A.] CSIRO Petr Resources, N Ryde, NSW 1670, Australia; [Barnes, Christopher R.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 2Y2, Canada; [Lecuyer, Christophe] Univ Lyon 1, Lab Paleoenvironn & Paleobiosphere, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Nicoll, Robert S.] Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Victoria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Australian National University	Trotter, JA (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Mills Rd, Canberra, ACT 0200, Australia.	julie.trotter@anu.edu.au	Barnes, Christopher R/J-7975-2016; Lecuyer, Christophe/C-8297-2012; Williams, Ian S/F-4302-2012; SHRIMP, ANU/F-5312-2011; Trotter, Julie/H-5981-2014; Lecuyer, Christophe/AAO-8154-2021	Williams, Ian S/0000-0003-4465-6493; Trotter, Julie/0000-0002-0505-488X; Lecuyer, Christophe/0000-0001-9513-2492				Azmy K, 1998, GEOL SOC AM BULL, V110, P1499, DOI 10.1130/0016-7606(1998)110<1499:OACICO>2.3.CO;2; Bassett D, 2007, PALAIOS, V22, P98, DOI 10.2110/palo.2005.p05-089r; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Brenchley PJ, 2004, CRIT MOM PERSP EARTH, P81; BRENCHLEY PJ, 1994, GEOLOGY, V22, P295, DOI 10.1130/0091-7613(1994)022<0295:BAIEFA>2.3.CO;2; Came RE, 2007, NATURE, V449, P198, DOI 10.1038/nature06085; Cocks LRM, 2004, CRIT MOM PERSP EARTH, P61; Gregory R. T., 1991, GEOCHEM SOC SPEC PUB, V3, P65; GREGORY RT, 1981, J GEOPHYS RES, V86, P2737, DOI 10.1029/JB086iB04p02737; Joachimski MM, 2002, GEOLOGY, V30, P711, DOI 10.1130/0091-7613(2002)030<0711:CAOSIC>2.0.CO;2; Joachimski MM, 2006, GEOLOGY, V34, P277, DOI 10.1130/G22198.1; Joachimski MM, 2004, INT J EARTH SCI, V93, P542, DOI 10.1007/s00531-004-0405-8; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Kauffman Erle G., 1993, P315; Lecuyer C, 1998, GEOCHIM COSMOCHIM AC, V62, P2429, DOI 10.1016/S0016-7037(98)00170-7; Lecuyer C, 1999, GEOCHIM COSMOCHIM AC, V63, P351, DOI 10.1016/S0016-7037(98)00277-4; Muehlenbachs K, 1998, CHEM GEOL, V145, P263, DOI 10.1016/S0009-2541(97)00147-2; Noble PJ, 2004, CRIT MOM PERSP EARTH, P97; Peterson KJ, 2005, GEOLOGY, V33, P929, DOI 10.1130/G21697.1; Saltzman MR, 2005, GEOLOGY, V33, P109, DOI 10.1130/G21219.1; Schmitz B, 2008, NAT GEOSCI, V1, P49, DOI 10.1038/ngeo.2007.37; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J. John Jr, 1995, P393; Shaviv NirJ., 2003, GSA TODAY, V137, P4, DOI DOI 10.1130/1052-5173(2003)013; Shields GA, 2003, GEOCHIM COSMOCHIM AC, V67, P2005, DOI 10.1016/S0016-7037(02)01116-X; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; VEIZER J, 1986, GEOCHIM COSMOCHIM AC, V50, P1679, DOI 10.1016/0016-7037(86)90130-4; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Wenzel B, 2000, GEOCHIM COSMOCHIM AC, V64, P1859, DOI 10.1016/S0016-7037(00)00337-9; Xu C, 2006, GEOL J, V41, P289, DOI 10.1002/gj.1051; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	32	417	461	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					550	554		10.1126/science.1155814	http://dx.doi.org/10.1126/science.1155814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653889				2022-12-24	WOS:000257888900044
J	Chamberlain, SR; Menzies, L; Hampshire, A; Suckling, J; Fineberg, NA; del Campo, N; Aitken, M; Craig, K; Owen, AM; Bullmore, ET; Robbins, TW; Sahakian, BJ				Chamberlain, Samuel R.; Menzies, Lara; Hampshire, Adam; Suckling, John; Fineberg, Naomi A.; del Campo, Natalia; Aitken, Mike; Craig, Kevin; Owen, Adrian M.; Bullmore, Edward T.; Robbins, Trevor W.; Sahakian, Barbara J.			Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives	SCIENCE			English	Article							PREFRONTAL CORTEX; INHIBITION; HUMANS	Obsessive-compulsive disorder (OCD) is characterized by repetitive thoughts and behaviors associated with underlying dysregulation of frontostriatal circuitry. Central to neurobiological models of OCD is the orbitofrontal cortex, a neural region that facilitates behavioral flexibility after negative feedback (reversal learning). We identified abnormally reduced activation of several cortical regions, including the lateral orbitofrontal cortex, during reversal learning in OCD patients and their clinically unaffected close relatives, supporting the existence of an underlying previously undiscovered endophenotype for this disorder.	[Chamberlain, Samuel R.; Menzies, Lara; Suckling, John; Fineberg, Naomi A.; del Campo, Natalia; Craig, Kevin; Bullmore, Edward T.; Sahakian, Barbara J.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 0QQ, England; [Chamberlain, Samuel R.; Menzies, Lara; Suckling, John; del Campo, Natalia; Aitken, Mike; Craig, Kevin; Bullmore, Edward T.; Robbins, Trevor W.; Sahakian, Barbara J.] Univ Cambridge, BCNI, Cambridge CB2 3EB, England; [Chamberlain, Samuel R.; Menzies, Lara; Fineberg, Naomi A.; Craig, Kevin] Queen Elizabeth II Hosp, Natl OCD Treatment Serv, Welwyn Garden City AL7 4HQ, Herts, England; [Hampshire, Adam; Owen, Adrian M.] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Aitken, Mike; Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Bullmore, Edward T.] Addenbrookes Hosp, Clin Unit Cambridge, GlaxoSmithKline, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge	Chamberlain, SR (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Box 189, Cambridge CB2 0QQ, England.	srchamb@gmail.com	Robbins, Trevor W/A-7551-2008; Bullmore, Ed/C-1706-2012; Owen, Adrian M/B-4997-2015; Chamberlain, Samuel R/A-7839-2008; Fineberg, Naomi/ABI-5522-2020; Suckling, John/ABD-7246-2021; Sahakian, Barbara/AAW-1198-2020	Bullmore, Ed/0000-0002-8955-8283; Chamberlain, Samuel R/0000-0001-7014-8121; Suckling, John/0000-0002-5098-1527; Sahakian, Barbara/0000-0001-7352-1745; Menzies, Lara/0000-0003-3710-501X; Aitken Deakin, Michael/0000-0001-9763-8999; Robbins, Trevor/0000-0003-0642-5977	Medical Research Council [MC_U105559847, G0001354, U1055.01.002.00001.01] Funding Source: Medline; Wellcome Trust [G001354] Funding Source: Medline; MRC [MC_U105559847] Funding Source: UKRI; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Chamberlain Samuel R, 2006, Curr Psychiatry Rep, V8, P458, DOI 10.1007/s11920-006-0051-x; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hollander E, 1996, J CLIN PSYCHIAT, V57, P3; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027	18	377	386	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					421	422		10.1126/science.1154433	http://dx.doi.org/10.1126/science.1154433			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635808				2022-12-24	WOS:000257713900055
J	Burke, KA; Franz, TM; Miller, DN; Schoenbaum, G				Burke, Kathryn A.; Franz, Theresa M.; Miller, Danielle N.; Schoenbaum, Geoffrey			The role of the orbitofrontal cortex in the pursuit of happiness and more specific rewards	NATURE			English	Article							NUCLEUS-ACCUMBENS CORE; CONDITIONED REINFORCEMENT; UNCONDITIONED STIMULUS; BASOLATERAL AMYGDALA; D-AMPHETAMINE; LESIONS; REPRESENTATION; COMPLEX; DISSOCIATION; POTENTIATION	Cues that reliably predict rewards trigger the thoughts and emotions normally evoked by those rewards. Humans and other animals will work, often quite hard, for these cues. This is termed conditioned reinforcement. The ability to use conditioned reinforcers to guide our behaviour is normally beneficial; however, it can go awry. For example, corporate icons, such as McDonald's Golden Arches, influence consumer behaviour in powerful and sometimes surprising ways(1), and drug- associated cues trigger relapse to drug seeking in addicts and animals exposed to addictive drugs, even after abstinence or extinction(2,3). Yet, despite their prevalence, it is not known how conditioned reinforcers control human or other animal behaviour. One possibility is that they act through the use of the specific rewards they predict; alternatively, they could control behaviour directly by activating emotions that are independent of any specific reward. In other words, the Golden Arches may drive business because they evoke thoughts of hamburgers and fries, or instead, may be effective because they also evoke feelings of hunger or happiness. Moreover, different brain circuits could support conditioned reinforcement mediated by thoughts of specific outcomes versus more general affective information. Here we have attempted to address these questions in rats. Rats were trained to learn that different cues predicted different rewards using specialized conditioning procedures that controlled whether the cues evoked thoughts of specific outcomes or general affective representations common to different outcomes. Subsequently, these rats were given the opportunity to press levers to obtain short and otherwise unrewarded presentations of these cues. We found that rats were willing to work for cues that evoked either outcome- specific or general affective representations. Furthermore the orbitofrontal cortex, a prefrontal region important for adaptive decision-making(4), was critical for the former but not for the latter form of conditioned reinforcement.	[Franz, Theresa M.; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Burke, Kathryn A.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Miller, Danielle N.] Baltimore Polytech Inst, Ingenu Project, Baltimore, MD 21209 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	schoenbg@schoenbaumlab.org			NIDA NIH HHS [R01 DA015718, R01 DA015718-06A2] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BALLEINE BW, 2005, SOC NEUR ABSTR, P7116; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Gallagher M, 1999, J NEUROSCI, V19, P6610; GANESAN R, 1988, J EXP PSYCHOL ANIM B, V14, P280, DOI 10.1037/0097-7403.14.3.280; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; O'Brien CP, 2005, AM J PSYCHIAT, V162, P1423, DOI 10.1176/appi.ajp.162.8.1423; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parkinson JA, 2005, Q J EXP PSYCHOL-B, V58, P19, DOI 10.1080/02724990444000023; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Pears A, 2003, J NEUROSCI, V23, P11189; Pickens CL, 2003, J NEUROSCI, V23, P11078; Rescorla RA, 1999, ANIM LEARN BEHAV, V27, P140, DOI 10.3758/BF03199671; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Robledo P, 1996, BEHAV NEUROSCI, V110, P981, DOI 10.1037/0735-7044.110.5.981; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Setlow B, 2002, EUR J NEUROSCI, V15, P1841, DOI 10.1046/j.1460-9568.2002.02010.x; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Weissenborn R, 1997, PSYCHOPHARMACOLOGY, V134, P242, DOI 10.1007/s002130050447	30	123	127	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					340	U45		10.1038/nature06993	http://dx.doi.org/10.1038/nature06993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	326ND	18563088	Green Accepted			2022-12-24	WOS:000257665300040
J	Miyoshi, T; Kanoh, J; Saito, M; Ishikawa, F				Miyoshi, Tomoichiro; Kanoh, Junko; Saito, Motoki; Ishikawa, Fuyuki			Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length	SCIENCE			English	Article							END-BINDING-PROTEIN; SINGLE-STRANDED-DNA; SCHIZOSACCHAROMYCES-POMBE; DOMAIN PROTEIN; POT1; COMPLEX; RECOGNITION; TPP1	Telomeres are specialized chromatin structures that protect chromosomal ends. Protection of telomeres 1 ( Pot1) binds to the telomeric G- rich overhang, thereby protecting telomeres and regulating telomerase. Mammalian POT1 and TPP1 interact and constitute part of the six- protein shelterin complex. Here we report that Tpz1, the TPP1 homolog in fission yeast, forms a complex with Pot1. Tpz1 binds to Ccq1 and the previously undiscovered protein Poz1 ( Pot1- associated in Schizosaccharomyces pombe), which protect telomeres redundantly and regulate telomerase in positive and negative manners, respectively. Thus, the Pot1- Tpz1 complex accomplishes its functions by recruiting effector molecules Ccq1 and Poz1. Moreover, Poz1 bridges Pot1- Tpz1 and Taz1- Rap1, thereby connecting the single- stranded and double- stranded telomeric DNA regions. Such molecular architectures are similar to those of mammalian shelterin, indicating that the overall DNA- protein architecture is conserved across evolution.	[Miyoshi, Tomoichiro; Kanoh, Junko; Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Kanoh, Junko/AGM-9632-2022; Ishikawa, Fuyuki/AAU-4056-2021	Ishikawa, Fuyuki/0000-0002-5580-2305; Miyoshi, Tomoichiro/0000-0002-5319-7877				Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Croy JE, 2006, J MOL BIOL, V361, P80, DOI 10.1016/j.jmb.2006.06.002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469	17	170	174	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1341	1344		10.1126/science.1154819	http://dx.doi.org/10.1126/science.1154819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18535244				2022-12-24	WOS:000256441100045
J	Krishnan, MN; Ng, A; Sukumaran, B; Gilfoy, FD; Uchil, PD; Sultana, H; Brass, AL; Adametz, R; Tsui, M; Qian, F; Montgomery, RR; Lev, S; Mason, PW; Koski, RA; Elledge, SJ; Xavier, RJ; Agaisse, H; Fikrig, E				Krishnan, Manoj N.; Ng, Aylwin; Sukumaran, Bindu; Gilfoy, Felicia D.; Uchil, Pradeep D.; Sultana, Hameeda; Brass, Abraham L.; Adametz, Rachel; Tsui, Melody; Qian, Feng; Montgomery, Ruth R.; Lev, Sima; Mason, Peter W.; Koski, Raymond A.; Elledge, Stephen J.; Xavier, Ramnik J.; Agaisse, Herve; Fikrig, Erol			RNA interference screen for human genes associated with West Nile virus infection	NATURE			English	Article							DENGUE-VIRUS; INTERACTION NETWORK; VIRAL SPREAD; HOST-CELLS; PROTEIN; ENTRY; REPLICATION; DATABASE; IDENTIFICATION; ENDOCYTOSIS	West Nile virus ( WNV), and related flaviviruses such as tick- borne encephalitis, Japanese encephalitis, yellow fever and dengue viruses, constitute a significant global human health problem(1). However, our understanding of the molecular interaction of such flaviviruses with mammalian host cells is limited(1). WNV encodes only 10 proteins, implying that it may use many cellular proteins for infection(1). WNV enters the cytoplasm through pH- dependent endocytosis, undergoes cycles of translation and replication, assembles progeny virions in association with endoplasmic reticulum, and exits along the secretory pathway(1-3). RNA interference ( RNAi) presents a powerful forward genetics approach to dissect virus - host cell interactions(4-6). Here we report the identification of 305 host proteins that affect WNV infection, using a human- genome-wide RNAi screen. Functional clustering of the genes revealed a complex dependence of this virus on host cell physiology, requiring a wide variety of molecules and cellular pathways for successful infection. We further demonstrate a requirement for the ubiquitin ligase CBLL1 in WNV internalization, a post- entry role for the endoplasmic- reticulum- associated degradation pathway in viral infection, and the monocarboxylic acid transporter MCT4 as a viral replication resistance factor. By extending this study to dengue virus, we show that flaviviruses have both overlapping and unique interaction strategies with host cells. This study provides a comprehensive molecular portrait of WNV - human cell interactions that forms a model for understanding single plus- stranded RNA virus infection, and reveals potential antiviral targets.	[Krishnan, Manoj N.; Sukumaran, Bindu; Sultana, Hameeda; Fikrig, Erol] Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Qian, Feng; Montgomery, Ruth R.] Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT 06520 USA; [Uchil, Pradeep D.; Adametz, Rachel; Agaisse, Herve] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Gilfoy, Felicia D.; Mason, Peter W.] Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Tsui, Melody] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Syst Biol, Boston, MA 02115 USA; [Brass, Abraham L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Genet,Ctr Genet & Genom, Boston, MA 02115 USA; [Lev, Sima] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Koski, Raymond A.] L2 Diagnost, New Haven, CT 06511 USA; [Elledge, Stephen J.; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Weizmann Institute of Science; Howard Hughes Medical Institute	Fikrig, E (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	Ng, Aylwin/AAQ-6478-2020; Qian, Feng/F-8186-2010; Lev, Sima/AAP-7880-2020	Lev, Sima/0000-0002-2108-3330; Montgomery, Ruth/0000-0002-8661-4454; Uchil, Pradeep/0000-0002-7236-858X	New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease [U54AI057159]; NIH [AI062773, U54 AI057156]; Crohn's and Colitis Foundation of America; CCIB development funds; Emerging and Tropical Infectious Diseases [AI07526]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070343, R01AI032947, U54AI057156, R01AI041440, R01AI062773, T32AI007526, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; CCIB development funds; Emerging and Tropical Infectious Diseases; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The human genome RNAi library wasmade available through the support of the New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease (U54AI057159). The screening was performed at the ICCB-Longwood screening facility (Harvard Medical School). We thank B. Lindenbach for suggestions and Y. Benita for illustrations. We thank L2 Diagnostics for providing the anti-WNV antibody. This work was supported by the NIH. A.N. is supported by a fellowship award from the Crohn's and Colitis Foundation of America. R.J.X. is supported by the NIH (AI062773) and by CCIB development funds. F.D.G was supported by an NIH training grant in Emerging and Tropical Infectious Diseases (AI07526); portions of this work were supported by a grant from NIAID to P.W.M. through the WRCE ( NIH U54 AI057156). E. F. and S.J.E. are Investigators of the Howard Hughes Medical Institute.	Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Ng TI, 2007, HEPATOLOGY, V45, P1413, DOI 10.1002/hep.21608; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rossi SL, 2005, VIROLOGY, V331, P457, DOI 10.1016/j.virol.2004.10.046; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Scholle F, 2005, VIROLOGY, V342, P77, DOI 10.1016/j.virol.2005.07.021; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781	34	404	420	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					242	U67		10.1038/nature07207	http://dx.doi.org/10.1038/nature07207			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18690214	Green Accepted			2022-12-24	WOS:000259090800051
J	Pesu, M; Watford, WT; Wei, L; Xu, LL; Fuss, I; Strober, W; Andersson, J; Shevach, EM; Quezado, M; Bouladoux, N; Roebroek, A; Belkaid, Y; Creemers, J; O'Shea, JJ				Pesu, Marko; Watford, Wendy T.; Wei, Lai; Xu, Lili; Fuss, Ivan; Strober, Warren; Andersson, John; Shevach, Ethan M.; Quezado, Martha; Bouladoux, Nicolas; Roebroek, Anton; Belkaid, Yasmine; Creemers, John; O'Shea, John J.			T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance	NATURE			English	Article							ACTIVATION; BETA; GROWTH; MICE; CONVERSION; INDUCTION; COLITIS; MASTER; FOXP3	Furin is one of seven proprotein convertase family members that promote proteolytic maturation of proproteins(1). It is induced in activated T cells and is reported to process a variety of substrates including the anti- inflammatory cytokine transforming growth factor (TGF)-beta 1 ( refs 2 - 4), but the non- redundant functions of furin versus other proprotein convertases in T cells are unclear. Here we show that conditional deletion of furin in T cells allowed for normal T- cell development but impaired the function of regulatory and effector T cells, which produced less TGF-beta 1. Furin-deficient T regulatory (T-reg) cells were less protective in a T- cell transfer colitis model and failed to induce Foxp3 in normal T cells. Additionally, furin- deficient effector cells were inherently over-active and were resistant to suppressive activity of wild- type T-reg cells. Thus, our results indicate that furin is indispensable in maintaining peripheral tolerance, which is due, at least in part, to its non- redundant, essential function in regulating TGF-beta 1 production. Targeting furin has emerged as a strategy in malignant and infectious disease(5,6). Our results suggest that inhibiting furin might activate immune responses, but may result in a breakdown in peripheral tolerance.	[Pesu, Marko; Watford, Wendy T.; Wei, Lai; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Xu, Lili; Fuss, Ivan; Strober, Warren] NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Andersson, John; Shevach, Ethan M.] NIAID, Cellular Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Quezado, Martha] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Roebroek, Anton; Creemers, John] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, B-3000 Louvain, Belgium; [Roebroek, Anton; Creemers, John] VIB, B-3000 Louvain, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); KU Leuven; Flanders Institute for Biotechnology (VIB)	Pesu, M (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	pesum@mail.nih.gov	Wei, Lai/D-1088-2014; Andersson, John/A-4436-2009; Pesu, Marko/L-6344-2013	Pesu, Marko/0000-0002-7541-3921; Belkaid, Yasmine/0000-0001-9962-3571; Andersson, John/0000-0003-2799-6349; Watford, Wendy/0000-0003-4261-5399; Bouladoux, Nicolas/0000-0003-1593-671X	Intramural Research Program of NIAMS; Academy of Finland; Finnish Medical Foundation; Maud Kuistila Memorial Foundation; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Geconcerteerde Onderzoeksactie van de Vlaamse Gemeenschap; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959, ZIAAI000354, Z01AI001061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041160, ZIAAR041159] Funding Source: NIH RePORTER	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Academy of Finland(Academy of Finland); Finnish Medical Foundation; Maud Kuistila Memorial Foundation; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Geconcerteerde Onderzoeksactie van de Vlaamse Gemeenschap; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Bonifacino (National Institute of Child Health and Human Development) and S. Wahl (National Institute of Dental and Craniofacial Research) for providing comments and reading the manuscript, A. Singer (National Cancer Institute) and L. Pobenzinsky (NCI) for providing suggestions, and M. Oukka (HarvardMedical School) for providing Foxp3- GFP mice. This work was supported by the Intramural Research Program of NIAMS, Academy of Finland, the Finnish Medical Foundation, the Maud Kuistila Memorial Foundation, the 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' and 'Geconcerteerde Onderzoeksactie van de Vlaamse Gemeenschap'.	ANDERSSON J, IN PRESS J EXP MED; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; FINK PJ, 1994, J IMMUNOL, V152, P4270; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Ornatowski W, 2007, J CLIN INVEST, V117, P3489, DOI 10.1172/JCI31499; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Schon MP, 1999, J IMMUNOL, V162, P6641; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110	25	150	159	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					246	U73		10.1038/nature07210	http://dx.doi.org/10.1038/nature07210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18701887	Green Accepted			2022-12-24	WOS:000259090800052
J	Macurek, L; Lindqvist, A; Lim, D; Lampson, MA; Klompmaker, R; Freire, R; Clouin, C; Taylor, SS; Yaffe, MB; Medema, RH				Macurek, Libor; Lindqvist, Arne; Lim, Dan; Lampson, Michael A.; Klompmaker, Rob; Freire, Raimundo; Clouin, Christophe; Taylor, Stephen S.; Yaffe, Michael B.; Medema, Rene H.			Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; PROTEIN-KINASE; MAMMALIAN-CELLS; DNA-DAMAGE; BIPOLAR SPINDLE; PHOSPHORYLATION; REVEALS; CYCLE; PLX1; POLO-LIKE-KINASE-1	Polo-like kinase-1 (PLK1) is an essential mitotic kinase regulating multiple aspects of the cell division process(1). Activation of PLK1 requires phosphorylation of a conserved threonine residue ( Thr 210) in the T- loop of the PLK1 kinase domain, but the kinase responsible for this has not yet been affirmatively identified(2-6). Here we show that in human cells PLK1 activation occurs several hours before entry into mitosis, and requires aurora A ( AURKA, also known as STK6)- dependent phosphorylation of Thr 210. We find that aurora A can directly phosphorylate PLK1 on Thr 210, and that activity of aurora A towards PLK1 is greatly enhanced by Bora ( also known as C13orf34 and FLJ22624), a known cofactor for aurora A ( ref. 7). We show that Bora/ aurora- A- dependent phosphorylation is a prerequisite for PLK1 to promote mitotic entry after a checkpoint- dependent arrest. Importantly, expression of a PLK1- T210D phospho- mimicking mutant partially overcomes the requirement for aurora A in checkpoint recovery. Taken together, these data demonstrate that the initial activation of PLK1 is a primary function of aurora A.	[Macurek, Libor; Lindqvist, Arne; Klompmaker, Rob; Medema, Rene H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Lim, Dan; Clouin, Christophe; Yaffe, Michael B.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Freire, Raimundo] Hosp Univ Canarias, Unidad Invest, La Cuesta 38320, Spain; [Taylor, Stephen S.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Utrecht University; Utrecht University Medical Center; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Universidad de la Laguna; University of Manchester	Medema, RH (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands.	r.h.medema@umcutrecht.nl	Medema, Rene H/G-5415-2011; Macurek, Libor/C-7865-2014; Medema, Rene H/E-2981-2013; Freire, Raimundo/Q-7660-2019; Taylor, Stephen/GZL-6499-2022; Macurek, Libor/B-8758-2009; Lindqvist, Arne/B-6792-2008	Macurek, Libor/0000-0002-0987-1238; Freire, Raimundo/0000-0003-4473-8894; Taylor, Stephen/0000-0003-4621-9326; Medema, Rene/0000-0002-6754-0381; Lindqvist, Arne/0000-0002-0141-1579	Dutch Cancer Society [UU2006-3579]; Dutch Organisation for Scientific Research [ZonMw 918.46.616, ZonMw 916.86.083]; Association for International Cancer Research [08-0172]; NIH [GM-60594, CA112967]; Wenner-Gren foundations; Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Association for International Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren foundations; Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to B. Ingelheim for the gift of BI2536, Millennium Pharmaceuticals for MLN8054, E. Nigg for antibodies and sharing unpublished work, A. Desai and I. Cheeseman for providing the pIC113 plasmid, M. Tanenbaum for U2OS cells expressing YFP-tubulin, S. Sen for GST-aurora A constructs, M. Vromans for recombinant GST-aurora A, Q. Verstralen for technical assistance, D. Littler for active recombinant PLK1, P. de Graaf for the U2OS-TR cell line, G. Kops for making the Deltavision imaging system available, L. Kleij for technical assistance with confocal microscopy, and all members of the Medema laboratory for discussions. We thank M. Alvarez, S. Lens, G. Kops and M. Tanenbaum for critically reading the manuscript. This work was supported by the Dutch Cancer Society (L.M. UU2006-3579), the Dutch Organisation for Scientific Research ( R. H. M. ZonMw 918.46.616 and A. L. 916.86.083), the Association for International Cancer Research ( L. M. 08-0172) and the NIH ( M. B. Y. GM-60594 and CA112967). A. L. was also funded by the Wenner-Gren foundations. R. H. M. was funded by the Netherlands Genomic Initiative of the Netherlands Organisation for Scientific Research (NWO).	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHAN E, IN PRESS CHROMOSOMA; CHEESEMAN IM, 2005, SCI STKE, pI1; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; van de Weerdt BCM, 2005, MOL CELL BIOL, V25, P2031, DOI 10.1128/MCB.25.5.2031-2044.2005; van Vugt MATM, 2005, CANCER RES, V65, P7037, DOI 10.1158/0008-5472.CAN-05-1054; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	32	501	514	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					119	U88		10.1038/nature07185	http://dx.doi.org/10.1038/nature07185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18615013				2022-12-24	WOS:000258890200049
J	Sultan, M; Schulz, MH; Richard, H; Magen, A; Klingenhoff, A; Scherf, M; Seifert, M; Borodina, T; Soldatov, A; Parkhomchuk, D; Schmidt, D; O'Keeffe, S; Haas, S; Vingron, M; Lehrach, H; Yaspo, ML				Sultan, Marc; Schulz, Marcel H.; Richard, Hugues; Magen, Alon; Klingenhoff, Andreas; Scherf, Matthias; Seifert, Martin; Borodina, Tatjana; Soldatov, Aleksey; Parkhomchuk, Dmitri; Schmidt, Dominic; O'Keeffe, Sean; Haas, Stefan; Vingron, Martin; Lehrach, Hans; Yaspo, Marie-Laure			A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome	SCIENCE			English	Article							RNA-POLYMERASE-II; EXPRESSION; RESOLUTION; GENOME; IDENTIFICATION; TECHNOLOGIES; TRANSLATION; DISCOVERY; MAPS	The functional complexity of the human transcriptome is not yet fully elucidated. We report a high- throughput sequence of the human transcriptome from a human embryonic kidney and a B cell line. We used shotgun sequencing of transcripts to generate randomly distributed reads. Of these, 50% mapped to unique genomic locations, of which 80% corresponded to known exons. We found that 66% of the polyadenylated transcriptome mapped to known genes and 34% to nonannotated genomic regions. On the basis of known transcripts, RNA- Seq can detect 25% more genes than can microarrays. A global survey of messenger RNA splicing events identified 94,241 splice junctions ( 4096 of which were previously unidentified) and showed that exon skipping is the most prevalent form of alternative splicing.	[Sultan, Marc; Magen, Alon; Borodina, Tatjana; Soldatov, Aleksey; Parkhomchuk, Dmitri; Schmidt, Dominic; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Schulz, Marcel H.; Richard, Hugues; O'Keeffe, Sean; Haas, Stefan; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Schulz, Marcel H.] Int Max Planck Res Sch Computat Biol & Sci Comp, D-80335 Munich, Germany; [Klingenhoff, Andreas; Scherf, Matthias; Seifert, Martin] Genomatrix Software Gmbh, D-80335 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Yaspo, ML (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	yaspo@molgen.mpg.de	Soldatov, Alexey/V-2383-2019; Seifert, Martin/GSE-3648-2022	Richard, Hugues/0000-0001-7776-1340; Schulz, Marcel H./0000-0002-1252-3656; Haas, Stefan/0000-0003-3418-3688; Borodina, Tatiana/0000-0002-6978-016X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Calarco JA, 2007, ADV EXP MED BIOL, V623, P64, DOI 10.1007/978-0-387-77374-2_5; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; Hampton GM, 2003, TRENDS MOL MED, V9, P5, DOI 10.1016/S1471-4914(02)00006-0; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; LEHRACH H., 1990, GENOME ANAL, P39; LENNON GG, 1991, TRENDS GENET, V7, P314, DOI 10.1016/0168-9525(91)90420-U; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Southern EM, 1992, CURR OPIN GENET DEV, V2, P412, DOI 10.1016/S0959-437X(05)80151-0; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang JPZ, 2005, J AM STAT ASSOC, V100, P942, DOI 10.1198/016214504000002005; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	29	923	998	8	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					956	960		10.1126/science.1160342	http://dx.doi.org/10.1126/science.1160342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18599741				2022-12-24	WOS:000258436700037
J	Ekstrom, LB; Roelfsema, PR; Arsenault, JT; Bonmassar, G; Vanduffel, W				Ekstrom, Leeland B.; Roelfsema, Pieter R.; Arsenault, John T.; Bonmassar, Giorgio; Vanduffel, Wim			Bottom-up dependent gating of frontal signals in early visual cortex	SCIENCE			English	Article							EYE FIELD; INTRACORTICAL MICROSTIMULATION; ATTENTION INCREASES; SPATIAL ATTENTION; SQUIRREL-MONKEYS; MACAQUE MONKEYS; SINGLE NEURONS; OWL MONKEYS; AREA V4; CONNECTIONS	The frontal eye field (FEF) is one of several cortical regions thought to modulate sensory inputs. Moreover, several hypotheses suggest that the FEF can only modulate early visual areas in the presence of a visual stimulus. To test for bottom-up gating of frontal signals, we microstimulated subregions in the FEF of two monkeys and measured the effects throughout the brain with functional magnetic resonance imaging. The activity of higher-order visual areas was strongly modulated by FEF stimulation, independent of visual stimulation. In contrast, FEF stimulation induced a topographically specific pattern of enhancement and suppression in early visual areas, but only in the presence of a visual stimulus. Modulation strength depended on stimulus contrast and on the presence of distractors. We conclude that bottom-up activation is needed to enable top-down modulation of early visual cortex and that stimulus saliency determines the strength of this modulation.	[Ekstrom, Leeland B.; Arsenault, John T.; Bonmassar, Giorgio; Vanduffel, Wim] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Ekstrom, Leeland B.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ekstrom, Leeland B.] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Roelfsema, Pieter R.] Royal Netherlands Acad Arts & Sci, Dept Vis & Cognit, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & cognit Res, NL-1081 HV Amsterdam, Netherlands; [Arsenault, John T.; Vanduffel, Wim] Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; [Vanduffel, Wim] Harvard Univ, Sch Med, Dept Radiol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; KU Leuven; Harvard University	Vanduffel, W (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	wim@nmr.mgh.harvard.edu	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034	NCRR NIH HHS [P41RR14075, P41 RR014075-13, P41 RR014075] Funding Source: Medline; NIBIB NIH HHS [R01 EB000790, R01 EB000790-05] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Fukushima K., 1988, IEEE COMPUT, V21, P65; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; van der Velde F, 2001, J COGNITIVE NEUROSCI, V13, P479, DOI 10.1162/08989290152001907; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	29	246	246	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2008	321	5887					414	417		10.1126/science.1153276	http://dx.doi.org/10.1126/science.1153276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635806	Green Accepted			2022-12-24	WOS:000257713900053
J	Martinez, JL				Martinez, Jose L.			Antibiotics and antibiotic resistance genes in natural environments	SCIENCE			English	Editorial Material							MULTIDRUG-RESISTANCE; QUINOLONE RESISTANCE; EFFLUX PUMPS; MEXEF-OPRN; OVEREXPRESSION; DISSEMINATION; BACTERIA; AGENTS; SOIL		CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Darwin 3,Campus UAM, E-28049 Madrid, Spain; CIBERESP, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Martinez, JL (corresponding author), CSIC, Dept Biotecnol Microbiana, Ctr Nacl Biotecnol, Darwin 3,Campus UAM, E-28049 Madrid, Spain.	jlmtnez@cnb.csic.es	Martinez, Jose L/C-4100-2008; Martinez, Jose L/A-4725-2013	Martinez, Jose L/0000-0001-8813-7607				Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Franklin K, 2001, ANTIMICROB AGENTS CH, V45, P2238, DOI 10.1128/AAC.45.8.2238-2244.2001; Gerber M, 2008, J MED MICROBIOL, V57, P776, DOI 10.1099/jmm.0.47739-0; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hernandez A, 1998, APPL ENVIRON MICROB, V64, P4317; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Linares JF, 2005, J BACTERIOL, V187, P1384, DOI 10.1128/JB.187.4.1384-1391.2005; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Macinga David R., 1999, Frontiers in Bioscience, V4, pD132, DOI 10.2741/Macinga; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Smith DL, 2005, PLOS MED, V2, P731, DOI 10.1371/journal.pmed.0020232; Waksman SA, 1940, J BACTERIOL, V40, P581, DOI 10.1128/JB.40.4.581-600.1940	27	1116	1231	44	841	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					365	367		10.1126/science.1159483	http://dx.doi.org/10.1126/science.1159483			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635792				2022-12-24	WOS:000257713900037
J	Noyes, MB; Christensen, RG; Wakabayashi, A; Stormo, GD; Brodsky, MH; Wolfe, SA				Noyes, Marcus B.; Christensen, Ryan G.; Wakabayashi, Atsuya; Stormo, Gary D.; Brodsky, Michael H.; Wolfe, Scot A.			Analysis of homeodomain specificities allows the family-wide prediction of preferred recognition sites	CELL			English	Article							DNA-BINDING SPECIFICITY; CRYSTAL-STRUCTURE; SEQUENCE RECOGNITION; ANGSTROM RESOLUTION; STRUCTURAL BASIS; IDENTIFYING DNA; MINOR-GROOVE; COMPLEX; PROTEIN; SEGMENTATION	We describe the comprehensive characterization of homeodomain DNA-binding specificities from a metazoan genome. The analysis of all 84 independent homeodomains from D. melanogaster reveals the breadth of DNA sequences that can be specified by this recognition motif. The majority of these factors can be organized into 11 different specificity groups, where the preferred recognition sequence between these groups can differ at up to four of the six core recognition positions. Analysis of the recognition motifs within these groups led to a catalog of common specificity determinants that may cooperate or compete to define the binding site preference. With these recognition principles, a homeodomain can be reengineered to create factors where its specificity is altered at the majority of recognition positions. This resource also allows prediction of homeodomain specificities from other organisms, which is demonstrated by the prediction and analysis of human homeodomain specificities.	[Noyes, Marcus B.; Wakabayashi, Atsuya; Brodsky, Michael H.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Wakabayashi, Atsuya; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Christensen, Ryan G.; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL)	Brodsky, MH (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.brodsky@umassmed.edu; scot.wolfe@umassmed.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249, R01HG002673, R21HG003721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008802] Funding Source: NIH RePORTER; NHGRI NIH HHS [R21 HG003721-02, R21 HG003721, HG002673, R01 HG002673, R01 HG000249-19, R01 HG000249, HG00249, 1R21HG003721] Funding Source: Medline; NIGMS NIH HHS [T32GM08802, T32 GM008802] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Benos PV, 2002, J MOL BIOL, V323, P701, DOI 10.1016/S0022-2836(02)00917-8; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Dave V, 2000, MOL CELL BIOL, V20, P7673, DOI 10.1128/MCB.20.20.7673-7684.2000; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Gruschus JM, 1997, BIOCHEMISTRY-US, V36, P5372, DOI 10.1021/bi9620060; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hazbun TR, 1997, BIOCHEMISTRY-US, V36, P3680, DOI 10.1021/bi9625206; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liu JJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni139; Mahony S, 2007, BIOINFORMATICS, V23, pI297, DOI 10.1093/bioinformatics/btm215; Mathias JR, 2001, J BIOL CHEM, V276, P32696, DOI 10.1074/jbc.M103097200; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PERCIVALSMITH A, 1990, EMBO J, V9, P3967, DOI 10.1002/j.1460-2075.1990.tb07617.x; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POMERANTZ JL, 1995, SCIENCE, V267, P93, DOI 10.1126/science.7809612; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; TREISMAN J, 1989, CELL, V59, P553; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wilson DS, 1999, NAT STRUCT BIOL, V6, P297, DOI 10.1038/7524; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	54	310	314	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1277	1289		10.1016/j.cell.2008.05.023	http://dx.doi.org/10.1016/j.cell.2008.05.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585360	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000257144600023
J	Andrews, ZB; Liu, ZW; Walllingford, N; Erion, DM; Borok, E; Friedman, JM; Tschop, MH; Shanabrough, M; Cline, G; Shulman, GI; Coppola, A; Gao, XB; Horvath, TL; Diano, S				Andrews, Zane B.; Liu, Zhong-Wu; Walllingford, Nicholas; Erion, Derek M.; Borok, Erzsebet; Friedman, Jeffery M.; Tschop, Matthias H.; Shanabrough, Marya; Cline, Gary; Shulman, Gerald I.; Coppola, Anna; Gao, Xiao-Bing; Horvath, Tamas L.; Diano, Sabrina			UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals	NATURE			English	Article							GROWTH-HORMONE SECRETAGOGUE; ACTIVATED PROTEIN-KINASE; BETA-CELL DYSFUNCTION; FATTY-ACID OXIDATION; ARCUATE NUCLEUS; UNCOUPLING PROTEIN-2; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; MESSENGER-RNA; POMC NEURONS	The gut-derived hormone ghrelin exerts its effect on the brain by regulating neuronal activity. Ghrelin-induced feeding behaviour is controlled by arcuate nucleus neurons that co-express neuropeptide Y and agouti-related protein (NPY/AgRP neurons). However, the intracellular mechanisms triggered by ghrelin to alter NPY/AgRP neuronal activity are poorly understood. Here we show that ghrelin initiates robust changes in hypothalamic mitochondrial respiration in mice that are dependent on uncoupling protein 2 (UCP2). Activation of this mitochondrial mechanism is critical for ghrelin-induced mitochondrial proliferation and electric activation of NPY/AgRP neurons, for ghrelin-triggered synaptic plasticity of pro-opiomelanocortin-expressing neurons, and for ghrelin-induced food intake. The UCP2-dependent action of ghrelin on NPY/AgRP neurons is driven by a hypothalamic fatty acid oxidation pathway involving AMPK, CPT1 and free radicals that are scavenged by UCP2. These results reveal a signalling modality connecting mitochondria-mediated effects of G-protein-coupled receptors on neuronal function and associated behaviour.	[Andrews, Zane B.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Andrews, Zane B.; Liu, Zhong-Wu; Walllingford, Nicholas; Erion, Derek M.; Borok, Erzsebet; Shanabrough, Marya; Coppola, Anna; Gao, Xiao-Bing; Horvath, Tamas L.; Diano, Sabrina] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Cline, Gary; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Horvath, Tamas L.; Diano, Sabrina] Yale Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Liu, Zhong-Wu] Yunyang Med Coll, Dept Neurobiol, Shiyan 442000, Hubei, Peoples R China; [Friedman, Jeffery M.] Rockefeller Univ, Genet Mol Lab, Howard Hughes Med Inst, New York, NY 10021 USA; [Tschop, Matthias H.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA	Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Rockefeller University; University System of Ohio; University of Cincinnati	Horvath, TL (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu; sabrina.diano@yale.edu	Wallingford, Nicholas/J-1367-2018; Gao, Xiao-Bing/C-3121-2011; Shulman, Gerald I./P-7176-2019; Liu, Zhong-Wu/C-2794-2011; Tschoep, Matthias H/I-5443-2014	Wallingford, Nicholas/0000-0003-2279-0480; Gao, Xiao-Bing/0000-0002-2035-4936; Shulman, Gerald I./0000-0003-1529-5668; Tschoep, Matthias/0000-0002-4744-371X; Andrews, Zane B./0000-0002-9097-7944	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022880] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG022880] Funding Source: Medline; NIDDK NIH HHS [R01 DK040936] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Horvath B, 2002, BIOCHEM PHARMACOL, V64, P369, DOI 10.1016/S0006-2952(02)01167-X; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	39	534	555	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2008	454	7206					846	851		10.1038/nature07181	http://dx.doi.org/10.1038/nature07181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18668043	Green Accepted			2022-12-24	WOS:000258398600027
J	Apostolou, E; Thanos, D				Apostolou, Effie; Thanos, Dimitris			Virus infection induces NF-kappa B-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression	CELL			English	Article							TRANSCRIPTION FACTORS; CHROMOSOME CONFORMATION; X-INACTIVATION; CELLS; ENHANCEOSOME; ACTIVATION; INDUCTION; BINDING; IL-4; COLOCALIZATION	Transcriptional activation of the IFN-beta gene by virus infection requires the cooperative assembly of an enhanceosome. We report that the stochastic and monoallelic expression of the IFN-beta gene depends on interchromosomal associations with three identified distinct genetic loci that could mediate binding of the limiting transcription factor NF-kappa B to the IFN-beta enhancer, thus triggering enhanceosome assembly and activation of transcription from this allele. The probability of a cell to express IFN-beta is dramatically increased when the cell is transfected with any of these loci. The secreted IFN-beta protein induces high- level expression of the enhanceosome factor IRF-7, which in turn promotes enhanceosome assembly and IFN-beta transcription from the remaining alleles and in other initially nonexpressing cells. Thus, the IFN-beta enhancer functions in a nonlinear fashion by working as a signal amplifier.	[Apostolou, Effie; Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, Athens 11527, Greece	Academy of Athens	Thanos, D (corresponding author), Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, 4 Soranou Efesiou St, Athens 11527, Greece.	thanos@bioacademy.gr	Apostolou, Effie/AAG-1559-2020; Thanos, Dimitris/AAE-5720-2019					Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Calado DP, 2006, J IMMUNOL, V177, P5358, DOI 10.4049/jimmunol.177.8.5358; de Laat W, 2007, CURR OPIN GENET DEV, V17, P456, DOI 10.1016/j.gde.2007.07.009; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Papatsenko D, 2007, CURR BIOL, V17, pR955, DOI 10.1016/j.cub.2007.09.035; Paun A, 2007, ADV VIRUS RES, V69, P1, DOI 10.1016/S0065-3527(06)69001-5; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; ZAWATZKY R, 1985, P NATL ACAD SCI USA, V82, P1136, DOI 10.1073/pnas.82.4.1136; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	40	190	195	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					85	96		10.1016/j.cell.2008.05.052	http://dx.doi.org/10.1016/j.cell.2008.05.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614013	Bronze			2022-12-24	WOS:000257513100016
J	Selbach, M; Schwanhausser, B; Thierfelder, N; Fang, Z; Khanin, R; Rajewsky, N				Selbach, Matthias; Schwanhaeusser, Bjoern; Thierfelder, Nadine; Fang, Zhuo; Khanin, Raya; Rajewsky, Nikolaus			Widespread changes in protein synthesis induced by microRNAs	NATURE			English	Article							MASS-SPECTROMETRY; AMINO-ACIDS; RNA; IDENTIFICATION; TARGETS; DETERMINANTS; DEGRADATION; REPRESSION; PROTEOMICS; TURNOVER	Animal microRNAs ( miRNAs) regulate gene expression by inhibiting translation and/ or by inducing degradation of target messenger RNAs. It is unknown how much translational control is exerted by miRNAs on a genome- wide scale. We used a new proteomic approach to measure changes in synthesis of several thousand proteins in response to miRNA transfection or endogenous miRNA knockdown. In parallel, we quantified mRNA levels using microarrays. Here we show that a single miRNA can repress the production of hundreds of proteins, but that this repression is typically relatively mild. A number of known features of the miRNA- binding site such as the seed sequence also govern repression of human protein synthesis, and we report additional target sequence characteristics. We demonstrate that, in addition to downregulating mRNA levels, miRNAs also directly repress translation of hundreds of genes. Finally, our data suggest that a miRNA can, by direct or indirect effects, tune protein synthesis from thousands of genes.	[Selbach, Matthias; Schwanhaeusser, Bjoern; Thierfelder, Nadine; Fang, Zhuo; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Khanin, Raya] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Glasgow	Selbach, M (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	matthias.selbach@mdc-berlin.de; rajewsky@mdc-berlin.de	Selbach, Matthias/C-5988-2008	Rajewsky, Nikolaus/0000-0002-4785-4332	DAAD scholarship	DAAD scholarship(Deutscher Akademischer Austausch Dienst (DAAD))	We thank J. Cox and M. Mann for early access to the MaxQuant software package, N. D. Socci for discussions, S. Schmidt, G. Born and N. Huebner for the hybridizations at the MDC microarray facility, C. Sommer for technical assistance, M. Huska and M. Andrade-Navarro for setting up the pSILAC website, P. Sharp for a CXCR4 luciferase construct, M. Peter for the IMP-1 reporters, and the Bundesministerium fur Bildung und Forschung for funding mass spectrometry instrumentation. R. K. gratefully acknowledges a DAAD scholarship for research stays at the MDC. pSILAC and microarray data can be queried at http://psilac.mdc-berlin.de.	Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; HE L, 2004, NAT REV GENET, V5, P522; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hofacker IL, 2007, NAT GENET, V39, P1191, DOI 10.1038/ng1007-1191; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; SCHWANHAEUSSER B, IN PRESS PROTEOMICS; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707	49	2657	2758	6	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					58	63		10.1038/nature07228	http://dx.doi.org/10.1038/nature07228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18668040				2022-12-24	WOS:000258890200036
J	Koh, K; Joiner, WJ; Wu, MN; Yue, ZF; Smith, CJ; Sehgal, A				Koh, Kyunghee; Joiner, William J.; Wu, Mark N.; Yue, Zhifeng; Smith, Corinne J.; Sehgal, Amita			Identification of SLEEPLESS, a sleep-promoting factor	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; REDUCED SLEEP; DEPRIVATION; HOMEOSTASIS; NARCOLEPSY; MUTATION; MODELS; MUTANT; GENES; REST	Sleep is an essential process conserved from flies to humans. The importance of sleep is underscored by its tight homeostatic control. Through a forward genetic screen, we identified a gene, sleepless, required for sleep in Drosophila. The sleepless gene encodes a brain-enriched, glycosylphosphatidylinositol-anchored protein. Loss of SLEEPLESS protein caused an extreme (> 80%) reduction in sleep; a moderate reduction in SLEEPLESS had minimal effects on baseline sleep but markedly reduced the amount of recovery sleep after sleep deprivation. Genetic and molecular analyses revealed that quiver, a mutation that impairs Shaker-dependent potassium current, is an allele of sleepless. Consistent with this finding, Shaker protein levels were reduced in sleepless mutants. We propose that SLEEPLESS is a signaling molecule that connects sleep drive to lowered membrane excitability.	[Koh, Kyunghee; Joiner, William J.; Yue, Zhifeng; Smith, Corinne J.; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA; [Wu, Mark N.] Univ Penn, Div Sleep Med, Dept Neurol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Koh, Kyunghee/0000-0003-0847-8204	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [P01 AG017628-070004, P01 AG017628, AG017628] Funding Source: Medline; NINDS NIH HHS [R01 NS072431] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hu WP, 2007, SLEEP, V30, P247; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Humphreys JM, 1996, GENOME, V39, P749, DOI 10.1139/g96-094; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Naylor E, 2000, J NEUROSCI, V20, P8138; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rosekind MR, 2005, SLEEP MED, V6, pS21, DOI 10.1016/S1389-9457(05)80005-X; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Wang JW, 2000, J NEUROSCI, V20, P5958, DOI 10.1523/JNEUROSCI.20-16-05958.2000; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277	37	212	220	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2008	321	5887					372	376		10.1126/science.1155942	http://dx.doi.org/10.1126/science.1155942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FB	18635795	Green Accepted			2022-12-24	WOS:000257713900040
J	Nader, PR; Bradley, RH; Houts, RM; McRitchie, SL; O'Brien, M				Nader, Philip R.; Bradley, Robert H.; Houts, Renate M.; McRitchie, Susan L.; O'Brien, Marion			Moderate-to-vigorous physical activity from ages 9 to 15 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; CHILDREN; YOUTH; ADOLESCENTS; GIRLS; ACCELEROMETER; POPULATION; OVERWEIGHT; LESSONS	Context Decreased physical activity plays a critical role in the increase in childhood obesity. Although at least 60 minutes per day of moderate- to- vigorous physical activity ( MVPA) is recommended, few longitudinal studies have determined the recent patterns of physical activity of youth. Objective To determine the patterns and determinants of MVPA of youth followed from ages 9 to 15 years. Design, Setting, and Participants Longitudinal descriptive analyses of the 1032 participants in the 1991- 2007 National Institute of Child Health and Human Development Study of Early Child Care and Youth Development birth cohort from 10 study sites who had accelerometer- determined minutes of MVPA at ages 9 ( year 2000), 11 ( 2002), 12 ( 2003), and 15 ( 2006) years. Participants included boys ( 517 [ 50.1%]) and girls ( 515 [ 49.9%]); 76.6% white ( n= 791); and 24.5% ( n= 231) lived in low- income families. Main Outcome Measure Mean MVPA minutes per day, determined by 4 to 7 days of monitored activity. Results At age 9 years, children engaged in MVPA approximately 3 hours per day on both weekends and weekdays. Weekday MVPA decreased by 38 minutes per year, while weekend MVPA decreased by 41 minutes per year. By age 15 years, adolescents were only engaging in MVPA for 49 minutes per weekday and 35 minutes per weekend day. Boys were more active than girls, spending 18 and 13 more minutes per day in MVPA on the weekdays and weekends, respectively. The rate of decrease in MVPA was the same for boys and girls. The estimated age at which girls crossed below the recommended 60 minutes of MVPA per day was approximately 13.1 years for weekday activity compared with boys at 14.7 years, and for weekend activity, girls crossed below the recommended 60 minutes of MVPA at 12.6 years compared with boys at 13.4 years. Conclusion In this study cohort, measured physical activity decreased significantly between ages 9 and 15 years.	[Nader, Philip R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Bradley, Robert H.] Univ Arkansas, Ctr Appl Studies Educ, Little Rock, AR 72204 USA; [Houts, Renate M.; McRitchie, Susan L.] RTI Int, Stat & Epidemiol, Res Triangle Pk, NC USA; [O'Brien, Marion] Univ N Carolina, Dept Human Dev & Family Studies, Greensboro, NC 27412 USA	University of California System; University of California San Diego; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Research Triangle Institute; University of North Carolina; University of North Carolina Greensboro	Nader, PR (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pnader@ucsd.edu	Houts, Renate/AAC-5304-2019	Houts, Renate/0000-0002-1518-2631; Vandell, Deborah/0000-0003-2373-9783				AARON DJ, 1993, MED SCI SPORT EXER, V25, P847, DOI 10.1249/00005768-199307000-00014; Aiken L.S., 1991, MULTIPLE REGRESSION; Anderson PM, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0001; [Anonymous], 1998, PHYS ACTIVITY CHILDR; [Anonymous], BMI BOD MASS IND BMI; Appelbaum M, 1999, DEV PSYCHOL, V35, P1399; Cavill N, 2001, PEDIATR EXERC SCI, V13, P12, DOI 10.1123/pes.13.1.12; Citro C.E., 1995, MEASURING POVERTY NE; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Frank GC, 2003, J SCHOOL HEALTH, V73, P51, DOI 10.1111/j.1746-1561.2003.tb03571.x; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; KANN L, 1999, MMWR-MORBID MORTAL W, V49, P1; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Koplan J., 2005, PREVENTING CHILDHOOD; Krishnamoorthy J. S., 2006, Social Policy Report, V20, P3; Pate RR, 2002, ANN EPIDEMIOL, V12, P303, DOI 10.1016/S1047-2797(01)00263-0; Pate RR, 2006, ARCH PEDIAT ADOL MED, V160, P1262, DOI 10.1001/archpedi.160.12.1262; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P294; Safrit MJ, 1989, MEASUREMENT CONCEPTS; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Thomas P, 2003, FISH PHYSIOL BIOCHEM, V28, P3, DOI 10.1023/B:FISH.0000030461.35242.57; Treuth MS, 2005, OBES RES, V13, P1606, DOI 10.1038/oby.2005.197; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; United States Department of Agriculture (USDA), DIET GUID AM; *US BUR CENS, 1990 CENS; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2	32	832	845	1	65	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2008	300	3					295	305		10.1001/jama.300.3.295	http://dx.doi.org/10.1001/jama.300.3.295			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325ZB	18632544	Bronze			2022-12-24	WOS:000257626600021
J	Gibbs, KA; Urbanowski, ML; Greenberg, EP				Gibbs, Karine A.; Urbanowski, Mark L.; Greenberg, E. Peter			Genetic determinants of self identity and social recognition in bacteria	SCIENCE			English	Article							PROTEUS-MIRABILIS; IDENTIFICATION	The bacterium Proteus mirabilis is capable of movement on solid surfaces by a type of motility called swarming. Boundaries form between swarming colonies of different P. mirabilis strains but not between colonies of a single strain. A fundamental requirement for boundary formation is the ability to discriminate between self and nonself. We have isolated mutants that form boundaries with their parent. The mutations map within a six- gene locus that we term ids for identification of self. Five of the genes in the ids locus are required for recognition of the parent strain as self. Three of the ids genes are interchangeable between strains, and two encode specific molecular identifiers.	[Gibbs, Karine A.; Greenberg, E. Peter] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Urbanowski, Mark L.] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa	Greenberg, EP (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	epgreen@u.washington.edu		Gibbs, Karine/0000-0002-1246-6401; Greenberg, Everett/0000-0001-9474-8041	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396] Funding Source: NIH RePORTER; NIAID NIH HHS [AI55396, T32 AI055396-04, T32 AI055396-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELAS R, 1991, J BACTERIOL, V173, P6289, DOI 10.1128/jb.173.19.6289-6293.1991; DIENES L, 1946, P SOC EXP BIOL MED, V63, P265; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Munson EL, 2002, J CLIN MICROBIOL, V40, P4285, DOI 10.1128/JCM.40.11.4285-4288.2002; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Sabbuba NA, 2004, J UROLOGY, V171, P1925, DOI 10.1097/01.ju.0000123062.26461.f9; Sabbuba NA, 2003, J CLIN MICROBIOL, V41, P4961, DOI 10.1128/JCM.41.11.4961-4965.2003; SENIOR BW, 1983, J MED MICROBIOL, V16, P323, DOI 10.1099/00222615-16-3-323; SENIOR BW, 1977, J GEN MICROBIOL, V102, P235, DOI 10.1099/00221287-102-2-235; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004	11	143	149	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2008	321	5886					256	259		10.1126/science.1160033	http://dx.doi.org/10.1126/science.1160033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324IS	18621670	Green Accepted			2022-12-24	WOS:000257512900042
J	Loytynoja, A; Goldman, N				Loytynoja, Ari; Goldman, Nick			Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis	SCIENCE			English	Article							NEUTRALIZING ANTIBODY; FUNCTIONAL ELEMENTS; GENOME; SENSITIVITY; INFECTION; ACCURACY; INSIGHTS; ENVELOPE; REGION	Genetic sequence alignment is the basis of many evolutionary and comparative studies, and errors in alignments lead to errors in the interpretation of evolutionary information in genomes. Traditional multiple sequence alignment methods disregard the phylogenetic implications of gap patterns that they create and infer systematically biased alignments with excess deletions and substitutions, too few insertions, and implausible insertion-deletion- event histories. We present a method that prevents these systematic errors by recognizing insertions and deletions as distinct evolutionary events. We show theoretically and practically that this improves the quality of sequence alignments and downstream analyses over a wide range of realistic alignment problems. These results suggest that insertions and sequence turnover are more common than is currently thought and challenge the conventional picture of sequence evolution and mechanisms of functional and structural changes.	[Loytynoja, Ari; Goldman, Nick] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, England	European Molecular Biology Laboratory (EMBL)	Loytynoja, A (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton CB10 1SD, England.	ari@ebi.ac.uk		Loytynoja, Ari/0000-0001-5389-6611; Goldman, Nick/0000-0001-8486-2211	Wellcome Trust [GR078968] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Jansson M, 2001, AIDS RES HUM RETROV, V17, P1405, DOI 10.1089/088922201753197079; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-278; Rosenberg MS, 2003, SYST BIOL, V52, P119, DOI 10.1080/10635150390132894; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; SULLIVAN N, 1993, J VIROL, V67, P3674, DOI 10.1128/JVI.67.6.3674-3679.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	17	560	568	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2008	320	5883					1632	1635		10.1126/science.1158395	http://dx.doi.org/10.1126/science.1158395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315NM	18566285				2022-12-24	WOS:000256886700047
J	Stefansson, H; Rujescu, D; Cichon, S; Pietilainen, OPH; Ingason, A; Steinberg, S; Fossdal, R; Sigurdsson, E; Sigmundsson, T; Buizer-Voskamp, JE; Hansen, T; Jakobsen, KD; Muglia, P; Francks, C; Matthews, PM; Gylfason, A; Halldorsson, BV; Gudbjartsson, D; Thorgeirsson, TE; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Bjornsson, A; Mattiasdottir, S; Blondal, T; Haraldsson, M; Magnusdottir, BB; Giegling, I; Moller, HJ; Hartmann, A; Shianna, KV; Ge, DL; Need, AC; Crombie, C; Fraser, G; Walker, N; Lonnqvist, J; Suvisaari, J; Tuulio-Henriksson, A; Paunio, T; Toulopoulou, T; Bramon, E; Di Forti, M; Murray, R; Ruggeri, M; Vassos, E; Tosato, S; Walshe, M; Li, T; Vasilescu, C; Muhleisen, TW; Wang, AG; Ullum, H; Djurovic, S; Melle, I; Olesen, J; Kiemeney, LA; Franke, B; Sabatti, C; Freimer, NB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Andreassen, OA; Ophoff, RA; Georgi, A; Rietschel, M; Werge, T; Petursson, H; Goldstein, DB; Nothen, MM; Peltonen, L; Collier, DA; St Clair, D; Stefansson, K				Stefansson, Hreinn; Rujescu, Dan; Cichon, Sven; Pietilainen, Olli P. H.; Ingason, Andres; Steinberg, Stacy; Fossdal, Ragnheidur; Sigurdsson, Engilbert; Sigmundsson, Thordur; Buizer-Voskamp, Jacobine E.; Hansen, Thomas; Jakobsen, Klaus D.; Muglia, Pierandrea; Francks, Clyde; Matthews, Paul M.; Gylfason, Arnaldur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel; Thorgeirsson, Thorgeir E.; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Bjornsson, Asgeir; Mattiasdottir, Sigurborg; Blondal, Thorarinn; Haraldsson, Magnus; Magnusdottir, Brynja B.; Giegling, Ina; Moeller, Hans-Juergen; Hartmann, Annette; Shianna, Kevin V.; Ge, Dongliang; Need, Anna C.; Crombie, Caroline; Fraser, Gillian; Walker, Nicholas; Lonnqvist, Jouko; Suvisaari, Jaana; Tuulio-Henriksson, Annamarie; Paunio, Tiina; Toulopoulou, Timi; Bramon, Elvira; Di Forti, Marta; Murray, Robin; Ruggeri, Mirella; Vassos, Evangelos; Tosato, Sarah; Walshe, Muriel; Li, Tao; Vasilescu, Catalina; Muehleisen, Thomas W.; Wang, August G.; Ullum, Henrik; Djurovic, Srdjan; Melle, Ingrid; Olesen, Jes; Kiemeney, Lambertus A.; Franke, Barbara; Sabatti, Chiara; Freimer, Nelson B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Andreassen, Ole A.; Ophoff, Roel A.; Georgi, Alexander; Rietschel, Marcella; Werge, Thomas; Petursson, Hannes; Goldstein, David B.; Noethen, Markus M.; Peltonen, Leena; Collier, David A.; St Clair, David; Stefansson, Kari		GROUP	Large recurrent microdeletions associated with schizophrenia	NATURE			English	Article							FRAGILE-X-SYNDROME; GENOMIC DISORDERS; LINKAGE ANALYSIS; DELETION; GENES; AMPLIFICATION; CHROMOSOMES; IMPAIRMENT; PHENOTYPE; DEFICIT	Reduced fecundity, associated with severe mental disorders(1), places negative selection pressure on risk alleles and may explain, in part, why common variants have not been found that confer risk of disorders such as autism(2), schizophrenia(3) and mental retardation(4). Thus, rare variants may account for a larger fraction of the overall genetic risk than previously assumed. In contrast to rare single nucleotide mutations, rare copy number variations ( CNVs) can be detected using genome- wide single nucleotide polymorphism arrays. This has led to the identification of CNVs associated with mental retardation(4,5) and autism(2). In a genome- wide search for CNVs associating with schizophrenia, we used a population-based sample to identify de novo CNVs by analysing 9,878 transmissions from parents to offspring. The 66 de novo CNVs identified were tested for association in a sample of 1,433 schizophrenia cases and 33,250 controls. Three deletions at 1q21.1, 15q11.2 and 15q13.3 showing nominal association with schizophrenia in the first sample ( phase I) were followed up in a second sample of 3,285 cases and 7,951 controls ( phase II). All three deletions significantly associate with schizophrenia and related psychoses in the combined sample. The identification of these rare, recurrent risk variants, having occurred independently in multiple founders and being subject to negative selection, is important in itself. CNV analysis may also point the way to the identification of additional and more prevalent risk variants in genes and pathways involved in schizophrenia.	[Crombie, Caroline; Fraser, Gillian; St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland; [Stefansson, Hreinn; Ingason, Andres; Steinberg, Stacy; Fossdal, Ragnheidur; Gylfason, Arnaldur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel; Thorgeirsson, Thorgeir E.; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Bjornsson, Asgeir; Mattiasdottir, Sigurborg; Blondal, Thorarinn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, CNS Div, IS-101 Reykjavik, Iceland; [Rujescu, Dan; Giegling, Ina; Moeller, Hans-Juergen; Hartmann, Annette] Univ Munich, Div Mol & Clin Neurobiol, Dept Psychiat, Genet Res Ctr, D-80336 Munich, Germany; [Cichon, Sven; Vasilescu, Catalina; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-53127 Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Pietilainen, Olli P. H.; Paunio, Tiina; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Biomedicum, Helsinki 00290, Finland; [Sigurdsson, Engilbert; Sigmundsson, Thordur; Haraldsson, Magnus; Magnusdottir, Brynja B.; Petursson, Hannes] Natl Univ Hosp Reykjavik, Dept Psychiat, IS-101 Reykjavik, Iceland; [Buizer-Voskamp, Jacobine E.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Netherlands Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Buizer-Voskamp, Jacobine E.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Hansen, Thomas; Jakobsen, Klaus D.; Werge, Thomas] Univ Copenhagen Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, DK-4000 Roskilde, Denmark; [Hansen, Thomas; Jakobsen, Klaus D.] Univ Copenhagen, Ctr Pharmacogenom, DK-2200 Copenhagen N, Denmark; [Muglia, Pierandrea; Francks, Clyde] GlaxoSmithKline R&D, Med Genet, I-37135 Verona, Italy; [Matthews, Paul M.] Hammersmith Hosp, GlaxoSmithKline, Clin Imaging Ctr, London W12 0NN, England; [Shianna, Kevin V.; Ge, Dongliang; Need, Anna C.; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Ctr Populat Genom & Pharmacogenet, Durham, NC 27708 USA; [Walker, Nicholas] Ravenscraig Hosp, Greenock PA16 9HA, Scotland; [Lonnqvist, Jouko; Suvisaari, Jaana; Tuulio-Henriksson, Annamarie; Paunio, Tiina] Natl Publ Hlth Inst, Dept Mental Hlth & Addict, FIN-00300 Helsinki, Finland; [Toulopoulou, Timi; Bramon, Elvira; Di Forti, Marta; Murray, Robin; Vassos, Evangelos; Walshe, Muriel; Li, Tao; Collier, David A.] Kings Coll London, Div Psychol Med & Social, Genet & Dev Psychiat Ctr, Inst Psychiat, London SE5 8AF, England; [Ruggeri, Mirella; Tosato, Sarah] Univ Verona, Sect Psychiat & Clin Psychol, I-37134 Verona, Italy; [Li, Tao; Collier, David A.] Sichuan Univ, W China Hosp, Dept Psychiat, Psychiat Lab, Chengdu 610041, Peoples R China; [Wang, August G.] Copenhagen Univ Hosp, Dept Clin Immunol, DK-2200 Copenhagen N, Denmark; [Ullum, Henrik] Copenhagen Univ Hosp, Mental Hlth Ctr Amager, DK-2300 Copenhagen S, Denmark; [Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Psychiat, N-0318 Oslo, Norway; [Djurovic, Srdjan; Melle, Ingrid; Andreassen, Ole A.] Ullevaal Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Djurovic, Srdjan; Melle, Ingrid; Andreassen, Ole A.] Ullevaal Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Olesen, Jes] Glostrup Cty Hosp, Dept Neurol, DK-2600 Glostrup, Denmark; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat EPIB 133, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol URO 659, NL-6500 HB Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Georgi, Alexander; Rietschel, Marcella] Heidelberg Univ, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peltonen, Leena] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [St Clair, David; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland	University of Aberdeen; University of Munich; University of Bonn; University of Bonn; Finland National Institute for Health & Welfare; University of Helsinki; Landspitali National University Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Copenhagen; University of Copenhagen; GlaxoSmithKline; GlaxoSmithKline; Imperial College London; Duke University; Finland National Institute for Health & Welfare; University of London; King's College London; University of Verona; Sichuan University; University of Copenhagen; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iceland	St Clair, D (corresponding author), Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland.	d.stclair@abdn.ac.uk; kari.stefansson@decode.is	Rujescu, Dan/GRS-3875-2022; Francks, Clyde/E-1384-2012; Bramon, Elvira/HHC-3809-2022; Ingason, Andres/G-6817-2012; Walshe, Muriel/E-5214-2010; Ruggeri, Mirella/E-6091-2010; van Os, Jim/I-9496-2012; Tosato, Sarah/E-6045-2010; Kiemeney, Lambertus A./D-3357-2009; Andreassen, Ole A./AAY-7531-2020; Melle, Ingrid S/B-4858-2011; Magnusdottir, Brynja/AAH-3482-2019; Sigurdsson, Engilbert/D-2486-2014; Krabbendam, Lydia/F-9163-2010; Myin-Germeys, Inez/L-5106-2014; Nöthen, Markus/B-2027-2009; van Os, Jim/C-2113-2014; Collier, David A/D-1649-2011; Cichon, Sven/B-9618-2014; Hartmann, Annette/AAS-6331-2021; Franke, Barbara/D-4836-2009; Werge, Thomas/G-7263-2012; Vassos, Evangelos/F-9825-2013; Bramon, Elvira/A-9463-2011; Francks, Clyde/AGU-8875-2022; Cichon, Sven/H-8803-2013; Muglia, Pierandrea/ABD-9235-2020; Goldstein, David/AAY-8125-2020; St Clair, David/AAN-2412-2021; Toulopoulou, Timothea/F-4458-2011; Hansen, Thomas Folkmann/O-5965-2014; Stefansson, Kari/AAE-7187-2019; Giegling, Ina/ABA-3677-2021; murray, robin/F-8658-2012; Walshe, Margaret/M-9102-2016	Francks, Clyde/0000-0002-9098-890X; Bramon, Elvira/0000-0003-1369-5983; Walshe, Muriel/0000-0001-6829-1105; van Os, Jim/0000-0002-7245-1586; Tosato, Sarah/0000-0002-9665-7538; Kiemeney, Lambertus A./0000-0002-2368-1326; Melle, Ingrid S/0000-0002-9783-548X; Magnusdottir, Brynja/0000-0002-6131-7269; Sigurdsson, Engilbert/0000-0001-9404-7982; Krabbendam, Lydia/0000-0003-4074-5149; Nöthen, Markus/0000-0002-8770-2464; Collier, David A/0000-0003-4087-1559; Cichon, Sven/0000-0002-9475-086X; Franke, Barbara/0000-0003-4375-6572; Vassos, Evangelos/0000-0001-6363-0438; Cichon, Sven/0000-0002-9475-086X; Muglia, Pierandrea/0000-0002-3973-8606; Hansen, Thomas Folkmann/0000-0001-6703-7762; Djurovic, Srdjan/0000-0002-8140-8061; murray, robin/0000-0003-0829-0519; Suvisaari, Jaana/0000-0001-7167-0990; Li, Tao/0000-0003-3831-901X; Olesen, Jes/0000-0002-6712-2702; Wang, August G./0000-0003-4518-0466; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Gudbjartsson, Daniel/0000-0002-5222-9857; Need, Anna/0000-0003-3955-8207; Walshe, Margaret/0000-0003-3924-8073; Myin-Germeys, Inez/0000-0002-3731-4930; Stefansson, Hreinn/0000-0002-9331-6666; Bruggeman, Richard/0000-0002-3238-8471; Ullum, Henrik/0000-0001-7306-9058; Ge, David/0000-0002-9732-8170; Matthews, Paul M/0000-0002-1619-8328; Andreassen, Ole A./0000-0002-4461-3568; Kong, Augustine/0000-0001-8193-5438; Halldorsson, Bjarni/0000-0003-0756-0767; Georgi, Alexander/0000-0002-1499-8524	EU grant [LSHM-CT-2006-037761 ( Project SGENE)]; Simons Foundation; NIMH [R01 MH078075]; Chinese National Natural Science Foundation; National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF); Alfried Krupp von Bohlen und Halbach-Stiftung;  [R01MH71425-01A1]; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075, R01MH071425] Funding Source: NIH RePORTER	EU grant(European Commission); Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfried Krupp von Bohlen und Halbach-Stiftung; ; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We want to thank the subjects and their relatives and staff at the recruitment centres. This work was sponsored by EU grant LSHM-CT-2006-037761 ( Project SGENE), Simons Foundation and R01MH71425-01A1. Genotyping of the Dutch samples was sponsored by NIMH funding, R01 MH078075. This work was also supported by the Chinese National Natural Science Foundation and the National Genomic Network (NGFN-2) of the German Federal Ministry of Education and Research (BMBF). M.M.N. received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. We are grateful to S. Schreiber and M. Krawczak for providing genotype data for PopGen controls, and to K.- H. Jockel and R. Erbel for providing control individuals from the Heinz Nixdorf Recall Study. We thank L. Priebe and M. Alblas for technical assistance and analysis of CNV data from Bonn.	Bieche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO;2-9; BORGHGRAEF M, 1990, CLIN GENET, V37, P341; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Dimitropoulos Anastasia, 2007, Curr Psychiatry Rep, V9, P159; Erdogan F, 2007, AM J MED GENET A, V143A, P172, DOI 10.1002/ajmg.a.31541; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hancock ML, 2008, J CELL BIOL, V181, P511, DOI 10.1083/jcb.200710037; Hastie T.J., 2017, STAT SCI; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Murthy SK, 2007, CYTOGENET GENOME RES, V116, P135, DOI 10.1159/000097433; Ni XQ, 2007, J MED GENET, V44, P532, DOI 10.1136/jmg.2006.047944; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; THOMPSON NM, 1994, AM J MED GENET, V54, P378, DOI 10.1002/ajmg.1320540418; VOGEL HP, 1979, ACTA PSYCHIAT SCAND, V60, P483, DOI 10.1111/j.1600-0447.1979.tb00558.x; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zheng YL, 2006, BIOCHEM BIOPH RES CO, V342, P1049, DOI 10.1016/j.bbrc.2006.02.041	30	1315	1373	3	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					232	U61		10.1038/nature07229	http://dx.doi.org/10.1038/nature07229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18668039	Green Published, Green Accepted			2022-12-24	WOS:000259090800049
J	Dimos, JT; Rodolfa, KT; Niakan, KK; Weisenthal, LM; Mitsumoto, H; Chung, W; Croft, GF; Saphier, G; Leibel, R; Goland, R; Wichterle, H; Henderson, CE; Eggan, K				Dimos, John T.; Rodolfa, Kit T.; Niakan, Kathy K.; Weisenthal, Laurin M.; Mitsumoto, Hiroshi; Chung, Wendy; Croft, Gist F.; Saphier, Genevieve; Leibel, Rudy; Goland, Robin; Wichterle, Hynek; Henderson, Christopher E.; Eggan, Kevin			Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons	SCIENCE			English	Article							DIRECTED DIFFERENTIATION; FIBROBLASTS; PROGRESSION; DEATH; LINES	The generation of pluripotent stem cells from an individual patient would enable the large- scale production of the cell types affected by that patient's disease. These cells could in turn be used for disease modeling, drug discovery, and eventually autologous cell replacement therapies. Although recent studies have demonstrated the reprogramming of human fibroblasts to a pluripotent state, it remains unclear whether these induced pluripotent stem (iPS) cells can be produced directly from elderly patients with chronic disease. We have generated iPS cells from an 82- year- old woman diagnosed with a familial form of amyotrophic lateral sclerosis (ALS). These patient- specific iPS cells possess properties of embryonic stem cells and were successfully directed to differentiate into motor neurons, the cell type destroyed in ALS.	[Dimos, John T.; Rodolfa, Kit T.; Niakan, Kathy K.; Weisenthal, Laurin M.; Saphier, Genevieve; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Stowers Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rodolfa, Kit T.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mitsumoto, Hiroshi] Columbia Univ, Med Ctr, Inst Neurol, Eleanor & Lou Gehrig MDA ALS Res Ctr, New York, NY 10032 USA; [Mitsumoto, Hiroshi; Chung, Wendy; Croft, Gist F.; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Chung, Wendy; Leibel, Rudy] Columbia Univ, Coll Phys & Surg, Div Mol Genet, New York, NY 10032 USA; [Chung, Wendy; Leibel, Rudy] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Croft, Gist F.; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Croft, Gist F.; Wichterle, Hynek; Henderson, Christopher E.] Columbia Univ, Med Ctr, Dept Neurol & Neurosci, New York, NY 10032 USA; [Goland, Robin] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Goland, Robin] Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Harvard University; Stowers Institute for Medical Research; Harvard University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Eggan, K (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Stowers Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018	Niakan, Kathy/0000-0003-1646-4734; Rodolfa, Kit/0000-0002-0829-1282; Henderson, Christopher/0000-0002-9936-3279; Croft, Gist/0000-0002-9721-0148; Wichterle, Hynek/0000-0002-7817-0080	Project ALS/Jenifer Estess Laboratory for Stem Cell Research; Harvard Stem Cell Institute; Project ALS; SMA Foundation; Claire and Leonard Tow Foundation; MDA Wings Over Wall Street; Spina and Bowen families; New York Stem Cell Foundation	Project ALS/Jenifer Estess Laboratory for Stem Cell Research; Harvard Stem Cell Institute; Project ALS; SMA Foundation; Claire and Leonard Tow Foundation; MDA Wings Over Wall Street(Muscular Dystrophy Association); Spina and Bowen families; New York Stem Cell Foundation	We thank D. Melton, D. Egli, A. McMahon, K. Osafune, K. Plath, S. Fielding, and K. Hochedlinger for helpful discussions; T. Kitamura, S. Yamanaka, and R. Weinberg for providing viral vectors through Addgene; L. Rubin for generously providing the small-molecule SHH agonist; the Developmental Studies Hybridoma Bank for monoclonal antibodies; and J. Montes and M. Lee for their support in obtaining institutional review board approval and culturing biopsies. This collaboration was supported and enabled by the Project ALS/Jenifer Estess Laboratory for Stem Cell Research, where much of the Columbia research was carried out. Supported by the Harvard Stem Cell Institute, Project ALS, the SMA Foundation, the Claire and Leonard Tow Foundation, MDA Wings Over Wall Street, the Spina and Bowen families, and the New York Stem Cell Foundation. K. T. R. is a National Science Foundation predoctoral fellow, G. F. C. is a Project ALS predoctoral fellow, and K. E. is a fellow of the John D. and Catherine T. MacArthur Foundation.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Cibelli J, 2007, SCIENCE, V318, P1879, DOI 10.1126/science.1153229; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Eggan K, 2007, CLONING STEM CELLS, V9, P21, DOI 10.1089/clo.2006.0013; Ferrera L, 2003, AMYOTROPH LATERAL SC, V4, P167, DOI 10.1080/aml.4.3.167.170; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	1467	1656	8	509	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1218	1221		10.1126/science.1158799	http://dx.doi.org/10.1126/science.1158799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18669821				2022-12-24	WOS:000258754400047
J	Pillow, JW; Shlens, J; Paninski, L; Sher, A; Litke, AM; Chichilnisky, EJ; Simoncelli, EP				Pillow, Jonathan W.; Shlens, Jonathon; Paninski, Liam; Sher, Alexander; Litke, Alan M.; Chichilnisky, E. J.; Simoncelli, Eero P.			Spatio-temporal correlations and visual signalling in a complete neuronal population	NATURE			English	Article							GANGLION-CELLS; INFORMATION; CONNECTIVITY; SPIKES; CODE	Statistical dependencies in the responses of sensory neurons govern both the amount of stimulus information conveyed and the means by which downstream neurons can extract it. Although a variety of measurements indicate the existence of such dependencies(1-3), their origin and importance for neural coding are poorly understood. Here we analyse the functional significance of correlated firing in a complete population of macaque parasol retinal ganglion cells using a model of multi-neuron spikeresponses(4,5). The model, with parameters fit directly to physiological data, simultaneously captures both the stimulus dependence and detailed spatio-temporal correlations in population responses, and provides two insights into the structure of the neural code. First, neural encoding at the population level is less noisy than one would expect from the variability of individual neurons: spike times are more precise, and can be predicted more accurately when the spiking of neighbouring neurons is taken into account. Second, correlations provide additional sensory information: optimal, model- based decoding that exploits the response correlation structure extracts 20% more information about the visual scene than decoding under the assumption of independence, and preserves 40% more visual information than optimal linear decoding(6). This model- based approach reveals the role of correlated activity in the retinal coding of visual stimuli, and provides a general framework for understanding the importance of correlated activity in populations of neurons.	[Pillow, Jonathan W.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst, San Diego, CA 92037 USA; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10027 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY 10003 USA	University of London; University College London; Salk Institute; Columbia University; Columbia University; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; New York University; New York University	Pillow, JW (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	pillow@gatsby.ucl.ac.uk		Simoncelli, Eero/0000-0002-1206-527X; Chichilnisky, E.J./0000-0002-5613-0248; Sher, Alexander/0000-0001-6655-6456; Pillow, Jonathan/0000-0002-3638-8831	Royal Society USA/Canada Research Fellowship; NSF IGERT [DGE-03345]; NEI [EY018003]; Gatsby Foundation Pilot Grant; Burroughs Wellcome Fund Career Award at the Scientific Interface; US National Science Foundation [PHY-0417175]; McKnight Foundation; HHMI; NATIONAL EYE INSTITUTE [R01EY018003] Funding Source: NIH RePORTER	Royal Society USA/Canada Research Fellowship; NSF IGERT(National Science Foundation (NSF)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gatsby Foundation Pilot Grant; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); US National Science Foundation(National Science Foundation (NSF)); McKnight Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Bethge, C. Brody, D. Butts, P. Latham, M. Lengyel, S. Nirenberg and R. Sussman for comments and discussions; G. Field, M. Greschner, J. Gauthier and C. Hulse for experimental assistance; M. I. Grivich, D. Petrusca, W. Dabrowski, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development; H. Fox, M. Taffe, E. Callaway and K. Osborn for providing access to retinas; and S. Barry for machining. Funding was provided a Royal Society USA/Canada Research Fellowship ( J. W. P.); NSF IGERT DGE-03345 ( J. S.); NEI grant EY018003 ( E. J. C., L. P. and E. P. S.); Gatsby Foundation Pilot Grant ( L. P.); Burroughs Wellcome Fund Career Award at the Scientific Interface ( A. S.); US National Science Foundation grant PHY-0417175 ( A. M. L.); McKnight Foundation ( A. M. L. and E. J. C.); and HHMI ( J. W. P., L. P. and E. P. S.).	Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Latham PE, 2005, J NEUROSCI, V25, P5195, DOI 10.1523/JNEUROSCI.5319-04.2005; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Panzeri S, 2001, VIS COGN, V8, P531, DOI 10.1080/13506280143000106; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pillow JW, 2008, ADV NEURAL INFORM PR, P1161; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Rigat F, 2006, BAYESIAN ANAL, V1, P733, DOI 10.1214/06-BA124; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schneidman E, 2003, J NEUROSCI, V23, P11539; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308	30	779	794	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					995	U37		10.1038/nature07140	http://dx.doi.org/10.1038/nature07140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18650810	Green Accepted			2022-12-24	WOS:000258591000039
J	Bassermann, F; Frescas, D; Guardavaccaro, D; Busino, L; Peschiaroli, A; Pagano, M				Bassermann, Florian; Frescas, David; Guardavaccaro, Daniele; Busino, Luca; Peschiaroli, Angelo; Pagano, Michele			The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint	CELL			English	Article							SCF-BETA-TRCP; ANAPHASE-PROMOTING COMPLEX; POLO-LIKE KINASE-1; CELL-CYCLE; MEDIATED DEGRADATION; CLASPIN; PHOSPHATASE; RECOVERY; PROLIFERATION; CENTROSOME	In response to DNA damage in G2, mammalian cells must avoid entry into mitosis and instead initiate DNA repair. Here, we show that, in response to genotoxic stress in G2, the phosphatase Cdc14B translocates from the nucleolus to the nucleoplasm and induces the activation of the ubiquitin ligase APC/C(Cdh1), with the consequent degradation of Plk1, a prominent mitotic kinase. This process induces the stabilization of Claspin, an activator of the DNA-damage checkpoint, and Wee1, an inhibitor of cell-cycle progression, and allows an efficient G2 checkpoint. As a by-product of APC/C(Cdh1) reactivation in DNA-damaged G2 cells, Claspin, which we show to be an APC/C(Cdh1) substrate in G1, is targeted for degradation. However, this process is counteracted by the deubiquitylating enzyme Usp28 to permit Claspin-mediated activation of Chk1 in response to DNA damage. These findings define a novel pathway that is crucial for the G2 DNA-damage-response checkpoint.	[Bassermann, Florian; Frescas, David; Guardavaccaro, Daniele; Busino, Luca; Peschiaroli, Angelo; Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@nyumc.org	Holt, Janet E/B-2415-2013	pagano, michele/0000-0003-3210-2442; Guardavaccaro, Daniele/0000-0002-4517-1765; PESCHIAROLI, ANGELO/0000-0001-6311-2382	NATIONAL CANCER INSTITUTE [R37CA076584, R21CA125173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R37 CA076584, R21 CA125173, R37 CA076584-11, R37 CA076584-09, R37 CA076584-10, R21 CA125173-02, R21 CA125173-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM057587-10, R01 GM057587-09S1, R01 GM057587, R01 GM057587-09, R01 GM057587-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kaiser BK, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-27; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Mitra J, 2006, CELL CYCLE, V5, P661; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tsimaratou K, 2007, J PATHOL, V211, P331, DOI 10.1002/path.2095; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	32	312	327	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2008	134	2					256	267		10.1016/j.cell.2008.05.043	http://dx.doi.org/10.1016/j.cell.2008.05.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	329SU	18662541	Green Accepted, Bronze			2022-12-24	WOS:000257891700015
J	Kuris, AM; Hechinger, RF; Shaw, JC; Whitney, KL; Aguirre-Macedo, L; Boch, CA; Dobson, AP; Dunham, EJ; Fredensborg, BL; Huspeni, TC; Lorda, J; Mababa, L; Mancini, FT; Mora, AB; Pickering, M; Talhouk, NL; Torchin, ME; Lafferty, KD				Kuris, Armand M.; Hechinger, Ryan F.; Shaw, Jenny C.; Whitney, Kathleen L.; Aguirre-Macedo, Leopoldina; Boch, Charlie A.; Dobson, Andrew P.; Dunham, Eleca J.; Fredensborg, Brian L.; Huspeni, Todd C.; Lorda, Julio; Mababa, Luzviminda; Mancini, Frank T.; Mora, Adrienne B.; Pickering, Maria; Talhouk, Nadia L.; Torchin, Mark E.; Lafferty, Kevin D.			Ecosystem energetic implications of parasite and free-living biomass in three estuaries	NATURE			English	Article							REPRODUCTIVE EFFORT	Parasites can have strong impacts but are thought to contribute little biomass to ecosystems(1-3). We quantified the biomass of free-living and parasitic species in three estuaries on the Pacific coast of California and Baja California. Here we show that parasites have substantial biomass in these ecosystems. We found that parasite biomass exceeded that of top predators. The biomass of trematodes was particularly high, being comparable to that of the abundant birds, fishes, burrowing shrimps and polychaetes. Trophically transmitted parasites and parasitic castrators subsumed more biomass than did other parasitic functional groups. The extended phenotype biomass controlled by parasitic castrators sometimes exceeded that of their uninfected hosts. The annual production of free-swimming trematode transmission stages was greater than the combined biomass of all quantified parasites and was also greater than bird biomass. This biomass and productivity of parasites implies a profound role for infectious processes in these estuaries.	[Kuris, Armand M.; Hechinger, Ryan F.; Shaw, Jenny C.; Whitney, Kathleen L.; Boch, Charlie A.; Lorda, Julio; Mababa, Luzviminda; Talhouk, Nadia L.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Aguirre-Macedo, Leopoldina] IPN, Ctr Invest & Estud Avanzados, Merida 97310, Mexico; [Dobson, Andrew P.] Princeton Univ, Princeton, NJ 08544 USA; [Dunham, Eleca J.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA; [Fredensborg, Brian L.] Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78539 USA; [Huspeni, Todd C.] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Mancini, Frank T.] NOAA, Natl Marine Fisheries Serv, Pacific Isl Fisheries Res Ctr, Honolulu, HI 96822 USA; [Mora, Adrienne B.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Pickering, Maria] Univ Connecticut, Unit 3043, Storrs, CT 06269 USA; [Torchin, Mark E.] Smithsonian Trop Res Inst, Balboa 03092, Panama; [Lafferty, Kevin D.] Univ Calif Santa Barbara, Western Ecol Res Ctr, US Geol Survey, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Instituto Politecnico Nacional - Mexico; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Rio Grande Valley; University of Wisconsin System; University of Wisconsin Stevens Point; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Riverside; University of Connecticut; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Kuris, AM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	kuris@lifesci.ucsb.edu	Aguirre-Macedo, Ma. Leopoldina/P-7812-2019; Lorda, Julio/A-3951-2009; Fredensborg, Brian Lund/G-1548-2014; Fredensborg, Brian L/A-5632-2010; Hechinger, Ryan/F-6754-2010; Lafferty, Kevin D./B-3888-2009; Lorda, Julio/J-1464-2019; Fredensborg, Brian Lund/N-9008-2019; Aguirre-Macedo, Ma. L/A-2511-2008	Aguirre-Macedo, Ma. Leopoldina/0000-0002-3910-8305; Lorda, Julio/0000-0002-4293-7518; Fredensborg, Brian Lund/0000-0002-4837-5974; Lorda, Julio/0000-0002-4293-7518; Fredensborg, Brian Lund/0000-0002-4837-5974; Aguirre-Macedo, Ma. L/0000-0002-3910-8305; Shaw, Jenny/0000-0002-2113-3692; Hechinger, Ryan/0000-0002-6633-253X				ALLEN LG, 1982, FISH B-NOAA, V80, P769; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P43, DOI 10.3354/meps320043; BROWNE RA, 1978, OECOLOGIA, V37, P23, DOI 10.1007/BF00349988; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CALOW P, 1983, PARASITOLOGY, V86, P197, DOI 10.1017/S0031182000050897; Dawkins R., 1982, pi; Erwin RM, 1996, ESTUARIES, V19, P213, DOI 10.2307/1352226; Fingerut JT, 2003, BIOL BULL-US, V205, P110, DOI 10.2307/1543232; Hechinger RF, 2009, EVOL ECOL, V23, P651, DOI 10.1007/s10682-008-9262-4; HUGHES RN, 1980, OECOLOGIA, V47, P130, DOI 10.1007/BF00541788; HUXHAM M, 1995, J ANIM ECOL, V64, P168, DOI 10.2307/5752; Kuris AM, 2000, DEV AN VET, V32, P9; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lafferty KD, 1996, ECOLOGY, V77, P1390, DOI 10.2307/2265536; Lafferty Kevin D., 2006, P119; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loreau Michel, 2005, P13; McLusky D., 1989, ESTUARINE ECOSYSTEM, V2nd; OBRIEN J, 1985, CRUSTACEAN ISSUES 3, P191; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Poulin R, 1999, INT J PARASITOL, V29, P903, DOI 10.1016/S0020-7519(99)00045-4; RAMER B A, 1991, Western Birds, V22, P157; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; Spruzen FL, 2008, HYDROBIOLOGIA, V598, P325, DOI 10.1007/s10750-007-9166-2; Thompson RM, 2005, J ANIM ECOL, V74, P77, DOI 10.1111/j.1365-2656.2004.00899.x; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	30	416	432	2	201	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2008	454	7203					515	518		10.1038/nature06970	http://dx.doi.org/10.1038/nature06970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18650923				2022-12-24	WOS:000257860300051
J	Levinson, NM; Seeliger, MA; Cole, PA; Kuriyan, J				Levinson, Nicholas M.; Seeliger, Markus A.; Cole, Philip A.; Kuriyan, John			Structural basis for the recognition of c-Src by its inactivator Csk	CELL			English	Article							PROTEIN-TYROSINE KINASE; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; V-SRC; DOMAIN; COMPLEX; ACTIVATION; PHOSPHORYLATION; RECEPTOR; ABL	The catalytic activity of the Src family of tyrosine kinases is suppressed byphosphorylation on a tyrosine residue located near the C terminus (Tyr 527 in c- Src), which is catalyzed by C-terminal Src Kinase (Csk). Given the promiscuity of most tyrosine kinases, it is remarkable that the C-terminal tails of the Src family kinases are the only known targets of Csk. We have determined the crystal structure of a complex between the kinase domains of Csk and c-Src at 2.9 angstrom resolution, revealing that interactions between these kinases position the C-terminal tail of c-Src at the edge of the active site of Csk. Csk cannot phosphorylate substrates that lack this docking mechanism because the conventional substrate binding site used by most tyrosine kinases to recognize substrates is destabilized in Csk by a deletion in the activation loop.	[Levinson, Nicholas M.; Seeliger, Markus A.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Howard Hughes Med Inst, Dept Chem,Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Howard Hughes Med Inst, Dept Chem,Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Seeliger, Markus A/D-6409-2013	Seeliger, Markus/0000-0003-0990-1756; Levinson, Nicholas/0000-0003-4338-8087	NATIONAL CANCER INSTITUTE [R29CA074305, R01CA074305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM080097] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R29 CA074305-04, R29 CA074305, R01 CA074305, R01 CA074305-07] Funding Source: Medline; NIGMS NIH HHS [K99 GM080097] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Breitenlechner CB, 2005, J MOL BIOL, V353, P222, DOI 10.1016/j.jmb.2005.08.023; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chong YP, 2006, J BIOL CHEM, V281, P32988, DOI 10.1074/jbc.M602951200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Creighton T. E., 1993, PROTEINS STRUCTURES; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kinoshita T, 2006, BIOCHEM BIOPH RES CO, V346, P840, DOI 10.1016/j.bbrc.2006.05.212; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Konkol L, 2000, BIOCHEMISTRY-US, V39, P255, DOI 10.1021/bi992096j; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Lee S, 2003, P NATL ACAD SCI USA, V100, P14707, DOI 10.1073/pnas.2534493100; Lee SS, 2006, J BIOL CHEM, V281, P8183, DOI 10.1074/jbc.M508120200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lieser SA, 2005, J BIOL CHEM, V280, P7769, DOI 10.1074/jbc.M411736200; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lin XF, 2003, J BIOL CHEM, V278, P24072, DOI 10.1074/jbc.M210596200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; NEET K, 1995, MOL CELL BIOL, V15, P4908; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; OKADA M, 1991, J BIOL CHEM, V266, P24249; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sun GQ, 1999, ARCH BIOCHEM BIOPHYS, V367, P167, DOI 10.1006/abbi.1999.1253; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Takashima Y, 2003, BIOCHEMISTRY-US, V42, P3567, DOI 10.1021/bi0272499; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; Till JH, 1999, J BIOL CHEM, V274, P4995, DOI 10.1074/jbc.274.8.4995; Walkenhorst J, 1996, ONCOGENE, V12, P1513; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yokoyama N, 1999, FEBS LETT, V456, P403, DOI 10.1016/S0014-5793(99)00992-8; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	66	91	95	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					124	134		10.1016/j.cell.2008.05.051	http://dx.doi.org/10.1016/j.cell.2008.05.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614016	Bronze, Green Accepted			2022-12-24	WOS:000257513100019
J	Lee, JE; Fusco, ML; Hessell, AJ; Oswald, WB; Burton, DR; Saphire, EO				Lee, Jeffrey E.; Fusco, Marnie L.; Hessell, Ann J.; Oswald, Wendelien B.; Burton, Dennis R.; Saphire, Erica Ollmann			Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor	NATURE			English	Article							GP120 ENVELOPE GLYCOPROTEIN; NEUTRALIZING HUMAN-ANTIBODY; INTERNAL FUSION PEPTIDE; HEMORRHAGIC-FEVER; MARBURG VIRUSES; VIRION GLYCOPROTEINS; CYSTEINES FLANKING; NONHUMAN-PRIMATES; VACCINE PROTECTS; FILOVIRUS ENTRY	Ebola virus ( EBOV) entry requires the surface glycoprotein ( GP) to initiate attachment and fusion of viral and host membranes. Here we report the crystal structure of EBOV GP in its trimeric, pre- fusion conformation ( GP1+GP2) bound to a neutralizing antibody, KZ52, derived from a human survivor of the 1995 Kikwit outbreak. Three GP1 viral attachment subunits assemble to form a chalice, cradled by the GP2 fusion subunits, while a novel glycan cap and projected mucin- like domain restrict access to the conserved receptor- binding site sequestered in the chalice bowl. The glycocalyx surrounding GP is likely central to immune evasion and may explain why survivors have insignificant neutralizing antibody titres. KZ52 recognizes a protein epitope at the chalice base where it clamps several regions of the pre- fusion GP2 to the amino terminus of GP1. This structure provides a template for unravelling the mechanism of EBOV GP- mediated fusion and for future immunotherapeutic development.	[Lee, Jeffrey E.; Fusco, Marnie L.; Hessell, Ann J.; Oswald, Wendelien B.; Burton, Dennis R.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Saphire, EO (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd,Mail Drop IMM-2, La Jolla, CA 92037 USA.	erica@scripps.edu	Saphire, Erica/A-7055-2009	Hessell, Ann/0000-0001-7471-9366; Saphire, Erica Ollmann/0000-0002-1206-7451	NIAID NIH HHS [R01 AI067927-03, R01 AI067927, R21 AI053423-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067927, R21AI053423] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alsop Z, 2007, LANCET, V370, P2085, DOI 10.1016/S0140-6736(07)61880-7; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; BRUNGER AT, 1991, ACTA CRYSTALLOGR A, V47, P195, DOI 10.1107/S0108767390011795; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delos SE, 2000, J VIROL, V74, P9738, DOI 10.1128/JVI.74.20.9738-9741.2000; Delos SE, 2008, J VIROL, V82, P3131, DOI 10.1128/JVI.02266-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P163, DOI 10.1001/jama.294.2.163; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; JOHNSON KM, 1977, LANCET, V1, P569; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Lutteke T, 2004, CARBOHYD RES, V339, P1015, DOI 10.1016/j.carres.2003.09.038; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J INFECT DIS, V179, pS235, DOI 10.1086/514280; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Mpanju OM, 2006, VIRUS RES, V121, P205, DOI 10.1016/j.virusres.2006.06.002; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; PETERS CJ, 1996, FIELDS VIROLOGY, V1, P1161; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RITCHIE GE, 2005, THESIS U OXFORD; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Sanchez A, 2007, J INFECT DIS, V196, pS251, DOI 10.1086/520597; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; *WHO, 2007, EB HAEM FEV UG; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	68	513	551	2	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					177	U27		10.1038/nature07082	http://dx.doi.org/10.1038/nature07082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18615077	Green Accepted			2022-12-24	WOS:000257466900035
J	Sanderson, MJ				Sanderson, Michael J.			Phylogenetic signal in the eukaryotic tree of life	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTERNAL SUPPORT; EVOLUTION	Molecular sequence data have been sampled from 10% of all species known to science. Although it is not yet feasible to assemble these data into a single phylogenetic tree of life, it is possible to quantify how much phylogenetic signal is present. Analysis of 14,289 phylogenies built from 2.6 million sequences in GenBank suggests that signal is strong in vertebrates and specific groups of nonvertebrate model organisms. Across eukaryotes, however, although phylogenetic evidence is very broadly distributed, for the average species in the database it is equivalent to less than one well- supported gene tree. This analysis shows that a stronger sampling effort aimed at genomic depth, in addition to taxonomic breadth, will be required to build high- resolution phylogenetic trees at this scale.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Sanderson, MJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	sanderm@email.arizona.edu						Ane C, 2007, MOL BIOL EVOL, V24, P412; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hughes J, 2006, MOL BIOL EVOL, V23, P268, DOI 10.1093/molbev/msj041; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kajita T, 2001, SYST BOT, V26, P515; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Salamin N, 2003, MOL PHYLOGENET EVOL, V27, P528, DOI 10.1016/S1055-7903(03)00011-3; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson MJ, 2007, AUST SYST BOT, V20, P287, DOI 10.1071/SB07006; SANDERSON MJ, 2007, PHYLOTA BROWSER; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846	24	36	42	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2008	321	5885					121	123		10.1126/science.1154449	http://dx.doi.org/10.1126/science.1154449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QE	18599787				2022-12-24	WOS:000257320800051
J	Hogg, R; Lima, V; Sterne, JAC; Grabar, S; Battegay, M; Bonarek, M; Monforte, AD; Esteve, A; Gill, MJ; Harris, R; Justice, A; Hayden, A; Lampe, F; Mocroft, A; Mugavero, MJ; Staszewski, S; Wasmuth, JC; van Sighem, A; Kitahata, M; Guest, J; Egger, M; May, M				Hogg, Robert; Lima, Viviane; Sterne, Jonathan A. C.; Grabar, Sophie; Battegay, Manuel; Bonarek, Mojgan; Monforte, Antonella D'Arminio; Esteve, Anna; Gill, M. John; Harris, Ross; Justice, Amy; Hayden, Anna; Lampe, Fiona; Mocroft, Amanda; Mugavero, Michael J.; Staszewski, Schlomo; Wasmuth, Jan-Christian; van Sighem, Ard; Kitahata, Mari; Guest, Jodie; Egger, Matthias; May, Margaret		Antiretroviral Therapy Cohort Coll	Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED INDIVIDUALS; HIV-1-INFECTED PATIENTS; DRUG USE; AIDS; MORTALITY; SURVIVAL; DEATH; IMPACT; LAMIVUDINE	Background Combination antiretroviral therapy has led to significant increases in survival and quality of life, but at a population-level the effect on life expectancy is not well understood. Our objective was to compare changes in mortality and life expectancy among HIV-positive individuals on combination antiretroviral therapy. Methods The Antiretroviral Therapy Cohort Collaboration is a multinational collaboration of HIV cohort studies in Europe and North America. Patients were included in this analysis if they were aged 16 years or over and antiretroviral-naive when initiating combination therapy. We constructed abridged life tables to estimate life expectancies for individuals on combination antiretroviral therapy in 1996-99, 2000-02, and 2003-05, and stratified by sex, baseline CD4 cell count, and history of injecting drug use. The average number of years remaining to be lived by those treated with combination antiretroviral therapy at 20 and 35 years of age was estimated. Potential years of life lost from 20 to 64 years of age and crude mortality rates were also calculated. Findings 18 587, 13 914, and 10 854 eligible patients initiated combination antiretroviral therapy in 1996-99, 2000-02, and 2003-05, respectively. 2056 (4.7%) deaths were observed during the study period, with crude mortality rates decreasing from 16.3 deaths per 1000 person-years in 1996-99 to 10 . 0 deaths per 1000 person-years in 2003-05. Potential years of life lost per 1000 person-years also decreased over the same time, from 366 to 189 years. Life expectancy at age 20 years increased from 36. 1 (S E 0 . 6) years to 49.4 (0.5) years. Women had higher life expectancies than did men. Patients with presumed transmission via injecting drug use had lower life expectancies than did those from other transmission groups (32.6 [1. 1] years vs 44.7 [0.3] years in 2003-05). Life expectancy was lower in patients with lower baseline CD4 cell counts than in those with higher baseline counts (32.4 [1. 1] years for CD4 cell counts below 100 cells per mu L vs 50.4 [0.4] years for counts of 200 cells per mu L or more). Interpretation life expectancy in HIV-infected patients treated with combination antiretroviral therapy increased between 1996 and 2005, although there is considerable variability between subgroups of patients. The average number of years remaining to be lived at age 20 years was about two-thirds of that in the general population in these countries. Funding UK Medical Research Council, GlaxoSmithKIine.	[Hogg, Robert; Lima, Viviane; Hayden, Anna] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Hogg, Robert] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Sterne, Jonathan A. C.; Harris, Ross; May, Margaret] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Grabar, Sophie] INSERM, U 720, F-75013 Paris, France; [Grabar, Sophie] Univ Paris 05, Fac Med, Paris, France; [Grabar, Sophie] Hop Cochin, AP HP, F-75674 Paris, France; [Battegay, Manuel] Univ Basel, Div Infect Dis & Hosp Epidemiol, CH-4003 Basel, Switzerland; [Bonarek, Mojgan] Univ Victor Segalen, INSERM, U897, Bordeaux, France; [Monforte, Antonella D'Arminio] Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Milan, Italy; [Esteve, Anna] Ctr Epidemiol Studies Sexually Transmitted Infect, Badalona, Spain; [Gill, M. John] Univ Calgary, Div Infect Dis, Calgary, AB, Canada; [Justice, Amy] Yale Univ, Sch Med, New Haven, CT USA; [Lampe, Fiona; Mocroft, Amanda] UCL Royal Free & Univ Coll Med Sch, Res Dept Infect & Populat Hlth, Div Populat Hlth, London WC1E 6BT, England; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Staszewski, Schlomo] Goethe Univ Frankfurt, Zentrum Inneren Med, Frankfurt, Germany; [Wasmuth, Jan-Christian] Univ Bonn, Dept Internal Med, D-5300 Bonn, Germany; [van Sighem, Ard] HIV Monitoring Fdn, Amsterdam, Netherlands; [Kitahata, Mari] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Guest, Jodie] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Egger, Matthias] Univ Bern, Dept Social & Prevent Med, Bern, Switzerland	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of Bristol; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; San Paolo-Polo Universitaria Hospital; University of Milan; University of Calgary; Yale University; University of London; University College London; UCL Medical School; University of Alabama System; University of Alabama Birmingham; Goethe University Frankfurt; University of Bonn; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Bern	Hogg, R (corresponding author), BC Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	bobhogg@cfenet.ubc.ca	Mocroft, Amanda/C-1527-2008; Lampe, Fiona/I-5826-2019; Sterne, Jonathan/Z-3106-2019; VALLET, Yannick/F-9979-2011; Grabar, Sophie/AAM-9857-2020; , Felipe/F-4242-2014; Hogg, Robert S/B-2783-2012; Dodsley, Maria/G-7083-2016; Mocroft, Amanda/G-8748-2011; Gill, Michael John/G-7083-2016	Lampe, Fiona/0000-0001-6851-5471; Sterne, Jonathan/0000-0001-8496-6053; , Felipe/0000-0001-7658-5832; Hogg, Robert S/0000-0003-3463-5488; Dodsley, Maria/0000-0001-7587-558X; Mocroft, Amanda/0000-0001-8316-1122; Gill, Michael John/0000-0002-8546-8790	Medical Research Council [G0700820] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA013566] Funding Source: NIH RePORTER; MRC [G0700820] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bonnet F, 2002, HIV Med, V3, P195, DOI 10.1046/j.1468-1293.2002.00117.x; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Chiasson MA, 1999, J ACQ IMMUN DEF SYND, V21, P59, DOI 10.1097/00126334-199905010-00008; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Lange JMA, 2003, JAIDS-J ACQ IMM DEF, V34, pS40, DOI 10.1097/00126334-200309011-00007; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Lloyd-Smith E, 2006, AIDS, V20, P445, DOI 10.1097/01.aids.0000206508.32030.92; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McGuire AL, 2005, HIV MED, V6, P57, DOI 10.1111/j.1468-1293.2005.00266.x; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Selik RM, 1997, AIDS, V11, P1635, DOI 10.1097/00002030-199713000-00013; Staehelin C, 2004, AIDS PATIENT CARE ST, V18, P665, DOI 10.1089/apc.2004.18.665; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Valdez H, 2001, CLIN INFECT DIS, V32, P1487, DOI 10.1086/320164; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wong KH, 2004, CLIN INFECT DIS, V39, P853, DOI 10.1086/423183	41	1186	1204	2	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2008	372	9635					293	299						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331WH	18657708	Green Accepted, Bronze			2022-12-24	WOS:000258042800030
J	Tada, Y; Spoel, SH; Pajerowska-Mukhtar, K; Mou, ZL; Song, JQ; Wang, C; Zuo, JR; Dong, XN				Tada, Yasuomi; Spoel, Steven H.; Pajerowska-Mukhtar, Karolina; Mou, Zhonglin; Song, Junqi; Wang, Chun; Zuo, Jianru; Dong, Xinnian			Plant immunity requires conformational charges of NPR1 via S-nitrosylation and thioredoxins	SCIENCE			English	Article							NITRIC-OXIDE; DISEASE RESISTANCE; OXIDATIVE STRESS; ARABIDOPSIS; PROTEINS; NITROSOTHIOLS; EXPRESSION; DOMAIN; SIGNAL	Changes in redox status have been observed during immune responses in different organisms, but the associated signaling mechanisms are poorly understood. In plants, these redox changes regulate the conformation of NPR1, a master regulator of salicylic acid ( SA)- mediated defense genes. NPR1 is sequestered in the cytoplasm as an oligomer through intermolecular disulfide bonds. We report that S- nitrosylation of NPR1 by S- nitrosoglutathione ( GSNO) at cysteine- 156 facilitates its oligomerization, which maintains protein homeostasis upon SA induction. Conversely, the SA- induced NPR1 oligomer- to- monomer reaction is catalyzed by thioredoxins ( TRXs). Mutations in both NPR1 cysteine- 156 and TRX compromised NPR1- mediated disease resistance. Thus, the regulation of NPR1 is through the opposing action of GSNO and TRX. These findings suggest a link between pathogen- triggered redox changes and gene regulation in plant immunity.	[Tada, Yasuomi; Spoel, Steven H.; Pajerowska-Mukhtar, Karolina; Mou, Zhonglin; Song, Junqi; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Wang, Chun; Zuo, Jianru] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Duke University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dong, XN (corresponding author), Duke Univ, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Song, Junqi/N-9219-2019; Tada, Yasuomi/M-5041-2014	Song, Junqi/0000-0002-2555-3408; Spoel, Steven/0000-0003-4340-7591; Tada, Yasuomi/0000-0001-9900-069X	NIGMS NIH HHS [1R01-GM69594, R01 GM069594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Grun S, 2006, J EXP BOT, V57, P507, DOI 10.1093/jxb/erj053; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Li XM, 1999, CANCER RES, V59, P5275; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Reichheld JP, 2002, PLANT PHYSIOL BIOCH, V40, P685, DOI 10.1016/S0981-9428(02)01406-7; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103	23	740	779	15	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2008	321	5891					952	956		10.1126/science.1156970	http://dx.doi.org/10.1126/science.1156970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337LD	18635760	Green Accepted			2022-12-24	WOS:000258436700036
J	Poulet, JFA; Petersen, CCH				Poulet, James F. A.; Petersen, Carl C. H.			Internal brain state regulates membrane potential synchrony in barrel cortex of behaving mice	NATURE			English	Article							CAT VISUAL-CORTEX; MOTOR CORTEX; SOMATOSENSORY CORTEX; RHYTHMIC WHISKING; IN-VIVO; NEURONS; RAT; OSCILLATIONS; RESPONSES; AWAKE	Internal brain states form key determinants for sensory perception, sensorimotor coordination and learning(1,2). A prominent reflection of different brain states in the mammalian central nervous system is the presence of distinct patterns of cortical synchrony, as revealed by extracellular recordings of the electroencephalogram, local field potential and action potentials. Such temporal correlations of cortical activity are thought to be fundamental mechanisms of neuronal computation(3-11). However, it is unknown how cortical synchrony is reflected in the intracellular membrane potential (V(m)) dynamics of behaving animals. Here we show, using dual whole-cell recordings from layer 2/3 primary somatosensory barrel cortex in behaving mice, that the Vm of nearby neurons is highly correlated during quiet wakefulness. However, when the mouse is whisking, an internally generated state change reduces the Vm correlation, resulting in a desynchronized local field potential and electroencephalogram. Action potential activity was sparse during both quiet wakefulness and active whisking. Single action potentials were driven by a large, brief and specific excitatory input that was not present in the Vm of neighbouring cells. Action potential initiation occurs with a higher signal-to-noise ratio during active whisking than during quiet periods. Therefore, we show that an internal brain state dynamically regulates cortical membrane potential synchrony during behaviour and defines different modes of cortical processing.	[Poulet, James F. A.; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Poulet, James/0000-0003-0296-5415				Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; DORFL J, 1985, J ANAT, V142, P173; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gao PH, 2003, SOMATOSENS MOT RES, V20, P191, DOI 10.1080/08990220310001622924; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Leiser SC, 2007, NEURON, V53, P117, DOI 10.1016/j.neuron.2006.10.036; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030	34	546	550	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2008	454	7206					881	U36		10.1038/nature07150	http://dx.doi.org/10.1038/nature07150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18633351				2022-12-24	WOS:000258398600035
J	Carpenter, KE; Abrar, M; Aeby, G; Aronson, RB; Banks, S; Bruckner, A; Chiriboga, A; Cortes, J; Delbeek, JC; DeVantier, L; Edgar, GJ; Edwards, AJ; Fenner, D; Guzman, HM; Hoeksema, BW; Hodgson, G; Johan, O; Licuanan, WY; Livingstone, SR; Lovell, ER; Moore, JA; Obura, DO; Ochavillo, D; Polidoro, BA; Precht, WF; Quibilan, MC; Reboton, C; Richards, ZT; Rogers, AD; Sanciangco, J; Sheppard, A; Sheppard, C; Smith, J; Stuart, S; Turak, E; Veron, JEN; Wallace, C; Weil, E; Wood, E				Carpenter, Kent E.; Abrar, Muhammad; Aeby, Greta; Aronson, Richard B.; Banks, Stuart; Bruckner, Andrew; Chiriboga, Angel; Cortes, Jorge; Delbeek, J. Charles; DeVantier, Lyndon; Edgar, Graham J.; Edwards, Alasdair J.; Fenner, Douglas; Guzman, Hector M.; Hoeksema, Bert W.; Hodgson, Gregor; Johan, Ofri; Licuanan, Wilfredo Y.; Livingstone, Suzanne R.; Lovell, Edward R.; Moore, Jennifer A.; Obura, David O.; Ochavillo, Domingo; Polidoro, Beth A.; Precht, William F.; Quibilan, Miledel C.; Reboton, Clarissa; Richards, Zoe T.; Rogers, Alex D.; Sanciangco, Jonnell; Sheppard, Anne; Sheppard, Charles; Smith, Jennifer; Stuart, Simon; Turak, Emre; Veron, John E. N.; Wallace, Carden; Weil, Ernesto; Wood, Elizabeth			One-third of reef-building corals face elevated extinction risk from climate change and local impacts	SCIENCE			English	Article							DISEASE	The conservation status of 845 zooxanthellate reef- building coral species was assessed by using International Union for Conservation of Nature Red List Criteria. Of the 704 species that could be assigned conservation status, 32.8% are in categories with elevated risk of extinction. Declines in abundance are associated with bleaching and diseases driven by elevated sea surface temperatures, with extinction risk further exacerbated by local- scale anthropogenic disturbances. The proportion of corals threatened with extinction has increased dramatically in recent decades and exceeds that of most terrestrial groups. The Caribbean has the largest proportion of corals in high extinction risk categories, whereas the Coral Triangle ( western Pacific) has the highest proportion of species in all categories of elevated extinction risk. Our results emphasize the widespread plight of coral reefs and the urgent need to enact conservation measures.	[Carpenter, Kent E.; Livingstone, Suzanne R.; Polidoro, Beth A.; Sanciangco, Jonnell; Smith, Jennifer] Old Dominion Univ, IUCN Species Programme SSC & CI Global Marine Spe, Norfolk, VA 23529 USA; [Abrar, Muhammad] Indonesian Inst Sci, Res Ctr Oceanog, Jakarta, Indonesia; [Aeby, Greta] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Aronson, Richard B.] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Banks, Stuart] Charles Darwin Res Stn Puerto Ayora, Santa Cruz, Galapagos, Ecuador; [Bruckner, Andrew] NOAA Fisheries, Silver Spring, MD 20910 USA; [Bruckner, Andrew] NOAA Coral Reef Conservat Program, Silver Spring, MD 20910 USA; [Chiriboga, Angel] Brown Univ, Providence, RI 02912 USA; [Cortes, Jorge] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Jose, Costa Rica; [Delbeek, J. Charles] Univ Hawaii Manoa, Waikiki Aquarium, Honolulu, HI 96822 USA; [DeVantier, Lyndon; Turak, Emre; Veron, John E. N.] Coral Reef Res, Townsville, Qld 4811, Australia; [Edgar, Graham J.] CI, CABS, Arlington, VA 22202 USA; [Edgar, Graham J.] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas 7011, Australia; [Edwards, Alasdair J.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fenner, Douglas] Dept Marine & Wildlife Resources, Pago Pago, AS USA; [Guzman, Hector M.] Smithsonian Trop Res Inst, Balboa 084303092, Panama; [Hoeksema, Bert W.] Natl Museum Nat Hist Naturalis, NL-2333 AA Leiden, Netherlands; [Hodgson, Gregor] Reef Check Fdn, Pacific Palisades, CA 90272 USA; [Johan, Ofri] Res Ctr Aquaculture, Jakarta, Indonesia; [Licuanan, Wilfredo Y.] De La Salle Univ, Dept Biol, Manila, Philippines; [Licuanan, Wilfredo Y.] De La Salle Univ, Shields Marine Stn, Manila, Philippines; [Lovell, Edward R.] Univ S Pacific, Sch Marine Studies, Suva, Fiji; [Moore, Jennifer A.] NOAA, Fisheries Serv, Protected Resources Div, St Petersburg, FL 33701 USA; [Obura, David O.] CORDIO E Africa, Mombasa, Kenya; [Ochavillo, Domingo] Reef Check Philippines, Manila, Philippines; [Precht, William F.] NOAA, Florida Keys Natl Marine Sanctuary, Damage Assessment & Restorat Program, Key Largo, FL 33040 USA; [Quibilan, Miledel C.] CI Philippines, Sulu Sulawesi Seascape Program, Quezon City, Philippines; [Reboton, Clarissa] Silliman Univ, Inst Environm & Marine Sci, Dumaguete, Philippines; [Richards, Zoe T.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Rogers, Alex D.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Sheppard, Anne; Sheppard, Charles] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Stuart, Simon] Conservat Int, IUCN SSC, Norfolk, VA 23529 USA; [Stuart, Simon] Conservat Int, CI CABS Biodivers Assessment Unit, Norfolk, VA 23529 USA; [Wallace, Carden] Museum Trop Queensland, Townsville, Qld 4810, Australia; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Lajas, PR USA; [Wood, Elizabeth] Marine Conservat Soc, Ross On Wye, Herts, England	Old Dominion University; Indonesian Institute of Sciences; Dauphin Island Sea Lab; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Brown University; Universidad Costa Rica; University of Hawaii System; University of Hawaii Manoa; University of Tasmania; Newcastle University - UK; Smithsonian Institution; Smithsonian Tropical Research Institute; Naturalis Biodiversity Center; De La Salle University; De La Salle University; University of the South Pacific; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Silliman University; James Cook University; Zoological Society of London; University of Warwick; Conservation International; Conservation International; University of Puerto Rico; University of Puerto Rico Mayaguez	Carpenter, KE (corresponding author), Old Dominion Univ, IUCN Species Programme SSC & CI Global Marine Spe, Norfolk, VA 23529 USA.	kcarpent@odu.edu	Cortés, Jorge/AAC-9782-2020; Edgar, Graham/C-8341-2013; Hoeksema, Bert W/B-2973-2010; Edgar, Graham/AAY-3797-2020; Hoeksema, Bert W./U-8530-2019; Weil, Ernesto/AAI-3591-2020; Weil, Ernesto/ABF-1290-2020; Edwards, Alasdair J/C-9558-2009	Cortés, Jorge/0000-0001-7004-8649; Edgar, Graham/0000-0003-0833-9001; Hoeksema, Bert W/0000-0001-8259-3783; Edgar, Graham/0000-0003-0833-9001; Hoeksema, Bert W./0000-0001-8259-3783; Weil, Ernesto/0000-0001-5275-1584; Edwards, Alasdair J/0000-0002-2979-7389; Sheppard, Anne/0000-0003-4686-5256; Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Abrar, Muhammad/0000-0002-9192-4043; Guzman, Hector M./0000-0001-9928-8523; Aronson, Richard/0000-0003-0383-3844; Licuanan, Wilfredo/0000-0001-7697-5902; sheppard, charles/0000-0002-2579-5124; Obura, David/0000-0003-2256-6649				Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; FRIEDLANDER A, 2005, STATE CORAL REEF ECO, P222; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoeksema Bert W., 2007, V29, P117; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kiessling W, 2004, PALAEOGEOGR PALAEOCL, V214, P195, DOI 10.1016/j.palaeo.2004.05.025; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 2008, REEF TIME GREAT BARR; WILKINSON C, 2004, STAT CORAL REEFS WOR; WILKINSON C, 2000, STAT CORAL REEFS WOR	24	885	920	20	819	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2008	321	5888					560	563		10.1126/science.1159196	http://dx.doi.org/10.1126/science.1159196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653892				2022-12-24	WOS:000257888900047
J	Houlton, BZ; Wang, YP; Vitousek, PM; Field, CB				Houlton, Benjamin Z.; Wang, Ying-Ping; Vitousek, Peter M.; Field, Christopher B.			A unifying framework for dinitrogen fixation in the terrestrial biosphere	NATURE			English	Article							SYMBIOTIC NITROGEN-FIXATION; SOIL; PHOSPHORUS; FOREST; AVAILABILITY; TEMPERATURE; ACQUISITION; LIMITATION; PHOSPHATASE; ECOSYSTEMS	Dinitrogen ( N(2)) fixation is widely recognized as an important process in controlling ecosystem responses to global environmental change, both today(1) and in the past(2); however, significant discrepancies exist between theory and observations of patterns of N(2) fixation across major sectors of the land biosphere. A question remains as to why symbiotic N(2)- fixing plants are more abundant in vast areas of the tropics than in many of the mature forests that seem to be nitrogen- limited in the temperate and boreal zones(3). Here we present a unifying framework for terrestrial N(2) fixation that can explain the geographic occurrence of N(2) fixers across diverse biomes and at the global scale. By examining trade- offs inherent in plant carbon, nitrogen and phosphorus capture, we find a clear advantage to symbiotic N(2) fixers in phosphorus-limited tropical savannas and lowland tropical forests. The ability of N(2) fixers to invest nitrogen into phosphorus acquisition seems vital to sustained N(2) fixation in phosphorus- limited tropical ecosystems. In contrast, modern- day temperatures seem to constrain N(2) fixation rates and N(2)- fixing species from mature forests in the high latitudes. We propose that an analysis that couples biogeochemical cycling and biophysical mechanisms is sufficient to explain the principal geographical patterns of symbiotic N(2) fixation on land, thus providing a basis for predicting the response of nutrient- limited ecosystems to climate change and increasing atmospheric CO(2).	[Houlton, Benjamin Z.; Vitousek, Peter M.] Stanford Univ, Stanford, CA 94305 USA; [Houlton, Benjamin Z.; Field, Christopher B.] Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; [Wang, Ying-Ping] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [Wang, Ying-Ping] Ctr Australian Weather & Climate Res, Aspendale, Vic 3195, Australia	Stanford University; Carnegie Institution for Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Houlton, BZ (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	bzhoulton@ucdavis.edu	Wang, Yingping/A-9765-2011	Wang, Yingping/0000-0002-4614-6203; Houlton, Benjamin/0000-0002-1414-0261				Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P1537, DOI 10.1016/j.soilbio.2005.11.008; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bormann F.H., 1979, PATTERN PROCESS FORE, DOI DOI 10.1007/978-1-4612-6232-9; Caldwell BA, 2006, APPL SOIL ECOL, V32, P149, DOI 10.1016/j.apsoil.2004.11.008; CEUTERICK F, 1978, EUR J BIOCHEM, V87, P401, DOI 10.1111/j.1432-1033.1978.tb12389.x; CHAN YK, 1991, CAN J MICROBIOL, V37, P715, DOI 10.1139/m91-122; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; Chestnut TJ, 1999, BIOGEOCHEMISTRY, V46, P85, DOI 10.1023/A:1006104229691; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; COXSON DS, 1983, CAN J BOT, V61, P2658, DOI 10.1139/b83-293; Crews TE, 1999, BIOGEOCHEMISTRY, V46, P233, DOI 10.1007/BF01007581; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; GIARDINA CP, 1995, CAN J FOREST RES, V25, P1652, DOI 10.1139/x95-179; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Houlton BZ, 2003, ECOSYSTEMS, V6, P431, DOI 10.1007/s10021-002-0198-1; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Kamh M, 2002, J PLANT NUTR SOIL SC, V165, P566, DOI 10.1002/1522-2624(200210)165:5<566::AID-JPLN566>3.0.CO;2-O; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Liengen T, 1997, CAN J MICROBIOL, V43, P759, DOI 10.1139/m97-109; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Nuruzzaman M, 2006, PLANT SOIL, V281, P109, DOI 10.1007/s11104-005-3936-2; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Pons TL, 2007, NEW PHYTOL, V173, P154, DOI 10.1111/j.1469-8137.2006.01895.x; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; REDFIELD AC, 1958, AM SCI, V46, P205; ROPER MM, 1985, SOIL BIOL BIOCHEM, V17, P65, DOI 10.1016/0038-0717(85)90091-4; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; SCHOMBERG HH, 1992, AGRON J, V84, P1046, DOI 10.2134/agronj1992.00021962008400060026x; SPRENT JI, 1985, P ROY SOC EDINB B, V85, P215, DOI 10.1017/S0269727000004036; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Wang YP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002797; ZOU XM, 1995, SOIL SCI SOC AM J, V59, P1452, DOI 10.2136/sssaj1995.03615995005900050035x	41	515	546	15	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					327	U34		10.1038/nature07028	http://dx.doi.org/10.1038/nature07028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18563086				2022-12-24	WOS:000257665300037
J	Koszul, R; Kim, KP; Prentiss, M; Kleckner, N; Kameoka, S				Koszul, R.; Kim, K. P.; Prentiss, M.; Kleckner, N.; Kameoka, S.			Meiotic chromosomes move by linkage to dynamic actin cables with transduction of force through the nuclear envelope	CELL			English	Article							BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; BOUQUET FORMATION; FISSION YEAST; MEIOSIS; SYNAPSIS; PROPHASE; RECOMBINATION; ORGANIZATION; TRANSITION	Chromosome movement is prominent during meiosis. Here, using a combination of in vitro and in vivo approaches, we elucidate the basis for dynamic mid-prophase telomere-led chromosome motion in budding yeast. Diverse findings reveal a process in which, at the pachytene stage, individual telomere/nuclear envelope (NE) ensembles attach passively to, and then move in concert with, nucleus-hugging actin cables that are continuous with the global cytoskeletal actin network. Other chromosomes move in concert with lead chromosome(s). The same process, in modulated form, explains the zygotene "bouquet'' configuration in which, immediately preceding pachytene, chromosome ends colocalize dynamically in a restricted region of the NE. Mechanical properties of the system and biological roles of mid-prophase movement for meiosis, including recombination, are discussed.	[Koszul, R.; Kim, K. P.; Kleckner, N.; Kameoka, S.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Prentiss, M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021	Koszul, Romain/0000-0002-3086-1173; Kim, Keun/0000-0002-5973-8259	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R01GM044794] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM025326-31, R01 GM025326, R01 GM025326-30, R01 GM-044794, R01 GM044794-14, R01 GM044794-17, R01 GM-025326, R01 GM025326-29, R01 GM044794-16, R01 GM044794-15, R01 GM044794-18, R01 GM044794, R01 GM025326-28, R01 GM025326-27] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; Bass HW, 2003, CELL MOL LIFE SCI, V60, P2319, DOI 10.1007/s00018-003-3312-4; Belgareh N, 1997, J CELL BIOL, V136, P747, DOI 10.1083/jcb.136.4.747; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BYERS B, 1975, P NATL ACAD SCI USA, V72, P5056, DOI 10.1073/pnas.72.12.5056; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Golubovskaya IN, 2002, GENETICS, V162, P1979; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; MARKO JF, 1997, MOL BIOL CELL, V8, DOI UNSP 221722-221731; OTT A, 1993, PHYS REV E, V48, pR1642, DOI 10.1103/PhysRevE.48.R1642; PARVINEN M, 1976, NATURE, V260, P534, DOI 10.1038/260534a0; Poirier MG, 2003, CURR TOP DEV BIOL, V55, P75, DOI 10.1016/S0070-2153(03)01002-0; RASMUSSEN SW, 1986, CARLSBERG RES COMMUN, V51, P401, DOI 10.1007/BF02907315; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; SCHERTHAN H, 1994, J CELL BIOL, V127, P273, DOI 10.1083/jcb.127.2.273; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Taxis C, 2006, TRAFFIC, V7, P1628, DOI 10.1111/j.1600-0854.2006.00496.x; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	39	150	151	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 27	2008	133	7					1188	1201		10.1016/j.cell.2008.04.050	http://dx.doi.org/10.1016/j.cell.2008.04.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585353	Green Accepted, Bronze			2022-12-24	WOS:000257144600016
J	Bayram, O; Krappmann, S; Ni, M; Bok, JW; Helmstaedt, K; Valerius, O; Braus-Stromeyer, S; Kwon, NJ; Keller, NP; Yu, JH; Braus, GH				Bayram, Oezguer; Krappmann, Sven; Ni, Min; Bok, Jin Woo; Helmstaedt, Kerstin; Valerius, Oliver; Braus-Stromeyer, Susanna; Kwon, Nak-Jung; Keller, Nancy P.; Yu, Jae-Hyuk; Braus, Gerhard H.			VelB/VeA/LaeA complex coordinates light signal with fungal development and secondary metabolism	SCIENCE			English	Article							TANDEM AFFINITY PURIFICATION; ASPERGILLUS-NIDULANS; COP9 SIGNALOSOME; REGULATOR; VEA; BIOSYNTHESIS; LOCUS	Differentiation and secondary metabolism are correlated processes in fungi that respond to light. In Aspergillus nidulans, light inhibits sexual reproduction as well as secondary metabolism. We identified the heterotrimeric velvet complex VelB/VeA/LaeA connecting light-responding developmental regulation and control of secondary metabolism. VeA, which is primarily expressed in the dark, physically interacts with VelB, which is expressed during sexual development. VeA bridges VelB to the nuclear master regulator of secondary metabolism, LaeA. Deletion of either velB or veA results in defects in both sexual fruiting-body formation and the production of secondary metabolites.	[Bayram, Oezguer; Krappmann, Sven; Helmstaedt, Kerstin; Valerius, Oliver; Braus-Stromeyer, Susanna; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Ni, Min; Kwon, Nak-Jung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Ni, Min; Kwon, Nak-Jung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Bok, Jin Woo; Keller, Nancy P.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Bok, Jin Woo; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Helmstaedt, Kerstin] Res Ctr Mol Physiol Brain CMPB, Deutsch Forschungsgemeinschaft DFG, D-37077 Gottingen, Germany	University of Gottingen; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; German Research Foundation (DFG)	Braus, GH (corresponding author), Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany.	gbraus@gwdg.de	Bayram, Özgür/P-6326-2019; Braus, Gerhard/ABC-6293-2021; Yu, Jae-Hyuk/A-2343-2008; Bok, Jin Woo/F-7140-2010; Krappmann, Sven/K-2615-2012; Keller, Nancy P./ABC-5911-2021; Braus, Gerhard H/G-3999-2012	Bayram, Özgür/0000-0002-0283-5322; Braus, Gerhard/0000-0002-3117-5626; Braus, Gerhard H/0000-0002-3117-5626; Yu, Jae-Hyuk/0000-0002-6530-8407; Krappmann, Sven/0000-0002-8299-7777; Braus-Stromeyer, Susanna A./0000-0003-0830-3949				Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brakhage AA, 1997, FEMS MICROBIOL LETT, V148, P1; Braus GH, 2002, MYCOLOGY S, V15, P215; Busch S, 2003, MOL MICROBIOL, V49, P717, DOI 10.1046/j.1365-2958.2003.03612.x; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hicks JK, 2002, MYCOTA, V11, P55; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Krappmann S, 2005, EUKARYOT CELL, V4, P1298, DOI 10.1128/EC.4.7.1298-1307.2005; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; MOONEY JL, 1990, GENE DEV, V4, P1473, DOI 10.1101/gad.4.9.1473; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Sprote P, 2007, ARCH MICROBIOL, V188, P69, DOI 10.1007/s00203-007-0224-y; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; WOLOSHUK CP, 1994, APPL ENVIRON MICROB, V60, P2408, DOI 10.1128/AEM.60.7.2408-2414.1994	26	607	661	16	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2008	320	5882					1504	1506		10.1126/science.1155888	http://dx.doi.org/10.1126/science.1155888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18556559	Green Accepted			2022-12-24	WOS:000256676400047
J	Park, IH; Arora, N; Huo, H; Maherali, N; Ahfeldt, T; Shimamura, A; Lensch, MW; Cowan, C; Hochedlinger, K; Daley, GQ				Park, In-Hyun; Arora, Natasha; Huo, Hongguang; Maherali, Nimet; Ahfeldt, Tim; Shimamura, Akiko; Lensch, M. William; Cowan, Chad; Hochedlinger, Konrad; Daley, George Q.			Disease-specific induced pluripotent stem cells	CELL			English	Article							CRITICAL REGION; DOWN-SYNDROME; GENE; MUTATION; LOCUS; CHROMOSOME-21; GENERATION	Tissue culture of immortal cell strains from diseased patients is an invaluable resource for medical research but is largely limited to tumor cell lines or transformed derivatives of native tissues. Here we describe the generation of induced pluripotent stem (iPS) cells from patients with a variety of genetic diseases with either Mendelian or complex inheritance; these diseases include adenosine deaminase deficiency-related severe combined immunodeficiency (ADA-SCID), Shwachman-Bodian-Diamond syndrome (SBDS), Gaucher disease (GD) type III, Duchenne (DMD) and Becker muscular dystrophy (BMD), Parkinson disease (PD), Huntington disease (HD), juvenile-onset, type 1 diabetes mellitus (JDM), Down syndrome (DS)/trisomy 21, and the carrier state of Lesch-Nyhan syndrome. Such disease-specific stem cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue formation in vitro, thereby enabling disease investigation and drug development.	[Park, In-Hyun; Arora, Natasha; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Childrens Hosp, Dept Med, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun; Arora, Natasha; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Park, In-Hyun; Arora, Natasha; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Maherali, Nimet; Ahfeldt, Tim; Cowan, Chad; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Maherali, Nimet; Ahfeldt, Tim; Cowan, Chad; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Maherali, Nimet; Ahfeldt, Tim; Cowan, Chad; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Shimamura, Akiko] Univ Washington, Div Hematol Oncol, Dept Pediat, Seattle, WA 98109 USA; [Shimamura, Akiko] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Cowan, Chad] Stowers Med Inst, Boston, MA 02115 USA; [Park, In-Hyun; Arora, Natasha; Huo, Hongguang; Maherali, Nimet; Ahfeldt, Tim; Lensch, M. William; Cowan, Chad; Hochedlinger, Konrad; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Lensch, M. William; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stowers Institute for Medical Research; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Dept Med, Div Pediat Hematol Oncol, Karp Family Res Bldg 7214,300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Ahfeldt, Tim/E-2935-2017	Ahfeldt, Tim/0000-0001-6377-7376	National Institutes of Health; Harvard Stem Cell Institute; Children's Hospital Stem Cell Program; John W. Henry Family Foundation; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; Natural Sciences and Engineering Council of Canada; Sir James Lougheed Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Children's Hospital Stem Cell Program; John W. Henry Family Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sir James Lougheed Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	G. Q. D. was supported by grants from the National Institutes of Health, the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research, and private funds contributed to the Harvard Stem Cell Institute and the Children's Hospital Stem Cell Program. The work was made possible by the support and vision of Douglas and Diana Berthiaume, Jonathan and Patti Kraft, and the John W. Henry Family Foundation. G. Q. D. is a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society and is an Investigator of the Howard Hughes Medical Institute. K. H. was supported by the NIH Director's Innovator Award and the Harvard Stem Cell Institute. N. M. was supported by the Natural Sciences and Engineering Council of Canada and a Sir James Lougheed Award.	Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; BEGGS AH, 1990, HUM GENET, V86, P45; BEUTLER E, 1991, P NATL ACAD SCI USA, V88, P10544, DOI 10.1073/pnas.88.23.10544; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Calado RT, 2007, BLOOD, V110, P1141, DOI 10.1182/blood-2007-03-080044; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; HIRSCHHORN R, 1993, HUM MUTAT, V2, P320, DOI 10.1002/humu.1380020415; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nelson DL, 2004, SCIENCE, V306, P619, DOI 10.1126/science.1105226; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	32	1635	1797	4	628	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					877	886		10.1016/j.cell.2008.07.041	http://dx.doi.org/10.1016/j.cell.2008.07.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18691744	Green Accepted, Bronze			2022-12-24	WOS:000258947500026
J	Sallee, NA; Rivera, GM; Dueber, JE; Vasilescu, D; Mullins, RD; Mayer, BJ; Lim, WA				Sallee, Nathan A.; Rivera, Gonzalo M.; Dueber, John E.; Vasilescu, Dan; Mullins, R. Dyche; Mayer, Bruce J.; Lim, Wendell A.			The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalency	NATURE			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; WASP/SCAR PROTEINS; ACTIVATION; EFFECTOR; NUCLEATION; NCK; CYTOSKELETON; MECHANISMS	Enterohaemorrhagic Escherichia coli attaches to the intestine through actin pedestals that are formed when the bacterium injects its protein EspFU ( also known as TccP) into host cells(1). EspFU potently activates the host WASP ( Wiskott - Aldrich syndrome protein) family of actin- nucleating factors, which are normally activated by the GTPase CDC42, among other signalling molecules. Apart from its amino- terminal type III secretion signal, EspFU consists of five- and- a- half 47- amino- acid repeats. Here we show that a 17- residue motif within this EspFU repeat is sufficient for interaction with N- WASP ( also known as WASL). Unlike most pathogen proteins that interface with the cytoskeletal machinery, this motif does not mimic natural upstream activators: instead of mimicking an activated state of CDC42, EspFU mimics an auto-nhibitory element found within N- WASP. Thus, EspFU activates N- WASP by competitively disrupting the autoinhibited state. By mimicking an internal regulatory element and not the natural activator, EspFU selectively activates only a precise subset of CDC42- activated processes. Although one repeat is able to stimulate actin polymerization, we show that multiple- repeat fragments have notably increased potency. The activities of these EspFU fragments correlate with their ability to coordinate activation of at least two N- WASP proteins. Thus, this pathogen has used a simple autoinhibitory fragment as a component to build a highly effective actin polymerization machine.	[Sallee, Nathan A.; Dueber, John E.; Mullins, R. Dyche; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sallee, Nathan A.; Dueber, John E.; Mullins, R. Dyche; Lim, Wendell A.] Univ Calif San Francisco, Cell Propuls Lab, NIH Nanomed Dev Ctr, San Francisco, CA 94158 USA; [Sallee, Nathan A.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Rivera, Gonzalo M.; Vasilescu, Dan; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Rivera, Gonzalo M.; Vasilescu, Dan; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, CCAM, Farmington, CT 06030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Connecticut; University of Connecticut	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu			NIH; NIGMS; Nanomedicine Development Centers; NIH Roadmap; NSF; Packard Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA082258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022232] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, R01GM061010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nanomedicine Development Centers; NIH Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Akin for reagents and assistance with the bead motility experiments; J. C. Anderson, A. Chau, R. Howard, M. Lohse, A. Remenyi and L. Weaver for assistance; and members of the Lim laboratory for discussion. This work was supported by grants from the NIH (NIGMS and Nanomedicine Development Centers, NIH Roadmap), the NSF and the Packard Foundation. G. M. R. was supported by the American Heart Association.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Garmendia J, 2006, CELL MICROBIOL, V8, P1444, DOI 10.1111/j.1462-5822.2006.00723.x; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mattoo S, 2007, CURR OPIN IMMUNOL, V19, P392, DOI 10.1016/j.coi.2007.06.005; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Sallee NA, 2007, J AM CHEM SOC, V129, P4606, DOI 10.1021/ja0672728; Stebbins CE, 2004, CURR OPIN STRUC BIOL, V14, P731, DOI 10.1016/j.sbi.2004.09.011; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	35	81	84	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					1005	U49		10.1038/nature07170	http://dx.doi.org/10.1038/nature07170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18650806	Green Accepted			2022-12-24	WOS:000258591000041
J	Green, RE; Malaspinas, AS; Krause, J; Briggs, AW; Johnson, PLF; Uhler, C; Meyer, M; Good, JM; Maricic, T; Stenzel, U; Prufer, K; Siebauer, M; Burbano, HA; Ronan, M; Rothberg, JM; Egholm, M; Rudan, P; Brajkovic, D; Kucan, Z; Gusic, I; Wikstrom, M; Laakkonen, L; Kelso, J; Slatkin, M; Paabo, S				Green, Richard E.; Malaspinas, Anna-Sapfo; Krause, Johannes; Briggs, Adrian W.; Johnson, Philip L. F.; Uhler, Caroline; Meyer, Matthias; Good, Jeffrey M.; Maricic, Tomislav; Stenzel, Udo; Pruefer, Kay; Siebauer, Michael; Burbano, Hernan A.; Ronan, Michael; Rothberg, Jonathan M.; Egholm, Michael; Rudan, Pavao; Brajkovic, Dejana; Kucan, Zeljko; Gusic, Ivan; Wikstrom, Marten; Laakkonen, Liisa; Kelso, Janet; Slatkin, Montgomery; Paeaebo, Svante			A complete neandertal mitochondrial genome sequence determined by high-throughput Sequencing	CELL			English	Article							CYTOCHROME-C-OXIDASE; ANCIENT DNA EXTRACTION; MODERN HUMANS; ANTHROPOID PRIMATES; EVOLUTION; PATTERNS; AMPLIFICATION; POLYMORPHISM; DROSOPHILA; ARTIFACTS	A complete mitochondrial (mt) genome sequence was reconstructed from a 38,000 year-old Neandertal individual with 8341 mtDNA sequences identified among 4.8 Gb of DNA generated from similar to 0.3 g of bone. Analysis of the assembled sequence unequivocally establishes that the Neandertal mtDNA falls outside the variation of extant human mtDNAs, and allows an estimate of the divergence date between the two mtDNA lineages of 660,000 +/- 140,000 years. Of the 13 proteins encoded in the mtDNA, subunit 2 of cytochrome c oxidase of the mitochondrial electron transport chain has experienced the largest number of amino acid substitutions in human ancestors since the separation from Neandertals. There is evidence that purifying selection in the Neandertal mtDNA was reduced compared with other primate lineages, suggesting that the effective population size of Neandertals was small.	[Green, Richard E.; Krause, Johannes; Briggs, Adrian W.; Meyer, Matthias; Good, Jeffrey M.; Maricic, Tomislav; Stenzel, Udo; Pruefer, Kay; Siebauer, Michael; Burbano, Hernan A.; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Malaspinas, Anna-Sapfo; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Johnson, Philip L. F.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Uhler, Caroline] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Ronan, Michael; Egholm, Michael] 454 Life Sci, Branford, CT 06405 USA; [Rothberg, Jonathan M.] Rothberg Inst Childhood Dis, Guilford, CT 06437 USA; [Brajkovic, Dejana] Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, HR-10000 Zagreb, Croatia; [Wikstrom, Marten] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki Bioenergent Grp, FIN-00014 Helsinki, Finland; [Laakkonen, Liisa] Univ Helsinki, Fac Biosci, Dept Biol & Environm Sci, Div Biochem, FIN-00014 Helsinki, Finland	Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Croatian Academy of Sciences & Arts; University of Helsinki; University of Helsinki	Green, RE (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	green@eva.mpg.de	Krause, Johannes/E-6640-2015; Krause, Johannes/AFP-2642-2022; Kelso, Janet/N-1812-2019; Burbano, Hernán/F-2952-2010	Krause, Johannes/0000-0001-5475-4690; Krause, Johannes/0000-0001-9144-3920; Kelso, Janet/0000-0002-3618-322X; Uhler, Caroline/0000-0002-7008-0216; Burbano, Hernan A./0000-0003-3433-719X; Wikstrom, Marten/0000-0002-7527-4415; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Green, Richard/0000-0003-0516-5827	Max Plank Society; NIH [R01-GM40282]; Roche company; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	Max Plank Society(Max Planck Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche company; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Croatian Academy of Sciences and Arts, the Berlin-Brandenburg Academy of Sciences, and the Presidential Innovation Fund of the Max Plank Society for making this work possible. We are indebted to Mark Stoneking, Weiwei Zhai, John Huelsenbeck, Jerome Fuchs, Mario Morl, Nick Patterson, David Reich, and Timothy White for helpful discussions. We also thank Bruce Rannala and Ziheng Yang for help with mcmctree, James Hudson Bullard for help with figures, and Christine Green for editing. A.-S.M., P.L.F.J., and M.S. are supported by NIH grant R01-GM40282. P.L.F.J. is also supported by a Chang-Lin Tien scholarship. M.E. is an employee of 454 Life Sciences, a Roche company.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Doan JW, 2004, MOL PHYLOGENET EVOL, V33, P944, DOI 10.1016/j.ympev.2004.07.016; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hublin JJ, 2006, CURR BIOL, V16, pR113, DOI 10.1016/j.cub.2006.02.009; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; LANDER E S, 1988, Genomics, V2, P231; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Malez M., 1982, PALAEONTOLOGIA JUGOS, V29, P1; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Nachman MW, 1996, GENETICS, V142, P953; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1988, NATURE, V334, P387, DOI 10.1038/334387b0; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; REID RA, 1966, NATURE, V212, P257, DOI 10.1038/212257a0; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Templeton AR, 1996, GENETICS, V144, P1263; Uddin M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-8; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	362	378	5	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2008	134	3					416	426		10.1016/j.cell.2008.06.021	http://dx.doi.org/10.1016/j.cell.2008.06.021			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SO	18692465	Bronze, Green Accepted			2022-12-24	WOS:000258665500015
J	Mancera, E; Bourgon, R; Brozzi, A; Huber, W; Steinmetz, LM				Mancera, Eugenio; Bourgon, Richard; Brozzi, Alessandro; Huber, Wolfgang; Steinmetz, Lars M.			High-resolution mapping of meiotic crossovers and non-crossovers in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; CROSSING-OVER; HOT-SPOTS; RECOMBINATION HOTSPOTS; MEIOSIS; DNA; EVOLUTION; GENOME; BIOINFORMATICS	Meiotic recombination has a central role in the evolution of sexually reproducing organisms. The two recombination outcomes, crossover and non-crossover, increase genetic diversity, but have the potential to homogenize alleles by gene conversion. Whereas crossover rates vary considerably across the genome, non-crossovers and gene conversions have only been identified in a handful of loci. To examine recombination genome wide and at high spatial resolution, we generated maps of crossovers, crossover-associated gene conversion and non-crossover gene conversion using dense genetic marker data collected from all four products of fifty-six yeast (Saccharomyces cerevisiae) meioses. Our maps reveal differences in the distributions of crossovers and non-crossovers, showing more regions where either crossovers or non-crossovers are favoured than expected by chance. Furthermore, we detect evidence for interference between crossovers and non-crossovers, a phenomenon previously only known to occur between crossovers. Up to 1% of the genome of each meiotic product is subject to gene conversion in a single meiosis, with detectable bias towards GC nucleotides. To our knowledge the maps represent the first high-resolution, genome-wide characterization of the multiple outcomes of recombination in any organism. In addition, because non-crossover hotspots create holes of reduced linkage within haplotype blocks, our results stress the need to incorporate non-crossovers into genetic linkage analysis.	[Mancera, Eugenio; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bourgon, Richard; Brozzi, Alessandro; Huber, Wolfgang] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Mancera, Eugenio/M-6334-2016	Mancera, Eugenio/0000-0003-0146-8732; Steinmetz, Lars/0000-0002-3962-2865; Huber, Wolfgang/0000-0002-0474-2218; Bourgon, Richard/0000-0002-5890-4374	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER; NHGRI NIH HHS [P01 HG000205-19, P01 HG000205] Funding Source: Medline; NIGMS NIH HHS [R01 GM068717-06, R01 GM068717] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BORTS RH, 1989, GENETICS, V123, P69; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen WL, 1999, GENETICS, V151, P1299; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gordo I, 2001, CURR BIOL, V11, pR684, DOI 10.1016/S0960-9822(01)00408-0; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hurles Matthew, 2005, Human Genomics, V2, P179; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; MCCUSKER JH, 1994, GENETICS, V136, P1261; Merker JD, 2003, GENETICS, V165, P47; MORTIMER RK, 1986, GENETICS, V113, P35; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Terasawa M, 2007, P NATL ACAD SCI USA, V104, P5965, DOI 10.1073/pnas.0611490104; Wall JD, 2004, NAT GENET, V36, P114, DOI 10.1038/ng0204-114; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451	49	432	436	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2008	454	7203					479	U1		10.1038/nature07135	http://dx.doi.org/10.1038/nature07135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329IC	18615017	Green Accepted			2022-12-24	WOS:000257860300043
J	Xiao, H; Murakami, H; Suga, H; Ferre-D'Amare, AR				Xiao, Hong; Murakami, Hiroshi; Suga, Hiroaki; Ferre-D'Amare, Adrian R.			Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme	NATURE			English	Article							PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; SYNTHETASE; ORIGIN; REVEALS; COMPLEX	In modern organisms, protein enzymes are solely responsible for the aminoacylation of transfer RNA. However, the evolution of protein synthesis in the RNA world required RNAs capable of catalysing this reaction. Ribozymes that aminoacylate RNA by using activated amino acids have been discovered through selection in vitro(1-5). Flexizyme is a 45- nucleotide ribozyme capable of charging tRNA in trans with various activated L- phenylalanine derivatives. In addition to a more than 10(5) rate enhancement and more than 10(4)-fold discrimination against some non- cognate amino acids, this ribozyme achieves good regioselectivity: of all the hydroxyl groups of a tRNA, it exclusively aminoacylates the terminal 3'-OH5-7. Here we report the 2.8-angstrom resolution structure of flexizyme fused to a substrate RNA. Together with randomization of ribozyme core residues and reselection, this structure shows that very few nucleotides are needed for the aminoacylation of specific tRNAs. Although it primarily recognizes tRNA through base- pairing with the CCA terminus of the tRNA molecule, flexizyme makes numerous local interactions to position the acceptor end of tRNA precisely. A comparison of two crystallographically independent flexizyme conformations, only one of which appears capable of binding activated phenylalanine, suggests that this ribozyme may achieve enhanced specificity by coupling active- site folding to tRNA docking. Such a mechanism would be reminiscent of the mutually induced fit of tRNA and protein employed by some aminoacyl- tRNA synthetases(8,9) to increase specificity.	[Xiao, Hong; Ferre-D'Amare, Adrian R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Murakami, Hiroshi; Suga, Hiroaki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Suga, Hiroaki] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo 1138656, Japan	Fred Hutchinson Cancer Center; University of Tokyo; University of Tokyo	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org						BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; ILLANGASEKARE M, 1995, SCIENCE, V267, P643, DOI 10.1126/science.7530860; Illangasekare M, 1999, P NATL ACAD SCI USA, V96, P5470, DOI 10.1073/pnas.96.10.5470; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Lee N, 2000, NAT STRUCT BIOL, V7, P28; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moulinier L, 2001, EMBO J, V20, P5290, DOI 10.1093/emboj/20.18.5290; Murakami H, 2003, CHEM BIOL, V10, P655, DOI 10.1016/S1074-5521(03)00145-5; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; ORGEL LE, 1989, J MOL EVOL, V29, P465, DOI 10.1007/BF02602917; Perona JJ, 2007, BIOCHEMISTRY-US, V46, P10419, DOI 10.1021/bi7014647; Ramaswamy K, 2004, J AM CHEM SOC, V126, P11454, DOI 10.1021/ja046843y; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Rupert Peter B, 2004, Methods Mol Biol, V252, P303; Saenger W., 1984, PRINCIPLES NUCL ACID; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Saito H, 2002, NUCLEIC ACIDS RES, V30, P5151, DOI 10.1093/nar/gkf641; Saito H, 2001, RNA, V7, P1867; Saito H, 2001, J AM CHEM SOC, V123, P7178, DOI 10.1021/ja015756s; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Serganov A, 2005, NAT STRUCT MOL BIOL, V12, P218, DOI 10.1038/nsmb906; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; WONG JTF, 1991, ORIGINS LIFE EVOL B, V21, P165, DOI 10.1007/BF01809445	36	102	105	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2008	454	7202					358	U60		10.1038/nature07033	http://dx.doi.org/10.1038/nature07033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18548004				2022-12-24	WOS:000257665300044
J	Ben-Zvi, D; Shilo, BZ; Fainsod, A; Barkai, N				Ben-Zvi, Danny; Shilo, Ben-Zion; Fainsod, Abraham; Barkai, Naama			Scaling of the BMP activation gradient in Xenopus embryos	NATURE			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; DROSOPHILA EMBRYO; TWISTED GASTRULATION; SPEMANN ORGANIZER; NEURAL INDUCTION; AMPHIBIAN EMBRYOS; VENTRAL MESODERM; MARGINAL ZONE; CHORDIN; ANTAGONIST	In groundbreaking experiments, Hans Spemann demonstrated that the dorsal part of the amphibian embryo can generate a well- proportioned tadpole, and that a small group of dorsal cells, the 'organizer', can induce a complete and well- proportioned twinned axis when transplanted into a host embryo. Key to organizer function is the localized secretion of inhibitors of bone morphogenetic protein ( BMP), which defines a graded BMP activation profile. Although the central proteins involved in shaping this gradient are well characterized, their integrated function, and in particular how pattern scales with size, is not understood. Here we present evidence that in Xenopus, the BMP activity gradient is defined by a 'shuttling- based' mechanism, whereby the BMP ligands are translocated ventrally through their association with the BMP inhibitor Chordin. This shuttling, with feedback repression of the BMP ligand Admp, offers a quantitative explanation to Spemann's observations, and accounts naturally for the scaling of embryo pattern with its size.	[Ben-Zvi, Danny; Shilo, Ben-Zion; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Fainsod, Abraham] Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Fac Med, IL-91120 Jerusalem, Israel; [Barkai, Naama] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	fainsod@cc.huji.ac.il; Naama.barkai@weizmann.ac.il	Fainsod, Abraham/AAE-5633-2019	Shilo, Ben Zion/0000-0003-4903-8889; Fainsod, Abraham/0000-0002-6368-0416; Ben-Zvi, Danny/0000-0002-8697-9744				Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; COOKE J, 1981, NATURE, V290, P775, DOI 10.1038/290775a0; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fagotto F, 1997, DEVELOPMENT, V124, P453; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; Ferguson EL, 1996, CURR OPIN GENET DEV, V6, P424, DOI 10.1016/S0959-437X(96)80063-3; FRANCOIS V, 1995, CELL, V80, P19, DOI 10.1016/0092-8674(95)90446-8; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; HARLAND RM, 1994, CURR OPIN GENET DEV, V4, P543, DOI 10.1016/0959-437X(94)90070-J; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Moos M, 1995, DEVELOPMENT, V121, P4293; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Salic AN, 1997, DEVELOPMENT, V124, P4739; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Spemann H., 1938, EMBRYONIC DEV INDUCT; Spemann Hans., 1924, ROUXS ARCH ENTW MECH, V100, P599, DOI 10.1007/BF02108133; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; ZernickaGoetz M, 1996, DEVELOPMENT, V122, P3719	49	187	188	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1205	U22		10.1038/nature07059	http://dx.doi.org/10.1038/nature07059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18580943				2022-12-24	WOS:000257075800035
J	Kanan, MW; Nocera, DG				Kanan, Matthew W.; Nocera, Daniel G.			In situ formation of an oxygen-evolving catalyst in neutral water containing phosphate and Co2+	SCIENCE			English	Article							COUPLED ELECTRON-TRANSFER; PHOTOSYSTEM-II; SOLAR-ENERGY; OXIDATION; ARCHITECTURE; PHOTOSYNTHESIS; MECHANISMS	The utilization of solar energy on a large scale requires its storage. In natural photosynthesis, energy from sunlight is used to rearrange the bonds of water to oxygen and hydrogen equivalents. The realization of artificial systems that perform "water splitting" requires catalysts that produce oxygen from water without the need for excessive driving potentials. Here we report such a catalyst that forms upon the oxidative polarization of an inert indium tin oxide electrode in phosphate- buffered water containing cobalt (II) ions. A variety of analytical techniques indicates the presence of phosphate in an approximate 1: 2 ratio with cobalt in this material. The pH dependence of the catalytic activity also implicates the hydrogen phosphate ion as the proton acceptor in the oxygen- producing reaction. This catalyst not only forms in situ from earth- abundant materials but also operates in neutral water under ambient conditions.	[Kanan, Matthew W.; Nocera, Daniel G.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Nocera, DG (corresponding author), MIT, Dept Chem, 6-335, Cambridge, MA 02139 USA.	nocera@mit.edu			NSF Chemical Bonding Center [CHE- 0802907]; Ruth L. Kirchenstein National Research Service Award; NIH [F32GM07782903]	NSF Chemical Bonding Center(National Science Foundation (NSF)); Ruth L. Kirchenstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NSF Chemical Bonding Center ( CHE- 0802907). M. W. K. is supported by a Ruth L. Kirchenstein National Research Service Award postdoctoral fellowship provided by NIH ( F32GM07782903). We thank E. Shaw for obtaining XPS spectra, G. Henoch for providing the videos in the supporting online material, and Y. Surendranath for many productive discussions.	Barber J, 2007, PHILOS T R SOC A, V365, P1007, DOI 10.1098/rsta.2006.1962; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Betley TA, 2008, INORG CHEM, V47, P1849, DOI 10.1021/ic701972n; BOCKRIS JO, 1984, J ELECTROCHEM SOC, V131, P290, DOI 10.1149/1.2115565; Bomben K.D., 1992, HDB XRAY PHOTOELECTR; BRUNSCHWIG BS, 1983, J AM CHEM SOC, V105, P4832, DOI 10.1021/ja00352a050; CASEY WH, 1991, J COLLOID INTERF SCI, V146, P586, DOI 10.1016/0021-9797(91)90225-W; Chang CJ, 2004, J AM CHEM SOC, V126, P10013, DOI 10.1021/ja049115j; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Eisenberg R, 2008, INORG CHEM, V47, P1697, DOI 10.1021/ic800155g; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Irebo T, 2007, J AM CHEM SOC, V129, P15462, DOI 10.1021/ja073012u; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; SHAFIROVICH VY, 1980, NOUV J CHIM, V4, P81; Tarasevich M. R., 1980, ELECTRODES CONDUCTIV; Trasatti S., 1994, ELECTROCHEMISTRY NOV; Yagi M, 2005, J PHYS CHEM B, V109, P21489, DOI 10.1021/jp0550208; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186	22	3392	3456	54	2466	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1072	1075		10.1126/science.1162018	http://dx.doi.org/10.1126/science.1162018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18669820				2022-12-24	WOS:000258594900035
J	Hao, LH; Sakurai, A; Watanabe, T; Sorensen, E; Nidom, CA; Newton, MA; Ahlquist, P; Kawaoka, Y				Hao, Linhui; Sakurai, Akira; Watanabe, Tokiko; Sorensen, Ericka; Nidom, Chairul A.; Newton, Michael A.; Ahlquist, Paul; Kawaoka, Yoshihiro			Drosophila RNAi screen identifies host genes important for influenza virus replication	NATURE			English	Article							CYTOCHROME-C-OXIDASE; MESSENGER-RNA; PROTEIN; EXPORT; APOPTOSIS; TARGETS	All viruses rely on host cell proteins and their associated mechanisms to complete the viral life cycle. Identifying the host molecules that participate in each step of virus replication could provide valuable new targets for antiviral therapy, but this goal may take several decades to achieve with conventional forward genetic screening methods and mammalian cell cultures. Here we describe a novel genome-wide RNA interference (RNAi) screen in Drosophila 1 that can be used to identify host genes important for influenza virus replication. After modifying influenza virus to allow infection of Drosophila cells and detection of influenza virus gene expression, we tested an RNAi library against 13,071 genes (90% of the Drosophila genome), identifying over 100 for which suppression in Drosophila cells significantly inhibited or stimulated reporter gene (Renilla luciferase) expression from an influenza-virus-derived vector. The relevance of these findings to influenza virus infection of mammalian cells is illustrated for a subset of the Drosophila genes identified; that is, for three implicated Drosophila genes, the corresponding human homologues ATP6V0D1, COX6A1 and NXF1 are shown to have key functions in the replication of H5N1 and H1N1 influenza A viruses, but not vesicular stomatitis virus or vaccinia virus, in human HEK 293 cells. Thus, we have demonstrated the feasibility of using genome-wide RNAi screens in Drosophila to identify previously unrecognized host proteins that are required for influenza virus replication. This could accelerate the development of new classes of antiviral drugs for chemoprophylaxis and treatment, which are urgently needed given the obstacles to rapid development of an effective vaccine against pandemic influenza and the probable emergence of strains resistant to available drugs.	[Sakurai, Akira; Watanabe, Tokiko; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Hao, Linhui; Sorensen, Ericka; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Hao, Linhui; Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Med Informat, Madison, WI 53706 USA; [Nidom, Chairul A.] Airlangga Univ, Fac Vet Med, Surabaya 60115, Indonesia; [Nidom, Chairul A.] Airlangga Univ, Collaborating Res Ctr Emerging & Reemerging Infec, Trop Dis Ctr, Surabaya 60115, Indonesia; [Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Kobe Univ, Grad Sch Med, Div Zoonosis, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Airlangga University; Airlangga University; University of Tokyo; University of Tokyo; Kobe University	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	ahlqust@wisc.edu; kawaokay@svm.vetmed.wisc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044386, R01AI069274, R01AI047446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035072, R01GM035072] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI044386-10, R01 AI069274-03, R01 AI047446-09, R01 AI047446, R01 AI044386, R01 AI069274] Funding Source: Medline; NIGMS NIH HHS [R01 GM035072, R01 GM035072-23, GM35072, R37 GM035072] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruce JW, 2005, J VIROL, V79, P12969, DOI 10.1128/JVI.79.20.12969-12978.2005; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Dave RS, 2006, VIROLOGY, V348, P489, DOI 10.1016/j.virol.2006.01.013; Dearolf CR, 1999, CELL MOL LIFE SCI, V55, P1578, DOI 10.1007/s000180050397; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; PEREZ L, 1994, J GEN VIROL, V75, P2595, DOI 10.1099/0022-1317-75-10-2595; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; WYERS F, 1980, J VIROL, V33, P411, DOI 10.1128/JVI.33.1.411-422.1980; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06	28	340	359	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 14	2008	454	7206					890	U46		10.1038/nature07151	http://dx.doi.org/10.1038/nature07151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18615016	Green Accepted, Bronze			2022-12-24	WOS:000258398600037
J	Pagliarini, DJ; Calvo, SE; Chang, B; Sheth, SA; Vafai, SB; Ong, SE; Walford, GA; Sugiana, C; Boneh, A; Chen, WK; Hill, DE; Vidal, M; Evans, JG; Thorburn, DR; Carr, SA; Mootha, VK				Pagliarini, David J.; Calvo, Sarah E.; Chang, Betty; Sheth, Sunil A.; Vafai, Scott B.; Ong, Shao-En; Walford, Geoffrey A.; Sugiana, Canny; Boneh, Avihu; Chen, William K.; Hill, David E.; Vidal, Marc; Evans, James G.; Thorburn, David R.; Carr, Steven A.; Mootha, Vamsi K.			A mitochondrial protein compendium elucidates complex I disease biology	CELL			English	Article							SUBCELLULAR-LOCALIZATION; GENOME; MOUSE; YEAST; SEQUENCE; DYSFUNCTION; EXPRESSION; EVOLUTION; SUBUNITS; MUSCLE	Mitochondria are complex organelles whose dysfunction underlies a broad spectrum of human diseases. Identifying all of the proteins resident in this organelle and understanding how they integrate into pathways represent major challenges in cell biology. Toward this goal, we performed mass spectrometry, GFP tagging, and machine learning to create a mitochondrial compendium of 1098 genes and their protein expression across 14 mouse tissues. We link poorly characterized proteins in this inventory to known mitochondrial pathways by virtue of shared evolutionary history. Using this approach, we predict 19 proteins to be important for the function of complex I (CI) of the electron transport chain. Wevalidate a subset of these predictions using RNAi, including C8orf38, which we further show harbors an inherited mutation in a lethal, infantile CI deficiency. Our results have important implications for understanding CI function and pathogenesis and, more generally, illustrate how our compendium can serve as a foundation for systematic investigations of mitochondria.	[Pagliarini, David J.; Calvo, Sarah E.; Chang, Betty; Sheth, Sunil A.; Ong, Shao-En; Carr, Steven A.; Mootha, Vamsi K.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Pagliarini, David J.; Calvo, Sarah E.; Chang, Betty; Sheth, Sunil A.; Ong, Shao-En; Carr, Steven A.; Mootha, Vamsi K.] Harvard Univ, Cambridge, MA 02142 USA; [Pagliarini, David J.; Calvo, Sarah E.; Sheth, Sunil A.; Vafai, Scott B.; Walford, Geoffrey A.; Chen, William K.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Pagliarini, David J.; Calvo, Sarah E.; Sheth, Sunil A.; Vafai, Scott B.; Walford, Geoffrey A.; Chen, William K.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA; [Calvo, Sarah E.; Sheth, Sunil A.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sugiana, Canny; Boneh, Avihu; Thorburn, David R.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sugiana, Canny; Boneh, Avihu; Thorburn, David R.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Boneh, Avihu; Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, CCSB, Boston, MA 02115 USA; [Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Evans, James G.] Whitehead MIT Bioimaging Ctr, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Carr, SA (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	scarr@broad.mit.edu; vamsi@hms.harvard.edu	Carr, Steven A./AAH-8366-2019; Hill, David E/B-6617-2011; Thorburn, David R/G-6266-2013	thorburn, david/0000-0002-7725-9470; Pagliarini, David J./0000-0002-0001-0087	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK57521, P30 DK043351, DK43351, P30 DK057521] Funding Source: Medline; NIGMS NIH HHS [R01 GM077465, R01 GM077465-04, GM077465] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	43	1439	1477	2	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 11	2008	134	1					112	123		10.1016/j.cell.2008.06.016	http://dx.doi.org/10.1016/j.cell.2008.06.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	324IU	18614015	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000257513100018
J	Srinivasan, J; Kaplan, F; Ajredini, R; Zachariah, C; Alborn, HT; Teal, PEA; Malik, RU; Edison, AS; Sternberg, PW; Schroeder, FC				Srinivasan, Jagan; Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Alborn, Hans T.; Teal, Peter E. A.; Malik, Rabia U.; Edison, Arthur S.; Sternberg, Paul W.; Schroeder, Frank C.			A blend of small molecules regulates both mating and development in Caenorhabditis elegans	NATURE			English	Article							DAUER-INDUCING PHEROMONE; GENE; LONGEVITY; SEX	In many organisms, population- density sensing and sexual attraction rely on small- molecule- based signalling systems(1,2). In the nematode Caenorhabditis elegans, population density is monitored through specific glycosides of the dideoxysugar ascarylose ( the 'ascarosides') that promote entry into an alternative larval stage, the non- feeding and highly persistent dauer stage(3,4). In addition, adult C. elegans males are attracted to hermaphrodites by a previously unidentified small- molecule signal(5,6). Here we show, by means of combinatorial activity- guided fractionation of the C. elegans metabolome, that the mating signal consists of a synergistic blend of three dauer- inducing ascarosides, which we call ascr#2, ascr#3 and ascr#4. This blend of ascarosides acts as a potent male attractant at very low concentrations, whereas at the higher concentrations required for dauer formation the compounds no longer attract males and instead deter hermaphrodites. The ascarosides ascr#2 and ascr# 3 carry different, but overlapping, information, as ascr# 3 is more potent as a male attractant than ascr#2 , whereas ascr# 2 is slightly more potent than ascr# 3 in promoting dauer formation(7). We demonstrate that ascr# 2, ascr# 3 and ascr# 4 are strongly synergistic, and that two types of neuron, the amphid single- ciliated sensory neuron type K ( ASK) and the male- specific cephalic companion neuron ( CEM), are required for male attraction by ascr#3. On the basis of these results, male attraction and dauer formation in C. elegans appear as alternative behavioural responses to a common set of signalling molecules. The ascaroside signalling system thus connects reproductive and developmental pathways and represents a unique example of structure- and concentration-dependent differential activity of signalling molecules.	[Srinivasan, Jagan; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Srinivasan, Jagan; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Edison, Arthur S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Edison, Arthur S.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Kaplan, Fatma; Ajredini, Ramadan; Zachariah, Cherian; Edison, Arthur S.] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL 32610 USA; [Alborn, Hans T.; Teal, Peter E. A.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32604 USA; [Malik, Rabia U.; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	art@mbi.ufl.edu; pws@caltech.edu; fs31@cornell.edu	Srinivasan, Jagan/B-6215-2015; Kaplan, Fatma/AAJ-7666-2020; Schroeder, Frank/H-5026-2012	Kaplan, Fatma/0000-0002-9565-0211; Edison, Arthur/0000-0002-5686-2350; Srinivasan, Jagan/0000-0001-5449-7938; Sternberg, Paul/0000-0002-7699-0173; Schroeder, Frank/0000-0002-4420-0237	Human Frontiers Science Program; US National Institutes of Health [P41 GM079571]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079571] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Human Frontiers Science Program (A.S.E., P.W.S. and P.E.A.T.), a US National Institutes of Health grant (P41 GM079571) to F. C. S., and the Howard Hughes Medical Institute, of which J. S. is an associate and P. W. S. an investigator. NMR data were collected in the UF-AMRIS facility; we thank J. Rocca for assistance. We thank E. Peden and D. Xue for the ceh-30 strains, C. J. Cronin and A. Choe for advice on behavioural assays, L. R. Baugh for liquid-culture dauer formation assays, B. Fox for assistance with the synthesis of ascr#2, ascr#3 and ascr#4, and M. de Bono, A. Dossey and M. Stadler for discussions. E. Hallem, J. Bungert and D. Hutchinson provided comments on the manuscript.	Bae YK, 2006, DEVELOPMENT, V133, P3859, DOI 10.1242/dev.02555; Brey WW, 2006, J MAGN RESON, V179, P290, DOI 10.1016/j.jmr.2005.12.008; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; CARDE RT, 1984, FIELD TRAPPING ATTRA, P111; Chasnov JR, 2007, P NATL ACAD SCI USA, V104, P6730, DOI 10.1073/pnas.0608050104; Collet J, 1998, GENETICS, V148, P187; CRONIN CJ, 2005, BMC GENET, V6; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Tissenbaum HA, 1998, GENETICS, V148, P703; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Zwaal RR, 1997, GENETICS, V145, P715	23	257	276	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1115	U46		10.1038/nature07168	http://dx.doi.org/10.1038/nature07168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	341MW	18650807	Green Accepted			2022-12-24	WOS:000258719600037
J	Tang, WQ; Kim, TW; Oses-Prieto, JA; Sun, Y; Deng, ZP; Zhu, SW; Wang, RJ; Burlingame, AL; Wang, ZY				Tang, Wenqiang; Kim, Tae-Wuk; Oses-Prieto, Juan A.; Sun, Yu; Deng, Zhiping; Zhu, Shengwei; Wang, Ruiju; Burlingame, Alma L.; Wang, Zhi-Yong			BSKs mediate signal transduction from the receptor kinase BRI1 in Arabidopsis	SCIENCE			English	Article							PLASMA-MEMBRANE; BAK1; GROWTH; MECHANISMS; PROTEOMICS; REGULATOR; PLANTS; BZR1	Brassinosteroids ( BRs) bind to the extracellular domain of the receptor kinase BRI1 to activate a signal transduction cascade that regulates nuclear gene expression and plant development. Many components of the BR signaling pathway have been identified and studied in detail. However, the substrate of BRI1 kinase that transduces the signal to downstream components remains unknown. Proteomic studies of plasma membrane proteins lead to the identification of three homologous BR- signaling kinases ( BSK1, BSK2, and BSK3). The BSKs are phosphorylated by BRI1 in vitro and interact with BRI1 in vivo. Genetic and transgenic studies demonstrate that the BSKs represent a small family of kinases that activate BR signaling downstream of BRI1. These results demonstrate that BSKs are the substrates of BRI1 kinase that activate downstream BR signal transduction.	[Tang, Wenqiang; Kim, Tae-Wuk; Sun, Yu; Deng, Zhiping; Zhu, Shengwei; Wang, Ruiju; Wang, Zhi-Yong] Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; [Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Zhu, Shengwei] Chinese Acad Sci, Key Lab Photosynth & Environm Mol Biol, Inst Bot, Beijing 100093, Peoples R China; [Wang, Ruiju] Nankai Univ, Inst Mol Biol, Coll Life Sci, Tianjin 300071, Peoples R China	Carnegie Institution for Science; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Botany, CAS; Nankai University	Wang, ZY (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Oses-Prieto, Juan/0000-0003-4759-2341; Tang, Wenqiang/0000-0002-2972-5748; Deng, zhiping/0000-0001-9663-3088	NCRR NIH HHS [RR01614, RR019934, RR012961] Funding Source: Medline; NIGMS NIH HHS [R01 GM066258-07, R01 GM066258, R01GM066258] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012961, S10RR019934, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Deng ZP, 2007, MOL CELL PROTEOMICS, V6, P2058, DOI 10.1074/mcp.M700123-MCP200; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Johnson KL, 2005, CURR OPIN PLANT BIOL, V8, P648, DOI 10.1016/j.pbi.2005.09.007; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044	24	444	487	11	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2008	321	5888					557	560		10.1126/science.1156973	http://dx.doi.org/10.1126/science.1156973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329RS	18653891	Green Accepted			2022-12-24	WOS:000257888900046
J	Berger, MF; Badis, G; Gehrke, AR; Talukder, S; Philippakis, AA; Pena-Castillo, L; Alleyne, TM; Mnaimneh, S; Botvinnik, OB; Chan, ET; Khalid, F; Zhang, W; Newburger, D; Jaeger, SA; Morris, QD; Bulyk, ML; Hughes, TR				Berger, Michael F.; Badis, Gwenael; Gehrke, Andrew R.; Talukder, Shaheynoor; Philippakis, Anthony A.; Pena-Castillo, Lourdes; Alleyne, Trevis M.; Mnaimneh, Sanie; Botvinnik, Olga B.; Chan, Esther T.; Khalid, Faiqua; Zhang, Wen; Newburger, Daniel; Jaeger, Savina A.; Morris, Quaid D.; Bulyk, Martha L.; Hughes, Timothy R.			Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences	CELL			English	Article							OPEN-ACCESS DATABASE; FUNCTIONAL SPECIFICITY; TRANSCRIPTION FACTORS; ANGSTROM RESOLUTION; STRUCTURAL BASIS; AMINO-ACID; IN-VIVO; RECOGNITION; HOX; PROTEIN	Most homeodomains are unique within a genome, yet many are highly conserved across vast evolutionary distances, implying strong selection on their precise DNA-binding specificities. We determined the binding preferences of the majority (168) of mouse homeodomains to all possible 8-base sequences, revealing rich and complex patterns of sequence specificity and showing that there are at least 65 distinct homeodomain DNA-binding activities. We developed a computational system that successfully predicts binding sites for homeodomain proteins as distant from mouse as Drosophila and C. elegans, and we infer full 8-mer binding profiles for the majority of known animal homeodomains. Our results provide an unprecedented level of resolution in the analysis of this simple domain structure and suggest that variation in sequence recognition may be a factor in its functional diversity and evolutionary success.	[Berger, Michael F.; Gehrke, Andrew R.; Philippakis, Anthony A.; Botvinnik, Olga B.; Newburger, Daniel; Jaeger, Savina A.; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pena-Castillo, Lourdes; Mnaimneh, Sanie; Khalid, Faiqua; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Badis, Gwenael; Talukder, Shaheynoor; Alleyne, Trevis M.; Chan, Esther T.; Zhang, Wen; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Botvinnik, Olga B.] MIT, Dept Math, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Bulyk, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu; t.hughes@utoronto.ca	Badis-Breard, Gwenael/AAE-3783-2019; Morris, Quaid/ABE-8343-2020	Pena Castillo, Lourdes/0000-0002-0643-2547; Badis-Breard, Gwenael/0000-0003-2078-3076; Morris, Quaid/0000-0002-2760-6999; Chan, Esther/0000-0002-2406-2623	NHGRI NIH HHS [R01 HG003985-01, R01 HG003985, R01 HG003985-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Banerjee-Basu S, 2003, NUCLEIC ACIDS RES, V31, P304, DOI 10.1093/nar/gkg118; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360; Galant R, 2002, DEVELOPMENT, V129, P3115; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liberzon A, 2004, NUCLEIC ACIDS RES, V32, P54, DOI 10.1093/nar/gkh156; LIN L, 1992, GENE DEV, V6, P1071, DOI 10.1101/gad.6.6.1071; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MAO CA, 1994, DEV BIOL, V165, P229, DOI 10.1006/dbio.1994.1249; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Miller JC, 2001, J MOL BIOL, V313, P309, DOI 10.1006/jmbi.2001.4975; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; PHILIPPAKIS AA, 2008, J COMPUT BI IN PRESS; Rajkovic A, 2002, GENOMICS, V79, P711, DOI 10.1006/geno.2002.6759; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; TREISMAN J, 1989, CELL, V59, P553; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; Wilson DS, 1999, NAT STRUCT BIOL, V6, P297, DOI 10.1038/7524; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3	49	443	450	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 27	2008	133	7					1266	1276		10.1016/j.cell.2008.05.024	http://dx.doi.org/10.1016/j.cell.2008.05.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319DP	18585359	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000257144600022
J	Green, M; Drife, JO				Green, Malcolm; Drife, James Owen			Are international medical conferences an outdated luxury the planet can't afford?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Green, Malcolm] Univ London Imperial Coll Sci Technol & Med, London SW8 2EF, England; [Drife, James Owen] Univ Leeds, Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Imperial College London; Leeds General Infirmary; University of Leeds	Green, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW8 2EF, England.	malcolm@malcolmgreen.net; j.o.drife@leeds.ac.uk							0	43	44	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 28	2008	336	7659					1466	1467		10.1136/bmj.a358	http://dx.doi.org/10.1136/bmj.a358			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324GN	18583676	Green Published			2022-12-24	WOS:000257505900031
